<SEC-DOCUMENT>0001493152-21-006659.txt : 20210324
<SEC-HEADER>0001493152-21-006659.hdr.sgml : 20210324
<ACCEPTANCE-DATETIME>20210323180059
ACCESSION NUMBER:		0001493152-21-006659
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		88
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210324
DATE AS OF CHANGE:		20210323

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Surna Inc.
		CENTRAL INDEX KEY:			0001482541
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE SERVICES [0700]
		IRS NUMBER:				273911608
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54286
		FILM NUMBER:		21765870

	BUSINESS ADDRESS:	
		STREET 1:		1780 55TH STREET, SUITE C
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
		BUSINESS PHONE:		303-993-5271

	MAIL ADDRESS:	
		STREET 1:		1780 55TH STREET, SUITE C
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>form10-k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
10-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[X]
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE FISCAL YEAR ENDED DECEMBER 31, 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>OR</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[&nbsp;&nbsp;]
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE TRANSITION PERIOD FROM ____ TO _______</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
File Number: 000-54286</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SURNA
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nevada</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>27-3911608</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                         or other jurisdiction of</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
        or organization)</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
                                         Employer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
        No.)</FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1780
    55<SUP>th </SUP>Street, Boulder, Colorado</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>80301</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(303)
993-5271</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&rsquo;s
telephone number, including area code)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Exchange Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
    of each class</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading
    Symbol(s)</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of each exchange on which registered</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Securities
registered pursuant to Section 12(g) of the Act: </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
of Each Class Registered</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 50%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT><B><FONT STYLE="font-family: Times New Roman, Times, Serif">Common
stock, par value $0.00001 per share</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>



<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. <B>Yes [&nbsp;&nbsp;]
No [X]</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. <B>Yes [&nbsp;&nbsp;]
No [X]</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during
the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the last 90 days. <B>Yes [X] No [&nbsp;&nbsp;]</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant
to Rule 405 of Regulation S-T (&sect; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit such files). <B>Yes [X] No [&nbsp;&nbsp;]</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &ldquo;large accelerated filer, &ldquo;accelerated filer,&rdquo;
&ldquo;non-accelerated filer,&rdquo; &ldquo;smaller reporting company,&rdquo; and &ldquo;emerging growth company&rdquo; in Rule
12b-2 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Large
    Accelerated Filer</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[&nbsp;&nbsp;]</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accelerated
    Filer</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[&nbsp;&nbsp;]</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-accelerated
    Filer</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[X]</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Smaller
    Reporting Company</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[X]</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Emerging
    Growth Company</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[&nbsp;&nbsp;]</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <B>[&nbsp;&nbsp;]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). <B>Yes [&nbsp;&nbsp;]
No [X]</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate market value of the voting and non-voting common stock held by non-affiliates of the registrant as of the last business
day of the registrant&rsquo;s most recently completed second fiscal quarter was approximately $7,090,000 based upon a closing
price of $0.03 reported for such date on the OTCMarkets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 23, 2021, the number of outstanding shares of common stock of the registrant was 236,526,638.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DOCUMENTS
INCORPORATED BY REFERENCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annual
Report on Form 10-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
Fiscal Year Ended December 31, 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Table
of Contents</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.6in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_001"><FONT STYLE="font-size: 10pt"><B>Part
    I</B></FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_002"><FONT STYLE="font-size: 10pt">Business</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1A.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_003"><FONT STYLE="font-size: 10pt">Risk
    Factors</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    1B.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_004"><FONT STYLE="font-size: 10pt">Unresolved
    Staff Comments</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_005"><FONT STYLE="font-size: 10pt">Properties</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_006"><FONT STYLE="font-size: 10pt">Legal
    Proceedings</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_007"><FONT STYLE="font-size: 10pt">Mine
    Safety Disclosures</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_008"><FONT STYLE="font-size: 10pt"><B>Part
    II</B></FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_032"><FONT STYLE="font-size: 10pt">Market
    for Registrant&rsquo;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities </FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_009"><FONT STYLE="font-size: 10pt">Selected
    Financial Data</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    7.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_010"><FONT STYLE="font-size: 10pt">Management&rsquo;s
    Discussion and Analysis of Financial Condition and Results of Operations</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    7A.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_011"><FONT STYLE="font-size: 10pt">Quantitative
    and Qualitative Disclosures About Market Risk </FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    8.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_012"><FONT STYLE="font-size: 10pt">Financial
    Statements and Supplementary Data</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_013"><FONT STYLE="font-size: 10pt">Changes
    in and Disagreements with Accountants on Accounting and Financial Disclosure</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9A.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_014"><FONT STYLE="font-size: 10pt">Controls
    and Procedures</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    9B.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_015"><FONT STYLE="font-size: 10pt">Other
    Information</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_016"><FONT STYLE="font-size: 10pt"><B>Part
    III</B></FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    10.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_017"><FONT STYLE="font-size: 10pt">Directors,
    Executive Officers and Corporate Governance</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    11.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_018"><FONT STYLE="font-size: 10pt">Executive
    Compensation</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    12.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_019"><FONT STYLE="font-size: 10pt">Security
    Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    13.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_020"><FONT STYLE="font-size: 10pt">Certain
    Relationships and Related Transactions, and Director Independence</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">54</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    14.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_021"><FONT STYLE="font-size: 10pt">Principal
    Accountant Fees and Services</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_022"><FONT STYLE="font-size: 10pt"><B>Part
    IV</B></FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Item
    15.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_023"><FONT STYLE="font-size: 10pt">Exhibits
    and Financial Statement Schedules</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Item
    16.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_024">Form
    10-K Summary</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">57</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_025"><FONT STYLE="font-size: 10pt">Signatures</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">58</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>In
this Annual Report, unless otherwise indicated, the &ldquo;Company&rdquo;, &ldquo;we&rdquo;, &ldquo;us&rdquo; or &ldquo;our&rdquo;
refer to Surna Inc. and, where appropriate, its wholly-owned subsidiary. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Hemp
and marijuana are technically both part of the &ldquo;Cannabis sativa L.&rdquo; plant. &ldquo;Hemp&rdquo; is a term used to classify
varieties of cannabis that contain 0.3% or less tetrahydrocannabinol (&ldquo;THC&rdquo;) content (by dry weight), the principal
psychoactive constituent of cannabis. Hemp and its derivatives were federally legalized in the United States as part the Agricultural
Act of 2018. &ldquo;Marijuana&rdquo; is a term used to classify varieties of cannabis that contain more than 0.3% THC (by dry
weight). Marijuana is not federally legal in the United States. Many states, however, have taken action to make marijuana legal
for all purposes, made it available for medical uses, decriminalized it or a combination thereof. We currently provide nearly
all of our products and services to customers that cultivate marijuana. In this Annual Report, unless otherwise indicated, &ldquo;cannabis&rdquo;
refers to &ldquo;marijuana.&rdquo; </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Although
our customers do, we neither grow, manufacture, distribute nor sell cannabis (marijuana) and hemp or any of their related products.
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CAUTIONARY
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annual Report on Form 10-K, including &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of
Operations&rdquo; in Item 7, contains forward-looking statements that involve substantial risks and uncertainties. These forward-looking
statements are not historical facts, but are based on current management expectations that involve substantial risks, uncertainties,
and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially
from those expressed in, or implied by, these forward-looking statements. Forward-looking statements relate to future events or
our future financial performance. We generally identify forward-looking statements by terminology such as &ldquo;may,&rdquo; &ldquo;will,&rdquo;
&ldquo;should,&rdquo; &ldquo;expects,&rdquo; &ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;could,&rdquo; &ldquo;intends,&rdquo;
&ldquo;target,&rdquo; &ldquo;projects,&rdquo; &ldquo;contemplates,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;predicts,&rdquo;
&ldquo;potential&rdquo; or &ldquo;continue&rdquo; or the negative of these terms or other similar words. All statements, other
than statements of historical fact, are statements that could be deemed forward-looking statements including, but not limited
to, any projections of revenue, gross profit, earnings or loss, tax provisions, cash flows or other financial items; any statements
of the plans, strategies or objectives of management for future operations; any statements regarding current or future macroeconomic
or industry-specific trends or events and the impact of those trends and events on us or our financial performance; any statements
regarding pending investigations, legal claims or tax disputes; any statements of expectation or belief; and any statements of
assumptions underlying any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that could cause
our actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry
results, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested
by, these forward-looking statements. These forward-looking statements are based on assumptions regarding our present and future
business strategies and the environment in which we operate. Important factors that could cause those differences include, but
are not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    business prospects and the prospects of our existing and prospective customers;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact on our business and that of our customers of the current and future response by the government and business to the
    COVID-19 pandemic, including what is necessary to protect our staff and the staff of our customers in the conduct of our business;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    overall impact of the COVID-19 pandemic on the business climate in our industry and the willingness of our customers to undertake
    projects in light of economic uncertainties;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    overall financial condition, including our reduced revenue and business disruption, due to the COVID-19 pandemic business
    and economic response and its consequences;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    inherent uncertainty of product development;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory,
    legislative and judicial developments, especially those related to changes in, and the enforcement of, cannabis laws;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">increasing
    competitive pressures in the CEA (Controlled Environment Agriculture) industry;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    ability to effectively operate our business, including servicing our existing customers and obtaining new business; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    relationships with our customers and suppliers;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    continuation of normal payment terms and conditions with our customers and suppliers, including our ability to obtain advance
    payments from our customers;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    economic conditions, our customers&rsquo; operations and access to capital, and market and business disruptions including
    severe weather conditions, natural disasters, health hazards, terrorist activities, financial crises, political crises or
    other major events, or the prospect of these events, adversely affecting demand for the products and services offered by us
    in the markets in which we operate;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in our business strategy or development plans, including our expected level of capital expenses and working capital;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to attract and retain qualified personnel;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to raise equity and debt capital to fund our operations and growth strategy, including possible acquisitions; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to identify, complete and integrate potential strategic acquisitions; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">future
    revenue being lower than expected; </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to convert our backlog into revenue in a timely manner, or at all; and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    intention not to pay dividends.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 4.5pt 0 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we believe that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could
prove to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In
light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this annual report on Form
10-K should not be regarded as a representation by us that our plans and objectives will be achieved. These risks and uncertainties
include those described or identified in &ldquo;Risk Factors&rdquo; in this Annual Report on Form 10-K. You should not place undue
reliance on these forward-looking statements, which apply only as of the date of this Annual Report on Form 10-K. Except as required
by the federal securities laws, we undertake no obligation to revise or update any forward-looking statements, whether as a result
of new information, future events or otherwise, to reflect events or circumstances occurring after the date of this Annual Report
on Form 10-K. The forward-looking statements and projections contained in this Annual Report on Form 10-K are excluded from the
safe harbor protection provided by Section 27A of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Non-GAAP
Financial Measures</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>To
supplement our financial results on U.S. generally accepted accounting principles (&ldquo;GAAP&rdquo;) basis, we use non-GAAP
measures including net bookings, backlog, as well as adjusted net income (loss) which reflects adjustments for certain non-cash
expenses such as stock-based compensation, certain debt-related items and depreciation expense. We believe these non-GAAP measures
are helpful in understanding our past performance and are intended to aid in evaluating our potential future results. The presentation
of these non-GAAP measures should be considered in addition to our GAAP results and are not intended to be considered in isolation
or as a substitute for financial information prepared or presented in accordance with GAAP. We believe these non-GAAP financial
measures reflect an additional way to view aspects of our operations that, when viewed with our GAAP results, provide a more complete
understanding of factors and trends affecting our business. For purposes of this Annual Report, (i) &ldquo;adjusted net income
(loss)&rdquo; and &ldquo;adjusted operating income (loss)&rdquo; mean GAAP net income (loss) and operating income (loss), respectively,
after adjustment for non-cash equity compensation expense, debt-related items and depreciation expense, and (ii) &ldquo;net bookings&rdquo;
means new sales contracts executed during the quarter for which we received an initial deposit, net of any adjustments including
cancellations and change orders during the quarter. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Our
backlog, remaining performance obligations and net bookings may not be indicative of future operating results, and our customers
may attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project
financing or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included
in the backlog or remaining performance obligations will actually generate revenues or when the actual revenues will be generated.
</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_001"></A>PART
I</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_002"></A>Item
1. Business </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (CEA) industry.
The CEA industry is one of the fastest-growing sectors of the United States&rsquo; economy. From leafy greens (kale, Swiss chard,
mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables and small fruits (such as
strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes and cannabis and hemp, some producers grow crops
indoors in response to market dynamics or as part of their preferred farming practice. In service of the CEA, our principal technologies
include: (i) liquid-based process cooling systems and other climate control systems, (ii) air handling equipment and systems,
(iii) a full-service engineering package for designing and engineering commercial scale thermodynamic systems specific to cultivation
facilities, and (iv) automation and control devices, systems and technologies used for environmental, lighting and climate control.
Our customers include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada as well as other international
locations. Customers are those growers building new facilities and those expanding or retrofitting existing facilities. Currently,
our revenue stream is derived primarily from supplying our products, services and technologies to commercial indoor facilities
ranging from several thousand to more than 100,000 square feet.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Headquartered
in Boulder, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers
that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and
local codes, permitting and regulatory requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
CEA facility operators are facing multiple headwinds of high energy costs, issues about water usage and waste materials, and,
in the case of cannabis growing, increasingly rigorous quality standards and declining cannabis prices. To be competitive, among
other things, our customers must develop innovative ways to meet the demands of their business and reduce energy costs, 90% of
which is typically related to their HVACD (50%) and lighting systems (40%). HVACD systems have historically been our focus. We
often have the advantage of early engagement with our customers at the pre-build and construction phases and the corresponding
opportunity to build longer-term relationships with our existing customers and their facilities. Going forward, our plan is to
leverage our existing customer relationships and attempt to sell them additional products and services, thereby becoming &ldquo;stickier&rdquo;
to our customers, in an effort to generate incremental revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have three core assets that we believe are important to our going-forward business strategy. First, we have multi-year relationships
with customers and others in the CEA industry, notably in the cannabis segment. Second, we have specialized engineering know-how
and experience gathered from designing environmental control systems for CEA cultivation facilities since 2016. Third, we have
a line of proprietary environmental control products, which we are in the process of expanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an integrated provider of MEP (mechanical, electrical, plumbing) engineering design, proprietary environmental control equipment,
and controls and automation offerings serving the CEA industry. Historically, nearly all of our customers have been in
the cannabis cultivation business. We believe our employees have more experience than most other MEP firms serving this industry.
Our customers engage us for their environmental and climate control systems because they want experts to design their facilities,
and they come to us because of our reputation. We leverage our reputation and know-how against the many local contractors and
MEP engineers who collectively constitute our largest competitors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
number of recent events have had an adverse impact on our operations and financial condition, including constraints on capital
availability for our customers and prospects who have commenced, or are contemplating, new and expanded CEA cultivation facilities
and the recent outbreak of COVID-19, a novel strain of coronavirus first identified in China, which has spread across the globe
including the U.S. Most recently, the response to this coronavirus by federal, state and local governments in the U.S. has resulted
in significant market and business disruptions across many industries and affecting businesses of all sizes. This pandemic has
also caused significant stock market volatility and further tightened capital access for most businesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of our common stock are traded on The OTC Markets under the ticker symbol &ldquo;SRNA.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Impact
of the COVID-19 Pandemic on Our Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of
our markets and disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales,
project implementation, operating margins, and working capital. As of the date of this filing, uncertainty continues to exist
concerning the magnitude and duration of the economic impact of the COVID-19 pandemic.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
response to the COVID-19 pandemic, in late March of 2020 the Company downsized operations to preserve cash resources, implementing
workforce reductions, reductions of salaried employee compensation (including all executives and the CEO) and reduction of hours
worked, cutting costs and focusing its operations on customer-centric sales and project management activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the receipt of loan funds in April 2020, the Company reinstated all staff who previously had been placed on furlough. Staff receiving
salaries of $100,000 per year or less were restored to their full salaries. All executives, including the CEO, had their compensation
reduced to the greater of $100,000 per year or 75% of their previous salary level. The Company re-engaged its staff so as to be
able to fulfill its current customer contracts and any new sales orders and to continue its marketing and selling efforts. Over
the course of the Summer 2020, the Company took further steps to adjust its work force by furloughing several employees, making
temporary hourly and salary reduction adjustments, and then, in late September 2020, in light of our then sales efforts, reinstating
continuing hourly employees to full-time status and restoring the salaries of continuing salaried employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the speed with which the COVID-19 pandemic developed and the resulting uncertainties, including the depth and duration of the
disruptions to customers and suppliers, its future effect on our business, on our results of operations, and on our financial
condition, we cannot predict the overall effect on our business over the longer term. Despite this uncertainty, we have undertaken
various plans to reduce costs so as to mitigate the impact of the COVID-19 pandemic to the best of our ability, although they
may not be sufficient in the long-run for us to avoid reduced sales, increased losses and reduced operating cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
to <I>Risk Factors</I>, included in Part II, Item 1A of this Annual Report on Form 10-K below, for further discussion of the possible
impact of the COVID-19 pandemic on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Growth Strategy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe there are several ways to grow a business: (i) increase the number of customers, (ii) increase the average revenue
per order, (iii) increase the frequency of orders, or (iv) expand the addressable market. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sell
    proverbial &ldquo;Chevys.&rdquo; In addition to &ldquo;Cadillac&rdquo; -level products, sell &ldquo;Chevy&rdquo; or equivalent
    products to satisfy a wider range of points along the demand curve. Anticipated result: Increase the number of customers</B>.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a sales and marketing program that generates many prospective customer relationships. However, our limited range of higher
cost products, mostly chilled water systems, reduces the number of customer prospects who can afford to buy from us. In 2018 we
started an aggressive effort to broaden our product and service offerings to provide a wider range of HVACD technical solutions
(see chart below). In 2018 we began to offer stamped mechanical plan sets and our first 4-pipe chilled water systems. In 2019
we broadened our engineering services to include full MEP (mechanical, electrical, and plumbing) design services. We also began
to offer our SentryIQ&reg; Controls System. And in 2020 we added new products to include: split system DX (direct expansion) with
integrated dehumidification, packaged DX systems with modulating hot gas reheat, heat recovery chiller/boiler for 4-pipe systems,
and our StrataAir&trade; &trade; racking airflow solution to address customer needs for multi-level cultivation facilities. These
various systems provide solutions to answer a broader range of technical and cost constraints, and we will continue to develop
and offer new solutions to our customers&rsquo; problems, so that a broader group of growers can take advantage of our engineering
expertise and capabilities. We believe these new products and services will increase our addressable market and increase sales,
further leveraging our investment in sales and marketing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
success of our product development initiative can be seen in the following table, which documents the number of commercial-scale
projects (over $100,000 sales) that have included one or more of our new products:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 40%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Percent
    using New Products</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 48%; font-weight: bold; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2018</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">35%</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">76%</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">100%</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 344px; width: 600px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sell
    proverbial &ldquo;steering wheels.&rdquo; Sell our customers the automated facilities control systems they need&mdash;directly.
    Anticipated result: Increase average order size.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Growing
live plants indoors in a controlled environment is a technically demanding business, and a failed crop can cost a grower significant
foregone revenue. We believe our licensed professional engineers are some of the industry&rsquo;s leading experts in the design
of such facilities, and we seek to extend that leadership into more advanced technology products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2019 we introduced our SentryIQ&reg; control system. If our climate control design and products are the proverbial car, then SentryIQ&reg;
is the proverbial steering wheel&mdash;one is needed to direct the car where to go. Before SentryIQ&reg; we had to send our customers
elsewhere for controls to regulate their cultivation environments, but we now have the ability to capture that revenue. To date,
we have signed thirteen contracts for controls systems with an aggregate value of approximately $1,700,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
next step down this technology and innovation road will be the eventual development of the equivalent of a self-driving car. Growers
will tell the control system what they want to achieve, and the system will sense the environment and direct the climate control
system to achieve the grower&rsquo;s goals. These systems will be able to integrate data analytics&mdash;and eventually deploy
artificial intelligence&mdash;to optimize multiple variables to maximize the grower&rsquo;s profits. While we are in the early
stages of development of these technology-driven systems, we believe it is important for us to become a player in this market
because it expands our addressable market for both sensors and software while offering the possibility of higher margins and recurring
revenue over time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Add
    more proverbial &ldquo;dealers.&rdquo; Engage in one or more strategic relationships with other technology leaders that serve
    our industry. Anticipated result: Increase the number of customers.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Strategic
relationships might include referral marketing agreements, selling through manufacturer&rsquo;s representative organizations,
co-development of unique integrated solutions with best-in-class partners, and acquisitions. To extend the automotive analogy,
engaging in these types of relationships is like adding more dealers to sell our products, at little cost to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
some of these strategic alliances are successful in driving top-line revenue for us and our partners, over time these relationships
could develop into more exclusive arrangements or evolve into possible acquisitions or a source of strategic capital for us. There
can be no assurance that we will be able to successfully execute any of these strategic initiatives. Efforts will be primarily
focused on working with new strategic partners to co-market each other&rsquo;s products and services and possibly jointly develop
new and improved products and services, as opposed to exclusively seeking acquisitions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Expand
    our addressable market</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #1F497D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
sales and marketing efforts have historically been oriented towards the cannabis-cultivation segment of the CEA industry. The
non-cannabis CEA industry is growing as well, and we believe our products and services can address that market either as currently
engineered or with minimal modification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #1F497D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surna&rsquo;s
core and historic expertise and products center on providing mechanical engineering for environmental controls for indoor growing
facilities. We believe that our demonstrated expertise and experience positions us to expand our product and service offerings
vertically, to include integrating many of the technologies and services required to build and operate a CEA cultivation facility,
such as space programming and facility layout in addition to the MEP engineering we do today. In addition, we believe we can expand
our product offerings to include the selection, integration, and provision of lighting, benching, irrigation and fertigation equipment
and add-on maintenance and other recurring revenue services to operating facilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; color: #1F497D"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
                                         Key Initiatives</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
strategic business plan has four primary objectives:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Achieve continued
    organic sales growth by broadening and vertically integrating our product and service offerings.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grow revenue
    and profitability by engaging in selective strategic relationships and acquisitions.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operate the business
    with disciplined financial management and become financially self-sustaining</FONT>.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seek uplisting
    to a national securities exchange at a propitious moment</FONT>.</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
goal for the immediate future is to grow organically, strategically and profitably within the CEA industry. We will
also consider acquisitions of complementary businesses both within and potentially outside of the CEA industry. We
believe the worldwide CEA market will grow substantially for the foreseeable future, and that this will lead to more new build,
retrofit and expansion projects to drive our continued growth. Here are some of the initiatives we pursued in 2020, and where
more work is needed to progress each of them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Focus
on Multi-facility Operators</I></B>. We actively pursue business from multi-facility operators (MFOs), which we define as businesses
that own and operate two or more CEA cultivation facilities in either the U.S. or Canada. These MFOs are typically larger and
have greater financial and organizational wherewithal to buy more and larger systems and are less prone to project delays and
cancellations, compared to the smaller (and riskier) independent cultivators that had been our primary customers in the past.
In 2020 we booked three projects totaling $3.5 million. We recorded $2.9 million in revenue from these projects, or 35% of our
total 2020 revenue. Going forward, we will conduct our operations to seek a sales pipeline with MFO customers that we believe
will result in more consistent and predictable revenue and cash flow. Because MFOs are typically more sophisticated and may, in
many cases, have in-house engineering teams, such MFOs may not need the engineering expertise and experience we offer. This contrasts
with the independent smaller grower market that places significant value in our overall expertise and experience, including our
specific CEA related growing knowledge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below shows our 2020 full year results for commercial-scale projects, which we define as contracts with a value over $100,000,
by project and customer type.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="form10-k_002.jpg" ALT="" STYLE="height: 450px; width: 670px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
achieve profitability in the future, we must first be able to generate a more consistent and predictable revenue stream. To do
so, we must: (i) maximize our new build facility projects, and (ii) supplement those projects with an increased number of retrofit
and expansion projects&mdash;which typically have shorter completion cycles and fewer external contingencies that we do not control.
Historically, whenever a new build project has been delayed or cancelled, which can occur often, our revenue and cash flow has
taken a corresponding dramatic hit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Offer
a Broader Range of Products and Services Across the Cultivation Facility Lifecycle</I></B><I>. </I>During 2019, we fulfilled the
first step of this goal with the introduction of our SentryIQ&reg; controls package. We also began offering full mechanical, electrical,
and plumbing engineering services, developed and sold a four-pipe, chilled water environmental control system with Surna branded
fan coil units and custom air handlers, developed a proprietary destratification fan, and performed facility retrofit services.
Our new custom air handlers alone generated $2.3 million in revenue in 2019, and another $516,000 in 2020. In 2020 we continued
this effort by introducing several new DX-based packaged products (EnviroPro&trade;) and our StrataAir&trade; air distribution
product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
up on our product launch successes in 2019 and 2020, we plan to address facility lifecycle revenue opportunities by leveraging
our strong brand name and positioning ourselves as the &ldquo;trusted advisor&rdquo; in environmental controls management. In
addition, we will begin to offer recurring-revenue services for facility monitoring and preventive maintenance services. Our expanded
product offering is illustrated by the following 4-phase matrix of product/service depth and facility lifecycle participation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I><IMG SRC="image_003.jpg" ALT="" STYLE="height: 418px; width: 670px">&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
attempt to become &ldquo;stickier&rdquo; to our customers by providing climate control products and services across the entire
4-phase facility lifecycle. Each phase of the facility lifecycle has many activities that present potential opportunities for
us. We do not intend to offer products and services in all activities in each phase, but rather we will focus on technology and
innovation that provide value-add to our customers as they attempt to seek out &ldquo;best-in-class&rdquo; partners to automate
and control the indoor grow facilities of the future. We believe, if successful, this could possibly translate into greater demand
for our proprietary, customized equipment, technology and software solutions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Enter
Strategic Alliances to Expand our Marketing and Sales Reach.</I></B> We have identified several business verticals that we believe
are logical and natural complements to our climate control business, such as: lighting, fertigation (automated process of delivering
nutrients and water to plants), benches (customized systems to optimize use of the growing space), cultivation management technology
(software), consumables (growing, packaging, facility and lab supplies), and operational improvement analytics (modeling, data
aggregation and artificial intelligence). We will also consider strategic alliances, such as distribution, reseller, co-marketing
or product development agreements, with select companies which are consistent with our strategic direction. Our strategic alliances
will likely involve development of more comprehensive, end-to-end, integrated solutions for our customers, as well as specialized
products and services that help cultivators compete in the market, whether through automation, software or operating efficiencies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 171px; width: 380px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
some of these strategic alliances are successful in driving top-line revenue for us and our partners, over time these relationships
could develop into more exclusive arrangements or evolve into possible acquisitions or a source of strategic capital for us. There
can be no assurance that we will be able to successfully execute any of these strategic initiatives. Efforts will be primarily
focused on working with new strategic partners to co-market each other&rsquo;s products and services and possibly jointly develop
new and improved products and services for the CEA industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cash
and Dilution</I>.</B> We started 2020 with just over $922,000 in cash but with a new discipline on cost control and increased
bookings in the second half of the year we were able to increase our cash to $2,285,000 at the end of 2020. In 2019 and 2020 we
used operating cash flows and loan proceeds to support our operations and did not engage in any dilutive financing. In 2020, we
exercised strict financial discipline to weather a dramatic drop in new projects in the first half of the year, largely due to
the Covid-19 pandemic response. We recovered in the second half. In the first two quarters of the year we had a major project
cancellation and fewer new project bookings. Our adjusted net loss in 2020 was $1,239,000 compared to an adjusted net income in
2019 of $92,000. Our adjusted net income (loss) is our GAAP net income (loss) after addback for our non-cash equity compensation
expenses, debt-related items and depreciation expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
working capital remains negative, which is a constant impediment to the overall viability of our business as planned, so we must
land more MFO and other contracts and we may have to raise capital again to fund our working capital needs and future growth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Investor
Relations</I>. </B>We previously had limited investor relations activities of any kind prior to 2019. In 2019 we began to attend
investor conferences and we engaged an Investor Relations firm. Due to the financial impact of the pandemic we terminated these
activities at the end of Q1 2020. Our goal remains to create an actively traded, widely held, and fully valued stock over time
and in concert with our achievement of consistent financial goals. We intend to resume Investor Relations activities as our finances
allow.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Products
and Services</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
now offer a broader range of products and services to the CEA market than the mechanical engineering and modular chilled water
systems we historically offered. This includes products and services targeting smaller indoor grow facilities and commercial-scale
facilities as well as sealed greenhouse, or hybrid, facilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Services:
Engineering and Design</U>.</B> We offer licensed professional mechanical, electrical and plumbing design and engineering services
to all customers, and those customers in the cannabis growing industry that are in cannabis-legal states and provinces. We believe
we have leading edge, sophisticated engineering capabilities, which we attempt to leverage with independent small growers as well
as MFOs that are building larger and more sophisticated commercial projects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Going
forward, we plan to: (i) emphasize our strong mechanical engineering team that includes an in-house staff of degreed engineers
including an experienced licensed professional engineer (PE), (ii) offer pre-construction energy modeling to help our customers
and enhance our sales closing rate, (iii) develop an engineering, design and audit services program for the expanding retrofit
market, which remediates existing grow facilities that suffer from sub-optimal performance, and (iv) potentially offer other facility
management programs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
technical experience and know-how in designing indoor cultivation facilities allow us to deliver to our customers practical solutions
to complicated problems in four primary areas: (i) precision climate and environmental controls, (ii) energy and water efficiency,
(iii) building code and permitting, and (iv) project management of construction of our products in the facility. Our engineering
design typically includes all mechanical components of a climate control system: cooling and heating, dehumidification, ventilation,
air sanitation and odor control. We provide load calculations, equipment specifications, and engineered systems drawings for both
the cultivation and comfort cooling portions of our customers&rsquo; facilities. We also have experience in, or knowledge of,
state and local permitting and code compliance for facilities in states and provinces where cannabis has been legalized for either
recreational or medical use or is expected to be legalized, and we provide stamped, engineered drawings in all states and provinces
where we operate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
competitive advantages are our experience and reputation. Since 2006 we have continuously improved our CEA facility design capabilities
which we believe distinguishes us from our competition. Our primary competitors include local heating, ventilation and air conditioning
(&ldquo;HVAC&rdquo;) contractors, traditional MEP engineering firms, and other CEA-focused design firms. CEA facilities present
a very difficult mechanical engineering challenge, and traditional mechanical engineers, without our experience, are typically
unfamiliar with the precise climate and air control requirements needed for such facilities. As important, they may be unable
to effectively navigate the local code and permitting rules which did not contemplate the special requirements of CEA facilities
when enacted. With our engineering design resources and experience, we are able to provide a code-compliant MEP plan set by collaborating
with local regulators and our customers to engineer creative solutions that not only meet the intent of the local codes but also
address concerns about the growing energy and resource usage of these facilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Energy
use is, and will increasingly become, a primary concern for regulators and indoor cultivators. Two states, Massachusetts and Illinois,
have already placed regulatory caps on energy density in indoor cultivation facilities and we expect this trend to continue. Energy
costs are frequently the second largest operating expense for a cultivation facility, after labor, with HVACD and lighting comprising
approximately 50% and 40%, respectively, of a facility&rsquo;s energy use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, licensed producers are adopting practices to maximize energy efficiency and thereby reduce operating costs, which will
become even more important as the industry matures and wholesale prices continue to decline. These practices include more efficient
uses of water, more efficient lighting (typically LED lighting), and renewable energy alternatives. Sealed greenhouses, or hybrid
facilities&mdash;which are insulated for energy efficiency and combine natural light with the use of artificial lights&mdash;also
provide a more economical way to grow agricultural products compared to warehouse type indoor production. But regardless of whether
an indoor or a hybrid facility is the grow venue, precise environmental controls are required to deliver consistent product quality
and yield. We are evaluating possible strategic relationships with providers that are seeking an environmental controls partner
for these specific facility applications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe the right solution for our cultivation customers must include: (i) precise temperature/humidity control; (ii) reduced
fungus, pollen, pesticide and insect contamination risk (&ldquo;bio-security&rdquo;); (iii) controlled regulatory compliance risk;
(iv) lower maintenance complexity, costs and downtime; and (v) energy and resource efficiency.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bio-security program uses a combination of a sealed facility and customized approaches to air sterilization to maintain facility
standards, while destroying harmful airborne microbes without the production of byproducts. Additionally, our ductless modular
chilled water systems&mdash;using fan coil units within each grow room&mdash;isolate the air and potential contaminants within
each room, while taking advantage of the energy efficiencies and redundancies offered by such systems. Our experience has shown
that our precision environmental controls can reduce the reliance on the use of harmful pesticides and fungicides. We also believe
our experience in the tightly regulated Canadian market where pharmaceutical-like standards (including Good Manufacturing Practice
standards) exist for filtration, air quality and post-harvest plant quality gives us an advantage over our competitors, especially
as product quality testing regulations continue to be enacted and made more stringent by state, provincial and local agencies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following perspectives explain and help conceptualize the complexity of the environmental controls systems that need to be deployed
by indoor cultivators:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.15in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Lighting</U>.
    Lighting demand is 70 times more energy intensive than commercial office buildings. This lighting intensity creates heat,
    which when combined with plant transpiration to create humidity, creates the need for dehumidification and corresponding additional
    energy demand. Further complicating matters, lighting schedules and density must be adjusted for the clone, vegetative and
    flowering stages of cultivation, and associated variances in watering rates and temperature and humidity targets. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>HVACD</U>.
    HVACD energy use is driven by the need to remove the heat emitted from lighting and the moisture released during the plant&rsquo;s
    evapotranspiration process, coupled with air circulation and odor and contaminant filtration requirements.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Legacy
    Systems</U>. Mechanical systems are often designed and/or installed poorly, which can increase energy consumption and inconsistencies
    in environmental conditions. Reasons include: (i) cultivators deploying HVACD systems without an understanding of how the
    HVACD system impacts the growing environment, (ii) cultivators failing to understand the criticality of proper installation,
    commissioning and servicing of the equipment, even if properly designed, (iii) HVACD systems selected without understanding
    the interrelationship between sensible (cooling) and latent (moisture) factors, and (iv) most HVACD systems are designed for
    human occupied spaces, not process loads to accommodate plants.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
technologies and applications, coupled with emerging cultivation innovations, are providing opportunities for increased efficiency,
which we are positioned to deliver to our customers. Our engineering and product development teams, which currently consist of
seven people, are fully qualified and committed to delivering energy and resource efficient solutions to commercial cultivators.
Leveraging their technical competence, and our customers&rsquo; increasing focus on energy efficiency, quality and yield, in the
future we intend to offer retrofit/design, energy audit, energy efficiency improvement, performance audit, and preventive maintenance
services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Products:
Environmental Control Systems</U></B><I>. </I>We offer, in addition to modular chilled water systems, other HVACD solutions, such
as custom air handling units, split systems, packaged roof-top units, and self-contained and complex water chilled systems. During
2019, we launched upgraded equipment lines of fan coils and air handlers. In 2020 we introduced our first DX-based packaged systems.
This expanded product line will allow us in the future to offer less expensive products that can help us serve customers who have
tighter budget constraints.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are now offering various configurations of our new Surna-branded fan coil units, which provide greater efficiency, design flexibility
and control for growers using modular chilled water systems. We are capable of offering a utility rebate consulting service to
help our new build customers obtain utility rebates. While this service is not expected to generate significant revenue, it should
help us sell our environmental controls systems because our customers will be able to use these rebates to offset some of their
capital costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that we will be able to successfully execute any of these product initiatives, or identify, test and develop
improved products or services, or that such products or services will generate revenue or profitability at the levels we expect.
We also intend to work with select &ldquo;best-in-class&rdquo; vendors and partners that may be interested in jointly developing
and marketing new and improved products and services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Technology:
Sensors, Controls and Automation Business</U></B>. One of our key initiatives for 2019 was the development of a branded, proprietary
controls and monitoring offering (consisting of sensors, controllers, software, monitoring and a user interface). We accomplished
this and launched in April 2019 our SentryIQ&reg; sensors, controls and automation (&ldquo;SCA&rdquo;) platform&mdash;a turnkey,
single-vendor HVACD equipment and controls integration solution to new build projects as well as existing facilities in the startup
and operation phases. We continued the rollout of SentryIQ&reg; and to date we have entered into thirteen contracts with twelve
different companies to implement our SentryIQ&reg; SCA platform. This product line is important for tactical and strategic reasons,
and we hope to offer this as a standalone offering in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cultivation
facilities must have SCA to operate their HVACD equipment. In simple form, SCA is the thermostat in the room, with the occupant
selecting the desired temperature set point, the wall thermostat (Sensor) detecting the actual temperature, and when the space
temperature deviates from the desired set point the thermostat (Control) commands the furnace or air-conditioner to supply heated
or cooled air to bring the room temperature back to the set point. In the case of the indoor cultivation facilities, there are
more environmental conditions to monitor and control (such as temperature, relative humidity, CO<SUB>2</SUB>, lighting, vapor
pressure deficit status, and more) than in a typical residential home.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indoor
CEA growers also need to vary and tightly control environmental conditions depending on the stage of plant growth (i.e., clone,
vegetative and flowering stages), the time of day, and the plant genetics. In a cultivation facility the desired conditions change
many times during the plant&rsquo;s growth cycle and even within a day, and this is most easily accomplished with a programmable
environmental control system (automation), not unlike a simple programmable thermostat in a home.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
SentryIQ&reg; SCA package includes precision sensors to measure temperature, humidity, and CO<SUB>2</SUB> levels&mdash;more accurately
than typical HVACD sensors and within tighter tolerance levels. Our controllers are purpose-built computers programmed by us to
ensure our industrial environmental control equipment follows the engineered sequences of operation to obtain desired set-points.
Our sensors connect to our branded controllers through wires installed in the facility, and similarly they are wired to our HVACD
equipment (e.g., chillers, fan coils and dehumidifiers) to direct these pieces of equipment. The controllers also provide a user
interface on a screen so they can be easily programmed and controlled to achieve the customer&rsquo;s environmental objectives,
and give the cultivator the ability to access this data and react to alerts remotely.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered this business to satisfy our customer&rsquo;s needs that we did not previously address and that historically was
provided by third-party controls contractors. Our entry into the SCA market helps both our customers&rsquo; and our businesses.
Our customers benefit because they are saved the extra work of finding and engaging a controls contractor, which allows them to
get their facility up and running more quickly by taking one decision off the table and thereby establishing a single point of
responsibility for controls implementation. We are also in a position to provide SCA because we know our proprietary equipment
better than anyone, thereby ensuring smooth integration with our equipment with no work scope shortcomings, what we refer to as
&ldquo;scope gap.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
a tactical perspective, with limited incremental selling costs, our current sales team can now offer our SCA package to nearly
every prospect since every cultivation facility should have SCA technology. We believe this technology value-added solution gives
us an opportunity to achieve incremental project revenue. Strategically, through our SCA package, we are also able to deepen our
long-term customer relationship by tethering us to the customer through a controls interface (dashboard) to their facility. Future
development will allow our customer to use artificial intelligence (AI) by aggregating environment and growing data to optimize
energy use, operating efficiency, and product quality and yield. While there are several other total controls systems providers,
we believe that our industry know-how, experience and reputation with climate control environments gives us a compelling and competitive
SCA offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sales
and Marketing </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Multi-Facility
Operator (&ldquo;MFO&rdquo;) Focus</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
sales and marketing efforts will continue to focus on MFOs. However, we face multiple sources of competition in our attempt to
penetrate the MFO market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First,
    some companies with multiple CEA facilities have internal staffs with the requisite expertise to manage their environmental
    control needs, and who are able to access and engage vendors for both engineering services and equipment without external
    help. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second,
    some large, multi-state and multi-national engineering and construction firms, which have deep engineering and construction
    management experience and expertise, have entered or are entering the CEA market. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third,
    we compete with other CEA service providers, that like us promote their specific industry expertise and experience. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fourth,
    several larger, brand name HVACD equipment manufacturers are now pursuing the CEA market directly through their own sales
    forces.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe we can compete in the MFO market for the following reasons:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    believe that MFOs value the expertise we have gained from many years of designing environmental control systems for enclosed
    cultivation facilities since 2016 and our expansion into other engineered products and services. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlike
    the local and regional engineering firms operating in the market, we have the capability and experience to perform work across
    the U.S. and Canada, thereby matching the facilities footprint of our MFO prospects. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    believe that the MFOs value the range of experience and expertise that our personnel provide. Our professional staff has expertise
    covering the gamut, including commercial agriculture, engineering and facility design, HVACD technology, applications and
    controls, energy efficiency, and sustainability. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have deep networks with CEA cultivators, HVACD technical experts, AgTech experts, sustainability leaders, and agricultural
    resources that we can easily access and bring to bear for the benefit of our customers. </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">And
    finally, during 2019 and 2020 we did business with five MFOs, covering a total of ten projects with an average contract value
    of $1.3 million, providing important validation and enhancing our credibility in the eyes of other MFOs we are pursuing. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to develop relationships with, and obtain new business from, other MFOs will be critical to generating consistent revenues
quarter-over-quarter. During the first half of 2020, we experienced project delays and cancellations due to the Covid pandemic.
Fortunately, our bookings rebounded in the second half, and we finished the 2020 year with $8.4 million of backlogged projects.
Notwithstanding our efforts, there is no assurance that we will be successful in growing and maintaining our business with these
MFOs, especially in light of the uncertainty surrounding the potential impact of the coronavirus on our business and the business
of our customers and customer prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>New
Commercial-Scale Projects </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
demand for our environmental control systems is driven primarily by the construction of new CEA facilities in the U.S. and Canada.
As the CEA industry expands, the cannabis cultivation segment is, in turn, driven by changed legislation approving either medical
or recreational use. Recent regulatory changes involving medical and/or recreational cannabis use in various jurisdictions, such
as California, Michigan, Oklahoma, Utah, Missouri, Illinois and Canada, tend to be a leading indicator for the granting of licenses
for new facility construction. As more new cultivation facilities become licensed, we in turn have an expanded set of potential
customers that might buy our environmental control systems. However, since both medical and recreational cannabis use remains
prohibited under U.S. federal law, uncertainty continues and tends to unfavorably impact the development and financing of new
cultivation facilities in the U.S.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth our commercial-scale project bookings, which we define as contracts executed with a value over $100,000,
for which we received an initial deposit for the years 2016 through 2020. Based on the current economic climate and our downsizing
measures, there is no assurance that we will be able to continue to obtain the level of bookings that we had in the past.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="18" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of New Commercial-Scale Project Bookings</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2018</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2017</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2016</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 35%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">12</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">23</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">22</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">18</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">18</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
marketing efforts will be targeted at MFOs, smaller independent growers, design-build firms, architects working in the CEA industry,
investors and consulting firms operating in that space. We believe these represent the largest markets, based on the state and
local regulatory framework, for our products and services. We believe our marketing efforts will be curtailed for the foreseeable
future due to our efforts to preserve our cash resources as we deal with the uncertainty surrounding the coronavirus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Retrofit
Market</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Existing
commercial retrofit projects also represent a business opportunity in the CEA industry. The estimated 3,000+ existing cannabis
producing CEA facilities in North America are easier to identify than new build projects. We believe, based on evidence and our
market knowledge, that some of these exiting facilities are operating sub-optimally and have environmental control problems that
our products can help remediate. We also believe that the energy consumption of these facilities can be reduced, and we have commenced
developing services and products to help them realize savings. We have a full product and service offering in mind, but we expect
that the roll-out will take up to two years. To expedite this roll-out, we are evaluating possible strategic partners that could
add products and services that are an immediate value-add to our customers. These CEA facilities retrofit projects do not typically
carry the uncertainties associated with new build projects such as licensing, permitting and funding. In the future, we also will
potentially launch an internally developed facility assessment and analysis tool to assist existing facilities in solving their
environmental controls challenges.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>New
Build Facility Sales Cycle and Risks</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
sales cycles for our new build commercial projects can vary significantly. From pre-sales and technical advisory meetings to sales
contract execution, to engineering and design services and equipment delivery, and all the way through installation and commissioning
of the installed system, the full cycle can range from six months to two years. Since we do not install the climate control systems,
our customers are required to use third-party installation contractors, which adds to the variability of the sales cycle.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
length of our sales cycle for new facilities is driven by numerous factors including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    large number of first-time participants interested in the CEA business;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    complexities and uncertainties involved in obtaining state and local licensure and permitting for certain types of CEA cultivation
    facilities, including relating to energy use, water use, and the environmental impacts of waste;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">local
    and state government delays in approving licenses and permits due to lack of staff or the large number of pending applications,
    especially in states where there is no cap on the number of cultivators; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    customer&rsquo;s need to obtain CEA cultivation facility financing and legal issues related to the crops sought to be grown;
    </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility
    (to the stage where climate control systems can be installed);</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    large price tag and technical complexities of the climate control and air sanitation system; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">availability
    of power and the cost; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    that are typical in completing any commercial construction project.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the foregoing, there are risks that we may not realize the full contract value of our backlog in a timely manner,
or at all. The performance of our obligations under a sales contract, and the timing of our revenue recognition, is dependent
upon our customers&rsquo; ability to secure funding and real estate, obtain a license and then build their cultivation facility
so they can take possession of the equipment&mdash;each of which are outside of our control. More recently, as some of our new
construction facility projects have become larger and more complex, the likelihood of delays&mdash;due to licensing and permitting,
lack of or delay in funding, staged facility construction, and/or the shifting priorities of certain customers with multiple facility
projects in progress at one time&mdash;has increased.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to address these risks, the obligations under our sales contracts are generally allocated into the following types of deliverables,
and we typically require non-refundable payments from our customers in advance of our performance of services or delivery of equipment.
However, in certain situations, especially as we expand our products and services offering for a customer&rsquo;s entire facility
lifecycle, we may extend credit to our customers in which case we are at risk for the collection of account receivables.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Engineering
Services</U></B>. We provide our customers with engineering and design services and drawings. In many cases, the engineering phase
is done as part of the license application or building permit process and takes approximately six to eight weeks to complete.
Our strategy is to secure the sales contract and commence the engineering and design portion of the project early in the customer&rsquo;s
planning phase of the project. This is important for a number of reasons: (i) we can assist our customers with their engineering
and design plans as part of their licensing application process as well as better assure the customer has the right-sized equipment
for their application, leading to a higher probability of a successful grow, (ii) we are better positioned to utilize our proprietary
equipment for the project at an earlier stage, and (iii) we are able to help reduce a customer&rsquo;s time to market. Before
we commence the engineering phase of the project, we will generally require an advanced payment intended to cover the engineering
value of the contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Surna
Manufactured Equipment</U></B>. Upon completion of the engineering and design phase, it may take our customer on average six to
twelve months to complete the facility build-out, with possible delays due to financing or other aspects which are beyond
our control as discussed above. Customer delays in obtaining financing and completing facility build-out make the completion timing
of our sales contract unpredictable. For this reason, we require an additional advance payment before we begin manufacturing our
proprietary equipment items.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Third-Party
Manufactured Equipment</U></B>. The final phase of our contract typically involves the delivery of third-party manufactured equipment
items and other equipment to complete the project. We typically will not deliver until we receive a final advance payment for
the remaining contract value. After the project is completed and the environmental control system has been fully installed by
third-party installation contractors, we will deploy our technicians to the customer&rsquo;s cultivation facility to support the
start-up of the system. Start-up support involves testing that the equipment has been properly assembled and installed by the
installation contractor and assuring the equipment is operating within the agreed specifications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
the timing of the deliverables of our sales contracts, we have often experienced large variances in quarterly revenue. Our revenue
recognition is dependent upon shipment of the equipment portions of our sales contracts, which, in many cases, may be delayed
while our customers complete permitting, prepare their facilities for equipment installation or obtain project financing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Competition</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
environmental control systems and our related engineering and design services compete with various national and local HVACD contractors
and traditional HVACD equipment suppliers who traditionally resell, design, and implement climate control systems for commercial
and industrial facilities, most of whom do not have the specific knowledge that we have about the complexities and challenges
of CEA facilities. We have positioned ourselves to differ from these competitors by providing engineering and design services
and environmental control systems, across most major HVACD solutions, including modular chilled water systems, custom air handling
units, split systems, packaged roof-top units, and self-contained and complex chilled-water systems, each tailored specifically
for managing the distinct challenges involved in CEA facilities. We believe our industry-specific applications and experience
in the CEA market allow us to deliver the right solution to our cultivation customers. Unlike many of our competitors, our solutions
are designed specifically for cultivators to provide tight temperature/humidity control, reduce bio-security risk, reduce energy
requirements, and minimize maintenance complexity, costs and downtime. However, we are seeing more competitors enter into the
CEA market offering the same types and crop-specific climate control systems and engineering services that we offer. We believe
this increased competition may adversely impact our ability to obtain new facility projects from both MFOs and independent smaller
growers and could require us to accept lower gross margins on our projects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the cannabis segment of the CEA industry continues to mature and develop and legalization becomes more prevalent, we expect to
see more competition from agricultural product and service providers who seek to expand into this niche of the CEA market. Going
forward, we intend to expand our focus to include non-cannabis crops grown in controlled environments such as leafy greens (kale,
Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables and small fruits
(such as strawberries, blackberries and raspberries), bell peppers, cucumbers, and tomatoes. Companies already operating in the
non-cannabis CEA industry may have longer operating histories, greater name recognition, larger client bases and significantly
greater financial, technical, sales and marketing resources. These competitors may adopt more aggressive pricing policies and
make more attractive offers to existing and potential clients, employees, strategic partners, distribution channels and advertisers.
Increased competition is likely to result in price reductions, reduced gross margins and a potential loss of market share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intellectual
Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on a combination of patent and trademark rights, licenses, trade secrets, and laws that protect intellectual property, confidentiality
procedures, and contractual restrictions with our employees and others to establish and protect our intellectual property rights.
We have several issued patents and pending patent applications; however, we do not believe that these issued and pending patents
currently provide us with any competitive advantage. We have registered trademark registrations around our core Surna brand (&ldquo;Surna&rdquo;)
in the United States and select foreign jurisdictions, as well as the Surna logo and the combined Surna logo and name in the United
States. Our trademark is also registered in the European Union and Canada. Subject to ongoing use and renewal, trademark protection
is potentially perpetual. We actively protect our inventions, new technologies, and product developments by maintaining trade
secrets and, in limited circumstances, filing for patent protection.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently have 26 active full-time employees and two part-time employees. However, we may engage, and have in the past utilized,
the services of consultants, independent contractors, and other non-employee professionals. Additional employees may be hired
in the future depending on need, available resources, and our achieved growth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Government
Regulation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>U.S.
Regulations</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we do not generate any revenue from the direct sale of cannabis products, we have historically, and continue to, offer our services
and engineering solutions to indoor cultivators that are engaged in various aspects of the cannabis industry. Marijuana is a Schedule
I controlled substance and is illegal under federal law. Even in those states in which specific uses of marijuana has been legalized,
such as medical marijuana or for adult recreational purpose, its use remains a violation of federal laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Schedule I controlled substance is defined as a substance that has no currently accepted medical use in the United States, a lack
of safety for use under medical supervision and a high potential for abuse. The Department of Justice defines Schedule I controlled
substances as &ldquo;the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence.&rdquo;
If the federal government decides to enforce the Controlled Substances Act with respect to cannabis, persons that are charged
with distributing, possessing with intent to distribute, or growing cannabis could be subject to fines and terms of imprisonment,
the maximum being life imprisonment and a $50 million fine. Any such change in the federal government&rsquo;s enforcement of current
federal laws could cause significant financial damage to us. While we do not intend to harvest, manufacture, distribute or sell
cannabis or cannabis products, we may be irreparably harmed by a change in enforcement by the federal or state governments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously,
the Obama administration took the position that it was not an efficient use of resources to direct federal law enforcement agencies
to prosecute those lawfully abiding by state-designated laws allowing the use and distribution of medical marijuana. The Trump
administration revised this policy but made no major changes in enforcement through Attorney General Sessions rescinding the Cole
Memorandum. The Department of Justice will continue to enforce the Controlled Substances Act with respect to cannabis under established
principles in setting their law enforcement priorities to prevent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    distribution of cannabis products, such as marijuana, to minors;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">criminal
    enterprises, gangs and cartels receiving revenue from the sale of cannabis;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    diversion of cannabis products from states where it is legal under state law to other states;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">state-authorized
    cannabis activity from being used as a cover or pretext for the trafficking of other illegal drugs or other illegal activity;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">violence
    and the use of firearms in the cultivation and distribution of cannabis products;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">driving
    while impaired and the exacerbation of other adverse public health consequences associated with cannabis product usage;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    growing of cannabis on public lands; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cannabis
    possession or use on federal property.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the use of marijuana is illegal under federal law, most federally chartered banks will not accept deposit funds from businesses
involved with marijuana. Consequently, businesses involved in the marijuana industry generally bank with state-chartered banks
and credit unions to provide banking to the industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2014, Congress passed a spending bill containing a provision (the Rohrabacher-Farr amendment, now referred to as the Rohrabacher-Blumenauer
Amendment) blocking federal funds and resources allocated under the 2015 appropriations bill from being used to &ldquo;prevent
such States from implementing their own State medical marijuana laws.&rdquo; The Rohrabacher-Blumenauer Amendment, however, did
not codify any federal protections for medical marijuana patients and producers operating within state law. The Justice Department
maintains that it can still prosecute violations of the federal cannabis laws and continue cases already in the courts. The Rohrabacher-Blumenauer
Amendment must be re-enacted every year, and it was continued for 2016, 2017, 2018, 2019 and 2020, and currently remains in effect.
The continued re-authorization of the Rohrabacher-Blumenauer Amendment cannot be assured. If the Rohrabacher-Blumenauer Amendment
is no longer in effect, the risk of federal enforcement and override of state marijuana use and cannabis related laws would increase.
However, state laws do not supersede the prohibitions set forth in the federal drug laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to participate in either the medical or the adult use aspects of the cannabis industry, all businesses and employees must
obtain licenses from the state and, for businesses, local jurisdictions as well. As an example, Colorado issues four types of
business licenses including cultivation, manufacturing, dispensing, and testing. In addition, all owners and employees must obtain
an occupational license to be permitted to own or work in a facility. All applicants for licenses undergo a background investigation,
including a criminal record check for all owners and employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colorado
has also enacted stringent regulations governing the facilities and operations of cannabis businesses that are involved with the
plant and its products. All facilities are required to be licensed by the state and local authorities and are subject to comprehensive
security and surveillance requirements. In addition, each facility is subject to extensive regulations that govern its businesses
practices, which includes mandatory seed-to-sale tracking and reporting, health and sanitary standards, packaging and labeling
requirements, and product testing for potency and contaminants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laws
and regulations affecting the medical marijuana industry are constantly changing, which could detrimentally affect our proposed
operations. Local, state and federal medical marijuana laws and regulations are broad in scope and subject to evolving interpretations,
which could require us to incur substantial costs associated with compliance or alter our business plan. In addition, violations
of these laws, or allegations of such violations, could disrupt our business and result in a material adverse effect on our operations.
It is also possible that regulations may be enacted in the future that will be directly applicable to our business. We cannot
predict the nature of any future laws, regulations, interpretations or applications, nor can we determine what effect additional
governmental regulations or administrative policies and procedures, when and if promulgated, could have on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Canadian
Regulations</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Summary
of the Cannabis Act</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 17, 2018, the Cannabis Act came into force as law with the effect of legalizing adult recreational use of cannabis across
Canada. The Cannabis Act replaced the Access to Cannabis for Medicinal Purposes Regulations (&ldquo;ACMPR&rdquo;) and the Industrial
Hemp Regulations, both of which came into force under the Controlled Drugs and Substances Act (Canada) (the &ldquo;CDSA&rdquo;),
which previously permitted access to cannabis for medical purposes for only those Canadians who had been authorized to use cannabis
by their health care practitioner. The ACMPR replaced the Marihuana for Medical Purposes Regulations (Canada) (the &ldquo;MMPR&rdquo;),
which was implemented in June 2013. The MMPR replaced the Marihuana Medical Access Regulations (Canada) (the &ldquo;MMAR&rdquo;)
which was implemented in 2001. The MMPR and MMAR were initial steps in the Government of Canada&rsquo;s legislative path towards
the eventual legalization and regulating recreational and medical cannabis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Cannabis Act permits the recreational adult use of cannabis and regulates the production, distribution and sale of cannabis and
related oil extracts in Canada, for both recreational and medical purposes. Under the Cannabis Act, Canadians who are authorized
by their health care practitioner to use medical cannabis have the option of purchasing cannabis from one of the producers licensed
by Health Canada and are also able to register with Health Canada to produce a limited amount of cannabis for their own medical
purposes or to designate an individual who is registered with Health Canada to produce cannabis on their behalf for personal medical
purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Cannabis Act, subject to provincial regulations, individuals over the age of 18 are able to purchase fresh cannabis,
dried cannabis, cannabis oil, and cannabis plants or seeds and are able to legally possess up to 30 grams of dried cannabis, or
the equivalent amount in fresh cannabis or cannabis oil. The Cannabis Act also permits households to grow a maximum of four cannabis
plants. This limit applies regardless of the number of adults that reside in the household. In addition, the Cannabis Act provides
provincial and municipal governments the authority to prescribe regulations regarding retail and distribution, as well as the
ability to alter some of the existing baseline requirements of the Cannabis Act, such as increasing the minimum age for purchase
and consumption.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provincial
and territorial governments in Canada have made varying announcements on the proposed regulatory regimes for the distribution
and sale of cannabis for adult-use purposes. For example, Qu&eacute;bec, New Brunswick, Nova Scotia, Prince Edward Island,
Yukon and the Northwest Territories have chosen the government-regulated model for distribution, whereas Saskatchewan and
Newfoundland &amp; Labrador have opted for a private sector approach. Alberta, Ontario, Manitoba, Nunavut and British
Columbia have announced plans to pursue a hybrid approach of public and private sale and distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the new framework for regulating cannabis in Canada, the federal government has introduced new penalties under
the Criminal Code (Canada), including penalties for the illegal sale of cannabis, possession of cannabis over the prescribed limit,
production of cannabis beyond personal cultivation limits, taking cannabis across the Canadian border, giving or selling cannabis
to a youth and involving a youth to commit a cannabis-related offence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 11, 2018, the Canadian federal government published regulations in the Canada Gazette to support the Cannabis Act, including
the Cannabis Regulations, the new Industrial Hemp Regulations, along with proposed amendments to the Narcotic Control Regulations
and certain regulations under the Food and Drugs Act (Canada). The Industrial Hemp Regulations and the Cannabis Regulations, among
other things, outline the rules for the legal cultivation, processing, research, analytical testing, distribution, sale, importation
and exportation of cannabis and hemp in Canada, including the various classes of licenses that can be granted, and set standards
for cannabis and hemp products. The Industrial Hemp Regulations and the Cannabis Regulations include strict specifications for
the plain packaging and labelling and analytical testing of all cannabis products as well as stringent physical and personnel
security requirements for all federally licensed production sites. The Industrial Hemp Regulations and the Cannabis Regulations
also maintain a distinct system for access to cannabis. With the Cannabis Act now in force, cannabis has ceased to be regulated
under the CDSA and is instead regulated under the Cannabis Act, and both the ACMPR and the Industrial Hemp Regulations have been
repealed effective October 17, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
regulations were added in October 2019 governing the legal production and sale of three classes of cannabis, edibles, extracts
and topicals. A processing license will be required in order to manufacture, package and label cannabis edibles, extracts and
topicals to consumers. The licensing also has quality control and testing requirements for production to prevent contamination
and address the risk of foodborne illness associated with cannabis. Cannabis products will have THC and cannabidiol limits per
unit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Security
Clearances</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Cannabis Regulations require that certain people associated with cannabis licensees, including individuals occupying a &ldquo;key
position&rdquo; directors, officers, large shareholders and individuals identified by the Minister of Health, must hold a valid
security clearance issued by the Minister of Health. Officers and directors of a parent corporation must be security cleared.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Cannabis Regulations, the Minister of Health may refuse to grant security clearances to individuals with associations to organized
crime or with past convictions for, or an association with, drug trafficking, corruption or violent offences. Individuals who
have histories of nonviolent, lower-risk criminal activity (for example, simple possession of cannabis, or small-scale cultivation
of cannabis plants) are not precluded from participating in the legal cannabis industry, and the grant of security clearance to
such individuals is at the discretion of the Minister of Health and such applications will be reviewed on a case-by-case basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cannabis
Tracking System</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Cannabis Act, the Minister of Health is authorized to establish and maintain a national cannabis tracking system. The Cannabis
Regulations set out a national cannabis tracking system to track cannabis throughout the supply chain to help prevent diversion
of cannabis into, and out of, the illicit market. The Cannabis Regulations also provides the Minister of Health with the authority
to make a ministerial order that would require certain persons named in such order to report specific information about their
authorized activities with cannabis, in the form and manner specified by the Minister of Health.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cannabis
Products</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Cannabis Regulations set out the requirements for the sale of cannabis products at the retail level permit the sale of dried cannabis,
cannabis oil, fresh cannabis, cannabis plants, and cannabis seeds, including in such forms as &ldquo;pre-rolled&rdquo; and in
capsules. The THC and cannabidiol content and serving size of cannabis products is limited by the Cannabis Regulations. These
regulations also cover labelling and packaging regulation and extensive prohibitions on representations that may be made with
respect to cannabis products covering areas such as health and cosmetic benefits, nutrition, comparisons to alcoholic beverages
and diet benefits and dietary requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Available
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
website address is <U>www.surna.com.</U> Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form
8-K, and amendments to reports filed pursuant to Sections 13(a) and 15(d) of the Securities Exchange Act of 1934, as amended (the
&ldquo;Exchange Act&rdquo;), are filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;). Such reports
and other information filed by us with the SEC are available free of charge through our website when such reports are available
on the SEC&rsquo;s website.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC maintains an Internet site that contains reports, proxy and information statements and other information regarding issuers
that file electronically with the SEC at <U>www.sec.gov.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
contents of the websites referred to above are not incorporated into this filing. Further, references to the URLs for these websites
are intended to be inactive textual references only.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_003"></A>Item
1A. Risk Factors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Investing
in our common stock involves significant risks. Certain factors may have a material adverse effect on our business, financial
condition, and results of operations. You should carefully consider the risks and uncertainties described below, in addition to
other information contained in this Annual Report on Form 10-K, including our consolidated financial statements and related notes.
The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties that we are unaware
of, or that we currently believe are not material, may also become important factors that adversely affect our business. If any
of the following risks actually occurs, our business, financial condition, results of operations, and future prospects could be
materially and adversely affected. In that event, the trading price of our common stock could decline, and you could lose part
or all of your investment.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Relating to Our Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
revenues have been limited, and we will need to obtain financing for future growth, and possibly our operations, which may not
be available to us and could dilute the ownership of current shareholders. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically,
we have raised equity and debt capital to support our operations. We anticipate we will require additional cash resources to finance
our growth or other future developments, including the launch of any new products and services and any investments or acquisitions
we may decide to pursue. As of December 31, 2020, we had a working capital deficit of approximately $2,220,000 and our cash balance
was $2,285,000. We are likely to need additional funds to complete further development of our business plan to achieve a sustainable
sales level where ongoing operations can be funded from operations. We currently have one debt obligation, a loan from our bank
of $514,200 provided in February of 2021, which we expect will be forgiven in full. We will likely need to raise debt or
equity financing in the future in order to continue our operations and achieve our growth targets. However, there can be no assurance
that such financing will be available in sufficient amounts and on acceptable terms, when and if needed, or at all. The precise
amount and timing of our funding needs cannot be determined accurately at this time, and will depend on a number of factors, including
market demand for our products and services, the success of our product development efforts, the timing of receipts for customer
payments, the management of working capital, and the continuation of normal payment terms and conditions for our purchase of goods
and services. The continuation of normal payment terms and conditions with our customers and suppliers, including our ability
to obtain advance payments from our customers, significantly impacts our ability to fund our ongoing operations. We believe our
cash balances and cash flow from operations will be insufficient to fund our operations and growth for the next 12 months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that we raise additional equity capital, existing shareholders will experience a dilution in the voting power and ownership
of their common stock, and earnings per share, if any, would be negatively impacted. Our inability to use our equity securities
to finance our operations could materially limit our growth. Any borrowings made to finance operations, which are difficult to
obtain from most traditional banks due to the federal laws prohibiting cannabis use, could make us more vulnerable to a downturn
in our operating results, a downturn in economic conditions, or increases in interest rates on borrowings that are subject to
interest rate fluctuations. The amount and timing of such additional financing needs will vary principally depending on the timing
of new product launches, investments and/or acquisitions, and the amount of cash flow from our operations. If our resources are
insufficient to satisfy our cash requirements, we may seek to issue additional equity or debt securities or obtain a credit facility.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
COVID-19 pandemic has adversely impacted, and may continue to adversely impact, the Company&rsquo;s operations and financial results.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
COVID-19 pandemic has resulted in significant economic uncertainty and disruption. The extent to which our business and financial
results are impacted will depend on numerous evolving factors which are uncertain and cannot be predicted, including: the duration
and scope of the pandemic; governmental, business and individuals&rsquo; actions taken in response; the effect on our customers
and customers&rsquo; demand for our services and products; the effect on our suppliers and disruptions to the global supply chain;
our ability to sell and manufacture our products; disruptions to our operations resulting from the illness of any of our employees;
restrictions or disruptions to transportation, including reduced availability of ground or air transport; the ability of our customers
to pay for our services and products; and any closures of our facilities, our suppliers&rsquo; facilities, and our customers&rsquo;
facilities. The effects of the COVID-19 pandemic have resulted and will result in additional expenses and lost or delayed revenue.
We have been experiencing disruptions to our business as we implement modifications to travel, work locations and cancellation
of events, among other modifications. In addition, the change in macroeconomic conditions may impact the proper functioning of
financial and capital markets, foreign currency exchange rates, commodity and energy prices, and interest rates. Even after the
COVID-19 pandemic subsides, we may continue to experience adverse impacts to our business and financial results due to any economic
recession or depression that occurs, and due to any major public health crises that may occur in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
our current accounting estimates contemplate current and expected future conditions, as applicable, it is reasonably possible
that actual conditions could differ from our expectations, which could materially affect our results of operations and financial
position. In particular, a number of estimates have been and will continue to be affected by the ongoing COVID-19 pandemic. The
severity, magnitude and duration, as well as the economic consequences of the COVID-19 pandemic, are uncertain, rapidly changing
and difficult to predict. As a result, our accounting estimates and assumptions may change over time in response to COVID-19.
Such changes could result in future impairments of goodwill, intangible assets, long-lived assets, incremental credit losses on
accounts receivable, or excess and obsolete inventory. Any of these events could amplify the other risks and uncertainties described
in in this Annual Report and could have an adverse effect on our business and financial results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have determined that our ability to continue as a going concern is dependent on raising additional capital to fund our operations
and ultimately on generating future profits. Our independent registered public accounting firm has also included a &ldquo;going
concern&rdquo; explanatory paragraph in its opinion on our financial statements, expressing substantial doubt that we can continue
as an ongoing business for the next 12 months. Our financial statements do not include any adjustments that may result from the
outcome of this uncertainty. If we are unable to successfully raise the capital we need, we may need to and believe we can reduce
the scope of our business to fully satisfy our future short-term liquidity requirements. If we cannot raise additional capital
or reduce the scope of our business, we may be otherwise unable to achieve our goals or continue our operations. While we believe
that we will be able to raise the capital we need to continue our operations, there can be no assurances that we will be successful
in these efforts or will be able to resolve our liquidity issues or eliminate our operating losses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Even
if we obtain more customers, there is no assurance that we will be able to convert our backlog into revenue or make a profit.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be unable to convert the full contract value of our backlog in a timely manner, or at all. The performance of our obligations
under a sales contract, and the timing of our revenue recognition, is dependent upon our customers&rsquo; ability to secure funding
and real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Our
sales contracts currently are not time specific as to when our customers are required to take delivery of our services and equipment.
More recently, we determined that some of our new construction facility projects are becoming larger and more complex and, as
a result, delays were more likely due to licensing and permitting, lack of or delay in funding, staged facility construction,
and/or the shifting priorities of certain customers with multiple facility projects in progress at one time. Even if we obtain
more customers, or increase the average size of our projects, there is no guarantee that we will be able to generate a profit.
Because we are a small company with limited capital, limited products and services, and limited marketing activities, we may not
be able to generate sufficient revenue to operate profitably. If we cannot operate profitably, we may have to suspend or cease
operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may extend credit to our customers in the future and, if we are unable to collect these accounts receivable, our future profitability
could be adversely impacted. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Historically,
we had little exposure to the collection risk on accounts receivable since we typically received payments from our customers in
advance of our performance of services or delivery of equipment. However, in certain situations, especially as we expand our products
and services offering for a customer&rsquo;s entire facility lifecycle, we may extend credit to our customers in which case we
are at risk for the collection of account receivables. Accordingly, we will be at greater risk for the collection of account receivables.
Our credit arrangements are negotiated and may not protect us if a customer develops operational difficulty or incurs operating
losses which could lead to a bankruptcy. In these cases, we may lose most of the outstanding balance due. In addition, we are
typically not able to insure our accounts receivables. The risk is that we derive our revenue and profits from selling products
and services to the emerging cannabis industry. The failure of our customers to pay in full amounts due to us could negatively
affect future profitability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Because
we currently do not maintain effective internal controls over financial reporting, we may be unable to accurately report our financial
results or prevent fraud, and investor confidence and the market price of our common stock may, therefore, be adversely impacted.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
reporting obligations as a public company place a significant strain on our management, operational and financial resources, and
systems, and will continue to do so for the foreseeable future. Annually, we are required to prepare a management report on our
management&rsquo;s assessment of the effectiveness of our internal control over financial reporting. Management has concluded
that our internal control over financial reporting is currently not effective and shall report such in management&rsquo;s report
in this annual report on Form 10-K. In the event that our status with the SEC changes to that of an accelerated filer from a smaller
reporting company, our independent registered public accounting firm will be required to attest to and report on our management&rsquo;s
assessment of the effectiveness of our internal control over financial reporting. Under such circumstances, even if our management
concludes that our internal control over financial reporting is effective, our independent registered public accounting firm may
still decline to attest to our management&rsquo;s assessment, or may issue a report that is qualified, if it is not satisfied
with our controls, or the level at which our controls are documented, designed, operated or reviewed, or if it interprets the
relevant requirements differently from us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have identified a material weakness in our internal control over financial reporting and, if we do not remediate the material
weakness or are unable to implement and maintain effective internal control over financial reporting in the future, the accuracy
and timeliness of our financial reporting may be adversely affected. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 20pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently do not maintain effective controls over certain aspects of the financial reporting process because: (i) we lack a sufficient
complement of personnel with a level of accounting expertise and an adequate supervisory review structure that is commensurate
with our financial reporting requirements, (ii) there is inadequate segregation of duties due to the limitation on the number
of our accounting personnel, and (iii) we have insufficient controls and processes in place to adequately verify the accuracy
and completeness of spreadsheets that we use for a variety of purposes including revenue, taxes, stock-based compensation and
other areas, and place significant reliance on, for our financial reporting. A material weakness is a deficiency or a combination
of deficiencies in internal control over financial reporting such that there is a reasonable possibility that a material misstatement
of the annual or interim consolidated financial statements will not be prevented or detected on a timely basis. If we are unable
to achieve effective internal control over financial reporting, or if our independent registered public accounting firm determines
we continue to have a material weakness in our internal control over financial reporting, we could lose investor confidence in
the accuracy and completeness of our financial reports, the market price of our shares could decline, and our reputation may be
damaged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
inability to effectively manage our growth could harm our business and materially and adversely affect our operating results and
financial condition.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
strategy envisions growing our business and expanding within the CEA industry. We plan to expand our product, sales, administrative
and marketing operations. Any growth in or expansion of our business is likely to continue to place a strain on our management
and administrative resources, infrastructure and systems. As with other growing businesses, we expect that we will need to further
refine and expand our business development capabilities, our systems and processes and our access to financing sources. We also
will need to hire, train, supervise, and manage new employees. These processes are time consuming and expensive, will increase
management responsibilities and will divert management attention. We cannot assure that we will be able to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">execute
    on our business plan and strategy;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">expand
    our products effectively or efficiently or in a timely manner;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocate
    our human resources optimally;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">meet
    our capital needs;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify
    and hire qualified employees or retain valued employees; or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">effectively
    incorporate the components of any business or product line that we may acquire in our effort to achieve growth.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
inability or failure to manage our growth and expansion effectively could harm our business and materially and adversely affect
our operating results and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
operating results may fluctuate significantly based on customer acceptance of our products, industry uncertainty, project financing
concerns, and the licensing and qualification of our prospective customers. As a result, period-to-period comparisons of our results
of operations are unlikely to provide a good indication of our future performance.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
expects that, under typical operating conditions, we will experience substantial variations in our revenues and operating results
from quarter to quarter. Our revenue recognition is dependent upon shipment of the equipment portions of our sales contracts,
which, in many cases, may be delayed while our customers complete permitting, prepare their facilities for equipment installation
or obtain project financing. Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective
customers, which are out of our control, make it difficult for us to predict when we will recognize revenue. If customers are
unable to obtain licensing, permitting or financing, our sales and revenue will decline, resulting in a reduction in our operating
income or possible increase in losses. Also, because of the coronavirus responses and our own cost savings actions, we cannot
predict the course of our revenues and operating results with accuracy at this time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
business is focused on providing engineering design, and equipment integration into CEA facilities. We believe the majority of
our revenues in the periods covered by this report have been generated from clients that operate in the legal cannabis industry
in the United States and Canada.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we are implementing a plan to broaden our market reach beyond the legal cannabis industry and are placing sales efforts on expansion
into the rapidly growing non-cannabis CEA vertical farming segment, we continue to provide the majority of our facility engineering
design and equipment integration and solutions to facilities in the legal cannabis industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Now
that the non-cannabis CEA segment is gaining strong momentum in the agricultural industry, and since almost all of the
equipment systems that we sell originate in the general horticulture industry and are agnostic to the crop grown in a facility,
we believe that the proportion of non-cannabis revenues will increase over time, commensurate with our sales efforts and success.
Notwithstanding our expansion plans, a decrease in demand in the legal cannabis industry could have a material adverse effect
on our revenues and the success of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
cannabis industry has been an emerging industry over the last several years, and cannabis has only been legalized in some states
and remains illegal in other states and under U.S. federal law, making it difficult to accurately forecast the demand for our
engineering and product solutions in this specific industry. Losing clients from the cannabis industry may have a material adverse
effect on our revenues and the success of our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
cannabis industry is still in its early stages of development in the United States and has only been legalized in some states
and remains illegal in other states and under U.S. federal law, making it difficult to accurately predict and forecast the demand
for our engineering and product solutions. If the U.S. Department of Justice (&ldquo;DOJ&rdquo;) did take action against the cannabis
industry, we believe those of our clients operating in the legal cannabis industry would be lost to us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
our operations, we rely heavily upon the various U.S. federal governmental memos issued in the past, including the memorandum
issued by the DOJ on October 19, 2009, known as the &ldquo;Ogden Memorandum&rdquo;, the memorandum issued by the DOJ on August
29, 2013, known as the &ldquo;Cole Memorandum&rdquo; and other guidance, in the attempt to keep our operations acceptable to those
state and federal entities that regulate, enforce, or choose to defer enforcement of certain current regulations regarding cannabis.
By doing this, we seek to avoid the many possible consequences of providing grow equipment to the cannabis industry as our customers
continue to comply with their state and local jurisdictional laws, rules and regulations and the interpretations of relevant authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
legal cannabis industry is not yet well-developed, and many aspects of this industry&rsquo;s development and evolution cannot
be accurately predicted, and therefore, the loss of any of our current clients or our inability to capture new client contracts
may have a material adverse effect on our business. While we have attempted to identify our business risks in the legal cannabis
industry, you should carefully consider that there are other risks that cannot be foreseen or are not described in this prospectus,
which could materially and adversely affect our business and financial performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
is heightened scrutiny by Canadian regulatory authorities related to the cannabis industry.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
seek customers in the CEA Canadian market, some of which are cannabis growers. Therefore, our existing and future operations may
become the subject of heightened scrutiny by those regulators and other authorities in Canada that oversee the cannabis industry.
As a result, we may become subject to direct and indirect interaction with public officials in one or both the United States and
Canada. No assurance can be provided that any heightened scrutiny will not in turn lead to the imposition of restrictions on our
ability to operate in the United States or Canada, in addition to those described herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we do not successfully develop additional products and services, or if such products and services are developed but not successfully
commercialized, we could lose revenue opportunities.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future success depends, in part, on our ability to expand our product and service offerings. We are currently investigating a
number of new and improved product opportunities, and we intend to collaborate with manufacturing partners to optimize these products
for the cannabis market. The processes of identifying and commercializing new products is complex and uncertain, and if we fail
to accurately predict customers&rsquo; changing needs and emerging technological trends our business could be harmed. We have
already and may have to continue to commit significant resources to commercializing new products before knowing whether our investments
will result in products the market will accept. We may be unable to differentiate our new products from those of our competitors,
and our new products may not be accepted by the market. There can be no assurance that we will successfully identify additional
new product opportunities, develop and bring new products to market in a timely manner, or achieve market acceptance of our products
or that products and technologies developed by others will not render our products or technologies obsolete or noncompetitive.
Furthermore, we may not execute successfully on commercializing those products because of errors in product planning or timing,
technical hurdles that we fail to overcome in a timely fashion, or a lack of appropriate resources. This could result in competitors
providing those solutions before we do and a reduction in revenue and earnings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
future success depends on our ability to grow and expand our customer base. Our failure to achieve such growth or expansion could
materially harm our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success and the planned growth and expansion of our business depend on us achieving greater and broader acceptance of our products
and services and expanding our commercial customer base. There can be no assurance our sales efforts will be successful. There
can be no assurance that customers will purchase our services or products or that we will continue to expand our customer base.
If we are unable to effectively market or expand our product and service offerings, we will be unable to grow and expand our business
or implement our business strategy. This could materially impair our ability to increase sales and revenue, and materially and
adversely affect our margins, which could harm our business and cause our stock price to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
suppliers could fail to fulfill our orders for parts used to assemble our products, which would disrupt our business, increase
our costs, harm our reputation, and potentially cause us to lose our market.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
depend on third party suppliers around the world, including in The People&rsquo;s Republic of China, for materials used to assemble
our products. These suppliers could fail to produce products to our specifications or in a workmanlike manner and may not deliver
the material or products on a timely basis. Our suppliers may also have to obtain inventories of the necessary parts and tools
for production. Any change in our suppliers&rsquo; approach to resolving production issues could disrupt our ability to fulfill
orders and could also disrupt our business due to delays in finding new suppliers, providing specifications and testing initial
production.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>International
trade disputes could result in tariffs and other protectionist measures that could adversely affect the Company&rsquo;s business.
</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tariffs
could increase the cost of our products and the components and raw materials that go into making them. These increased costs could
adversely impact the gross margin that we earn on sales of our products. Tariffs could also make our products more expensive for
customers, which could make our products less competitive and reduce customer demand. Countries may also adopt other protectionist
measures that could limit our ability to offer our products and services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
inability to effectively protect our intellectual property would adversely affect our ability to compete effectively, our revenue,
our financial condition, and our results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may be unable to obtain intellectual property rights to effectively protect our branding, products, and other intangible assets.
Our ability to compete effectively may be affected by the nature and breadth of our intellectual property rights. While we intend
to defend against any threats to our intellectual property rights, there can be no assurance that any such actions will adequately
protect our interests. If we are unable to secure intellectual property rights to effectively protect our branding, products,
and other intangible assets, our revenue and earnings, financial condition, or results of operations could be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also rely on non-disclosure and non-competition agreements to protect portions of our intellectual property portfolio. There can
be no assurance that these agreements will not be breached, that we will have adequate remedies for any breach, that third parties
will not otherwise gain access to our trade secrets or proprietary knowledge, or that third parties will not independently develop
competitive products with similar intellectual property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may become subject to additional regulation of CEA facilities.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
engineering and design services and solutions are focused on CEA facilities that are able to grow a wide variety of crops such
as leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic
vegetables and small fruits (such as strawberries, blackberries and raspberries), bell peppers, cucumbers, and tomatoes. Some
of these crops and their growing methodologies are subject to regulation by the United States Food and Drug Administration, environmental
agencies, public utility agencies and other federal, state or foreign agencies. Changes to any regulations and laws that complicate
the design and engineering of a subject CEA facility, such as waste water treatment and electricity-related mandates, make it
possible that potential related zoning and enforcement could decrease the demand for our services, and in turn negatively impact
our revenues and business opportunities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
CEA industry is highly competitive, and we have less capital and resources than many of our competitors, which may give them an
advantage in developing and marketing products similar to ours or make our products obsolete.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are many competitors in the CEA industry, including some companies that focus on the cannabis industry. These companies generally
offer products and services similar or the same as those offered by us. There can be no guarantees that in the future other companies
will not enter this arena by developing products that are in direct competition with us or even superior in quality or price.
The barriers to entry into the CEA industry are not overly significant. Over time we anticipate growth in our competition. Some
of our current and future competition may have longer operating histories, greater name recognition, larger client bases and significantly
greater financial, technical, sales and marketing resources. One or more of these qualities may allow them to respond more quickly
than us to market opportunities. They may be able to devote greater resources to the marketing, promotion and sale of their products
and/or services. Competitors may also adopt more aggressive pricing policies and make more attractive offers to clients, employees,
strategic partners, distribution channels and advertisers. Increased competition is likely to result in price reductions, reduced
gross margins and a potential loss of market share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
we believe we are better positioned to meet the exacting demands of a cannabis cultivation environment through precise temperature,
humidity, light, and process controls and to satisfy the evolving code and regulatory requirements being imposed at the state
and local levels, there can be no assurance that we will be able to successfully compete against these other contractors and suppliers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will be required to attract and retain top quality talent to compete in the marketplace.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe our future growth and success will depend in part on our ability to attract and retain highly skilled managerial, product
development, sales and marketing, and finance personnel. Our ability to attract and retain personnel with the requisite credentials,
experience and skills will depend on several factors including, but not limited to, our ability to offer competitive wages, benefits
and professional growth opportunities. There can be no assurance of success in attracting and retaining such personnel. Shortages
in qualified personnel could limit our ability to increase sales of existing products and services and launch new product and
service offerings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are dependent upon certain key sales, managerial and executive personnel for our future success. If we lose any of our key personnel,
our ability to implement our business strategy could be significantly harmed.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
depend on the industry knowledge, technical and financial skill, and network of business contacts of certain key employees. Our
future success will depend on the continued service of these key employees or our ability to engage others who are similarly situated
in the industry. While we may have employment agreements with certain of these key employees, they are free to terminate their
employment with us at any time, although they may be subject to certain restrictive covenants on their post-termination activities.
We do not carry key-man life insurance on the lives of our key employees. The departure of any one of our key employees could
have a material adverse effect on our ability to achieve our business objective and maintain the specialized services that we
offer our customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>System
security risks, data protection breaches, cyber-attacks and systems integration issues could disrupt our internal operations or
services provided to customers, and any such disruption could reduce our expected revenue, increase our expenses, damage our reputation
and adversely affect our stock price. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Experienced
computer programmers and hackers may be able to penetrate our network security and misappropriate or compromise our confidential
information or that of third parties, create system disruptions or cause shutdowns. Computer programmers and hackers also may
be able to develop and deploy viruses, worms, and other malicious software programs that attack or otherwise exploit any security
vulnerabilities of the products that we may sell in the future, especially our recently launched SentryIQ&reg; sensors, controls
and automation platform. The costs to us to eliminate or alleviate cyber or other security problems, bugs, viruses, worms, malicious
software programs and security vulnerabilities could be significant, and our efforts to address these problems may not be successful
and could result in interruptions, delays, cessation of service and loss of existing or potential customers that may impede our
engineering, sales, manufacturing, distribution or other critical functions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Portions
of our IT infrastructure may also experience interruptions, delays or cessations of service or produce errors in connection with
systems integration or migration work that takes place from time to time. We may not be successful in implementing new systems
and transitioning data, which could cause business disruptions and be more expensive, time consuming, disruptive and resource
intensive. Such disruptions could adversely impact our ability to fulfill orders and interrupt other processes. Delayed sales,
lower profits, or lost customers resulting from these disruptions could adversely affect our financial results, stock price and
reputation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
incur significant costs as a result of being a public company, which will make it more difficult for us to achieve profitability.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a public company, we incur legal, accounting and other expenses, including costs associated with the periodic reporting requirements
applicable to a company whose securities are registered under the Exchange Act, as well as additional corporate governance requirements,
including requirements under the Sarbanes-Oxley Act, and other rules implemented by the SEC. These costs will make it more difficult
for us to achieve profitability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
ability to use net operating losses to offset future taxable income may be subject to limitations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company has U.S. federal and state net operating losses (&ldquo;NOLs&rdquo;) of approximately $19,322,000,
of which $11,196,261 will expire, if not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December
31, 2017 do not expire but may only be used against taxable income to 80%. In response to the novel coronavirus COVID-19, the
Coronavirus Aid, Relief, and Economic Security Act temporarily repealed the 80% limitation for NOLs arising in 2018, 2019 and
2020. It is uncertain if and to what extent various states will conform to the newly enacted federal tax law. In addition, under
Section 382 of the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;), and corresponding provisions of state law,
if a corporation undergoes an &ldquo;ownership change,&rdquo; which is generally defined as a greater than 50% change, by value,
in its equity ownership over a three-year period, the corporation&rsquo;s ability to use its pre-change net operating loss carryforwards
and other pre-change tax attributes to offset its post-change income or taxes may be limited. We have experienced ownership changes
in the past and we may experience additional ownership changes in the future as a result of subsequent shifts in our stock ownership,
some of which may be outside of our control. If an ownership change occurs and our ability to use our net operating loss carryforwards
is materially limited, it would harm our future operating results by effectively increasing our future tax obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to the Cannabis Industry </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>U.S.
federal laws, regulations and enforcement may adversely affect the implementation of state and local cannabis laws and regulations
and, correspondingly, may adversely impact our customers. Such impact may negatively affect our revenue and profits, or we may
be found to be in violation of the Controlled Substances Act or other U.S. federal, state or local laws. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
a majority of the states and the District of Columbia permit some form of whole-plant cannabis use and cultivation either for
medical or recreational use. There are efforts in other states to begin permitting cannabis use and/or cultivation in various
contexts, and there are a number of states actively considering bills to permit recreational use. Nevertheless, the U.S. federal
law continues to prohibit cannabis in all its forms as well as its derivatives. Under the federal Controlled Substances Act (the
&ldquo;CSA&rdquo;), the policy and regulations of the U.S. federal government and its agencies is that marihuana (cannabis), or
its more commonly spelled name marijuana, has no currently accepted medical use and a high potential for abuse, and a range of
activities, including cultivation and use of marijuana, is prohibited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December of 2018, the Agricultural Improvement Act of 2018 (the &ldquo;2018 Farm Act&rdquo;) was enacted into law which included
an amendment to wholly remove &ldquo;hemp&rdquo; from the CSA and defined &ldquo;hemp&rdquo; as all parts of a cannabis plant
containing less than 0.3% of tetrahydrocannabinol (&ldquo;THC&rdquo;) thereby excluding hemp and its derivatives, including hemp-derived
cannabidiol (&ldquo;CBD&rdquo;) oil, as a &ldquo;controlled substance.&rdquo; Under the 2018 Farm Act, the cultivation of hemp
is no longer prohibited under federal law. Further, although hemp-derived CBD is now federally legal under the 2018 Farm Act,
the U.S. Food and Drug Administration has regulatory oversight on the use of hemp-derived CBD in food, beverage and dietary products
as well as any medical or therapeutic claims related thereto. Cannabis-derived CBD oil remains federally illegal in the U.S. However,
state laws vary on the permitted sale and use of both hemp-and cannabis-derived CBD oil.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2021, the U.S. Department of Agriculture adopted a Final Rule addressing hemp producer licensing, recordkeeping, procedures
for sampling and testing THC concentrations and harvesting procedures. The Rule was set to become effective on March 22, 2021.
However, on January 20, 2021, the new administration instituted a regulatory freeze pending review for published rules that are
not yet effective. The final rule requires all laboratories testing for THC concentration to be registered with the Drug Enforcement
Agency.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
Congress amends the CSA or the executive branch de-schedules or reschedules marijuana under it, there is a risk that federal authorities
may enforce current federal law. Enforcement of the CSA by federal authorities could impair our revenue and earnings, and it could
even force us to cease operating entirely in the cannabis industry. The risk of strict federal enforcement of the CSA in light
of congressional activity, judicial holdings and stated federal policy, including enforcement priorities, remains uncertain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
an effort to provide guidance to federal law enforcement, the U.S. Department of Justice (the &ldquo;DOJ&rdquo;) issued Guidance
Regarding Marijuana Enforcement to all United States Attorneys in a memorandum from Deputy Attorney General David Ogden on October
19, 2009, in a memorandum from Deputy Attorney General James Cole on June 29, 2011 and in a memorandum from Deputy Attorney General
James Cole on August 29, 2013 (the &ldquo;Cole Memo&rdquo;). The Cole Memo also provided guidance to federal prosecutors concerning
cannabis enforcement in light of state laws legalizing medical and recreational cannabis possession in small amounts. Each memorandum
provided that the DOJ was committed to enforcement of the CSA, but the DOJ was also committed to using its limited investigative
and prosecutorial resources to address the most significant threats in the most effective, consistent and rational way.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Cole Memo sets forth certain enforcement priorities that are important to the federal government:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distribution
    of marijuana to children;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
    from the sale of marijuana going to criminals;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diversion
    of medical marijuana from states where it is legal under state law to states where it is not;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Using
    state-authorized marijuana activity as a pretext for other illegal drug activity;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Violence
    in the cultivation and distribution of marijuana;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Drugged
    driving and other adverse public health consequences;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Growing
    marijuana on public lands; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Possession
    or use of marijuana on federal property.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2018, the Cole Memo was rescinded by Attorney General Jeff Sessions (the &ldquo;Sessions Memo&rdquo;). The effect of
rescinding the Cole Memo guidance is that U.S. Attorneys now have greater discretion to prosecute CSA violations with respect
to individuals and companies that are otherwise complying with state law and the tenets previously set forth in the Cole Memo.
The DOJ has not historically devoted resources to prosecuting individuals whose conduct is limited to possession of small amounts
of cannabis for use on private property but relied on state and local law enforcement to address that form of cannabis activity.
In the event the DOJ goes beyond the objectives of the Cole Memo guidance and begins strict enforcement of the CSA in states that
have laws legalizing medical and recreational cannabis in small amounts, there may be a direct and adverse impact to our revenue
and earnings, and it could even force us to cease operating entirely in the cannabis industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2014, the U.S. House of Representatives passed an amendment (the &ldquo;Rohrabacher-Farr Amendment&rdquo;) to the Commerce, Justice,
Science, and Related Agencies Appropriations Bill, which funds the DOJ. The Rohrabacher-Farr Amendment prohibits the DOJ from
using federally appropriated funds to prevent states with medical cannabis laws from implementing such laws by investigating and
prosecuting individuals or businesses operating in accordance with applicable state laws. In August 2016, a Ninth Circuit federal
appeals court ruled in <I>United States v. McIntosh</I> that the Rohrabacher-Farr Amendment bars the DOJ from spending funds on
the prosecution of conduct that is allowed by state medical cannabis laws, provided that such conduct is in strict compliance
with applicable state law. In March 2015, bipartisan legislation titled the Compassionate Access, Research Expansion, and Respect
States Act (the &ldquo;CARERS Act&rdquo;) was introduced, proposing to allow states to regulate the medical use of cannabis by
changing applicable federal law, including reclassifying cannabis under the CSA to a Schedule II controlled substance and thereby
changing the plant from a federally-criminalized substance to one that has recognized medical uses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
these developments have been met with a certain amount of optimism in the scientific community, the CARERS Act has not yet been
adopted, and the Rohrabacher-Farr Amendment, as an amendment to an appropriations bill, must be renewed annually on a bipartisan
basis in order to remain in effect. The Rohrabacher-Farr Amendment has been renamed the Rohrabacher-Blumenauer Amendment through
the amendment language, but the intent remains the same. The currently enacted Commerce, Justice, Science, and Related Agencies
Act, which includes the Rohrabacher-Blumenauer Amendment, is effective, by passage of continuing resolutions, through September
30, 2021. Following the Sessions Memo, however, the federal government could at any time change its enforcement priorities against
the cannabis industry. Any change in enforcement priorities could render our operations unprofitable or even prohibit such operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
former Obama administration effectively stated that it is not an efficient use of resources to direct federal law enforcement
agencies to prosecute those lawfully abiding by state-designated laws allowing the use and distribution of medical marijuana.
However, as discussed above, the Sessions Memo rescinded the Cole Memo enforcement guidance. Any further change in enforcement
policy and a decision to enforce the federal laws more aggressively could cause significant financial damage to us and our shareholders
and could adversely affect our ability to obtain equity or debt financing, or even prohibit our operating in the cannabis industry
entirely.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2018, the Strengthening the Tenth Amendment Through Entrusting States (the &ldquo;STATES Act&rdquo;) was introduced that
would recognize legalization of cannabis and the U.S. state laws that have legalized it through their legislatures or citizen
initiatives. The STATES Act, if enacted into law, would amend the CSA to exempt from federal enforcement individuals or corporations
in states who are in compliance with U.S. state, U.S. territory and the District of Columbia, or tribal law on cannabis, with
certain additional provisions such as minimum ages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not requested or obtained any opinion of counsel or ruling from any authority to determine if our operations are in compliance
with or violate any state or federal laws or whether we are assisting others to violate a state or federal law. In the event that
our operations are deemed to violate any laws or if we are deemed to be assisting others to violate a state or federal law, we
could have liability that could cause us to modify or cease our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
business efforts in Canada present opportunities, but no assurance can be given that our revenues and earnings will be improved
on the basis of our addressing the Canadian business. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to U.S. operations, we seek to sell products and services to cannabis growers in Canada, where medical and recreational
cannabis has been legal since 2018 across the country both federally and provincially (subject to certain restrictions relating
to CBD). We believe Canada, with its federal legal regime, represents a business opportunity for us, but we have noticed softening
demand from Canadian prospects due, in part, to limited capital being available for new facilities and an overbuilding of cultivation
capacity following federal legalization. As a result, Canada now appears to be in a period of correction. There can be no assurance
that we will be able to make any additional sales of products or services in Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Successful
litigation by non-cannabis states affected by cannabis legalization could have significant adverse effects on our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to variations in state law among states sharing borders, certain states which have not approved any legal sale of cannabis may
seek to overturn laws legalizing cannabis use in neighboring states. For example, in December 2014, the attorney general of each
of Nebraska and Oklahoma filed a complaint with the U.S. Supreme Court against the state of Colorado arguing that the Supremacy
Clause (Article VI of the U.S. Constitution) prohibits Colorado from passing laws that conflict with federal anti-drug laws and
that Colorado&rsquo;s laws are increasing cannabis trafficking in neighboring states that maintain cannabis bans, thereby putting
pressure on such neighboring states&rsquo; criminal justice systems. In March 2016, the U.S. Supreme Court, voting 6-2, declined
to hear this case, but there is no assurance that it will do so in the future. Additionally, nothing prevents states&rsquo; attorneys
general from using the same or similar cause of action for a lawsuit in a lower federal or other court.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Previously,
the U.S. Supreme Court has held that drug prohibition is a valid exercise of federal authority under the commerce clause; however,
it has also held that an individual state itself is not required to adopt or enforce federal laws with which it disagrees. If
the U.S. Supreme Court rules that a legal cannabis state&rsquo;s legislation is unconstitutional, that could result in legal action
against other states with laws legalizing medical and/or recreational cannabis use. Successful prosecution of such legal actions
by non-cannabis states could have significant adverse effects on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Variations
in state and local regulation and enforcement in states that have legalized cannabis may impose certain restrictions on cannabis-related
activities that may adversely impact our revenue and earnings.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Individual
state laws do not always conform to the federal standard or to other states&rsquo; laws. A number of states have decriminalized
cannabis to varying degrees; other states have created exemptions specifically for medical cannabis, and several have both decriminalization
and medical laws. Seventeen states and the District of Columbia have legalized the recreational use of cannabis and various state
legislatures are considering recreational in 2021. Variations exist among states that have legalized, decriminalized, or created
medical cannabis exemptions. For example, Alaska and Colorado have limits on the number of cannabis plants that can be grown by
an individual in the home. In most states, the cultivation of cannabis for personal use continues to be prohibited except by those
states that allow small-scale cultivation by the individual in possession of cannabis for medicinal purposes or that person&rsquo;s
caregiver. Active enforcement of state laws that prohibit personal cultivation of cannabis may indirectly and adversely affect
our revenue and earnings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
cannabis industry could face strong opposition from other industries.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that established businesses in other industries may have a strong economic interest in opposing the development of the
cannabis industry. Cannabis may be seen by companies in other industries as an attractive alternative to their products, including
recreational marijuana as an alternative to alcohol, and medical marijuana as an alternative to various commercial pharmaceuticals.
Many industries that could view the emerging cannabis industry as an economic threat are well established, with vast economic
and United States federal and state lobbying resources. It is possible that companies within these industries could use their
resources to attempt to slow or reverse legislation legalizing cannabis. Any inroads these companies make in halting or impeding
legislative initiatives that would be beneficial to the cannabis industry could have a detrimental impact on our clients and,
in turn on our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
legality of cannabis uses could be reversed in one or more states.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
voters or legislatures of states in which various marijuana uses have been legalized could potentially repeal applicable laws
which permit the operation of both medical and retail marijuana and cannabis related businesses. These actions might force us
to cease aspects of our operations in one or more states entirely.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Changing
legislation and evolving interpretations of law, which could negatively impact our clients and, in turn, our operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Laws
and regulations affecting the medical and adult-use marijuana industry are constantly changing, which could detrimentally affect
our clients involved in that industry and, in turn, our operations. Local, state and federal cannabis laws and regulations are
often broad in scope and subject to constant evolution and inconsistent interpretations, which could require our clients and ourselves
to incur substantial costs associated with modification of operations to ensure compliance. In addition, violations of these laws,
or allegations of such violations, could disrupt our clients&rsquo; business and result in a material adverse effect on our operations.
In addition, it is possible that regulations may be enacted in the future that will limit the amount of cannabis growth or related
products that our commercial clients are authorized to produce. We cannot predict the nature of any future laws, regulations,
interpretations or applications, nor can it determine what effect additional governmental regulations or administrative policies
and procedures, when and if promulgated, could have on our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>As
the possession and use of marijuana is illegal under the CSA, it is possible that our manufacture and sale of equipment that is
used to cultivate marijuana may be deemed to be aiding and abetting illegal activities. It is also possible that our products
could be considered &ldquo;drug paraphernalia.&rdquo; </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal
practices could change with respect to providers of equipment potentially usable by cultivators in the medical and recreational
cannabis industry, which could adversely impact us. Cannabis growers use equipment that we offer for sale. While we are not aware
of any threatened or current federal or state law enforcement actions against any supplier of equipment that might be used for
cannabis growing, law enforcement authorities, in their attempt to regulate the illegal use of cannabis, may seek to bring an
action or actions against us, including but not limited to a claim of aiding and abetting, or being an accessory to, another&rsquo;s
criminal activities or that our products are considered &ldquo;drug paraphernalia.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
federal aiding and abetting statute, U.S. Code Title 18 Section 2(a), provides that anyone who &ldquo;commits an offense against
the United States or aids, abets, counsels, commands, induces or procures its commission, is punishable as a principal.&rdquo;
Under U.S. Code Title 21 Section 863, the term &ldquo;drug paraphernalia&rdquo; means &ldquo;any equipment, product or material
of any kind which is primarily intended or designed for use in manufacturing, compounding, converting, concealing, producing,
processing, preparing, injecting, ingesting, inhaling, or otherwise introducing into the human body a controlled substance.&rdquo;
Any drug paraphernalia involved in any violation of Section 863 shall be subject to seizure and forfeiture upon the conviction
of a person for such violation. While Section 863(f) contains an exemption for any person authorized by local, state or federal
law to manufacture, possess, or distribute such items, any such action may force us to cease operations and our investors could
lose their entire investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
risk exists that our activities could be deemed to be facilitating the selling or distribution of cannabis in violation of the
CSA, or to constitute aiding or abetting, or being an accessory to, a violation of the CSA. There is also a risk that our products
could be considered drug paraphernalia and could be subject to seizure. We believe, however, that such risks are relatively low.
Federal authorities have not focused their resources on such tangential or secondary violations of the CSA, nor have they threatened
to do so, with respect to the sale of equipment that might be used by cannabis cultivators, or with respect to any supplies marketed
to participants in the medical and recreational cannabis industry. We are unaware of such a broad application of the CSA or the
seizure of drug paraphernalia by federal authorities, and we believe that such an attempted application would be uncustomary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the federal government were to change its practices, or were to expend its resources investigating and prosecuting providers of
equipment that could be usable by participants in the medical or recreational cannabis industry, such action could have a materially
adverse effect on our operations, our customers, or the sales of our products. As a result of such an action, we may be forced
to cease operations and our investors could lose their entire investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
fact that we provide products and services to companies in the cannabis industry may impact our ability to raise adequate capital
for future expansion, which could hinder our growth potential as well as our revenue and earnings. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
very large percentage, if not all, of our customers are operating in an industry that is still illegal under U.S. federal law.
With the lingering uncertainty of federal enforcement, many potential investors, especially institutional investors, either refuse
to invest in the industry or are very reluctant to make such investments. Our inability to raise adequate capital for future expansion
could substantially hinder our growth potential as well as our revenue and earnings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
success may be dependent on additional states legalizing recreational and/or medical cannabis use.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continued
development of the recreational and medical cannabis markets is dependent upon continued legislative authorization of cannabis
at the state level for recreational and/or medical purposes. Any number of factors could slow or halt the progress. Furthermore,
progress, while encouraging, is not assured, and the process normally encounters setbacks before achieving success. While there
may be ample public support for legislative proposals, key support must be created in the relevant legislative committee or a
bill may never advance to a vote. Numerous factors impact the legislative process. Any one of these factors could slow or halt
the progress and adoption of cannabis for recreational and/or medical purposes, which would limit the overall available market
for our products and services, which could adversely impact our business, revenue and earnings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
customers may have difficulty accessing the service of banks, which may make it difficult for them to purchase our products and
services.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the federal illegality of marijuana, many banks do not provide banking services to the cultivation and distribution
segments of the cannabis industry, the argument being that they would be accepting for deposit funds derived from the operation
of a federally illegal business. On February 14, 2014, the U.S. Department of the Treasury Financial Crimes Enforcement Network
(&ldquo;FinCEN&rdquo;) released guidance to banks &ldquo;clarifying Bank Secrecy Act (&ldquo;BSA&rdquo;) expectations for financial
institutions seeking to provide services to marijuana-related businesses.&rdquo; In addition, there have been legislative attempts
to allow banks to transact business with state-authorized cannabis businesses. While these are positive developments, there can
be no assurance that legislation will be successful, or that, even with the FinCEN guidance, banks will decide to do business
with cannabis companies, or that, in the absence of actual legislation, state and federal banking regulators will not strictly
enforce current prohibitions on banks handling funds generated from an activity that is illegal under federal law. Moreover, the
FinCEN guidance may be rescinded or amended at any time in order to reconcile the now conflicting guidance of the Sessions Memo.
At present, few banks have taken advantage of the FinCEN guidance, resulting in many cannabis businesses still operating on an
all-cash basis. This makes it difficult for cannabis businesses to manage their businesses, pay their employees and taxes, and
having so much cash on hand also creates significant public safety issues. Many ancillary businesses that service cannabis businesses
have to deal with the unpredictability of their clients or customers not having a bank account. The inability of our customers
to open bank accounts and otherwise access the services of banks, including obtaining credit, may make it more difficult and costly
for them to operate and more difficult for such customers to purchase our products and services, which could materially harm our
business, revenue and earnings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are subject to certain federal regulations relating to cash reporting. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
BSA, enforced by FinCEN, requires us to report currency transactions in excess of $10,000, including identification of the customer
by name and social security number, to the Internal Revenue Service. This regulation also requires us to report certain suspicious
activity, including any transaction that exceeds $5,000 that we know, suspect or have reason to believe involves funds from illegal
activity or is designed to evade federal regulations or reporting requirements and to verify sources of funds. Substantial penalties
can be imposed against us if we fail to comply with this regulation. If we fail to comply with these laws and regulations, the
imposition of a substantial penalty could have a material adverse effect on our business, financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>State
and municipal governments in which our customers do business or seek to do business may have or may adopt laws that adversely
affect our ability to do business with such customers.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
the federal government has the right to regulate and criminalize cannabis, state and municipal governments may adopt or amend
additional laws and regulations that further criminalize or adversely affect cannabis businesses. States that currently have laws
that decriminalize or legalize certain aspects of cannabis, such as medical marijuana, could in the future, reverse course and
adopt new laws that further criminalize or adversely affect cannabis businesses. Additionally, municipal governments in certain
states may have laws that adversely affect cannabis businesses, even though there are no such laws at the state level. For example,
municipal governments may have zoning laws that restrict where cannabis operations can be located and the manner and size of which
they can expand and operate. These municipal laws, like the federal laws, may adversely affect our customers&rsquo; ability to
do business. Also, given the complexity and rapid change of the federal, state and local laws pertaining to cannabis, our customers
may incur substantial legal costs associated with complying with these laws and in acquiring the necessary state and local licenses
required by their business endeavors. All of the foregoing may impact our customers&rsquo; ability to purchase our products and
services, which may adversely affect our business, revenue and earnings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Most,
if not all, of our customers are impacted by Section 280E of the Code, which limits certain expenses marijuana companies can deduct.
This negative impact could affect the financial condition of our customers, which in turn may negatively affect the ability of
our customers to purchase our products and services. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
280E of the Code forbids businesses from deducting otherwise ordinary business expenses from gross income associated with the
&ldquo;trafficking&rdquo; of Schedule I or II substances, as defined by the CSA. The Internal Revenue Service (the &ldquo;IRS&rdquo;)
has subsequently applied Section 280E to state-legal cannabis businesses since marijuana is still a Schedule I substance. Section
280E states that no deductions should be allowed on any amount &ldquo;in carrying on any trade or business if such trade or business
consists of trafficking in controlled substances.&rdquo; Section 280E affects all businesses that engage in the cultivation, sale
or processing of marijuana. This includes cultivators, medical dispensaries, marijuana retail stores and infused product manufacturers,
as well as marijuana-derived concentrates and oil manufacturers. Because Section 280E limits certain deductions, it can have a
dramatic effect on the profitability of these businesses, which in turn may adversely affect their ability to purchase our products
and services. Such result may adversely impact our revenue and earnings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
contracts may not be legally enforceable in the United States.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of our historic contracts, and those we may enter into in the future, relate to services that are ancillary to the cannabis industry,
which industry or aspects of the industry are not legal under U.S. federal law and under some state laws. As a result, we may
face difficulties in enforcing our contracts in U.S. federal and certain state courts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Due
to our involvement in the cannabis industry, we may have a difficult time obtaining the various insurances that are desired to
operate our business, which may expose us to additional risk and financial liability.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance
that is otherwise readily available, such as general liability and directors&rsquo; and officers&rsquo; insurance, is more difficult
for us to find, and more expensive, because we are product and service providers to companies in the cannabis industry. There
are no guarantees that we will be able to find such insurances in the future, or that the cost will be affordable to us. If we
are forced to go without such insurances, it may prevent us from entering into certain business sectors, may inhibit our growth,
and may expose us to additional risk and financial liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>A
drop in the retail price of cannabis products may negatively impact our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fluctuations in economic and market conditions that impact the prices of commercially grown cannabis, such as increases in the
supply of cannabis and decreases in demand for cannabis, could have a negative impact on our clients that are cannabis producers,
and therefore could negatively impact our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 3.3pt 0 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
common stock price may be volatile and may decrease substantially.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 3.3pt 0 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 3.3pt 0 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading price of our common stock has fluctuated substantially, and we expect that it will continue to do so. The price of our
common stock in the market on any particular day depends on many factors including, but not limited to, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">price
    and volume fluctuations in the overall stock market from time to time;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">investor
    demand for our shares;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant
    volatility in the market price and trading volume of companies in the cannabis industry; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">variations
    in our operating results and market conditions specific to our business;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    emergence of new competitors or new technologies;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">operating
    and market price performance of other companies that investors deem comparable;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in our Board of Directors or management;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sales
    or purchases of our common stock by insiders, including sales of our common stock issued to employees, directors and consultants
    under our equity incentive plan which were registered under the Securities Act of 1933, as amended (the &ldquo;Securities
    Act&rdquo;) under our S-8 registration statement; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">commencement
    of, or involvement in, litigation;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in governmental regulations, in particular with respect to the cannabis industry; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">actual
    or anticipated changes in our earnings, and fluctuations in our quarterly operating results; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">market
    sentiments about the cannabis industry; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    economic conditions and trends; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">departures
    of any of our key employees. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 3.3pt 0 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Presently,
an exchange listing of our common stock is not likely since we are a U.S.-based company focused on the cannabis industry, which
remains illegal under federal law. Moreover, we may not be able to attract institutional ownership of our stock or research analysts
to cover our stock in the foreseeable future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 3.3pt 0 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 3.3pt 0 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the past, following periods of volatility in the market price of a company&rsquo;s securities, securities class action litigation
has often been brought against that company. Due to the potential volatility of our stock price, we may therefore be the target
of securities litigation in the future. Securities litigation could result in substantial costs and divert management&rsquo;s
attention and resources from our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, if the market for stocks in our industry, or the stock market in general, experiences a loss of investor confidence,
the market price of our common stock could decline for reasons unrelated to our business, financial condition, or results of operations.
If any of the foregoing occurs, it could cause the price of our common stock to fall and may expose us to lawsuits that, even
if unsuccessful, could be costly to defend and a distraction to our Board of Directors and management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
application of the &ldquo;penny stock&rdquo; rules could adversely affect the market price of our common shares and increase an
investor&rsquo;s transaction costs to sell those shares.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC has adopted Rule 3a51-1, which establishes the definition of a &ldquo;penny stock,&rdquo; for the purposes relevant to us,
as any equity security that has a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share,
subject to certain exceptions. For any transaction involving a penny stock, unless exempt, Rule 15g-9 requires:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
    a broker or dealer approve a person&rsquo;s account for transactions in penny stocks, and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    broker or dealer receives from the investor a written agreement to the transaction, setting forth the identity and quantity
    of the penny stock to be purchased.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    order to approve a person&rsquo;s account for transactions in penny stocks, the broker or dealer must:</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">obtain
    financial information and investment experience objectives of the person, and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
    a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient
    knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the SEC relating
to the penny stock market, which, in highlight form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">sets
    forth the basis on which the broker or dealer made the suitability determination, and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">that
    the broker or dealer received a signed, written agreement from the investor prior to the transaction.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
brokers may be less willing to execute transactions in securities subject to the &ldquo;penny stock&rdquo; rules or involving
the cannabis industry. This may make it more difficult for investors to dispose of our common stock and may cause a decline in
the market value of our stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
Board of Directors is authorized to reclassify any unissued shares of our preferred stock into one or more classes, which could
convey special rights and privileges to its owners.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
articles of incorporation permit our Board of Directors to reclassify any authorized but unissued shares of preferred stock into
one or more classes. Our Board of Directors will generally have broad discretion over the size and timing of any such classification,
subject to a finding that the classification and issuance of preferred stock is in our best interests. We are authorized to issue
up to 350,000,000 shares of common stock and 150,000,000 shares of preferred stock. As of December 31, 2020, we had 236,526,638
shares of common stock issued and outstanding and 42,030,331 shares of preferred stock issued and outstanding. In the event our
Board of Directors opts to classify a portion of our unissued shares of preferred stock into a class of preferred stock, those
preferred shares would have a preference over our common stock with respect to dividends and liquidation. The cost of any classification
would be borne by our existing common stockholders. The class voting rights of any preferred shares we may issue could make it
more difficult for us to take some actions that may, in the future, be proposed by the Board of Directors and/or the holders of
our common stock, such as a merger, exchange of securities, liquidation, or alteration of the rights of a class of our securities,
if these actions were perceived by the holders of preferred shares as not in their best interests. These effects, among others,
could have an adverse effect on your investment in our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Rule
144 contains risks for certain shareholders.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, we issue shares on an unregistered basis, which may be eligible for resale under SEC Rule 144 promulgated under
the Securities Act. In the event there are shares outstanding that can be sold under Rule 144, there may be market pressure on
our stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 3.3pt 0 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
do not intend to pay cash dividends on our common stock. </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently are not profitable and do not expect to achieve profitability in the foreseeable future. We have never declared or paid
dividends on our common stock. We intend to invest any available funds to continue to grow our revenue. Accordingly, we do not
expect to pay cash dividends to our stockholders now or in the foreseeable future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
market price of our shares of common stock may be adversely affected by the sale of shares by our management or large stockholders.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of our shares of common stock by our officers or senior managers through 10b5-1 plans or otherwise or by large stockholders could
adversely and unpredictably affect the price of our common stock. Additionally, the price of our shares of common stock could
be affected even by the potential for sales by these persons. We cannot predict the effect that any future sales of our common
stock, or the potential for those sales, will have on our share price. Furthermore, due to relatively low trading volume of our
stock, should one or more large stockholders seek to sell a significant portion of their stock in a short period of time, the
price of our stock may decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_004"></A>Item
1B. Unresolved Staff Comments </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act, and therefore we are not required to provide information
under this item.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_005"></A>Item
2. Properties </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.95pt; text-align: justify; text-indent: -48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
own no real property. On June 27, 2017, we executed a lease, which became effective September 29, 2017, for our manufacturing
and office space at 1780 55<SUP>th</SUP> Street, Boulder, Colorado 80301. The term of the lease commenced September 29, 2017 and
continues through August 31, 2022. Our leased space is approximately 18,600 square feet. We believe that our lease is at market
rates and that there is sufficient space available in the Boulder, Colorado area to obtain additional or other space if and when
required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_006"></A>Item
3. Legal Proceedings </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 48.95pt; text-align: justify; text-indent: -48.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2019, there were 6,750,000 restricted stock units that had not been settled due to a dispute with a former employee
over the required withholding taxes to be paid to the Company for remittance to the appropriate tax authorities. The Company commenced
an arbitration action against the former employee regarding the dispute. The former employee also made claims in the arbitration
action against the Company for unpaid wages. As stated in a pleading in the arbitration, on March 9, 2020, the Company issued
the former employee 6,750,000 shares of the Company&rsquo;s common stock in settlement of these restricted stock units after taking
measures to mitigate the Company&rsquo;s exposure to penalties and liability for the failure to properly withhold income taxes.
The Arbitrator issued an interim award of approximately $10,000 in the Company&rsquo;s favor and a finding against the former
employee. Effective June 9, 2020, the Arbitrator issued his final award in the Company&rsquo;s favor, in the Colorado arbitration.
The Arbitrator found against the former employee and awarded the Company costs of $33,985, with interest at 8% per year. Effective
July 22, 2020, the Colorado Court confirmed the Arbitration award and entered a final judgement in favor of the Company and against
the former employee. The Company pursued collection of this debt and has now collected the debt owed. This former employee is
continuing to pursue separate litigation against the Company for recovery of alleged consulting fees owed to him for the 2015
calendar year prior to his appointment as an executive officer of the Company. </FONT>The Company strongly disputes the ongoing
litigation and in the remote event of an adverse outcome, the amount of any settlement loss for this case is not reasonably estimable
as of the date of the issuance of these financial statements.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not currently subject to any material legal proceedings, nor, to our knowledge, is any material legal proceeding threatened
against us. From time to time, we may be a party to certain legal proceedings in the ordinary course of business, including proceedings
relating to the enforcement of our rights under contracts with our customers. While the outcome of these legal proceedings cannot
be predicted with certainty, we do not expect that these proceedings will have a material effect upon our financial condition
or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_007"></A>Item
4. Mine Safety Disclosures</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_008"></A>PART
II </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_032"></A>Item
5. Market for Registrant&rsquo;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
shares of common stock are quoted on the OTCQB operated by The OTCMarkets under the symbol &ldquo;SRNA.&rdquo; Over-the-counter
market quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not necessarily represent
actual transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have approximately 130 shareholders of record and approximately 15,400 beneficial shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 3.3pt 0 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity
Compensation Plans </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 1, 2017, our Board of Directors adopted and approved the 2017 Equity Incentive Plan (the &ldquo;2017 Equity Plan&rdquo;)
in order to attract, motivate, retain, and reward high-quality executives and other employees, officers, directors, consultants,
and other persons who provide services to us by enabling such persons to acquire an equity interest in us. Under the 2017 Equity
Plan, our Board of Directors may award stock options, stock appreciation rights (&ldquo;SARs&rdquo;), restricted stock awards
(&ldquo;RSAs&rdquo;), restricted stock unit awards (&ldquo;RSUs&rdquo;), shares granted as a bonus or in lieu of another award,
and other stock-based performance awards. The 2017 Equity Plan allocates 50,000,000 shares of our common stock (&ldquo;Plan Shares&rdquo;)
for issuance of equity awards under the 2017 Equity Plan. As of December 31, 2020, we have granted, under the 2017 Equity Plan,
awards in the form of RSAs for services rendered by independent directors and consultants, non-qualified stock options, RSUs and
stock bonus awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information for our 2017 Equity Plan as of December 31, 2020 is summarized as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of shares to be issued upon exercise of outstanding options</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted-average
    exercise price of outstanding options</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in first
    column)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Equity compensation plans approved by
    shareholders</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 38%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Equity
    compensation plans not approved by shareholders (1)</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21,651,000</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.078</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 20%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,795,182</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21,651,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.078</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,795,182</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="13" STYLE="padding-bottom: 2.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="13" STYLE="text-align: justify; padding-bottom: 2.5pt">(1)
Of the 50,000,000 Plan Shares allocated for issuance under the 2017 Equity Plan, as of December 31, 2020, 24,553,818 shares have
been issued, options over 21,651,000 shares were issued and outstanding and securities in respect of the remaining 3,795,182 shares
were available for future issuance.</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
to Note 14 &ndash; <I>Equity Incentive Plan </I>of our consolidated financial statements, which are included as part of this Annual
Report for the further details on our 2017 Equity Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_009"></A>Item
6. Selected Financial Data</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a smaller reporting company, as defined by Rule 12b-2 of the Exchange Act, and therefore we are not required to provide the
information under this item.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item
7. <A NAME="a_010"></A>Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following discussion should be read in conjunction with our consolidated financial statements and related notes and other financial
information included elsewhere in this Annual Report, which include additional information about our accounting policies, practices,
and the transactions underlying our financial results. In addition to historical information, this Annual Report contains forward-looking
information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking
information due to the factors discussed under &ldquo;Cautionary Statements&rdquo; appearing elsewhere herein and the risks and
uncertainties described or identified in &ldquo;Item 1A &ndash; Risk Factors&rdquo; in this Annual Report. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Please
also refer to &ldquo;Non-GAAP Financial Measures&rdquo; discussed elsewhere in this Annual Report. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion should be read in conjunction with Item 1 &ndash; Business in this Annual Report, and our consolidated financial
statements and accompanying notes to consolidated financial statements included in this Annual Report. Our Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations (&ldquo;MD&amp;A&rdquo;) is segregated into four sections,
including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.1pt; background-color: white; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Executive
Overview</I></B>. This section provides a summary of our operating performance and cash flows, industry trends and our strategic
initiatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.1pt; background-color: white; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Critical
Accounting Policies and Estimates</I></B><I>.</I> This section describes the accounting areas where management makes critical
estimates to report our financial condition and results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Results
of Operations</I></B><I>. </I>This section provides an analysis of our consolidated results of operations for the two comparative
periods presented in our consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 28.1pt; background-color: white; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Liquidity,
Capital Resources and Financial Position</I></B><I>.</I> This section provides an analysis of cash flow, contractual obligations,
and certain other matters affecting our financial position.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executive
Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenue for the year ended December 31, 2020 was $8,514,000 compared to $15,224,000 for the year ended December 31, 2019, a decrease
of $6,710,000, or 44%. Overall, we had a net loss of $1,759,000 for the year ended December 31, 2020 as compared to a net loss
of $1,339,000 for the year ended December 31, 2019, an increase of $420,000, or 31%. Our 2020 adjusted net loss was $1,239,000
compared to a 2019 adjusted net income of $92,000. Our adjusted net income (loss) is our GAAP net income (loss) after addback
for our non-cash equity compensation expenses, debt-related items and depreciation expense. Historically, one of the most significant
financial challenges we face is the inconsistent and unpredictable revenue we generate quarter-over-quarter, and our revenue and
cash flow remain difficult to predict.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Impact
of the COVID-19 Pandemic on Our Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white; color: #212529"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of
our markets and disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales,
project implementation, operating margins, and working capital. As of the date of this filing, uncertainty continues to exist
concerning the magnitude and duration of the economic impact of the COVID-19 pandemic.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
response to the COVID-19 pandemic and its changing conditions the Company reduced its operational expenses to conserve its cash
resources. Many expenses, including travel, marketing, headcount, work hours, and compensation were reduced, deferred, or eliminated
while still allowing us to meet our customer obligations and develop new business. As the fiscal year progressed and our sales
rebounded, and we were able to obtain additional funds through a forgivable bank loan, we restored our workforce and compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the speed with which the COVID-19 pandemic developed and the resulting uncertainties, including the depth and duration of the
disruptions to customers and suppliers, its future effect on our business, on our results of operations, and on our financial
condition, cannot be predicted. We expect that the economic disruptions will continue to have an effect on our business over the
longer term. Despite this uncertainty, we continue to monitor costs and continue to take actions to reduce costs so as to mitigate
the impact of the COVID-19 pandemic to the best of our ability, although they may not be sufficient in the long-run for us to
avoid reduced sales, increased losses and reduced operating cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
to <I>Risk Factors</I>, included in Part I, Item 1A of this Annual Report on Form 10-K above, for further discussion of the possible
impact of the COVID-19 pandemic on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a three-prong growth strategy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<B><I><U>Expand our Customer Base</U></I></B>. We have a sales and marketing program that generates many prospect relationships.
However, our limited range of higher cost products, mostly chilled water systems, reduces the number of customer prospects who
can afford to buy from us. This year, we will broaden our product line to include lower- and mid-cost products, such as split
systems and packaged roof top units. We believe these new products and services will increase our addressable market and sales,
further leveraging our investment in sales and marketing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
of our key 2019 and 2020 goals was to obtain more business from MFOs, which have greater financial resources, are more sophisticated,
buy more and larger systems, and are less prone to project delays and cancellations, compared to the smaller cultivators that
had been our primary customers in the past. Although we booked fewer projects with MFOs in 2020 than we did in 2019, we, booked
three projects representing $3.5 million in potential future revenue. We recorded $2.9 million in revenue from these projects,
or 35% of our total 2020 revenue. However, we still have significant work ahead of us to fill our sales pipeline with MFO customers
that we believe will result in more consistent and predictable revenue and cash flow.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<B><I><U>Sell More Automation and Control Systems</U></I></B>. In 2019 we fulfilled a key goal by launching our SentryIQ&reg;
sensors, controls and automation (&ldquo;SCA&rdquo;) platform&mdash;a turnkey, single-vendor HVACD equipment and controls integration
solution. We continued the rollout in 2020 and to date we have entered into thirteen contracts with twelve different companies
to implement our SentryIQ&reg; SCA platform. This product line is important for tactical and strategic reasons, and we hope to
offer this as a standalone offering in the future. These systems provide a steady stream of data that our customers can use to
make daily cultivation decisions. Additionally, we can use this data to track trends and apply future enhancements to our products
and services, fostering closer relationships with our customers throughout their facilities&rsquo; life cycles. This product line
is important for tactical and strategic reasons previously discussed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to continue to develop technology and innovations that provide value-add to our customers. We also intend to seek out &ldquo;best-in-class&rdquo;
partners to help us automate and control the indoor grow facilities of the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B><I><U>Engage in Strategic Relationships with other Technology Leaders</U></I>. </B>During 2019, we identified several business
verticals that we believe could be logical and natural complements to our climate control business, including: lighting, fertigation
(automated process of delivering nutrients and water to plants), benches (customized systems to optimize use of the growing space),
cultivation management technology (software), consumables (growing, packaging, facility and lab supplies), and operational improvement
analytics (modeling, data aggregation and artificial intelligence). We intend to work with &ldquo;best-in-class&rdquo; vendors
to develop more comprehensive, end-to-end, integrated solutions and specialized products and services that can help our cultivators
compete in the market, whether through automation, software or operating efficiencies. We hope to establish one or more strategic
alliances, such as reseller, distribution, co-marketing or product development agreements, with select companies which are consistent
with our strategic direction. In 2020 we were unable to find suitable partners for such strategic relationships, but we continue
to pursue this growth initiative.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
time, if some of these strategic alliances are successful in driving top-line revenue for us and our partners, such relationships
could develop into more exclusive arrangements or evolve into possible acquisitions or a source of strategic capital for us. There
can be no assurance that we will be able to successfully execute any of these strategic initiatives. Our efforts will be primarily
focused on working with new strategic partners to co-market each other&rsquo;s products and services and possibly jointly develop
new and improved products and services with CEA-specific applications, as opposed to seeking acquisitions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*******</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Revenue</U></I></B>.
Our 2020 revenue was $8,514,000. Our 2020 revenue represents a decrease of 44% compared to 2019. One of our MFO customers accounted
for 28% of our 2020 revenue. We believe, among other things, that we need to build a diversified sales pipeline of MFOs, which
we believe will increase our consistency and predictability of revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Gross
Margin</U></I></B>. Our 2020 gross margin was 18.2%, a decrease from 29.9% in 2019. This decrease was primarily due to our fixed
cost base, a lower margin on equipment sales, and an increase in variable costs as a percent of revenue as described in <I>Results
of Operations</I> below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Profitability</U></I></B>.
Our 2020 adjusted net loss was $1,239,000 compared to a 2019 adjusted net income of $92,000. Our adjusted net income (loss) is
a key management metric and point of focus for us because it provides a proxy for the cash we generate from operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Capital
Resources.</U></I></B> Our working capital remains negative, and we have limited capital resources, which are impediments to the
overall viability of our business as planned. The effect of the COVID-19 response has presented further challenges for us in 2020.
Without increasing our current revenue and adding new sources of revenue, we cannot predict our future. As discussed elsewhere
in this Annual Report, we have taken steps to reduce costs. We cannot predict how long our cost cutting measures will sustain
the Company or how long the current economic situation will last.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Contract
Bookings.</U></I></B> Our bookings dropped significantly in the first half of 2020 but recovered in the second half, and our backlog
at December 31, 2020, was $8,448,000, a decrease of $1,110,000, or 12%, from our December 31, 2019 backlog. During 2020, we had
net bookings of $7,404,000, consisting of: (i) $10,343,000 of new sales contracts executed in 2020, (ii) $151,000 net positive
changes orders, and (iii) $3,089,000 in project cancellations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth: (i) our beginning backlog (the remaining contract value of outstanding sales contracts for which we
have received an initial deposit as of the previous period), (ii) our net bookings for the period (new sales contracts executed
during the period for which we received an initial deposit, net of any adjustments including cancellations and change orders
during the period), (iii) our recognized revenue for the period, and (iv) our ending backlog for the period (the sum of the beginning
backlog and net bookings, less recognized revenue). Based on the current economic climate and our cost cutting measures, there
is no assurance that we will be able to continue to obtain the level of bookings that we have had in the past and or fulfill our
current backlog, and we may experience contract cancellations, project scope reductions and project delays.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="18" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
    the quarter ended </B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">March
    31, 2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">June
    30, 2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">September
    30, 2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 30%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Backlog, beginning balance</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,143,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,558,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,875,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5,592,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8,198,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net bookings, current period</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,134,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,127,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,601,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,241,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,637,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Recognized revenue, current period</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,719,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,810,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,682,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,635,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,387,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Backlog, ending balance</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,558,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,875,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,592,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,198,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,448,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
has historically been the case at each quarter-end, there remains significant uncertainty regarding the timing of revenue recognition
of our backlog as of December 31, 2020. As of December 31, 2020, $2,643,000 of our backlog, or 31%, was attributable to customer
contracts for which we have only received an initial advance payment to cover our engineering services (&ldquo;engineering only
paid contracts&rdquo;). There are always risks that the equipment portion of our engineering only paid contracts will not be completed
or will be delayed, which could occur if the customer is dissatisfied with the quality or timeliness of our engineering services,
there is a delay or abandonment of the project due to the customer&rsquo;s inability to obtain project financing or licensing,
or the customer determines not to proceed with the project due to economic factors, such as declining cannabis wholesale prices
in the state.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have provided an estimate in our consolidated financial statements for when we expect to recognize revenue on our remaining performance
obligations (i.e., our Q4 2020 backlog), using separate time bands, with respect to engineering only paid contracts and partial
equipment paid contracts. However, there continues to be significant uncertainty regarding the timing of our recognition of revenue
in our Q4 2020 backlog. Refer to the <I>Revenue Recognition</I> section of Note 2 in our consolidated financial statements, included
as part of this Annual Report for additional information on our estimate of future revenue recognition on our remaining performance
obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
backlog, remaining performance obligations and net bookings may not be indicative of future operating results, and our customers
may attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project
financing or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included
in backlog or remaining performance obligations will actually generate revenues or when the actual revenues will be generated.
Net bookings and backlog are considered non-GAAP financial measures, and therefore, they should be considered in addition to,
rather than as a substitute for, our GAAP measures for recognized revenue, deferred revenue and remaining performance obligations.
Further, we can provide no assurance as to the profitability of our contracts reflected in remaining performance obligations,
backlog and net bookings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Critical
Accounting Policies and Estimates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements,
which have been prepared in conformity with accounting principles generally accepted in the United States of America. Certain
accounting policies are particularly important to the understanding of our financial position and results of operations and require
the application of significant judgment by our management or can be materially affected by changes from period to period in economic
factors or conditions that are outside of our control. As a result, they are subject to an inherent degree of uncertainty. In
applying these policies, management uses their judgment to determine the appropriate assumptions to be used in the determination
of certain estimates. Those estimates are based on our historical operations, our future business plans and projected financial
results, the terms of existing contracts, observance of trends in the industry, information provided by our customers, and information
available from other outside sources, as appropriate. Actual results could materially differ from those estimates. For information
regarding our critical accounting policies as well as recent accounting pronouncements, see Note 2 of our consolidated financial
statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management has discussed the development and selection of critical accounting estimates with the Board of Directors and the Board
of Directors has reviewed our disclosure relating to critical accounting estimates in this Annual Report. We believe the following
are the more significant judgments and estimates used in the preparation of our consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Allowance
for accounts receivable</I>. Accounts receivables are recorded at the invoiced amount or based on revenue earned for items
not yet invoiced, and generally do not bear interest. An allowance for doubtful accounts is established, as necessary, based
on past experience and other factors, which, in management&rsquo;s judgment, deserve current recognition in estimating bad
debts. Based on its review, we establish or adjust the allowance for specific customers and the accounts receivable portfolio
as a whole. As of December 31, 2020, and December 31, 2019, the allowance for doubtful accounts was $165,098 and
$151,673, respectively. If the financial condition of our customers were to deteriorate, resulting in an impairment of their
ability to make payments, additional allowances may be required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Excess
and obsolete inventory</I>. Inventory is stated at the lower of cost or net realizable value. The inventory is valued based on
a first-in, first-out (&ldquo;FIFO&rdquo;) basis. Lower of cost or net realizable value is evaluated by considering obsolescence,
excessive levels of inventory, deterioration and other factors. Adjustments to reduce the cost of inventory to its net realizable
value, if required, are made for estimated excess, obsolescence or impaired inventory. Excess and obsolete inventory is charged
to cost of revenue and a new lower-cost basis for that inventory is established and subsequent changes in facts and circumstances
do not result in the restoration or increase in that newly established cost basis. As of December 31, 2020, and December 31,
2019, the allowance for excess and obsolete inventory was $93,045 and $71,376, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Goodwill
impairment</I>. Goodwill, defined as unidentified asset(s) acquired in conjunction with a business acquisition, is tested for
impairment on an annual basis and between annual tests whenever events or changes in circumstances indicate that the carrying
amount may not be recoverable. We recorded goodwill in connection with our acquisition of Hydro Innovations in July 2014. We perform
a quantitative impairment test annually during the fourth quarter by comparing the fair value of the reporting unit with its carrying
amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired.
An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&rsquo;s fair value.
We completed this assessment as of December 31, 2020 and concluded that no impairment existed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Product
warranty</I>. We warrant the products that we manufacture for a warranty period equal to the lesser of 12 months from start-up
or 18 months from shipment. Our warranty provides for the repair, rework, or replacement of products (at our option) that fail
to perform within stated specification. Our third-party suppliers also warrant their products under similar terms, which are passed
through to our customers. We assess the historical warranty claims on our manufactured products and, since 2016, warranty claims
have been approximately 1% of annual revenue generated on these products. We continue to assess the need to record a warranty
reserve at the time of sale based on historical claims and other factors. As of December 31, 2020, and December 31, 2019,
we had an accrued warranty reserve amount of $173,365 and $185,234, respectively, which are included in accounts payable and accrued
liabilities on our consolidated balance sheets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Income
taxes.</I> We account for deferred tax liabilities and assets for the future consequences of events that have been recognized
in our consolidated financial statements or tax returns. Measurement of the deferred items is based on enacted tax laws. In the
event the future consequences of differences between financial reporting bases and tax bases of our assets and liabilities result
in a deferred tax asset, we perform an evaluation of the probability of being able to realize the future benefits indicated by
such asset. A valuation allowance related to a net deferred tax asset is recorded when it is more likely than not that some portion
or all of the net deferred tax asset will not be realized. Management&rsquo;s judgment is required in determining our provision
for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets.
We recorded a full valuation allowance as of December 31, 2020 and December 31, 2019. Based on the available evidence,
we believe it is more likely than not that we will not be able to utilize our net deferred tax assets in the foreseeable future.
We intend to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances.
We make estimates and judgments about our future taxable income that are based on assumptions that are consistent with our plans.
Should the actual amounts differ from our estimates, the carrying value of our deferred tax assets could be materially impacted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Share-based
compensation</I>. We recognize the cost resulting from all share-based compensation arrangements, including stock options, restricted
stock awards and restricted stock units that we grant under our equity incentive plan in our consolidated financial statements
based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the
award. The service inception date is typically the grant date, but the service inception date may be prior to the grant date.
Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based
vesting conditions which require the achievement of a specific company financial performance goal at the end of the performance
period and required service period are recognized over the performance period. Each reporting period, we reassess the probability
of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized, and
any previously recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation
cost is based on the grant date fair value and expected achievement of market condition and is not subsequently reversed if it
is later determined that the condition is not likely to be met or is expected to be lower than initially expected. The grant date
fair value of stock options is based on the Black-Scholes Model. The Black-Scholes Model requires judgmental assumptions including
volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest
rates whose term is consistent with the expected term of the option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Allocation
of transaction price; standalone selling price</I>. A contract&rsquo;s transaction price is allocated to each distinct performance
obligation and recognized as revenue when, or as, the performance obligation is satisfied. When there are multiple performance
obligations within a contract, we allocate the transaction price to each performance obligation based on standalone selling price.
When estimating the selling price, we use various observable inputs. The best observable input is our actual selling price for
the same good or service, however, this input is generally not available for our contracts containing multiple performance obligations.
For engineering services, we estimate the standalone selling price by reference to certain physical characteristics of the project,
such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering
services to be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of
the equipment and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending
on the nature of the performance obligations, we may use a combination of different methods and observable inputs if certain performance
obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, we apply the
relative values to the total contract consideration and estimates the amount of the transaction price to be recognized as each
promise is fulfilled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Remaining
performance obligations. </I>The revenue standard requires certain quantitative and qualitative disclosures about our remaining
performance obligations, which are defined as performance obligations that are unsatisfied (or partially unsatisfied) as of the
end of the reporting period, including (i) the aggregate amount of the transaction price allocated to the remaining performance
obligations, and (ii) when we expect to recognize as revenue with respect to such amounts on either: (x) a quantitative basis
using appropriate time bands for the duration of the remaining performance obligations, or (y) by using qualitative information.
Industry uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are
out of our control, make it difficult for us to predict when we will recognize revenue on our remaining performance obligations.
There are risks that we may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&rsquo;s cultivation facility project is dependent upon the customer&rsquo;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time
it takes for customers to complete a project, which corresponds to when we are able to recognize revenue, is driven by numerous
factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii)
the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government
delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states
where there is no cap on the number of cultivators; (iv) the customer&rsquo;s need to obtain cultivation facility financing; (v)
the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility
(to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate
control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction
project. Further, based on the current economic climate, the uncertainty regarding the COVID-19 virus, and the Company&rsquo;s
recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may
experience contract cancellations, project scope reductions and project delays.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is significant uncertainty regarding the timing of our recognition on all remaining performance obligations as of December 31,
2020. Customer contracts for which we have only received an initial advance payment to cover the allocated value of our engineering
services (&ldquo;engineering only paid contracts&rdquo;) carry enhanced risks that the equipment portion of these contracts will
not be completed or will be delayed, which could occur if the customer is dissatisfied with the quality or timeliness of our engineering
services or there is a delay or abandonment of the project due to the customer&rsquo;s inability to obtain project financing or
licensing. In contrast, after the customer has made an advance payment for a portion of the equipment to be delivered under the
contract (&ldquo;partial equipment paid contracts&rdquo;), we are typically better able to estimate the timing of revenue recognition
since the risks and delays associated with licensing, permitting and project funding are typically mitigated once the initial
equipment payment is received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Commitments
and contingencies</I>. In the normal course of business, we are subject to loss contingencies, such as legal proceedings and claims
arising out of our business, that cover a wide range of matters, including, among others, customer disputes, government investigations
and tax matters. An accrual for a loss contingency is recognized when it is probable that an asset had been impaired, or a liability
had been incurred and the amount of loss can be reasonably estimated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Results
of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Comparison
of Years ended December 31, 2020 and 2019 </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Revenues
and Cost of Goods Sold</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
for the year ended December 31, 2020 was $8,514,000 compared to $15,224,000 for the year ended December 31, 2019, a decrease of
$6,710,000, or 44%. This revenue decrease was partly the result of our decreased net bookings in 2020, which fell from $16,300,000
in 2019 to $7,405,000 in 2020, or 55%. We remain unable to consistently convert our backlog into revenue on a quarter-over-quarter
basis. Our revenue conversion is largely dependent on customer-centric factors&mdash;outside of our control&mdash;such as industry
uncertainty, project financing concerns, the licensing and qualification of our prospective customers, and other reasons such
as a challenging business climate including an overall post-COVID-19 economic downturn, which makes it difficult for us to predict
when we will recognize revenue on our backlog.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenue decreased by $3,714,000 from $10,676,000 for the year ended December 31, 2019 to $6,961,000 for the year ended December
31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
gross profit for the year ended December 31, 2020 was $1,553,000 compared to $4,549,000 for the year ended December 31, 2019.
Gross profit margin decreased by approximately twelve percentage points from 29.9% for the year ended December 31, 2019 to 18.2%
for the year ended December 31, 2020. This decrease was primarily due to our fixed cost base, a lower margin on equipment sales,
and an increase in variable costs as a percent of revenue as described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenue cost structure is comprised of both fixed and variable components. The fixed cost component represents engineering, manufacturing
and project management salaries and benefits and manufacturing overhead that totaled $1,167,000, or 13.7% of total revenue, for
the year ended December 31, 2020 as compared to $1,426,000, or 9.4% of total revenue, for the year ended December 31, 2019. The
decrease of $259,000 was primarily due to a decrease in salaries and benefits (including stock-based compensation) of $277,000,
offset by an increase of $18,000 in fixed overhead. The variable cost component, which represents our cost of equipment, outside
engineering costs, shipping and handling, travel and warranty costs, totaled $5,795,000, or 68.1% of total revenue, in the year
ended December 31, 2020 as compared to $9,250,000, or 60.8% of total revenue, in the year ended December 31, 2019. In the year
ended December 31, 2020 as compared to the prior year, our cost of equipment decreased by $3,331,000 primarily due to the decrease
in revenue and a decrease in our equipment margin of 3.5 percentage points. Additionally in the year ended December 31, 2020 as
compared to the year ended December 31, 2019: (i) our warranty costs increased by $144,000, (ii) our excess and obsolete inventory
and other variable overheads increased by $45,000, which were offset by (iii) a reduction in outside engineering costs of $156,000,
(iv) a reduction in shipping and handling costs of $89,000 and, (v) decreased travel of $69,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Operating
Expenses</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
expenses decreased by 33% from $5,859,000 for the year ended December 31, 2019 to $3,916,000 for the year ended December 31, 2020,
a decrease of $1,944,000. The operating expense decrease consisted primarily of: (i) a decrease in selling, general and administrative
expenses (&ldquo;SG&amp;A expenses&rdquo;) of $1,567,000, (ii) a decrease in advertising and marketing expenses of $246,000 and,
(iii) a decrease in product development expenses of $131,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
decrease in SG&amp;A expenses for the year ended December 31, 2020 compared to the year ended December 31, 2019, was due primarily
to: (i) a decrease of $762,000 in stock-based compensation, (ii) a decrease of $191,000 in commissions, (iii) a decrease in travel
of $122,000, (iv) a decrease of $138,000 in accounting and other professional fees, (v) a decrease of $111,000 in loss on asset
disposal, (vi) a decrease of $69,000 in board fees, (vii) a decrease of $57,000 in salaries, benefits and other employee related
costs, (viii) a decrease of $44,000 in bad debt expense, (ix) a decrease in depreciation of $40,000, (x) a decrease of $17,000
in facilities, insurance and office supplies and, (xi) a decrease in investor relations costs of $15,000. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
decrease in marketing expenses were due primarily to: (i) a decrease of $205,000 for industry trade shows and events, (ii) a decrease
in stock-based compensation of $26,000, (iii) a decrease of $17,000 in travel, (iv) a decrease of $15,000 in collateral and other
marketing expenses, offset by (v) an increase of $20,000 for web development.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
decrease in product development costs was due to (i) a decrease in materials costs of $88,000, (ii) a decrease in stock-based
compensation of $23,000, (iii) a decrease in salaries and benefits of $12,000 and, (iv) a decrease in travel of $7,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Operating
Loss </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had an operating loss of $2,363,000 for the year ended December 31, 2020, as compared to an operating loss of $1,311,000 for
the year ended December 31, 2019, an increase of $1,052,000, or 80%. The operating loss included $406,000 of non-cash,
stock-based compensation expenses and $114,000 for depreciation and amortization in the year ended December 31, 2020 as
compared to $1,277,000 for stock-based compensation and $154,000 of depreciation and amortization for the year ended December
31, 2019. Excluding these non-cash items, our operating loss increased by $1,964,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Income (Expense) </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
other income (net) increased by $632,000 from other expense (net) of $28,000 for the year ended December 31, 2019 to other income
(net) of $604,000 for the year ended December 31, 2020. This change is primarily due to loan forgiveness of $557,000 and income
from a legal judgement of $35,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Net
Loss</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overall,
we had a net loss of $1,759,000 for the year ended December 31, 2020 as compared to a net loss of $1,339,000 for the year ended
December 31, 2019, an increase of $420,000. The net loss included $406,000 of non-cash, stock-based compensation costs and depreciation
and amortization expense of $114,000 in the year ended December 31, 2020 as compared to non-cash, stock-based compensation expense
of $1,277,000 and depreciation and amortization of $154,000 in the year ended December 31, 2019. Excluding these non-cash items,
our net loss increased by $1,332,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liquidity,
Capital Resources and Financial Position </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cash
and Cash Equivalents</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, we had cash and cash equivalents of $2,285,000, compared to cash and cash equivalents of $922,000 as of
December 31, 2019, an increase of 148%. The $1,363,000 increase in cash and cash equivalents during the year ended December 31,
2020 was primarily the result of cash provided by our operating and financing activities. Our cash is held in bank depository
accounts in certain financial institutions. We currently have deposits in financial institutions that exceed the federally insured
amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, we had accounts receivable (net of allowance for doubtful accounts) of $33,000, inventory (net of excess
and obsolete allowance) of $327,000, and prepaid expenses and other of $1,038,000 (including $916,000 in advance payments on inventory
purchases). While we typically require advance payment before we commence engineering services or ship equipment to our customers,
we have made exceptions requiring us to record accounts receivable, which carry a risk of non-collectability especially since
most of our customers are funded on an as-needed basis to complete facility construction. We expect our exposure to accounts receivable
risk to increase as we pursue larger projects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, we had no indebtedness, total accounts payable and accrued liabilities of $1,785,000, deferred revenue of
$3,724,000, accrued equity compensation of $128,000, and the current portion of operating lease liability of $266,000. As of December
31, 2020, we had a working capital deficit of $2,220,000, compared to a working capital deficit of $1,437,000 as of December 31,
2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on our common stock. We currently intend to retain all available funds and any
future earnings for use in the operation and expansion of our business and do not anticipate paying any cash dividends in the
foreseeable future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of the economic situation that developed during 2020, we cannot predict the continuing level of working capital that we will have
in the future. Additionally, we cannot predict that our future financial position will not deteriorate due to cancelled or delayed
contract fulfillment, reduced sales and our ability to perform our contracts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Summary
of Cash Flows </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summarizes our cash flows for the years ended December 31, 2020 and 2019:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
                                         the Years Ended</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
                                         31,</FONT></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash provided by operating
    activities</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">818,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">672,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash used in investing activities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(9,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash provided
    by financing activities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">554,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net increase
    in cash</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,363,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">669,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Operating
Activities </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred a net loss for the year ended December 31, 2020 of $1,759,000 compared to a net loss for the year ended December 31,
2019 of $1,339,000. We had an accumulated deficit of $27,444,000 as of December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
provided by operations for the year ended December 31, 2020 was $818,000 compared to cash provided by operations of $672,000 for
the year ended December 31, 2019, an increase of $146,000. The increase was primarily attributable to: (i) an increase in cash
from working capital of $1,370,000, offset by, (ii) a decrease in non-cash operating charges of $804,000, and (iii)
an increase in net loss of $420,000. Significant non-cash items included: (i) a gain on note payable forgiveness of $557,000,
(ii) stock-related compensation of $277,000, (iii) $190,000 for amortization of ROU asset, and (iv) depreciation
and amortization expense of $120,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Investing
Activities</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
used in investing activities for the year ended December 31, 2020 was $9,000, compared to cash used in investing activities of
$3,000 for the year ended December 31, 2019. The change related to purchases of property and equipment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Financing
Activities</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2020 and 2019, cash from financing activities was $554,000 and $0, respectively. The cash from financing
activities was the result of a loan received from our bank on April 22, 2020 which was subsequently forgiven on December 11, 2020.
<I>See Note 9 &ndash; Note Payable and Accrued Interest</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Going
Concern</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
consolidated financial statements for the year ended December 31, 2020, have been presented on a going concern basis, which contemplates
the realization of assets and the satisfaction of liabilities in the normal course of business. Our independent registered public
accounting firm included in its audit opinion on our consolidated financial statements for the year ended December 31, 2020, a
statement that there is substantial doubt as to our ability to continue as a going concern, and our consolidated financial statements
for the year ended December 31, 2020 were prepared assuming that we would continue as a going concern. We have determined that
our ability to continue as a going concern is dependent on raising additional capital to fund our operations and ultimately on
generating future profitable operations. There can be no assurance that we will be able to raise sufficient additional capital
or eventually have positive cash flow from operations to address all of our cash flow needs. If we are not able to generate positive
cash flow from operations or find alternative sources of cash, our business and shareholders will be materially and adversely
affected. The foregoing factors raise substantial doubt about our ability to continue as a going concern for a period of one year
from the date our condensed consolidated financial statements for the year ended December 31, 2020, are issued. Our condensed
consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to a number of risks similar to those of other similar stage and situated companies, including general economic
conditions, its customers&rsquo; operations and prospects for and ability to obtain project financing, and market and business
disruptions, that include the outbreak of COVID-19, dependence on key individuals, successful development, marketing and branding
of products; uncertainty of product development and generation of revenues; dependence on outside sources of financing; risks
associated with research, development; dependence on third-party suppliers and collaborators; protection of intellectual property;
and competition with larger, better-capitalized companies. Ultimately, the attainment of profitable operations is dependent on
future events, including obtaining adequate financing to fulfill its development activities and generating a level of revenues
adequate to support the Company&rsquo;s cost structure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also will be affected by constraints on the availability of capital to its customers and prospects who have commenced,
or are contemplating, new or expanded cultivation facilities and the overall impact of the Covid-19 pandemic. The extent to which
COVID-19 will impact the Company&rsquo;s business and financial results will depend on future developments, which are uncertain
and cannot be predicted. See Note 16. The duration and likelihood of operational success going forward resulting from the fiscal
year 2020 measures of adjusting the workforce reductions and cost-cutting measures are uncertain. If these actions do not meet
management&rsquo;s expectations, or additional capital is not available, there is substantial doubt about the Company&rsquo;s
ability to continue as a going concern. Other factors that will impact the Company&rsquo;s ability to continue operations include
the market demand for the Company&rsquo;s products and services, the ability to service its customers and prospects, potential
contract cancellations, project scope reductions and project delays, the Company&rsquo;s ability to fulfill its backlog, the management
of working capital, and the continuation of normal payment terms and conditions for purchase of the Company&rsquo;s products.
The Company believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next
twelve months. If the Company is unable to increase revenues, or otherwise generate cash flows from operations, there is substantial
doubt about the Company&rsquo;s ability to continue as a going concern for a period of one year from the date the financial statements
are issued. These consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Capital
Raising</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe our cash balances and cash flow from operations will be insufficient to fund our operations for the next 12 months. If
we are unable to increase revenues or otherwise generate cash flows from operations, we will need to raise additional funding
to continue as a going concern. Based on management&rsquo;s estimate for our operational cash requirements, during the first quarter
of 2020, we took steps to downsize and reorient our operations to reduce costs. We will need to obtain financing in order to continue
our operations and achieve our growth strategies. There can be no assurance that we will be able to raise the necessary financing,
when and if needed, on acceptable terms or at all. If our operating results do not meet management&rsquo;s expectations, or additional
capital is not available, management believes it can downsize or reorient operations to reduce certain expenditures. The precise
amount and timing of our financing needs cannot be determined accurately at this time, and will depend on a number of factors,
including the market demand for our products and services, management of working capital, and continuation of normal payment terms
and conditions for purchase of our products and services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that the Company will be able to raise debt or equity financing in sufficient amounts, when and if needed,
on acceptable terms or at all. The Company&rsquo;s ability to raise equity capital is also limited by the Company&rsquo;s stock
price, and any such issuance could be highly dilutive to existing shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Inflation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the opinion of management, inflation has not and will not have a material effect on our operations in the immediate future. Management
will continue to monitor inflation and evaluate the possible future effects of inflation on our business and operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Contractual
Payment Obligations </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
to Note 4 &ndash; <I>Leases </I>of our consolidated financial statements, which are included as part of this Annual Report for
the further details on our obligations under a lease for our manufacturing and office space.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Commitments
and Contingencies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Litigation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2019, there were 6,750,000 restricted stock units that had not been settled due to a dispute with a former employee
over the required withholding taxes to be paid to the Company for remittance to the appropriate tax authorities. The Company commenced
an arbitration action against the former employee regarding the dispute. The former employee also made claims in the arbitration
action against the Company for unpaid wages. As stated in a pleading in the arbitration, on March 9, 2020, the Company issued
the former employee 6,750,000 shares of the Company&rsquo;s common stock in settlement of these restricted stock units after taking
measures to mitigate the Company&rsquo;s exposure to penalties and liability for the failure to properly withhold income taxes.
The Arbitrator issued an interim award of approximately $10,000 in the Company&rsquo;s favor and a finding against the former
employee. Effective June 9, 2020, the Arbitrator issued his final award in the Company&rsquo;s favor in the Colorado arbitration.
The Arbitrator found against the former employee and awarded the Company costs of $33,985, with interest at 8% per year. Effective
July 22, 2020, the Colorado Court confirmed the Arbitration award and entered a final judgement in favor of the Company and against
the former employee. The Company pursued collection of this debt and has now collected the debt owed. This former employee is
continuing to pursue separate litigation against the Company for recovery of alleged consulting fees owed to him for the 2015
calendar year prior to his appointment as an executive officer of the Company. </FONT>The Company strongly disputes the ongoing
litigation and in the remote event of an adverse outcome, the amount of any settlement loss for this case is not reasonably estimable
as of the date of the issuance of these financial statements.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, in the normal course of our operations, we are subject to litigation matters and claims. Litigation can be expensive
and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict and
our view of these matters may change in the future as the litigation and events related thereto unfold. An unfavorable outcome
to any legal matter, if material, could have an adverse effect on our operations or our financial position, liquidity or results
of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other
Commitments</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the ordinary course of business, we may provide indemnifications of varying scope and terms to customers, vendors, lessors, business
partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of our breach of
such agreements, services to be provided by us, or from intellectual property infringement claims made by third parties. In addition,
we have entered into indemnification agreements with our directors and certain of our officers and employees that will require
us to, among other things, indemnify them against certain liabilities that may arise by reason of their status or service as directors,
officers, or employees. We maintain director and officer insurance, which may cover certain liabilities arising from our obligation
to indemnify our directors and certain of our officers and employees, and former officers, directors, and employees of acquired
companies, in certain circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Off-Balance
Sheet Arrangements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are required to disclose any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect
on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures,
or capital resources that are material to investors. As of December 31, 2020, we had no off-balance sheet arrangements. During
2020 and 2019, we did not engage in any off-balance sheet financing activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recent
Developments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
to Note 16 - <I>Subsequent Events</I> of our consolidated financial statements, included as part of this Annual Report, for the
more significant events occurring since December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_011"></A>Item
7A. Quantitative and Qualitative Disclosures About Market Risk</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a smaller reporting company, as defined by Rule 12b-2 of the Exchange Act, therefore are not required to provide the information
under this item.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_012"></A>Item
8. Financial Statements and Supplementary Data </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
consolidated financial statements are included herein, beginning on page F-1. The information required by this item is incorporated
herein by reference to the consolidated financial statements set forth in Item 15. &ldquo;Exhibits and Financial Statement Schedules&rdquo;
of this Annual Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_013"></A>Item
9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
Item 14.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 55.05pt; text-align: justify; text-indent: -55.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_014"></A>Item
9A. Controls and Procedures</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Evaluation
of Disclosure Controls and Procedures </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management conducted an evaluation, with the participation of our Chief Executive Officer and our Principal Financial and Accounting
Officer, which positions are currently held by the same person, of the effectiveness of our disclosure controls and procedures
(as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this Annual Report
on Form 10-K. Based upon that evaluation, our Chief Executive Officer and our Principal Financial and Accounting Officer concluded
that as a result of the material weakness in our internal control over financial reporting described below, our disclosure controls
and procedures were not effective as of December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Management&rsquo;s
Annual Report on Internal Control over Financial Reporting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
is responsible for the preparation of our financial statements and related information. Management uses its best judgment to ensure
that the financial statements present fairly, in material respects, our financial position and results of operations in conformity
with generally accepted accounting principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
is responsible for establishing and maintaining adequate internal control over financial reporting as defined in the Exchange
Act. These internal controls are designed to provide reasonable assurance that the reported financial information is presented
fairly, that disclosures are adequate and that the judgments inherent in the preparation of financial statements are reasonable.
There are inherent limitations in the effectiveness of any system of internal controls including the possibility of human error
and overriding of controls. Consequently, an effective internal control system can only provide reasonable, not absolute, assurance
with respect to reporting financial information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
internal control over financial reporting includes policies and procedures that: (i) pertain to maintaining records that, in reasonable
detail, accurately and fairly reflect our transactions; (ii) provide reasonable assurance that transactions are recorded as necessary
for preparation of our financial statements in accordance with generally accepted accounting principles and that the receipts
and expenditures of company assets are made in accordance with our management and directors authorization; and (iii) provide reasonable
assurance regarding the prevention of or timely detection of unauthorized acquisition, use or disposition of assets that could
have a material effect on our financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the supervision of management, by our Chief Executive Officer and our Principal Financial and Accounting Officer, we conducted
an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control
&ndash; Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (&ldquo;COSO&rdquo;)
published in 2013 and subsequent guidance prepared by COSO specifically for smaller public companies. Based on that evaluation,
our management concluded that our internal control over financial reporting was not effective as of December 31, 2020 for the
reasons discussed below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
material weakness is a deficiency or a combination of deficiencies in internal control over financial reporting such that there
is a reasonable possibility that a material misstatement of the annual or interim consolidated financial statements will not be
prevented or detected on a timely basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
identified the following material weakness in its assessment of the effectiveness of internal control over financial reporting
as of December 31, 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not maintain effective controls over certain aspects of the financial reporting process because: (i) we lack a sufficient
complement of personnel with a level of accounting expertise and an adequate supervisory review structure that is commensurate
with our financial reporting requirements, (ii) there is inadequate segregation of duties due to the limitation on the number
of our accounting personnel, and (iii) we have insufficient controls and processes in place to adequately verify the accuracy
and completeness of spreadsheets that we use for a variety of purposes including revenue, taxes, stock-based compensation and
other areas, and place significant reliance on, for our financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to take appropriate and reasonable steps to make the necessary improvements to remediate these deficiencies. We are committed
to continuing to improve our financial organization including, without limitation, expanding our accounting staff and improving
our systems and controls to reduce our reliance on the manual nature of our existing systems. However, due to our size and our
financial resources, remediating the several identified weaknesses has not always been possible and may not be economically feasible
now or in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management, including our Chief Executive Officer and our Principal Financial and Accounting Officer, does not expect that our
disclosure controls and procedures or our internal control over financial reporting will prevent all error and all fraud. A control
system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of
the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints
and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems,
no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our Company
have been detected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
material weaknesses in internal control over financial reporting as of December 31, 2020, remained unchanged from December 31,
2019. Management believes that the material weaknesses set forth above did not have an effect on our financial reporting for the
year ended December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will continue to monitor and evaluate the effectiveness of our internal control over financial reporting on an ongoing basis and
are committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow.
We do not, however, expect that the material weaknesses in our disclosure controls will be remediated until such time as we have
improved our internal control over financial reporting. In January of 2020, we implemented an inventory management system and
perpetual inventory which we believe has addressed some of our weaknesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annual Report on Form 10-K does not include an attestation report of our registered public accounting firm regarding internal
control over financial reporting. Management&rsquo;s report was not subject to attestation by our registered public accounting
firm pursuant to rules of the SEC that permit us to provide only management&rsquo;s report in this Annual Report on Form 10-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Changes
in Internal Control over Financial Reporting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no changes identified in connection with our internal control over financial reporting during the quarter ended December
31, 2020, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 55.05pt; text-align: justify; text-indent: -55.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_015"></A>Item
9B. Other Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_016"></A>PART
III</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 55.05pt; text-align: justify; text-indent: -55.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 55.05pt; text-align: justify; text-indent: -55.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_017"></A>Item
10. Directors, Executive Officers and Corporate Governance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information
about our Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s current directors are set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 62%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Positions
    &amp; Committees</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony
    K. McDonald </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board; Chief Executive Officer and President</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    R. Shipley </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas
    J. Etten</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
information, as of March 23, 2021, with respect to the Company&rsquo;s current directors is set forth below. The business address
of each of the directors is 1780 55th Street, Boulder, Colorado 80301.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    and Year First Elected Director</B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Background
    Information and Principal Occupation(s) During Past Five Years and Beyond</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony
    K. McDonald (2018)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         McDonald was appointed a director on September 12, 2018. On November 28, 2018, Mr. McDonald
                                         was appointed our Chief Executive Officer and President. On June 24, 2020, Mr. McDonald
                                         was appointed Chairman of the Board. Mr. McDonald has been involved in building businesses
                                         in the cleantech, energy efficiency and heating, ventilation and air conditioning (&ldquo;HVACD&rdquo;)
                                         industries over the past 10 years. From 2008 to 2018, Mr. McDonald led sales and business
                                         development as Vice-President&mdash;Sales for Coolerado Corp., a manufacturer and marketer
                                         of innovative, energy-efficient air conditioning systems for commercial, government,
                                         and military use. Along with Coolerado&rsquo;s CEO, Mr. McDonald was instrumental in
                                         growing the business to become an INC. 600 high-growth company award winner and assisted
                                         in raising $15 million of private funding from a cleantech investment fund. In 2015,
                                         Coolerado was acquired by Seeley International, Australia&rsquo;s largest air conditioning
                                         manufacturer and an innovative global leader in the design and production of energy-efficient
                                         cooling and heating products, where Mr. McDonald served as National Account Manager.
                                         He is also the founder and Managing Partner of Cleantechsell.com and the author of Cleantech
                                         Sell: The Essential Guide To Selling Resource Efficient Products In The B2B Market.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
        to joining Coolerado, Mr. McDonald spent over ten years in the private equity industry where he was involved in numerous
        transactions in the technology, manufacturing, and power development industries. As a business development officer at
        several private equity acquisitions groups Mr. McDonald identified, financed, or acquired numerous transactions with total
        enterprise value in excess of $200 million.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
        McDonald was also a consultant to international banks with KMPG from 1994 to 1997 and served as a director for Keating
        Capital, Inc., a publicly traded business development company that made investments in pre-IPO companies. He previously
        served as a mentor for companies in the Clean Tech Open competition.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
        McDonald is a U.S. Army veteran and a graduate of the U.S. Military Academy at West Point, N.Y. where he earned a B.S.
        degree in Engineering and Economics. He also received an M.B.A. degree from the Harvard Business School.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Among
        the reasons for Mr. McDonald to be selected for service on the Board is his experience in sales, sales and operations
        management, mergers and acquisitions, the HVACD industry, his in-depth knowledge of climate control systems and technologies.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    R. Shipley (2020)</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 68%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Shipley was appointed a director on June 24, 2020. Mr. Shipley recently retired from
                                         AgTech Holdings where he was the Chief Strategy Officer of GroAdvisor and the Vice-President
                                         of Sales VividGro since 2017. Since 2017, Mr. Shipley has assisted in design and build
                                         consulting along with supply chain management for cultivation operations in 12 states
                                         covering more than 500,000 square feet of warehouse indoor cultivation and continues
                                         to consult independently with operators in North America. From 2014 to 2017 Mr. Shipley,
                                         acting in several executive roles, helped build multiple business lines for MJIC Inc.
                                         (now CNSX: MSVN ); these roles included being a member of the board of directors, Chairman
                                         and President. Mr. Shipley is currently president and a principal in RSX Enterprises
                                         Inc., a sales agency and marketing firm that sells and markets equipment for use in controlled
                                         environment agriculture on behalf of various manufacturers. Mr. Shipley has been
                                         active in the cannabis business, where he has founded various summits such as the Marijuana
                                         Investor Summit and been involved in many educational workshops and business expos. Previously,
                                         Mr. Shipley was an officer and chief revenue officer with Carrier Access Corporation
                                         (CACS), a public company trading on Nasdaq. Prior to Carrier Access, Mr. Shipley worked
                                         at Williams Companies in their telecommunications divisions.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
        Shipley has been selected for service on the Board because of his experience in and commitment to the cannabis industry,
        his demonstrated and consistent record of success as an executive and entrepreneur, and his extensive network of contacts
        in the cannabis industry.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas
    J. Etten (2020)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
                                         Etten was appointed a director on June 24, 2020. Mr. Etten joined Acreage Holdings in
                                         2018 where he is currently the Head of Government Affairs. Acreage is a vertically integrated,
                                         multi-state operator of cannabis licenses and assets in the U.S. In 2017 he founded the
                                         Veterans Cannabis Project where he continues to serve as Chairman. Veterans Cannabis
                                         Project (VCP) is an organization dedicated to advocating on behalf of cannabis access
                                         issues for U.S. military veterans. From 2015 to 2017, Mr. Etten set aside his career
                                         to provide care for his seriously ill son. Mr. Etten&rsquo;s career has been focused
                                         on the growth equity market, and prior to Acreage, he held positions including Vice President
                                         of Global Business Development for FreightWatch International, and Director of Corporate
                                         Development for Triple Canopy. Mr. Etten was an investment professional at Trident Capital,
                                         where he focused on the cyber-security space, and an investment banker at Thomas Weisel
                                         Partners. Mr. Etten served on active duty as a U.S. Navy SEAL officer. He earned an MBA
                                         from the J.L. Kellogg Graduate School of Management at Northwestern University, and a
                                         BS in political science from the United States Naval Academy.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
        Etten has been selected for service on the Board because of his experience in and commitment to the cannabis industry,
        his experience with multi-site cannabis operators, his demonstrated and consistent record of success as an executive,
        and his extensive network of contacts in the cannabis industry and investment banking world.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of the directors on our Board of Directors was elected or appointed because he has demonstrated an ability to make meaningful
contributions to our business and affairs and has skills, experience and background that are complementary to those of our other
Board members.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Independence </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board annually determines each director&rsquo;s independence, although we are not required to have any independent directors because
the common stock of the Company is not listed on a national exchange. We do not consider a director independent unless the Board
has determined that the person has no material relationship with us. We intend to monitor the relationships of our directors and
officers through a questionnaire each director completes no less frequently than annually and updates periodically as information
provided in the most recent questionnaire changes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to evaluate the materiality of any such relationship, the Board uses the definition of director independence set forth in
Rule 5605(a)(2) promulgated by the Nasdaq Stock Market. The Board has determined that Messrs. Shipley and Etten are independent
directors. Mr. McDonald is not an independent director as a result of his position as an executive officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Audit
Committee Functions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board currently does not have an Audit Committee. Rather, the functions that an audit committee would carry </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">out
are handled by the Board. These responsibilities include recommending the selection of our independent registered public accounting
firm; evaluating the appointment, compensation and retention of our registered public accounting firm; receiving formal written
statements from our independent registered public accounting firm regarding its independence, including a delineation of all relationships
between it and the Company; reviewing with such independent registered public accounting firm the planning, scope and results
of their audit of our financial statements; pre-approving the fees for services performed; reviewing with the independent <FONT STYLE="font-size: 10pt">registered
public accounting firm the adequacy of internal control systems; reviewing our annual financial statements and periodic filings,
and receiving our audit reports and financial statements. The Board also considers the effect on the Company of any changes in
accounting principles or practices proposed by management or the independent registered public accounting firm, any changes in
service providers, such as the accountants, that could impact the Company&rsquo;s internal control over financial reporting, and
any changes in schedules (such as fiscal or tax year-end changes) or structures or transactions that required special accounting
activities, services or resources.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nominations
for Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has not established a nominating committee. Accordingly, the Board is responsible for identifying individuals qualified
to serve on the Board as directors and on committees of the Board, establishing procedures for evaluating the suitability of potential
director nominees consistent with the criteria approved by the Board, reviewing the suitability for continued service as a director
when his or her term expires and at such other times as the Board deems necessary or appropriate, and determining whether or not
the director should be re-nominated, and reviewing the membership of the Board and its committees and making changes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
evaluating director nominees, the Board of Directors will generally consider the following factors:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    appropriate size and composition of our Board of Directors;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">whether
    or not the person is an &ldquo;independent&rdquo; director as defined in Rule 5605(a)(2) promulgated by the Nasdaq Stock Market;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    needs of the Company with respect to the particular talents and experience of its directors;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    knowledge, skills and experience of nominees in light of prevailing business conditions and the knowledge, skills and experience
    already possessed by other members of the Board of Directors;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">familiarity
    with national and international business matters and the requirements of the industry in which we operate;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">experience
    with accounting rules and practices;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    desire to balance the considerable benefit of continuity with the periodic injection of the fresh perspective provided by
    new members; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    applicable laws, rules, regulations and listing standards, if applicable.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no stated minimum criteria for director nominees, although the Board may consider such factors as it may deem are in the best
interests of the Company and its stockholders. The Board also believes it is appropriate for certain key members of our management
to participate as members of the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board identifies nominees by first evaluating the current members of the Board willing to continue in service. Current members
of the Board with skills and experience that are relevant to our business and who are willing to continue in service are considered
for re-nomination, balancing the value of continuity of service by existing members of the Board with that of obtaining a new
perspective. If any member of the Board does not wish to continue in service, or if the Board decides not to re-nominate a member
for re-election, the Board identifies the desired skills and experience of a prospective director nominee in light of the criteria
above, or determines to reduce the size of the Board. Research may also be performed to identify qualified individuals. To date,
we have not engaged third parties to identify or evaluate or assist in identifying potential nominees, nor do we anticipate doing
so in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stockholder
Communications with Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
may communicate with the Board by sending a letter to the Corporate Secretary, Surna Inc., 1780 55th Street, Boulder, Colorado
80301. Each communication must set forth the name and address of the stockholder on whose behalf the communication is sent and
should indicate in the address whether the communication is intended for the entire Board, the non-employee directors as a group
or an individual director. Each communication will be screened by the Corporate Secretary or his designee to determine whether
it is appropriate for presentation to the Board or any specified director(s). Examples of inappropriate communications include
junk mail, spam, mass mailings, resumes, job inquiries, surveys, business solicitations and advertisements, as well as unduly
hostile, threatening, illegal, unsuitable, frivolous, patently offensive or otherwise inappropriate material. Communications determined
to be appropriate for presentation to the Board, or the director(s) to whom they are specifically addressed, will be submitted
to the Board or such director(s) on a periodic basis. Any communications that concern accounting, internal control or auditing
matters will be handled in accordance with procedures adopted by the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Code
of Business Conduct and Ethics </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board has adopted a Code of Business Conduct and Ethics, which is available for review on our website at <U>www.surna.com</U>
and is also available in print, without charge, to any stockholder who requests a copy by writing to us at Surna Inc., 1780 55th
Street, Boulder, Colorado 80301, Attention: Corporate Secretary. Each of our directors, employees and officers, including our
Chief Executive Officer, and all of our other principal executive officers, are required to comply with the Code of Business Conduct
and Ethics. There have not been any waivers of the Code of Business Conduct and Ethics relating to any of our executive officers
or directors in the past year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Meetings
and Committees of the Board</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board is responsible for overseeing the management of our business. We keep our directors informed of our business at meetings
and through reports and analyses presented to the Board and the committees of the Board, if any. Regular communications between
our directors and management also occur outside of formal meetings of the Board and committees of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Meeting
Attendance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board generally holds meetings on a quarterly basis but may hold additional meetings as required. In 2020, the Board held four
meetings. Each of our directors attended 100% of the Board meetings that were held during the periods when he was a director and
100% of the meetings of each committee of the Board on which he served that were held during the periods that he served on such
committee. We do not have a policy requiring that directors attend our annual meetings of stockholders. We did not hold a 2020
annual meeting of stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board
Leadership Structure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board may, but is not required to, select a Chairman of the Board who presides over the meetings of the Board and meetings of
the stockholders and performs such other duties as may be assigned to him by the Board. The positions of Chairman of the Board
and Chief Executive Officer may be filled by one individual or two different individuals. Currently the positions of Chairman
of the Board and Chief Executive Officer are held by Mr. McDonald.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Board&rsquo;s
Role in Risk Oversight</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
risk management is primarily the responsibility of the Company&rsquo;s management team, the Board is responsible for the overall
supervision of the Company&rsquo;s risk management activities. The Board as a whole has responsibility for risk oversight, and
each Board committee has responsibility for reviewing certain risk areas and reporting to the full Board. The oversight responsibility
of the Board and its committees is enabled by management reporting processes that are designed to provide visibility to the Board
about the identification, assessment, and management of critical risks and management&rsquo;s risk mitigation strategies in certain
focus areas. These areas of focus include strategic, operational, financial and reporting, succession and compensation and other
areas.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board oversees risks associated with their respective areas of responsibility. The Board oversees: (i) risks and exposures associated
with our business strategy and other current matters that may present material risk to our financial performance, operations,
prospects or reputation, (ii) risks and exposures associated with management succession planning and executive compensation programs
and arrangements, including equity incentive plans, and (iii) risks and exposures associated with director succession planning,
corporate governance, and overall board effectiveness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
provides regular updates to the Board regarding the management of the risks they oversee at each regular meeting of the Board.
We believe that the Board&rsquo;s role in risk oversight must be evaluated on a case-by-case basis and that our existing Board&rsquo;s
role in risk oversight is appropriate. However, we continually re-examine the manners in which the Board administers its oversight
function on an ongoing basis to ensure that they continue to meet the Company&rsquo;s needs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Section
16(a) Beneficial Ownership Reporting Compliance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;) requires our executive officers, directors
and persons who beneficially own more than 10% of our common stock to file initial reports of ownership and reports of changes
in ownership with the SEC. Such persons are required by SEC regulations to furnish us with copies of all Section 16(a) reports
filed by such persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
solely on our review of the copies of such reports furnished to us, we believe that during the fiscal year ended December 31,
2020, all executive officers, directors and greater than 10% beneficial owners of our common stock complied with the reporting
requirements of Section 16(a) of the Exchange Act, except as stated hereinafter, Mr. McDonald, the Chief Executive Officer, filed
a late Form 4 report, on March 12, 2021, indicating and acquisition of 268,700 nonqualified stock options on February 16, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executive
Officer</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
officers are appointed by our Board and serve at its discretion. Set forth below is information regarding our executive officers
as of March 22, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Positions
    </B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony
    K. McDonald* </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">62</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and President; Director</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="5" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
    Mr. McDonald currently also serves as our Principal Financial and Accounting Officer.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
McDonald&rsquo;s biographical information is included with such information for the other members of our Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 55.05pt; text-align: justify; text-indent: -55.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_018"></A>Item
11. Executive Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Compensation Program </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 2, 2020, the Board approved a revised compensation plan for independent directors. Under this plan, the Company was to
pay its independent directors an annual cash fee of $30,000, payable quarterly in advance, covering attendance at all regular
or special meetings of the Board or any committee thereof (including telephonic meetings) and any other services provided by them
as a director (other than services as the Chairman of the Board and lead independent director and the Chairman of the Audit Committee).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
this plan, the Company was to pay the Chairman of the Board and lead independent director an additional annual fee of $15,000,
payable in cash quarterly in advance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also,
under this plan, the Company was to pay the Audit Committee Chairman an additional annual fee of $15,000, payable in cash quarterly
in advance, for his services as the Audit Committee Chairman. There was no additional compensation paid to members of the Audit
Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
independent directors elected or appointed on or after January 1, 2020, at the time of initial election or appointment, the independent
director received an equity award consisting of a grant of non-qualified stock options to purchase 500,000 shares of the Company&rsquo;s
common stock. The options vested 50% upon grant and 50% on the first anniversary of the grant date, had a term of 10 years, and
an exercise price equal to the closing price of the Company&rsquo;s common stock on The OTC Markets on the day immediately preceding
the grant date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, on the first business day of January each year, each independent director received a grant of non-qualified stock options
to purchase 250,000 shares of the Company&rsquo;s common stock, which options immediately vested on the date of grant, had a term
of 10 years, and an exercise price equal to the closing price of the Company&rsquo;s common stock on The OTC Markets on the day
immediately preceding the grant date. In the case of a mid-year election or appointment, the 250,000 options were pro-rated for
each full quarter of service in the year of appointment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
each of the two independent directors serving on January 1, 2020, Messrs. Keating and Simonton, the Board also approved a special
one-time grant of non-qualified stock options to purchase 2,000,000 shares of the Company&rsquo;s common stock, in recognition
of the prior services of each such independent director. These non-qualified stock options were granted January 2, 2020, were
immediately vested on the date of grant, had a term of 10 years, and had an exercise price of $0.07 per share, the closing price
of the Company&rsquo;s common stock on The OTC Markets on the day immediately preceding the grant date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 26, 2020, Timothy J. Keating resigned as Chairman of the Board and a member of the Board and J. Taylor Simonton resigned
as a member of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 24, 2020, the Board adopted a new plan for Director compensation (the &ldquo;Plan&rdquo;) related to the appointment
of Messrs. Shipley and Etten as directors. Under the Plan, each such independent director will receive an equity award consisting
of a grant of non-qualified stock options to purchase 1,000,000 shares of the Company&rsquo;s common stock. The options will vest
50% upon grant and 50% on April 1, 2021, if the Director remains on the Board up to that time. The options have a term of 5 years
and have an exercise price equal to the closing price of the Company&rsquo;s common stock on The OTC Markets on the day immediately
preceding the grant date. Options will also provide that they will expire 3 months after the termination of service to the Company
for any reason. The directors will not receive any cash payment for meeting attendance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
June 24, 2020, the Company appointed two new independent directors, James R. Shipley and Nicholas J. Etten, and Mr. McDonald was
appointed Chairman of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
new independent directors, Messrs. Shipley and Etten, are subject to the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
board of directors, acting unanimously, may also grant additional stock options to the independent directors, no more frequently
than every six months in recognition of special services as a director to the Company, which award will not be greater than 1,000,000
per award, with an exercise period of not greater than three years, on the same general terms as the award on initial election
or appointment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
independent director is responsible for the payment of any and all income taxes arising with respect to the issuance of any equity
awarded under the plan, including the exercise of any non-qualified stock options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also reimburses independent directors for out-of-pocket expenses incurred in attending Board and committee meetings and
undertaking certain matters on the Company&rsquo;s behalf.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee
directors do not receive separate fees for their services as directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Nevada Revised Statutes and pursuant to our charter and bylaws, as currently in effect, the Company may indemnify the Company&rsquo;s
officers and directors for various expenses and damages resulting from their acting in these capacities. Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to our officers and directors pursuant to the foregoing provisions,
we have been informed that, in the opinion of the SEC, this indemnification is against public policy as expressed in the Securities
Act, and is therefore unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has entered into indemnification agreements with its directors and executive officers. The indemnification agreements
are intended to provide the Company&rsquo;s directors the maximum indemnification permitted under the Nevada Revised Statutes,
unless otherwise limited by the Company&rsquo;s charter and bylaws. Each indemnification agreement provides that the Company shall
indemnify the director or executive officer who is a party to the agreement (an &ldquo;Indemnitee&rdquo;), including the advancement
of legal expenses, if, by reason of his corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness
in any threatened, pending, or completed proceeding. Each indemnification agreement further provides that the applicable provisions
of the Company&rsquo;s charter and bylaws regarding indemnification shall control in the event of any conflict with any provisions
of such indemnification agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Compensation Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the compensation earned by or awarded or paid in 2020 to the individuals who served as our independent
directors during such period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees
                                         Earned</B></FONT></P>
                                                                                                    <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>or
                                         Paid in</B></FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cash</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Awards</FONT></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option
                                         Awards</B></FONT></P>
                                                                                                    <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><SUP>(1),
                                         (2)</SUP></B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">James R. Shipley</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">19,800</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">19,800</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nicholas J. Etten</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">19,800</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">19,800</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="17" STYLE="text-align: left"><P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>(1)
</SUP>Reflects the dollar amount of the grant date fair value of awards,
measured in accordance with FASB Accounting Standards Codification (&ldquo;ASC&rdquo;) Topic 718 (&ldquo;Topic 718&rdquo;) without adjustment
for estimated forfeitures. For a discussion of the assumptions used to calculate the value of equity awards, refer to Note 14 to our consolidated
financial statements for the fiscal year ended December 31, 2020 included in this Annual Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(2)
</SUP>Reflects grant to each independent director on June 24, 2020 of non-qualified stock options to purchase 1,000,000 shares of the
Company&rsquo;s common stock.</FONT></P>
</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disclosure
Relating to Former Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Keating was a Director of the Company until his resignation in March 2020. During the period from January 1, 2020 until his resignation,
Mr. Keating received $7,500 fees paid or earned in cash and stock option non-qualified stock options to purchase 250,000 shares
of the Company&rsquo;s common stock valued at $14,625 in respect of the annual 2020 grant in recognition of his prior services
to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Simonton was a Director of the Company until his resignation in March 2020. During the period from January 1, 2020 until his resignation,
Mr. Keating received $7,500 fees paid or earned in cash and stock option non-qualified stock options to purchase 250,000 shares
of the Company&rsquo;s common stock valued at $14,625 in respect of the annual 2020 grant in recognition of his prior services
to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate number of non-qualified stock options held as of December 31, 2020 by each independent director are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares
    Underlying Non-Qualified Stock Options <SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares
    Underlying Restricted Stock Units</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">James R. Shipley</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 17%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 15%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nicholas J. Etten</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ndash;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="12" STYLE="text-align: justify">(1)
Includes grant to each independent director on June 24, 2020 of non-qualified stock options to purchase 1,000,000 shares of the
Company&rsquo;s common stock</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>&nbsp;</SUP></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0">.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Executive
Compensation Philosophy and Objectives</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has not established a compensation committee. Accordingly, the Board is responsible for setting compensation policies
for executive officers which has two fundamental objectives: (i) to provide a competitive total compensation package that enables
the Company to attract and retain highly qualified executives with the skills and experience required for the achievement of business
goals; and (ii) to align certain compensation elements with the Company&rsquo;s annual performance goals. The Board considers,
with respect to each of the Company&rsquo;s executive officers, the total compensation that may be awarded, including base salary,
discretionary cash bonuses, annual stock incentive awards, stock options, restricted stock units and other equity awards, and
other benefits and perquisites. Under certain circumstances, the Board may also award compensation payable upon termination of
the executive officer under an employment agreement or severance agreement (if applicable). The Board recognizes that its overall
goal is to award compensation that is reasonable when all elements of potential compensation are considered. The Board believes
that cash compensation in the form of base salary and discretionary cash bonuses provides our executives with short-term rewards
for success in operations, and that long-term compensation through the award of stock options, restricted stock units and other
equity awards aligns the objectives of management with those of our stockholders with respect to long-term performance and success.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board also has historically focused on the Company&rsquo;s financial condition when making compensation decisions and approving
performance objectives. Because the Company has historically sought to preserve cash and currently does not operate at a profit,
overall compensation traditionally has been weighted more heavily toward equity-based compensation. The Board will continue to
periodically reassess the appropriate weighting of cash and equity compensation in light of the Company&rsquo;s expenditures in
connection with commercial operations and its cash resources and working capital needs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
Executive Compensation Table</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes compensation earned by or awarded or paid to our named executive officers for the years ended December
31, 2020 and 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Name
    and Principal Position</FONT></TD><TD STYLE="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Year</FONT></TD><TD STYLE="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Salary</FONT></TD><TD STYLE="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Bonus</FONT></TD><TD STYLE="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt"><B>Stock
    Awards <SUP>(1)</SUP></B></FONT></TD><TD STYLE="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt"><B>Option
    Awards <SUP>(1)</SUP></B></FONT></TD><TD STYLE="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Non-equity
    Incentive Plan Compensation</FONT></TD><TD STYLE="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Non-qualified
    Deferred Compensation Earnings</FONT></TD><TD STYLE="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">All
    Other Compensation</FONT></TD><TD STYLE="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 9pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Total</FONT></TD><TD STYLE="font: bold 9pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 28%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">Anthony
    K. McDonald - Chief Executive Officer and President <SUP>(2)</SUP></FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 6%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">2020</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">174,593</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">20,000</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">33,333</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">15,314</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 4%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">243,240</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 9pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 9pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">2019</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">180,000</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">58,532</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">-</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">13,900</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">$</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">252,432</FONT></TD><TD STYLE="font: 9pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 9pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(1)
</SUP>Reflects the dollar amount of the grant date fair value of awards granted in 2019 or 2020, measured in accordance with FASB
Accounting Standards Codification (&ldquo;ASC&rdquo;) Topic 718 (&ldquo;Topic 718&rdquo;) without adjustment for estimated forfeitures.
For a discussion of the assumptions used to calculate the value of equity awards, refer to Note 14 to our consolidated financial
statements for the fiscal year ended December 31, 2020 included in this Annual Report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(2)
</SUP>Mr. McDonald was appointed Chief Executive Officer and President in November 2018. Amounts presented include all compensation
for Mr. McDonald for the full 2019 and 2020 years. Bonus includes cash bonus paid in recognition of services rendered and contributions
to the Company&rsquo;s performance in 2019. 2019 option awards include non-qualified stock options to purchase 1,000,000 shares
of common stock awarded in January 2020, based on our 2019 performance and Mr. McDonald&rsquo;s contributions to such performance,
some of which options are subject to certain to vesting (see Outstanding Equity Awards table, below). 2020 option awards include
non-qualified stock options to purchase 268,700 shares of common stock awarded in February 2021, based on Mr. McDonald&rsquo;s
2020 performance. The options vested and became exercisable on the grant date. Other compensation in 2019 and 2020 includes (i)
employer-paid portion of health plan benefits ($6,700 and $7,780, respectively), and (ii) employer matching contributions under
our 401(k) plan ($7,200 and $7,535, respectively).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disclosure
Relating to Former Executives</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Bechtel was Chief Executive Officer and President from August 2017 until his resignation in November 2018. During the year ended
December 31, 2019, Mr. Bechtel received salary of $7,561 in respect of services provided in the prior year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Smiens was Chief Financial Officer and Treasurer from July 2018, and Secretary from September 2018, until his termination of employment
in December 2018. During the year ended December 31, 2019, Mr. Smiens received slasy of $18,454 in respect of services provided
in the prior year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding
Equity Awards </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information regarding outstanding equity awards held by our named executive officers as of
December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&nbsp;</TD><TD COLSPAN="16" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Option Awards</B></FONT></TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">&nbsp;</TD><TD COLSPAN="12" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
                                         Awards</B></FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                         of Securities Underlying Unexercised Options Exercisable</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                         of Securities Underlying Unexercised Options Unexercisable</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity
                                         Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option
                                         Exercise Price</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Option Expiration Date</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                         of Shares or Units of Stock That Have Not Vested</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Market
                                         Value of Shares or Units of Stock That Have Not Vested</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity
                                         Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not
                                         Vested</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity
                                         Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights
                                         That Have Not Vested</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony K. McDonald
    <SUP>(1)</SUP></FONT></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 4%; text-align: right">5,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 4%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 4%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 4%; text-align: right">0.089</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: right; width: 4%">11/28/2028</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 4%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 4%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 4%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 4%; text-align: right">&ndash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.070</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">1/2/2030</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">268,700</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.130</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">2/16/2031</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(1)
</SUP>On November 28, 2018, we granted to Mr. McDonald non-qualified stock options to purchase 5,000,000 shares of common stock
under our 2017 Equity Incentive Plan, of which: (i) 1,000,000 options vested and became exercisable on the grant date, (ii) 2,000,000
options vested and became exercisable on December 31, 2019, and (iii) 2,000,000 options vested and became exercisable on December
31, 2020. On January 2, 2020, we granted to Mr. McDonald non-qualified stock options to purchase 1,000,000 shares of common stock
under our 2017 Equity Incentive Plan in recognition of his performance during 2019, which options vested and became exercisable
on the grant date. On February 16, 2021, we granted to Mr. McDonald non-qualified stock options to purchase 268,700 shares of
common stock under our 2017 Equity Incentive Plan in recognition of his performance during 2020, which options vested and became
exercisable on the grant date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Compensation
Arrangements with Named Executive Officers </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Anthony
K. McDonald</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 28, 2018, the Company entered into an employment agreement with Mr. McDonald, the Company&rsquo;s Chief Executive Officer
and President. The initial term of the employment agreement commenced on November 28, 2018 and was to continue until December
31, 2020. During the year ended December 31, 2020, the term of Mr. McDonald&rsquo;s employment agreement was extended to December
31, 2021. However, the Company and Mr. McDonald may terminate the employment agreement, at any time, with or without cause, by
providing the other party with 30-days&rsquo; prior written notice. In the event Mr. McDonald&rsquo;s employment is terminated
by the Company during the initial term without cause, Mr. McDonald will be entitled to receive his base salary for an additional
30 days. Following the initial term, the Company and Mr. McDonald may extend the employment agreement for additional one-year
terms by mutual written agreement. Under the employment agreement, Mr. McDonald received in 2019 an annualized base salary of
$180,000. Effective January 1, 2020, the annualized base salary was increased to $200,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the employment agreement, the Board approved an award of non-qualified stock options to purchase 5,000,000 shares of the Company&rsquo;s
common stock under the Company&rsquo;s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to
time (the &ldquo;2017 Equity Plan&rdquo;), which vest as follows: (i) 1,000,000 options vested and became exercisable on November
28, 2018, the grant date, (ii) 2,000,000 options vested and became exercisable on December 31, 2019, and (iii) 2,000,000 options
vested and became exercisable on December 31, 2020. The exercise price of these options is $0.089, based on the closing of the
Company&rsquo;s common stock on November 27, 2018. In the event of a change of control involving the Company, any non-qualified
stock options not already vested will become vested, provided Mr. McDonald continues to provide services to the Company on the
date immediately preceding the date of the change of control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration of the grant of the above non-qualified stock options, Mr. McDonald agreed to cancel 197,368 RSUs, which were granted
to him as an equity retention award in connection with Mr. McDonald&rsquo;s appointment to the Board on September 12, 2018 and
which had not vested as of November 28, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 2, 2020, the Board also awarded Mr. McDonald a special one-time grant of non-qualified stock options to purchase 1,000,000
shares of the Company&rsquo;s common stock and a $20,000 cash bonus, in recognition of his services as the Company&rsquo;s Chief
Executive Officer during 2019. These non-qualified stock options were immediately vested on the date of grant, had a term of 10
years, and had an exercise price of $0.07 per share, the closing price of the Company&rsquo;s common stock on The OTC Markets
on the day immediately preceding the grant date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 16, 2021, Mr. McDonald was awarded non-qualified stock options to purchase 268,700 shares of common stock under our 2017
Equity Incentive Plan. This grant was based on his performance during 2020. The options vested and became exercisable on the grant
date. The associated equity compensation expense was accrued during 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 55.05pt; text-align: justify; text-indent: -55.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 55.05pt; text-align: justify; text-indent: -55.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_019"></A>Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the shares of our common stock beneficially owned by (i) each of our directors, (ii) each of our named
executive officers, (iii) all of our directors and executive officers as a group, and (iv) all persons known by us to beneficially
own more than 5% of our outstanding common stock. The Company has determined the beneficial ownership shown on this table in accordance
with the rules of the SEC. Under these rules, shares are considered beneficially owned if held by the person indicated, or if
such person, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares
the power to vote, to direct the voting of and/or to dispose of or to direct the disposition of such shares. A person is also
deemed to be a beneficial owner of shares if that person has the right to acquire such shares within 60 days through the exercise
of any warrant, option or right or through conversion of a security. Except as otherwise indicated in the accompanying footnotes,
the information in the table below is based on information as of March 23, 2021. Unless otherwise indicated in the footnotes to
the following table, each person named in the table has sole voting and investment power with respect to shares of common and
preferred stock and the address for such person is c/o Surna Inc. 1780 55th Street, Boulder, Colorado 80301.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common
    Stock</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Preferred
    Stock</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name
    of Beneficial Owner</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of Shares Owned Beneficially <SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage
    of Class <SUP>(2)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
    of Shares Owned Beneficially <SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage
    of Class <SUP>(3)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Directors</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 40%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony
    K. McDonald <SUP>(4)</SUP></FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,466,068</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.7</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James R. Shipley <SUP>(5)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.4</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas J. Etten <SUP>(6)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.4</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Executive Officers
    who are not Directors</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Executive Officers
    and Directors as a Group</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,466,068</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.5</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">5% or More Stockholders</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">John F. Jansen <SUP>(7)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,253,546</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.4</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brandy M. Keen <SUP>(8)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,020,614</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.5</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Morgan Paxhia <SUP>(9)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33,428,023</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">79.5</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="17" STYLE="padding-top: 0; padding-left: 0; text-align: left; padding-right: 0"><P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(1)
Beneficial ownership has been determined in accordance with Rule 13d-3 under the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(2)
Based on a total of 236,526,638 shares of the Company&rsquo;s common stock issued and outstanding as of March 23, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(3)
Based on a total of 42,030,331 shares of the Company&rsquo;s preferred stock issued and outstanding as of March 23, 2021. The
holders of preferred stock vote as a separate class on matters affecting the preferred stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(4)
Includes 6,268,700 shares of common stock issuable upon the exercise of options exercisable within 60 days of which 268,700 were
granted on 02/16/21.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(5)
Includes 1,000,000 shares of common stock issuable upon the exercise of options exercisable within 60 days.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(6)
Includes 1,000,000 shares of common stock issuable upon the exercise of options exercisable within 60 days.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(7)
Beneficial ownership based on Schedule 13G dated May 25, 2018 filed by Mr. Jansen with the SEC, and share ownerhsip reported by
Mr. Jansen to the Company as of March 8, 2020. Includes 2,500,000 shares of common stock issuable upon the exercise of warrants
exercisable within 60 days. The address for Mr. Jansen is 4910 Kaylan Court, Richmond, TX 77407.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(8)
Beneficial ownership based on share ownership reported by Ms. Keen to the Company as of March 4, 2021. Includes shares of common
stock held jointly with her spouse, Stephen B. Keen. The address for the Keens is 359 Ash Juniper Dr., New Braunfels, TX 78132.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(9)
Includes 33,428,023 shares of preferred stock owned by Demeter Capital Group LP (&ldquo;Demeter&rdquo;). Mr. Paxhia and his sister,
Emily Paxhia, are the managing members of Poseidon Asset Management, LLC (&ldquo;Poseidon&rdquo;), which is the general partner
and/or investment manager of Demeter and in such capacity exercises voting and dispositive power over the securities beneficially
owned by Demeter. The address for Mr. Paxhia, Ms. Paxhia, Poseidon and Demeter is 130 Frederick Street, #102, San Francisco, CA
94117.</FONT></P>

</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 55.05pt; text-align: justify; text-indent: -55.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_020"></A>Item
13. Certain Relationships and Related Transactions, and Director Independence</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transactions
with Related Parties</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following describes certain agreements and transactions between the Company and its co-founders, Brandy and Stephen Keen (the
&ldquo;Co-founders&rdquo;). The Co-founders held various executive officer and director positions with the Company until May 2018.
One of the Co-founders also was a consultant to the Company until May 2018. The Co-founders are also shareholders of the Company.
Based on information available to the Company, the Co-founders did not own more than 10% of the Company&rsquo;s outstanding common
stock at any time during 2020 or 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Equipment,
Demonstration and Product Testing Agreement</U></I></B><U>.</U> In May 2017, we entered into a three-year equipment, demonstration
and product testing agreement with a licensed cannabis cultivation company affiliated with Mr. Keen. Under this agreement, we
agreed to lease the cultivation company certain cultivation equipment in exchange for a quarterly fee of $16,500, which was increased
to $18,330 to reflect additional leased equipment requested by the cultivation company (the &ldquo;Lease Fee&rdquo;). In consideration
for access to the cultivation facility to conduct demonstration tours and for the product testing and data to be provided by the
cultivation company, we agreed to pay the cultivation company a quarterly fee of $12,000 (the &ldquo;Demo and Testing Fee&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties each made their respective payments under this agreement through June 30, 2018. Thereafter, the cultivation company failed
to make any subsequent payments of the Lease Fee and, as a result, the Company did not pay the Demo and Testing Fee. During the
second quarter of 2019, we notified the cultivation company of its breach for non-payment of the Lease Fee. In February 2020,
the parties mutually agreed to terminate this agreement and release each other from all claims related to this agreement, including
any unpaid Lease Fees or Demo and Testing Fees. We also agreed to transfer the equipment to the cultivation company for no additional
consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I><U>Employment
Agreement</U></I></B><U>.</U> In May 2018, we entered into an employment agreement with Ms. Keen, which provided for an initial
base salary of $150,000 per year and certain sales incentive. Pursuant to the employment agreement, we awarded 4,800,000 restricted
stock units (&ldquo;RSUs&rdquo;) to Ms. Keen that vested at certain dates in the future, subject to her continued employment.
These RSU&rsquo;s have now fully vested and Ms. Keen continues her employment with the Company under this agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">***************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2020, except as discussed above, there have been no transactions in which the Company was or is a participant, and there are no
currently proposed transactions in which the Company is to be a participant, in which the amount involved exceeds the lesser of
$120,000 or 1% of the Company&rsquo;s average assets at year-end for the last two completed fiscal years, and in which any director,
executive officer or beneficial holder of more than 5% of any class of our voting securities or member of such person&rsquo;s
immediate family had or will have a direct or indirect material interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 7, 2021, the Company entered into a consulting agreement with RSX Enterprises, Inc. (RSX), a company controlled by Mr.
James R. Shipley, a director of the Company. RSX will provide consulting services to the Company focused on product offerings,
engineering requirements, key customer marketing outreach, and related matters, as mutually determined by the Company and RSX.
The Company will pay a monthly consulting fee of $6,500 for up to 50 hours per month for the various consulting activities undertaken
and provide for reimbursement of expenses. The term of the agreement is set for three months. Any intellectual property developed
by RSX will belong to the Company, and the contract provides for typical indemnification obligations and confidentiality provisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Company
Policy Regarding Related Party Transactions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has procedures in place for the review, approval and monitoring of transactions involving the Company and certain persons
related to the Company. For example, the Company has a code of business conduct and ethics that generally prohibits any employee,
officer or director from engaging in any transaction where there is a conflict between such individual&rsquo;s personal interest
and the interests of the Company. Waivers to the code of business conduct and ethics can generally only be obtained from the Board
and are publicly disclosed as required by applicable law and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our Board will review all related party transactions for potential conflict of interest situations on an ongoing basis
(if such transactions are not reviewed and overseen by another independent body of the Board). In accordance with that policy,
the Board&rsquo;s general practice is to review and oversee any transactions that are reportable as related party transactions
under the Financial Accounting Standards Board (&ldquo;FASB&rdquo;) and SEC rules and regulations. Management advises the Board
on a regular basis of any such transaction that is proposed to be entered into or continued and seeks approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_021"></A>Item
14. Principal Accountant Fees and Services</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACM
LLP (&ldquo;ACM&rdquo;) acted as the Company&rsquo;s independent registered public accounting firm for the fiscal year ended December
31, 2019. ACM has advised us that neither the firm nor any present member or associate of it has any material financial interest,
direct or indirect, in the Company or its affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sadler,
Gibb &amp; Associates, L.L.C. (&ldquo;SGA&rdquo;) has acted as the Company&rsquo;s independent registered public accounting firm
for the fiscal year ended December 31, 2020. SGA has advised us that neither the firm nor any present member or associate of it
has any material financial interest, direct or indirect, in the Company or its affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the fees of SGA and ACM for the years ended December 31, 2020 and 2019, respectively:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Audit Fees</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">116,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">135,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Audit-Related Fees</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax Fees</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>(1)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16,960</FONT></TD><TD STYLE="text-align: left"><SUP>(2)</SUP></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other Fees</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">137,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">151,960</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="9" STYLE="padding-bottom: 2.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="9" STYLE="padding-bottom: 2.5pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>(1)
</SUP>Tax fees in 2020 relate to tax returns for the 2019 year</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>(2)
</SUP>Tax fees in 2019 relate to tax returns for the 2018 year</FONT></P>

</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Audit
Fees</I>. Audit fees consist of fees billed by our independent registered public accounting firms for professional services rendered
in connection with the audit of our annual consolidated financial statements, and the review of our consolidated financial statements
included in our quarterly reports.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Audit-Related
Fees</I>. Audit-related services consist of fees billed by our independent registered public accounting firms for assurance and
related services that are reasonably related to the performance of the audit or review of the Company&rsquo;s financial statements
and are not reported under &ldquo;Audit Fees.&rdquo; These services include the review of our registration statements on Forms
S-8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Tax
Fees</I>. Tax fees consist of fees billed by our independent registered public accounting firms for professional services rendered
for tax compliance, tax planning and tax advice. These services include assistance regarding federal, state, and local tax compliance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>All
Other Fees</I>. All other fees would include fees for products and services other than the services reported above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pre-Approval
Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors pre-approves all services to be provided by our independent registered public accounting firm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Change
in Accountants Disclosure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 26, 2020, the Company notified ACM, that the Company had dismissed ACM as its independent registered public accounting firm.
The dismissal of ACM was approved by the Board of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACM
served as the Company&rsquo;s independent registered public accounting firm since 2017 until its dismissal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACM&rsquo;s
reports on the consolidated financial statements of the Company as of and for the fiscal years ended December 31, 2019 and 2018,
did not contain any adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope
or accounting principles, except that such reports contained explanatory paragraphs in respect to uncertainty as to the Company&rsquo;s
ability to continue as a going concern and the change in its method of accounting for leases due to the adoption of the Accounting
Standards Codification Topic 842, <I>Leases</I>, which was discussed in Footnote 4 to the consolidated financial statements for
the year ended December 31, 2019. During the fiscal years ended December 31, 2019 and 2018, and through May 26, 2020, there were
no disagreements with ACM on any matter of accounting principles or practices, financial statement disclosure, or auditing scope
or procedure, which if not resolved to ACM&rsquo;s satisfaction would have caused it to make reference thereto in connection with
its reports on the financial statements for such years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal years ended December 31, 2019 and 2018 and through May 26, 2020, there were no events of the type described in Item
304(a)(1)(v) of Regulation S-K, other than certain material weaknesses in respect of effectiveness of internal controls over certain
aspects of the financial reporting process because: (i) the Company lacked a sufficient complement of personnel with a level of
accounting expertise and an adequate supervisory review structure that was commensurate with the financial reporting requirements
of the Company, (ii) there was inadequate segregation of duties due to the limited number of accounting personnel, and (iii) the
Company has insufficient controls and processes in place to adequately verify the accuracy and completeness of spreadsheets that
management uses for a variety of purposes including revenue, taxes, stock-based compensation and other areas, and place significant
reliance on, for our financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 28, 2020, the Company engaged SGA, as its new independent registered public accounting firm. The engagement of SGA was approved
by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal years ended December 31, 2019 and 2018 and thereafter through May 28, 2020, the Company did not consult with SGA with
respect to any matter whatsoever including without limitation with respect to any of (i) the application of accounting principles
to a specified transaction, either completed or proposed; (ii) the type of audit opinion that might be rendered on the Company&rsquo;s
financial statements; or (iii) any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation
S-K) or an event of the type described in Item 304(a)(1)(v) of Regulation S-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provided ACM with a copy of the foregoing disclosure and requested that it furnish the Company with a letter addressed
to the Securities and Exchange Commission stating whether it agrees with the statements made therein. A copy of such letter, dated
May 28, 2020, was filed as Exhibit 16.1 to the Current Report on Form 8-K, dated May 26, 2020, filed with the SEC on May 29, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_022"></A>PART
IV</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 55.05pt; text-align: justify; text-indent: -55.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 55.05pt; text-align: justify; text-indent: -55.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_023"></A>Item
15. Exhibits and Financial Statement Schedules</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>a.
Documents Filed as Part of this Report</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 8.8pt; text-indent: 27.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 8.8pt; text-indent: 27.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following consolidated financial statements of Surna Inc. are filed as part of this Annual Report on Form 10-K:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 8.8pt; text-indent: 27.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
    Statements</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page(s)</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_026"><FONT STYLE="font-size: 10pt">Reports
    </FONT><FONT STYLE="font-size: 10pt">of Independent Registered Public Accounting Firms</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1
    - F-3</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_027"><FONT STYLE="font-size: 10pt">Consolidated
    Balance Sheets as of December 31, 2020 and 2019</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_028"><FONT STYLE="font-size: 10pt">Consolidated
    Statements of Operations for the Years Ended December 31, 2020 and 2019</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_029"><FONT STYLE="font-size: 10pt">Consolidated
    Statements of Changes in Shareholders&rsquo; Deficit for the Years Ended December 31, 2020 and 2019</FONT></A></FONT></TD>
    <TD STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_030"><FONT STYLE="font-size: 10pt">Consolidated
    Statements of Cash Flows for the Years Ended December 31, 2020 and 2019 </FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_031"><FONT STYLE="font-size: 10pt">Notes
    to Consolidated Financial Statements</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-8</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>b.
Exhibits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&ldquo;Exhibit Index&rdquo; on the page following the consolidated financial statements and related footnotes and the signature
page to this Annual Report on Form 10-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>c.
Financial Statement Schedules </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
financial statement schedules are filed herewith because (i) such schedules are not required, or (ii) the information has been
presented in the aforementioned financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_024"></A>Item
16. Form 10-K Summary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has elected not to provide the summary of information under this item.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc. </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Index
to Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
    Statements</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page(s)</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_026"><FONT STYLE="font-size: 10pt">Reports
    of Independent Registered Public Accounting Firms</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1
    - F-3</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_027"><FONT STYLE="font-size: 10pt">Consolidated
    Balance Sheets as of December 31, 2020 and 2019</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_028"><FONT STYLE="font-size: 10pt">Consolidated
    Statements of Operations for the Years Ended December 31, 2020 and 2019</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_029"><FONT STYLE="font-size: 10pt">Consolidated
    Statements of Changes in Shareholders&rsquo; Deficit for the Years Ended December 31, 2020 and 2019</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_030"><FONT STYLE="font-size: 10pt">Consolidated
    Statements of Cash Flows for the Years Ended December 31, 2020 and 2019 </FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#a_031"><FONT STYLE="font-size: 10pt">Notes
    to Consolidated Financial Statements</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-8</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U><A NAME="a_026"></A>Report
of Independent Registered Public Accounting Firm</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Board of Directors and Shareholders of Surna Inc.:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Opinion
on the Financial Statements</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheet of Surna Inc. (&ldquo;the Company&rdquo;) as of December 31, 2020, the
related consolidated statements of operations, changes in shareholders&rsquo; deficit, and cash flows for the year ended December
31, 2020 and the related notes (collectively referred to as the &ldquo;financial statements&rdquo;). In our opinion, the financial
statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31,
2020, and the results of its operations and its cash flows for the year ended December 31, 2020, in conformity with accounting
principles generally accepted in the United States of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Explanatory
Paragraph Regarding Going Concern</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed
in Note 3 to the financial statements, the Company has experienced losses since its inception, has a net working capital deficiency
and has an accumulated deficit, which creates substantial doubt about its ability to continue as a going concern. Management&rsquo;s
plans in regard to these matters are also described in Note 3. The financial statements do not include any adjustments that might
result from the outcome of this uncertainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Basis
for Opinion</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&rsquo;s management. Our responsibility is to express an opinion on
the Company&rsquo;s financial statements based on our audit. We are a public accounting firm registered with the Public Company
Accounting Oversight Board (United States) (&ldquo;PCAOB&rdquo;) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error
or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but
not for the purpose of expressing an opinion on the effectiveness of the Company&rsquo;s internal control over financial reporting.
Accordingly, we express no such opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to
error or fraud, and performing procedures that respond to those risks. Such procedures included examining on a test basis, evidence
regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that our audit provides a reasonable basis for our opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Critical
Audit Matters</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was
communicated or required to be communicated to the audit committee and that: (1) related to accounts or disclosures that are material
to the financial statements and (2) involved our especially challenging, subjective, or complex judgements. The communication
of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not,
by communicating the critical matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures
to which they relate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
Recognition &ndash; Contracts with Multiple Performance Obligations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Critical
Audit Matter Description</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Note 2 to the financial statements, the Company&rsquo;s contracts with customers often include the promise to transfer
multiple goods and services to a customer. Distinct promises within a contract are referred to as performance obligations and
are accounted for as separate units of account. Management assesses whether each promised good or service is distinct for the
purpose of identifying the performance obligations in the contract. This assessment involves subjective determinations and requires
management to make judgments about the individual promised goods or services and whether such goods or services are separable
from the other aspects of the contractual relationship. The Company&rsquo;s performance obligations include various distinct goods
and services such as equipment and various engineering services. When multiple performance obligations are identified within a
contract, management exercises judgement in allocating the transaction price amongst the various performance obligations. In addition,
when discounts are provided for a particular contract, the discount is allocated to each performance obligation proportionally
based upon the stand-alone selling price of each performance obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 59; Options: NewSection -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
determined that performing procedures related to the identification of performance obligations in revenue contracts and allocation
of the transaction price to the respective performance obligations is a critical audit matter as there was significant judgment
by management in identifying performance obligations in revenue contracts and allocating the consideration, which in turn led
to a high degree of auditor judgment, subjectivity and effort in performing procedures to evaluate whether performance obligations
in revenue contracts were appropriately identified by management and consideration was appropriately allocated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>How
the Critical Audit Matter Was Addressed in the Audit</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 13.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit procedures related to the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    gained an understanding of the internal controls related to the revenue recognition process, including controls related to
    the proper identification of performance obligations and allocation of the transaction price to the various performance obligations.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    examined revenue contracts, on a test basis, to test the accuracy and completeness of management&rsquo;s identification of
    the performance obligations.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    evaluated management&rsquo;s process for allocation of the transaction price to the identified performance obligations including
    evaluating the reasonableness of management&rsquo;s estimate of stand-alone selling prices.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
Sadler, Gibb &amp; Associates, LLC</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&rsquo;s auditor since 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draper,
UT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
23, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Report
of Independent Registered Public Accounting Firm</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
and Board of Directors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surna
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boulder,
Colorado</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Opinion
on the Consolidated Financial Statements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheet of Surna Inc. and subsidiary (the &ldquo;Company&rdquo;) as of December
31, 2019, the related consolidated statements of operations, shareholders&rsquo; (deficit) equity, and cash flows for the year
then ended, and the related notes (collectively referred to as the &ldquo;consolidated financial statements&rdquo;). In our opinion,
the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December
31, 2019, and the results of their operations and their cash flows for the year then ended<B>,&nbsp;</B>in conformity with accounting
principles generally accepted in the United States of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Going
Concern Uncertainty</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern.
As discussed in Note 3 to the consolidated financial statements, the Company has suffered recurring losses from operations and
has a working capital deficiency and a shareholders&rsquo; deficit as of December 31, 2019 that raise substantial doubt about
its ability to continue as a going concern. Management&rsquo;s plans in regard to these matters are also described in Note 3.
The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Change
in Accounting Principle</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in Note 4 to the consolidated financial statements, on January 1, 2019, the Company changed its method of accounting
for leases due to the adoption of the Accounting Standards Codification Topic 842,&nbsp;<I>Leases</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Basis
for Opinion</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements are the responsibility of the Company&rsquo;s management. Our responsibility is to express an
opinion on the Company&rsquo;s consolidated financial statements based on our audit. We are a public accounting firm registered
with the Public Company Accounting Oversight Board (United States) (&ldquo;PCAOB&rdquo;) and are required to be independent with
respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities
and Exchange Commission and the PCAOB.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether
due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over
financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting
but not for the purpose of expressing an opinion on the effectiveness of the Company&rsquo;s internal control over financial reporting.
Accordingly, we express no such opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the
accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the
consolidated financial statements. We believe that our audit provides a reasonable basis for our opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
ACM LLP</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
served as the Company&rsquo;s auditor from 2017 to 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greeley,
Colorado</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
24, 2020</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 61 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_027"></A>Consolidated
Balance Sheets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">ASSETS</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current
    Assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    and cash equivalents</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,284,881</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">922,177</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts
    receivable (net of allowance for doubtful accounts of $165,098 and $151,673, respectively)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33,480</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">138,357</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Inventory,
    net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">327,109</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,231,243</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prepaid
    expenses and other</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,037,823</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">269,491</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Current Assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,683,293</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,561,268</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Noncurrent
    Assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Property
    and equipment, net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">147,732</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">257,923</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Goodwill</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">631,064</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">631,064</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intangible
    assets, net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,227</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,930</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deposits</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">51,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    lease right-of-use asset</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">343,950</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">534,133</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Noncurrent Assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,129,973</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,486,050</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">TOTAL
    ASSETS</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,813,266</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,047,318</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">LIABILITIES
    AND SHAREHOLDERS&rsquo; DEFICIT</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">CURRENT
    LIABILITIES</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts
    payable and accrued liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,784,961</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,832,959</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deferred
    revenue</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,724,189</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,444,472</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued
    equity compensation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">128,434</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">503,466</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current
    portion of operating lease liability</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">266,105</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">217,843</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Current Liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,903,689</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,998,740</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">NONCURRENT
    LIABILITIES</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">74,156</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    lease liability, net of current portion</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">169,119</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">404,209</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Noncurrent Liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">243,275</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">404,209</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">TOTAL
    LIABILITIES</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,146,964</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,402,949</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Commitments
    and Contingencies (Note 11)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">SHAREHOLDERS&rsquo;
    DEFICIT</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Preferred
    stock, $0.00001 par value; 150,000,000 shares authorized; 42,030,331 shares issued and outstanding</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">420</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">420</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common
    stock, $0.00001 par value; 350,000,000 shares authorized; 236,526,638 and 228,216,638 shares issued and outstanding, respectively</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,366</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,283</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additional
    paid in capital</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,107,159</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25,326,593</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated
    deficit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(27,443,643</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(25,684,927</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Shareholders&rsquo; Deficit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,333,698</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(355,631</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">TOTAL
    LIABILITIES AND SHAREHOLDERS&rsquo; DEFICIT</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,813,266</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,047,318</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 62 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surna
Inc.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_028"></A>Consolidated
Statements of Operations</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
                                         the Years Ended</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
                                         31,</FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Revenue,
    net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,514,272</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,224,454</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cost
    of revenue</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,961,305</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,675,601</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gross
    profit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,552,967</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,548,853</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    expenses:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Advertising
    and marketing expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">430,012</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">675,703</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Product
    development costs</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">390,229</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">521,044</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Selling,
    general and administrative expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,095,350</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,662,695</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    operating expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,915,591</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,859,442</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,362,624</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,310,589</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    income (expense):</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    income (expense), net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">621,340</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(27,977</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest
    expense</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(17,432</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    other income (expense)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">603,908</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(27,977</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss
    before provision for income taxes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,758,716</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,338,566</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Income
    taxes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,758,716</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,338,566</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss
    per common share &ndash; basic and dilutive</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.01</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.01</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    average number of common shares outstanding, basic and dilutive</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">236,168,059</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">227,662,184</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
accompanying notes are an integral part of these consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surna
Inc.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_029"></A>Consolidated
Statements of Changes in Shareholders&rsquo; Deficit</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Preferred
    Stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="10" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common
    Stock</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of Shares</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amount</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of Shares</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of Shares to be Issued</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amount</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additional
    Paid in Capital</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated
    Deficit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shareholders&rsquo;
    Deficit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance
    December 31, 2018</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">42,030,331</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">420</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">224,989,794</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,250</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">24,538,027</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(24,346,361</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 7%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">194,336</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common
    shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,240,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">560,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">23</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(23</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common
    shares issued as compensation for services</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">986,844</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">74,990</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">75,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    value of vested restricted stock units awarded to employees</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">278,906</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">278,906</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    value of vested stock options granted to employees and consultants</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">390,484</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">390,484</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    value of vested incentive stock bonuses awarded to employees</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">44,209</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">44,209</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,338,566</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,338,566</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance December
    31, 2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">42,030,331</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">420</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">228,216,638</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,560,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,283</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25,326,593</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(25,684,927</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(355,631</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common
    shares issued or to be issued on settlement of restricted stock units and award of stock bonuses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,310,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,560,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">83</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(83</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    value of vested restricted stock units awarded to employees</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25,163</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25,163</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    value of vested stock options accrued in 2019 and issued to employees and directors in 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">503,466</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">503,466</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
    value of vested stock options granted to employees and directors</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">252,020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">252,020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,758,716</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,758,716</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance
    December 31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">42,030,331</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">420</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">236,526,638</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,366</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,107,159</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(27,443,643</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,333,698</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surna
Inc.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="a_030"></A>Consolidated
Statements of Cash Flows</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
                                         the Twelve Months Ended</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
                                         31,</FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    Flows From Operating Activities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,758,716</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,338,566</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Adjustments
    to reconcile net loss to net cash provided by (used in) operating activities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Depreciation
    and intangible asset amortization expense</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">120,103</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">161,180</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gain
    on forgiveness of note payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(557,203</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Share-based
    compensation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">277,183</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">788,599</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Provision
    for doubtful accounts</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,425</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">32,651</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Provision
    for excess and obsolete inventory</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21,669</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(223,971</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss
    on disposal of assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,124</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">115,359</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortizion
    of ROU Asset</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">190,183</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Changes
    in operating assets and liabilities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts
    receivable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">91,452</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">39,179</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Inventory</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">882,466</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(71,386</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prepaid
    expenses and other</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(768,333</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(141,143</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts
    payable and accrued liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,157</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">23,830</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deferred
    revenue</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,279,717</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">802,674</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued
    interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,203</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    lease liability, net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(135,828</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(20,039</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued
    equity compensation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">128,434</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">503,466</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    cash provided by operating activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">818,036</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">671,833</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    Flows From Investing Activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Purchases
    of property and equipment</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(9,332</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,043</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    cash used in investing activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(9,332</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,043</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    Flows From Financing Activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds
    from issuance of note payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">554,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    cash provided by financing activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">554,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    increase in cash</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,362,704</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">668,790</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash,
    beginning of period</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">922,177</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">253,387</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash,
    end of period</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,284,881</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">922,177</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-cash
    investing and financing activities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest
    paid</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Income
    taxes paid</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_031"></A>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
1 &ndash; Description of Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surna
Inc. (the &ldquo;Company&rdquo;) was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control
and other technologies for the Controlled Environment Agriculture (CEA) industry. The CEA industry is one of the fastest-growing
sectors of the United States&rsquo; economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens
harvested at the first true leaf stage), ethnic vegetables and small fruits (such as strawberries, blackberries and raspberries)
to bell peppers, cucumbers, tomatoes and cannabis and hemp, some producers grow crops indoors in response to market dynamics or
as part of their preferred farming practice. In service of the CEA industry, our principal technologies include: (i) liquid-based
process cooling systems and other climate control systems, (ii) air handling equipment and systems, (iii) a full-service engineering
package for designing and engineering commercial scale thermodynamic systems specific to cultivation facilities, and (iv) automation
and control devices, systems and technologies used for environmental, lighting and climate control. Our customers include commercial,
state- and provincial-regulated CEA growers in the U.S. and Canada as well as other international locations. Customers are those
growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived
primarily from supplying our products, services and technologies to commercial indoor facilities ranging from several thousand
to more than 100,000 square feet. Headquartered in Boulder, Colorado, we leverage our experience in this space to bring value-added
climate control solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency,
and satisfy the evolving state and local codes, permitting and regulatory requirements. Although our customers do, we neither
produce nor sell cannabis or its related products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Impact
of the COVID-19 Pandemic on Our Business</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of
our markets and disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales,
project implementation, operating margins, and working capital. As of the date of this filing, uncertainty continues to exist
concerning the magnitude and duration of the economic impact of the COVID-19 pandemic.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
response to the COVID-19 pandemic and its changing conditions the Company reduced its operational expenses to conserve its cash
resources. Many expenses, including travel, marketing, headcount, work hours, and compensation were reduced, deferred, or eliminated
while still allowing us to meet our customer obligations and develop new business. As the fiscal year progressed and our sales
rebounded, and we were able to obtain additional funds through a forgivable bank loan, we restored our workforce and compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the speed with which the COVID-19 pandemic developed and the resulting uncertainties, including the depth and duration of the
disruptions to customers and suppliers, its future effect on our business, on our results of operations, and on our financial
condition, cannot be predicted. We expect that the economic disruptions will continue to have an effect on our business over the
longer term. Despite this uncertainty, we continue to monitor costs and continue to take actions to reduce costs so as to mitigate
the impact of the COVID-19 pandemic to the best of our ability, although they may not be sufficient in the long-run for us to
avoid reduced sales, increased losses and reduced operating cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
to <I>Risk Factors</I>, included in Part I, Item 1A of this Annual Report on Form 10-K above, for further discussion of the possible
impact of the COVID-19 pandemic on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
2 &ndash; Basis of Presentation; Summary of Significant Accounting Policies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Financial
Statement Presentation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United
States of America (&ldquo;GAAP&rdquo;) requires management to make estimates and assumptions that affect reported amounts and
related disclosures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
further discussed in <I>Note 3 Going Concern</I> below, the accompanying consolidated financial statements have been prepared
on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course
of business. The Company has not generated sufficient revenue and has historically funded its operations through the sale of common
stock, the issuance of debt and the receipt of advance payments from customers. The Company is subject to risks, expenses and
uncertainties similar to those encountered by similarly situated companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Principles
of Consolidation </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro Innovations,
LLC (&ldquo;Hydro&rdquo;). Intercompany transactions, profit, and balances are eliminated in consolidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Use
of Estimates</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets
and liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the
reporting period. The Company bases its estimates on historical experience and on various other assumptions that it believes to
be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets
and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates
include: allocation of transaction prices to performance obligations under contracts with customers, standalone selling prices,
timing of expected revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible
assets as it applies to impairment analysis, valuation of equity-based compensation, valuation of deferred tax assets and liabilities,
warranty accruals, inventory allowances, and legal contingencies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cash
and Cash Equivalents</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents.
The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company
has not experienced any losses to date on depository accounts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Accounts
Receivable and Allowance for Doubtful Accounts</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivables are recorded at the invoiced amount or based on revenue earned for items not yet invoiced, and generally do not bear
interest. An allowance for doubtful accounts is established, as necessary, based on past experience and other factors, which,
in management&rsquo;s judgment, deserve current recognition in estimating bad debts. Based on the Company&rsquo;s review, it establishes
or adjusts the allowance for specific customers and the accounts receivable portfolio as a whole. As of December 31, 2020, and
December 31, 2019, the allowance for doubtful accounts was $165,098 and $151,673, respectively. If the financial condition
of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may
be required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Inventory</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
is stated at the lower of cost or net realizable value. The inventory is valued based on a first-in, first-out (&ldquo;FIFO&rdquo;)
basis. Lower of cost or net realizable value is evaluated by considering obsolescence, excessive levels of inventory, deterioration
and other factors. Adjustments to reduce the cost of inventory to its net realizable value, if required, are made for estimated
excess, obsolescence or impaired inventory. Excess and obsolete inventory is charged to cost of revenue and a new lower-cost basis
for that inventory is established and subsequent changes in facts and circumstances do not result in the restoration or increase
in that newly established cost basis. As of December 31, 2020, and December 31, 2019, the allowance for excess and obsolete
inventory was $93,045 and $71,376, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Property
and Equipment</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment are stated at cost. For financial statement purposes, property and equipment are recorded at cost and depreciated
using the straight-line method over their estimated useful lives, which is generally five years. Leasehold improvements are amortized
on a straight-line basis over the lesser of their useful lives or the life of the lease. Upon sale or retirement of assets, the
cost and related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss is
reflected in operations. Maintenance and repairs are charged to operations as incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Long-lived
Assets</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
tangible assets, including property and equipment, are reviewed for impairment whenever events or changes in business circumstances
indicate the carrying value of the assets may not be recoverable. When such an event occurs, management determines whether there
has been impairment by comparing the anticipated undiscounted future net cash flows to the related asset&rsquo;s carrying value.
If an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash
flows or appraised value, depending on the nature of the asset. The Company has not identified any indicators of impairment during
the years ended December 31, 2020 and 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Goodwill
and Intangible Assets</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded goodwill in connection with its acquisition of Hydro in July 2014. Goodwill is reviewed for impairment annually
on December 31<SUP>st</SUP> or more frequently when events or changes in circumstances indicate that fair value of the reporting
unit has been reduced to less than its carrying value. The Company performs a quantitative impairment test annually during the
fourth quarter by comparing the fair value of the reporting unit with its carrying amount, including goodwill. If the fair value
of the reporting unit exceeds its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized
for the amount by which the carrying amount exceeds the reporting unit&rsquo;s fair value. The Company determined that it has
one reporting unit. The Company completed this assessment as of December 31, 2020 and concluded that no impairment existed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Separable
identifiable intangibles consist of intellectual property such as patents and trademarks, and capitalized website costs. Except
for trademarks, which are not amortized, the Company&rsquo;s separable identifiable intangible assets are subject to amortization
on a straight-line basis over their estimated useful lives. Trademarks are tested annually for impairment. Separable identifiable
intangibles are also subject to evaluation for potential impairment if events or circumstances indicate the carrying value may
not be recoverable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Fair
Value Measurement</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records its financial assets and liabilities at fair value. The accounting standard for fair value provides a framework
for measuring fair value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair
value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly
transaction between market participants at the reporting date. The accounting standard establishes a three-tier hierarchy, which
prioritizes the inputs used in the valuation methodologies in measuring fair value:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 - inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 - inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset
or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 - inputs are unobservable inputs based on the Company&rsquo;s assumptions used to measure assets and liabilities at fair value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
financial asset or liability&rsquo;s classification within the hierarchy is determined based on the lowest level of input that
is significant to the fair value measurement. The Company&rsquo;s assessment of the significance of a particular input to the
fair value measurement in its entirety requires management to make judgments and consider factors specific to the asset or liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to their short-term nature, the carrying values of cash and cash equivalents, accounts receivable, accounts payable, and accrued
expenses, approximate fair value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Derivative
Financial Instruments</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify
as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument
is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported
in the statements of operations. For stock-based derivative financial instruments, the Company uses the Black-Scholes Option Pricing
Model (the &ldquo;Black-Scholes Model&rdquo;) to value the derivative instruments. The classification of derivative instruments,
including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.
Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash
settlement of the derivative instrument could be required within twelve months of the balance sheet date. As of December 31, 2020,
and December 31, 2019, there were no derivative financial instruments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Revenue
Recognition</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 1, 2018, the Company adopted Accounting Standards Update (&ldquo;ASU&rdquo;) 2014-09 (Topic 606), <I>Revenue from Contracts
with Customers</I> and all the related amendments (&ldquo;ASC 606&rdquo; or the &ldquo;revenue standard&rdquo;) to all contracts
and elected the modified retrospective method.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the Company&rsquo;s revenue by source:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 55%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
    the Years Ended December 31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; width: 65%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Equipment
    and systems sales</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,730,371</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,692,863</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Engineering
    and other services</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">568,131</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,239,130</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shipping
    and handling</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">215,770</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">292,461</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    revenue</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,514,272</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,224,454</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Revenue
Recognition Accounting Policy Summary</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in
a contract with a customer to transfer a distinct good or service to the customer. Most of the Company&rsquo;s contracts contain
multiple performance obligations that include engineering and technical services as well as the delivery of a diverse range of
climate control system equipment and components, which can span multiple phases of a customer&rsquo;s project life-cycle from
facility design and construction to equipment delivery and system installation and start-up. The Company does not provide construction
services or system installation services. Some of the Company&rsquo;s contracts with customers contain a single performance obligation,
typically engineering only services contracts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
contract&rsquo;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as,
the performance obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates
the transaction price to each performance obligation based on standalone selling price. When estimating the selling price, the
Company uses various observable inputs. The best observable input is the Company&rsquo;s actual selling price for the same good
or service, however, this input is generally not available for the Company&rsquo;s contracts containing multiple performance obligations.
For engineering services, the Company estimates the standalone selling price by reference to certain physical characteristics
of the project, such as facility size and mechanical systems involved, which are indicative of the scope and complexity of the
mechanical engineering services to be provided. For equipment sales, the standalone selling price is determined by forecasting
the expected costs of the equipment and components and then adding an appropriate margin, based on a range of acceptable margins
established by management. Depending on the nature of the performance obligations, the Company may use a combination of different
methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices.
Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates
the amount of the transaction price to be recognized as each promise is fulfilled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
satisfaction occurs when control of the promised goods is transferred to the customer or as services are rendered or completed
in exchange for consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the
sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company&rsquo;s historical
rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns
at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all
taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with
a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue
net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the
Company&rsquo;s customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue
is recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain
specified milestones.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by
the contracts with customers and does not have any material separate performance obligations related to these warranties. The
Company maintains a warranty reserve based on historical warranty costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Other
Judgments and Assumptions</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company typically receives customer payments in advance of its performance of services or transfers of goods. Applying the practical
expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration
for the effects of a significant financing component since the Company expects, at contract inception, that the period between
when the Company transfers a promised good or service to a customer and when the customer pays for that good or service will be
one year or less. Accordingly, the remaining performance obligations related to customer contracts does not consider the effects
of the time value of money.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense
when incurred since the amortization period of the assets that the Company otherwise would have recognized is one year or less.
These costs include certain sales commissions and incentives, which are included in selling, general and administrative expenses,
and are payable only when associated revenue has been collected and earned by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Contract
Assets and Contract Liabilities</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract
assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate
to payments received in advance of the satisfaction of performance under the contract. The Company receives payments from customers
based on the terms established in its contracts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract
assets include unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is
conditional, subject to completing a milestone, such as a phase of a project. The Company typically does not have material amounts
of contract assets since revenue is recognized as control of goods are transferred or as services are performed. As of December
31, 2020, and 2019, the Company had no contract assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract
liabilities consist of advance payments in excess of revenue recognized. The Company&rsquo;s contract liabilities are recorded
as a current liability in deferred revenue in the consolidated balance sheets since the timing of when the Company expects to
recognize revenue is generally less than one year. As of December 31, 2020, and December 31, 2019, deferred revenue, which
was classified as a current liability, was $3,724,189 and $1,444,472, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2020, the Company recognized revenue of $1,103,447 related to the deferred revenue at January 1, 2020,
or 76%. For the year ended December 31, 2019, the Company recognized revenue of $473,682 related to the deferred revenue at January
1, 2019, or 74%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Remaining
Performance Obligations</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining
performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations
that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in
ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original
expected duration of one year or less. Accordingly, the information disclosed about remaining performance obligations includes
all customer contracts, including those with an expected duration of one year or less.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry
uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the
Company&rsquo;s control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance
obligations. There are risks that the Company may not realize the full contract value on customer projects in a timely manner
or at all, and completion of a customer&rsquo;s cultivation facility project is dependent upon the customer&rsquo;s ability to
secure funding and real estate, obtain a license and then build their cultivation facility so they can take possession of the
equipment. Accordingly, the time it takes for customers to complete a project, which corresponds to when the Company is able to
recognize revenue, is driven by numerous factors including: (i) the large number of first-time participants interested in the
indoor cannabis cultivation business; (ii) the complexities and uncertainties involved in obtaining state and local licensure
and permitting; (iii) local and state government delays in approving licenses and permits due to lack of staff or the large number
of pending applications, especially in states where there is no cap on the number of cultivators; (iv) the customer&rsquo;s need
to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers to acquire real estate
and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the large price
tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii) delays
that are typical in completing any construction project. Further, based on the current economic climate, the uncertainty regarding
the COVID-19 virus, and the Company&rsquo;s recent cost cutting measures, there is no assurance that the Company will be able
to fulfill its backlog, and the Company may experience contract cancellations, project scope reductions and project delays.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company&rsquo;s remaining performance obligations, or backlog, was $8,448,000, of which $2,643,000,
or 31%, was attributable to customer contracts for which the Company has only received an initial advance payment to cover the
allocated value of the Company&rsquo;s engineering services (&ldquo;engineering only paid contracts&rdquo;). There is the risk
that the equipment portion of these engineering only paid contracts will not be completed or will be delayed. The reasons include
the customer being dissatisfied with the quality or timeliness of the Company&rsquo;s engineering services, delay or abandonment
of the project because of the customer&rsquo;s inability to obtain project financing or licensing, or other reasons such as a
challenging business climate including an overall post-COVID-19 economic downturn, or change in business direction. After the
customer has made an advance payment for a portion of the equipment to be delivered under the contract (&ldquo;partial equipment
paid contracts&rdquo;), the Company is typically better able to estimate the timing of revenue recognition since the risks and
delays associated with licensing, permitting and project funding are typically mitigated once the initial equipment payment is
received. There is significant uncertainty regarding the timing of the Company&rsquo;s recognition of revenue on its remaining
performance obligations, and there is no certainty that these will result in actual revenues. The backlog at December 31, 2020,
includes booked sales orders of $390,000 from several customers that the Company does not expect to be realized until 2022, if
at all. Given the present economic uncertainty arising from the impact of the novel coronavirus COVID-19, the Company believes
that several of its current contracts may be delayed or canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
remaining performance obligations expected to be recognized through 2022 are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 52%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Remaining
    performance obligations related to engineering only paid contracts</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,355,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">288,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,643,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Remaining
    performance obligations related to partial equipment paid contracts</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,703,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">102,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,805,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    remaining performance obligations</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,058,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">390,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,448,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Product
Warranty</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company warrants the products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18
months from shipment. The Company&rsquo;s warranty provides for the repair, rework, or replacement of products (at the Company&rsquo;s
option) that fail to perform within stated specification. The Company&rsquo;s third-party suppliers also warrant their products
under similar terms, which are passed through to the Company&rsquo;s customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately
1% of annual revenue generated on these products. Based on the Company&rsquo;s warranty policy, an accrual is established at 1%
of the trailing 18 months revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based
on historical claims and other factors. As of December 31, 2020, and December 31, 2019, the Company had an accrued warranty
reserve amount of $173,365 and $185,234, respectively, which are included in accounts payable and accrued liabilities on the Company&rsquo;s
consolidated balance sheets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cost
of Sales</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of sales includes product costs (material, direct labor and overhead costs), shipping and handling expense, outside engineering
costs, engineering, project management and service salaries and benefits, client visits and warranty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Concentrations</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
customers accounted for 28%, 11% and 10% of the Company&rsquo;s revenue for the year ended December 31, 2020. One customer accounted
for 44% of the Company&rsquo;s revenue for the year ended December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s accounts receivable from two customers made up 48% and 38%, respectively, of the total balance as of December
31, 2020. The Company&rsquo;s accounts receivable from three customers made up 59%, 16%, and 10%, respectively, of the total balance
as of December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
suppliers accounted for 27%, 25% and 12% of the Company&rsquo;s purchases of inventory for the year ended December 31, 2020, and
three suppliers accounted for 30%, 17% and 12% of the Company&rsquo;s purchases of inventory for the year ended December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Product
Development</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expenses product development costs as incurred. Internal product development costs are expensed as incurred, and third-party
product developments costs are expensed when the contracted work has been performed or as milestone results have been achieved.
For the years ended December 31, 2020 and December 31, 2019, the Company incurred $390,229 and $521,044, respectively,
on product development.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Accounting
for Share-Based Compensation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock
awards and restricted stock units that the Company grants under its equity incentive plan in its consolidated financial statements
based on their grant date fair value. For awards subject to service conditions, compensation expense is recognized over the vesting
period on a straight-line basis. Awards subject to performance conditions are attributed separately for each vesting tranche of
the award and are recognized ratably from the service inception date to the vesting date for each tranche, based on the probability
of vesting. The probability of awards with future performance conditions is evaluated each reporting period and compensation expense
is adjusted based on the probability assessment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Awards
are considered granted, and the service inception date begins, when mutual understanding of the key terms and conditions of the
award between the Company and the recipient has been established. For awards that provide discretion to adjust the amount of the
award, the service inception date for such awards could precede the grant date as a mutual understanding of the key terms and
conditions of the award between the Company and the recipient has not yet been established. For awards in which the service inception
date precedes the grant date, compensation cost is accrued beginning on the service inception date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent
to December 31, 2020, the Company&rsquo;s Board of Directors (the &ldquo;Board&rdquo;) approved annual incentive compensation
awards to certain employees payable in non-qualified stock options, based on the Company&rsquo;s performance and each employee&rsquo;s
contributions to such performance for the 2020 year. See Note 16. The non-qualified stock options were granted subsequent to December
31, 2020, were not subject to an additional service requirement and were immediately vested at the date of the grant. The final
amount of the annual incentive compensation award, and number of non-qualified stock options granted, were determined, and communicated
to the employee, subsequent to December 31, 2020. The estimated compensation expense of $128,434 related to the 2020 incentive
awards was accrued as of December 31, 2020. Since such incentive awards will be settled in non-qualified stock options, the accrued
compensation expense has been classified as a current liability until the number of non-qualified stock options is fixed pursuant
to a grant by the Board. At that time, the incentive award becomes equity-classified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
grant date fair value of stock options is based on the Black-Scholes Model. The Black-Scholes Model requires judgmental assumptions
including volatility and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury
interest rates whose term is consistent with the expected term of the option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on
the date of the grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does
not have historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether
particular groups of employees have significantly different forfeiture expectations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based
compensation costs (including expenses from the accrued compensation liabilities related to the annual incentive awards subsequently
settled in non-qualified stock options totaled $405,617 and $1,292,065 for the years ended December 31, 2020 and 2019, respectively.
Such share-based compensation costs are classified in the Company&rsquo;s consolidated financial statements in the same manner
as if such compensation was paid in cash.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of such share-based compensation costs included in the Company&rsquo;s consolidated statements of operations
for the years ended December 31, 2020 and 2019:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 65%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
    the Years Ended December 31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Share-based
    compensation expense included in:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cost
    of revenue</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">31,006</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">91,081</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Advertising
    and marketing expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,333</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33,977</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Product
    development costs</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21,882</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">45,330</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Selling,
    general and administrative expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">344,396</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,121,677</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    share-based compensation expense included in consolidated statement of operations</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">405,617</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,292,065</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Income
Taxes</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets
and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under
this method, the Company determines deferred tax assets and liabilities on the basis of the differences between the financial
statement and tax bases of assets and liabilities by using enacted tax rates in effect for the year in which the differences are
expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the
period that includes the enactment date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes deferred tax assets to the extent that the Company believes that these assets are more likely than not to be
realized. In making such a determination, the Company considers all available positive and negative evidence, including future
reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of
recent operations. If the Company determines that it would be able to realize its deferred tax assets in the future in excess
of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would
reduce the provision for income taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records uncertain tax positions on the basis of a two-step process in which: (i) the Company determines whether it is
more likely than not that the tax positions will be sustained on the basis of the technical merits of the position, and (ii) for
those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax
benefit that is more likely than not to be realized upon ultimate settlement with the related tax authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Basic
and Diluted Net Loss per Common Share</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss)
per common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially
dilutive common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards,
except in periods when losses are reported where the effect of the common stock equivalents would be antidilutive. Potential common
stock equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock
units using the treasury method. As of December 31, 2020, 29,213,500 potential common shares equivalents from warrants and options
were excluded from the diluted EPS calculations as their effect is anti-dilutive.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Commitments
and Contingencies</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the normal course of business, the Company is subject to loss contingencies, such as legal proceedings and claims arising out
of its business, that cover a wide range of matters, including, among others, customer disputes, government investigations and
tax matters. An accrual for a loss contingency is recognized when it is probable that an asset had been impaired or a liability
had been incurred and the amount of loss can be reasonably estimated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other
Risks and Uncertainties</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
achieve profitable operations, the Company must successfully develop, manufacture and market its products. There can be no assurance
that any such products can be developed or manufactured at an acceptable cost and with appropriate performance characteristics,
or that such products will be successfully marketed. These factors could have a material adverse effect upon the Company&rsquo;s
financial results, financial position, and future cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 73 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to risks common to similarly-situated companies including, but not limited to, general economic conditions,
its customers&rsquo; operations and access to capital, and market and business disruptions including severe weather conditions,
natural disasters, health hazards, terrorist activities, financial crises, political crises or other major events, or the prospect
of these events, new technological innovations, dependence on key personnel, protection of proprietary technology, compliance
with government regulations, uncertainty of market acceptance of products, product liability, and the need to obtain additional
financing. As a supplier of services and equipment to cannabis cultivators, the Company is also subject to risks related to the
cannabis industry. Although certain states have legalized medical and/or recreational cannabis, U.S. federal laws continue to
prohibit marijuana in all its forms as well as its derivatives. Any changes in the enforcement of U.S. federal laws may adversely
affect the implementation of state and local cannabis laws and regulations that permit medical or recreational cannabis and, correspondingly,
may adversely impact the Company&rsquo;s customers. The Company&rsquo;s success is also dependent upon its ability to raise additional
capital and to successfully develop and market its products. See Note 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Segment
Information</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
segments are defined as components of an enterprise about which separate financial information is available that is evaluated
regularly by the Company&rsquo;s senior management team in deciding how to allocate resources and in assessing performance. The
Company has one operating segment that is dedicated to the manufacture and sale of its products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Recently
Issued Accounting Pronouncements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU 2020-06: &ldquo;<I>Accounting for Convertible Instruments and Contracts In An Entity&rsquo;s
Own Equity&rdquo; (&ldquo;ASU 2020-06&rdquo;)</I> ASU 2020-04 simplifies the accounting for certain convertible instruments by
removing the separation models for convertible debt with a cash conversion feature and for convertible instruments with a beneficial
conversion feature. As a result, more convertible debt instruments will be reported as a single liability instrument with no separate
accounting for embedded conversion features. Additionally, ASU 2020-04 amends the diluted earnings per share calculation for convertible
instruments by requiring the use of the if-converted method. The treasury stock method is no longer available. Entities may adopt
the ASU 2020-04 using either a full or modified retrospective approach, and it is effective for interim and annual reporting periods
beginning after December 15, 2021. Early adoption is permitted for interim and annual reporting periods beginning after December
15, 2020. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows
and financial position.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the FASB issued ASU 2019-12, <I>Income Taxes (Topic 740) &ndash; Simplifying the Accounting for Income Taxes, </I>which
simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments
also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance.
ASU 2019-12 is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company does not
expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial position.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected
to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are
not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
3 &ndash; Going Concern </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern,
which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has experienced recurring losses since its inception. The Company incurred a net loss of approximately $1,759,000 for
the year ended December 31, 2020 and had an accumulated deficit of approximately $27,444,000 and a shareholders&rsquo; deficit
of approximately $1,334,000 as of December 31, 2020. Since inception, the Company has financed its activities principally through
debt and equity financing, advance payments from customers and revenues from completed contracts. Management expects to incur
additional losses and cash outflows in the foreseeable future in connection with its operating activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to a number of risks similar to those of other similar stage and situated companies, including general economic
conditions, its customers&rsquo; operations and prospects for and ability to obtain project financing, and market and business
disruptions, that include the outbreak of COVID-19, dependence on key individuals, successful development, marketing and branding
of products; uncertainty of product development and generation of revenues; dependence on outside sources of financing; risks
associated with research, development; dependence on third-party suppliers and collaborators; protection of intellectual property;
and competition with larger, better-capitalized companies. Ultimately, the attainment of profitable operations is dependent on
future events, including obtaining adequate financing to fulfill its development activities and generating a level of revenues
adequate to support the Company&rsquo;s cost structure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 74 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that the Company will be able to raise debt or equity financing in sufficient amounts, when and if needed,
on acceptable terms or at all. The Company&rsquo;s ability to raise equity capital is also limited by the Company&rsquo;s stock
price, and any such issuance could be highly dilutive to existing shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s 2020 revenue of approximately $8,514,000 which represents a decrease of 44% over the prior year. The Company&rsquo;s
revenue recognition on contracts continues to be unpredictable and inconsistent quarter-over-quarter, and the Company has incurred,
and expects to incur, additional operating expenses to support such growth. The Company generated approximately $818,000 in cash
flow from operating activities in 2020. However, as a result of the Company&rsquo;s growth and its efforts to expand and upgrade
its products, the Company&rsquo;s working capital deficit as of December 31, 2020 was approximately $2,220,000, compared to approximately
$1,437,000 as of December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also will be affected by constraints on the availability of capital to its customers and prospects who have commenced,
or are contemplating, new or expanded cultivation facilities and the overall impact of the COVID-19 pandemic. The extent to which
COVID-19 will impact the Company&rsquo;s business and financial results will depend on future developments, which are uncertain
and cannot be predicted. See Note 16. The duration and likelihood of operational success going forward resulting from the fiscal
year 2020 measures of adjusting the workforce reductions and cost-cutting measures are uncertain. If these actions do not meet
management&rsquo;s expectations, or additional capital is not available, there is substantial doubt about the Company&rsquo;s
ability to continue as a going concern for a period of one year from the issuance of these financial statements. Other factors
that will impact the Company&rsquo;s ability to continue operations include the market demand for the Company&rsquo;s products
and services, the ability to service its customers and prospects, potential contract cancellations, project scope reductions and
project delays, the Company&rsquo;s ability to fulfill its backlog, the management of working capital, and the continuation of
normal payment terms and conditions for purchase of the Company&rsquo;s products. The Company believes its cash balances and cash
flow from operations will be insufficient to fund its operations for the next twelve months. If the Company is unable to increase
revenues, or otherwise generate cash flows from operations, there is substantial doubt about the Company&rsquo;s ability to continue
as a going concern for a period of one year from the date the financial statements are issued. These consolidated financial statements
do not include any adjustment that might result from the outcome of this uncertainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
4 &ndash; Leases</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2016, the FASB issued ASU 2016-02, <I>Leases (Topic 842)</I>(&ldquo;ASC 842&rdquo; or the &ldquo;new lease standard&rdquo;).
The Company adopted ASC 842 as of January 1, 2019, using the effective date method. Consequently, financial information will not
be updated, and the disclosures required under the new lease standard will not be provided, for dates and periods prior to January
1, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
new lease standard provides a number of optional practical expedients in transition. The Company has elected to apply the &ldquo;package
of practical expedients&rdquo; which allow the Company to not reassess: (i) whether existing or expired arrangements contain a
lease, (ii) the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify
for capitalization under the new lease standard. The Company has also elected to apply the short-term lease exemption for all
leases with an original term of less than 12 months, for purposes of applying the recognition and measurements requirements in
the new lease standard.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 27, 2017, the Company entered into a lease for its manufacturing and office space (the &ldquo;Facility Lease&rdquo;), which
commenced September 29, 2017 and continues through August 31, 2022. The Company occupied its 12,700 square foot space for $12,967
per month until January 1, 2018. On January 2, 2018, the leased space was expanded to 18,600 square feet, and the monthly rental
rate increased to $18,979 until August 31, 2018. Beginning September 1, 2018 and 2019, the monthly rent increased to $19,549 and
$20,135, respectively. On each September 1 through the end of the lease, the monthly rent will increase by 3%. Pursuant to the
current lease, the Company made a security deposit of $51,000 on July 31, 2017. The deposit of $1,600 paid to the previous owner
of the property was forwarded to the current landlord. The Company has the option to renew the Facility Lease for an additional
five years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2020, the Company entered into an agreement with its landlord to apply its rent deposit of $52,600 to rent payments due during
the period. The deposit required on the lease will be reduced to approximately $32,000 and will be payable in 12 monthly installments
from January through December of 2021. Further, the landlord also agreed to defer payment of fifty percent of the three months
of lease payments (base rent only) for the period July to September 2020. The deferred lease payments amount to approximately
$30,000 and will be payable in 12 monthly installments from January to December 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
rent under the Facility Lease is charged to expense over the term of the lease on a straight-line basis, resulting in the same
monthly rent expense throughout the lease. The difference between the rent expense amount and the actual rent paid is recorded
to operating lease liability on the Company&rsquo;s condensed consolidated balance sheets. As of January 1, 2019, the remaining
deferred rent of $26,477 was reclassified to the operating lease liability under the new lease standard.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 75 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
adoption of the new lease standard, the Company recognized its lease for manufacturing and office space (the &ldquo;Facility Lease&rdquo;)
on the balance sheet as an operating lease right-of-use asset in the amount of $714,416 and as a lease liability of $822,374.
The renewal option to extend the Facility Lease is not included in the right-of-use asset or lease liability as the option is
not reasonably certain of exercise. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise,
the Company will include the renewal period in its lease term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Facility Lease, the landlord agreed to pay the Company or the Company&rsquo;s contractors for tenant improvements made by
the Company not to exceed $100,000, which were used for normal tenant improvements. The Company determined that these improvements
were not specialized and could be utilized by a subsequent tenant and, as such, the improvements were considered assets of the
lessor. As of January 1, 2019, the unamortized amount of tenant improvement allowance of $81,481 was treated as a reduction in
measuring the right-of-use asset.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Facility Lease, the Company pays the actual amounts for property taxes and insurance, excludes such payments from lease contract
consideration, and records such payments as incurred. The Company also pays the landlord for common area maintenance, which is
considered a non-lease component. For the Facility Lease, the Company has elected to exclude non-lease components from lease contract
consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining the right-of-use asset and lease liability, the Company applied a discount rate to the minimum lease payments under
the Facility Lease. ASC 842 requires the Company to use the rate of interest that the Company would have to pay to borrow on a
collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment. Since the discount
rate is not implicit in the lease agreement, we utilized an estimated incremental borrowing rate provided by the Company&rsquo;s
depository bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
lease cost, cash flows and other information related to the Facility Lease were as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 65%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
                                         the Year Ended</B></FONT></P> <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>December
    31, 2020</B></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 80%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    lease cost</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">216,889</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    cash outflow from operating lease</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">160,934</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 65%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; white-space: nowrap; font-weight: bold; text-align: center; width: 16%"><P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>As
                                         of</B></FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December
                                         31, 2020</B></FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: left; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    lease right-of-use assset</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">343,950</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    lease liability, current</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">266,105</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating
    lease liability, long-term</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">169,119</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Remaining
    lease term</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.7
                                         years</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Discount
    rate</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.00</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
annual minimum lease payments on the Facility Lease as of December 31, 2020 were as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 65%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Years
    ended December 31,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 80%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">281,864</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">170,891</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    minimum lease payments</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">452,755</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less
    imputed interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(17,531</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Present
    value of minimum lease payments</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">435,224</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 76 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
5 &ndash; Inventory</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 65%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
    of December 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Finished
    goods</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">201,778</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,041,369</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Work
    in progress</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,231</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,851</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Raw
    materials</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">214,145</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">257,399</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Allowance
    for excess &amp; obsolete inventory</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(93,045</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(71,376</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Inventory,
    net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">327,109</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,231,243</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overhead
expenses of $17,974 and $31,831 were included in the inventory balance as of December 31, 2020 and 2019, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
6 &ndash; Property and Equipment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 65%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
    of December 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Furniture
    and equipment</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">398,422</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">389,090</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Vehicles</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Leasehold
    improvements</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">215,193</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">215,193</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">628,615</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">619,283</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated
    depreciation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(480,883</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(361,360</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Property
    and equipment, net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">147,732</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">257,923</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense amounted to $119,524 for the year ended December 31, 2020, of which $6,394 was allocated to cost of revenue. Depreciation
expense amounted to $157,860 for the year ended December 31, 2019, of which $7,010 was allocated to cost of revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2018, the Company&rsquo;s property and equipment, net included the gross cost of the equipment leased to a cultivation
company affiliated with one of the Co-founders of $176,042, and accumulated depreciation of $39,120. During the year ended December
31, 2019, the Company wrote-off the carrying value of the leased equipment. See Note 10.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
7 &ndash; Intangible Assets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 65%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
    of December 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Patents</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,110</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,234</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Website
    development costs</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">22,713</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">22,713</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Trademarks</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,830</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,830</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">32,653</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">36,777</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated
    amortization</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(25,426</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(24,847</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intangible
    assets, net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,227</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,930</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 77 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents
when issued are amortized over 14 years, and web site development costs are amortized over five years. Trademarks are not amortized
since they have an indefinite life. Amortization expense for intangibles amounted to $579 and $3,320 for the years ended December
31, 2020 and 2019, respectively. During the years ended December 31, 2020 and 2019, the Company wrote-off $4,124 and $7,778, respectively,
related to patents that had been abandoned.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
8 &ndash; Accounts Payable and Accrued Liabilities </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
payable and accrued liabilities consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 65%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
    of December 31,</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts
    payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">918,639</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,299,015</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sales
    commissions payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">48,263</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">69,532</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued
    payroll liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">288,071</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">169,052</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Product
    warranty accrual</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">173,365</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">185,234</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    accrued expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">356,623</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">110,127</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,784,961</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,832,959</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
payable and other accrued expenses includes $402,651 relating to a one-time warranty issue experienced on three customers&rsquo;
projects. The expenses related to parts and labor to repair units that had been delivered to these customers prior to year-end.
Since the issue is limited to these three projects and is not anticipated to reoccur in the future, we have made no adjustment
to the ongoing 1% warranty reserve that we accrue on all sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
9 &ndash; Note Payable and Accrued Interest</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 22, 2020, the Company entered into a note payable with its current bank in the principal amount of $554,000, for working
capital purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
loan amount was subject to interest at 1% and was initially due on April 20, 2022. Subsequently, the term of the loan was potentially
to be extended to April 20, 2025. The loan could be repaid in advance without penalty. The loan was also potentially forgivable
in full provided proceeds were used for payment of payroll expenses, rent, utilities and mortgage interest and certain other terms
and conditions were met. The loan had typical default provisions, including for change of ownership, general lender insecurity
as to repayment, non-payment of amounts due, defaults on other debt instruments, insolvency, dissolution or termination of the
business as a going concern and bankruptcy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2020, interest of $3,203 was accrued in respect of this note payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 11, 2020, the Company received notice from the bank that its loan received on April 22, 2020, in the principal amount
of $554,000 and all accrued interest of $3,203, was fully forgiven. This gain on loan forgiveness was recorded as Other Income in the Statement of Operations during the year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
further discussed in <I>Note 16 Subsequent Events</I> below, on February 10, 2021, we received funding based on a loan agreement
entered into on February 5, 2021 with its current bank in the principal amount of $514,200 for working capital purposes. Consistent
with the loan provisions, the Company will use the proceeds to meet payroll and benefit expenses as well as for rent and utilities.
The loan amount bears interest at 1% and is due on February 5, 2026. The loan may be repaid in advance without penalty. The loan
has typical default provisions, including for change of ownership, general lender insecurity as to repayment, non-payment of amounts
due, defaults on other debt instruments, insolvency, dissolution or termination of the business as a going concern and bankruptcy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
10 &ndash; Related Party Agreements and Transactions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Agreements
and Transaction with Company&rsquo;s Co-Founders</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following describes certain agreements and transactions between the Company and its co-founders (the &ldquo;Co-founders&rdquo;).
The Co-founders held various executive officer and director positions with the Company until May 2018. One of the Co-founders
also was a consultant to the Company until May 2018. The Co-founders are also shareholders of the Company. Based on information
available to the Company, the Co-founders did not own more than 10% of the Company&rsquo;s outstanding common stock at any time
during 2019 or 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 78 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Equipment,
Demonstration and Product Testing Agreement</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2017, the Company entered into a three-year equipment, demonstration and product testing agreement with a licensed cannabis
cultivation company affiliated with one of the Co-founders. Under this agreement, the Company agreed to lease the cultivation
company certain cultivation equipment in exchange for a quarterly fee of $16,500, which was increased to $18,330 to reflect additional
leased equipment requested by the cultivation company (the &ldquo;Lease Fee&rdquo;). In consideration for access to the cultivation
facility to conduct demonstration tours and for the product testing and data to be provided by the cultivation company, the Company
agreed to pay the cultivation company a quarterly fee of $12,000 (the &ldquo;Demo and Testing Fee&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and the cultivation company each made their respective payments under this agreement through June 30, 2018. Thereafter,
the cultivation company failed to make any subsequent payments of the Lease Fee and, as a result, the Company did not pay the
Demo and Testing Fee. During the second quarter of 2019, the Company notified the cultivation company of its breach for non-payment
of the Lease Fee. In February 2020, the parties mutually agreed to terminate this agreement and release each other from all claims
related to this agreement, including any unpaid Lease Fees or Demo and Testing Fees. The Company also agreed to transfer the equipment
to the cultivation company for no additional consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2018, the Company recorded Demo and Testing Fees of $32,000 as operating expenses in the consolidated
statements of operations. During the year ended December 31, 2018, the Company also recorded Lease Fees of $48,880 as &ldquo;Other
income, net&rdquo; in the consolidated statements of operations. As of December 31, 2018, unpaid Lease Fees of $36,660 were included
in accounts receivable and unpaid Demo and Testing Fees of $24,000 were included in accounts payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the third quarter of 2019, the Company determined that it was unlikely that any further payment of Lease Fees would be paid by
the cultivation company, and the Company: (i) wrote off the balance of the accounts receivable related to unpaid Lease Fees, with
a corresponding charge to &ldquo;Other income, net&rdquo; in the consolidated statements of operations, (ii) reversed the accounts
payable related to the unpaid Demo and Testing Fees, with a corresponding credit to operating expenses, and (iii) wrote-off the
remaining carrying value of the leased equipment of $107,581, which was included in property and equipment on the Company&rsquo;s
consolidated balance sheet. For the year ended December 31, 2019, the net impact of the foregoing items on the consolidated statements
of operations was a charge of $120,241.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Employment
Agreement</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2018, the Company and one of the Co-founders entered into an employment agreement which provided for an initial base salary
of $150,000 per year and certain sales incentive. Pursuant to the employment agreement, the Company awarded 4,800,000 restricted
stock units (&ldquo;RSUs&rdquo;) to the Co-founder that vested at certain dates in the future, subject to the co-founder&rsquo;s
continued employment. As of December 31, 2019: (i) the Company has issued 2,000,000 shares of common stock in settlement of vested
RSUs, (ii) 1,000,000 shares of common stock in settlement of RSUs that vested December 31, 2019 were issued subsequent to December
31, 2019, (iii) the parties mutually agreed to cancel 1,000,000 RSUs, and (iii) 800,000 RSUs vested on April 30, 2020, however,
the holder elected to cancel the RSUs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Consulting
Agreement</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
further discussed <I>in Note 16 Subsequent Events</I> below, on January 7, 2021, the Company entered into a consulting agreement
with RSX Enterprises, Inc. (RSX), a company controlled by Mr. James R. Shipley, a director of the Company. RSX will provide consulting
services to the Company focused on product offerings, engineering requirements, key customer marketing outreach, and related matters,
as mutually determined by the Company and RSX. The Company will pay a monthly consulting fee of $6,500 for up to 50 hours per
month for the various consulting activities undertaken and provide for reimbursement of expenses. The term of the agreement is
set for three months. Any intellectual property developed by RSX will belong to the Company, and the contract provides for typical
indemnification obligations and confidentiality provisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 79 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
11 &ndash; Commitments and Contingencies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Litigation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2019, there were 6,750,000 restricted stock units that had not been settled due to a dispute with a former employee
over the required withholding taxes to be paid to the Company for remittance to the appropriate tax authorities. The Company commenced
an arbitration action against the former employee regarding the dispute. The former employee also made claims in the arbitration
action against the Company for unpaid wages. As stated in a pleading in the arbitration, on March 9, 2020, the Company issued
the former employee 6,750,000 shares of the Company&rsquo;s common stock in settlement of these restricted stock units after taking
measures to mitigate the Company&rsquo;s exposure to penalties and liability for the failure to properly withhold income taxes.
The Arbitrator issued an interim award of approximately $10,000 in the Company&rsquo;s favor and a finding against the former
employee. Effective June 9, 2020, the Arbitrator issued his final award in the Company&rsquo;s favor in the Colorado arbitration.
The Arbitrator found against the former employee and awarded the Company costs of $33,985, with interest at 8% per year. Effective
July 22, 2020, the Colorado Court confirmed the Arbitration award and entered a final judgement in favor of the Company and against
the former employee. The Company pursued collection of this debt and has now collected the debt owed. This former employee is
continuing to pursue separate litigation against the Company for recovery of alleged consulting fees owed to him for the 2015
calendar year prior to his appointment as an executive officer of the Company. </FONT>The Company strongly disputes the ongoing
litigation and in the remote event of an adverse outcome, the amount of any settlement loss for this case is not reasonably estimable
as of the date of the issuance of these financial statements.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can
be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to
predict and the Company&rsquo;s view of these matters may change in the future as the litigation and events related thereto unfold.
The Company expenses legal fees as incurred. The Company records a liability for contingent losses when it is both probable that
a liability has been incurred and the amount of the loss can be reasonably estimated. An unfavorable outcome to any legal matter,
if material, could have an adverse effect on the Company&rsquo;s operations or its financial position, liquidity or results of
operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other
Commitments</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the ordinary course of business, the Company may provide indemnifications of varying scope and terms to customers, vendors, lessors,
business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the
Company&rsquo;s breach of such agreements, services to be provided by the Company, or from intellectual property infringement
claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain
of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities
that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer
insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers
and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
12 &ndash; Preferred and Common Stock </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Preferred
Stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, and 2019, there were 42,030,331 shares of Series A preferred stock, par value $0.00001 per share, issued
and outstanding. The holders of Series A preferred stock have one vote per share of Series A preferred stock equivalent to one
vote of the Company&rsquo;s common stock. The Series A preferred stock ranks senior to the Company&rsquo;s common stock. The holders
of shares of Series A preferred stock are not entitled to receive dividends and have no conversion or preemptive rights. Upon
liquidation, dissolution or winding up of the Company&rsquo;s business, after payment to the holders of any senior securities,
the holders of Series A preferred stock are entitled to receive a preferential cash payment per share of Series A preferred stock
equal to the stated value of the preferred stock, prior to any payment to the holders of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Common
Stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2020, the Company did not issue any shares of its common stock in a private, non-registered transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2019, the Company did not issue any shares of its common stock in a private, non-registered transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 80 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2020, the Company issued shares of its common stock under the 2017 Equity Plan as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000
    shares to an employee in settlement of certain RSUs that vested December 31, 2019;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">560,000
    shares pursuant to a special incentive stock bonus approved by the Board for the period ended December 31, 2019; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,750,000
    shares in settlement of restricted stock units to a former employee after taking measures to mitigate the Company&rsquo;s
    exposure to penalties and liability for the failure to properly withhold income taxes, as further discussed in <I>Note 11
    &ndash; Commitments and Contingencies, Litigation</I> above.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2019, the Company issued shares of its common stock under the Company&rsquo;s 2017 Equity Plan as
follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">197,370
    shares of common stock were issued to independent directors in lieu of cash director fees; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">789,474
    shares of common stock were issued to independent directors as the 2019 equity retainer fee; </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,120,000
    shares of common stock were issued to certain employees in settlement of vested restricted stock units; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,120,000
    shares of common stock were issued to certain employees as a stock incentive bonus.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
13 &ndash; Outstanding Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes information with respect to outstanding warrants to purchase common stock during the years ended December
31, 2020 and 2019:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Average</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Average</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aggregate</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Remaining
    Life</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intrincic</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Price</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
    Months</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Value</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding
    at December 31, 2018</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">40,010,250</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.25</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issued</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expired</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(901,250</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">(<FONT STYLE="font-family: Times New Roman, Times, Serif">0.66</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding
    at December 31, 2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">39,109,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.24</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issued</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expired</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(31,546,500</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">(<FONT STYLE="font-family: Times New Roman, Times, Serif">0.23</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding
    at December 31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,562,500</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.25</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 81 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes information about warrants outstanding at December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average Life of</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrants</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding
    Warrants</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise
    price</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
    Months</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.25</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,562,500</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 30%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Series
2 Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2014, the Company offered up to 60 investment units at a price per unit of $50,000. Each unit consisted of (i) 250,000
shares of the Company&rsquo;s common stock, (ii) a $50,000 10% convertible promissory note (&ldquo;Series 2 Convertible Note&rdquo;),
and (iii) warrants for the purchase of 50,000 shares of the Company&rsquo;s common stock (&ldquo;Series 2 Warrants&rdquo;). As
of December 31, 2018, Series 2 Warrants to purchase 901,250 shares of common stock were outstanding, all of which expired unexercised
during the year ended December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Warrants
Issued to Investment Bank</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a certain agreement for services rendered in connection with the conversion of the Series 2 Convertible Notes, during the year
ended December 31, 2017, the Company issued to an investment bank or its designees a warrant (&ldquo;Banker Warrant&rdquo;) to
purchase, at an exercise price $0.35 per share, 500,000 shares of the Company&rsquo;s common stock. The Banker Warrants were fully
vested on the date of issuance, were exercisable beginning December 20, 2017 and expired unexercised on June 20, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q1
2017 Warrants </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2017, the Company issued 16,781,250 investment units, for aggregate gross proceeds of $2,685,000, or $0.16 per unit. Each
unit consisted of one share of the Company&rsquo;s common stock and one warrant for the purchase of one share of the Company&rsquo;s
common stock (&ldquo;Q1 2017 Warrants&rdquo;); however, one investor declined receipt of the warrant to purchase 468,750 shares
of the Company&rsquo;s common stock. Pursuant to the Q1 2017 Warrants, the holder thereof may at any time on or after six months
after the issuance date and on or prior to the close of business on the date that is the third anniversary of the issuance date,
purchase up to the number of shares of the Company&rsquo;s common stock as set forth in the respective warrant. The exercise price
per share of the common stock under the Q1 2017 Warrants is $0.26, subject to customary adjustments as provided in the warrant.
Each Q1 2017 Warrant was callable at the Company&rsquo;s option commencing six months from the issuance date, provided the closing
price of the Company&rsquo;s common stock was $0.42 or greater for five consecutive trading days. Commencing at any time after
the date on which such call condition was satisfied, the Company had the right, upon 30 days&rsquo; notice to the holder, to redeem
the warrant shares at a price of $0.01 per warrant share. The holder could have exercised the warrant at any time (in whole or
in part) prior to the redemption date at the exercise price. These warrants expired unexercised in March 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q4
2017 Warrants </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2017, the Company issued 14,734,000 investment units for aggregate proceeds of $1,768,080, or $0.12 per unit. Each unit
consisted of one share of the Company&rsquo;s common stock and one warrant for the purchase of one share of the Company&rsquo;s
common stock (&ldquo;Q4 2017 Warrants&rdquo;). The Q4 2017 Warrants had an exercise price of $0.20 per share, subject to customary
adjustments as provided in the warrant, and had a term of three years. The Q4 2017 Warrants were callable at the Company&rsquo;s
option, provided the closing price of the Company&rsquo;s common stock was $0.36 or greater for five consecutive trading days.
Commencing at any time after the date on which the call condition is satisfied, the Company had the right, upon notice to the
holders, to redeem the shares of common stock underlying each warrant at a price of $0.01 per share, but such redemption could
not occur earlier than sixty-one (61) days following the date of the receipt of notice by the holder. The holder could exercise
the warrant at any time (in whole or in part) prior to the redemption date at the exercise price. These warrants expired unexercised
in December 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Q2
2018 Warrants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2018, the Company completed a private placement offering of investment units, with each unit consisting of one share of the
Company&rsquo;s common stock and one Q2 2018 Warrant. The Q2 2018 Warrants have an exercise price of $0.25 per share of the common
stock underlying each warrant, subject to customary adjustments as provided in the warrant. The Q2 2018 Warrants are exercisable
commencing July 1, 2018 until June 30, 2021. The Q2 2018 Warrants are callable at the Company&rsquo;s option, beginning on July
1, 2019 until the expiration thereof on June 30, 2021, provided the closing price of the Company&rsquo;s common stock is $0.40
(subject to adjustment as provided in the warrant) or greater for five consecutive trading days. Commencing at any time after
the date on which the call condition is satisfied, the Company has the right, upon notice to the holders, to redeem the shares
of common stock underlying each warrant at a price of $0.01 per share, but such redemption may not occur earlier than sixty-one
(61) days following the date of the receipt of notice by the holder. The holder may exercise the warrant (in whole or in part)
prior to the redemption date at the exercise price. As of December 31, 2020, Q2 2018 Warrants to purchase 7,562,500 shares of
common stock were outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 82 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
14 &ndash; Equity Incentive Plan </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 1, 2017, the Board adopted and approved the Company&rsquo;s 2017 Equity Incentive Plan (the &ldquo;2017 Equity Plan&rdquo;)
in order to attract, motivate, retain, and reward high-quality executives and other employees, officers, directors, consultants,
and other persons who provide services to the Company by enabling such persons to acquire an equity interest in the Company. Under
the 2017 Equity Plan, the Board (or the compensation committee of the Board, if one is established) may award stock options, stock
appreciation rights (&ldquo;SARs&rdquo;), restricted stock awards (&ldquo;RSAs&rdquo;), restricted stock unit awards (&ldquo;RSUs&rdquo;),
shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates
50,000,000 shares of the Company&rsquo;s common stock (&ldquo;Plan Shares&rdquo;) for issuance of equity awards under the 2017
Equity Plan. As of December 31, 2020, the Company has granted, under the 2017 Equity Plan, awards in the form of RSAs for services
rendered by independent directors and consultants, non-qualified stock options, RSUs and stock bonus awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total unrecognized compensation expense for unvested non-qualified stock options at December 31, 2020 was $6,412, which will be
recognized over approximately 3 months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted
Stock Awards </U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2018, the Company had accrued fees owed to the Company&rsquo;s independent directors totaling $15,000, which were
payable in equity. During the year ended December 31, 2019, the Company issued 197,370 shares of restricted stock, which were
fully vested at the time of the award, in settlement of these accrued fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2019, the Company also awarded 789,474 shares of restricted stock under the 2017 Equity Plan to the
Company&rsquo;s independent directors and consultants as an equity retainer fee for 2019. These restricted shares were fully vested
at the time of the award and the aggregate value attributable to these shares was $60,000, as calculated using the fair value
of the Company&rsquo;s common stock on date the Board approved these awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Non-Qualified
Stock Options</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the Black-Scholes Model to determine the fair value of options granted. Option-pricing models require the input of
highly subjective assumptions, particularly for the expected stock price volatility and the expected term of options. Changes
in the subjective input assumptions can materially affect the fair value estimate. The expected stock price volatility assumptions
are based on the historical volatility of the Company&rsquo;s common stock over periods that are similar to the expected terms
of grants and other relevant factors. The Company derives the expected term based on an average of the contract term and the vesting
period taking into consideration the vesting schedules and future employee behavior with regard to option exercise. The risk-free
interest rate is based on U.S. Treasury yields for a maturity approximating the expected term calculated at the date of grant.
The Company has never paid any cash dividends on its common stock and the Company has no intention to pay a dividend at this time;
therefore, the Company assumes that no dividends will be paid over the expected terms of option awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected
stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant
dates. As such, the Company may use different assumptions for options granted throughout the year. The valuation assumptions used
to determine the fair value of each option award on the date of grant were: expected stock price volatility 114.97% - 122.48%;
expected term in 5 years and risk-free interest rate 0.2% - 2.37%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 83 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><U>Employee
and Consultant Options</U></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the years ended
December 31, 2020 and 2019 are presented in the table below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of Options</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average Exercise Price</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average Remaining Contractual Term</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aggregate
                                         Intrinsic</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Value</FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2018</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,560,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.104</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.4</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,000,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.080</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,408,333</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.116</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expired</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(16,667</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.105</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,135,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.096</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.7</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,616,900</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.070</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expired</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,500,900</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.101</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.3</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14,251,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.083</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.3</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercisable,
    December 31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14,251,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.083</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.3</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the years
ended December 31, 2020 and 2019 are presented in the table below: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<TR STYLE="vertical-align: bottom">
    <TD>&#65279;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<BR>
    Options</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<BR>
    Average<BR>
    Grant-Date<BR>
    Fair Value</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Aggregate<BR>
    Intrinsic<BR>
    Value</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Grant-Date<BR>
    Fair Value</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&#65279;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">Nonvested, December 31, 2018</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">7,333,329</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">0.086</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">628,756</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9px">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.065</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">130,120</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9px">Vested</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,924,996</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.074</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">362,998</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9px">Forfeited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,408,333</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.102</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">246,344</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 9px">Expired</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Nonvested, December 31, 2019</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.075</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">149,534</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9px">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,616,900</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.059</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">387,199</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9px">Vested</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,616,900</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.062</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">536,733</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9px">Forfeited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 9px">Expired</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Nonvested, December 31, 2020</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2020 and 2019, the Company recorded $189,568 and $390,485 as compensation expense related to vested
options issued to employees and consultants, net of forfeitures, respectively. As of December 31, 2020, there was no unrecognized
share-based compensation related to unvested options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company had granted non-qualified options to purchase 10,250,000 shares which were performance-based.
At December 31, 2020, non-qualified options to purchase 6,000,000 shares were forfeited due to the failure to satisfy the 2017,
2018 and 2019 revenue-based performance thresholds and 4,250,000 shares were forfeited due to employee terminations. No compensation
expense had been recognized with respect to these performance-based awards since the likelihood of performance levels being obtained
was determined to be remote.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 84 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Director
Options</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the non-qualified stock options granted to directors under the 2017 Equity Plan during the years ended December 31,
2020 and 2019 are presented in the table below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
                                         of</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options</FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Average</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Price</FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Average</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Remaining</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Contractual</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Term</FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aggregate</FONT></P>
                                                                                                                                                                     <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intrinsic</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Value
                                         ($000)</FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2018</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">900,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.135</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.6</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited/Cancelled</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expired</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">900,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.135</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.6</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,500,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.057</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.5</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited/Cancelled</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expired</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,400,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.067</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.5</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exerciseable,
    December 31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,400,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.073</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.0</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan for the years ended December
31, 2020 and 2019 are presented in the table below: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#65279;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
    of Options</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average Grant-Date Fair Value</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aggregate
    Intrinsic Value</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Grant-Date
    Fair Value</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#65279;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nonvested,
    December 31, 2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Vested</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expired</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nonvested,
    December 31, 2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,500,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.057</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">373,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Vested</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5,500,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.063</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">344,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expired</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nonvested,
    December 31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.029</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,800</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">29,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended December 31, 2020 and 2019, the Company incurred $62,452 and $0, respectively, as compensation expense related
to 1,500,000 and 0 vested options, respectively, issued to directors. As of December 31, 2020, total unrecognized share-based
compensation related to unvested options was $6,412.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
January 2, 2020, the Company issued 4,000,000 fully vested stock options to directors valued at $234,126 in respect of a 2019
special equity award that had been accrued for in full in the Company&rsquo;s financial statements at December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further
on January 2, 2020, the Company issued an additional 500,000 fully vested, non-qualified stock options under the 2017 Equity Plan
valued at $29,266 to directors. The options have a term of 5 years and have an exercise price equal to the closing price of the
Company&rsquo;s common stock on The OTC Markets on the day immediately preceding the grant date of $0.07.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
June 24, 2020<I>, </I>the Company issued 2,000,000 non-qualified stock options under the 2017 Equity Plan, valued at $39,600,
to newly appointed directors. The options vested 50% upon grant and 50% on April 1, 2021, if the Director remains on the Board
up to that time. The options have a term of 5 years and have an exercise price equal to the closing price of the Company&rsquo;s
common stock on The OTC Markets on the day immediately preceding the grant date of $0.029.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, awards related to 21,651,000 shares remain issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 85 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted
Stock Units</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the RSUs awarded to employees, directors and consultants under the 2017 Equity Plan during the years ended December
31, 2020 and 2019 are presented in the table below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
                                         of</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Units</FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Average</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Grant-Date</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
                                         Value</FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aggregate</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intrinsic</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Value</FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 52%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2018</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,867,368</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.140</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">730,185</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Vested
    and settled with share issuance</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,120,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.181</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited/canceled</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,197,368</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.179</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,550,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.128</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Vested
    and settled with share issuance</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(6,750,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.121</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited/canceled</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(800,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.184</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding,
    December 31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2020 and 2019, the Company recorded $25,163 and $278,906 as compensation expense related to vested
RSUs issued to employees, directors and consultants. As of December 31, 2020, there was no unrecognized share-based compensation
related to unvested RSUs. The total intrinsic value of RSUs vested and settled with share issuance was $199,125 and $79,120 for
the years ended December 31, 2020 and 2019. During the year ended December 31, 2020, the total intrinsic value of RSUs vested
and settled with share issuance was $1,105,750, including the intrinsic value of $1,035,750 related to RSUs that had vested in
2018 but had not been settled until 2020 due to a dispute with a former employee over the required withholding taxes to be paid
to the Company for remittance to the appropriate tax authorities as further discussed in Note 11 Commitments and Contingencies
above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
April 30, 2020, 800,000 RSUs vested. However, the holder elected to cancel the RSUs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Incentive
Stock Bonuses</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has entered into certain &ldquo;at-will&rdquo; employment agreements with certain employees. Under these agreements, the
employees are eligible to receive special incentive stock bonuses, provided the Board has determined, in its sole discretion,
that the employee&rsquo;s performance has been average or better for the applicable special bonus period. This special stock incentive
bonus is payable only if the employee continues in the employment of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
accounting purposes, the Company treats these special incentive stock bonuses as vesting over each bonus&rsquo;s service period
based on the fair value of the award at the time of grant. Even though these bonuses are subject to Board approval, the awards
are vested over each service period because it is more likely than not that the Board will approve the award based on the &ldquo;average
or better&rdquo; employee performance standard. Since the awards are denominated in shares of common stock, the fair value of
the vested bonus is charged to additional paid-in capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 86 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the incentive stock bonus awards granted to employees under the 2017 Equity Plan during the years ended December 31,
2020 and 2019 are presented in the table below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number
                                         of</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares</FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Average
                                         Grant-Date</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair
                                         Value</FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aggregate</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intrinsic</FONT></P>
                                                                                <P STYLE="font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Value</FONT></P></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#65279;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 52%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Unvested,
    December 31, 2018</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,680,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.112</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">124,320</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Awarded</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Vested</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,680,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.112</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Unvested,
    December 31, 2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Awarded</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested<SUP></SUP></FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forfeited</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Unvested,
    December 31, 2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the years ended December 31, 2020 and 2019, the Company recorded $0 and $44,209 as compensation expense related to vested stock
bonus awards issued to employees, net of forfeitures of $0 and $0, respectively. As of December 31, 2020, there was no unrecognized
share-based compensation related to unvested stock bonus awards. The total intrinsic value of stock bonus awards vested and settled
with share issuance was $0 and $58,240 for the years ended December 31, 2020 and 2019, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
15 &ndash; Income Taxes </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
financial reporting purposes, there were no provisions for U.S. federal, state or international income taxes for the years ended
December 31, 2020 or 2019 due to the Company&rsquo;s net operating losses (&ldquo;NOLs&rdquo;) in such periods and full valuation
allowance recorded against the net deferred tax assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
differences between income taxes expected at the U.S. federal statutory income tax rate and the reported provision for income
taxes are summarized as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Income
    taxes computed at the federal statutory rate</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(369,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(281,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">States
    taxes, net of federal benefits</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(69,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(53,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Permanent
    differences</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(136,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">True-up
    adjustments</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">115,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">199,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Adjustment
    to net operating loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(17,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(86,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Change
    in valuation allowance</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">476,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">204,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Reported
    income tax (benefit) expense</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
components of the net deferred tax assets as of December 31, 2020 and 2019 are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">2019</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deferred
    tax assets:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    operating losses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,821,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,081,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Equity
    compensation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">118,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">392,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    deferred tax assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">169,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">149,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    deferred tax assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,108,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,622,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deferred
    tax liabilities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    deferred tax liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(68,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(58,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    deferred tax liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(68,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(58,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    deferred tax assets before valuation allowance</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,040,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,564,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less
    valuation allowance</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5,040,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,564,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    deferred tax assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 87 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="font-family: Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2020, the Company has U.S. federal and state net operating losses (&ldquo;NOLs&rdquo;) of approximately $19,322,000,
of which $11,196,261 will expire, if not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December
31, 2017 do not expire but may only be used against taxable income to 80%. In response to the novel coronavirus COVID-19, the
Coronavirus Aid, Relief, and Economic Security Act temporarily repealed the 80% limitation for NOLs arising in 2018, 2019 and
2020. Pursuant to Section 382 of the Internal Revenue Code of 1986, as amended, use of the Company&rsquo;s NOLs carryforwards
may be limited in the event of cumulative changes in ownership of more than 50% within a three-year period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent
the Company believes that recovery is not likely, the Company establishes a valuation allowance. Management&rsquo;s judgment is
required in determining the Company&rsquo;s provision for income taxes, deferred tax assets and liabilities, and any valuation
allowance recorded against the net deferred tax assets. The Company recorded a full valuation allowance as of December 31, 2020
and 2019. Based on the available evidence, the Company believes it is more likely than not that it will not be able to utilize
its net deferred tax assets in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence
exists to support the reversal of such valuation allowances. The Company makes estimates and judgments about its future taxable
income that are based on assumptions that are consistent with the Company&rsquo;s plans. Should the actual amounts differ from
the Company&rsquo;s estimates, the carrying value of the Company&rsquo;s deferred tax assets could be materially impacted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to examination by the IRS for the calendar year 2016 and thereafter. These examinations may lead to ordinary
course adjustments or proposed adjustments to the Company&rsquo;s taxes or the Company&rsquo;s net operating losses with respect
to years under examination as well as subsequent periods. The Company has filed Colorado state income tax returns for years 2014
through 2019, Alaska, California and Connecticut state income tax returns for the years 2017 through 2019, Michigan state income
tax returns for the years 2018 and 2019 and Alabama, District of Columbia, Massachusetts, Oklahoma and Texas state income taxes
in 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes in its consolidated financial statements the impact of a tax position, if that position is more likely than
not of being sustained on audit, based on the technical merits of the position. The Company&rsquo;s policy is to recognize interest
and penalties accrued on any unrecognized tax benefits as a component of operating expense. The Company does not believe there
are any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly
increase or decrease within twelve months of the reporting date. There were no penalties or interest liabilities accrued as of
December 31, 2020 or 2019, nor were any penalties or interest costs included in expense for the years ended December 31, 2020
and 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
16 &ndash; Subsequent Events </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 855, <I>Subsequent Events</I>, the Company has evaluated all subsequent events through the date the financial
statements were available to be issued. The following events occurred after December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board approved annual incentive compensation awards to certain employees payable in non-qualified stock options, based on the
Company&rsquo;s performance and each employee&rsquo;s contributions to such performance for the 2020 year. A total of 1,035,800
non-qualified stock options were granted under the 2017 Equity Plan subsequent to December 31, 2020, with an exercise price of
$0.13 per share. These non-qualified stock options were immediately vested at the date of the grant. The estimated compensation
expense of $128,434 related to the 2020 incentive awards was accrued as of December 31, 2020. The accrued compensation expense
was classified as a current liability as of December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
further discussed <I>in Note 10 Related Party Agreements and Transactions </I>above, on January 7, 2021, the Company entered into
a consulting agreement with RSX Enterprises, Inc. (RSX), a company controlled by Mr. James R. Shipley, a director of the Company.
RSX will provide consulting services to the Company focused on product offerings, engineering requirements, key customer marketing
outreach, and related matters, as mutually determined by the Company and RSX. The Company will pay a monthly consulting fee of
$6,500 for up to 50 hours per month for the various consulting activities undertaken and provide for reimbursement of expenses.
The term of the agreement is set for three months. Any intellectual property developed by RSX will belong to the Company, and
the contract provides for typical indemnification obligations and confidentiality provisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
further discussed in <I>Note 9 Note Payable and Accrued Interest</I> above, on February 10, 2021, we received funding based on
a loan agreement entered into on February 9, 2021 with our current bank in the principal amount of $514,200 for working capital
purposes. Consistent with the loan provisions, the Company will use the proceeds to meet payroll and benefit expenses as well
as for rent and utilities. The loan amount bears interest at 1% and is due on February 5, 2026. The loan may be repaid in advance
without penalty. The loan has typical default provisions, including for change of ownership, general lender insecurity as to repayment,
non-payment of amounts due, defaults on other debt instruments, insolvency, dissolution or termination of the business as a going
concern and bankruptcy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
further discussed in Note 11 Commitments and Contingencies above, a former employee is pursuing litigation against the
Company for recovery of alleged consulting fees owed to him for the 2015 calendar year prior to his appointment as an executive
officer of the Company. </FONT>The Company strongly disputes the ongoing litigation and in the remote event of an adverse outcome,
the amount of any settlement loss for this case is not reasonably estimable as of the date of the issuance of these financial
statements.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 88 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="a_025"></A>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report
to be signed on its behalf by the undersigned, thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SURNA
    INC.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the
    &ldquo;Registrant&rdquo;)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    March 23, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Anthony K. McDonald</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony
    K. McDonald</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and President</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    March 23, 2021</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Anthony K. McDonald</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony
    K. McDonald </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Financial and Accounting Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf
of the Registrant and in the capacities and on the dates indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    March 23, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Anthony K. McDonald</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony
    K. McDonald, Chairman of the Board</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    March 23, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    James R. Shipley</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">James
    R. Shipley, Director</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    March 23, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Nicholas J. Etten</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nicholas
    J. Etten, Director </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 89; Options: NewSection; Value: 58 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBITS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: justify; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description
    of Exhibit</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1482541/000100201410000070/exh31.htm" STYLE="-sec-extract: exhibit">Articles of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Registration Statement on Form S-1 as filed on January 28, 2010).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1482541/000149315218004376/ex3-1b.htm" STYLE="-sec-extract: exhibit">Amendment to Articles of Incorporation (incorporated herein by reference to Exhibit 3.1(b) to the Annual Report on Form 10-K filed April 2, 2018).</A> </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1482541/000149315214001395/ex3-2.htm" STYLE="-sec-extract: exhibit">Certificate of Designations of Preferences, Rights, and Limitations of Preferred Stock (incorporated herein by reference to Exhibit 3.2 to the Current Report on Form 8-K as filed on May 12, 2014).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1482541/000149315218004376/ex3-2.htm" STYLE="-sec-extract: exhibit">Bylaws, as amended (incorporated herein by reference to Exhibit 3.2 to the Annual Report on Form 10-K filed April 2, 2018).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1482541/000100201410000070/exh41.htm" STYLE="-sec-extract: exhibit">Specimen Stock Certificate (incorporated herein by reference to Exhibit 4.1 to the Registration Statement on Form S-1 filed on January 28, 2010).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1482541/000149315218004376/ex4-2.htm" STYLE="-sec-extract: exhibit">Form of Common Stock Warrant issued with Convertible Notes (incorporated herein by reference to Exhibit 4.2 to the Annual Report on Form 10-K filed April 2, 2018).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1482541/000149315217003264/ex10-15.htm" STYLE="-sec-extract: exhibit">Form of Note Conversion and Warrant Amendment Agreement (incorporated herein by reference to Exhibit 10.15 to the Annual Report on Form 10-K filed March 31, 2017).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1482541/000149315217003264/ex10-17.htm" STYLE="-sec-extract: exhibit">Form of Common Stock Warrant issued in Q1 2017 Unit Offering (incorporated herein by reference to Exhibit 4.4 to the Annual Report on Form 10-K filed April 2, 2018).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1482541/000149315218004376/ex4-5.htm" STYLE="-sec-extract: exhibit">Form of Common Stock Warrant issued in Q4 2017 Unit Offering (incorporated herein by reference to Exhibit 4.5 to the Annual Report on Form 10-K filed April 2, 2018).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1482541/000149315218008520/ex4-2.htm" STYLE="-sec-extract: exhibit">Form of Common Stock Warrant issued in Q2 2018 Unit Offering (incorporated herein by reference to Exhibit 4.2 to the Current Report on Form 8-K filed June 12, 2018).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">4.7*</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex4-7.htm">Description of Capital Stock.</A></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1+</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1482541/000149315218016790/ex10-1.htm" STYLE="-sec-extract: exhibit">Executive Employment Agreement between the Company and Anthony K. McDonald dated effective November 28, 2018 (incorporated herein by reference to Exhibit 10.1 to the Current Report on Form 8-K filed November 28, 2018).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2+</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1482541/000149315217003264/ex10-18.htm" STYLE="-sec-extract: exhibit">Board of Directors Agreement between Surna Inc. and Timothy J. Keating dated March 7, 2017 (incorporated herein by reference to Exhibit 10.18 to the Annual Report on Form 10-K filed March 31, 2017).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3+</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1482541/000149315217008485/ex99-1.htm" STYLE="-sec-extract: exhibit">Surna Inc. 2017 Equity Incentive Plan (incorporated herein by reference to Exhibit 99.1 to the Registration Statement on Form S-8 filed on August 3, 2017).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1482541/000149315218008028/ex10-2.htm" STYLE="-sec-extract: exhibit">Stock Repurchase Agreement by and among the Company, Brandy M. Keen and Stephen B. Keen dated May 29, 2018 (incorporated herein by reference to Exhibit 10.2 to the Current Report on Form 8-K filed May 31, 2018).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1482541/000149315218008028/ex10-3.htm" STYLE="-sec-extract: exhibit">Preferred Stock Option Agreement by and among the Company, Brandy M. Keen and Stephen B. Keen dated May 29, 2018 (incorporated herein by reference to Exhibit 10.3 to the Current Report on Form 8-K filed May 31, 2018).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="https://www.sec.gov/Archives/edgar/data/1482541/000149315218002044/ex14.htm" STYLE="-sec-extract: exhibit">Code of Business Code and Ethics adopted February 13, 2018 (incorporated herein by reference to Exhibit 14 to the Current Report on Form 8-K filed February 14, 2018).</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex21-1.htm">Subsidiaries</A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ex23-1.htm"><FONT STYLE="font-size: 10pt">Consent
    of ACM LLP, Independent Registered Public Accounting Firm, relating to Registration Statement on Form S-8.</FONT></A></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 90; Value: 58 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><A HREF="ex23-2.htm">Consent of Sadler, Gibb &amp; Associates, L.L.C., Independent Registered Public Accounting Firm, relating to Registration Statement on Form S-8.</A></FONT></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1
    *</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ex31-1.htm"><FONT STYLE="font-size: 10pt">Certification
    of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley
    Act of 2002.</FONT></A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2
    *</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ex31-2.htm"><FONT STYLE="font-size: 10pt">Certification
    of Principal Financial and Accounting Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the
    Sarbanes-Oxley Act of 2002.</FONT></A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ex32-1.htm"><FONT STYLE="font-size: 10pt">Certification
    of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley
    Act of 2002.</FONT></A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ex32-2.htm"><FONT STYLE="font-size: 10pt">Certification
    of Principal Financial and Accounting, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley
    Act of 2002.</FONT></A></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Instance Document</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Schema</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Calculation Linkbase</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Definition Linkbase</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Label Linkbase</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Presentation Linkbase</FONT></TD></TR>
</TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates
    a management contract or compensatory plan.</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith.</FONT></TD>
    </TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furnished
    herewith.</FONT></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>


<!-- Field: Page; Sequence: 91; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>form10-k_002.jpg
<TEXT>
begin 644 form10-k_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )V ZL# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\;MOW3D#N,9YI)WMYV_&_P#D4XV_KRN>J7]_;:983WUY)Y5M A>1]I;:HZG
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M@8'51C/-"T'9LTY_#>DW,FI236FYM3C6*[/F./,51@#@\<>F*P/$_A"^U_\
MLW2(FL(?#ML8VD#!VN 4R-JGI@K@9//7K776]U!=VD=U;RK+!(H='0Y# ]Q5
M4:WIQTN#4A<9M)V18WV-EB[!5&W&<Y(&,<4[:_U\@3>Y?50JA5& !@ =JY?2
M_!MI";U]1C65[B^EN=L<\@C=6;*B1,A7(]P<=JTYO$NDP7+027$@VOY;RB"0
MPHV<;6E"[%.>,$U7_P"$CBM=2U6+4'CAMK6:"&)U1B6:51@'&?XCCH*2WO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%<?\>\GTK)K6N/\
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M(/\ CWB_W!_*N7KJ(/\ CWB_W!_*LJO0[<'NR2BBBL3O"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:M-??K]Z=ONT1+6GII]S7YZF9XJ\:W>J^#=4N+(3Z;-8:TMCYD%R=T@5ADY
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MA>^#M>E\->.K1+#,^J:CY]FGG1_O4W@YSNP.!WQ2DNW]:Q_X(X;J_=?^W?\
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M4]5U>X8>#=.U17 %I?VUZ;26# P#*"?WA!Z8["CQ!I>H0:/X#\.WMU]KU/\
MM*.267<6)6,%F.3R0 0,GTHAK;U7ZW_#_AP?7T?Y+]3U2BBBD 4444 %%%%
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MZ;5H-4DMI'O;>-HHI"DGR*V-V!TR<#G&:TJ* (OM*?W9?^_3?X4?:4_NR_\
M?IO\*EHH B^TI_=E_P"_3?X4?:4_NR_]^F_PJ6B@"+[2G]V7_OTW^%'VE/[L
MO_?IO\*EHH A^U1Y Q)D\X\IO\*7[2G]V7_OTW^%#?\ 'Y'_ -<W_FM2T 1?
M:4_NR_\ ?IO\*/M*?W9?^_3?X5+10!%]I3^[+_WZ;_"C[2G]V7_OTW^%2T4
M1?:4_NR_]^F_PH^TI_=E_P"_3?X5+10!%]I3^[+_ -^F_P */M*?W9?^_3?X
M5+10!%]I3^[+_P!^F_PH^TI_=E_[]-_A4M% $7VE/[LO_?IO\*/M*?W9?^_3
M?X5+10!%]I3^[+_WZ;_"C[2G]V7_ +]-_A4M% $)NHU&2)!VYB;_  I?M*?W
M9?\ OTW^%%S_ *I?^NB?^A"I: (OM*?W9?\ OTW^%'VE/[LO_?IO\*EHH B^
MTI_=E_[]-_A1]I3^[+_WZ;_"I:* (OM*?W9?^_3?X4?:4_NR_P#?IO\ "I:*
M (OM*?W9?^_3?X4?:4_NR_\ ?IO\*EHH B^TI_=E_P"_3?X4?:4_NR_]^F_P
MJ6B@"+[2G]V7_OTW^%*LR.P4"3)]8V _,BI** "BL"BL?;>1G[0WZ*P**/;>
M0>T-^BL"BCVWD'M#?HK HH]MY![0WZ*P**/;>0>T-^BL"BCVWD'M#?HK$@_X
M^(O]\?SHG_X^)?\ ?/\ .G[72]@Y]#;HK HI>V\@]H;]%8%%'MO(/:&_16!1
M1[;R#VAOT5@44>V\@]H;]%8%%'MO(/:&_16!4D'_ !\1?[X_G0JOD'.:[3(C
M%2),CTC8C\P*3[2G]V7_ +]-_A4M%;&A%]I3^[+_ -^F_P */M*?W9?^_3?X
M5+10!%]I3^[+_P!^F_PH^TI_=E_[]-_A4M% $7VE/[LO_?IO\*/M*?W9?^_3
M?X5+10!%]I3^[+_WZ;_"C[2G]V7_ +]-_A4M% $7VE/[LO\ WZ;_  H^TI_=
ME_[]-_A4M% $7VE/[LO_ 'Z;_"GQNLJ!TR5/()&*=45K_P ></\ US7^5 $M
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 1-_Q^1_\ 7-_YK4M1-_Q^1_\ 7-_YK4M '.Z7XUTK5_[96W\X2Z1(
MZ7$3A0QVY^90"<@X.,XZ=JU-&U6#7-&M-4MDD2"ZC$J+* & /K@D9_&O'H;*
MYLM+\2^)=.C+W%KJE];W<2_\MK9L9_%2=P_&GS?8O^$7\%_\)+]J_P"$5_L\
M_:/)\S9YW&SS/+YQZ>]"V^[\5<;6OW_A;^O0]LHKSOP-K%OHOAYWO[BYATFY
MU,V^C?:4=G:)O]6O0D*2#@GM6S\1?[0_X0^?[!]I_P!;']H^RY\WR-PW[,<Y
MQ^F:):?UZ?E?42U.GN)X[:VEN)3MCB0NYQG  R:R?#7B6W\4Z<U_:V5_;6^_
M;&UW#Y?FC&=Z<G*G/6O,-)L-"U*76[;PQ'=R>%&TIS=)(TPB-T#N7;O^;=@<
MXXKN?AAIMIIWP^TLVD7EFYB%Q-\Q.Z0@9/)XZ#@<4TM[^7YO_('T_KI_P2F?
MBMI2O.[Z+KZV4$S0RW_V(-;H5;:27#'C/MGVKNHY$FB22-@R. RL#P0>AKR#
MPMX4U?Q'HVIP'Q-):Z+/J5RD]A'9QEG'F'.)3R,_2M:#PWINI?%K4A<PNZZ=
M9VDEL@E955USM8@$9QCOQR:2V5_ZT3_X8'N[?UK8]+JE9ZE]KOKZU^Q7D/V1
MU7S9HML<V1G,9S\P'0^]>(XB,@&=4'Q(^W]?WV/+\WMGY/*V?YQ6QK9U4+\1
M?[)$AN?M5KO\K=N\O8-^-O/3.<<XS1TO_73_ #!JSM_77_+0]CIDLL<$+S3.
ML<<:EG=C@*!U)->$^%UU?_A$?$[^';JS>W-JHCM],6\Q')GYBAG7[Q0MPK'G
M'%;&CZ?X1U72=;L_#$.L302Z:WVJ-BXM_/'(SO\ F\W('W?EQ1+1-]D.*NUZ
M_P"7^?YGK5G=V]_9Q7=K*LMO,H>.1>C*>A%3U\_R6OA=_AWX?E.HK;VT6_[3
M;75O=O;S7)5=VYHR"K CCG')P.M>L?#Z[%YX/M)$T^6QA5F2*-YI)0R \,K2
M?/M/;.*IK5^1-]O,Z.Y_U2_]=$_]"%2U%<_ZI?\ KHG_ *$*EJ1A1110 444
M4 ,FFCMX9)I7"1QJ6=CT ')-8=AXLM;ZXLXWL;ZTCO@393W"*$N,#=QAB5)4
M9 <*2*V[BXBM+:6XN)%CAB0N[L<!5 R2:X;2O$.C>+_$5EJ#:M91PVK-_9UB
M;I//ED(*F1TSD?+D*O7DD]@!:NP/:YWM%%% !1110 4444 8%%%%<9SA1110
M 4444 9L>NV,VNG1XI#)=+"TKE!E4 (!!/\ >^8<?GCBM*N=>*.'Q[9+&BHI
MTZX;"C R98R3^)YKHJ;6B![A1112 **** )(/^/B+_?'\Z)_^/B7_?/\Z(/^
M/B+_ 'Q_.B?_ (^)?]\_SI_9'T(Z***0@HHHH *P4\5VCSJ/LMVMH]Q]E2]*
MKY32[MN!\V[[P(SMQGO6]7F\5Q"_AFS\/+,IU:/5%5[7/[Q0MQO+E>H7;SGI
MS3BKNWI^8^G]=CTBBBBD(**** "I(/\ CXB_WQ_.HZD@_P"/B+_?'\Z%N"W-
MNBBBNPZ HHHH **** .?G\7V,%Y+$UO=FUAN%M9;Y44PQS$@!#\V[J0"0I )
MY-=!7 >,-4MM1MI;:*ZFCU.RN 8=&F"?Z<ZL"IV#YV0]05(''(X(KOE)* L,
M,1R/2A;7_K^OZW![BT444 %%%% !45K_ ,></_7-?Y5+45K_ ,></_7-?Y4
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M+;OQ!YGAF[N)"4MC>/._V:/)PJ!5 '!Y/7\S7HMYI\>I6D<-V]PA!#$VMU+
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M444 1-_Q^1_]<W_FM2U7E8K=1$(S_(_"X]5]33_.?_GVE_-?\: ):*B\Y_\
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M9R;C!W'(V'BGRNP[:%2BK'E6_P#S]?\ D,T>5;_\_7_D,TN5BL5Z*L>5;_\
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M]QCWQ7IM%3;2W]=/\BN;6YP5[X9OF\3Z1=);^586VBRVDTJ,I,3%< !0<G\
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MM16O_'G#_P!<U_E0!+1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% %>4.;J+8RJ=C\LN>Z^XI^VX_P">L7_?L_\
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M_P!!;2O_  62?_'ZV**+A<Q_LWB3_H+:5_X+)/\ X_1]F\2?]!;2O_!9)_\
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M^"F7_P"2:VU^Z/I2UV&YA_9?%7_09T;_ ,%,O_R31]E\5?\ 09T;_P %,O\
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M\/[O49-4L]6E5DCM9E/SJ[D#$J]L$Y'/(KM/$&G7FIZ4T.GW\EE>(ZR12JQ
MW*<X8#JIZ$5Q^G^ ;^Y\/ZE'JEQ;V^H7R1!1;)\D1C8LK'^\2>I]*J%K._E^
MG_!+TLC9\-7^KPZ]J&@ZS?1W\UO#'<1W*PB(E6R"I4<<$5E>//$.KZ?K=E8:
M5=W=LGV9[BX:TL%NGQD 95L8 P<G(K4TK1/$%M+JFKWL^FR:W<PK# L:N+=
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M[X?TA-!T"STQ)/,^SQ[2^,;FZDX^I-3IRV_KK^EA2MI;^OZ9IT445(@HHHH
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M_DO^% $M%1>2_P#S\R_DO^%'DO\ \_,OY+_A0!+147DO_P _,OY+_A1Y+_\
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M2_\ S\R_DO\ A0!+147DO_S\R_DO^%'DO_S\R_DO^% $M%1>2_\ S\R_DO\
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ML_\ ?NT_^,4>RD'(R6BHO^$5N?\ H:-9_P"_=I_\8H_X16Y_Z&C6?^_=I_\
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ML_\ XQ1_86H_]#9K/_?JS_\ C% &Y16'_86H_P#0V:S_ -^K/_XQ1_86H_\
M0V:S_P!^K/\ ^,4 ;E%8?]A:C_T-FL_]^K/_ .,4?V%J/_0V:S_WZL__ (Q0
M!N5A^"_^1%\/?]@RV_\ 12T?V%J/_0V:S_WZL_\ XQ5[1M,31=&M-,BGFGBM
M8A#')/MW[!PH.T <# Z=N<GF@"]1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*SU5;J.TBNI/)1+IUC;S<XV<GEO8=:O#Q!HK6\]P-7L#!;MLGD%RFV)O1CG
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MGV((H U**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O._''_)2? G_7Q/_P"@
MK7HE5Y]/LKJY@N;BTMY9[<DPRR1AFB)ZE21D?A0MT^P=&NZ/'M+\/Z5J6E?$
M:]O;""XN8KR[$4DJ!FBPI8%2?NG/<5!:OITL_P /G\2^2='_ ++=5-T?W'G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9E:4$#_GJW^-4=S_ //67_OXW^-:=Q_Q[O\ 2LN@!=S_ //67_OXW^-&Y_\
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M_P :@?5M-CU%-.DU"T6^<96V:91(P]0N<FKE $7V9/[TO_?UO\:/LR?WI?\
MOZW^-2T4 1?9D_O2_P#?UO\ &C[,G]Z7_OZW^-2T4 1?9D_O2_\ ?UO\:+7)
MM(B222@)).3DBI:BM?\ CSA_ZYK_ "H EHHHH **** "BBB@ HHHH **** "
MBBN*UKXFZ1HNMG3WM;ZXCA<I>74$!:*V.W=@GN<<G'09^E'6P=+G:T5S.O\
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M44 %%%% !1110!7ED2.ZB+NJC8XRQQW6G_:K?_GO%_WV*&_X_(_^N;_S6I:
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M_P#/:/\ [Z%245QZ'.1_:(?^>T?_ 'T*/M$/_/:/_OH5)11H!']HA_Y[1_\
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M_OL5+10!%]JM_P#GO%_WV*/M5O\ \]XO^^Q4M% $7VJW_P">\7_?8H^U6_\
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MXGDN;AD&%$DC;B%]AG'X5L4,84444@"HK7_CSA_ZYK_*I:BM?^/.'_KFO\J
M):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX2>P_P"??5O_  477_QNC_A)[#_GWU;_ ,%%U_\ &Z -FIK7_CY3\?Y5@?\
M"3V'_/OJW_@HNO\ XW4MMXHT];A2;?5^_31[L]O^N= %VBL?_A)K#_GWU7_P
M4W7_ ,;H_P"$FL/^??5?_!3=?_&ZX[,PLS8HK'_X2:P_Y]]5_P#!3=?_ !NC
M_A)K#_GWU7_P4W7_ ,;HLPLS4F@BN87AGB26)QM='4,K#T(/6H-.TNQTBT6U
MT^UBMH%YV1KCGU/J?>J7_"36'_/OJO\ X*;K_P"-T?\ "36'_/OJO_@INO\
MXW3LPLS1-E:F&:$VT)BG+&5/+&V0GKN'?/?-17.DZ;>QPQW6GVD\<./*66%6
M"?[H(X_"J?\ PDUA_P ^^J_^"FZ_^-T?\)-8?\^^J_\ @INO_C=%F%F:X
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M?PQX?NHH8[C0],EC@7;$LEI&PC7.<*".!GTJ#_A+-._Y]M9_\$MY_P#&J/\
MA+-._P"?;6?_  2WG_QJ@#2L--L=+MS;Z?96UG"6+>7;Q+&N?7  &:M5A_\
M"6:=_P ^VL_^"6\_^-4?\)9IW_/MK/\ X);S_P"-4 ;E%8?_  EFG?\ /MK/
M_@EO/_C5'_"6:=_S[:S_ ."6\_\ C5 &Y45K_P ></\ US7^59'_  EFG?\
M/MK/_@EO/_C5:&E7<-]I=M<6[EX70;'VD!@.,C/4'&01P1@@D$&@"Y1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M $3?\?D?_7-_YK4M1-_Q^1_]<W_FM2T %%%% !15#6]2_L;0K_4_)\[[) \W
ME[MN_:"<9P<=/2N-MOB'K*1:??:QX0DL-)O7C1+U-0CFV^9C82@ .#D?2A:N
MP/17/0:*J3:KIUO?16,]_:Q7<W^J@>95D?Z*3D_A3EU"R=[E$O+=GM?^/A1(
M"8>,_/S\O'/- %FBJ$NNZ1!%;2S:K8QQW6/L[O<(!-GIL)/S?A3[O5M-L'V7
MFH6EN_EF7;-,J'8.K<GH/6@"Y15,:KIQAM9AJ%J8KM@MN_G+B9CT"'/S'Z4]
M=0LGEN8EO+=I+7!N$$H)BR,C<,_+QSS0!9HJK8ZE8ZI!Y^GWMM=PYV^9;RK(
MN?3()%6J "BBB@# \8_\@&/_ +"-A_Z5Q5/4'C'_ ) ,?_81L/\ TKBJ>@ H
MHHH ***Q?$^OGP_IT<L=H]W=7$HAMX%8+O<@GDG@#@\TF[#2N;5%<G;>-'7P
M<=:U+2[BVN$V)]GQCSG;&WRR>"IW#GMSZ5>\.>(I=9DO+2^TV33=1LF43VS2
MB0 ,,J0PX((JK:M=B;Z7-ZBN4\1^+[O0;J79X?N[JPMHUDNKSS!&B G^#</W
MA]0#Q740RK/!',F=DBAER,'!&:6ZN-Z:#Z*** "IK7_CY3\?Y5#4UK_Q\I^/
M\J *5%%%<9SA1110 45QDWCBY_X2K^S;31;BYL(Y'@GN(_F<.I0$J@Y*KO&?
MKGL<S:WXW.E:G=6\&DS7MK8*CZA<QRJOV<-TPIY<XY.,8I\KT\Q\KO8ZVBJE
M]J5MI^DSZE,W^CPQ&9B.Z@9XKG-.\<^8+L:OI4VF-#:&^C#2K+YL']X8Z-_L
M^]*SU\@2;U1UU%<IH7C&?5-4AL;_ $6;3FNX#<V;M,L@EC'<X^Z<$'!KJZ;3
M6X@HHHI 20?\?$7^^/YT3_\ 'Q+_ +Y_G1!_Q\1?[X_G1/\ \?$O^^?YT_LC
MZ$=%%%(0445G:[K$6A:1-J$T;RB/:%C3J[,0H _$B@$KFC17*:+XON+C1+^_
MUK2YM/-DKNY'S1NH+#"-T)&W!'K]:F\/^*YM7U!K"^TF73;AH!=0*\JR"6$G
M ;(Z'ID4^5A;2YTM%<[XA\33Z3>P6&GZ7)J=]+$TYA298]D2\%B3]>!WK5T?
M5(-:TBUU*V#"&X0.H8<CU!]P:5G:XVK%VBBB@04444 ;R_='TI:1?NCZ4M=A
MT!1110 451UG5(-$T:\U.Y#&&UB:5@@R2 .@KF?#OCB[U"WU.?6M$GTR*S5Y
MEFSYD;1KU!8<!QW%*^_D.QVE%<AX:\;S:YJ<=C?:)/IC7-M]KLF>99!/#D<G
M'W6Y!VFM'Q)KNH:.MM'I>@W.KW4Y;"1N(HXU49)>0@JOL#UIO3<2U-ZBLGPU
MK\'B?0+;5K:*2*.;(,<G564D$>_(/-:U-JV@!1112 *P_!?_ "(OA[_L&6W_
M **6MRL/P7_R(OA[_L&6W_HI: -RBBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** (F_X_(_\ KF_\UJ6HF_X_(_\
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M?^BEH W**** "BBB@ HHHH *C9I@QV1QE>Q+D'^5244 1;KC_GE%_P!_#_\
M$T;KC_GE%_W\/_Q-2T4 1;KC_GE%_P!_#_\ $T;KC_GE%_W\/_Q-2T4 1;KC
M_GE%_P!_#_\ $T;KC_GE%_W\/_Q-2T4 1;KC_GE%_P!_#_\ $T;KC_GE%_W\
M/_Q-2T4 1;KC_GE%_P!_#_\ $T;KC_GE%_W\/_Q-2T4 1;KC_GE%_P!_#_\
M$T;KC_GE%_W\/_Q-2T4 1;KC_GE%_P!_#_\ $T;KC_GE%_W\/_Q-2T4 1;KC
M_GE%_P!_#_\ $T;KC_GE%_W\/_Q-2T4 1;KC_GE%_P!_#_\ $T;KC_GE%_W\
M/_Q-2T4 1;KC_GE%_P!_#_\ $T;KC_GE%_W\/_Q-2T4 1;KC_GE%_P!_#_\
M$T;KC_GE%_W\/_Q-2T4 1;KC_GE%_P!_#_\ $T;KC_GE%_W\/_Q-2T4 1;KC
M_GE%_P!_#_\ $T;KC_GE%_W\/_Q-2T4 1;KC_GE%_P!_#_\ $T;KC_GE%_W\
M/_Q-2T4 1;KC_GE%_P!_#_\ $T;KC_GE%_W\/_Q-2T4 1;KC_GE%_P!_#_\
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MGV?Q5_T#-&_\&DO_ ,CT?9_%7_0,T;_P:2__ "/75T4>SCV#E1RGV?Q5_P!
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M[%"@@E5/( .,<9QSC)U:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6M];3SP'$T44RLT9_P!H Y'XU5M_$6E7.KW6EI>0_;+9U1XS(N2S*6P!G).
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M2\=DC*@8!52QSSZ T 6Z*J6VHPW5_>V:*XDM"@D+ 8.Y=PQSZ5F1>*[66XC
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MJ)[>TN$LQ<R33-<2PS0'<I!>,X$J2$GD8"XS2^)O#]_JFO+/%:":V)L=Q+J
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,\R7I\N&/S6=H)%#1YQO0E?G7/\ $N1[U/>>(]*L))(I[EO-C=(S''"\CLS
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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..1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.7
<SEQUENCE>3
<FILENAME>ex4-7.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.7</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Description
of Securities</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description
of Capital Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of information concerning capital stock of Surna Inc. (&ldquo;Company&rdquo;). The summaries and descriptions
below do not purport to be complete statements of the relevant provisions of the Company&rsquo;s Articles of Incorporation (&ldquo;Charter&rdquo;)
and Amended and Restated By-laws (the &ldquo;By-laws&rdquo;), and are entirely qualified by these documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock (&ldquo;Common Stock&rdquo;)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends.
Subject to prior dividend rights of the holders of any shares of preferred stock of the Company (&ldquo;Preferred Stock&rdquo;),
holders of shares of Common Stock are entitled to receive dividends when, as and if declared by the Company&rsquo;s Board of Directors
(the &ldquo;Board&rdquo;) out of funds legally available for that purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting
Rights. Each share of Common Stock is entitled to one vote on all matters submitted to a vote of stockholders. Holders of shares
of Common Stock do not have cumulative voting rights. The holders of a majority of the shares of Common Stock present and entitled
to vote in the election of directors can elect all directors standing for election.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
Rights. In the event of any liquidation, dissolution or winding up of the Company, after the satisfaction in full of the liquidation
preferences of holders of any shares of Preferred Stock, holders of shares of Common Stock are entitled to ratable distribution
of the remaining assets available for distribution to stockholders. The shares of Common Stock are not subject to redemption by
operation of a sinking fund or otherwise. Holders of shares of Common Stock are not currently entitled to pre-emptive rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fully
Paid. The issued and outstanding shares of Common Stock are fully paid and non-assessable. Any additional shares of Common Stock
that the Company may issue in the future will also be fully paid and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has one class of issued and outstanding Preferred Stock that is designated the Series A Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Series
A Preferred Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rank.
The Series A Preferred Stock ranks superior to all other classes, including the Common Stock</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends.
The Series A Preferred Stock is not entitled to dividends.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidation
Preference. Each holder of Series A Preferred Stock shall be entitled to receive, for each share thereof, out of assets of the
Corporation legally available therefore, a preferential amount in cash, per share of Preferred Stock, equal to (and not more than)
the sum of the (x) stated value, plus (y) all accrued and unpaid dividends thereon. The stated value is not determined. Therefore,
there is no liquidation preference as there is no stated value or dividend entitlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting.
The holders of Series A Preferred Stock shall have one vote per share of Series A Preferred Stock equivalent to one vote of the
Common Stock. This is interpreted to mean that the Series A Preferred Stock votes with the Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion
Rights. The Series A Preferred Stock is not convertible into Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preemption
Rights. The Series A Preferred Stock does not have preemptive rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>ex21-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibit
21.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SIGNIFICANT
SUBSIDIARIES OF THE REGISTRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
following are the significant subsidiaries of Surna Inc. as of December 31, 2020 and the states or jurisdictions in which they
are organized. Except as otherwise specified, in each case Surna Inc. owns, directly or indirectly, 100% of the voting securities
of each subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Name</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>State
    or jurisdiction of Entity</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Hydro
    Innovations, LLC</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Colorado</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Exhibit
23.1</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Consent
of Independent Registered Public Accounting Firm</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surna
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boulder,
Colorado</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (Registration No. 333-219674) pertaining
to the Surna Inc. 2017 Equity Incentive Plan of our report dated March 24, 2020, relating to the consolidated financial statements
of Surna Inc. and subsidiary (which report expresses an unqualified opinion of the consolidated financial statements and an explanatory
paragraph referring to the Company&rsquo;s ability to continue as a going concern), which appears in this Form 10-K for the year
ended December 31, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
ACM LLP</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greeley,
Colorado</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
23, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>6
<FILENAME>ex23-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surna
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boulder,
CO</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">We
hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (Registration No. 333-219674) pertaining
to the Surna Inc. 2017 Equity Incentive Plan of our report dated March 23, 2021, relating to the December 31, 2020 consolidated
financial statements of Surna Inc. and subsidiary (which report expresses an unqualified opinion of the consolidated financial
statements and an explanatory paragraph referring to the Company&rsquo;s ability to continue as a going concern), which appears
in this Form 10-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Sadler, Gibb &amp; Associates, LLC</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Draper,
UT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
23, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>7
<FILENAME>ex31-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibit
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CERTIFICATION
PURSUANT TO RULE 13a-14(a) and 15d-14(a) </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>UNDER
THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">I,
Anthony K. McDonald, the Chief Executive Officer of Surna Inc. certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.
I have reviewed this annual report on Form 10-K of Surna Inc. for the fiscal year ended December 31, 2020;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
to the period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.
The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)
evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on
such evaluation; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)
disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the
registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that
has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial
reporting; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.
The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant&rsquo;s auditors and registrant&rsquo;s board of directors (or persons performing
the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Dated
this 23<SUP>rd</SUP> day of March 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 3%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 47%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/
    Anthony K. McDonald</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 50%">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Anthony
                                         K. McDonald</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Chief
        Executive Officer</B></FONT></P></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>8
<FILENAME>ex31-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibit
31.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CERTIFICATION
PURSUANT TO RULE 13a-14(a) and 15d-14(a) </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>UNDER
THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">I,
Anthony K. McDonald, the Principal Financial and Accounting Officer of Surna Inc. certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.
I have reviewed this annual report on Form 10-K of Surna Inc. for the fiscal year ended December 31, 2020;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
to the period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">4.
The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(c)
evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on
such evaluation; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(d)
disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the
registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that
has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial
reporting; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">5.
The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control
over financial reporting, to the registrant&rsquo;s auditors and the registrant&rsquo;s board of directors (or persons performing
the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">(b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Dated
this 23<SUP>rd</SUP> day of March 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 3%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 47%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/
    Anthony K. McDonald</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 50%">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Anthony
                                         K. McDonald</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Principal
        Financial and Accounting Officer</B></FONT></P></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>9
<FILENAME>ex32-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibit
32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CERTIFICATION
PURSUANT TO SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
connection with the Annual Report on Form 10-K for the year ended December 31, 2020 (the &ldquo;Report&rdquo;) of Surna Inc. (the
&ldquo;Registrant&rdquo;), as filed with the Securities and Exchange Commission on the date hereof, I, Anthony K. McDonald, the
Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Registrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 5%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/
    Anthony K. McDonald</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Anthony K. McDonald,</FONT></P>
                                                         <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Chief Executive Officer</FONT></P></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">March
    23, 2021</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
certification accompanies this Annual Report on Form 10-K pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall
not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of
1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>10
<FILENAME>ex32-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibit
32.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>CERTIFICATION
PURSUANT TO SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">In
connection with the Annual Report on Form 10-K for the year ended December 31, 2020 (the &ldquo;Report&rdquo;) of Surna Inc. (the
&ldquo;Registrant&rdquo;), as filed with the Securities and Exchange Commission on the date hereof, I, Anthony K. McDonald, the
Principal Financial and Accounting Officer of the Registrant, hereby certify, to the best of my knowledge, that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Registrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 5%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/
    Anthony K. McDonald</I></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Anthony
    K. McDonald, Principal Financial and Accounting Officer</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">March
    23, 2021</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">This
certification accompanies this Annual Report on Form 10-K pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall
not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of
1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_001.jpg
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" '! W8# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \>^(O[0?
MP&^$-[8:7\6?C=\(OA?J>JQ&;3-.^(OQ(\'>"+[4HP2#+867B?6M*N;Z(,"&
M-LK@8P3Z>G:=J>GZSI]GJND:A9:IIM_;PW=EJ6FW4-_I]];3C,,]G>VQ>VN(
M+A3N6>W9D((8'!!K^'+]J/\ 8=^+7P<_;E_;+^//[6?_  2Y\2_\%=_@=\?/
MB)K7C/X;?%_X9?$;7[_X@?!/P'--?C1/A[I?P]\,C5=4^W^#-(GTGPO]D_LF
MRL[.R\.6M_H.M_8<:/7IGPR_;@^&W[&'_!"S]JOXN?\ !,'XO_'=?$_P._:"
M\":<?AI^V3X>\&^*/&/[-NI_$SXH>!/#NN?#*'0K#3-(T:X\'W&DWVM7>AW=
MS=ZS=C6KC6B;T:A:7-I9!IR>?X']JE%?SV_\%!_^"A'[3W[/6D_\$;+SX7^)
MO#&FW'[9G[0_P#^'/QX_M?P;I&LC7_"WQ @^'T_B.'0A<'_BF+BZ_P"$BU7[
M%>::"UD;B  @6N#\[:W^V1_P5V_:+_X*M_MQ_L*_LB_%#]G'X=_#?]F_4OA+
MXLA\9_%WX:3:Y>>$O!&N>"? ]_JWA:R_L:VNKCQ1K_C+6?%>JWEE=ZK:;-%L
M]"%G]MLA<AKH)Y9=OQ1_4W17\D%G^W!_P6B_:._:\_X*?_LU_LH_$']EOP]X
M7_8Q\>QS:9X^^+/P^N!K.C^';.S\2G2_ >A:3HQU6V\0:SX^N=#U:]?7_$]G
M=V?ANUT*VM#?6;:H&N_I']G3_@J+^V7^T[_P2,TS]J7P;IG[+O@/]I33?B]K
M/P5\??$'XX^/].^%/[/G@^Q\.ZQ#:ZI\5KX^(-:MH9]0&C:EI2V?@Y-72RU?
MQ"UU>V9M--^QZ, ?(^Z/Z.[_ %"RTJQO=3U6]L]-T[3[6ZO[[4K^ZAM-/L;*
MRA>XGO;Z\N"EM:VUI!"US=WER5MK55)9R%+#F/ 'Q(^'OQ6\.0>,/AAX\\&?
M$GPC>7-S9VWBKP#XGT+QAX<NKNQF,%_9V^M^'K_5=,GN+2X/V>\MUN]]L^58
M(R\?S#?L=_\ !2GXT?'O_@H;XX_X)H_$']JO]GS]O3X'_%O]G/QOJMG^T5\%
M?A?:?"R?PCXF/A&_'B/P?_96@>+?%7AO7]-M;7[=;M<C5KR\NS>:;?"]TG;=
MZ.<G]H#5?BA_P;O_ /!/S]D3]F#X(>.CK'@_QC\=?B!IGQA_;2USX":GXVLO
M@SH'B35[[QE#K(^!^D>-KG3M8\07EO?P>']'M=5\;V>C7MIX:U2\/V*^N[86
M8')TOJ?UD @]*\V^)/Q=^%'P=TJPUSXM_%#X>_"S1-4O_P"RM-UGXC>-/#G@
M?2]0U5K>>\_LZROO$VIZ5:W-_P#9H)[G[);W#77V:">3;B,L/QE_X)"?M]_%
MK]K;QU\<O!?BO]IG]EW]L'X7>#[#0-?^%WQN^$-@WP8^,=Y%J?V$:WH/Q;_9
M=UBZN]:\'VVDW%]_9MAXOTJ\UCPY>WUA=6::S>O=@V?R%_P=7R>#[;]F;]BV
M[^(&GC5O EG^V_X'NO&FF?8IM0EO_"4'@CQQ-XDLX+*W/VFYN+K1A?6@M;4?
M:KOSB@)Q@ <CY^1[G]&7P]_:1_9V^+>M3^&_A/\ 'OX,?$WQ#;6<VI7&@_#[
MXI^"?&FL0V,3+%-=S:5X>US5+Z"QA>6$&Z-N+8,Z\C< WM]?Y^NJVW[ '[0G
M[:7_  3^C_X(6_LL?&?X6?&OX?\ [3/@WQ=\<?B+HWPY^)'PZ\!Z'\"[*]\_
MQA!XRF\8:G>6T!NM/AO?]*NK2RL[W2/M.AB\N[[5K*Q'ZTQ?MC?\%=?VG?\
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M%%K9G[8MK8_;;/[5=X]"\3_\%R?VL_B)^P/_ ,$X-;^ WPX^&=K^VY_P4/\
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MW?BWP)H_BW0=4\8^%;6^,8L;GQ)X6L=0N-:T"WNQ- ;2XU2TM5NA."F<J:]
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M59(RKQNF]&7HW3I[=,?EVJ2OY:_C#^VO_P %7?B9_P %7?VE?^">?[%'C/\
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M_P $J/\ @L+^T%\8_P!ME/V(?VBOBU^S_P#M6Z?X\^'VO^./AA^TK^SA\/\
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MN1>V5]>V=J;O^GRB@/:2[_+IW/YD='_X(!^+A_P3G_9<_9AD_:,TOP/^U/\
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M*0%K:WU)?#D%CI>OV]M_KC_9.O6=CKMG ><VJ*Q[#ZLHH%S/O^1^+'_!'/\
MX)4:[_P3/^#/Q:T#XE?$W1OC+\;_ (Q>,+/4_%7Q+T:PUBSLSX.\*^'K;PYX
M \,PCQ ]WK+'0[8:K<79:Y^QW)O[:T6T_P!#-W>?&GPP_P"#>Z]7_@F3XD_8
M4^,OQUT5?B-8_M,ZM^T]\'_C3\,O#VI1VW@#QN(39>'#?:'X@N+6YU>W&FWN
MK:9K5K;7ECQ?6U]87C7VE66/Z<J* YI=_P C\"_V=_\ @FA_P4/U?XX:9\2_
M^"A?_!1J_P#C_P##SPW\+_%OPCMO@3\'_"LWPN^'WQ)\*^+-&U#1+]_C%8V@
MTO3_ !/?M;ZI<W5Y=MH]WJ][?6^FD:U9V-H+(_/GPA_X(Q?\%'_V<+6T_9L_
M9X_X*J:Q\*_V$+#XBWGC;1?#>A?"S1(OVB_#&C:GK,^JZIX)\.^/Y[>]TZWT
M^Z$YAN[H7-II-WJLUWKG_"+63W9L#_3O10/VDN_^7W;'X\_M8_L,?M@^//BW
M9?$;X"?M(?"?Q]\.-3\!:7X#\:?LD_MZ?"B\^/?[.LVH:)96,%C\3_"UOX7U
M/PGXNT?Q_=W&EV]UK5P=6:TN[VXU&_&?M7]DUU?_  2C_P"":6F_\$W?A1\4
M_#EQXVTOQO\ $#XX_%+4/BMX^G\(^%O^$&^&GAK4+BS%CI?@_P"&_@YM0U:Z
MTCPOH5L)UM;C4KZ[O;Q;B%6Q:V5FJ_JW10+F>U_P1^./_!13_@E=JO[6GQ8^
M$?[6_P"S?\?_ !#^R9^VG\";&[T/P1\7=$T>+Q!H'BCPG?&X,_@[Q_X<-S:'
M4=._T_5+9+O-Y_Q+]4U/1=1T;5[&ZM/L7R7X;_X(V?M@?M+?'GX/?&7_ (*Q
M?MS:1^U!X4_9^\5P^,_AG\!?A'\,[3X7_##4/%%E]AN+#6/&-M;VVDPW,ZZA
M9?Z<+32/MFK64%OI_P#;5E875]9W7](5% <S[_@O\C\I/#G_  3\\>:)_P %
M<?B'_P %%I?B#X2E^'WC+]FKPY\#;/X;Q:9K \86>LZ+<6-Q<:[-JK#^Q#IU
MQ]BVK:VX^U@!2V1D5\\?L^_\$;&\,?#+_@J[\%_V@?B'X?\ &GP^_P""D/[1
M7Q0^,.F#P%I^JZ3X@^'>@^.=4U76]"@OI_$'VJUU#Q=X6U>?2]5M;NVW:1<7
MFE+^[-H0I_>*B@.9_E^!_.Y^RQ_P2]_X*A_!SQ1\#OAQ\2_^"J-_K?['7[.>
MI6DO@[X=?"SX:6'@/XJ?$+PIH<H&A> _B=XZGM[VZG\+"VCAM+ZV&JZS>"QA
M:QT^\L]RW=M]>_LL_P#!/7Q]\ O^"D7[>_[;>N_$3PAK_@O]KO3?AQ9>%/ ^
MDZ7K5MXG\)2^"-,TS3KV7Q%?WQ.F7RW9L-UD-,)V+,-ZJ#7ZS44!S/O^"_R/
MYXD_X(V?& 2_\%JY!\9?AQ_QM#TB/3?AJ/[!\2?\6OD&F>,K S>.>?\ B<#_
M (J6V?\ XD(/_'O<<989G_:$_P"".7Q<^,G_  2>_9#_ .">ND?&+X<Z-X]_
M9PU;X,ZEXA^(6H^'_$MQX0\21_#$WXU6'1=+MC_;5K_:HOA]B^UX"!<R%?EK
M^A:B@.=^7]*Q_%[_ ,%9?'/P^_8Y_P""JWA[XZ?"S]MOQ9_P3\_:#^(/P$\+
M>%_BOX_^*O[+_B3XR?LT?%'P=86G]EZ3J6AZWX?M?%9OO&-G;Z'8:#>:#=^"
M+RTLM9TG3+XZUHQNKPWGL_\ P;':'XHU_P")/_!4#X^GQAXT^,'PZ^+?QG^'
M-CX,_:&\:^%;OP?>_&_6/#47Q&U;Q5XPMM#N>-/@N6\8Z1=_V7;!ETBTOK73
MF^Q7MM>6@_JI\6_#[P'X]@M[7QUX(\(^-+>TD,UI;^+/#FC^(X+67',MO!K%
MI>) V>,P 'GDYS6QHN@Z'X;TRUT3PYH^E>']%L(_)L-)T33[32M,LXL']U9V
M-A!;6UL@YPENBA3GB@KG]SDM\S\K?VV_^">/Q _:G_;L_P"";G[6/ACXA^$/
M"OA?]B/Q=\2_$7C/PEKVEZU>:_XUM?''_"&BQ@\*W]AG3;"YM#X5G-Z=4P"+
MBVVYVMC._P""D'_!.+X@_ML?M#?\$[OC+X-^)'@[P1I'[&7[0EA\8_&&B>)]
M*UF_U#QGH]CXC\#ZX=&\.3Z1_HVGZBT'A2XM?M.J'[)FXM\C@D?K[109GXA>
M$_\ @E?\5]%_;<_X*,_M0V_[1T_PXTG]M7X4^'/A_P##[6?A):ZAI?Q?^#&O
M:"-$FM_&$.JZU;W?AN_N+6\TD7"VBVOV:]MIQ8WPV;W'R3XQ_P""(7[37[2O
MBCX!Z7^V-\</V2O%WA/X#_$GPWX\O_CW\'_V;M8\!?MH?'NU\'WMO_9>D?&+
MXF7/BV[\)?:-<TZQL+?7-4T'P[]L^UP?;Q]MO_\ 2Z_ISHH*YI=_P1^&>H_\
M$Q?VF?"?_!5_Q;^WO\#/VE_ 7@[X-_'K1_A]X:_:<^#7B;X;_P#"0^*_&7A+
MP/9V]C=^%O"WB*Y%UIVBP:^NEZ>YURV&CZQ8F?4ES>@JS?(5W_P0_P#VZO@K
M#\<_@1^P[_P4:L/@E^Q/^T?XP\4>)/&WPK\8_">S\8?$#P':^.0T'BK1_AOX
MR@Q<6-O=:=*=,,]E>^$6N[."U-_NO3=WU[_4310'._+[C^?O4O\ @B-IO@.X
M_P""3GAC]GSXBZ)X?^&G_!.;XJ:Q\1_&2>.M,U+4/&GQ=U#Q)>66M^)-6M[W
M1O\ B7Z?X@USQ M_>/\ :Q]CL;*?3]%L2+&RM0OTK^U]_P $[OB!^TA_P4%_
M8$_;%\/?$3P=X;\(_L@:AXHN_%O@W7-,UFY\1^,8]=F$MN/#U]8$Z98FUP-W
M]J8W')ZFOUOHH#FEW_+J?S4_$[_@C+^VQ\+OC?\ M-^-?^";_P"WIHW[-'PA
M_;/UR\\1_'7X:>-?AN/%NJ^&]=UO[?#KFJ?"KQ3;FZN] OS;ZWK=SHNI6B^'
M-:T9KBTL?[9O5M+*_LL_]HC_ ((0_%WX@W_[#'Q!T3]I[PO^TK\4_P!D+POX
MH\*^++#]OOP5XI^,'PH^-/\ PE5YJ>JS:[KWASPQXMT?6],.A:A?BVT/0;?5
MKP?8M)\-G4=;NK[2;R[U?^F:B@?M)=_7STMJ?RZ_#+_@@]\>_AUX9_X*G>$S
M\>?@'=V7_!1/X(:7X(T3_A$?A/KGPT\/?"WQOI<FK>0MAX!T?4M7TW3OAQ:6
MWB35-.LM,TO5[S6"+'3;Z^-Y>7=]C]TOV%/V>/$/[)W['/[-O[-7BGQ#H_BS
MQ'\$/A+X2^'6L^)O#MI>66AZW?\ AO35LI]3TNRU%O[0@LKATW1P71%RN<-D
M\GZXHH%S-]?R/R2_X*L?\$[_ !]_P4$TC]E73_ ?Q$\'> )/V?\ ]HSPO\:M
M>?QAI.L:HGB'1M!,)FT32AH^?LVH7/DG9<7?^B <$\59_P""NW_!/?Q[_P %
M&_@7\'?A-\/OB%X1^&^I_#/]I;X;_'+4=6\9Z5K&J:=J6B^"-)\6:??:'90Z
M-^^AU.]/B.%K2ZN!]D18)]X&5S^LE% N9Z:['Y"?"'_@G-\0OAS_ ,%:/VB?
M^"A]_P#$?P?J7@#XS? CX<?"+2/AS9Z1K4/C#1]4\$^%OA_X>OM9U75;C;HM
MQI]W<>$+VYL[>U_TI;:^@#'*L*^6_A'_ ,$:_B]\.O\ @FE^WE^PWJ'QE^'&
MH^-?VM/B1\4?&WA3QU9:!XE3POX2M/'^KZ)?6-EXBL;C_B97\^F?V1/]L.F8
M#>>-I/!']#]% ^:7?\$?SA_$C_@B=\<[3PK^P5\6/V8OVJ]"^ W[='[$OP#T
M;]GZ+XHS^"#XM^%?Q)\&V-IJJW&F:MX5U '4+:W^TZ[XA"_:[76+6^TC5[G3
MK_3PUG97MKZOXD_X)@_MJ?%K]@#]L/\ 9S_:3_;PN_V@/V@_VK+;1XK'Q9XG
M\+MX>^!GP;BTKQ)HOB";0/A_X!\.V]G?P:/J9L+TWLY^SGG2[&QT^PLK.Z-[
M^\M% <[\ON1_/[#_ ,$?_BU%\6/^"0/Q$/Q@^';:?_P3?^'MMX,^(.F_V'XD
M-Y\2+JWTR"Q^V>#IE_T?28#]GR!KGS=!@'%>G?L<_P#!+OXF?LU^)O\ @JMK
M?B/XH>!O$T/_  4"\::SXH\"0Z%I'B"RE^']IJ>C_%/3;>S\8?;\+J,]NWCZ
MPN"VAD#%C>+GYK0U^VE% <\O+[OF?S'Z!_P0!\7+_P $Y?V<OV7M5_:0L/!O
M[47[)GQX\4?'_P" _P"T/\.O#^IR:!X;\9Z[XI_MVWBOO#FLW-GJ<]J!!I=R
MUU:W5I>6.LZ5IU_8FZ6-[2[_ $+_ &%_V2/^"AGPR^*'BKXR_MY?\% +S]I/
M5;[PM%X2\(_!WX9>!=,^%_P0T'$]NUQXUU30K+3K.ZUGQ<]O;BRL@MK96=FM
MSJ5]>MJ]]=63:-^LM% <S[_@O\@HHHH)"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "D8X!/I2U'+_ *I_]TT ?,G_
M  U7X"_Z WB__P  -'_^7='_  U7X"_Z WB__P  -'_^7=?G]17X/_K_ ,1_
M\_<'_P"$C_\ DC\\_P!9<Q_D7_A&_P#Y(_0'_AJOP%_T!O%__@!H_P#\NZ/^
M&J_ 7_0&\7_^ &C_ /R[K\_J*/\ 7_B/_G[@_P#PD?\ \D'^LN8_R+_PC?\
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MY9/$/_!6*XN?V</V;_'G@/X7^'X_CU^TA\8/$?P!L_A[XX\8?V?X#^&GQ!\
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M<<0\4SP2GDE7!?7EL\9@W]4Q;W^J)WNGY[GW/_PVQ\*L8&@^.OI_9NA =_\
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M\-2?#K_GT\2_^"RQ_P#EE1_PU)\.O^?3Q+_X++'_ .65?GM11_Q$3B+OA/\
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M-X/ZF\9A,8OKW^Q2P7US"?6WB[66-PB5L6VG_4@/VS_A/T:Q\8[.>/[)L6[
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M7MHK1'-,]G?E6"UWW_V/_L,U?X?\ _JD'[4OPZ'_ "Y^)1TQ_P 2ZSR<>O\
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M6C_AG_XM_P#0JY^FM>&R/S&M8KU\KPN<Y:L8X<.YM[;$+ZK]=^K8GZY@X_\
M,8\&_JVV,[W2\SKP=/'X/VULMQG^T[?['B_]D]-=3^9GXO\ @KXY? /X@_\
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M<3P6OV6ZM+.\O/\ GR^PVEG7[L?\,_\ Q;Y_XI7D8R/[:\-Y&?4?VUD=*/\
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MN[K_ $/P?K%C]AOZ_H-/[*WQL4X;PUIZ^F[Q#H@SGTSJ7/X9I3^RI\;0 ?\
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M#4+6W\BUO;JU_P"/R\M[F^]Z^D:]Q_X9R^*__0$M/_!SI/\ \DT?\,Y_%?\
MZ MIQUQK6DD_D+G->%B,ES[$UJV)GD6,O7QGUS_<\7=?*_YGGU,NS*<ZT_J>
M,UV_V-:_CJ>'45[C_P ,Y?%?_H"6G_@YTG_Y)H_X9R^*_P#T!+3_ ,'.D_\
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M^-O_ $+-A_X4&B?_ "QK[[^VLI_Z&6$_\+,)_D?*?ZD<9?\ 1+<1?^&C$?\
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M_P#,Q\Z5MZ-I-QJ=PK+OAMX7WS7/]8/^GC)_+UXKW6W_ &4OC.9HQ/X<LXX
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M;;VWO_ ?SQ[?A7M__#.7Q7_Z EI_X.=)_P#DFC_AG+XK_P#0$M/_  <Z3_\
M)-']@9[_ -"?-_\ PDQ7_P D']EYA_T!XS_PC7^9_(]\;/'7Q4_:T_;"U"\_
M:T_9G_;HL_V*_@'XJ%Y\'_@G\,?V6?B;XHL_C9XMT/4IX(/&WQ-OK>VTFVN-
M'NI['^U++2L7EG>:/?:;8V'_ !]ZQK%Y]7_%&R^+'[/G[6/[6'QL\/?LW_'#
MXN> _P!LS]F/X?>&/AU_PJOP3-X@UCPK\6?#>@S^'(/!_P 3=#^T_:?AOH]W
MI\^E75[XHU0?V/H_^D_;[W%I7]&/_#.GQ6_Z MI]?[9TG'Y_:<4?\,Z?%8==
M&LP/5M:TA1^!:Y /X5]3[;//W$(<+XI4</@OJGU/ZKBOJ=OKF$Q=TOJW^^?7
M<%A,9C,8O]\L^SMZW-C[48PR?&?5_J7U-X2^+27^YXS>_P#T&8/NMS^4+XO0
M_MI?LA_L+_LA_L+_  /^&/QPN/&GB3P'%_PT;\=?@Y\)?&'Q8_X4_P"'-<UZ
M^G\1^%?!T_@^VN[:X^('^G3VM[]EU8WEE9V/^@?\A:SUBS[77/V<M%F_8F^
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M_"^?@E_T5SX;?^%MX;_^65'_  OGX)?]%<^&W_A;>&__ )95T?4<?_T"XO\
M\(\7_P#('#_K%P__ -#S*/\ P[X#_P";3UW!_N_^@?\ Q-&#_=_] _\ B:\B
M_P"%\_!+_HKGPV_\+;PW_P#+*C_A?/P2_P"BN?#;_P +;PW_ /+*CZCC_P#H
M%Q?_ (1XO_Y /]8N'_\ H>91_P"'? ?_ #:>NX/]W_T#_P")HP?[O_H'_P 3
M7D7_  OGX)?]%<^&W_A;>&__ )94?\+Y^"7_ $5SX;?^%MX;_P#EE1]1Q_\
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M_0?_ (JC:/7_ -!_^*KR/_A?WP0_Z+#\,_\ PN_#/_RTH_X7]\$/^BP_#/\
M\+OPS_\ +2H_M;)_^AME?_A7A/\ Y:+Z[A/^@O"?^%F$_P#EQZYM'K_Z#_\
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MP?[O_H'_ ,31@_W?_0/_ (FO(O\ A?/P2_Z*Y\-O_"V\-_\ RRH_X7S\$O\
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M@WES/<:CIA)QF70-0N7%IDY71KFVL5&=*;/Y[_MK_M!R?'?XKW$6C7;3> O
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M)KR+_A?/P2_Z*Y\-O_"V\-__ "RH_P"%\_!+_HKGPV_\+;PW_P#+*CZCC_\
MH%Q?_A'B_P#Y /\ 6+A__H>91_X=\!_\VGKN#_=_] _^)HP?[O\ Z!_\37D7
M_"^?@E_T5SX;?^%MX;_^65'_  OGX)?]%<^&W_A;>&__ )94?4<?_P! N+_\
M(\7_ /(!_K%P_P#]#S*/_#O@/_FT];!!X4?D5'OQA13V)4#'/U_^M7E^B_%_
MX6^)-1M='\._$?P/K>K7ID6STG2O%FB:AJ-WY,,UQ,;>QM+V6XG^SVT-Q<R"
M%6VV\,\C +&QKTY6&P%<8)]<@Y_+]<<?6L)TJM.7+4HNCVYKIOUYHK\CNPF.
MP6-I^UP6,PN.I=\)BL+BX_?A9S2]&[];#]W^RWY4TX/1>>^0W_LOU[\USNO^
M*/#?A+3WU;Q5KVB^'-*26.*34];U.TTNP268B.")[V^GMK=)9W^6-2X+'*J#
MCG@6^/OP1/"_%_X8#Z^.?#)'Z:MG]!QFO.KX[!X67LZ^+PE"KHTL5BL+AFT]
MFN>:T^1K/$X6E+EK8K"T=-I8F*=O/FE'3Y=#U[:/7_T'_P"*HVCU_P#0?_BJ
M\C_X7]\$/^BP_#/_ ,+OPS_\M*/^%_?!#_HL/PS_ /"[\,__ "TK+^ULG_Z&
MV5_^%>$_^6D?7<)_T%X3_P +,)_\N/7-H]?_ $'_ .*HVCU_]!_^*KR/_A?W
MP0_Z+#\,_P#PN_#/_P M*/\ A?WP0_Z+#\,__"[\,_\ RTH_M;)_^AME?_A7
MA/\ Y:'UW"?]!>$_\+,)_P#+CUS:/7_T'_XJC:/7_P!!_P#BJ\C_ .%_?!#_
M *+#\,__  N_#/\ \M*/^%_?!#_HL/PS_P#"[\,__+2C^ULG_P"AME?_ (5X
M3_Y:'UW"?]!>$_\ "S"?_+CUO(."!\N?0_KD\\=LX(],UR'CKQCX=^'/A#Q!
MXV\47L>GZ!X8TRZU74+EB 1%!AC# K$>?=W,OEVUG;*<W=W-!:H-[ 'DE^/G
MP0P'_P"%P_#+<P (/COPN ,=RIU?(/?!Z9]A7Y#_ /!1O]I_2_'5YI'P:^'O
MB"QUCPKIGV?7/&&M:'?QWNF:MJ\T9FTC1H+NQ+07]OI=M,-5OC;WIMFO)[6R
M.+ZTVCX_CCCW*>$N&LPSBGBL'CL:TL)E.#CB\)B'B\=C(M82+M4;^J*ZQ6*=
MY6P<9.^L3Y_BGBG \/Y+B\SC5PF(KQ5L%A?K4%]<QC_W6":E*]VKO3;3K<[#
M]D_]N+7O%G[0OBS1OB1?O!X7^+FL"3P9:74@-IX+U>V_T+0]$MIP0HL=5L+:
MWMKLE2!J_P!GO/E%]>L/V>V$GC: 2PR1G(*_+SSRK$GZ'GBOXX(IIK>6.XMY
M)+>XMYHIK6:%_+N(98/W\$T$_P#S\6MSZX_,"OZ-OV6?VP_ ?Q(^$^B77Q#\
M;^%_"_CG0(T\/^)K7Q%X@TG1I=5N[""%8_$5F-3N+,SP:M:NES<K;*5M;[[9
M:$@QYK\A\"_$Z>9QS+AOB;'QECWB\;F^48S&8J+>,CB\3+%8W!*[BO\ 8\2Y
M8G!K_H">+BE;".WYUX8<;U,?];R7.L6WB.;$XW!XS%R47BUB9.>,PB;:V;^M
MX17UA*44O]D9]X;1Z_\ H/\ \51M'K_Z#_\ %5Y'_P +^^"'_18?AG_X7?AG
M_P"6E'_"_O@A_P!%A^&?_A=^&?\ Y:5_1W]K9/\ ]#;*_P#PKPG_ ,M/V7Z[
MA/\ H+PG_A9A/_EQZYM'K_Z#_P#%4;1Z_P#H/_Q5>1_\+^^"'_18?AG_ .%W
MX9_^6E'_  O[X(?]%A^&?_A=^&?_ ):4?VMD_P#T-LK_ /"O"?\ RT/KN$_Z
M"\)_X683_P"7'KFT>O\ Z#_\51M'K_Z#_P#%5Y'_ ,+^^"'_ $6'X9_^%WX9
M_P#EI1_PO[X(?]%A^&?_ (7?AG_Y:4?VMD__ $-LK_\ "O"?_+0^NX3_ *"\
M)_X683_Y<>N\?WA_WP/\*./[P_[X'^%>2?\ "_/@A_T6/X8_^%YX9_\ EI4E
MM\</@Y>W5M9V?Q:^'-Y>7EQ%9V=I:^-?#MS<W5U-+Y,,%O;P7YFGN)KC$"V\
M(9G?Y%7=D4?VKE/_ $,<L_\ "W"_K4#Z[A/^@W"?^%>%_6J>N4445Z9UD8Z-
M_NK_ .@U_G0?\'$$4;_\%3_B^S1QNW_"N_@D,NF?^:?V7K]/PZ=1S_HOCHW^
MZO\ Z#7^=)_P</\ _*4[XO\ _9//@E_ZK^SK]C\"/^2UQ7_9-8__ -3<H/RS
MQ;_Y)G#?]CG"?^HN-/Q:\/>%M:\7:WIOAOPGX;U3Q1XDUBZ^QZ/H/A[1[S6-
M<U6ZX'V.QTK3[:[U+4+C_IUM;2NU\:_ WXN?#?PKX&\<^/\ X3^.?!/@SXGV
M$NJ_#OQ3XJ\'ZQH?A_QK8P\SWGAW5=0TVTMM7MR)X+L?9CS9SVU]_P >-W7U
M/_P32UOQQH'[8OP[OO /AO1_$>H2>'OBAIOB1->\<S_"[3/#WPYU7X;^)+'X
MC>-I_B;I]M=W/P_N/!O@^?5?%%EXHM;.\O-'O+'_ $"RO;[[%7Z#_P#!5WQY
M\5?%/PLU*RE\.?#6Y^$=O\>/AJNF^)_AY\5M>\>:-X2\,0_LU>%KC]G3P3X<
M\*^*-$\.ZEX/T#5?A1KE_P"*;[Q1<VEG>?$C63<DV5G8^'[//])8_B#&X7B7
M Y)"C@5A\1A/KF-QCQC^NZIX-*.#6E[KK?ZXO]B2O_N?XU@<APV)X>QF<3K8
MSV^'QGU/ZG]3_P"P/^O^H/\ WS_L,^$O^"2<$8_X*9_L2?NX_P#DNVA?P<_\
M@?7?KC_/;./]0:X_X]I_^N<O\FK_ "__ /@DI_RDT_8C_P"RZ:%_Z9=<K_4
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M_8_QH\M/[D?_ '['^-244 1^6G]R/_OV/\:/+3^Y'_W['^-244 1^6G]R/\
M[]C_ !H\M/[D?_?L?XU)10!'Y:?W(_\ OV/\:/+3^Y'_ -^Q_C4E% '[V?\
M!+,;?@)XNXZ_%37AC_N6O!X_KFOTO'1?JO\ -J_-#_@EI_R03Q=_V537?_4;
M\'U^EXZ+]5_FU?R+QG_R5O$'_8?4_*!_MKX ?\F6\-?^R7P/Y8D_ K_@JLJM
M\>/ VY%<_P#"K+#JN?\ F:O%?^<=1^=?F+Y:?W(_^_8_QK]._P#@JK_R7CP1
M_P!DLT[_ -2KQ;7YD5_EWXN_\G(XP_[&\/\ U!P!^.^(?_):Y_\ ]A<?_4#
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M^FC3Z_U'\._^2PR?_KYB_P#U!QI][])__DQ/'G_8%E/_ *T.2'XL>6G]R/\
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M@Z]!^$__ "5?X5_]E+^'_P#ZE.E5VY9_R,LM_P"PS!?^IIUX'_?,'_V&8/\
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M./\ D<?\+'^QX/\ VS!_\(__ $!^A3S#@.'L?;9;C/\ <_\ J,_Z@_\ 8_\
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MNTO+R\O)[;TQ5/Q)^RG\'_%'Q#E^)&H6_BZSU34-2T'6/$_AO1/&VO:/\/\
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M#>C_ .C?;[VSL3:5];?#W]D/X-_#?Q%I?B;2X_''B*\\,:5JF@>!K#QYX_\
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M]3_MCZY_R)_[8^I_7,9C/]L^IG'_ &MPE/._;8S+?K&5?V/D^#^I_4\9@_\
M;,'C,']<QG^^?7/]S^N?4_\ ;/\ ?#P;6_VQ_&GP\\-?'J\^*?POT/3?%GPC
MO_AZF@Z)X)\3ZQXHTOQ#:_%2:"#P=#?7W_"-VFMV^H:7<3_\5/\ V7X>O/MG
MD7)T&RO/]$^V8_A+]N#Q1XA^'37US\*X[?XJ:E\5/"7PB\'Z5<I\0O"?P_\
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M+>/X2Z]\0?$/@FVN?$,VH6]G?_$WSO\ A*H;X7%M]JU"W_?3_8OM=W]LL_\
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MQ8:1_:$$%U?:9; VEYQ^'%1X6SZ%*K2G6_?_ -CX/!X/&?7?]SQGU/ZG_P!
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M[3T[WAN(/"ZBU1_L'&>PKO!?7+X/1_4K;VSG%XUXS"?[8L;C,$\%@\8G@_\
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M_JW_ +G@_KG^^?7,9C/]L..GC/#WVU'GRW&>P^N?]3C_ '/ZYG'^^?[9_P!
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MXU@L;?3O[1T_QQX8N-*@_L;5+7539V?&+/&<^@?"GX46GPKTS5;7_A-_B/\
M$35]=OX]1UOQ9\3_ !3-XG\07\D-K#96,!^SVVDZ+8V%K;PD"WT32K6UQY]Y
M?F\O;D7@[,MP?$^&S7_:<9_PE?7,X_Z \9C/]LQF,^I_[9;ZY_T!_P#EY?\
MY@SPN+.(/!C->"ZW]E<.?5^.?['X.P>#Q>#6<X/!X/\ L?)^','G-\)]<QF"
MQGUO&8/B1XS&8Q/&8UXS)\7_ +9C%C?J?SYHG[7UYJW[16H? ^X^'%OH>EV?
MC"_\$PZWK?C_ $?1_'%YJ%C9SW\'BNQ^&6L:;I-SK'P_U00?\2;7M!\0ZQ>7
MGG_;O[%^P\58T/\ :WFUC0/A_KG_  @,=N/''[6^L_LN_9O^$G\S^S8M*UGQ
M)I7_  FWG_V)_P 3#[5_PCGVG_A%_P#0\?;O^0U_HE=CJ'[*/@?5OB;I7Q&U
M3QA\4]4T[1/&'_"Q-'^&.J>,A?\ PSTWQYG[1!XKL=+O],N]<L+FUN3]JLM,
MMO$1\.6=V !HNT #GK/]BOX7V'C?1_&-IXL^*=O9Z#\:1\>M$\"CQ?#<> M'
M\>37E]?:Y-8Z'<:)=?\ $OU[4+V>ZOB;O[99X^Q:%>Z/9?;+.\QIT^-H3]^M
M@\10^N?]0?\ N?US!_\ 4'_T!_7/^HS_ &P[<1COH]5L-1]AEN<9?7_U;P7U
MS3B3&?7<XP>"XDP>-P?_ ".'_MF+QF,X;QF,_P!C_L?"?V/]4P>,Q?US&?7.
M/T3]L?Q3=7NDZYK_ ,%6T3X1ZA\:=9^!=U\18/B%INH7EGXMM_%4_@[0]2_X
M0[^Q+34KCP]J>H006M[=?:_MFCZQ.;*QL]7L,WE.TG]L7Q4VM>&;_P 2_!*3
M0/A/XD^..L_L^0?$6'Q]INJZ@GCRW\8:KX5\.S_\(<-$M-3_ .$>U[4-)^RW
MNJ?:[.\T>[^TV7V*\L;0WE.^$/['4>BWD7B#XF>)?%M]<:7\:?B#\5-*^'NE
M^,YKOX5W.JZKXJU75?!WBK5/#EQIUJ/^$@TK3YX,6MK=V6CF[_TZ_LKN^/VP
M'PJ_8WM-(U33_%/Q(\2>,-0O-!^,WQ"^+>C_  [L_&<^H?"=_$6K>-M=USP/
MXUOO#EQIOVC_ (2C0M'O['-K:W5GH]GK'^G?8KR^M#>5Y^'_ -?)_4^>M_O"
M_P"8S!Y/_L?^Y_[Y_L?^Y_[Y_L?^^?[Y_MA]1FD?HW8:/$GL<'@\1_9_U/!X
M/ZGC.+_]L^N?VQ_R)O\ C)/]LSC!WP?US.,9]<X;P?\ L?\ PC_[X:EA^UUK
M%YXBL]8D^#^H6_P U;XJ2?!G2OB[_P );ILNL3>-SXD_X16#4K[X<_V;]IM_
M ]UX@@GTNRU[_A(;R\&;:^_L46-U_H?D_P 8?VK?CU)\'OCMXP^'?PJTOPOI
M_P -_'-_\.M*\?ZEX_TVXO-5U30_B%I7A75;S2?"MQX;)M[?^S[Z?_2KJ[_T
M/6(+FQL/M?V3[9>?1&F_L@_#'2_'-OXLM]:^(G_"-V?C:Z^)UA\(IO&,TGPD
ML/B7?:E_:L_C:'PK]F_M+^V/[0GGU3[+=:M_PC?VR;[=_8OV[[']CZ;4_P!F
MWP'J_P *OB+\(;S4/%!\-_$SQ/XH\8ZQ?PZE9VWB#3=9\5>)/^$JN)M#OK?3
M?LUO_9>L>1=:+]JM+SF#_3S><5U5,OXSQ.&QE&MF7U?_ &/&?[G]3_WSZG_L
M?^V?4_\ 8\']<_W/_F,_Z#,8>/@^)/H_9/FN3YE@^%?[0^KYQPWC,9@\XP?$
MF,P?]CX/./KF<?7,'C.)/J>,XD_L?_D<?\TWC/\ F#R?!_[8>S^%[O7+[PUH
M%YXETNUT3Q)=Z+IESKNBVFJ?VW9Z7K$]G!/JNFV.N?9[7^U[>UU#S[7^U/LM
MF+PP&]^QVF,G;K#\,Z++X<\.Z'X?DUO7/$DFAZ58:4_B'Q)<PZCX@UN6QLH(
M/[1UR^M[:TMKC6-4\C[5>W5K:6=F;R?/V*S[[E?<4^?V-'G_ *W/YQQWL9XS
M&?5OJ?L/KF,^I_4_KGU/ZG]<_P"8/ZY?&?4_^PS_ &S_ *#&S][/^"6G_)!/
M%W_95-=_]1OP?7Z7CHOU7^;5^:'_  2T_P"2">+O^RJ:[_ZC?@^OTO'1?JO\
MVK^2>,_^2MX@_P"P^I^4#_:KP _Y,MX:_P#9+X'\L2?@7_P55_Y+QX(_[)9I
MW_J5>+:_,BOTW_X*J_\ )>/!'_9+-._]2KQ;7YD5_EWXN_\ )R.,/^QO#_U
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MQ?VQ_L>,^IXSZG]3^N8S_F,QGU/Z[]<^N?[&5FF(X ]CC(9;@_W^(P?^Q_\
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M/_P27_X_OCY_U[?#+_T=\0*_'BOV'_X)+_\ ']\?/^O;X9?^COB!7ZKX)_\
M)SN%O7-?_6?S,^\\,_\ DN<A_P"YS_U58H_:5ON+^'\C7Y#?\%7_ /D6O@Q_
MV,OBW_TT:?7Z\M]Q?P_D:_(;_@J__P BU\&/^QE\6_\ IHT^O]1_#O\ Y+')
M_P#KYB__ %!QI][])_\ Y,3QY_V!93_ZT.2'XN4445_5A_C,%%%% !1110!X
M'\=_C-K'PIB\ Z'X/\"M\2/B)\4O%H\&>!?"LWB&'PGH\U_!IM]KFJZGKGBJ
MXTW5O['T?2]/L9\77]DWEX+W[-8FR%?#^D?MN^)OA+\.OB9XD^+6FWFJ>-M6
M_:Q^*'PN\!^"_$_B2ST_2_"6E^'--TK7/['U7Q5X?T/Q#_Q3_A>WG^RV6J:7
MX>UB\O/MUM_RX_;/L?WY\9/@KX;^-6D>'[36-8\6^$]<\'^(+7Q7X,\<^ ]8
MAT/QAX2U^"SGL?[2T.^N--U>V_TK3[Z^TN]M=5TF\L[VSGKR"Q_8L^&^E^$;
MSPUIOB_XKV6LM\6M>^-6B_$BW\80_P#"R_"WCSQ'9C2M<U'0_$8T4&XM]5T_
MS[6]M==M=7-YY]U]O^V&OB\XP?%M;,JU;+<9]7H?\P?^Y_4_]SP?^^8/ZG_M
MF,^N?7/]\QGU/_<S^A. \\\$\!PK1P'&&0XS,,UQ&-P?]L/ZGG'US&?4\XQF
M,P;P><8+&?4\GR?ZG_8^#QGU/!X/.<9]3SC_ &S&8-X/!GENI_M\VS_!_P"&
M?Q.\,_#(ZA<?$#Q)XI\*ZE_PEGB__A#/AWX/UKP:(?[4@U;XC:CX<NK;[-KY
MG'_"O[NZ\/:.?$8AS?C2"+P'JM<_:8MK/QI\$/%NHKXGT;PAXE_9V^.7Q>\0
M>'=*\3^%M8T00_#_ $SPOJIM[V#1]/U6T\4:O;G4+VV\,ZIH7C72-)S)<?;;
M35A>,+7U'6OV8/#NI^!_"O@W3/B7\;?"NH>$WUAK;Q]H/Q%O&\;ZS)XB 'BK
M_A*[[7M.U_1/$!UZX NC;:IX?^R:1R="L](;.<^W_9+^&&A:9X,M?#^GZA=6
M_P .OA;\4_AAH7AS6]8/]@^)-,^+$$0\4S>,+^WTZ[UNXU#5-0LS=G5-+N[,
MV9O=1Q9W>+.SM.:6%XVY_?QF#_W/)NN#TQF#^I_7/]SP?UW3_;+KKM@_^H/T
MJ6<_1ZA1_P!FR+.,-7Q&+XRP5_K6<8UO)\;@N(\'DR^N8W&O!8+&81XS)U@L
M:L&L;&V,QN<8W!_5$\W\[\&_M<>/]6\0>%=%\;_ ?_A [?QQ\$_'GQR\,7[_
M !"L_$'VGPYX5AT.?0]-OH-/\-6G]GZQJFGZY!=:U:W5W_Q)_P#EP&L<7E;7
MP0_:G\8?%#Q;\._#WC#X+R?#?2_BU\*+OXH_#W6T\>:;XLN=2M=+FTJ#6]-U
MS2]/T32?^$?^R_VY8W6BW7VN[%Y9X^WV=F3]C'B_P#_9$^+&B?$2U\1?%2Z3
M1_"?A/X/^-_@YX3TJ'XNZS\7-<FT+QC>:5Y$-AJNL>"?">F^#_#_ (7T?2AI
M>BZ8=)U>\O?/M[Z_O;S[("?LCPI\ ?!O@_5/A#JVEZAXCN+CX+?#O6?ACX52
M_O--DM[_ $'7/[#%]>:Y]GTVS%QK'_%.6'V*ZM/['L_W]S_H/&;-93_KAB9T
M:V)K8S#T/KF#_P!CQF#P>#QF,P?_  C_ %S_ )@\'_U./J?^Y_\ ,&;<<?\
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MSSZ].-/\)76M^#_#^E^3]J\::]=7?C#_ )=OL%E9C_0Z]0\8?LG_  [\;?\
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MC^;FBOZ1O)_8A_Z);\,__#.6/_S-T>3^Q#_T2WX9_P#AG+'_ .9NC_B L?\
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M  ;'_P"1/Y"_XD_K_P#1VN!O_!.-_P#EQ_-_17](']E?L5_]$K^&O_AI-/\
M_E#1_97[%?\ T2OX:_\ AI-/_P#E#1_Q%!?]$QG'_@V/_P B'_$G]?\ Z.UP
M-_X)QO\ \N/YOZ*_I _LK]BO_HE?PU_\-)I__P H:/[*_8K_ .B5_#7_ ,-)
MI_\ \H:/^(H+_HF,X_\ !L?_ )$/^)/Z_P#T=K@;_P $XW_Y<?S?T5_2!_97
M[%?_ $2OX:_^&DT__P"4-']E?L5_]$K^&O\ X:33_P#Y0T?\107_ $3&<?\
M@V/_ ,B'_$G]?_H[7 W_ ()QO_RX_F_HK^D#^ROV*_\ HE?PU_\ #2:?_P#*
M&C^ROV*_^B5_#7_PTFG_ /RAH_XB@O\ HF,X_P#!L?\ Y$/^)/Z__1VN!O\
MP3C?_EQ_-_17](']E?L5_P#1*_AK_P"&DT__ .4-']E?L5_]$K^&O_AI-/\
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MS=?(_P#$!8_]'#X2_P#!3_\ DSP?^(2O_HK<H_\  '_\D?S<T5_2-Y/[$/\
MT2WX9_\ AG+'_P"9NCR?V(?^B6_#/_PSEC_\S='_ ! 6/_1P^$O_  4__DP_
MXA*_^BMRC_P!_P#R1_-S17](WD_L0_\ 1+?AG_X9RQ_^9NCR?V(?^B6_#/\
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MLE]J&G6/S7=R(ZLOJ7[":2QV_P#PK7X:S7%QK$&@6\,/P@LYI+K5-OFWUI;
M>'F%R/#]M_I?B6XAWVOAVU^?4Y;4X%<DO&' 0ERSR3%I]N?!?GRM?@=T/H,\
M5U8<\./>'70\LOSG_P"6+]#^>"BOWU^(_P 2_P#@G+\)=#\7^)/B!X2^$VAZ
M'X%GT6Q\1:B_PDM+FW@UK6HVN;#0+$VOARX.I^(+:P:'4[_2M-%W=Z18WMI>
M7ZVBW(KE/#'QS_X)V>*?!GAGQU:?![3=+TOQQK\V@> ]/\2?LSZUX;\4^.1!
M#!--K_A7PIK'@VT\0ZCX1%M.;H^*!8KHIM(;EOM?R89_\1BRS_H2XO\ \+L)
M_D5_Q(QQ5_T7O#W_ (09S_\ )_\ #'X:T5^A^L?\%6?^"*GAOQ7X4\'^)_#V
MG^%]5\7_ !(A^$FCW/B']D?QSI.A_P#"=SW'V&'0K[7+KX=#3-.)E&3<W=U;
M6@M(FO0_V)1(?OC4_%O[ VDV=]?7GPQ\ ^5IUM=W-RD'P0-Q<F*RA>>=8;>#
MPLTT\X$( MP-YP/3DGXO8.E+V5;),8J^NCG@DUY6Y&_34(?07XJE'GAQ[P\_
M-9?G%O\ TXORN?S\45^OG[,/[;7_  26_;!\%:Y\0/@1X=\$>)O#OAOQ3=^#
M=>?4_P!G?6/#&IZ?XCL[>">XLKC2?$/@S3-2 \BX&+D6WV:?R[@;\V[J#]I'
M]MC_ ()._LG>'_#7BCXV^$?#.@Z)XLUV7PWI-YHW[->O>+-VJ0:;>ZL8;V'P
M[X)U.XL+<:?87%P+JZ1+7;#]]3BKP_BSAL37I8;#</9O7K5]L)@YX)\W_;JC
M=?-ZBE]!GBJ$>>?'W#J\W@,Y_P#DV?D'17[^V'C_ /X)ZZGI^GZI8_#WX>3V
M.J6-IJ=G*GP3_P!=:WL$$\$H'_"+\9AG@)ZG!QV KY'^+O\ P4?_ .",_P "
MOC7X'_9^^*.D^$_#?Q+^(J:/)X2L/^&9/$NH:/J<>NZG_8=C+_PD>G^ [O1;
M9?[0_P!&O?M%XILSQ>A!12\6<+6G[&EP_F]>OY3P3_*"^6HI?09XJA'FGQ[P
M\O/^S\YM_P"G/Z_$_+JBOZ!CXR_X)^J=O_"N/A[_ .&5/M_U*OO7PK^TQ_P5
M/_X(I?LB^.]#^''QTTOP]X8\4>(])AUO2K?3_P!ECQAXDT^XTRXO?L)G.K:#
MX O=.M_+N.+H3W2_9S_K,UG_ ,1AP$_^9)BW?^_@?_D%_74K_B1CBK_HO>'_
M /P@SG_Y8?G'17] ;^-_^"?:?>^'/P]_\,J?_F5_SD5\V?M/?MU?\$COV/O
MEE\1_COX=\(>&_!^H:Y;>'X-2TW]G'7?$SC5;^&>>"*:RT#P5?7D/V@03D3M
M;A2>#P2:7_$8<O\ ^A)B_P#P/ __ "(?\2,<5?\ 1>\/_P#A!G/_ ,L/D/\
M85S_ ,-8?!_&,_VAXJQGIG_A ?%>,^U?TQQJ,;N0W(;& !N"EP,]<'(]>1^/
MY$?L%?MX_P#!,#]MB_@\5_L;6/AO4=7T+Q+J/ABWUP_ ;6_AMJ^F:[_PC-SJ
M]]%9WGB'PCH5S%]IT%KP&[MG6WNE>XLB[,SH?UY!&1C' / /W@<_-T([Y.?_
M *U?F'&?$M/BO,J./HX?%X7ZO@W@^7%R4Y/_ &S%XO>*BK7QFUNEWHTC^N/
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M%% !1110 4444 ?='[,7_(CZO_V-%Y_Z:]&KZ.;O_NM_2OG']F+_ )$?5_\
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MT\/>);*.XUSPNLC2)8:E<VVI6=F))OL'[_2O.Z?VA;VMQ]H^Q6MU]LLQ>?\
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M..XM9?#NL:KH?V.>#3[F[TP?9;>P@_X];O['GVK^;G_@X*^-W[0&@?M Z?\
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MY]_UP\W,>'*]&U; _OZ':]_E?^KGZ&45&)H3+)"LT<LEOY7G(C^9(AG_ '\
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M$GW_ "[.'[1(?^V'\O7WQFLNB%OL]W'J%N?L^HVZ;(;R']W<0Q#]_P#N)_\
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M9-\G'_7S_G\:U(+'49=W_$KN)F9_D%JLT?'?C[-=_P ^O/%?Q(ZS_P ' _\
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M_P#'K=_8[S_I^NP,5]1_$;X2^+/ )CNM2M8M3\/WR;]*\5:)-_:'A_4HI_\
M4307UO\ \>_8_9;K'XBOXL?A\/%GP+\)W&N>'[QOBQ\"8]2EL]8\0V&E36^K
M_#V_[Z/\5/!UQ_Q,O!^H6O%K_;UK_P 2>\,&,U^SW[$?_!2_XA?"RR_L/PWX
M@L_B9\*[BSNIK_X1>-K^'4+"6PAA\^<>%=5U#[7]G_T?SS_9?%G_ -.)YK^Y
M*?"='-<MHXS(*U\=]3_VS)\;?_RRQG3OUP7:Q53/)Y;C*V&S*C_L/US_ &/&
M?_-G]7/TYO%\F7WWC\.#_GZ=?2LZ2X#CDY_G^6?\/UKZ"^'FK?LV?MG:/)K'
M[/OB:W^'OQ-AMS<ZW\%_&MS]CECNN?/_ +$E-S=_9[;[3@67V,WND$X.VR&<
M>*^-/"7BOX?:Q<>'O%OA_4- U6+_ )97\0031?\ />PN,_9=0M^G^E6O-?"5
MZ-7#UWA<31QF'Q&&WP6-5GZZ[K7=772Z>A]AA\11Q-'VU&M]8H6_K^MSD;F?
M;^[Z?)V_^O\ TY_*L&>7#'<W\?;OU_SC\N*=>3*%=C(?]_W_ %R,]_\ (Y&]
MU%U'WMW\_KCT_4=L5A4Z?/\ 0Z*?O^6]S4OK^2,?++[GI_GZ8_+UX&\UB\L+
MO^T-/U"]T_4(_GAO]-O9M/O$E_Y8#SX,77^B^?Z^_P!'75[-+]U??Y#P/\X_
M*O/];OV#R1R_PC.],_)]1U_'L/I7'4P\*T.2M1^L4#H]R?N3^7YV_4]HT7]K
M+Q[X.:*W\01Z?XTTJ/Y/]/SI^N)$/^HKI_\ HUP?LY_YBEI]L^V ?;[V\KZ<
M\ _M4_"/QSY=O-JTG@_6)$B_XEOB=#;V[S?N/W-CKEM_Q+;@?:)_LO\ I5W9
MWMYC'V*OREU.[CO/,CDC\R-AQ^\_I[_XY[UBV6GL+C_1UW;L?<QU_/G'0\CC
MWKX'./#?AO,H>VHT?['K_P#4'_\ ,?\ N?\ X1_4SS<1D> Q,_<_V>O_ -09
M_0!#-#<11W%O-#<V\T>^&YMIH;BWFB_Z83V_^CW&?\^E25^)?A'X[>(OAUXA
MT/PGX,UB;4M0U&YE.L:)INMPR1Z5:P6?[B\N-*N+:[TVX_Y]1:75W9WEG^E?
M</[*_P"U/K_QZ\8?%3P'XD\#Q^'=0^%MMX<FO->L[S[1I^I3>(_W\&FSP<_9
M]0^S_P"E?Z+_ *']C[D?Z8/R'B#P_P XR'!ULU_WC*L/_P QG^Y_^6?_ ,Q_
M7#YW,LCG@/\ F,P>(_\ 4P^TZ***^#/#"OL;]D?_ (^/'W_7'PQ_Z'K]?'-?
M8W[(_P#Q\>/O^N/AC_T/7Z^KX'_Y*?+?7%?^HF+/8R'_ )&N!_[F_P#U#1]J
MKANNXGU(P>/7ZX[C^E?SC?\ !PS_ ,%"_C__ ,$__!G[+&O? [0_A7XI@^)W
MC7XG>'/'GACXL>'+SQ#I&MZ%HOAKP]?P6=A]@UG1[NQGNA?7MG>29O;%K2\9
M;ZQNF2U%?T<C/7&2.?O9^G'4CTYY_&OYQ/\ @XF_X)S^-?\ @H5\,OV:M(\
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MQF,_]0_^8S_PC/B^).">#.,*/U;BKA7)\X_[#,'@\9C/_"S_ 'S!GX=_#_\
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MI_V6_%'B+Q%<?'#_ (3C]G?7/$FOW5_;0^/_  Q>7G@JVM;C]Q8V<'CCPO\
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MOH+S0OM_-O<W0G^RWN/^7,\<U_2;14Y.?W.WX>1F?/?[3G_)*[S_ +#6A_\
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MW-W;07%K_P OOV2[O./^7VMJDK^K_)'FT</"$ZT_;?6/Z_K_ (8H_M+?%/\
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M?V?_ */JL0LTTU\QPQ06?D7$,\'VD_9[C[1!]J_T7[%9_8N0.N?B>.LKP?\
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M^Q7UD0=&-YRW_!T=\2-:U;X-^ _ =G]HA\+Q^,Y=5O,O_H[ZA8S?V5^_P?\
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MX;XDSC,JV#^O9/XD<2<'X/)\'_L?_"/D^<8W!8/&XOZYC/KF,_W/!_7/J?\
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M9QC,'@\9]<P>,_W/_L#QF,^I_P#8'C"Q1117TA\&?='[,7_(CZO_ -C1>?\
MIKT:OHYN_P#NM_2OG']F+_D1]7_[&B\_]->C5]'-W_W6_I7YKFO_ ",L9_U\
MD?U7P?\ \DUDO_8%#\V? '[5O_(^:'_V*T/_ *=M4KY@KZ?_ &K?^1\T/_L5
MH?\ T[:I7S!7\Q\6?\E-G'_86O\ U!B?,YU_R,\;\OR05'+''-%);31QS13)
M+#-#,GF1S13Y\^&X@X[5)17SIY1^3?[37_!.R.ZUN^^-'[*^H+\-_BI#;77]
MJ^';:&&X\-^,["?]_<:#JNAW!_LWQ!H]U_T*VO\ ^AXG_P")#>Z/?5^#?B?X
M+_;/'4VD^"]+T_\ 9S_:,EU"47_P?UZ>:P^"?Q@U2#]_/_PJO7-0^Q_\*_\
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MSH?$]GBJQE/ 9E1]CGV0X+.*'_09@_\ 8\9@_P#W3_\ +,]:.(PU;W)_[/\
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MW-1Y.2='^OZ_[ S'VD_L5F?P?^,_V6/VS/V0K;6KC]JS]B_XE>(/ ZI=0O\
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MO_;WZ?UM_6IE5<)_#LUJ?/O[3G_)*[S_ +#6A_\ I:M?G'7Z.?M.?\DKO/\
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M,%GI/_"/ZU=W/B#4+JW\.7W^BVMW]LO-8OO[#^Q?Z)]CK]POV0_A_-X(\/\
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M'X-?L_>&?A?XFO+;[-#J5S-_;'C'6XK&;_3OW]Q:VFF_Z+I_G_;;7_0_L?\
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MG:'HGU7^5?EY\1/^1]\9?]C-K7_IPN*_4,]$^J_RK\O/B)_R/OC+_L9M:_\
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MM9P_!O\ 9;^#_A>\T^&6&'Q+?^%;/QAXPFBG_P!?]N\8^.!XA\27_P#KY_\
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MPOXF8#/LJK0PV,^K_P#09@_^@/\ [D_^8/&?]1F#_P"$?&?]09ZW]GX;,O\
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M+5>.-!^Q^'_VE/ ]MXXTQ?*AD\?^ X8-"\40P_\ +>;5O#G^B:)K'7_F&?\
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M5[6:Z\&3:K_PD'P^O(I_W\$-]X'\46VK>$KBVNN/^/72;/WO?M]?V0?M5_\
M!$/]@_\ :B_M36;?X;Q?!_QWJ'VJ\3QM\*#_ ,(O<377_+>\U7PY;C_A&]8Y
M_P!*O?M6D_;+SC_317\R/[5/_!OS^VA\ _[8USX)ZAIO[1'@6.VEAAMM!?\
ML/X@PV$!GG@$_AS4+G^S=0N+3'_,!U:]O+S'_(%L^AY\1E];[='ZQ_ZF'H9?
MQ1EM;W(8S^SZ_P#T!XS_ '/_ ,+/]S_]0SX4_;'_ &U_VBOVPO'(^+G[4WQ
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M_P!+>U=/#WQIM?[<\06=I!SG0_B-I_V3QM;W'V?_ (\KK5+OQ)BOZ5OV1?\
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MN]-_X0"+PEX;2=S]G\,:I_;%Q?:Y-! /^7CQ1;_8;6]U3_GSTK[",5YC\/\
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M^R:S#_U.R@_+?%O_ ))FC_V-\+_ZB8P_$:BBBOZ\/YQ/T0_X)*?\I-/V(_\
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MX3!_4W^<\NG_ +6'[*$\UQI]S)\0/A_I[_.]@EYJEG81?\L)K[2K@?VWX7U
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M *[7/#GV;&H:A=7$$'V*ZU3_ $/]Q;9_T'[97]&9+C,3#*N&Z-'_ *$^#_\
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MT^#I/^+=>$Y-WE1KX;T9]SN,I%_9L'U_G^E?!^G>$OB1_P %!/VE+?\ 8V^
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M%_F'U7#?\^<%_P"$C_R///\ A5G@?_H#R_\ @UU3_P"2:/\ A5G@?_H#R_\
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MI_\ R57H%%'UK$_\_P#&?^ O_(/['RC_ *%V#_\ "3!GG_\ PK'P9_T"I/\
MP9ZG_P#)5'_"L?!G_0*D_P#!GJ?_ ,E5Z!11]:Q/_/\ QG_@+_R#^Q\H_P"A
M=@__  DP9Y__ ,*Q\&?] J3_ ,&>I_\ R51_PK'P9_T"I/\ P9ZG_P#)5>@4
M4?6L3_S_ ,9_X"_\@_L?*/\ H78/_P ),&>?_P#"L?!G_0*D_P#!GJ?_ ,E4
M?\*Q\&?] J3_ ,&>I_\ R57H%%'UK$_\_P#&?^ O_(/['RC_ *%V#_\ "3!G
MG_\ PK'P9_T"I/\ P9ZG_P#)5'_"L?!G_0*D_P#!GJ?_ ,E5Z!11]:Q/_/\
MQG_@+_R#^Q\H_P"A=@__  DP9Y__ ,*Q\&?] J3_ ,&>I_\ R51_PK'P9_T"
MI/\ P9ZG_P#)5>@44?6L3_S_ ,9_X"_\@_L?*/\ H78/_P ),&>?_P#"L?!G
M_0*D_P#!GJ?_ ,E4?\*Q\&?] J3_ ,&>I_\ R57H%%'UK$_\_P#&?^ O_(/[
M'RC_ *%V#_\ "3!G?_"S0=,\/:!<VFDP-;VTNK7$[QO++.1+]ELH2=\YW?<@
MBP. ,<<DUZ8!DD^H8CMR>WU'/\ZXSP-_R!YQG&=1EYXX_<6F<Y['CZXZ\5V?
M0CG[HR<>Y_KD"OE<5*4L37G)ZN;=N^S?W62/TC*Z5.EEN"HT:/L:2PL;+MI;
M];GSC\7?!/AKQ%K^G7FKV#W-Q#I,5O&T=Y=VX2,75[*W_'M.H/,I[=3UQ@+Y
M/_PJSP/_ - >7_P:ZI_\DU]!_$7']K6N,#_B719QZ_:Y@:\_K\NSC X.>98R
M<\)A'HM7A-7HMWU]3R\;AZ,\36G4HX1WMJ]WHMSSS_A5G@?_ * \O_@UU3_Y
M)H_X59X'_P"@/+_X-=4_^2:]#HKS?[/P'_0'@_\ PBP7^9R_5<-_SYP7_A(_
M\CSS_A5G@?\ Z \O_@UU3_Y)H_X59X'_ .@/+_X-=4_^2:]#HH_L_ ?] >#_
M /"+!?YA]5PW_/G!?^$C_P CSS_A5G@?_H#R_P#@UU3_ .2:/^%6>!_^@/+_
M .#75/\ Y)KT.BC^S\!_T!X/_P (L%_F'U7#?\^<%_X2/_(\\_X59X'_ .@/
M+_X-=4_^2:/^%6>!_P#H#R_^#75/_DFO0Z*/[/P'_0'@_P#PBP7^8?5<-_SY
MP7_A(_\ (\\_X59X'_Z \O\ X-=4_P#DFHKCX1_#^\M[BSO-!^U6=U#+;7-M
M<W^I7%O<VL_^NAGM[BY^S3V]UVKTBBC^S\!_T!8/_P (@^KX;_GS@_\ PC?^
M1_//^V]_P09\(_';7)/$_P"S?X^\-_!N34'\[6/ WC/0=2\2>#_M)_Y?/#E]
MI]S_ &EH_P!J[:7=?;;.S_YA][9V)^QV7$_LA_\ !N=\'?AIXAM_&G[7'CRS
M_:(U#1YHG\/?#KPW8:EX3^%]M+_S^>)#/<_VWX@^R\?\2O\ XD^C\G[?_;'_
M !YC^DZBO<EFF,G1]C.L>I_:&)A1]C[8\/C_ &;/@7#=^$]0A^&?A>&\\!V<
MNF^!KR&P@CN/!]A/";>>S\*S_P#'SX?MKJ"#[+]ETK[']*ZW_A5G@?\ Z \O
M_@UU3_Y)KT.BO#_L[ 3^/!X/U^IGF_5\-/XZ.#T_'[SSS_A5G@?_ * \O_@U
MU3_Y)H_X59X'_P"@/+_X-=4_^2:]#HH_L_ ?] >#_P#"+!?YD_5<-_SYP7_A
M(_\ (\\_X59X'_Z \O\ X-=4_P#DFO;O@UX2T+PU)XB;1;-K4W:Z6MR);F[N
M?,%O]O,)'VF=CUGF^[ST&<5RE>H?#7[VL]/NV'7/?[;QQS]?I7J9)@L%1S3"
M3I83"1K_ .V>\L)RM?[(MGTOHO1VZG9@</1AB:,X4;>?]?UH>KL,@@5YG\1K
M>&YM],CN(Q*GFW.5;OF*+^1Y^N<UZ6QP#^0_S]*\\\?C]UI9[F:XS^$%?I^$
MIQG7I0GLW;\#U,SJ2IX&M.&KY5UZ'SQ-\,O \\KR-HIC\S^"VO+RSMT_ZX06
MUR;:W''2OE_XP?\ !.W]D_X[>()/%'Q(\%^+M2UB3PQ+X/=]$^+7Q.\)V<V@
MS_VKF&XL?"_BW2=-N+C_ (GFJ_\ $T^R?;/L=P/]-%?;E%>W]2PO_/C!_P!?
M(^3_ +0Q_P#T&8O_ ,+<:>!VG[,/P/T_3X]+T_P3;Z79PSRS1PZ;J6I:?NNI
M_P#7SS_V?<VOVBXNO^7VZNO]+O*DU?\ 9G^">OZ-<>'M<\%QZQI-Q#+"]MJN
MI:EJ&SSX#!/-!/<7-W<V]P+?/^E6O^F5[Q11'#T8>Y"B$LPQ\_CQF,_\+#\J
M_$7_  11_P"";?BK4/[5UCX#ZM]LV;&DTWXM?%31XY_^N\&G^+;2VN.O2Z_I
M7(7O_!!G_@E_J#QR7'P+\8+Y$T4VRV^/?QRLXYI8)O/@\^"V\?\ ^D>GV:ZK
M]@Z*JG3A1G[:C_L]<QJ8C$UH>QK5L9B*'](_*NQ_X(K?\$Y]-3%G\&_%EON\
MWYT^-_QF-Q^_'GS_ .D?\)M]I^S_ /3KTSVS7LGA?_@FE^QGX/O_ .T-$^%-
MYY_V;[-]FU7QSXVUS3_*&FSZ'_R"M8UN[T[_ $6PGG^Q 6G^A7GV:_XOK3[7
M7WA17U$N,.+9PK49\2<2>PQ'_4XQG_S8?(UN">#,36HXFMPKPWB*^'_W/&?V
M/@_]C_[ _P#8S\M?'7_!&+_@G9\2O#]WX8\8_!?Q!J>CWWVI;N%/C!\6M.N9
M8YYO/GA^WV'C:TN1!]H@_P"/7[7]CXS7S*G_  ;0_P#!&J.8W$?[,GC".8_/
MO3]I#]H0'_U9 _SW[5^\E%>/F699EG$Z,\UQF,S#ZO\ [G]<QF,QG_J8>YE.
M7X#(:%;"Y)@\'D]#$:_4LGP?U/R_Y@^MOZZ+\6_#/_!OG_P2C\(2^9H/[/\
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MGSY\,\%QJ7;T_P *_/?XQ_\ ! G_ ()1_'CQ!;^*/B)^R_')K%I;?9D?P?\
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M'\(_$_Q:T/X2S_&+_A5=CXXO_P#B6_\ "8#PO!_:E]X7&K7FL6=G]IL?MO\
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MKQCXXO/#FN6_A(>+=0N-+\4:'!JGAC_A*/$.L6>CV<_]A_8KS0_L=G4.K?\
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MAO[/?A^2/6-2\4>(H]#;2M&L[GP9#\(OB%>_%32O'FN?&:#X'V/AO5=*M_\
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M>(-/\$_#GPK\9O&/P6@^(7C+Q'I^FC3?#_A^Z\0>#K[^VOM7_(MWG]I6-_\
M;+'2;V\KK;'_ ()R_!K2_#7B?PW9^+/&ECI_BC1/V9-*U7^S;#X>^'[.V_X9
M7^*E]\8O"NI:5H7A_P $Z3X;T?\ X3+Q1JM]_P )I:Z7I-GHXT:?&@V6CWP^
MV5#X:_8>\#_"S1_C-XH\':AXT^-DWQ&^#/Q&^&FB?#3Q#K?@/P_X?O?"_P 1
M?B=\3?C3_8.D^*K?1-)/^E>,/BIXCM;+Q1KVK7GV/PW_ &9_Q^7UI]LK/]__
M %8K_A/_ .HW\0^-'[?_ (3^&/CW6/#_ (;T/_A//#_@7PW\??\ A/[FV2\T
MN\F^(WPDT'X5ZKH?@GP=KEQ_Q3>L:?JE_P#%32=!\3Z]F\L]'UBWN;'_ (_M
M)O;.NST?XO\ [2GA;XC?#OX;_&CP_P#!2.;X[>#_ !O>?#'Q/\-+;QY<:7X&
M^(W@[0;'Q'/X#^(VE>(-;_M+QAH]UH]]]JLO&7A>Z\'_ -L7NAZE8_\ ",>&
M_M=G>5YQ\%?^"=?P_P#"_P $/@;\._BQJFN>--:\!_"'XM> _B*CZQ]HM_B%
MKWQ^&AWWQ-U[7/$G]FVGB6X\06NL:5!=Z+XHTN[T:\^V0_;O^?3['V7@/]B;
M6/"/[07@OX^>)/VH/C9\8)O OA[Q'X8\._#_ .*-G\/=0\'Z#8:YH.E>'/[8
M\.?\(_X;\/:EHWC Z=I5CI>M>*/MEY>>)+."Y^W_ .G7=Y>7E^_Y_@'^S?!
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M]#O+R]U3P+K'AOX?)\,?^$2\'^*M<^*'BWXF:YJ7Q4@\<?#V^\#FV-SI^L>
M[?X5^(_[:TNZM++6+.\L=3L+_P"V7WV.SKT'3_V%?#6C:?>7FA_&+XHZ/\2)
M?C]%^TAI7Q4MK/X>R:YHGQ!G^#_@?X'ZY#!X5N/!%UX)U#POKW@[P/!]MT'5
M/#UY_P 3C5=3OK"]L_LFCV=GYY-_P3!^$<>D:_I>E?$7QY;OXP2PF\=3^*O#
M'P?^*&C^.=9'BKXC^./$6O>*O!WQ(^&_BSPEJ&H>*/&'Q4\1Z_>_9=)L_P#A
M&[R#1/\ A$O['^R?Z8OW_P#5@_X3_P"KGZ(^&_$&G^+/#VA^*-'_ +0.E^(-
M*L-8TU-5TK4]#U1+6^A$\'V[0]8MK34M&U',_P#INF:I:6=Y9WO^@W_%;5>=
M_"+X9:#\%_A=X!^$GA>\UK4/#?P[\,:7X5T2_P#$>I3:QKES8:5#Y$$VJWUP
M/](N!_X!V?\ QXV'^@V=F:]$KH..7]S\?Z_,**** .B\*_\ (>T__>NO_2.>
MO;/X/^ _TKQ/PK_R'M/_ -ZZ_P#2.>O;/X/^ _TKQ\Q_CO\ KN?4\/\ ^Z5O
M^PI?^H>#.+\>_P#(N2?]?%I_Z.2O#:]R\>_\BY)_U\6G_HY*\-K\[X@_W]?]
M@3_]*D:X_P#C+T_R/*[7XV?#.]^)=Y\)+;Q)'+X_LTE>;1_L=Y]G,L$/VZ>S
M@OOLW]F_VA:V_P#I7V7[7]LQ[FOGW]KW]I3Q=^S]>?#.WTG_ (0/P7X6\:S>
M*4\3_&_XN^%OB1XP^%?@.ZTJRL/^$<\-^(['X7W.D:EH^H>,M0OOLMEXHU[Q
M#H_AO1[/2KG[?]LOOL=G7TM;?"OX=VGCNX^)EOX3TF+QY>0RVUSXD2'_ $Q_
M/A\B>;G_ $;[1=6_^B_:OLGVPV?YUYW\6OAY_P )QXT\%S>%_P!H#QQ\$_B5
MIN@^*(=-TWP?J7@[7+?QAX-OIM*_X2,:[\*_B!HGBSPEX@M]!U#^P[JR\8_\
M(]_;'AN\G^PV&M6=CJUY9WGS>3_7X3K?VQ]3_P!\QGU/ZG]<_P!S_P"8/ZY]
M<_YC/^@S_F#/)P'URU;^TOJ?^^8SZG]3^N?[G_S!_7/^HS_H,/$_!W[?OPCG
MB\"Z#\2/[0T3QUK7@GX5>+?'-_\ #?2=>^+/P/\  T7QBU*?1/ ^I7WQP\/Z
M;_PB1\+^,O$$'V71=4NOL?V/S[;^W[+1_P#3,>'_  >_X*6_\)S??"O0-?\
M \FK>-/B1XV\$>#]8\)?#?P9XVN(_AG8>./&'Q^\.:'XPUSQ5J&I:MIOB#3]
M=T_X'WWV+0=+M-'O/#5Y8ZW?:]>WEC>:/9V=SPE_P3ML_#OQ2\7>&X?B1XT\
M-_LYZAX ^!FCP^ --UOP?=ZA\8[_ .&7BGQ5X_\ &,WCC^T/#=WXD\/Z?=>.
M/$<%U>W7@.[\-V>L:/JMSH?^AZ']CLZ] ^'W_!-WX:?"_P 1Z/XL\(_$[XJ6
M_B#0]>^%6O6%Y?IX#U"V\WX5^*OCAXJL;.>PN/"/V:XM_%'_  O[QCH&M?\
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M<'[*]M\=]0^+VE^-O%&H^/\ P%\;/'GQFU[04\3^&[BW\,7_ ,5/ ?A6#2O
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MM/\ ^OZW_P#1UO5T?XU#^NQ4/B^3/IRBBBOTT^F(N[?4_P GK_.E_P"#A_\
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M])8:^;*^D]#_ .0-I7_8.L?_ $EAKZ/AS^)7_KL>EEOQXCU7YLU&Z'Z'^5>
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ML_\ AX!JVB?$SQ=J'B+]JK39/ASX B\2?L]^'4L]2T_4/B%:P?M7>*K+P/\
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M<TNRU3X<ZMXP\8>)/^$.UOQ5H/@RSL;6B-3$_'/!_P#,85&I/_GS_7YGR_\
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M6_B9^U1I?C'P'XC^$D_AOXJ?"OQ!H?A/_A(;CX(^,-<^&6J>"_B-:^"/ ?\
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M_P"$Q^(WB2""#1/^*?UC_AHC0X=!O?B-]K_MCPWXPU74M#L+W1KZ[^QUYO\
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M "Z"SLOKC3?^0EI__7];_P#HZWJG5S3?^0EI_P#U_6__ *.MZX_:<^)HS_[
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MAJ-'$XS^T*_U/_?/J?\ OA\L2_ML_%3X6?M'?M->&_'G@_\ X3CX(:'^T_\
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ML?#<_P *_P#A"?\ B7_V#I_B/^R]:U35/&]G=_;+"VO[#1;S[7BSV[3]BO\
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MXCP)_P @JX_Z_P"3_P!$VM=NGW1^/\S7SV*_WFMZH^[R[_<J'^%_F>-?$?\
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M]+_ACY=^&W_!.;]GKX27?@>X\!ZA\5=%L_!>C^ ]*?2$\9Z;)9^-KKX9:/\
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M]>\.6%Q<_:=0\/W=Q!/]BU3[)97EYY%U_H5'UC&3AS^V)]I6[?U_X"?'</\
MP2L_9;M]3\6:O%>_%R.[\7>"?BAX GV>-M'M_P"Q_#GQ;\5:'XX\5?V5>V_@
MBTU+4-8M?%'AS2M>T7Q1XRU;QAXDL_(^P7]]>:'_ ,2>NTN/^"=7P'GM=;MX
M?$GQDT^X\<0_$'3?BIJNE>/--T_5/C!X7^*GC"_\?^,?!7Q&GM_"7V:X\+ZG
MXPU37-4LK7PO:>#]8T<^(_$ECI^M6=CJUY9U]T175K/)+';W5O-)#_KH89H9
M)(>#_KX,_P LU()[<RR6_P!HMOM%NGG3P^=#]HAB[S3P'BW^O^-1]<Q/_/\
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MX;U234OGO++5=2\5:QH\TI^'$'PDGO!X<U'Q)=Z);ZC=?#>QL?"][JEKI/\
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M5TNRT'QYX>L[/6++^TM<T&]T?7-)LZ]SL?V$?VC)(?$MGXD\#_ W5/B=XR^
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M#Q!=6_Q&\*VEEXRNLZQXDLX+G[?>XTFTK]XJ*?LH=OR_R)CC*T(<A_./I?\
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MPI\2/%6N:A\ ?%GP*_X6#X7UCPKXXM3XH^%_PG\'^,-'\-^(]-US0;T>*O\
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MQ%]9_:[.OC'PU_P42C\1^,/C!X3_ .%9V>EGP+^T)X,^%W@._O\ QG^[\?\
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M %"%Z#Z#^5?Y?'_!)3_E)I^Q'_V730O_ $RZY7^H.O0?0?RK\'\?O^2ER?\
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M  K/_P *4N]$U#POJGC@:J;VZ_X0CQA>Z1>6.F^![_QI]NU:SO*^VF_X*(?
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M^/$>J_-FHW0_0_RKP'6?^0SJ?_7[<_\ HP5[\W0_0_RKP'6?^0SJ?_7[<_\
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M G_(*N/^O^3_ -$VM=NGW1^/\S7SV*_WFMZH^WR[_<J'^%_F>-?$?_D+VO\
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M@^3Q1^S]?ZK\8+'PK\6[SP!X<\/_  DM+:WUFU\#WT%UK6@^,?#WCR[\-_\
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MGA^>^NK[P;I7B&R\-_\ "27USKGV(7U?HQ10J<)]O(*>(KP^!/7T/S;\3_\
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M\%U]ENK2SO/RS5C[?G7O^$;_ +/US^T/[*_MCSCX>U[^PTM?MGV'['_PD?\
M9O\ PC?]L_\ +U_8/]K?VQ]C_P!.^Q?8?],/3]<QG_/[\5_F:^VK>?W,_,?4
M?^"3WP+\1'5-0\<?$+XI_$#Q-JM_XW\0S>)/&UG\*_$'_%9>./CEH?Q^OO%<
M_A74/AO_ ,(3K%Q:^,-#M]+LM!U[P]K'@^\\-W]S8W^BWE\+2\L_7O W[ OP
MS^'R:G<>&_&GCC2=8UCX,^,O@S>:QX;T3X2^"[>'2_'/C:?QQJOB32O"O@?X
M;^'O!.CZ_:ZAY&EV6F6OA[_A#_['L;:QO_#%YB\O+S[P%M<,TD?V>XW0_P"N
MC\F;]S_UWQCT_IGM4<<4DQVQQ22-]_Y$\SZ__JZ=> :R^N8F?_+[_+]"/K%;
MM^)\V_LU?LS^"_V8/#7C#P_X-U34M8_X3KQG=>//$EY>:)X)\'Z?_;T^FZ5H
M8_L/P/\ "_PEX'\ >#].%AI4%U>VOA?PGH]G>:Q]IUR_^V7UW>7E?1U2>3-W
MCE^Y$_W#QYY_<G_/3]:P]1\0Z'I'B'P]X2U35+/3_%'BJ+6;GPWH-S-Y>J:W
M%X=LX+[7)K&QYN;BWTO3YX+J]_Y\_/MJSE*=:?/,GWI^?Y?\/]YL45/]DN_,
M\O[-<>9]_9Y,V_'7&/\ /-,>*2,+YD<D?F9\L.A^;_/>LR2.BJ.L7QT.WL[J
M\T_7)8[[4K#38?[*\/:]X@N?-OIO(@FN(/#^FW=S;Z/:_P#+[KUS]CT?1[/_
M $V_O;.Q_P!,'._$;Q[X3^$OA/4/''Q"U23PWX7TF;2X;_4IM,U+4/)EUS6+
M#0]*_P!!T>VN]2N/M6L:K8VO^B6G_+?_ )\:.6<_@^?_  X'8458^R7@EDMQ
M:W!EC'SQ>3\Z?3U_+WIIMK@1^>+>;R^\WE?N_I_G]: (:*\6\3?M"_!_P=\3
M+7X.^)/%PTOXD7D_PTMK7PW-H/B2XDFE^+>I>,=*^'/_ !-;?1+O1!_;VH>!
M_%5K_P A;_B3_P!E?\3[[']KL_MGN*VET72/[-<>8R!T3R9O,>+J>/P_EZU4
MJ<X?&!7KU'X:?ZS6/]RQ_P#0KNO+J]1^&G^LUC_<L?\ T*[KT\H_Y&5'T_\
M=,WP?^\T?1_^DH]2[K]1_)*\_P#'_P#J],_Z[W/_ *3BO0.Z_4?R2O/_ !__
M *O3/^N]S_Z3BOT7!_[S2]?T1VYI_N%?_MW_ -/Q/-****]X^+"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH Z+PK_R'M/\ ]ZZ_](YZ]L_@_P"
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M!'_):XG_ +)K,/\ U.R@_+?%O_DF:/\ V-\+_P"HF,/Q&HHHK^O#^<3]$/\
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M4 %%%% !1110 4444 %%%% '1>%?^0]I_P#O77_I'/7MG\'_  '^E>)^%?\
MD/:?_O77_I'/7MG\'_ ?Z5X^8_QW_7<^IX?_ -TK?]A2_P#4/!G%^/?^1<D_
MZ^+3_P!')7AM>Y>/?^1<D_Z^+3_T<E>&U^=\0?[^O^P)_P#I4C7'_P 9>G^0
M5\[_ !H_:,T?X-^(_!?@N'X<_%CXN>./'&F^*/$.G>#/@_X>T'Q!XDLO!W@[
M^RH/%7C"^L?$'B3PG;7&GZ7<:YI5I_9>@W>L>,-8O+X6.@^&-8OO]#KZ(KP/
MXR?LY^"?C9K'A'Q)K7B3XF>!_%G@NP\1Z)H_C#X2>/+SX?\ BAO"_C&&Q@\5
M>%;[7=/MKNZ_X1_7_P"RK"ZO?[+_ +'UBRO+&VOM!UK1[[_3*\>C['G_ 'OE
M8XZ?L^=<_;\/,^<?%_\ P4G^"'@CP_XL\;:[X(^-"_#G0[;XTIX2^(MMX8\*
MW'AOXKZ]^ST-5_X6IX6^'-B?&W_"6_\ "0:!_P (YXC_ +$_X3SP]X#\-^)/
M^$<UO^P=:UC[(*S?%G_!33X/^!8KRS\6?#/XV>'_ !II_P 2/^%::KX UNS^
M$ND:YINLS_#?2OBWH=Y/XCUCXQVGPN-OXR\#ZYI5UX+T&V^(5YX\\2:Q/_PB
MUAX8_P"$JM+W1[/L?$/_  3J_9R\4Z9XI\-ZXWQ0O/!/B*V^*J:3\/'^(MY_
MPA?P]U3XX?;O^%J>)/ASI7]G?VEX?\4>,O[5U7[9JFJ:MXDL]'_MS6_[!L]'
M_M:\^V=7X[_8D^$?CZ_^)&J7'B3XN>&;SXN:KHVJ_$)/!_CV'3]+\21:%\,=
M*^$D&CWWAS6-$\0^&[C1[KP?H5C_ ,?6DWNL:/K'VG7-!UK1[Z[KMYLM_P"H
MS[G_ )&W^R_U8\-\+_\ !1634/B_X^^%.N?L\_%R2ZM_C?KWPQ^%USX8?X5R
M?V]X7\'? ?X9?&GQ5XP\8_\ "0_%KP]<^%O[+T?Q_P#VI_9?V3[9>://X;L?
M[%_X3G_A)/#>C]M)_P %&_@=_P (_P##_7+/PS\5-3O/BI\'/@9\8_AUX5L_
M#WA7_A)/%5K^T9X\_P"%9?#+P'8P7'C:TTVW^(&I^*!_IMKJFK6?@_1[+_3K
M[Q/]AM+S['W'@O\ 85_9_P#A_P#$;2_B5X7L_&EG?:'<W5YH_A6?Q;->>!["
M_P!5^#_@WX$:K>0:'<:;_:1N-4^&_@#PKIE[]JU:\L_MFE&^L+*SOKN\^V>?
MZ)_P3/\ V;]!TZ/3;?5OC1>'2?!_PT\!^ [_ %7XE_VCJGPH\.?!;QY/\3?A
M)#\,K[^Q/^*?N/ ?BB?_ (DNJ:G_ &Q>7FCP6UCKW]L6./MBY\N[8S[O^ '^
MR_U8X/Q%_P %";[P_P#%/QAX3\<?!_XJ?!/X?^#_  9^S)XJO/&'C/PQX#U#
MQ19ZI\</B#\5/!VN>&_%7@ZW^*)N='T>UM_AQ/:V7BC0;3Q)_P @KQ;KMA_;
M&AW?@.\\8=U/_P %&_A?9VWA7^TOA'^T!I.M_$J'X?:K\'_!]]X5\!_\)1\6
MO"7Q-\50>!_"OC#PK!;_ !(N]-T?1_\ A(+[2CK6E^/-6\'^+_#=GJNFWVO>
M&+.Q^V?8^VUG]@SX'^)M1BU/Q;K'Q>\87EQH7PZT#Q._BWXEWGB#_A/XOA7X
M\\8_$;P/>>.)]0TV[N=0U#2_$'C_ ,8VO_$KN]'T?_A&]<N=#_L6SL;31_L<
M?A[]@7X#Z#J/@[6+G4/BIXKU'X;W/P^3X:7GC;XA7GB"X^'OA?X9>*H/&/@[
MX>^%9_[-M/L_@>UU^"QNKVUU3^V/$FL6=CIMC?\ B>\^R6=5[3+>3W_Z_KU#
M_9?ZL>N_"WQI\._VD?"_A7XI+X%O+/5/ /CSQE8:5I7Q"T303XS^%WQ+\*_\
M)'\./&,,%QH^I>(=$T_6;73]5\1Z#_:GA?Q#K%GK'AO7+G[!>WEC=U[O7GOP
MU^&'A/X3Z-KF@^#X]2CT[Q!XZ\9?$+4DU74/[0N'\1^/]8GUSQ'Y$XMK/[/I
M_P#:$Y^PVO\ RYV>>*]"KAJ<G/[G\ PEO[F_S_X<****S$%%%% !1110 5<T
MW_D):?\ ]?UO_P"CK>J=7--_Y"6G_P#7];_^CK>KH_QJ']=BH?%\F?3E%%%?
MII],1=V^I_D]?YTO_!P__P I3OB__P!D\^"7_JO[.O\ 1:[M]3_)Z_SI?^#A
M_P#Y2G?%_P#[)Y\$O_5?V=?LG@1_R6N)_P"R:S#_ -3LH/RWQ;_Y)FC_ -C?
M"_\ J)C#\1J***_KP_G$_1#_ ()*?\I-/V(_^RZ:%_Z9=<K_ %!UZ#Z#^5?Y
M?'_!)3_E)I^Q'_V730O_ $RZY7^H.O0?0?RK^4_'[_DI<G_[$7_O0QA_0GA!
M_P B+,O^QN__ %!P9\L445'))'#'+)))'&D:2O,[OY<:10?Z^:?^?^>/X[/M
M"2OFOQ%^RW\+SJ'C[QU\/_"/@_PG\8/&FE>,K:S\;>(=-\5>-/"^CZ]X_P!'
M_P"$<\4^)/\ A67_  FWA[PE_:&O:/\ Z+XGNM!'@_6/$EI_H6O:U>6-W>6=
MY[QX?\4>&?%ME)J7A7Q!HOB33X[F6SFO]!U*SU2S2Z@!,\,\^GW/_'Q[]:^1
MT_;,M]1^,_CGX5^%OA#XL\8:;\+_ (H^'/A%\0O$GA[Q)X;O/&/AWQ'XCM-#
MG_X2J#X+?\C_ *Q\+]!_X2/2KK6OB-:_Z'9V9U+7+"RO-#TF\O*TP=2>)A[;
M!UOK% K#R]M#GH_U_EN:'A']A#]F7PW\+/@Q\*=5^&VE^)-'^"/@"U^'/AB\
MFN=>\/\ ]I>'/.L=5U73?$=CX7UO2=-\4>']>\06,&O7O@WQ1:>)/#7VS_ER
MO.E=CKO['?[,_B5;S^V/A'H\W]I^)_%OC"_^QZ]XVT/[3KWC_P C_A.//_X1
M_P 2:3CP_P",O(@NO$_@W_D3_$EY_I^O:+>7UW>7E)I_[9/[(^K221Z7^TU\
M"=2DCU71M!=+#XH^#[C_ (G/B.\GLM#TW-OJ1/VC5-0L;[2[+_G\O(+FQ_X_
MNO)_&+]N;]GGX3^#/C)KVG_$#P7\3O&7P/\ #&L^*O&/PE\#>.?"MQ\0$M=#
MUBQT+7(?[*_M+.GW&EZA?06NM_:O^0/>?Z#?_8[ZNC_;YS_YC/Z_KRW-/]IY
M_G_7S_ ];M?V>O@A8W]GJEG\,_#-GJ&F^,->^(6FS6T-Y;_8/&7BKP'??#'7
M->L8+>Y^RV]QJGP^U6^\+_9K6T^QV>CS_P"@65G_ ,?E>@^$/"/AGX?^%?#O
M@?P7H]GX=\(^$='L/#WAO0;#SO[/T?1M*@\BQTVQ^T7-W<_9[6W@^R_Z7=\5
M\SZW^VK\(_!GP)\:?M"?$3^T/ _@/P/\5_$_PCU)]2N=-N+RYU[PY\2/^%8P
M7D'^DVEL-/U/6/\ B:?Z5>?;+/1_M/V__CTKTQ_VG?V;UO\ QIIO_"_/@_\
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MSO(/^$J^VWGBO5M8JY!_P3H^*'AGQ!KG@_P#X7^&7A_P])K'['EY\/?VEO\
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M?VQK'_']?_Z=Q7NFF_\ (2T__K^M_P#T=;UPT_\ >?<_Z#/Z_P"!_P ,8_\
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M2I]*O=+^U_;+S6)_MWVT?\>=>3?%;_@EQ^T!\9-;\37WC3]J#POJFGW'@_\
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MO_9W_;9_: ^&^@?!'X2^%X_":Z':Z)X#O/#VB>-M2^&.GZA\;)?B;^T)X_\
M#GC@0>(_B!\4?#WQ(N#X,T>Q@TO1;7X-_#WXD7EEXC_Y&W['H=W9U[)XX_;F
M_:K\ _";X8_&#7/C!\)8]*^(%Y\9->O_  K#\.OA[9^,-*TOX8_$[5? ^AZ#
MX.\'>,/B1X(_X7!;ZIH^E?:O$^E^#?&]G\8+S6+ZV_X0/PQK%C_H8Y99764^
M0Q^JS_K_ (8_>RBJMC=QZA8V>H1QW$<>H6=K>0PWEM-97$,5]#!/!#/8W/\
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M !1110 5ZC\-/]9K'^Y8_P#H5W7EU>H_#3_6:Q_N6/\ Z%=UZN4?\C*CZ?\
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MX2/P!IL%]J&MVGB/4+C7M/S:WNJ>%_"?B3PWX;UB>VT/7M:T>^_T*E]3Q/\
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M/NC\?YFOGL5_O-;U1]WEW^Y4/\+_ #/&OB/_ ,A>U_[!T7_I7/7GU>@_$?\
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M%=G]N\.?\(KX.\/^&]5\;>(+C5-/\_5/LNE>'KV\L[."YOK^RL[&TO#7E?\
MPW;^S+%=>'[R;XN>$[SPKXXL_"/_  KV;PWH_P 3O%GCCQ7K/BJ;QQ]BT>#P
M!X>^&]WJ5O<?\6X\56MGI=K=WGB,ZQX<UO0]=\,>&[^TM/MGE?A3]D3XJ7G[
M#_[+/[.]Y\8-4^$_CSX0^!OAS8>/+_P];:QK.A^+;_PYX5GTK7/"NMP>#_&W
MPRUNXT?^T+[^U/\ B0^-]'L_[8L;;_D,:$/L=YY_\"_^"76D_!'Q-^S_ .(K
M?XX:UXH_X4'XPL/%5A;7G@.STZX\3_8-2_::OQ97U]_PEMW_ &=<7?\ PTG?
M'^U+6TN_^15MO]!_XFUY]CSC3P')6YZW[\FV&_Y^_@:GP2_X*<^ _B7KNM2>
M.O#-G\*_AV='\9ZWX,\6ZE?_ !"O/%'B3_A&_C!8_!;0_#=Q\.-8^$OA/Q)<
M>./&7B">>ZT7POX#_P"$]O/^/;0_MMYKAUBST?Z?'[;'[*/]B1^(Y/CAX3M]
M'DU+P;H_VF_MO$FGR6VL^/\ QMJOPR\*Z#?6.H:)9ZCI_B"Z^(&AZYX-O=!U
M2TL]8\-ZQI5S8^+;+1^:^9C_ ,$V+>SUSX;^--!^.&I:7XY^#^H:SXA^'NL7
MGP]L]8T>V\6WWQXU7XX07GB/PY_PEMI_PD'A^U_MR^\&WN@VNK>&[R\LI_[<
ML/$^CWU<G\1?^"4/A7XJ0Z5?>,OC5XBD\77EY^T/XG^(7B'1/!FFZ%9^,_B-
M\</[5OO#GC#2M"M_$EV?"]O\$?%&J_\ "4?#[0;K5O$EY]LL;87_ (GO+Z[O
M-8N]JE/*IS]RM]7-/]E\_P 3]0O"'C;PGX^TN\UOP7KEGXBT>Q\0^(_"MS?V
M"3?9T\1^#M9OO#?B/31/<6UI]HN-!\06-]I=[=6O^A_;+*X_TVNTTW_D):?_
M -?UO_Z.MZ\?^!OPIL?@=\'_ (=_"/3]8U#Q)'X#\,6NCWGB?588;;5?%6O3
MSSZKXC\8ZK!;_P"C0:CXH\47VJ^*+VUM?^7S5;G'VS->P:;_ ,A+3_\ K^M_
M_1UO7#'D^L^YO]<_RO\ @8?;]SY?TOZOL?3E%%%?I!](1=V^I_D]?YTO_!P_
M_P I3OB__P!D\^"7_JO[.O\ 1:[M]3_)Z_SI?^#A_P#Y2G?%_P#[)Y\$O_5?
MV=?LG@1_R6N)_P"R:S#_ -3LH/RWQ;_Y)FC_ -C?"_\ J)C#\1J***_KP_G$
M_1#_ ()*?\I-/V(_^RZ:%_Z9=<K_ %!UZ#Z#^5?Y?'_!)3_E)I^Q'_V730O_
M $RZY7^H.O0?0?RK^4_'[_DI<G_[$7_O0QA_0GA!_P B+,O^QN__ %!P9\L5
M'/!;W4%Q:W4,=Q;W$,UM<VTR>9;SQ3_N)X9[<Y/V>ZX_K4E%?QV?:')^$? W
M@_P#IUQI?@OPWH_A?3[J\EO[FST>SALX[F[GS^_G]O\ #I7S/XQ_8H^'?BCQ
M3K'Q T?X@?&+X9_$35OB+XM^)">/_AUXG\-:7XET>_\ '_@G0_ASXQ\-Z'_P
MD'@GQ#ID'A?7O#_AS0[K[+=Z3>^(]'UC2M-US0?$^CZY:6=Y9_8E%&%C#!P]
MC@_]GH?] >#)HQAAH<E'_9Z']?UJ?'?A/]A_X/\ @GXTR?&[0=4\:1ZY<>)Y
M?'-_H-Y+X)U#3]5\>7V@P>'-5\8:KXQO_!-W\8]0U#7K?_B::UH-U\3;SP?>
M>))[G7/^$8^W7='B[]B7X7^.OB;XL^(7BKQ7\4M8T/QYXS\!_$7QG\&;GQ#X
M;_X4_P"(?&_PQT>#2O &O7VE?\(E_P );;W&@_8;'5/[+TOQO9Z/K&L6.FW^
MO66L?V39_8_L2BNCZQB>?G]LOO-O:S[_ )_YGP;I7_!._P""EMI^GZ'XD\7?
M&#XB>%=%\)>%_A=HGA+QMXNT&Y\/Z5\$?"NL0>)+'X&^1X?\$^'M2UCX;ZIK
M%CH=UXG_ .$HU;6/'GB2S\.:'H>O>-+S0[0Z/=^]:E^SUX/UGP#\*_AWK.O>
M.-4T?X/^._!'Q#\):EJ6N6=YX@N=4^'-Y?7'A73=<U6XT3_B<:/:V]]_9=[_
M *+9ZQ>6=C;?;]:^W?;+R\]XHH^L5Y_'6#VL^_Y_YGY^Z[_P3:_9_P!:\13>
M++?5/B!H?B+4-;\;ZKXAUBPF^&^J:AXAL/'_ ,2-5^*NJ^&Y[[QA\-_%ESX7
MT[2_%&N:K_8NO?#FZ\'_ !(T?1[ZYL?^$T_Y?*YV/_@EK^SROB[Q)XRD\6?&
M2YU+Q%H_Q?T'R;GQ#X)_XE6C?&FS\CQ59PZK_P *W_X2WQ!_9=S]@U3P7JGC
MSQ#XPUCPW]AMK'[;>:']MT>\_22BJ^N8F'_+[\5_7YA[:O\ U_PQ\J?&C]D+
MX=_'?0_A;9^-?$'BW_A*/@_87]AX2^(MMIOPKUCQ0\6N:#!X<\1_VYH?CCX;
M^+/A=J']O:?8P7-Z?^%>V?\ 8^L06U]X2'AR^K&A_8=^"HU&UU:\O/B!K&H6
M7@RU^&,=YK'BW[9(_P )?^$/O_!^J_"6>#^S?LUQX'\4?VK/XI\3VMU:?VQ>
M>//[-\5?VU9WVDZ/]C^Q**F.(K0]R%8/:S[_ )_YGQAX-_8A\!>$]4^&>KZC
M\5/CQ\0+KX/Z)XM\*_#J'Q_XS\-ZII_AOPEXQ^%<_P '9_#=CI6C^"O#VF_V
M?I?@Z?\ T+4_LG_"1ZQK$%MKGBW6O$M[7C^D_P#!*G]G?1M<^%^M6OC#XT2?
M\*?A^!B>#M,O_$G@/4+>&Z_9Z\-:'X.\'2SZK<_#?_A+;>WU3P_H<%KXT\+Z
M7XAT?P?K%Y?:EKEAX8T?7+O^V!^E]%'US$P^"M^0>VK_ -?\,?FS\4/V#-%T
MGP?\*+KX(1^*-2^(GP+\'_"_X;_#34M8^*FF_#_6/#WA?X<^/-6\96/BK0_%
M0^$OQ"T3_A9%K<:YJNE?\51X(\2> _$FCWUSH>O^&/L-W]LKA?A#_P $P?"<
M'@#P7<?&KQ5XDNOC!;W_ ,5;SQYXA\-WGP]\42>*M!^*?QS\8_'#_A#]5\5>
M./A+JVI?:-!UCQCJMJ?'GPOTGX5^)+S[=K?V"]T>QN_L=G^L%%:?7L3R<GMO
MS+]O/DY.AYG\*?A1X7^#NA^)/#_A.;6+C3_%/Q(^(/Q1U+^V[R&\N(?$?Q-\
M27WBGQ'!8SV]M:?9]'M=0OI_[%M;K[9>6=G]E^WWMY_Q^5Z9117&Y3E[\_Z_
MKL8!7TGH?_(&TK_L'6/_ *2PU\V5])Z'_P @;2O^P=8_^DL-?1\.?Q*_]=CT
MLM^/$>J_-FHW0_0_RKP'6?\ D,ZG_P!?MS_Z,%>_-T/T/\J\!UG_ )#.I_\
M7[<_^C!7WF7?'6_PO]#DS_\ @T_^WC.HHHKV3Y@**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#U?P)_R"KC_ *_Y/_1-K7;I]T?C_,UQ'@3_ )!5
MQ_U_R?\ HFUKMT^Z/Q_F:^>Q7^\UO5'W>7?[E0_PO\SQKXC_ /(7M?\ L'1?
M^E<]>?5Z#\1_^0O:_P#8.B_]*YZ\^K\XS7_?\9Z+\D>9B_\ >JW_ &[^2"BB
MBO/.<**** "BBB@ HHHH **** "BBB@ HHHH **** "O4?AI_K-8_P!RQ_\
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MHH Z+PK_ ,A[3_\ >NO_ $CGKVS^#_@/]*\3\*_\A[3_ />NO_2.>O;/X/\
M@/\ 2O'S'^._Z[GU/#_^Z5O^PI?^H>#.+\>_\BY)_P!?%I_Z.2O#:]R\>_\
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M8XC%/%R^LRYFI-6LG9?CJ]SQ3_A7NO?\]-._\"+C_P"0Z/\ A7NO?\]-._\
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M+1_PA&M_W]._\"I?_D6O7<+Z+_WV?\*,+Z+_ -]G_"CZ]B?YH_U\P_L3 _\
M43_X$_\ Y$\B_P"$(UO^_IW_ (%2_P#R+1_PA&M_W]._\"I?_D6O7<+Z+_WV
M?\*,+Z+_ -]G_"CZ]B?YH_U\P_L3 _\ 43_X$_\ Y$\B_P"$(UO^_IW_ (%2
M_P#R+1_PA&M_W]._\"I?_D6O7<+Z+_WV?\*,+Z+_ -]G_"CZ]B?YH_U\P_L3
M _\ 43_X$_\ Y$\B_P"$(UO^_IW_ (%2_P#R+1_PA&M_W]._\"I?_D6O7<+Z
M+_WV?\*,+Z+_ -]G_"CZ]B?YH_U\P_L3 _\ 43_X$_\ Y$\B_P"$(UO^_IW_
M (%2_P#R+1_PA&M_W]._\"I?_D6O7<+Z+_WV?\*,+Z+_ -]G_"CZ]B?YH_U\
MP_L3 _\ 43_X$_\ Y$\B_P"$(UO^_IW_ (%2_P#R+1_PA&M_W]._\"I?_D6O
M7<+Z+_WV?\*,+Z+_ -]G_"CZ]B?YH_U\P_L3 _\ 43_X$_\ Y$YKPSI=SI&G
MRP7?EF22[DE7RF+H$,4*+]X _P#+)@01W'%=*@QN_+^=/(!Z_6@ #I]:Y*DY
M5)N<MWJSUJ5*-&FJ4-DG^/XGF_BSPOJ>M7T%Q9FS2*.T$+_:)9D_>"6:4$!;
M=^HE'?)(P0,'',#X?:\>DFG?^!%Q_P#(=>X4AQCDX_'%>1B,HPF)J^VJ1U\G
MH9U,)1J3]I--O^O7\#Q'_A7NO?\ /33O_ BX_P#D.C_A7NO?\]-._P# BX_^
M0Z]LV#U/Z?X4;!ZG]/\ "N?^P\#WQ/\ X$_\B/[/PW\C^_\ X!XG_P *]U[_
M )Z:=_X$7'_R'1_PKW7O^>FG?^!%Q_\ (=>V;!ZG]/\ "C8/4_I_A1_8>![X
MG_P)_P"0?V?AOY']_P#P#Q/_ (5[KW_/33O_  (N/_D.C_A7NO?\]-._\"+C
M_P"0Z]LV#U/Z?X4;!ZG]/\*/[#P/?$_^!/\ R#^S\-_(_O\ ^ >)_P#"O=>_
MYZ:=_P"!%Q_\AT?\*]U[_GIIW_@1<?\ R'7MFP>I_3_"C8/4_I_A1_8>![XG
M_P "?^0?V?AOY']__ /$_P#A7NO?\]-._P# BX_^0Z/^%>Z]_P ]-._\"+C_
M .0Z]LV#U/Z?X4;!ZG]/\*/[#P/?$_\ @3_R#^S\-_(_O_X!XG_PKW7O^>FG
M?^!%Q_\ (='_  KW7O\ GIIW_@1<?_(=>V;!ZG]/\*-@]3^G^%']AX'OB?\
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MUZ[A?1?^^S_A1A?1?^^S_A1]>Q/\T?Z^8?V)@?\ J)_\"?\ \B>1?\(1K?\
M?T[_ ,"I?_D6C_A"-;_OZ=_X%2__ "+7KN%]%_[[/^%&%]%_[[/^%'U[$_S1
M_KYA_8F!_P"HG_P)_P#R)Y%_PA&M_P!_3O\ P*E_^1:/^$(UO^_IW_@5+_\
M(M>NX7T7_OL_X487T7_OL_X4?7L3_-'^OF']B8'_ *B?_ G_ /(GD7_"$:W_
M ']._P# J7_Y%H_X0C6_[^G?^!4O_P BUZ[A?1?^^S_A1A?1?^^S_A1]>Q/\
MT?Z^8?V)@?\ J)_\"?\ \B><:'X5U.PU.TO)VLS# )0XBEF>3)AF@&-ULN>H
MR,C/(X/%>E%00!SQ3 K=V_F?T/%2#ZY_S^E<]:M.M/GFUM_7R^9Z6%PE'"0]
MG25EYG,>*-,N=9TA[.T\H3-)"P,S%5Q#+N.2 3R0,?\ ZJ\W'P^UX])--_\
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M:=_X$7'_ ,AU[9L'J?T_PHV#U/Z?X4?V'@>^)_\  G_D']GX;^1_?_P#Q/\
MX5[KW_/33O\ P(N/_D.C_A7NO?\ /33O_ BX_P#D.O;-@]3^G^%&P>I_3_"C
M^P\#WQ/_ ($_\@_L_#?R/[_^ >)_\*]U[_GIIW_@1<?_ "'1_P *]U[_ )Z:
M=_X$7'_R'7MFP>I_3_"C8/4_I_A1_8>![XG_ ,"?^0?V?AOY']__  #Q/_A7
MNO?\]-._\"+C_P"0Z/\ A7NO?\]-._\  BX_^0Z]LV#U/Z?X4;!ZG]/\*/[#
MP/?$_P#@3_R#^S\-_(_O_P" >)_\*]U[_GIIW_@1<?\ R'1_PKW7O^>FG?\
M@1<?_(=>V;!ZG]/\*-@]3^G^%']AX'OB?_ G_D']GX;^1_?_ , \3_X5[KW_
M #TT[_P(N/\ Y#JU9^ ];@N[.XDDL/+M[JVF8+<3C]U!/Y^!NM@,D^_XXS7L
M>$'''XX_K2E5/8?R_E51R3!0GSKZS?MS.WWV']1H=G]__ %HHHKVSL"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
JHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_003.jpg
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" (. TP# 2(  A$! Q$!_\0
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M#SE55<9PHVN[=R$C68RL996^598X#)LC>>=/*W1XW:.1&1T.UT=2KJPZAE8
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M',(2<)SC5PD:&%E*56HH4G4J850BJRC;^YVBBBOY=/Z#"BBB@ HHHH ****
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MFO[N769?B[I>J2:G)-(]])J+:;9WC7[W#$RM=/=$W+3EC(TY,S,9"6/]-_\
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MNR(64 E5)P)***]LY0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFAC+!]0\*?!O2]+DCTN<9"M9S>+/'?AK5R,,RWGA^S;*#[_\1G[(O[-WB_\
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MKI>D>*3);>-= 6UTEET_2GT3Q-#I5I%Y#'2[RU@@MA],_LE?LO\ CO\ 8J^
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M0QS/"'D\IY40.T8=]C,5W-C)Q;;U9Y4G*3YI-MMO5^6MEV2NM%MH?T!^/O\
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MWAJ*&+4_#-SJ :,Z*>G:R_KU?W E%K5O\O\ ,^R/@?\ '7X3_MQ?#KQ!XU\
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MC?@=X&T32? GC2?SK_PU<3+H6BV7B;P3XL^Q027EUX8U2]TJ.?3]:L+>74M
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M(>)@9?$>O21@R1R:QJ+QR(-Z.CW<S(Z.N5964AE920P(()!K_9?\)_ WX*>
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M_P %0[]5"+^R1^T0$"[0@O-&"A0,!=HMMH '&T< <#BG?\/1M1_Z-*_:)_\
M [2/_D:N>G1JP=1SG5J.I4<XJ3I1C2A9*%&G&'*N2"3?/+FJ5)2<YM-1BO7S
M+&8;&T\LIX/)<ORB.7Y91P6)E@Y8VO6S?'*MB*^,SK,:^/Q-:;QF,G5I4X87
M"PPV79=A,+2PF HRIU*]:>SX0^(/[ ?B_P"'W[1MC^R1I7P,T_QK:_L__$6[
M\52?"SX,6_PTUF3PJ?#VJ111ZEJ\/@#PDVHZ8-6>V8::;ZZ N_*NOLF8O.3[
M6_8M_P"32?V<O^R.^ __ $P6=?FW\2?^"CNN>./AWX\\%Z?^R?\ 'F#4/%W@
MWQ/X7L;O5KO3I-.LKKQ#HE]HT5]>);6,]R\%I]M,[QV\332K&8D*;RZ_IO\
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MX[?]',SWJO\ =\AM=:-7_P!7;73T:O=/1I/0_6?_ (>M^._^B;>$O^^M8_\
MEU1_P];\=_\ 1-O"7_?6L?\ RZK\F**/^(?\&?\ 1/X/_P &8W_YN#_B97QW
M_P"CEY[_ .$V0_\ T.GZS_\ #UOQW_T3;PE_WUK'_P NJ/\ AZWX[_Z)MX2_
M[ZUC_P"75?DQ11_Q#_@S_HG\'_X,QO\ \W!_Q,KX[_\ 1R\]_P#";(?_ *'3
M]9_^'K?CO_HFWA+_ +ZUC_Y=4?\ #UOQW_T3;PE_WUK'_P NJ_)BBC_B'_!G
M_1/X/_P9C?\ YN#_ (F5\=_^CEY[_P"$V0__ $.GZS_\/6_'?_1-O"7_ 'UK
M'_RZK]#OV0_VBM8_:1\$^(O%6LZ%IF@3:+XB&B16^F-=&.9/[/MKTRR"ZNKM
M@P-P%!6100""@(W-_,57[S?\$K/^2.>//^R@'_TPZ77Q/B%PCPWE'"^*QV6Y
M3A\)BZ>+R^G"O3GB93C"MB9PJ12JXJK"TXI1=X-V6C3U/W[Z,OC5XJ<:^+N3
M\/\ %7&N:YWDN(R;B;$U\OQ='*84:E?!951KX2I*6$R?!UU*A6E*I!1KQBV_
M?C./NK]0J***_GX_TQ"OS@_:U_;=\3_LY_$NP\"Z1X0T'7;2\\(Z3XD-[J3:
M@+A9M1U/7K"2W M;^TC$4:Z1&Z'8S%I7W-@*!^C]?S^?\%1_^3AM#_[)9X8_
M]2+QM7W7AUE>7YQQ-3P69X6GC,++ 9A5=&JZD8NI1IT)4YWI5:4[P<I->_;5
MW3TM_.OTI.,.)N!O"?$9]PEG&)R+.(<2\-8*./PD,+.M'"XW$YE#%45'&83&
MT>6M"C2C-N@YI07).#NWZ%_P];\=_P#1-O"7_?6L?_+JC_AZWX[_ .B;>$O^
M^M8_^75?DQ17[[_Q#_@S_HG\'_X,QO\ \W'^;7_$ROCO_P!'+SW_ ,)LA_\
MH=/UG_X>M^._^B;>$O\ OK6/_EU1_P /6_'?_1-O"7_?6L?_ "ZK\F**/^(?
M\&?]$_@__!F-_P#FX/\ B97QW_Z.7GO_ (39#_\ 0Z?K/_P];\=_]$V\)?\
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M $3;PE_WUK'_ ,NJ/^'K?CO_ *)MX2_[ZUC_ .75?DQ11_Q#_@S_ *)_!_\
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M!_\ @S&__-QYG_$ROCO_ -'+SW_PFR'_ .AT_6?_ (>M^._^B;>$O^^M8_\
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MH_XA_P &?]$_@_\ P9C?_FX/^)E?'?\ Z.7GO_A-D/\ ]#I^L_\ P];\=_\
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M2RSAF,.,/[.\-.%N"\%A>*W6K8VEEV$R7/N':_$>!J8*CFN(5/,L0\MJY3Q
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M/^QFL?\ T='7]0E?R]_L7?\ )S'PH_[&:Q_]'1U_4)7\[>,G_(\RC_L3R_\
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M.E63]G5^OO!U*^#J_?Y7XW\)T:>-Q&:U^-,QQN9>'W"/!V)P=7"X*KED%DG
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M[<2S/%;V\47RF%X3S&&,Q='#RIX2&#]AA<-GE2>*CF-:A#@ZED[HX>C%NC+
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M:\(VTNB:%-J6CWOAC4HM7T!(]:FT^34Y[+2M0@MIK:QN;B6V*6MM;3I-:0I
M.? <&YCA:>%=6&5U*E',,=B8TXUJD:>&AC^&GD]2IAG3P5&"JTLPA''JG"C%
MU8U>:KBJN+IUL1B?2XC\=.%\VQ6;K!5^,,-AL?PUP]E%3$5,%AJF*S:OPUXL
M1XXPV&S6.*X@QN(G@\9PQ7J\.3Q-;&U5@ZN%]EA,HP>28K 99E'Z"ZT4^&_B
M']O[XV^ M T:_P#BM\/?B-X1\/>$[FXT*TUE?A_X9UVVT4ZSXHTO1I();2*=
MTDO6DOGMFC@31F,Y:R_M&"XI:+.WQ1;]@SXW_$/1M)M_BOXQ^-VI>$=;U6'1
M+/1Y/B1X-TAM5?3/$NK:7;P6]C>R6SVME%%J$%HEO*FIN8=MI/:0Q?GUX>_:
M$^,GA7XC:[\6-"\;WUEXZ\4O(WBC4_L>ERV'B1)4B1[?6]!>R_L.]MAY$310
MM8(+:1/,MC"[R,YXG_:$^,7C'X@>'/B?XA\:W=YXR\'2VTOA&\CL-*M=,\,&
MTP84T3P]!9+H5G$7 >=#82&[<(;MIQ%$$Z%PEF:DE[7 NHL'"E_:?M\9]>5.
M/"\LC>2JG[/D_LN6/?\ :+J^T6EYO"/'\N)7F2\:.%'"<E@^(5A)9[6QG^J?
M]GY'_J_+$U/%^EXA0X]EB5B/K"XOI<.0?"\<&L*_>Y:$<[CPXZF5R_1/Q'\1
M-;^(_@__ (*'_#?Q+IWA<^"OA.-1U3X=Z)I?AK2-(3PQJ6G^*_$D1U*UNM/M
MH+NYU"_O-(M]7O[V^FN;B749KP1R16-S)9G\AJ]*A^,'Q(@;XG/%XGG5OC,E
MPGQ,;[#I3'Q4MW>7U_<"XW6+?8/,N]2OIB=(^P$?:&12L:HB^:U])P_DTLEC
MCJ?[B-'$SRVK3IX=U.6-7#Y-@<#CJLE/15,5CL-6Q,IIN593C5K/VSDE^6^)
M/'=+CNKD&*;S"KC<JH<4X/$XK,HX;VU7!9CQWQ%Q!P]A*4\.[O#9/P_FN"RJ
MG0G&%+!/#U,'@8_4:=*4RBBBOH3\S"BBB@ HHHH U]!BT*?6M,A\47VJZ9X=
MENT36=0T/3[75=9L[$JWF3Z9IE[>Z;:7UVK; EO<7]I$REB9E*@'V[_A'_V4
M?^BI_'W_ ,-!X&_^>;7SU17'B<)/$2C*..Q^%48\KAA*M"G"3O?FFJN"Q3<_
MLW4XKE27+?WG[669Q1RVE5I5<@X=S=U*BJ*MG."S#%5Z*4%#V5&>#X@R>$:+
M:]HXSHUINHW)5E%JFOH7_A'_ -E'_HJ?Q]_\-!X&_P#GFT?\(_\ LH_]%3^/
MO_AH/ W_ ,\VOGJFNRQI)(YVI%%)-(V"=L<,;22-@ D[41C@ DXP 20*Y_[-
MJ_\ 0XSG_P *<'_\Z#T_]:,*]%P3P+=V2_X2,[W;22_Y+?JVE\SZ'_X1_P#9
M1_Z*G\??_#0>!O\ YYM'_"/_ +*/_14_C[_X:#P-_P#/-K\T-5_;;_9BT3PC
MI/CO5?B4UEX4USX9^#_C%INK2>$O&,@F^'/CWX@1?"[PKXB>S@T*:_A_M+QS
M/%HSZ7+:KJ]DK'4+RQAT\?::W+O]JGX12_L[_$3]IGPIJ6K>-/ 'PVT+QOJ>
MO:=IF@:YI7C"WUKP&DT>M>#-5\*:_ING>(?#'B6"_6WM;ZT\1:58?V19WD6N
MZD(=%5[T<"G@9.:CQ/CIRIX:IC)QAF.7SG'"TJ?MJF(Y(95*;I0I-3<HQE[L
MHM)J2O\ 12H<0P6'E5\)<@HT\7FF&R3#UJ_"W$N'H5<WQF*>"PV6K$5^-*5"
M&,K8M3P\*-2K2?M:=6$IQE2J*/Z)_P#"/_LH_P#14_C[_P"&@\#?_/-H_P"$
M?_91_P"BI_'W_P -!X&_^>;7Y@^"_P!N3]FWQCJWPT\*'QW)H?CKXF:+X%O+
M'PUJWA7QO96F@>)?B%H7]N^&? 'B?Q5?>&;+PUX<\;:[:I/+X9\-^(M1TC6_
M$U@++4]+TV2UU33S/ZWXI^/'PL\&_$CPY\(]?U_4T\?^)K70]0M=&TGPAXP\
M26^CZ9XGU^Y\*^&M7\8ZSX=T/5-'\%:1X@\26=YHNDZIXIO=+L;J^M+E//2.
M(R4Z;P=:G[:EQ-CITE5I47..89>U&M7C"=&C*V5-QK5(SBXTY14W[VB]G5]E
M&*CGF"Q2P.+\*>'L/BY87&X^%"KPOQ+"=3 9=4K4<=CZ7-QHH5<%A:E"I&MB
MZ=25"/[IJ4UB<)]=^X_^$?\ V4?^BI_'W_PT'@;_ .>;1_PC_P"RC_T5/X^_
M^&@\#?\ SS:_(GPY_P %&?V;M1\(:]XU\5ZCXT\ Z1HWQ5^)OPT5-7^&WQ(U
M6Z>S^%^K6FE:UX^U6/1/"%XOA_P;$-0TV?7-8U)DTSP?<ZG9Z#XDU&TU];O3
M[:[\5?\ @H3^S[\,->E\)PS>.?&_B72_C-X%^"OBFU\)_#CXA:GHWA?7O&=[
M;B2[N/%-EX5O?#^LS:7HL_\ ;=GX=\/W^I:_XE22RMM%LYA=&XAYGC<J5'V[
MXKQJIVB[_7\%S>^Y*'[K^QO:WER3:7LK\L7)\L5=^K'(N,IXUY='P;R*6+4J
MT7%<-9][%/#PI3KMXM\>K!*-)5Z,)R^MV56K"C'VM67*OUI_X1_]E'_HJ?Q]
M_P##0>!O_GFT?\(_^RC_ -%3^/O_ (:#P-_\\VOS^^,7[4/P%^ .N:%X<^+?
MQ!M_"NL^(-/FURWM(M!\4>(ETCPO;ZK;Z'<>-/%]SX8T76;7P3X(@UFZATN7
MQ=XJFTG05OC) +TM!<&+BO@M^U1I_P 9?BK^U#X+M/"O_",>!/V9_$=IX2OO
MB1KNI:M91^)]7@TM]6\2:A_9^J>%]*T32?#&D6D-Q=VNK6WBO6[B]TI+37;O
M3]-T36=$U#4NB<L)#%4\$^(\S>+J594%AX8S!5*L*D,-/%S5:,,IE[",<-3E
M5E.LZ<$K1<E.2@>91IYU7RG$9]'PPX4ADV'P5','F6(R'/L-A,1A<1FN'R2A
M+ 5<1QM3_M*I5S3%4<)"A@(XFO*3G45-T*<ZY^FW_"/_ +*/_14_C[_X:#P-
M_P#/-H_X1_\ 91_Z*G\??_#0>!O_ )YM?EYIW[>O[)NK>%-:\9Z?\59;C1]%
MUKPKX?2S'@+XC1^*O$VH>.TU*7P-)X!\$3>$X_%_Q!TOQE!HNM77AG6O!NBZ
MSI.JVFCZI=0W@@LIG6OJW_!0#]D'1#X*:_\ C%:FV^('AG2_&7AS4;'PCX[U
M/2X_#&J^+]2^'ZZSXFU'3O#5S;>";72O&^E7GA;Q)_PF#Z))X:UI8+'6DLYK
MNV67-XC+%%2?%N(47&$U+^ULKLX5*DJ4)7_LSX9U(RA%Z7:V46IRZEEG%LJD
MJ*\&,M=6-6O1E27!7%[FJV&PU/&8BERKBV_M*.%JTZ]2*YG&$TDYU5/#T_U+
M_P"$?_91_P"BI_'W_P -!X&_^>;1_P (_P#LH_\ 14_C[_X:#P-_\\VOS*^)
MW[:'P0^&>G?'&62^\4>*M=^ ?AWQQJWC#1?#?@CQG=:9<:]X T[1K[Q#X%T_
MQY_PC[^!9/%FE-XD\/KK^G#79)O#=CJ,NL:K%'IVF:C+;Y7AO]O']FSQ!$L3
M>*O$NF:Q9:5\*;SQ1IE[\,_B;;P^$M3^,LG@BS\">'];U6\\(6FGV>JZYJ?Q
M!\.VNGV=Y+:7MS9R7VL-9PZ;I>ISV;E7RZ%7V$N*<;&K:3Y99A@5\%6I0FE)
MY/R.4*M*K"4%-RC[.<I)1BY*:67\45L$LPH^$.0U<&YTH>VI\,<13M[?!8;,
M*$Y4X\<NO&C7P>-P=>C7G0A2JK%8>G3E*M5IT9?J5_PC_P"RC_T5/X^_^&@\
M#?\ SS:/^$?_ &4?^BI_'W_PT'@;_P">;7YN^-_VR_V;/ASI^H:EXO\ B+)8
MIIGQ$^(WPLN]/T[P?XW\1Z\/%_PA2WF^*"P^'O#?A[5M:G\.> [:[M;OQ)XR
MBL6\*:?:7$-P^KF-U)\\\'?MW_"CQ_\ %K5?A?X:=;>WT7XMCX7OXN\20^*M
M(T'Q5:CX,:Q\8)?%?@76HO"%YX4U*QBLM$U$+!KOB;P_;S>$[1?'$>I&PUSP
MK9:XIU\OIU:="7%&/=:K.-.%*&/P$ZCG+F<4XQRI\B?+/6;@O=DK\R4)/#Y?
MQ-BL)B<PI>$G#RP&$P]7%5\;6X9XCH8:-"BZ:J3A5K<:05=Q=6C>&'AB)VK4
MY\OLI2K4?UE_X1_]E'_HJ?Q]_P##0>!O_GFT?\(_^RC_ -%3^/O_ (:#P-_\
M\VORVL_V_?V1[_PQXD\8VWQ9<^'_  I?>$;34[B?P)\1;.]N[/Q]K,WA[P7X
MF\-:->^%+?6?&'@GQ-KEO/IFD^,O"MAJ_AZXNXQ$;Y6E@$OT'\+?BIX#^-/@
MG3?B'\-=<?Q!X3U2\U?38;RXTG6= U"TU;P_J5QH^O:+K&@>(;#2]=T/6M&U
M2TN+'4M+U;3K2]M9X\/%L>-WVPZPF+FJ6%XFQV)J2INM&G0S'+JLW2C-PE54
M896Y.FIIQ<K63MT<92XLR_MO)\//%YOX4\/Y7A:>*A@:F)S#A7BC!T(8VI16
M(AA)U<1QC"$<1.A)58T6^>4+V?-&I2I?8W_"/_LH_P#14_C[_P"&@\#?_/-H
M_P"$?_91_P"BI_'W_P -!X&_^>;7SU17;_9M7_H<9S_X4X/_ .=!X/\ K3A?
M^B)X$_\ #1G?_P!&Y[1XFT;]G>VT+4I_!OQ!^,6L>)HX5.D:;XD^&OA/1-#N
M[DRQAH]1U73_ !YJU[90" RN);?3KIS*D<9C"NSK^OW_  2L_P"2.>//^R@'
M_P!,.EU^#-?O-_P2L_Y(YX\_[* ?_3#I=?#^)="6'X*QT98G%8IRS#*Y<^+J
M4JDXKZU)<D72PV%BH:<UG"3YFWSVM%?T)]$_,*>8^/G#M:GE6491&'#7&%-X
M?)L-B\+AZC_LBC/VU6&,S7-ZDJ[4O9N<<13A[.,(^Q4DZD_Y:?$?_!X;^UIH
M?B'7M%A_X).W=Y#H^LZII<5W_P +.^)L7VJ/3[Z>TCN?+/P-)C\]81+L))3=
MMR<5^>__  43_P"#@_Q)_P %,OV<O$G[/?[27_!&ZXO=,>*]UOP%\0-,^)WQ
M%M_&_P (?'$.GW$.F^/?!FKR? K=:W-AOQK6DW#G1?%&B"[T/7K>>PN28O\
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M4_C[_P"&@\#?_/-KYZHK7^S:O_0XSG_PIP?_ ,Z#D_UIPO\ T1/ G_AHSO\
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M P>&E*&(Q6,X7XDPV'HRC7CAI1J5JO&RIIK$2C1T=1.<ERRJ0_?+[B_X1_\
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M  C_ .RC_P!%3^/O_AH/ W_SS:/^$?\ V4?^BI_'W_PT'@;_ .>;7XM^%_\
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MQ2=2>"3Q*A;F]DFI<E9/"K]2_P#A'_V4?^BI_'W_ ,-!X&_^>;1_PC_[*/\
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M/#W[!W]EZKH UK]H7XC>(_ Z>-/@W\5_B-\-_P#A$O >B:'\3_C!\!]#\/\
MAWX?>.+O6+"QD\1>$=/73O!_@Z3Q'X.T"_DTO7-1\.6]W]KLDO+NW/HOQK_9
M(TKXU?&KX:_&B]^(WB'PGJ7PYN/"4UK9^'?#?AV/Q"T?A+Q9<^+FLO#GQ(B%
MCXN\+:7XQGN?[&\>Z)<OXGT'6]$@B33M*T/49+O4;G^G;_AV)\)?^BF^*_\
MPFI/_DJC_AV)\)?^BF^*_P#PFI/_ )*K5>('A9&C/#K,4Z,ZV'KRA*EF,VZN
M%DYX=J<\9*I&-*<IU(TX3A3]I5K5.7VE:K.7+/P*^E%4Q]',W@\HCCJ&!S/+
MJ5:EQ'P'14<)G-*%#,X2H4,#2PU6IC,/2P^'JXFO0Q&)^K8/ 895GAL!A*%+
M^0WXE?\ !-B#XE:7XO\ "=[^T[\6=(^'/BWQG\>/%[_#FS\+>"KGPYIQ^/\
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M_81E'#X>*IQG-5*LHI*=5J-.G2_$*BOV]_X=B?"7_HIOBO\ \)J3_P"2J/\
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M6I4(JFFH*4DKSE.3<G^(5%?M[_P[$^$O_13?%?\ X34G_P E4?\ #L3X2_\
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M4L-@Z<*%*E&$8QA^(5%?M[_P[$^$O_13?%?_ (34G_R51_P[$^$O_13?%?\
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MVX-**NWI:U[7WO\ A>S3L?;]%%%8&04444 %%%% '\TK-M5FP3M4M@<DX!.
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MJW[NF^1RA4A.JJ?S3_P3D_Y.@^/_ /V;5\$O_5O_ !JK]!OVO/V4/A5^VU\
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M\%^*O%7Q0^'&E06GQ%3XFZ/;>$%\(>)KW5O$7B[P-X+\/^*M#\%>.3\-=?\
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M:>)M<\>6/Q"U7Q-\/_$/BNT^(FO?M&6O[45SXWO;+Q'\,]6\#>)=1B^)EO-
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MN^$]0M_''@[XN?$'2/B!X4\4^%-=\$ZC::[#:>'O#?AFQT70K73=JY_X*,^
M+2^T;P9=?L__ +5%I\<M8^,/ASX)M^SA=^ / =O\7](\1^-?A%XQ^.G@CQ-J
MY?XHGX<6_P .O$WPU\!>+-67QE!\0KJT\/ZGH&N>'/%5MHFN:)JEE;9WQS_X
M* +^SO\ M$_%CX9^.O@E\3O$7PH^&/[./P!^+\?Q!^&FBZ'XK\0^(_'?Q[_:
M-U3]GOP[X#TCPU<>-M)U'4$O->;0[31%MM$CNKC6;+QFU_>6^EV7AR77#FQ\
MGR<]6[3FHN5)<RCR0O%;37[R,8I7C)2DHWCSBOBK\MY)VO9N"NERQT3W^))=
M-7;2YT'A_P#X)O\ [//A3X?_ !+^&F@:A\3;;P[\6/"_P'\->,KN_P#%UKK7
MB34;KX!?%[QA\=-)\8SZ]JFB7%U>^-?B%\3?'OBKQ%\3]8U!+JVUV75)(M%T
M[PY%'$J/L_\ @G+\!K3P=\:? B^(/BFNB?'GX>VOPR\:W,7B+01J]AX=MOVB
M/C5^TTEUX7N&\,&VT_6A\0/CSXSL%N[^UU.U'ABQ\.:>;/[=8WFIZAA:S_P4
MA^&'A_XR:)^SUXX^%WQS^$/Q/\9Z1XM@\+'X@:)\)9XH_&GA3X,Z]\:M7T&X
M\'>'OC/JWQ#U#3M&\-^&]?LX_B#:^$Q\%?%/BO0+SPQX=^*5\MYI^J7&!\,?
M^"F?PK\8'P!H5UX'^/FH6VO7G[/'PZU_X_-\)?#GASX,VGQA_:3^ /P^^./P
MHT*^L8?B=K_B?2;SQSIOQ$T'3Y](T+3O%^A_#_Q-J%MX>\5^+[72I]-\3Z@K
M8]IR_?.]JC:<7=+55$[M-+V:2:DW>-E!I!;$[KG_ )NFRWEO9I<MMV]-CSW]
MF+]A[X\?#3]L6'XR^/\ 7-&T'X,_"C2OVM;#X._#GPG\6M4\>> +B^_:T^*O
MA_X@Z]>_#_X::[\,O#'BGX&Z3ID>@W.K>*]'\9_%CXW7%WXRU^30OAK>^$/A
MEI-GI+?KI7Y8?#K_ (*I_!75/#?@J_\ %?AKXY7?AA= _9@7XI?M)2?"3PYX
M.^"'@G7_ -JKX7^$OB+\*;OQ=80_%#Q1XG\-1^)H_&&C:;KNB^%+#XAVWPVU
M/4K9/$VNKX>DL_$EY]$_LU?MK^ /VH/%NO\ @WPO\,_CI\.=3TKX1?#/X^Z+
M<?&3P1HO@^R\>?!GXR:QXJTGX8^/_!O]F>+?$M[/I_BE/"&J:DVE:]9Z!XCT
M"V>VL?$NC:3K1N-,MYQ$,5-NK6I-*$5%R48QBHQ;5_C;;<I<TKIR]Y-QC%ID
MU8UY-SJ0:44DW9)63>N]]6[[==DK6^QJ***Y# **** "BBB@ HHHH ^O-&_Y
M!T/_ %TNO_2N>M2LO1O^0=#_ -=+K_TKGK4K]/P?^Z87_L&P_P#Z9I'U='^#
M2_Z]4_\ TB(4445TFI_)1\;_ /DLGQ4_[*#XN_\ 3[?5Z[X,_9<E\5?"J#XH
MWGC^PT.TU3PWXFU70[.31FN+&?7?#7_";7MUX>U'6)-3M5M!;Z#X$OM1UJ_M
M[.Z.BW/B'P?9R6MR-7:6+R+XW_\ )9/BI_V4'Q=_Z?;ZOM3X%>'_ (8ZA\%?
M"_B37?A1X5\2:?X?T;XA+X^U77O@C\9/&'B&_P#$L6K7\WAG5]"\2>$U/@*?
MPII.DMIT/B^YU"_L-7M;'3M1@$:7&GV9D_S@X<RG YQQ-Q#AL?0P]>%/^W<1
M16)Q&88>E2JPSG'TY8F3RVG4KU(8:C5G7JQDXTX4Z4:K55QE0G_&V38#"YCG
MF<4<52HU8P_M2K35>MC*,*<XYCBHNLW@H3JSC0ISE5J)\L8P@JG[SEE2E\C_
M +'#;_VW_@>^"N_X-?M0-M889=UE\'3AAV(S@CUK]GOC5\(O _[0/P=^*GP(
M^)EC=:G\._C)\/\ Q5\-/&UC87C:=J$_AOQ?I%SH^I/IFH+'*VGZI:Q7(O=*
MOA#-]CU&VM;DPS+$8G_)']GN?P9=?\%'? EU\.;:[L_A_<> OVN9O!5K?&X-
MW;^&9/\ A43:3%/]KEGNP1;%#&EU-+=1Q&..XD:9'-?MS))'%')+-+%##$CR
MS33R)#!#%&I>2:::5DBAAB16>661UCC16=V55)']"^%5-X?@K+:4:U*L\/F&
M>THXG#3<Z%9T,\Q5..(P]1Q@Y4:KHQKT)N$'*E4HS<(N7*OV?P^A['A?!4XU
M*=7V.-S>G&M1DY4JOLLTK05:C)QBY4JGLU5I2<8N5.=.3BF[+P']ES]F7X3_
M +'GP+\$_L]_!;3=4LO _@J+4+AM3\1ZF=>\9^,_%&O7LFJ^*O'OCWQ(\%M-
MXC\:>*]5FDO=8U62WMX5C2RTK3;2PT;3--T^U\]M?V2M9\/_ !J^(_QC^'7[
M6/[3OPML_BW\4_#?Q@^(?PA\'W/P-N_A7XC\7>'O!7@'X>3I)%XQ^"?BKQY8
M:5XD\)?#;PUINOVFF>.;.5F6]NM)N=*NKA)HJ?\ PTAXX^(7[85U^S;\#/#?
MAC6?A]\"=(L==_;,^-?B0:M=Z9X'\5>+=*;4_AC^S3\*[/3+W3;+7?C;K^C2
M6WQ#^).JZA=ZEH7PC^'M[X:35M%U#Q/XUTFQM/E6Q_:]^*/B[]N7XX?LZ)^U
M7\'_ (2VGPS_ &AO _PN\#?!'4/V-/BC\5O&WQ&\(ZI\&/@]\4-4O;GXZ:'\
M0=)\%>&-;\2:MXY\4^'=(%[H1D\/0:;IM[<:?J3RP0WOZ9&&(E*K)S7-.E[>
MJY^_*5.<[ISC[*JU*3M42<8N,'&;<(R@G]S&-5N<N:TI0YYMZMQD].9<LFF]
MUHK)I^ZFD+XQ_P""4W@O7?BOHVFV7CSXJR_LM:M\&OVOOA]JGPNNOB7;V!^
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M5*7-9O1/%75W)<MGKRV=O>3=KMW6C:5FK)NY]!^$/V$OA5X1\>Z'\4[SQ_\
M&KXD_%+2_'GQ$^(.N?$[XF^*O#VL>+_B%K'C[X$)^S5;6WC%=#\(^'- AT7P
M-\(;:PT;P5H_A71/#EO::Q;W/B/6VUW5]9UNYU'SG6O^"8/[/&M>&/AEX?;Q
M#\5M-U+X+?!+]G?X)_"7QI8:WX0N?$_@:U_9@UKQSK/PS\>VEOKW@C6_">N>
M-+N+XC^,/#WC>T\5>%]<\"^+?"VKW.C7G@V$2-<UY7^RG_P4[L?C'XSC\(_$
M/P!XT\/^"-?U;]ECP7\*_P!H74/"7A?P7X.\=>*OVA_V6+K]HVTN_'WA:T^*
MOCG4_A?_ &__ &7J6D^$M*M1KNEV#WGAS1=6\0W.M:L6A^M-2_;(\!VG[+?@
M3]K72_ 'Q9\2?#_XE6/A?6?"/AW3](\&:'XM;PYXTO+E?#/B[Q7J'COQUX0^
M&OP[\':EHD%OXH/BCQ_\0O#>C6NDZQH%C/=+XEUO3M!GB:QU.<8R=12;C&%G
M"S<DTHQ:2CLI)Q=E&SC)1V<2^LQDDW.[:47=6;::26RV3372S3ML<%)_P3O^
M#EYX%^*W@76_'/QC\2K\:?V=-&_9H^('BK7/$?A0^*-1\'Z-\2OB5\54\1:>
M=(\$Z/X<T3Q7<>)OBIXCLTATGPY:>#])\-67A[0=#\*:;;Z49;GT>7]C[X=3
M_!+]I[]GNX\4_$>Y^&?[5'B+X]^(_%6GW&L:"^I^ )?VDYM6U3XIZ5\,M53P
MS%<6&CWOBGQ%XD\7:+#XN'C&]T75M=NK&"_D\/VFF:/9?/7PN_X*O?LU?&?Q
M;\$_!OPT\+_&?Q/JGQJT#3/$<+VGASP(/^$$TW5OBGXZ^"\-QKVE_P#"R6\1
M?$"PT[XA?#;QA9^)M>_9^T7XS>'?"7ANQL?&_B75M,\+:SIFI7-/P[_P5M_9
M?\2?"SQ7\8[;0/BWI_@C2?%W@SP)X&U#6--^&.GQ_%[Q;\0?$OB3PMX5\-^%
M]2D^*K>'OAUXG>\\)ZSJ_B?PC^T3K?P4\6> O"-N/%?C70]$T@330IPQU[2A
M6NIPE9J-U-3:IM+=-2@^6R6D6[<B;0XXGJIZ2B]HZ24O==NC33MZ/HF>Z^)/
MV'_ACKG[0%A^T7I/C3XJ>!/%=Q+\)KGXB>&?!FJ^"H/"'Q?O?@;;QV/PTO?&
MDOB#P'XA\;:%/INCP6OAOQ*/A=XS^'L7CWPM8V'A_P 7QZI9V<>>$\,?\$T_
MV=O#WACXP>!M1U7XI^,?!/QC^%FK?!;4O#OB3Q;IL#>"_ASJ'QK^)'[06EZ5
MX!U[PQX<\/>(M*U;P?\ $_XJ>)M;\(>*=6U/7/$.F?9]"%UJ&H2Z3'-)R>B?
M\%7_ -F'Q;KGP8\,>!=%^+/CSQ'\8SXG4Z%X5T;X?7NI_#Z;P1\6(O@EXUL?
M$$-Q\2[2+XA:QX4^(!NH]8T+]GB?XUZS'X0M$^(,%C/X,U;0-8U::W_X*H_L
M^7OAWXW>,=+\ ?'_ %WPA\#_ !?IW@;4-=\.>!_"?B&;QOXGOOC_ */^S2^@
M^%?#&C?$&\\9^&_$R?$W7M-;3?!WQC\._"OQ?XK\(/-XO\(:'KNDVT[QM1Q\
M4HVKQLH16T7:-3EIJ]U+2HK0N[^[9-PCH[8I:?O%HET3LI6BKW3^)65W?33W
M4>C:;^P+\+TG37_%_P 1_C9\4/B5??%R/XT>,/BY\0/$WA2Z\=^//%&G?L^?
M$#]F+PMI&OQ>&_!'AKP?IW@[P7\*/B1X@MO#GA[PEX4\.H/$S'Q3J]UJNJ:E
MKCZGRWA+_@FM\'/ =SX+N/!WQ,^.VA#X?^,/@%X^\,6L/B;P3>6=GXN^ O[-
MA_9#_M2:+4OA]>274/Q<_9[2S\#?%339IS8-=:?;>*?A]#X"\2/=ZA<\W;_\
M%5_V?=.G\02?$[X;?M'_  .\.^#KSX[^&/&?C7XJ?#GPU;>%/#7Q1_9L\':Q
M\1_BU\(9[SP9\0/&=_K'C72?AUHL_B[1=2\.:;K'P^\31W%MX<T?QM/XO6\T
M"T/#?_!57X">-;'2[/P/\./CKXZ^)VK?&+PS\$+?X&^!=,^$/C;XDQ^+O'?P
ME^(/QJ\ ZG<ZIX4^,NL_">#PAXJ\#_"_QFTGB"3XFJ/"&N:'JFA^.[/PS>:7
MJ MVX9@KIPKJ[5[J/+K=)?RI637V5%-+W5*/,..+O9JI=NUFEN]+?IT[=4GW
M?@G_ ()S_ CP#\-9_A7HFL?$.[\-S>)OV._%I.OZSHVI3RZI^P]X=^&WAKX/
M6=\+?P_8176A:Y8?"SPV/B98+'%<^(Q=ZZFC7OAO[;;?8O"/^"?G[$'QU_9W
M^+_B/XE?&7Q%:PZ#X6_9J\)?LH_!SX=Z3\8M2^,WA?P]X&\._$S4OB1)<_#^
MXUGX7_#;Q'\-_ACHH.D>&/ 7@/Q_JOQ@^*PTE&B\=?%C6[?PWX;B/M?['O[=
MD/[8GQC^.OA'PE\*/&WA+X6?#3P-\"_$_A#X@>,[#1]$U'6/$'Q%3QYIGQ \
M$^+M&@\6ZQ?Z1XA\%^,O!&M>&-/CL-'DT:Z;P=XTOI/$%Y:2^$[G7>!U'_@K
M3^SEH.J_'+0O%'@#X^^&?$'P(^&^I_%W6?#%_P"%/A]J7C+Q5X!TCXN>$?@I
M>WNB^!O#/Q1U_P :>$/$\GC3QYX3?2_AW\9= ^%WCW6=$U;^TM.\/3/97UK;
MG^W/VU%QE4E.,)54^2<HJHX--/F2BY^Y&=DVK)-QW9_M'OT[.3<8\RT;2DTU
MU25W9/1V?;<_4&BOS5\=?\%+_A_X:T'QSH>G? []IF;]H3PA>?%K1M5_9U_X
M5IX6U;XI^#(OA7\(?"GQEUKXH>+[#2OB/<>"KGX5Z9X+^)7PMUR:;PUX\UKQ
M=K5UXVTOP1H7A>^\<_:]"M/L+]FSX@Z[\7/V</V>/BUXI72T\4?%7X#?!SXF
M>)DT.VFLM$3Q%X^^'/AOQ9KB:+97,]U<V>D)JFKW2Z9:7%S<SVUD(()KB>2-
MI6YIT*M.*G.#A%RY%S6NVH\[:2<KQM;WMFW:+EJUC*G."4IQ<4Y.*OU:5W;5
MZ+OW/:****R("BBB@#^;/3K.TU#4+&PO]5M-"L;VZBM;S6]0@O+JQTBVF;9-
MJ-Y;:?!=7\]O:H3++%9VT]RZJ5BBD8A3]Q_&#QAX1U#X3V&BZ_XB\ )\2;'X
M7_#+2+'0;?Q%^TI:>+6TRRT7P]/HI?PUJT%M\(KJ^FT"2.]N+J:*72KJW=KS
M3KB>X2QE/PO;65[J5S!IVFV-UJ>H7\J6ECIUC;S7=[?W<[>7!9VEK;))<7-S
M<2,L4,$$;RR.P5$9B!7Z0_%/5[%/V6=$M+OX\W6KS3_#;PSIL7A35-0^'JZM
MJ?B&VO\ P'+I_@:/P/'X8MOB%X=T;PYHY\86<.IW.HJDH\*6.M76IW-GKMG;
M3_QGPC&<\IXQC'V,(QR6-6I4Q%2C&E5C3EBTJ4(8C%X2,L32E55;#SP[Q%:E
M*LU5PU6.(PD9?S%P\I2R_B-+V4(K+5.<ZTZ:A44)8BU.,:V(P\76INHJE&5'
MVU2#JM3HS57#J7BG_!.3_DZ#X_\ _9M7P2_]6_\ &JOT _;#_90^''[;7[/O
MB[]G/XJ:SXZ\,>%O%.K^"_$MKXM^&7B"/PM\0?!_BKX?>+-*\9>%?$WA+7IK
M+4K?3]7T[5M)B19;BPNHS:W-T$2.Y\BX@_/_ /X)R?\ )T'Q_P#^S:O@E_ZM
M_P"-5?LZB-(ZHBEG=D1%'5GD=8HT4=WDE=(HT'S22ND:!G=5/],>&LY0X'X6
MG"3C.&7N49+1QE',,U::T:NGW36]TTVG^[<#R<>%,@E%M2C@Y--;IK&X^SZ_
MDS@_A+\,O 7P*^''P]^$7PH\,V'@_P"''PL\,Z+X/\$>&+#S'MM*T/0H5CMD
MGN)6:ZU'4;Z?S]3US6+V674M<UN^U'6=2N)]0O[F9_C;P3_P3V\+>&=6T.R\
M4_'_ .._Q2^#?@_XU?$S]H3P'^SKXM3X3:/\,O"/Q3^)_BKXC^,;[6_[<\$_
M#7PY\5/$]EX6USXL>-;_ ,':/XH\?ZE8:;J%UI&IWL>HW>@Z:8O0/@C^TCXM
M_:)_:+^+?AKX8^%/#<O[*'P(U*[^$_B+X\ZA>ZG<ZS\8OVE].N[>/QWX"^"N
MGVDUOHC_  V^!:N?#7Q*^)&IC6K?Q%\3WU'P+X0@@_X1'Q#JH_//X.?\%(_B
M_P",_BOX1TNY^+W[)_Q3AU?]JC]H?X+?$O\ 90^&'P[\::;^TK\"/@S\'O&O
MQQ\/)\=/%7C5?C#XLT&:S\,:!\*_#7B?Q?!XL^&W@G0-=M?&D>E:#K%CX@N?
M#MGJ?W].GBFZO)*TN2-2K>5Y^^JDUS2=.HX5&G-N\Z4E[11E-2J*!]?"%:\^
M5VERJ4[N\O>4G9OEE:37->[B_>Y6[RY3Z)\/?\$J?AOX>MO";K^TA^U!K/B7
MX3^ OA!\.OV>?&^NZY\++KQ)^SUX?^ 'C^_\>?!S_A!4M?A=9:)XGN?"T.JZ
MIX&UR3XI:1XY7X@^!M2O=)\:#5)Y(+NV^2/CI_P2A^,H@'PG_9V^)/C5OAW\
M7]$@\/\ [07QL\9?&[P[I/Q \5C5_P!K7QO^U+XLN?C=\/9_@OK-I\4]"\.Z
MS\0_%K?"B#X'^(?@MXPO9?$OB7P!\4-;OOAW>:;-8_:'AW_@JQ^SGKWA[PYX
MSF^'7[4'A[P1JW@WX9_%+Q5XP\1_!>*ST+X0?!KXUZH-#^#?QD^,;V'B_5-1
M\&?#[XG:I!K'_"-S6^FZWXIL_#WAW7/'GBCPMX>\ V]GXGO\[6?^"J7[-'PO
M?4](^*GBSQ-J6JZ!XT^-%OX]UGPS\.K#0-#^#GP[^''[0_Q"^ 5IXO\ B38:
MQ\1]0U6X\/V_BCX?^(M&CU[P*OB[Q'XNTOPGXA^)K?#GP=X6\RQT[>,\RC/X
M:LY*]H2IQEK>2O:*2O"5Y<KDESM2Y)RDF]%+%Q>TVU>T7%/75-V25VG?1O?[
M+;.OF_X)F_ 8^-OCOKEGXK^)>G^ ?C_;?M$_\)1\(;"U^$ECH6D:U^U-I6OZ
M7\8/$&C_ !&M?A<GQRN1J$_BOQ3XB\+^$O$/Q0UOP/X+\4>(-0U#1/#ZV2:?
MIECV/PS_ &$_ 7PX^+'A+XVS_$KXH>.OB+X6FO;R?5O%/_"$65IXFU'4?V8_
MAG^RG=ZAK6E^%/"6@6%M-)X ^%7A[71!H<&EV:>+KS5KE;<:3+;:5;>'?M*?
M\%2?!GPC^&_QT\5_"CX(_'CXR:C\)KKQ-X?\-^,K/X7:K!^SW\2?&_PX^*7A
M#X6_%[PEX<^+<6M6ULVH?#75_$U]%=3:Q:^'-)\8:GX9\1:9\/=7\73:!K2V
MGK_[5O[8^L?LZ^/O@!X+B^%?C.?0?C9\-?VIO'OBGQU<>'+#7[KX(0_L_P#P
M6@^)]K_PE/A&T\;Z FN:A9W5VR^-?#^F:Y(C6&E7-CX?UU[R]BOH,U''3Y8M
MS;JJ44I.FI24*2E)-6<OX32UM*6D4G-)*>7%2:3O>=TDW%-\L+O1*_P[=7LE
M=(^&M,_X)C?&#X?_ !W^ W@_X4^)M4\/_LC_  K^*_[('QA\2ZO-\8]%F;XD
MZC^R#\/]+\+:!=?$_P""EQ\(SXEOOC/XD;PUX=\(1Z_\-?BSX+^"EQX/TGPI
MXU\7>!+_ .(G@R.#6/W6)R2?4YK\TM,_X*>_"":^T'PK9?"C]JCXC^)-4\2^
M'/A-IFN_#OX"0S>$?B#\=]8^!7A;]H.'X9>"KB^^(1BLO$>L_##Q!=^-4M];
MU*+PIX1L-$UO2O%?CRTO;*PGUF_H?_!5W]C/7=?^%.E6?B;QN='^*&G_  8O
M;SQ?=^%=/T?P[\*[_P#:#U6/0OA%X3^+$&M>)+#Q7H7BSQ3KDUOI-]9>%_"O
MC33/!<U_I-]XZU?PYH^L:9J5TJT,96Y'4HSER1DE)05Y:\\I2:DW*4M'=I-J
MRC%:02J1Q%3E<J<GRIQ34=]7)MN^[O?6W2RZ'Z.T5^0OP$_X*?V7B#X6_#_Q
M3\7/"WC7QC\3_B)'^S'X3T[X2?L^?!F]U35H?BK^T'\-OC/\2-&T71+_ %WX
ME20>(]%UO1/@]K=U/J&IKX1L/AM+;I:^(]6UK3+^Y\1:)Z?I_P#P5E_8\U#6
M/!>CG5OB)I;^(KKPEI'CB^U[PCI.@VGP"\5^.OB/K?P@\,>"_CC;:KXLM=<T
M7Q+<_$WPYK/A;5H_ 6C?$;1_#$=M;>*/$VL:3X+U;2/$5[E+"8F+:]C.5FUS
M17-%\M[V::;6FCY4I.RCS-I$.A67_+N36NJ5T[7O9WUV[:]+GZ5T5\E_LV_M
MG_"?]JO7?'FD_"KP]\54TGP+>:Y9Q^._%G@JVT?P'XR;PQXUUKX?>(4\,:SI
M^OZW?:5JNE>)]"NXI?!WQ+TCX>>/KG29;;Q#8>$[O1#=7UI]:5C.$H2<9Q<9
M*UXO1JZ35U=VT:=KW75)Z&4HRB[233T=GOJKKJ^C_P" @HHHJ1!1110 4444
M %?0_P ,/^0"W_74_P#HV>OGBOH?X8?\@%O^NI_]&SU[.0?\C.E_UZQ'_II'
M=EO^]1_P5/\ TE'I-%%%??GT05_/U_P5'_Y.)T/_ +)5X8_]2/QM7] M?S]?
M\%1_^3B=#_[)5X8_]2/QM7X;](?_ )-O6_['^0_^G\>?E_B]_P D;5_[&N5?
M^G<4>2?LXZWH/A3P9\1Y/$?BWP39^#_%*> E\5IXEO/CIH$6@ZWINN^,&\+:
M3+KGPAL%NEU+48K&YUF(R7_]GW&FW,=@LDEW'JEI#\0?M/W6D7T7CR\\/W>F
MW^B7/C_X;RZ7>Z/?>*=3TJZLS\5?A^$ET_4/&Y/C"\MBP<+/XD)U1F5A*3&(
MJ^_?V.DU'3+;XHW3_$#5/AQ)K7A*UG\*6=[>>$_"7ACQYJ>FGQ-!97]WXM^(
M.AZEX=N[;PIXAAL[#^P[.YL[J_NM9N[B2Y:+0;R!/AO]L*YTF\USXL76@^+&
M\>:+-\5/ 9TOQFT5A$?$EDGQ;\ Q1:CMTJRT[3)!^[-LMUIVGV5E?+;K?6]O
M'%<J*_F;"1G_ &7X:U)>QA#_ %HP-*G1E5HSQ<%#/,/.4E!XN6+IX2K*K]9C
M3JX&E"%7$NI#$2H8G!QE^*8>,OJ/!4Y>RC'^W<)3A3<Z<L1'ES2C)M1>(>(C
M0J.I[90GA81C.LYQK2I5L-&7],VK?\A74_\ L(7O_I3+5%59V5$5G=F"JJ@L
MS,QPJJHR2Q)   )).!S6AJBE]7U%05!;4KM068*H)NI "S'A5&>6/ &2:_&#
MQ=^U*G_!1KXM>-/V&OV5/$_Q>^&7A3X,?$OQ?X8_X*+?&^#1/$OPL\;_  X\
M+_#OQ1=>&=-_9Y^#'B-UCN5^(7[3GB'2]6$/Q"T"^CN?!?P-\+^,M>@CL_$/
MB;P_';_UO2I2J7:TA3BI5:C3<:<-N:5FF[M<L(J\IS<81LW=?T="#G=K2,5>
M<GM"/=VUU>D4M92:BM7I^L_B;X9>"?B'=>&Y?&OPW\'>/K[P%XCM/%_@Z7Q=
MX)T'Q=>>"/%VGN!8^*?"LNN:7J,_A?Q)921I]FUO1VL=3@DBB,=RKPQ[,O4/
MA;\,-5L&TG5OAI\/=4TLWOC/4'TO4_!/AF_TXZC\1HM3M_B-?M8W>ERVQO\
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M&&"&#[,8H(D3.T?X/?";PQH\/A[P]\)_AKX<\/)<^$=3MM!T/P!X5T;1%O/
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MQ)X@T#PC_P +),?COXFQ>&->;2O!5OIUU<?U0:P -7U0   :C?  #  %S*
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M.@Z3J4LFJ:GJ-S]WU^ 'Q<_X*?\ QXT?XM_ML>'_  SXC^$/PZ^"7P:_:/\
MV-O@C\'/BYK7PD\5_%G4=-\*?$[XP?$/X%?M&_$GQ3X2\.^+]+N_B<ND?$+X
M;^*++X>:-X7&BO;1Z-<13_VQ))YI]H^+/[;'CKX>? O]E/QI:_ML?L^6VB?'
MK]I[QI\*/%W[6/CC]D?QOX#^'7A+P?X<^"?Q3\>V.C6_P+\7?%30O$,/B.X\
M;_#_ $WPT/%.I>+8+&^M===K32F%O%<354PN*G*FZLE*<U&$;N4FE&BJBB_9
MTG%<L';E5Y.5U&,G=E3H5I-.;3D[16KDURPYK/DBUI'HKMNZ7,?LO17R'^Q%
M\9OB1\=_@EJ'C?XEW'A;Q%<V'Q9^*/@GP-\5O O@WQ'\.?!/Q^^%OA#7H]/\
M$?'3PIX!\6:OK^M^%=&\;6\E]8I:'7=:T35+SP]>>)/"FJ7OA76]&F;Z\KCG
M!TYRA*W-"3B[.ZNK;/3OV33NFDTTN>47"3B[7B[.SNKKLU_73=,****DD***
M* "OH?X8?\@%O^NI_P#1L]?/%?0_PP_Y +?]=3_Z-GKV<@_Y&=+_ *]8C_TT
MCNRW_>H_X*G_ *2CTFBBBOOSZ(*_GZ_X*C_\G$Z'_P!DJ\,?^I'XVK^@6OY^
MO^"H_P#R<3H?_9*O#'_J1^-J_#?I#_\ )MZW_8_R'_T_CS\O\7O^2-J_]C7*
MO_3N*.A_9=\<KXJ^ ]Y\(?"_BGXC:?XO\.W=IJNJ:8OPN^&OQ-\)6>GWGC/6
MM0MKW19_B)=:/H&CP7YU&TLI-&UO6K6Z/B)[G4/"]OJ%UJ5Y;P_E?^U<UTUW
M\2A?S:I/?1_$OX?V][+KGA/3? FLF\M?BUX"M;I-3\&:,\FD^&;R&XAD@ETK
M3I'M(O*$D;'S2:^D?@Y=_%#1/"_CF]T'X,K\8/AAKEUX2M/&FB:YX5\2ZYX:
MEU[1-7NM0\&WT,_AB\TW6?[5TG4C?!ETVYN+9+:ZEM];@C@NK9C\X_M97OCG
M4KWXE:C\3K.73_B%?_$GX>7GC#3YK>"T>PUBY^*_@"9[);2VEG@MH;6U>V@M
MH(YYO*MDA1Y9) [M_--/-ZF9X/PVHXFEF$,3EV?9#@U.I@,RP^6SP-#,Z5+
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M3BG)6BW%.TI0FE&2C1A>TL0K:[25KI-Q;_>7]ZUE9.UTFXO1_P!$VC?"_P
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MI).$)?KR]I-0UTA*,(7=DI3DFE'35W]YO6RU;M9-!_P2U^"$OP@_8N^#U_\
M$#XLZE8?L7_%*Z^*VE>,;G5-'7QI\<=5UWQ9+\0/'>B?&;4XM-5-1T7XA_$"
M'0/&7B<Z''IM^VL^$] EL[J$6[EO./AS_P $>/A!\.H+^QMOCC\6M;TN;P9\
M*_AWI=A-X(^ OA9],\(?!G]H;X6?M(^"FU;5/ 'PQ\*:O\0?'M[XM^%=CHGC
M[XJ_$>]\4^._'VBZ[?7>L:I'K.G:;>KI_"C]N.]T+X5^,?C-XR^/-I^VAX9T
M[5_ 7A!="^!_[(]]^R7<?#GQ+XKL]7UB75_&_CC]I7XU>'/ARO@Z73M*NK)=
M?\0^+/"6D6FL1Z7HUIJ&J^(_$^BZ'<>J?"S_ (*9? KXWGX87?P?^'/[1_Q,
M\/>/M%^&6N^,/%?@SX40Z_H/P"L_C'XL\5>!_AR/C4=+\3W>K6D>L>(_!/B:
M75=2^'&E?$C0_"7@^QM?B-XKU32/ >K:7K]UTN6814U&=24%*?/**BHJ3;JS
MNZD*<HMN5[.,4VU&FFK1>U\4N9*4G%-\S25KM\[3YE%K5WLTEK:/8O?&/_@G
MG\/OB_<>*]6?XE^-O"GB3Q+^UCJW[7]IJ8\(?"+XD>']#\>Z]\"_#_[/>J^'
M)OAI\7? GCCX;>,/#,?@OP_%K7ARZ\8^&=7\0>$/'=PGBG0-3MKC3[2"N3\,
M?\$O_A)X5^"?CSX%6WQ1^*VH^'/'O[,OPZ_95O=?U1/!;^)M/\"?#'XP_%SX
MR^'?$,,EEX=LM)N_&5UJ_P 8=9T+6KN?3(](O=+T72;JVTFQU":_>;Y@OO\
M@J5XSTCPWJ7C6PA_X6!H1_9V^ /Q>^%^BZ?\']-\.^*OBUXP^)'[./[=GQL\
M1^&?%]G/\8Y=)^$V@7G_  RYX?U"UU+1_$/CJ\\.VUEK/AR"/7)/%L&M>'?M
M#X-?\% / 7Q(T'X4Z9XH\!_$7P-\9_B!XP_9Y^&FI?"?4-(\/2ZOI_BSX_\
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MB^,-8_MNVT;AY_\ @J;X2\&^+OV@M$^+'P@^(?A2Q\#_ +0W@CX%?L_VSO\
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M\1/%;G8VQ\)X@O&/EO\ P28!V/\ P/ANU?IA\2?'-Q\5O@\/B)X*\7_%F_\
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MAVUMX-O+BTO;">]\(6\-@D/A>\GL-3U*QGNM!33YYK+4=0M))&M[VYCEJ/\
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M[^+_ (GN/!'P^^&OQ=AUGQ19>*-%\:ZKXTMO^$:U>/PCX9\;^&O!]W>Z-?\
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M_!RRO?$*7.F:5%IK-J#/9Z8O[B'5A<PM#+9_"O[4[VTLGQ$DLY-*FMY/B/\
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M_7/'=EKNKZ[XA\!37J:_IND>%/C#IOQ7TCQ!I'P*A\4ZGHGPXT_5Z\4\9_\
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M+:^)?!FI'1]<?3/%&@3:9KFCV-TOSQ\(_P#@F9\+/@A/X'C^'OQO_:6T?0-
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MR#^#?_!*_P .:?\ L3?#3]F_X@>+O%'PY\1VWQ ^)/QB^(ND^!+[X?\ Q?\
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MYS=[*RO>;O9:*]]--M!\TOYI:[^]+7_R8^7_ (R_LA?!;XS>!)?AM=^'-)\
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MV?O!>E?'+P_\=+:YOHM0\ _!B[^!?PD^']AIGA?0_AS\'O!^OZYX=UWQU=^
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M*\$Z1I_@G0?C/X\\7W5Y_P (M?7GQ%\;ZWJEQ\0_[=\.ZM=^'1] ?L@_L@>
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M\)Y\,OBIXZ\,V7A73?CU:>"U^('B_4-9U'XK?MY?$[X.>)?VJOAMIWA'P/\
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MXL>!DL-1ANO!W@[]DUO@]K=SJ4]LT>E7\7C8_'SXABVMM-NRES=:?_PC4_\
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MRFT.\T[59]?&F6.E:A=6V?X%_:Z_9D^)7@#XP_%7P9\;/ VI_#/]G[QEX[\
M_&GQW>7USH'A?X<^*?AG%!<>-K+7]4\0V>E0?8=(MKJVN+;7=/-]H.OP3PR>
M'-2U<2H&_)CXG_ K]KSX=?'#XV>&_A)\$?$/C;X%_L[^.OVI_P!O7]C:\TI_
M#[:!X[_:H_:F^'>E>#?A=\(M-TVZO;=M+A_9[^.?Q9_:B^.&LW=[;V^F:-X>
MU7PAJ.G,;JRAB?A+'_@F_P#M4_L]Z#XC^"'A>_\ !W[3?@#Q?\#/V1/&4)\-
M_#FQ^!O@O5?C9_P3;^.7PT\:^'_AC\4)=:^)/CNTUKQ+^UM\*KGQ+H(^*6KO
MHFC:OXO^'VC_ /"8Z;I%H%O&Z/JN%Y4_K*4IN,X)SI_PFXR<975HU8TY6?,X
M1]HOA:4HK;V%&R_?*\G>/O12Y-'9W6D^5VU<5S=-T?M9\"_VI_@'^TFWB>V^
M#7C\^)-7\%Q:%=^+/"NO>$/'OPV\<:#I7BF"YN?"GB.^\!_%#PMX,\9?\(EX
MJALK_P#X1KQ?!H<WAC7)M.U&UTW5KB[L+N"'Z)^R76V!_LUQLN6VVS>3)MN&
MSC; VW$K9XQ&6.:^2_@G\8O'OQM^.>O^,=>_8]^)/P)^'>B?#32-!N?BI^T;
MHO@[PG\>_'/BN[\:/KC?"SPMX5\*>)?&M_-\'_!FD2:MX@UKQ3K7B:TT?5O'
M^N6-MX+TF[AM]>UEOR$/[.7[4;>&OB!!>_ ?]K:_^.I\67%W^V?\6=,_:2O-
M!\%_ME?!>?\ ;*\-^-[KX:_LT^&AX].D:UXHUK]EK3]:T+PMJ>CV_P !=2^$
MG@]+WX G5+W6/'Q33,8X>$YSC[145%0:C.=*I*\[W3G"I"%HV5[.4E*=.,HI
M.4X9JC&4I+G5-146E*4)/6]]8R47:RV;:<HIVU:_HR6POV>5%LKMGA.V9%MI
MB\3;2^V50F8SL!?# ':"W09KA/"<_@'Q/XB\?ZUX'B\*:UXNT+78OAG\4->\
M-Z9ITWB:R\1>#=-LM:MO ?C77+.S75;F[\):5XQL=1L]"U.\N8-!M_$HDM(;
M5M1N _\ /K;_ +%OQT^(B_&237/A#^T?X5^#NC?LQ?M[ZW^PW\*?$WQA\;Z3
MXW^#OC?6_%_P9U;]E?P/XE3PS\3WO+?XC6WB?P_\3_'OP?\ !GB_Q+XMC^%?
MA77M(\/76H:1>:9#H^E]%\%_V'OB1??'_0[;XC_ _P"*>@^'?$?[97Q@_:0^
M-/C/4_%7B73_ (=?$*?QC^PYX)E^%/B3Q?-X9\>";Q9:Z'^T]8^+H?&/@NYT
MV/38/',MA9:OHFIZ,NG>1I]4HI5;XRG>$;Z*-I:MN*_?-S?*DN6%TJFEYQ2D
M[6'IKGO7BN57T2L[/;XWS72V5[2WNK-_O1\2/'_A#X0^$V\<_$K64\)>$EUK
MP=X>_MN_LM2GMFUGX@>,= ^'_@ZQCBT^SO+N5M<\8^*- T.">.W>VMY]3BN+
MZ:VL8[BZA[FYL[NS8+=VT]N6W;/.B=!($.&,;, LB@D?,A93D$$@@G^:CPC^
MS!^UQ=^"[+2/^%)?M&>'O%,'@C]EJT_;'O?BQ\38?'FB?M/?M?\ @O\ ;U_9
MF^)GB/X^_"&TN_'?BNSU3PMX4^%7@[XX^+-:^(.A:9\/])E\"^*/!_@*U\+7
MNH>$HM$\/_4W_!,SX0_M,?!_X\?'^R^)GPQ^+&D_#?Q-X>UF_P!6^*'QQU/5
M+?XA>)OBK9?%S6+OP_:WEUI7QZ^*OPF_:*N-=\$Z_P"(/$%[^TG\/_AC^S[>
M)I%KX6\%^(_!LMW=#2O#LU,+3A"<HXFG.5-7Y4X^^FX)**523O[TI67.Y1<=
M(-3C&)T(QC)JK&3CK9./O*\4DO?>NK>G-=6TB[I?M11117$<YW'P_P#^0^O_
M %SMO_3MIE?3%?,_P_\ ^0^O_7.V_P#3MIE?3%?9\,_[KB?^PF/_ *8B>YE7
M\&I_U]_]L04445]*>H?$G_!0_P#Y-3\??]A/P7_ZE^C5_/1\,[ZZTSXD_#W4
MK#S/MVG^-_"U[9^5H=_XFD^U6NM6<T 3PUI=Q::GXB8RHH&AZ==VU]JI/V&U
MGBFG1U_H7_X*'_\ )J?C[_L)^"__ %+]&K^=CP5>Z#IGC3P?J7BE-6D\,:=X
MI\/WWB2/0+B2TUU] M-5M)]831KJ*:VFMM3?3TN%LIX;FVGCN"C0W$$H25?X
MH^D%/V?B7D=3VD:/L\ER&?MIRY(4>3.\7/VTY\L^2%+D]K.?)/DA2G/DER<L
MOYH\6Y<G&N5SYXT^3+<IE[24N6-/ES*O+VDI6ERQI\OM)2Y9<L82ERRY>5_5
M_P"U1X"T?P_X4\!>,-'\%^%O!T7B;Q9XOTNYBTGX$^//@7KUW>:58:7?W$FI
MZ3X[\9^);C4]'D;5 ^E3:7I]A8I<QWT8NG:W-JGN7_!,'_DW'QW_ -G6_M+_
M /J:VU?)GQZUCX::EIF@0^%?%\7CWQ7_ ,)G\0=;NM?TI_B/_8FD_#O7[JPN
MO!/@F>/XDW,NH_V_X:FCU"&0Z5";*'2WMH+S4M4O0)Q]9_\ !,'_ )-Q\=_]
MG6_M+_\ J:VU=?A[4PU7Q XFJ82.$A1EPWEEXX*MA*^']LL;AU7DIX"E2P<:
MDZB52K2P[K4Z4JL(?6:]1UG1[N"YT*G%^>3P\</&F\DP5UAJF'JTO:+%455?
M-A:<,.IRFE.I"DZD:<JD8^VJS=1T_P!$:***_=#]9"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** /KS1O\ D'0_]=+K_P!*YZU*R]&_Y!T/
M_72Z_P#2N>M2OT_!_P"Z87_L&P__ *9I'U='^#2_Z]4__2(A11172:G\E'QO
M_P"2R?%3_LH/B[_T^WU?7_PO\'6/Q$^ FFPZCX)\,ZOJ7A'X;?$V\T3Q-XG_
M &;/B7JJZ?I>B7?BOQ/-9V'QLM/'FA^!I;V.\EO)="EN-):VTS59QI1MKR[@
MFBN_D#XW_P#)9/BI_P!E!\7?^GV^KVKP?XF^"R?"31K/Q'XLU*WN](\"_%;0
M_%OPZ>Z^);ZWXL\=>)+V:Y^&OB'PB=,U%?AQ:>'_  OLTI[N+65L'BDD\4/J
M.F:U->Z?*O\ F_P]7PU#B+B;ZY+!?5ZL,]ISHX_$X3#4:S_MC,Y1Y:F,H8BG
MSX>:ABU[&C5QD8T^;!T:]>7LE_&N45:%+.<[^L/#>RG'-(2IXJMAZ%.K_P *
M.-:M/$4JT.:C+EQ'[NG/$)0YL/3JU7R+S#]C9MW[;OP.;).[X,?M/MDG).;'
MX.G)("Y)[G R><#I7[V5^"G['.[_ (;?^"&\@O\ \*:_:@WE<A2WV+X.[BH/
M(!.<9YQ7[UU_0'A)_P D%D__ &$9Q_ZM:OK^;/V/PZ_Y)#+?^O\ F?\ ZGS"
MBBBOT@^W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /YIZ
M***_SW/XW/KW_@G)_P G0?'_ /[-J^"7_JW_ (U5]^?MD?LL^'/VSOV?/%G[
M/OB;X@_$KX3V_B+6_ _BG1OB;\(-=_X1WXC^!O%7P]\7Z3XR\-^(/#&IL&@2
MZAU#25M9HKE&C^SW4EQ 8-0MK&[M_@/_ ()R?\G0?'__ +-J^"7_ *M_XU5^
MS=?VIX:RE#@?A:<&XRAE[E&2M=2CF&:M/5-:/HTT]4TTVG_4/!$G'A3()1=G
M'!MI]FL;C[/5-?>FO(\Y^"GPE^'O[//PM^''P7^$OAZ+PS\.?A7X=T[PSX1T
M03274ZV=C))=W>I:QJ4O^EZUXD\1ZO<ZAXC\6>(;UGU'Q%XFU?5]<OY'O;^9
MC\U^'OV&_ _A2+]GV^\/?$#QOI?C3]G']H'XX_'#PCX\M;30(]8\1>&_VD?B
M#\1?'GQJ_9_\9V0M39:M\'O&H^(C:5-8(T&J6&J>"_ GCFRN8O%.A">;[:HK
M[=5:D7*2G*\VW)NS<F^=-RYD[W]I.][I\SNG9<OU2J33;4G>3O)Z.[=[WNG>
M_,[IZ.^J9^.OA[_@C+\'/!?@_P 6>!/ 7QF\9^ -!NKOP%/\+=5\%_!;]F3P
M[\2_A/!\._COX$^/_A]+_P",.E?"BT^)/QMU"Q\0_#OP[X3TW4_B[X@UU+;P
M6EQ%K.G>)/$CIXB2U\5_^"/?P_\ C'HTP\8?M&?%'4?'WBY/VA)/C-\2M<^%
MWP"\<7GQ(UC]I*?P:OC/Q?X2\%>// 7B3P-\ O'GAK0/A_X2\"?#SQQ\)]'T
M[Q-X6\!:;)H4>I75[<_VU#^P%%;_ %W%WYO;SYK\W-:#;?*HW;=-MZ)-INSD
MN9KF]XOZQ7O?VDKWO>T;[<O\O;IM?6U]3\K/B)_P2E^'/Q&?4;W5?B[KMQJT
M?Q#\"_%OP9_PE_P7^!?Q8\(>#_B+H7[.'A3]EOXBZA??#CXH^$O%/A'Q_P"&
M/B[\-O ?@C4+SPIXPM+N;X;^-_#5IXG^'GB'2Y[B\@F^K;W]E#PA>_ OX%_
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M^Z87_L&P_P#Z9I'U='^#2_Z]4_\ TB(4445TFI_)1\;_ /DLGQ4_[*#XN_\
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M?\^H?<__ )(XG_A!=-_Y_+[_ ,E__C='_""Z;_S^7W_DO_\ &Z[:BCZEA/\
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MQ/\ P@NF_P#/Y??^2_\ \;H_X073?^?R^_\ )?\ ^-UVU%'U+"?\^(?^3_\
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M-'"=)$,<U]J%Q=21Q;[!G\M'E*Q[V9]@&XDUP/\ PRKX)_Z&7Q;_ -]:/_\
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MY??^2_\ \;KMJ*/J6$_Y\0_\G_\ DP^KT/\ GU#[G_\ )'$_\(+IO_/Y??\
MDO\ _&Z/^$%TW_G\OO\ R7_^-UVU%'U+"?\ /B'_ )/_ /)A]7H?\^H?<_\
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M/_Y(XG_A!=-_Y_+[_P E_P#XW1_P@NF_\_E]_P"2_P#\;KMJ*/J6$_Y\0_\
M)_\ Y,/J]#_GU#[G_P#)'$_\(+IO_/Y??^2__P ;H_X073?^?R^_\E__ (W7
M;44?4L)_SXA_Y/\ _)A]7H?\^H?<_P#Y(_*>BBBOP$_-3H/V6/\ D\CXN?\
M9H_P8_\ 5Z_'>OTXK\Q_V6/^3R/BY_V:/\&/_5Z_'>OTXK]LX:_Y$&5?]@TO
M_4G%GZ!E/_(LP7_7J7_I^N%%%%>X>@%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5V6C_\ 'K'_ -<Q_P"C[BN-KLM'_P"/6/\ ZYC_ -'W%=N
M_P!X_P"W)_H;4/C?^%_FC6HHHKVSJ"OSW_:G_P"2AVG_ &*^C_\ IPU^OT(K
M\]_VI_\ DH=I_P!BOH__ *<-?KX;Q$_Y)N?_ &,,O_\ 3F(/ XE_Y%<O^PG#
M?^EU#YGKP+]J7_D@'Q!_Z^?AQ_ZMWX?U[[7@7[4O_) /B#_U\_#C_P!6[\/Z
M_%,M_P"1CEW_ &,,#_ZF84^%PG^]87_L)P__ *?HG[O7O_'Y=_\ 7S/_ .C7
MJM5F]_X_+O\ Z^9__1KU6K]^G\<_\<__ $J1^E/=^K_-A1114B"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH UM'_P"/E_\ KG'_ .EEK795QNC_
M /'R_P#USC_]++6NRKVLO_@/_'+\SJH_!\V%%%%=QL>)_M"_\DJU_P#Z^-(_
M].EK7YEU^FG[0O\ R2K7_P#KXTC_ -.EK7YEU^'>)'_(_H?]BO#?^I&,/@>)
M_P#D8P_[!*/_ *76"O:?^"?/_),OCE_V>3^TU_ZF%G7BU>T_\$^?^29?'+_L
M\G]IK_U,+.L> O\ D89A_P!BZ/\ ZFT!<-_[UB?^P3_W8I'W?1117Z>?7A11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'H</W&_ZZS_ /H^
M2I:BA^XW_76?_P!'R5+7TZV7I_F=ZV04444QGY(?$'_D=O$__89OO_1[UQU=
MC\0?^1V\3_\ 89OO_1[UQU?RMBO]ZQ7_ &%8K_U*Q)^1UOXU;_K]6_\ 3M4S
M_AS_ ,GI_LO_ /9-?VMO_3-\$:_6BOR7^'/_ ">G^R__ -DU_:V_],WP1K]:
M*_7>$?\ DGL#_P!?<=_ZF2/MLC_Y%=#_ *^XK_T^@HHHKZ0]8**** "BBB@
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M6;W_ (_+O_KYG_\ 1KU6K]^G\<_\<_\ TJ1^E/=^K_-A1114B"BBB@ HHHH
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M+?4;3QB^G7MG'J-[JGC6\BN!+X.FMDL;"QABA6<W5U<?UY?\$J?^"_W[%?\
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MOYO%5Y#X=\6:5XG29_!_@FWL](T;^T)=#L8#;GQ9K[6D,]V/M,\ODR1^(?\
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M7IT-BMO!&>QH-J,:O,W)).ZT7*V]+6;=MVTD@]G#6TKNZ2U7]:I,_:F/X_\
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M:!/\0O"OCWX,^(++]GO7/AS:^,](\%?#^\33?&6LVWB:++_91_X)1?M'^)O
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MX!N/''A>'QOI'@M<[O&&J>$I=57Q!IWA5 "S>(KS3H='5 9&O @W5^(6H_\
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M$U0^ /#GA[[#JWQ)UFYN+1].^9_AO_P3Q_:-_:,^"?Q--MX-^!GP;L+'4O\
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M<WB*<^7O)1ES)75W&UU='\:OQ(_;<_X)>S^"O$W[$_P\_:P^.6G_ +%/Q?\
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M?B''!<W$*/=?#<ND4TD:,5^+WP^(+*C ,00""0<$ CFO=:\"_:E_Y(!\0?\
MKY^''_JW?A_7XIEO_(QR[_L88'_U,PI\+A?]ZPO_ &$X?_T_1/W@OW=[NY#N
MSA)YE7<Q;:HD8!5R3A0   ,  <"JE6;W_C\N_P#KYG_]&O5:OWZ?QS_QS_\
M2I'Z5+XI>K_-GQ_X+_:KN?%W[4/C+]G5_AKJNF6GAB'61#XNDNIGNFFT*WAN
M)=2UC2FM$MM/\-ZX)/*\.:A%>RR7<D^G[U?[;M@^:/\ @HY^UGXT_9T^)?[)
M'@31_P!I+X9?LH>"/C:W[0,OCGXO_$GX+S?&^&VO?A=X=^'6J>#_  SHWAR+
MQ5X533YM>N/%>N27VIS7%TJPZ;!$L4;'<WZIB&!9I+E8+=;J:*.":Z6"%;J>
M"$YA@FN503S0PGF&*21HXCS&JFO)?%?P5\*>,/C/\%?CIJ5_X@MO&/P(T;XN
MZ'X-L].OK6WT"^L_C3I?A'2/%;^(;.2QFO+V>RM_!6CS:"]GJ&GI9W+WDMU'
M?"2%+?S<BPV88".*6<9K_;,ZN8X_%86J\#0P7U7 8BLIX++?9T)2C6^I4KTO
MK4_WE6_-)/=<.64,;A85UF&8?VE.IC<77H5/JE'"_5\)6J*6&P/)2<HU?JM.
M]/V\K3J7N^Y^7_PW_P""KL_@GX:>"H?VGO@W\7M:^(:?"75OC-XS^(7PC^$_
M_")^ -5^%&L?M%_$K]GC]G#QW9_#3XD>.K'XI>'?&W[5NJ>$? FI?#WX+VNF
M>)M?LM1^*>E)?WVG>'-&\0:KHGK/C+_@J)X+T/0O$/AG2OV>OVF;C]IO0=8^
M*'AGQ#^R]#X-^'>L_%7X>2?"WX1^$_C-XF^(GBF[L/BBWPLU[X9Z=X&^)/PP
MUK2M3\%?$CQ'JGCC4?'6A^"O".CZIXQ.I:+I_P!&?'#]BCX,?M#>*/BAXK^)
M-QXYFO\ XK_ OP%\!=93P]XH/AUO#^C?"_XL>(/C?\/_ !WX-U.QL?[9T+XF
M^$_B7KT7B31_$+:A>:?;W6@: 7T246UW]M\)UO\ X);?"G7;*?7;OX\_M56G
MQSUWQ=X_\3^./VIM)\?^!])^./Q"L?B?\,?!WP:\>^ M>>S^&<?PPTSP!J/P
MU^'GPYT'1=#\'?#;PU=>"=2\"^&O&/@_4]&\90W^NZA[:EA7:34U*Z;6O*GK
M=)*RMMY;V/3O2W:=][:V\]M+&1\ O^"E/@WQ9^SCX-^(GQ.T3Q+/X]T'P'_P
M3BB^,%YX8T'2M*\+7_Q&_P""@GAGX32>%=3\%V.H^(_M5EX.T#Q'\3[6Z\50
M:N]M?Z!HMK>1Z9%K]Q:Q+<\%X]_X*L:M<^'?@UXJ^!G[(?[2'BOPA\9/V@OV
M;? ?@/XD>/?!WA'PC\-OBY\%?CC\2=2\!W/Q+^$WB6[^*&GP6GB.?^RX;OPA
MX'^*"^"O&5UH7BKPE\0;WP9-X(O-1U'2_2X?^"2?P-TR;P3;:!\4/VE?#/@[
MPOX8_8T\.>)/AKI/CGPK+X!^+&H_L(:CX2N_V?/%WQ*L-7\ :GK5QXAL].\%
M:'X?\:6GA37O"7ACQOIME97&L>'Y-6TO3-0M=+3/^"5WP?\ #_A[3O#&F?&+
M]J6#1/ ?B/X1:[^SYIFH?$S0M;T?]F+2/@?\3#\6/!/@SX0^']7\#7?A^_\
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M$G7M*O8? OQ^\/?"/QEJO@FY?Q7H^BWME:7T=KY/\0O^"JFL1?$1[/PQX/\
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MC'X.ZG9>.--\4>#(_B[HMX9=7^#EY<:A\5?@)\+/$WQ=^+WP=M/!.E_%:_\
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M]?<5_P"GT8/BK7XO"?A;Q+XJGL-1U6#PSH&KZ_-I>D0_:=5U&/2+">^>QTZ
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MGH(5\+?12LDK*2F[N^NS^;N]>FH7I7VM\G_P?4G_ &<O^"K/[,?[3_[1%_\
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M-?\ (@RK_L&E_P"I.+/T#*?^19@O^O4O_3]<****]P] **** "BBB@ HHHH
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M$^#WC+X6?M,?!OX+>$+O3_@7X5^+,/BWX?>%[;2_B?K\&J:?^V9\3[368?\
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MZM\+/!L#7K)X9\(>%/$6MZ/KGB?_ (1OPU#%%I^FZUXEF\,^$]-U?645[IM
M\*Z)H=D+*PCOHKXEB(2C*/*XWY[;67,K+1)+?>]_T9[2+35GULK*VJ\CT:BB
MBN,P"BBB@ HHHH _*>BBBOYW/R\Z#]EC_D\CXN?]FC_!C_U>OQWK].*_,?\
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M:BBBO;.H*_/?]J?_ )*':?\ 8KZ/_P"G#7Z_0BOSW_:G_P"2AVG_ &*^C_\
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M(^VR/_D5T/\ K[BO_3Z"BBBOI#U@HHHH **** "BBB@ HHHH **** "BBB@
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MWZ?QS_QS_P#2I'Z4]WZO\V%%%%2(**** "BBB@ HHHH **** "BBB@ HHHH
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MK8K_ 'K%?]A6*_\ 4K$GY'6_C5O^OU;_ -.U3/\ AS_R>G^R_P#]DU_:V_\
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M_P"1_0_[%>&_]2,8? \3_P#(QA_V"4?_ $NL)7M/_!/G_DF7QR_[/)_::_\
M4PLZ\7P?0_D:]H_X)\_\DS^.7_9Y/[37_J86=8\!?\C#,?\ L71_]3: N&_]
MZQ/_ &"?^[%(^[Z***_3SZ\**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH ]#A^XW_76?_T?)4M10_<;_KK/_P"CY*EKZ=;+T_S.];(****8
MS\D/B#_R.WB?_L,WW_H]ZXZNR^((/_";>)^#_P AF^['_GN]<=@^A_(U_*V*
M:^M8K5?[UBNJ_P"@K$^9^1UOXU;_ *_5O_3M4SOAS_R>G^R__P!DU_:V_P#3
M-\$:_6BOR8^'0(_;3_9?R"/^+:_M;=?^P-\$:_6>OUWA'_DGL#_U]QW_ *F2
M/MLC_P"170_Z^XK_ -/H****^D/6"BBB@ HHHH **** "BBB@ HHHH ****
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M)E@,RPDE3QN7UZN'E4H?6\!B55P6.I4ZM98;'8;%X25:K4PM6;_H(_MC5O\
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M_&LZBCDA_)3_ /!=/_Y ++LON7^1H_VQJW_02O?^_P"_^-']L:M_T$KW_O\
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MFDTTTTTFK:,_N7O=8U;[9=_\3*]_X^9_^6[_ //5_>JW]L:M_P!!*]_[_O\
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M^#KY]9LC97MCJNCZ<<D/Y*?_ (+I_P#RL++LON7^1^T/]L:M_P!!*]_[_O\
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M)'#?&_XJ*?1_&&M(?R:<&OZ7_P#@EKK^N:A^QSX7UR_UC4;S6O$GQ&^+FO\
MB'5KFZDEU#7-<O\ QI>"]U?5+IR9;S4;L11"XNIBTLHC3<QVBOPK_P""AT'B
M?3_BM\/-"\3ZIXJUMO#?PFBT'1-7^(^L:IJ_Q:U70=-^)?Q(MK+5?BC_ &IH
MGAMK/7M4:.6^T.&UT.SMY/!<WAN22?5+S[3J5S^WW_!*G_DR3X>?]CA\4?\
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M_P!_\:/[8U;_ *"5[_W_ '_QK.HHY(?R4_\ P73_ /D LNR^Y?Y&C_;&K?\
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MY(?R4_\ P73_ /D LNR^Y?Y&C_;&K?\ 02O?^_[_ .-']L:M_P!!*]_[_O\
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M$7P UZ'X;6_[)%W\,5^,PUOXBM\8X/A1XMT^/1?BSX3\2> =>^&GC;QEI7Q
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M_P"'WC;1RUSI.HW/A_7M<\.ZUINHVFL>&/$_A[5]1T/Q1H&LZ7<M:CYTO/\
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MY9S^./#FFFP;Q->^-+SPMX8:^\&^#+OPWX<OKBP;B[W_ (*??#C3=5T6.^^
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MPKIDD?T/X2_9M^&7@O\ 9WD_9=T9O&:?"N7PQXY\)/*OC;7-*\>Q:9\0]?\
M$WB?Q!=Z;\0?#,V@>(]#U^WUGQ9JEWX?\1:#<Z9J^@R1:=+8W2W%BD[^]44
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M !1110 4444 =MX"_P"0V?\ KC;?^GC2Z^BJ^=? 7_(;/_7&V_\ 3QI=?15
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ME_14_A+U7EW_ *_'J.'Q/T_R/T2HHHKF- HHHH **** "BBB@ HHHH ****
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MO>V7PQTOJMTWV[&"Z^AO?\$=<?\ #6>LXZ?\*3\<8^G]N>#,?I7].E?S&?\
M!'7_ ).SUG/_ $1/QQ_Z?/!E?TYUA6^/_MU?J:0^'YL****Q+"BBB@ HHHH
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M110 4444 %%%% ';> O^0V?^N-M_Z>-+KZ*KYU\!?\AL_P#7&V_]/&EU]%4
M%%%% 'YA_P#!8?\ Y,%^+7_8<^&7_JQ_#%?R??LG_#:#XI_'[X>>&=5^'OBW
MXF>$H]4N-6\;>&O!VCZSK5\?#>FZ9?W4E_JMIH%Q9:LWANSU*/3Y?$$&G:CI
MNK:KI0NM$T"\7Q!J>E12_P!8/_!8?_DP7XM?]ASX9?\ JQ_#%?R??LI>&M$\
M8_'#PIX5UCQ]\5?AS<>(8M8T?0-;^#6@W.O>-[W7[[1[Z'3]"MTM-<T.?3=-
MU-R5U?4G>\L8M-BNH=333;":?7=*Z:7\.7J^_9=M3*7Q?<=9^V%X T;P!XO^
M&L.F>!;3P+J/B3X2:1X@\5P:#X+^(/PW\"^(/%"^+/&&B7GB#X?> /BQ+_PL
MGPQX>>PTC3-+O(?%%CHXU+Q'INM:MHFE0Z+>6=Q=?O\ _P#!*G_DR3X>?]CA
M\4?_ %-+^OYT?VE/AE9?"CQ;X4\.P:_\0_%U[?\ @+3?$&J>+?'EKX?@L/$<
MVH:UKT%A?_#RY\,>.?B3I6I^"(=*LK/3Q?Q^-=9?_A)[/Q';?Z(ENEI%_1=_
MP2I_Y,D^'G_8X?%'_P!32_HJ_P -==5^O?4(?$_3_(_1*BBBN8U"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** /J_2O^/&/_KK=_P#I7/6C
M6=I7_'C'_P!=;O\ ]*YZT:;W?J_S8!1112 _SY?VFB!^T9\>R2 !\8OB622<
M  >,=9)))X  ZFOM7X>_L[>'_P#ADV7Q3XN^ GB0^(M5^%GQ^\<W/BK5_AG\
M6#XSU#4/#:->_";QG\./B79WEG\'/!OPN\.Z;IMW=^.='^($=KX@\76L.K3^
M&['Q1'KOA.6U^*OVFL_\-&?'O !/_"XOB7@$X!/_  F.LX!(!(&>IP<>AZ5]
M36'P-\+^)_V8]#^*-C\7?VFO%FC>'OAI\4KG4?AW;>%]'L/#.F^)?#5Y<2/:
M>&+?6_BL-1O?A9X3U?4M%O/B=XA\)^!O&&GPVDFH7T]SX4U*632=+[9;1UMJ
MN_966C7XF"Z^GE^IZ!_P1U.?VLM9/K\$_'!XZ<ZYX,Z9Y_.OZ=*_F+_X(ZY_
MX:SUG.,_\*3\<9QTS_;G@SI[>E?TZ5A6^/\ [=7ZFD/A^;"BBBL2PHHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^#&Y_X]Y\H9!Y4GR*6#
M/\I^52OS GH"OS \CG%?IY^W#9>*-%\$:5I>I>(;GQ3#J7CSPUK?BWQ]I'@'
MX >#_#OQE\9VGP[GTJR\?Z[K'PV^)WB[XD>+?$FFZ0;[1M,O/&_A7PU%'%=>
M(;[5HX?$^I2B]_,FH8[:WA8O#;PQ,PPS1Q1HQ!()!*J"1D X)QD UWM7:?:^
MEC"^C\S]W/\ @B1_R%?VE?\ L%_"S_TM\:U^R'QV^#FG_'OP ?ACK_B+6=!\
M':QXG\*:EX]T_0TA$_CSP7X?U>'6=8^&FI7<CI+IWAWQK):66G^)+JS\R[GT
M6.\TH1/;ZE<X_&__ ((D?\A7]I7_ +!?PL_]+?&M?OE7#BJ5.LJM&K%3I58>
MSJ0;:4X224H2Y7%N,DN62NE*+E"5XSG&7JY/FN89'F.7YSE.)G@LTRO%4L=E
MV-IPHSJX/&X=U'A\705>C7I1Q&&J5/;X:JZ,YX;%4L+BZ#IXK!X.OAN1\ ^
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M^_\ ^UKF@#T.BBB@ K^1G_@NM_R>)X5_[(+X)_\ 4S^)=?US5_(S_P %UO\
MD\3PK_V07P3_ .IG\2ZUH_&O27Y(B?P_-'A'[$=EXC7X:^-?$&C:U+J$OA[X
MO^%M3\+^#M.^'_P"\;>)?!GCFR\%:K)8_'/PK>?';XF?#JV\,ZSH]I-#X8M+
M_P -#7F:_;3KG5[$/I^D36_P]\)=_P#PNKX5^9)++)_PN'X?^;-<.)+B:7_A
M/M'\R:YD#R+)<RONDN'621'F9V2212';R^6VMYR#-!#,5&%,L22%1G. 74D#
M/.!QGFO2_@[Q\8?A!CC_ (NO\-?_ %-M"KIM;F??RVT,V]O(_N,O?^/R[_Z^
M9_\ T:]5JLWO_'Y=_P#7S/\ ^C7JM7";A1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% ';> O^0V?^N-M_Z>-+KZ*KYU\!?\AL_]<;;_ -/&
MEU]%4 %%%% 'YA_\%A_^3!?BU_V'/AE_ZL?PQ7\FG[*=KJM[^T=\(+71/&<'
MP]U.7Q3.(/&%WIF@ZU::7#'H.LRZA:W>C>*]0TGPMJUKXATV.\\+W&F^)=3L
M- O8=:>WU>YCL))S7]9?_!8?_DP7XM?]ASX9?^K'\,5_%BZ)(K)(BNC##(ZA
ME89!PRL"",@'!'4 UTT5>$EW;7X(RG\7R1]9_M@)J-IX]\&:/<:5J7AG1M!^
M&^F:3X2\&7'A3X0>"=%\'>'T\0>([TZ/X6\-_!3Q]\1_"UGI5QK%]JNKWMUJ
M7B)O$FH:[J.J76H0?9&T^>7^@7_@E3_R9)\//^QP^*/_ *FE_7\HL4,,*E88
MHX5)W%8D6-2V -Q"  G  SC. !VK^KK_ ()4_P#)DGP\_P"QP^*/_J:7].JK
M4TNS7ZA#XGZ?Y'Z)4445RFH4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!]7Z5_QXQ_]=;O_P!*YZT:SM*_X\8_^NMW_P"E<]:--[OU?YL
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>image_004.jpg
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $+ E(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_"BBBN<Z
M HHHH **** "BBD^OX<?_7.:+[7TOU>VGGTZ;V6NXFTOGMYBTUB!@D\>G7].
MIYQTSVX[UDZ[X@T/PQI5YKOB/6-,T'1=/C>:]U76+ZWT_3[6- 27GN[J2*%,
MXP$+[W;Y4!;Y:_,?XT?\%-_!7A][S1/@MX??QYJD:R0KXMUS[1I/A&&8,4$E
MC9!4UG78U(\P,RZ3:OA?+GG1F9/G\^XIR#AJ@J^=9E1P7-&3I8=N53&8CE3T
MH82BYXFK%M<KE&$:6Z=9*[/*S3.LKRBBZN8XREAUO"FWSUZMNE*A%3JSOM=4
MTEUG%K3]2WE2-))I9$BAB0O))(RQQHBJ79Y)'VHB*HRS,P48))P":^7?B/\
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M9\+?V"?A)X,6TU'QL;GXE:["T<K+K"FP\,P3+M?%OH%O*PO(U8 '^U[F[69
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M+ _W*^6O''[%7[1'@A9ISX,3Q=I\)8_VAX*OX=;9HXXA-+-_9<BVFM! 08D
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MQ1PP001I%%!%&H5(H8HU2.*)% 5(T551550H YFP.G;!&/K^OZ_KS1TP!GG
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M:W/B3PX++PA\3HDDECUJ.WV:9XG=(P(K'Q5!",NQ*A(-:@C;4+4,PE^UVX$
M_!_QIX/\3^ /$>J^$?&6C7F@^(](G,%]IUZOSX.?+NK:=,P7UC=(OG6E];22
M6\\15T=LG'WV4YEA\?3C&FU&O&WM*$FW)6^U&^LZ;:OS*[5[22:N?Q3X@>'6
M><"XJ7UJ,L;E6*E.G@<UHQ?L*TDG4C1KI*3P>*45K1J+DGRN6'G5AI'K?@U\
M;O'?P(\6Q>+?!%_L$YA@U_0+QG?1?$VG1R%S8ZG;HWRR*K2&RU*';>Z?+(SP
M.4>6*7^ACX#_ !X\%?M >"XO%?A29K:]M6BL_$WAF[D1M6\-ZJ\>XVEXJ8\^
MTGP\NFZG"JVVH6X+ILFCN((?YB7S@#MDG\?\_P">*].^#GQA\7_ [QQIWCGP
M?<D36[1V^LZ-+*Z:;XDT5I5:[T?4XURK1RJ-]I<[6EL+M8KJ JRNKWFV14\S
MI2JTE&GCJ<?<G)KEK6B[TZJ25^>RC2:UC)Q4F>AX7^*N.X'Q=/ 9A5K8[A?$
MU$L5A^9U:F62G-0EC\"ZC33C)N>+PJ4(8F$95:5.&)C&=;^I09'')&,@_P!.
MF..WMBG5Y9\'?C!X.^-W@?2_'/@R[\VSO5\C4M-G9!J7A_6(4C:^T358%8^3
M>6C2 JXS#=V[0WEJ\EO,CGU(G\>,\8/Z9S_2OS6I3J4YSIU(3A4IR=.=.2M.
MG*+:<9)VVMH]K-:G]VX+&X3'X/#8[!8BEBL)C*-+$8;$T)JI2KT:T(SIU(2B
MVG&46K_"XR4XRC"4)QBM%%%9G6%%%% !1G].:*0]1U^GKTZ_0<T;Z=7>U]KI
M7U?1))MNSM;83T7]:];?UZ@3P<<D8.,9[_\ UJ_"G_@HM^UI)XMUB^^ /P[U
M:3_A%-"NQ%\2-7L;B,P^)=<MG21?"T$\3,TNBZ'.@?6 '5+W5XULW5H-/?S_
M +L_;O\ VF&^ 7PP.C>&+Y(OB=\0H[S2O##1NIGT#2Q&L6M>+&3:^Q]/CF6V
MTCS%59M5GB=2R6D^W^;(EF+L[O)([,[RR,7EED=B\DLLC$M)++(S/+(Y+N[,
MQ.3FOYH\=?$5X.#X)R;$2AB<7153/\12FXU,-A*D>:CEU.5-\T:N,C:KBDI0
MFL+*G0:3Q%2*_*/$/B?V$/["P-5QK5X1EF%6G)J5*C-7I86Z=XNNOWF(Z*@N
M27*ZNLZ?ZTG@<?T'3Z5;C1Y)(XXHY)9998X88HD:6:::5UCBBBB3,DDLLC+'
M''&K.\C*BJ68530@.22  !GL.1Z] !CUX]:_:#_@GC^R)"L&E_M"?$W2HYI9
MPEY\*M OX]PM8?F \<ZA:2+L-S."5\,Q3J6MH-^K>6L\]A)#_/\ P9PCF?&>
M>8;)\NBX4W&E7QV-J*52A@,'%PC4K5F[J;BKPHT%*+K8B:IPBJ<:]2G^8Y#D
MF+S[,*>"PWNQ]V6*Q#IWI8;#W3<M$H*>C]E%6E.I**O92MZQ^Q!^Q):?#.RT
MOXM?%C2X;SXEWL,=[X<\.WL:3VO@&SN(P8;B>%]T<GBZ:)MTTYWKHR-]EM0M
MY]HF'Z<D'G&.>23SU_'K^&#ZT#L <@=6)R3]??H<]^:6O[YX;X;ROA;*L/E.
M4T%1HT8MU:DK3Q&*Q$XI5<7BZEDJU:K9NUY4J=-PI4HQITXI_P!)Y3E6"RC!
M4L%@J2A2IJ\Y/6I6JNW/6K3LI3JSDN9N7P:1BHQBDVC&,#C'&/3V_.O)_BY\
M:_ 'P5T(:SXUU;R;BY60:/H%@L=UK^NSQE0T>FV!="8XV9?/OKAX+&U!S/.I
M*HWD?[2W[5/A[X'67]@:/':>(_B3J-L9K+0S-FRT&UE5A!J_B1X3YD4<C8:Q
MTM&2[U *7+6]K_I#?B5XN\8>)_'OB"^\4^,-:O=>U[49"]Q?7DF=D>XM'9VE
MNN+>RT^WSMM;&UCBMX$ "+G<6^AC#:ZT_P"!H=\I=$WZ];W_ *UZL^@/C?\
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M5O!#%!;P1QPV\$,:1PPP1((XH8HHU6..**-5BCC10J(@50  !XA^SG\$='^
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M*"A82+^I7Q#T'4/"O[+'[0OAG5U@75/#WQV^%^C:B+:87%M]LTZ/Q#:SFVG
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M?/[Z#..<9'! .<>WMCWQ^5?D/$&6/*\RJT(I^QJWKX9O_GS-R:CYRISYH/\
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M\::S:DS7:AU92V@Z),73&&CNM7M9U_>0QLOY9C=EPJ/([;52.-2TDCMPD4:
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MZ.'92RB10:\CHKT*F&P]>#IU*%"K#9QG1I3A[ZMLZ<H^\FU>S6NI\=@\WS?
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M6%UX;GBT2/6;73T^PW"0WZV^H:E:Q"VO;G,\-? /X;>(M>TO08M1\5 +\-?
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M&CNO\]_QA^+7B/XT>.=2\:^)"(3,!9:)I$3,]GH.AP2.UEIEOOX=P6-S>W0
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M$_CSQAXSM/#EEXKUZ[U^+PGIDVC:!-J*6\M_8Z7-=->&P?4A"NH7UO'<22/
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M8_MQ> 7\&?'75=9@@,>E?$"PM?%%HZ ^7_:04:=KL+/\PWF]MEOF4E&/]H*
MJQ[-_P >U^X'[<GPL;Q]\()O$FFVQG\0?#:XF\16PC0O//H,T:0^)+.,*"[
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M_P!HDL=W89YX'<<1);HC;LEL$$ G@8.0> ,G\A[=Z^^OVK-4^$?B?P'X#N_
M?CCPMJ&J>!;Q/"5CX;T7^RGO_$?AN72[&TB^(<HL(+3_ (1NPOX] TUA\/FM
MA>^&]<O]=O[V25M3WR_!O^>F/T[?3MTKP.)N',+E&;K"3Q&#S;V.'PF(H8Z@
MJ;IN.)H0J\D?9UJTOW-=8BGRU:CF_90K*,(8BGS?:9;XD^)'ASDV?<#<*\<Y
MOEO#/$F&@\YR_*\52IX''K&87V&,Y>3ZS5PM3$8=U<%BJN%Q6$KXK"RY:LG&
MK$*55=V1(XY)I9'2**&%&DFFED81Q0PQKEI)I9&6.*-06DD944$D"DQG_/\
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MY;1^6_$?QI\;?%/PQFT'Q[HVA>&O#/P^\4^'O#YT)_!K>$/%NF2:O:^(=?\
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MQA\1OHTUA=^%I9P^C6W@+2]9\#:D+FXTZ-Y[G5]2>\O)-.LXV;X% !4 C((
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MA2Q\7Z1H=MK,TUMI-E:6FO>/O%FGZ-\!/"GQ FTSP3)>7D-GK-QXBU?4+QK
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M)00.?7@>@]*BBB6*-(HT2*.-%2)(T5(XDC542-$7"K&J*JHJ@!4 7H.9A_\
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MCY#B_AJ'$. M1Y89CA%.I@JDM%.Z:J8:I+?V=5/W6W^[J\D[).9_*)&,2X]
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MG_[+%\(?_2+6^O\ ]?V[5^>-?P5])#_DXR_[)_)__=T_ O$[_DHJ/_8LPO\
MZ<Q 444?_6/X'H?Q[>M?@EUU=MW?79>23?X6[M'YXE=V6_;7\[-+YV"BM/0]
M$UKQ/JEOH?AG1M6\1ZU=ND=MI.@Z=>:OJ4[R.D2!+.PAGG*M*Z1AR@02.J%@
MS*#^C7P1_P""87QK^($EIJOQ/N;7X1^%Y=DSV=V(-7\<7<+,3Y<&C6\K6&C,
MRALOJUX;B >7G3I"[K%])P[PAQ-Q7B%AL@R;&YA*Z4ZT*,J>#H<S23Q&-K0I
MX.DK/FM*O.;2?+2DU8]7+<DS7-ZBI9=@L37U2=:--PHTVVE>=>HHT8I7N[U'
M)+7V<MC\XM*TG5->U.QT30],U'6M:U.X2UT[1](LKC4-3O[B0A4AM+.U22>5
MRS*&*(5C4EY"J L/V7_92_X)E/YNF>/OVE(8F1?*O=*^$MO.)8W+QB6&7QW?
MVS@.T;,KMX<T^=X68"/5+R5!-8G]*/@9^RY\&_V>;$P?#SPM#'KD]N(=0\8Z
MTZZKXNU0 ,&$^KR1(UI;2%B6T_2X;"QP,"W&%8?1  ZX&3UXYSC\_:OZS\/?
MH_99D<Z&;<7U,/G6:4N6I0RRG>>4X*LK3A+$.?O9G5I-M*%2G3P5.:_A8G1+
M]AX:\.,'E\H8O.94L=BXM5(86$$\%1DK<KFY1C/%.+Z3BL/S)25.;2*MC9V>
MG6EMIVGVEM86%A;PVEE8V5O%:V=G:6\:Q06UK;0JD,%M#&BQPPQ(D<<:JB*%
M  M'@=A[GH!W)]@.:"<?CTX/7\/\_E7S)^T)^U%X%^ FFRVMY*GB'QY=VQET
M3P98W 6Y996VQ7^N7**ZZ-I*-EC+,K7=V%:*QMIN9$_H;&8O!Y9A98G%U:.$
MPE"FO>J6C2C&*Y84H0T<Y-14:=&G!MVC&,5'X/T;%XS"9=AIXC%UJ6&PU&%Y
M3J.,()):0A'>4G:T*=.$F]$HV^'U+XI?%;P7\'O"MUXN\;ZDEA81$PV5K'LE
MU36M09&:'2]'LMRR7=[-L8D B&"%))[N2"!&D'X,_M!?M#>+_C_XG_M#5C)H
M_A32I95\*^#X+@R6FEQME&U#4'5434=>NTP;F^9 ELF+.Q6.W5VGX?XI?%GQ
MQ\8_%%QXK\<ZK)?73/,NF:9"7BT;0+&1RRZ=HUD79;>%%P)9W+W=X^9KN>60
MG'F__P!<^G;_ #_*OP[B;C+$9]6>#P2GALJC)KD<FJN,<'=5<4]HTHVYJ="+
ME!)1<^:<4E^#\6<:8G/9SP."<L-E4'K!2M5Q<H.\:F):TA15N:&'BY0:Y9U>
M:<5%21Y^;DD#''8>Y]_3V('N;-O!<7ES;V=I;SWEY>3Q6MI9VL3W%W=74[K'
M!;6UM&K27$\\C".*&)6DD=D4+EL5+HVE:IKVJ:?HFB:?>:MK.K745CI>EV$#
M7-]?WLS!8[:V@0$O(Q)W$C;&@=Y"L:NZ_MI^RK^R#I_PACM?'/CN*SUCXEW$
M :T@ CN=-\%1RH1+;Z?(=Z76MR(?*OM64!(!YEMIVV)I9KCBX>R#&Y]BU"A>
M&&I23Q6-DG[&E!O:#=HSJSLXTJ46TG[TFJ:DWXO#O#>.XBQ2HT5R82DXO%8V
M2;I4H)II)V4:F(FD_9T(N5DU.<XT[MT?V1?V2;?X66]K\1/B':PWGQ)O;4/I
MNER>7<6W@>TN4^:-6PR3^)+B,E+^]0F.P4O963$FXN)_O<=.Y]SG)]^<GGK2
MX'H**_?,OR_"Y9A:>$P=-4Z5-*[=G4JS:7/5JSLG.I)J[>W1*,8QBOZ-RO*\
M'D^#IX+!4E3I05Y2=G4K56DIUJU2R=2I.RNW912481C"*B%%%%=IZ(4444 %
M%%% !1110 4444 ,Z9&/E.<GC@Y_0#'X=_2O!_C[\!O"OQV\*'1M6*Z;XBTX
M2W'A7Q3! DMYHUZPR;>< *]WHUZP6._L"ZEALGMWBNXH95][IA"J0<=>_;_Z
MV.V/>HG3IU(2IU8QG"2Y7&6MT[Z/YZW5GI=-/4X\;@<+F&%KX/&4(8G#8BG*
MG6HU$G&I%K3>SC-.TH3@XSC*,91DFDS^:#X@> /%/PQ\5ZKX.\8Z:VFZSIA&
M0-SV6H6CL!;:GI5R55;W3KM-LD$Z#*$M!.L<\,T:<37]$?QU^ OA'X[>%VT;
M78_[/UJQ$LOACQ3;0I)J6AW<BY*D91KS2[E@!>Z=(XCE"K*C17*12I^$/Q2^
M%?C+X/>++KPAXTT_[+>1[[C3-0MU=])U[2_,,<6J:1=%5$UNY&R>%L7%A<9M
MKM$E +_(XW+9X*I*<$YT).\9:MPUTC-[)):0E9<VB:YKG\Q<:\$XOAK$2Q-#
MFQ.359M4,4[REAISDW'"XM1C:G.+:A2JM1IU[+X:KE!X_@;QUXJ^&_B?3?&'
M@W5IM'UW2W!BGCR]O=6[,IGT_4K4GRK_ $V\11%=6D^4=2&C,4RQ2)^YO[/'
M[3OA#X\:9]CB2/P_X^TZU6;7/"4\H;<B[4FU/0)WVMJ.DF1E+K@7FGF1(KR(
M9CFF_ 4CM_\ 7K2T?6-6\/:I8ZYH.IWVC:SI=PEUIVJ:=</:WMG.A&'@G0[E
MR"0Z$-%*A:.5&C9E;HP.,J8:3BKRHRUE!Z.-^L+Z1:>LD]TFO-<7"7&N8<*X
MGE7M,7E56498K+Y3=HN7NRKX.3;5"NE\5FJ-6W[V#?+4C_4&H(.0?E/.#G@]
M\9[>F>WKQ3B,^H]""00<8ZCZU^?7[-O[;&C>//[/\%_%>XLO#7C5_LUEIOB$
MXMO#_BR<A8E$Q.(=#UN>38QMI&&FWCR@6<L,A%FWZ!X4X&<XZ<D>AR#P3G@C
M&01R/ER:^FIU*=:*G2FIQ:7R=M5;IKNM^NJU/Z=R7/,LS_!0QV68B->E-1]K
M#W88C#5.57HXJC=3I587L^9.,DE.G.<)19\<_M$_L@>$OC&;KQ/X:DM?!_Q&
M93))JD<&-&\22*0RIXDM+=-PNB RQZW:)]M3<WVN.^C2.-/QO^('PU\;?"S7
MI/#GCO0;O0M1!?[/)*OFZ=J<"''VO1]4CS9ZA;.1NW02&6(LJ7,-NY,8_I8'
M('0^^/0G^5<OXQ\$^$_B!HEQX=\9Z!IGB/1KG)DLM3MEF"/VGM)OEN+*[3K'
M=6LL,Z<@2 $UK&35KO3KUT_JVQZSCHVEJ_73^OZL?S,#T[<X&/N]..G&#U
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M[HMNEMI>BZ1:Q6=C9PQ]DBC W/(Q,LT\A:>>9FFGDDE=V;HSSG/?K[TTY!X
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M#GBN=(_.\&^+7@T?6?/(421:?-)*=.UM%=ML<FEW4TLBKO>"%Q)&GU0>.O\
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MXBN^_P"'_ _K[C]R?FSC:3C!/!]_;V)!P<XQC)I"V%+$8102SD@*% R6))P
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MQT'![8Z8Z]?K]:6OC^^^[WO^%]EV2T[']*1V6ENFNFVGX[^K84444QA1110
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M_7EY'>F_^!ZZ?F?N@#GL0.<$\9Q_G\N>XI>X Y)SQWX&?Y?S'K7\VFG?&O\
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M-I6UC&-S^?U>C_3^AIE?9W[1GPC^'WP_T;2+OPEH+Z5<7=Z8;B1M9U_41)&
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4M@HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>14
<FILENAME>srna-20201231.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SRNA %2D 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D23T20:34:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:SRNA="http://surna.com/20201231">
    <link:schemaRef xlink:href="srna-20201231.xsd" xlink:type="simple" />
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_AdvertisingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:AdvertisingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-07-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QFourTwoThousandSeventeenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_EngineeringAndOtherServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:IndependentDirectorsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_InventoryValuationAndObsolescenceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">us-gaap:InventoryValuationAndObsolescenceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-27_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-06-26to2017-06-27_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-06-26</xbrli:startDate>
        <xbrli:endDate>2017-06-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-01-02_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-12-30to2018-01-02_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-12-30</xbrli:startDate>
        <xbrli:endDate>2018-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-08-30to2018-09-02_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-08-30</xbrli:startDate>
        <xbrli:endDate>2018-09-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-08-30to2019-09-02_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-08-30</xbrli:startDate>
        <xbrli:endDate>2019-09-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_CoFoundersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_WebSiteDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">SRNA:WebSiteDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EquipmentDemonstrationAndProductTestingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-05-01to2017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EquipmentDemonstrationAndProductTestingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-05-01</xbrli:startDate>
        <xbrli:endDate>2017-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-05-01to2017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EquipmentDemonstrationAndProductTestingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-05-01</xbrli:startDate>
        <xbrli:endDate>2017-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_AccountsPayableMember1108719890">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-05-01to2018-05-31_custom_EmploymentAgreementMember_custom_CoFoundersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-05-01</xbrli:startDate>
        <xbrli:endDate>2018-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-05-01to2018-05-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-05-01</xbrli:startDate>
        <xbrli:endDate>2018-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QTwoTwoThousandEighteenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_QTwoTwoThousandEighteenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QTwoTwoThousandEighteenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:IndependentDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:TwoThousandAndTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:TwoThousandAndTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_EngineeringAndOtherServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_AdvertisingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:AdvertisingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandSeventeenEquityPlanMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-08to2020-03-09_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-08</xbrli:startDate>
        <xbrli:endDate>2020-03-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-23to2020-06-24_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_TwoNewIndependentDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:TwoNewIndependentDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-23</xbrli:startDate>
        <xbrli:endDate>2020-06-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-23to2020-06-24_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_AprilOneTwentyTwentyOneMember_custom_TwoNewIndependentDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:TwoNewIndependentDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:AprilOneTwentyTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-23</xbrli:startDate>
        <xbrli:endDate>2020-06-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-29to2020-04-30_us-gaap_SubsequentEventMember_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-29</xbrli:startDate>
        <xbrli:endDate>2020-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-22_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-21to2020-04-22_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-21</xbrli:startDate>
        <xbrli:endDate>2020-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-07to2020-06-09_us-gaap_SubsequentEventMember_custom_FormerEmployeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:FormerEmployeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-07</xbrli:startDate>
        <xbrli:endDate>2020-06-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_AgreementWithLandLordMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:AgreementWithLandLordMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WarrantsRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">SRNA:WarrantsRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WarrantsRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">SRNA:WarrantsRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-24_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:TwoNewIndependentDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_InventoryValuationAndObsolescenceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">us-gaap:InventoryValuationAndObsolescenceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:OneCustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">SRNA:PurchasesOfInventoryMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:SupplierThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandAndTwentyIncentiveAwardsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndTwentyIncentiveAwardsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_CoFoundersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_WebSiteDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">SRNA:WebSiteDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_PatentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_WebSiteDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">SRNA:WebSiteDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ThreeCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">SRNA:ThreeCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-10to2020-12-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-10</xbrli:startDate>
        <xbrli:endDate>2020-12-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-10_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-09to2021-02-10_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-09</xbrli:startDate>
        <xbrli:endDate>2021-02-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-30_custom_LeasedEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">SRNA:LeasedEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-24_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember_custom_AprilThirtyTwoThousandAndTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:EmploymentAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:AprilThirtyTwoThousandAndTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-06to2021-01-07_custom_ConsultingAgreementMember_custom_MrJamesRShipleyMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:ConsultingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:MrJamesRShipleyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-06</xbrli:startDate>
        <xbrli:endDate>2021-01-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CoFoundersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:CoFoundersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-01-02_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2014-10-31_custom_SeriesTwoWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SeriesTwoWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2014-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-10-31_custom_SeriesTwoWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SeriesTwoWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-10-31_custom_SeriesTwoWarrantsMember_custom_SeriesTwoConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SeriesTwoWarrantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SRNA:SeriesTwoConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_SeriesTwoWarrantsMember1464400812">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:SeriesTwoWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_WarrantMember_custom_InvestmentBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SRNA:InvestmentBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_InvestmentBankMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SRNA:InvestmentBankMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-03-01to2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QOneTwoThousandSeventeenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-03-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QOneTwoThousandSeventeenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-12-01to2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QFourTwoThousandSeventeenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-12-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-06-01to2018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:QTwoTwoThousandEighteenWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-06-01</xbrli:startDate>
        <xbrli:endDate>2018-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_EmployeeMember_custom_TwoThousandAndSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_IndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:IndependentDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_IndependentDirectorsOneMember_custom_TwoThousandAndSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:IndependentDirectorsOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_UnvestedOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:UnvestedOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember1368509609">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember1123876531">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-12-30to2020-01-02_custom_TwoThousandAndNineteenSpecialEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndNineteenSpecialEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-12-30</xbrli:startDate>
        <xbrli:endDate>2020-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-12-30to2020-01-02_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-12-30</xbrli:startDate>
        <xbrli:endDate>2020-01-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-01-02_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CustomerContractsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31_custom_ThreeCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">SRNA:ThreeCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-21to2020-04-22_us-gaap_ExtendedMaturityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LoanRestructuringModificationAxis">us-gaap:ExtendedMaturityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-21</xbrli:startDate>
        <xbrli:endDate>2020-04-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-02_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="usd">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="usdPershares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Percentage">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Number">
      <xbrli:measure>SRNA:Number</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Sqft">
      <xbrli:measure>utr:sqft</xbrli:measure>
    </xbrli:unit>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">-355631</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31" unitRef="usd" decimals="0">194336</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">-1333698</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_PreferredStockMember" unitRef="usd" decimals="0">420</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember" unitRef="usd" decimals="0">420</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="usd" decimals="0">2250</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" unitRef="usd" decimals="0">2283</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">24538027</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">25326593</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="0">-24346361</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="0">-25684927</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember" unitRef="usd" decimals="0">420</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" unitRef="usd" decimals="0">2366</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">26107159</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="0">-27443643</us-gaap:StockholdersEquity>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2019-12-31" unitRef="usdPershares" decimals="INF">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2020-12-31" unitRef="usdPershares" decimals="INF">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember" unitRef="usdPershares" decimals="INF">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember" unitRef="usdPershares" decimals="INF">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-12-31" unitRef="shares" decimals="INF">42030331</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">42030331</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">42030331</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">42030331</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-12-31" unitRef="shares" decimals="INF">42030331</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">42030331</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">42030331</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-12-31_us-gaap_SeriesAPreferredStockMember" unitRef="shares" decimals="INF">42030331</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-12-31" unitRef="shares" decimals="INF">228216638</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">236526638</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2014-10-31_custom_SeriesTwoWarrantsMember" unitRef="shares" decimals="INF">250000</us-gaap:CommonStockSharesIssued>
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">-1758716</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">-1338566</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="0">-1338566</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="0">-1758716</us-gaap:NetIncomeLoss>
    <dei:EntityRegistrantName contextRef="From2020-01-01to2020-12-31">Surna Inc.</dei:EntityRegistrantName>
    <dei:DocumentType contextRef="From2020-01-01to2020-12-31">10-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2020-01-01to2020-12-31">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2020-01-01to2020-12-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2020-01-01to2020-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityFilerCategory contextRef="From2020-01-01to2020-12-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:DocumentFiscalPeriodFocus contextRef="From2020-01-01to2020-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2020-01-01to2020-12-31">0001482541</dei:EntityCentralIndexKey>
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">277183</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usd" decimals="0">278906</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember" unitRef="usd" decimals="0">44209</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanMember" unitRef="usd" decimals="0">390485</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">788599</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-12-31_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usd" decimals="0">25163</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" decimals="0">189568</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_UnvestedOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember" unitRef="usd" decimals="0">62452</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember1123876531" unitRef="usd" decimals="0">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember" unitRef="usd" decimals="0">0</us-gaap:ShareBasedCompensation>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">151673</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">165098</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-12-31" unitRef="shares" decimals="INF">150000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">150000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-12-31" unitRef="usdPershares" decimals="INF">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2020-12-31" unitRef="usdPershares" decimals="INF">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-12-31" unitRef="shares" decimals="INF">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-12-31" unitRef="shares" decimals="INF">228216638</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">236526638</us-gaap:CommonStockSharesOutstanding>
    <dei:DocumentFiscalYearFocus contextRef="From2020-01-01to2020-12-31">2020</dei:DocumentFiscalYearFocus>
    <dei:EntitySmallBusiness contextRef="From2020-01-01to2020-12-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-01-01to2020-12-31">false</dei:EntityEmergingGrowthCompany>
    <us-gaap:AssetsCurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">2561268</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">3683293</us-gaap:AssetsCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">1231243</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">327109</us-gaap:InventoryNet>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">138357</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">33480</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">1486050</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">1129973</us-gaap:AssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">51000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2020-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:Goodwill contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">631064</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">631064</us-gaap:Goodwill>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">257923</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">147732</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2019-09-30_custom_LeasedEquipmentMember" unitRef="usd" decimals="0">107581</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Assets contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">4047318</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">4813266</us-gaap:Assets>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">3998740</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">5903689</us-gaap:LiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">1832959</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">1784961</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31_custom_ThreeCustomersMember" unitRef="usd" decimals="0">402651</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">404209</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">243275</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">4402949</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">6146964</us-gaap:Liabilities>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">25326593</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">26107159</us-gaap:AdditionalPaidInCapital>
    <us-gaap:CommonStockValue contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">2283</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">2366</us-gaap:CommonStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">420</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">420</us-gaap:PreferredStockValue>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">4047318</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">4813266</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">922177</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">2284881</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">1444472</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">3724189</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">534133</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member" unitRef="usd" decimals="0">714416</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">343950</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">217843</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">266105</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">404209</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">169119</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2019-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2020-12-31" unitRef="usd" xsi:nil="true" />
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2021-03-23" unitRef="shares" decimals="INF">236526638</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCurrentReportingStatus contextRef="From2020-01-01to2020-12-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2020-01-01to2020-12-31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityShellCompany contextRef="From2020-01-01to2020-12-31">false</dei:EntityShellCompany>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">11930</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">7227</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">8514272</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31_custom_EngineeringAndOtherServicesMember" unitRef="usd" decimals="0">1239130</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31_us-gaap_ShippingAndHandlingMember" unitRef="usd" decimals="0">292461</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31_us-gaap_EquipmentMember" unitRef="usd" decimals="0">7730371</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31_custom_EngineeringAndOtherServicesMember" unitRef="usd" decimals="0">568131</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-12-31_us-gaap_ShippingAndHandlingMember" unitRef="usd" decimals="0">215770</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">15224454</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-12-31_us-gaap_EquipmentMember" unitRef="usd" decimals="0">13692863</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">503466</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">128434</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="AsOf2021-01-02_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember" unitRef="usd" decimals="0">128434</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">269491</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">1037823</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:CostOfRevenue contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">6961305</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">10675601</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">1552967</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">4548853</us-gaap:GrossProfit>
    <us-gaap:MarketingAndAdvertisingExpense contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">430012</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">675703</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">390229</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-12-31" unitRef="usd" decimals="0">32000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">521044</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">3095350</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">4662695</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">3915591</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">5859442</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">-2362624</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">-1310589</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">621340</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">-27977</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpense contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">17432</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2019-01-01to2019-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:NonoperatingIncomeExpense contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">603908</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">-27977</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">-1758716</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">-1338566</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2020-01-01to2020-12-31" unitRef="usdPershares" decimals="INF">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2019-01-01to2019-12-31" unitRef="usdPershares" decimals="INF">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">-25684927</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">-27443643</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 2 &amp;#8211; Basis of Presentation; Summary&#13;of Significant Accounting Policies&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Financial Statement&#13;Presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The preparation of the&#13;consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&amp;#8220;GAAP&amp;#8221;)&#13;requires management to make estimates and assumptions that affect reported amounts and related disclosures.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As further discussed in&#13;&lt;i&gt;Note 3 Going Concern&lt;/i&gt; below, the accompanying consolidated financial statements have been prepared on a going-concern basis,&#13;which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company&#13;has not generated sufficient revenue and has historically funded its operations through the sale of common stock, the issuance&#13;of debt and the receipt of advance payments from customers. The Company is subject to risks, expenses and uncertainties similar&#13;to those encountered by similarly situated companies.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Principles of Consolidation&#13;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The consolidated financial&#13;statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro Innovations, LLC (&amp;#8220;Hydro&amp;#8221;).&#13;Intercompany transactions, profit, and balances are eliminated in consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Management makes estimates&#13;and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities&#13;at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period.&#13;The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under&#13;the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities&#13;that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation&#13;of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected&#13;revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets as it applies&#13;to impairment analysis, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals,&#13;inventory allowances, and legal contingencies.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;All highly liquid investments&#13;with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may,&#13;from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has not experienced&#13;any losses to date on depository accounts.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Accounts Receivable&#13;and Allowance for Doubtful Accounts&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Accounts receivables&#13;are recorded at the invoiced amount or based on revenue earned for items not yet invoiced, and generally do not bear&#13;interest. An allowance for doubtful accounts is established, as necessary, based on past experience and other factors, which,&#13;in management&amp;#8217;s judgment, deserve current recognition in estimating bad debts. Based on the Company&amp;#8217;s review, it&#13;establishes or adjusts the allowance for specific customers and the accounts receivable portfolio as a whole. As of December&#13;31, 2020, and December 31, 2019, the allowance for doubtful accounts was $165,098 and $151,673, respectively. If the&#13;financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments,&#13;additional allowances may be required.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Inventory&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Inventory is stated&#13;at the lower of cost or net realizable value. The inventory is valued based on a first-in, first-out (&amp;#8220;FIFO&amp;#8221;)&#13;basis. Lower of cost or net realizable value is evaluated by considering obsolescence, excessive levels of inventory,&#13;deterioration and other factors. Adjustments to reduce the cost of inventory to its net realizable value, if required, are&#13;made for estimated excess, obsolescence or impaired inventory. Excess and obsolete inventory is charged to cost of revenue&#13;and a new lower-cost basis for that inventory is established and subsequent changes in facts and circumstances do not result&#13;in the restoration or increase in that newly established cost basis. As of December 31, 2020, and December 31, 2019, the&#13;allowance for excess and obsolete inventory was $93,045 and $71,376, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Property and Equipment&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Property and equipment&#13;are stated at cost. For financial statement purposes, property and equipment are recorded at cost and depreciated using the straight-line&#13;method over their estimated useful lives, which is generally five years. Leasehold improvements are amortized on a straight-line&#13;basis over the lesser of their useful lives or the life of the lease. Upon sale or retirement of assets, the cost and related accumulated&#13;depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operations. Maintenance&#13;and repairs are charged to operations as incurred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Long-lived Assets&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Long-lived tangible assets,&#13;including property and equipment, are reviewed for impairment whenever events or changes in business circumstances indicate the&#13;carrying value of the assets may not be recoverable. When such an event occurs, management determines whether there has been impairment&#13;by comparing the anticipated undiscounted future net cash flows to the related asset&amp;#8217;s carrying value. If an asset is considered&#13;impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value,&#13;depending on the nature of the asset. The Company has not identified any indicators of impairment during the years ended December&#13;31, 2020 and 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Goodwill and Intangible&#13;Assets&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company recorded goodwill&#13;in connection with its acquisition of Hydro in July 2014. Goodwill is reviewed for impairment annually on December 31&lt;sup&gt;st&lt;/sup&gt;&#13;or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less&#13;than its carrying value. The Company performs a quantitative impairment test annually during the fourth quarter by comparing the&#13;fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds&#13;its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the&#13;carrying amount exceeds the reporting unit&amp;#8217;s fair value. The Company determined that it has one reporting unit. The Company&#13;completed this assessment as of December 31, 2020 and concluded that no impairment existed.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Separable identifiable&#13;intangibles consist of intellectual property such as patents and trademarks, and capitalized website costs. Except for trademarks,&#13;which are not amortized, the Company&amp;#8217;s separable identifiable intangible assets are subject to amortization on a straight-line&#13;basis over their estimated useful lives. Trademarks are tested annually for impairment. Separable identifiable intangibles are&#13;also subject to evaluation for potential impairment if events or circumstances indicate the carrying value may not be recoverable.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Fair Value Measurement&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company records its&#13;financial assets and liabilities at fair value. The accounting standard for fair value provides a framework for measuring fair&#13;value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined&#13;as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction&#13;between market participants at the reporting date. The accounting standard establishes a three-tier hierarchy, which prioritizes&#13;the inputs used in the valuation methodologies in measuring fair value:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Level 1 - inputs are quoted&#13;prices (unadjusted) in active markets for identical assets or liabilities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;Level 2 - inputs are quoted prices&#13;for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly&#13;or indirectly through market corroboration, for substantially the full term of the financial instrument.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;Level 3 - inputs are unobservable&#13;inputs based on the Company&amp;#8217;s assumptions used to measure assets and liabilities at fair value.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A financial asset or liability&amp;#8217;s&#13;classification within the hierarchy is determined based on the lowest level of input that is significant to the fair value measurement.&#13;The Company&amp;#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires&#13;management to make judgments and consider factors specific to the asset or liability.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Due to their short-term&#13;nature, the carrying values of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses, approximate&#13;fair value.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Derivative Financial&#13;Instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company evaluates&#13;its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded&#13;derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is&#13;initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in&#13;the statements of operations. For stock-based derivative financial instruments, the Company uses the Black-Scholes Option&#13;Pricing Model (the &amp;#8220;Black-Scholes Model&amp;#8221;) to value the derivative instruments. The classification of derivative&#13;instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of&#13;each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based&#13;on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance&#13;sheet date. As of December 31, 2020, and December 31, 2019, there were no derivative financial instruments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Revenue Recognition&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On January 1, 2018, the&#13;Company adopted Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) 2014-09 (Topic 606), &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;&#13;and all the related amendments (&amp;#8220;ASC 606&amp;#8221; or the &amp;#8220;revenue standard&amp;#8221;) to all contracts and elected the modified&#13;retrospective method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets&#13;forth the Company&amp;#8217;s revenue by source:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;For the Years Ended December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="white-space: nowrap; width: 68%"&gt;&lt;font style="font-size: 10pt"&gt;Equipment and systems sales&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,730,371&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,692,863&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="white-space: nowrap"&gt;&lt;font style="font-size: 10pt"&gt;Engineering and other services&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;568,131&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,239,130&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Shipping and handling&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;215,770&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;292,461&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,514,272&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,224,454&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;u&gt;Revenue Recognition&#13;Accounting Policy Summary&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for&#13;revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer&#13;to transfer a distinct good or service to the customer. Most of the Company&amp;#8217;s contracts contain multiple performance obligations&#13;that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment&#13;and components, which can span multiple phases of a customer&amp;#8217;s project life-cycle from facility design and construction to&#13;equipment delivery and system installation and start-up. The Company does not provide construction services or system installation&#13;services. Some of the Company&amp;#8217;s contracts with customers contain a single performance obligation, typically engineering only&#13;services contracts.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A contract&amp;#8217;s transaction&#13;price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is&#13;satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each&#13;performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable&#13;inputs. The best observable input is the Company&amp;#8217;s actual selling price for the same good or service, however, this input&#13;is generally not available for the Company&amp;#8217;s contracts containing multiple performance obligations. For engineering services,&#13;the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility&#13;size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to&#13;be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment&#13;and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending&#13;on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain&#13;performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the&#13;Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be&#13;recognized as each promise is fulfilled.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Generally, satisfaction&#13;occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for&#13;consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when&#13;control transfers to the customer, which primarily occurs at the time of shipment. The Company&amp;#8217;s historical rates of return&#13;are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the&#13;Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales,&#13;use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing&#13;transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The&#13;revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&amp;#8217;s customers.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company also has performance&#13;obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type&#13;of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company offers assurance-type&#13;warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers&#13;and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve&#13;based on historical warranty costs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;u&gt;Other Judgments and&#13;Assumptions&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company typically receives&#13;customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18,&#13;which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant&#13;financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised&#13;good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining&#13;performance obligations related to customer contracts does not consider the effects of the time value of money.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Applying the practical&#13;expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since&#13;the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include&#13;certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only&#13;when associated revenue has been collected and earned by the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;u&gt;Contract Assets and&#13;Contract Liabilities&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Contract assets reflect&#13;revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments&#13;received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on&#13;the terms established in its contracts.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Contract assets include&#13;unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject&#13;to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets&#13;since revenue is recognized as control of goods are transferred or as services are performed. As of December 31, 2020, and 2019,&#13;the Company had no contract assets.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Contract liabilities&#13;consist of advance payments in excess of revenue recognized. The Company&amp;#8217;s contract liabilities are recorded as a&#13;current liability in deferred revenue in the consolidated balance sheets since the timing of when the Company expects to&#13;recognize revenue is generally less than one year. As of December 31, 2020, and December 31, 2019, deferred revenue, which&#13;was classified as a current liability, was $3,724,189 and $1,444,472, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For the year ended December&#13;31, 2020, the Company recognized revenue of $1,103,447 related to the deferred revenue at January 1, 2020, or 76%. For the year&#13;ended December 31, 2019, the Company recognized revenue of $473,682 related to the deferred revenue at January 1, 2019, or 74%.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;u&gt;Remaining Performance&#13;Obligations&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Remaining performance obligations,&#13;or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has&#13;not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which&#13;exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of&#13;one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts,&#13;including those with an expected duration of one year or less.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Industry uncertainty, project&#13;financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&amp;#8217;s control,&#13;make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are&#13;risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion&#13;of a customer&amp;#8217;s cultivation facility project is dependent upon the customer&amp;#8217;s ability to secure funding and real estate,&#13;obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time&#13;it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by&#13;numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business;&#13;(ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government&#13;delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states&#13;where there is no cap on the number of cultivators; (iv) the customer&amp;#8217;s need to obtain cultivation facility financing; (v)&#13;the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility&#13;(to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate&#13;control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction&#13;project. Further, based on the current economic climate, the uncertainty regarding the COVID-19 virus, and the Company&amp;#8217;s&#13;recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience&#13;contract cancellations, project scope reductions and project delays.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020,&#13;the Company&amp;#8217;s remaining performance obligations, or backlog, was $8,448,000, of which $2,643,000, or 31%, was attributable&#13;to customer contracts for which the Company has only received an initial advance payment to cover the allocated value of the Company&amp;#8217;s&#13;engineering services (&amp;#8220;engineering only paid contracts&amp;#8221;). There is the risk that the equipment portion of these engineering&#13;only paid contracts will not be completed or will be delayed. The reasons include the customer being dissatisfied with the quality&#13;or timeliness of the Company&amp;#8217;s engineering services, delay or abandonment of the project because of the customer&amp;#8217;s&#13;inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall&#13;post-COVID-19 economic downturn, or change in business direction. After the customer has made an advance payment for a portion&#13;of the equipment to be delivered under the contract (&amp;#8220;partial equipment paid contracts&amp;#8221;), the Company is typically&#13;better able to estimate the timing of revenue recognition since the risks and delays associated with licensing, permitting and&#13;project funding are typically mitigated once the initial equipment payment is received. There is significant uncertainty regarding&#13;the timing of the Company&amp;#8217;s recognition of revenue on its remaining performance obligations, and there is no certainty that&#13;these will result in actual revenues. The backlog at December 31, 2020, includes booked sales orders of $390,000 from several customers&#13;that the Company does not expect to be realized until 2022, if at all. Given the present economic uncertainty arising from the&#13;impact of the novel coronavirus COVID-19, the Company believes that several of its current contracts may be delayed or canceled.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The remaining performance&#13;obligations expected to be recognized through 2022 are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 55%"&gt;&lt;font style="font-size: 10pt"&gt;Remaining performance obligations related to engineering only paid contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,355,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;288,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,643,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Remaining performance obligations related to partial equipment paid contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,703,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;102,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,805,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total remaining performance obligations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,058,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;390,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,448,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Product Warranty&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company warrants the&#13;products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment.&#13;The Company&amp;#8217;s warranty provides for the repair, rework, or replacement of products (at the Company&amp;#8217;s option) that fail&#13;to perform within stated specification. The Company&amp;#8217;s third-party suppliers also warrant their products under similar terms,&#13;which are passed through to the Company&amp;#8217;s customers.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company assesses the&#13;historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue&#13;generated on these products. Based on the Company&amp;#8217;s warranty policy, an accrual is established at 1% of the trailing 18 months&#13;revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and&#13;other factors. As of December 31, 2020, and December 31, 2019, the Company had an accrued warranty reserve amount of $173,365 and $185,234,&#13;respectively, which are included in accounts payable and accrued liabilities on the Company&amp;#8217;s consolidated balance sheets.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Cost of Sales&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Cost of sales includes&#13;product costs (material, direct labor and overhead costs), shipping and handling expense, outside engineering costs, engineering,&#13;project management and service salaries and benefits, client visits and warranty.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Concentrations&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Three customers accounted&#13;for 28%, 11% and 10% of the Company&amp;#8217;s revenue for the year ended December 31, 2020. One customer accounted for 44% of the&#13;Company&amp;#8217;s revenue for the year ended December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company&amp;#8217;s accounts&#13;receivable from two customers made up 48% and 38%, respectively, of the total balance as of December 31, 2020. The Company&amp;#8217;s&#13;accounts receivable from three customers made up 59%, 16%, and 10%, respectively, of the total balance as of December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Three suppliers accounted&#13;for 27%, 25% and 12% of the Company&amp;#8217;s purchases of inventory for the year ended December 31, 2020, and three suppliers accounted&#13;for 30%, 17% and 12% of the Company&amp;#8217;s purchases of inventory for the year ended December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Product Development&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company expenses&#13;product development costs as incurred. Internal product development costs are expensed as incurred, and third-party product&#13;developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. For&#13;the years ended December 31, 2020 and December 31, 2019, the Company incurred $390,229 and $521,044, respectively, on product&#13;development.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Accounting for Share-Based&#13;Compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company recognizes&#13;the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted&#13;stock units that the Company grants under its equity incentive plan in its consolidated financial statements based on their grant&#13;date fair value. For awards subject to service conditions, compensation expense is recognized over the vesting period on a straight-line&#13;basis. Awards subject to performance conditions are attributed separately for each vesting tranche of the award and are recognized&#13;ratably from the service inception date to the vesting date for each tranche, based on the probability of vesting. The probability&#13;of awards with future performance conditions is evaluated each reporting period and compensation expense is adjusted based on the&#13;probability assessment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Awards are considered granted,&#13;and the service inception date begins, when mutual understanding of the key terms and conditions of the award between the Company&#13;and the recipient has been established. For awards that provide discretion to adjust the amount of the award, the service inception&#13;date for such awards could precede the grant date as a mutual understanding of the key terms and conditions of the award between&#13;the Company and the recipient has not yet been established. For awards in which the service inception date precedes the grant date,&#13;compensation cost is accrued beginning on the service inception date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Subsequent to December&#13;31, 2020, the Company&amp;#8217;s Board of Directors (the &amp;#8220;Board&amp;#8221;) approved annual incentive compensation awards to certain&#13;employees payable in non-qualified stock options, based on the Company&amp;#8217;s performance and each employee&amp;#8217;s contributions&#13;to such performance for the 2020 year. See Note 16. The non-qualified stock options were granted subsequent to December 31, 2020,&#13;were not subject to an additional service requirement and were immediately vested at the date of the grant. The final amount of&#13;the annual incentive compensation award, and number of non-qualified stock options granted, were determined, and communicated to&#13;the employee, subsequent to December 31, 2020. The estimated compensation expense of $128,434 related to the 2020 incentive awards&#13;was accrued as of December 31, 2020. Since such incentive awards will be settled in non-qualified stock options, the accrued compensation&#13;expense has been classified as a current liability until the number of non-qualified stock options is fixed pursuant to a grant&#13;by the Board. At that time, the incentive award becomes equity-classified.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The grant date fair value&#13;of stock options is based on the Black-Scholes Model. The Black-Scholes Model requires judgmental assumptions including volatility&#13;and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose&#13;term is consistent with the expected term of the option.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The grant date fair value&#13;of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company has elected&#13;to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical&#13;data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of&#13;employees have significantly different forfeiture expectations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Share-based compensation&#13;costs (including expenses from the accrued compensation liabilities related to the annual incentive awards subsequently settled&#13;in non-qualified stock options totaled $405,617 and $1,292,065 for the years ended December 31, 2020 and 2019, respectively. Such&#13;share-based compensation costs are classified in the Company&amp;#8217;s consolidated financial statements in the same manner as if&#13;such compensation was paid in cash.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 1pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following is a summary&#13;of such share-based compensation costs included in the Company&amp;#8217;s consolidated statements of operations for the years ended&#13;December 31, 2020 and 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;For the Years Ended December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Share-based compensation expense included in:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Cost of revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;31,006&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;91,081&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Advertising and marketing expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,333&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;33,977&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Product development costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;21,882&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;45,330&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Selling, general and administrative expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;344,396&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,121,677&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total share-based compensation expense included in consolidated statement of operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;405,617&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,292,065&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for&#13;income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the&#13;expected future tax consequences of events that have been included in the financial statements. Under this method, the Company&#13;determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of&#13;assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The&#13;effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the&#13;enactment date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company recognizes&#13;deferred tax assets to the extent that the Company believes that these assets are more likely than not to be realized. In making&#13;such a determination, the Company considers all available positive and negative evidence, including future reversals of existing&#13;taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the&#13;Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount,&#13;the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income&#13;taxes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company records uncertain&#13;tax positions on the basis of a two-step process in which: (i) the Company determines whether it is more likely than not that the&#13;tax positions will be sustained on the basis of the technical merits of the position, and (ii) for those tax positions that meet&#13;the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more likely than&#13;not to be realized upon ultimate settlement with the related tax authority.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Basic and Diluted&#13;Net Loss per Common Share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Basic income (loss) per&#13;common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common&#13;shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share&#13;is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive&#13;common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in&#13;periods when losses are reported where the effect of the common stock equivalents would be antidilutive. Potential common stock&#13;equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units&#13;using the treasury method. As of December 31, 2020, 29,213,500 potential common shares equivalents from warrants and options were&#13;excluded from the diluted EPS calculations as their effect is anti-dilutive.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Commitments and Contingencies&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In the normal course of&#13;business, the Company is subject to loss contingencies, such as legal proceedings and claims arising out of its business, that&#13;cover a wide range of matters, including, among others, customer disputes, government investigations and tax matters. An accrual&#13;for a loss contingency is recognized when it is probable that an asset had been impaired or a liability had been incurred and the&#13;amount of loss can be reasonably estimated.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Other Risks and Uncertainties&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;To achieve profitable operations,&#13;the Company must successfully develop, manufacture and market its products. There can be no assurance that any such products can&#13;be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that such products will&#13;be successfully marketed. These factors could have a material adverse effect upon the Company&amp;#8217;s financial results, financial&#13;position, and future cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 1pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company is subject&#13;to risks common to similarly-situated companies including, but not limited to, general economic conditions, its customers&amp;#8217;&#13;operations and access to capital, and market and business disruptions including severe weather conditions, natural disasters, health&#13;hazards, terrorist activities, financial crises, political crises or other major events, or the prospect of these events, new technological&#13;innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, uncertainty&#13;of market acceptance of products, product liability, and the need to obtain additional financing. As a supplier of services and&#13;equipment to cannabis cultivators, the Company is also subject to risks related to the cannabis industry. Although certain states&#13;have legalized medical and/or recreational cannabis, U.S. federal laws continue to prohibit marijuana in all its forms as well&#13;as its derivatives. Any changes in the enforcement of U.S. federal laws may adversely affect the implementation of state and local&#13;cannabis laws and regulations that permit medical or recreational cannabis and, correspondingly, may adversely impact the Company&amp;#8217;s&#13;customers. The Company&amp;#8217;s success is also dependent upon its ability to raise additional capital and to successfully develop&#13;and market its products. See Note 3.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Segment Information&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Operating segments are&#13;defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the&#13;Company&amp;#8217;s senior management team in deciding how to allocate resources and in assessing performance. The Company has one&#13;operating segment that is dedicated to the manufacture and sale of its products.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Recently Issued Accounting&#13;Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In August 2020, the FASB&#13;issued ASU 2020-06: &amp;#8220;&lt;i&gt;Accounting for Convertible Instruments and Contracts In An Entity&amp;#8217;s Own Equity&amp;#8221; (&amp;#8220;ASU&#13;2020-06&amp;#8221;)&lt;/i&gt; ASU 2020-04 simplifies the accounting for certain convertible instruments by removing the separation models&#13;for convertible debt with a cash conversion feature and for convertible instruments with a beneficial conversion feature. As a&#13;result, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded&#13;conversion features. Additionally, ASU 2020-04 amends the diluted earnings per share calculation for convertible instruments by&#13;requiring the use of the if-converted method. The treasury stock method is no longer available. Entities may adopt the ASU 2020-04&#13;using either a full or modified retrospective approach, and it is effective for interim and annual reporting periods beginning&#13;after December 15, 2021. Early adoption is permitted for interim and annual reporting periods beginning after December 15, 2020.&#13;The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial&#13;position.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In December 2019, the FASB&#13;issued ASU 2019-12, &lt;i&gt;Income Taxes (Topic 740) &amp;#8211; Simplifying the Accounting for Income Taxes, &lt;/i&gt;which simplifies the accounting&#13;for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent&#13;application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12 is effective&#13;for fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company does not expect this ASU to have a&#13;material impact on its consolidated results of operations, cash flows and financial position.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Other accounting standards&#13;that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material&#13;impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to&#13;have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.&lt;/p&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 4 &amp;#8211; Leases&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In February 2016, the FASB&#13;issued ASU 2016-02, &lt;i&gt;Leases (Topic 842)&lt;/i&gt;(&amp;#8220;ASC 842&amp;#8221; or the &amp;#8220;new lease standard&amp;#8221;). The Company adopted&#13;ASC 842 as of January 1, 2019, using the effective date method. Consequently, financial information will not be updated, and the&#13;disclosures required under the new lease standard will not be provided, for dates and periods prior to January 1, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The new lease standard&#13;provides a number of optional practical expedients in transition. The Company has elected to apply the &amp;#8220;package of practical&#13;expedients&amp;#8221; which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii) the&#13;lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization&#13;under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original&#13;term of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On June 27, 2017, the Company&#13;entered into a lease for its manufacturing and office space (the &amp;#8220;Facility Lease&amp;#8221;), which commenced September 29, 2017&#13;and continues through August 31, 2022. The Company occupied its 12,700 square foot space for $12,967 per month until January 1,&#13;2018. On January 2, 2018, the leased space was expanded to 18,600 square feet, and the monthly rental rate increased to $18,979&#13;until August 31, 2018. Beginning September 1, 2018 and 2019, the monthly rent increased to $19,549 and $20,135, respectively. On&#13;each September 1 through the end of the lease, the monthly rent will increase by 3%. Pursuant to the current lease, the Company&#13;made a security deposit of $51,000 on July 31, 2017. The deposit of $1,600 paid to the previous owner of the property was forwarded&#13;to the current landlord. The Company has the option to renew the Facility Lease for an additional five years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During 2020, the Company&#13;entered into an agreement with its landlord to apply its rent deposit of $52,600 to rent payments due during the period. The deposit&#13;required on the lease will be reduced to approximately $32,000 and will be payable in 12 monthly installments from January through&#13;December of 2021. Further, the landlord also agreed to defer payment of fifty percent of the three months of lease payments (base&#13;rent only) for the period July to September 2020. The deferred lease payments amount to approximately $30,000 and will be payable&#13;in 12 monthly installments from January to December 2021.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Total rent under the Facility&#13;Lease is charged to expense over the term of the lease on a straight-line basis, resulting in the same monthly rent expense throughout&#13;the lease. The difference between the rent expense amount and the actual rent paid is recorded to operating lease liability on&#13;the Company&amp;#8217;s condensed consolidated balance sheets. As of January 1, 2019, the remaining deferred rent of $26,477 was reclassified&#13;to the operating lease liability under the new lease standard.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Upon adoption of the new&#13;lease standard, the Company recognized its lease for manufacturing and office space (the &amp;#8220;Facility Lease&amp;#8221;) on the balance&#13;sheet as an operating lease right-of-use asset in the amount of $714,416 and as a lease liability of $822,374. The renewal option&#13;to extend the Facility Lease is not included in the right-of-use asset or lease liability as the option is not reasonably certain&#13;of exercise. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will&#13;include the renewal period in its lease term.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Under the Facility Lease,&#13;the landlord agreed to pay the Company or the Company&amp;#8217;s contractors for tenant improvements made by the Company not to exceed&#13;$100,000, which were used for normal tenant improvements. The Company determined that these improvements were not specialized and&#13;could be utilized by a subsequent tenant and, as such, the improvements were considered assets of the lessor. As of January 1,&#13;2019, the unamortized amount of tenant improvement allowance of $81,481 was treated as a reduction in measuring the right-of-use&#13;asset.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Under the Facility Lease,&#13;the Company pays the actual amounts for property taxes and insurance, excludes such payments from lease contract consideration,&#13;and records such payments as incurred. The Company also pays the landlord for common area maintenance, which is considered a non-lease&#13;component. For the Facility Lease, the Company has elected to exclude non-lease components from lease contract consideration.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In determining the right-of-use&#13;asset and lease liability, the Company applied a discount rate to the minimum lease payments under the Facility Lease. ASC 842&#13;requires the Company to use the rate of interest that the Company would have to pay to borrow on a collateralized basis over a&#13;similar term an amount equal to the lease payments in a similar economic environment. Since the discount rate is not implicit in&#13;the lease agreement, we utilized an estimated incremental borrowing rate provided by the Company&amp;#8217;s depository bank.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The lease cost, cash flows&#13;and other information related to the Facility Lease were as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="white-space: nowrap; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;For the Year Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 82%"&gt;&lt;font style="font-size: 10pt"&gt;Operating lease cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;216,889&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Operating cash outflow from operating lease&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;160,934&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 82%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Operating lease right-of-use assset&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;343,950&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Operating lease liability, current&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;266,105&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Operating lease liability, long-term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;169,119&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Remaining lease term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.7 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Discount rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Future annual minimum lease&#13;payments on the Facility Lease as of December 31, 2020 were as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Years ended December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 82%"&gt;&lt;font style="font-size: 10pt"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;281,864&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;170,891&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Total minimum lease payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;452,755&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Less imputed interest&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(17,531&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Present value of minimum lease payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;435,224&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 5 &amp;#8211; Inventory&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Inventory consisted of&#13;the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;As of December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Finished goods&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;201,778&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,041,369&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Work in progress&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,231&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,851&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Raw materials&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;214,145&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;257,399&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Allowance for excess &amp;#38; obsolete inventory&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(93,045&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(71,376&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Inventory, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;327,109&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,231,243&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Overhead expenses of $17,974&#13;and $31,831 were included in the inventory balance as of December 31, 2020 and 2019, respectively.&lt;/p&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 6 &amp;#8211; Property and Equipment&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Property and equipment&#13;consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;As of December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Furniture and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;398,422&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;389,090&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Vehicles&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Leasehold improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;215,193&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;215,193&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;628,615&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;619,283&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Accumulated depreciation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(480,883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(361,360&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Property and equipment, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;147,732&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;257,923&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Depreciation expense amounted&#13;to $119,524 for the year ended December 31, 2020, of which $6,394 was allocated to cost of revenue. Depreciation expense amounted&#13;to $157,860 for the year ended December 31, 2019, of which $7,010 was allocated to cost of revenue.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2018,&#13;the Company&amp;#8217;s property and equipment, net included the gross cost of the equipment leased to a cultivation company affiliated&#13;with one of the Co-founders of $176,042, and accumulated depreciation of $39,120. During the year ended December 31, 2019, the&#13;Company wrote-off the carrying value of the leased equipment. See Note 10.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 8 &amp;#8211; Accounts Payable and Accrued&#13;Liabilities &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Accounts payable and accrued&#13;liabilities consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;As of December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;918,639&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,299,015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Sales commissions payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;48,263&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;69,532&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accrued payroll liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;288,071&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;169,052&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Product warranty accrual&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;173,365&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;185,234&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Other accrued expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;356,623&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;110,127&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,784,961&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,832,959&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Accounts payable and other&#13;accrued expenses includes $402,651 relating to a one-time warranty issue experienced on three customers&amp;#8217; projects. The expenses&#13;related to parts and labor to repair units that had been delivered to these customers prior to year-end. Since the issue is limited&#13;to these three projects and is not anticipated to reoccur in the future, we have made no adjustment to the ongoing 1% warranty&#13;reserve that we accrue on all sales.&lt;/p&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 14 &amp;#8211; Equity Incentive Plan&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;On&#13;August 1, 2017, the Board adopted and approved the Company&amp;#8217;s 2017 Equity Incentive Plan (the &amp;#8220;2017 Equity Plan&amp;#8221;)&#13;in order to attract, motivate, retain, and reward high-quality executives and other employees, officers, directors, consultants,&#13;and other persons who provide services to the Company by enabling such persons to acquire an equity interest in the Company. Under&#13;the 2017 Equity Plan, the Board (or the compensation committee of the Board, if one is established) may award stock options, stock&#13;appreciation rights (&amp;#8220;SARs&amp;#8221;), restricted stock awards (&amp;#8220;RSAs&amp;#8221;), restricted stock unit awards (&amp;#8220;RSUs&amp;#8221;),&#13;shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates&#13;50,000,000 shares of the Company&amp;#8217;s common stock (&amp;#8220;Plan Shares&amp;#8221;) for issuance of equity awards under the 2017&#13;Equity Plan. As of December 31, 2020, the Company has granted, under the 2017 Equity Plan, awards in the form of RSAs for services&#13;rendered by independent directors and consultants, non-qualified stock options, RSUs and stock bonus awards.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The&#13;total unrecognized compensation expense for unvested non-qualified stock options at December 31, 2020 was $6,412, which will be&#13;recognized over approximately 3 months.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;u&gt;Restricted Stock Awards&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2018,&#13;the Company had accrued fees owed to the Company&amp;#8217;s independent directors totaling $15,000, which were payable in equity.&#13;During the year ended December 31, 2019, the Company issued 197,370 shares of restricted stock, which were fully vested at the&#13;time of the award, in settlement of these accrued fees.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#13;31, 2019, the Company also awarded 789,474 shares of restricted stock under the 2017 Equity Plan to the Company&amp;#8217;s independent&#13;directors and consultants as an equity retainer fee for 2019. These restricted shares were fully vested at the time of the award&#13;and the aggregate value attributable to these shares was $60,000, as calculated using the fair value of the Company&amp;#8217;s common&#13;stock on date the Board approved these awards.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;u&gt;Non-Qualified&#13;Stock Options&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The&#13;Company uses the Black-Scholes Model to determine the fair value of options granted. Option-pricing models require the input of&#13;highly subjective assumptions, particularly for the expected stock price volatility and the expected term of options. Changes in&#13;the subjective input assumptions can materially affect the fair value estimate. The expected stock price volatility assumptions&#13;are based on the historical volatility of the Company&amp;#8217;s common stock over periods that are similar to the expected terms&#13;of grants and other relevant factors. The Company derives the expected term based on an average of the contract term and the vesting&#13;period taking into consideration the vesting schedules and future employee behavior with regard to option exercise. The risk-free&#13;interest rate is based on U.S. Treasury yields for a maturity approximating the expected term calculated at the date of grant.&#13;The Company has never paid any cash dividends on its common stock and the Company has no intention to pay a dividend at this time;&#13;therefore, the Company assumes that no dividends will be paid over the expected terms of option awards.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;font style="font-size: 10pt"&gt;The&#13;Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected&#13;stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant&#13;dates. As such, the Company may use different assumptions for options granted throughout the year. The valuation assumptions used&#13;to determine the fair value of each option award on the date of grant were: expected stock price volatility 114.97% - 122.48%;&#13;expected term in 5 years and risk-free interest rate 0.2% - 2.37%.&lt;/font&gt;&lt;font style="font-size: 1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&lt;i&gt;&lt;u&gt;Employee&#13;and Consultant Options&lt;/u&gt;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;A&#13;summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the years ended&#13;December 31, 2020 and 2019 are presented in the table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted Average Remaining Contractual Term&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Aggregate Intrinsic&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 46%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding, December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10,560,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.104&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8.4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.080&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2,408,333&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.116&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(16,667&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.105&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10,135,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.096&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7.7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6,616,900&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.070&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2,500,900&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.101&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;14,251,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.083&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8.3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercisable, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;14,251,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.083&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8.3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of non-vested&#13;non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the years ended December 31,&#13;2020 and 2019 are presented in the table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Tahoma, Helvetica, Sans-Serif"&gt;&amp;#65279;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of&lt;br /&gt;&#13;Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted&lt;br /&gt;&#13;Average&lt;br /&gt;&#13;Grant-Date&lt;br /&gt;&#13;Fair Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Aggregate&lt;br /&gt;&#13;Intrinsic&lt;br /&gt;&#13;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Grant-Date&lt;br /&gt;&#13;Fair Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Tahoma, Helvetica, Sans-Serif"&gt;&amp;#65279;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 46%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Nonvested, December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7,333,329&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.086&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;628,756&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 6.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.065&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;130,120&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 6.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4,924,996&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.074&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;362,998&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 6.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2,408,333&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.102&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;246,344&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 6.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Nonvested, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.075&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;149,534&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 6.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6,616,900&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.059&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;387,199&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 6.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(8,616,900&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.062&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;536,733&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 6.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 6.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Nonvested, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For the years ended December&#13;31, 2020 and 2019, the Company recorded $189,568 and $390,485 as compensation expense related to vested options issued to employees&#13;and consultants, net of forfeitures, respectively. As of December 31, 2020, there was no unrecognized share-based compensation&#13;related to unvested options.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;As&#13;of December 31, 2020, the Company had granted non-qualified options to purchase 10,250,000 shares which were performance-based.&#13;At December 31, 2020, non-qualified options to purchase 6,000,000 shares were forfeited due to the failure to satisfy the 2017,&#13;2018 and 2019 revenue-based performance thresholds and 4,250,000 shares were forfeited due to employee terminations. No compensation&#13;expense had been recognized with respect to these performance-based awards since the likelihood of performance levels being obtained&#13;was determined to be remote.&lt;/font&gt;&lt;font style="font-size: 1pt"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;Director Options&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of the non-qualified&#13;stock options granted to directors under the 2017 Equity Plan during the years ended December 31, 2020 and 2019 are presented in&#13;the table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Term&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Value ($000)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 46%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding, December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;900,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.135&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited/Cancelled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;900,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.135&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6,500,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.057&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8.5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited/Cancelled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7,400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.067&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7.5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Exerciseable, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6,400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.073&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of non-vested&#13;non-qualified stock options activity for directors under the 2017 Equity Plan for the years ended December 31, 2020 and 2019 are&#13;presented in the table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Tahoma, Helvetica, Sans-Serif"&gt;&amp;#65279;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted Average Grant-Date Fair Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Aggregate Intrinsic Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Grant-Date Fair Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Tahoma, Helvetica, Sans-Serif"&gt;&amp;#65279;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Nonvested, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Nonvested, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 40%; padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6,500,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.057&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;373,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(5,500,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.063&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;344,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Nonvested, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.029&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;29,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the years ended&#13;December 31, 2020 and 2019, the Company incurred $62,452 and $0, respectively, as compensation expense related to 1,500,000 and&#13;0 vested options, respectively, issued to directors. As of December 31, 2020, total unrecognized share-based compensation related&#13;to unvested options was $6,412.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Effective January 2, 2020,&#13;the Company issued 4,000,000 fully vested stock options to directors valued at $234,126 in respect of a 2019 special equity award&#13;that had been accrued for in full in the Company&amp;#8217;s financial statements at December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Further on January 2, 2020,&#13;the Company issued an additional 500,000 fully vested, non-qualified stock options under the 2017 Equity Plan valued at $29,266&#13;to directors. The options have a term of 5 years and have an exercise price equal to the closing price of the Company&amp;#8217;s common&#13;stock on The OTC Markets on the day immediately preceding the grant date of $0.07.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Effective June 24, 2020&lt;i&gt;,&amp;#160;&lt;/i&gt;the&#13;Company issued 2,000,000 non-qualified stock options under the 2017 Equity Plan, valued at $39,600, to newly appointed directors.&#13;The options vested 50% upon grant and 50% on April 1, 2021, if the Director remains on the Board up to that time. The options have&#13;a term of 5 years and have an exercise price equal to the closing price of the Company&amp;#8217;s common stock on The OTC Markets&#13;on the day immediately preceding the grant date of $0.029.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;As&#13;of December 31, 2020, awards related to 21,651,000 shares remain issued and outstanding.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Restricted Stock Units&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of the RSUs awarded&#13;to employees, directors and consultants under the 2017 Equity Plan during the years ended December 31, 2020 and 2019 are presented&#13;in the table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Units&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Grant-Date&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 53%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding, December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9,867,368&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.140&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;730,185&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vested and settled with share issuance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,120,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.181&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited/canceled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,197,368&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.179&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7,550,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.128&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vested and settled with share issuance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(6,750,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.121&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited/canceled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(800,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.184&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Outstanding, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For the years ended December&#13;31, 2020 and 2019, the Company recorded $25,163 and $278,906 as compensation expense related to vested RSUs issued to employees,&#13;directors and consultants. As of December 31, 2020, there was no unrecognized share-based compensation related to unvested RSUs.&#13;The total intrinsic value of RSUs vested and settled with share issuance was $199,125 and $79,120 for the years ended December&#13;31, 2020 and 2019. During the year ended December 31, 2020, the total intrinsic value of RSUs vested and settled with share issuance&#13;was $1,105,750, including the intrinsic value of $1,035,750 related to RSUs that had vested in 2018 but had not been settled until&#13;2020 due to a dispute with a former employee over the required withholding taxes to be paid to the Company for remittance to the&#13;appropriate tax authorities as further discussed in Note 11 Commitments and Contingencies above.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Effective April 30, 2020,&#13;800,000 RSUs vested. However, the holder elected to cancel the RSUs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;u&gt;Incentive Stock Bonuses&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company has entered&#13;into certain &amp;#8220;at-will&amp;#8221; employment agreements with certain employees. Under these agreements, the employees are eligible&#13;to receive special incentive stock bonuses, provided the Board has determined, in its sole discretion, that the employee&amp;#8217;s&#13;performance has been average or better for the applicable special bonus period. This special stock incentive bonus is payable only&#13;if the employee continues in the employment of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For accounting purposes,&#13;the Company treats these special incentive stock bonuses as vesting over each bonus&amp;#8217;s service period based on the fair value&#13;of the award at the time of grant. Even though these bonuses are subject to Board approval, the awards are vested over each service&#13;period because it is more likely than not that the Board will approve the award based on the &amp;#8220;average or better&amp;#8221; employee&#13;performance standard. Since the awards are denominated in shares of common stock, the fair value of the vested bonus is charged&#13;to additional paid-in capital.&lt;/p&gt;&#13;&#13;&lt;p style="font: 1pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of the incentive&#13;stock bonus awards granted to employees under the 2017 Equity Plan during the years ended December 31, 2020 and 2019 are presented&#13;in the table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Average Grant-Date&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Tahoma, Helvetica, Sans-Serif"&gt;&amp;#65279;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Unvested, December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,680,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.112&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;124,320&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Awarded&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,680,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.112&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Unvested, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Awarded&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Unvested, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For the years ended December&#13;31, 2020 and 2019, the Company recorded $0 and $44,209 as compensation expense related to vested stock bonus awards issued to employees,&#13;net of forfeitures of $0 and $0, respectively. As of December 31, 2020, there was no unrecognized share-based compensation related&#13;to unvested stock bonus awards. The total intrinsic value of stock bonus awards vested and settled with share issuance was $0 and&#13;$58,240 for the years ended December 31, 2020 and 2019, respectively.&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 15 &amp;#8211; Income Taxes &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For financial reporting&#13;purposes, there were no provisions for U.S. federal, state or international income taxes for the years ended December 31, 2020&#13;or 2019 due to the Company&amp;#8217;s net operating losses (&amp;#8220;NOLs&amp;#8221;) in such periods and full valuation allowance recorded&#13;against the net deferred tax assets.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The differences between&#13;income taxes expected at the U.S. federal statutory income tax rate and the reported provision for income taxes are summarized&#13;as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Income taxes computed at the federal statutory rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(369,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(281,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;States taxes, net of federal benefits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(69,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(53,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Permanent differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(136,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;17,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;True-up adjustments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;115,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;199,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Adjustment to net operating loss&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(17,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(86,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Change in valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;476,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;204,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Reported income tax (benefit) expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The components of the net&#13;deferred tax assets as of December 31, 2020 and 2019 are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Deferred tax assets:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 62%; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Net operating losses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,821,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,081,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Equity compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;118,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;392,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Other deferred tax assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;169,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;149,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 20pt"&gt;&lt;font style="font-size: 10pt"&gt;Total deferred tax assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,108,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,622,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Deferred tax liabilities:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Other deferred tax liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(68,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(58,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 20pt"&gt;&lt;font style="font-size: 10pt"&gt;Total deferred tax liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(68,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(58,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Net deferred tax assets before valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,040,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,564,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Less valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(5,040,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(4,564,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Net deferred tax assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020,&#13;the Company has U.S. federal and state net operating losses (&amp;#8220;NOLs&amp;#8221;) of approximately $19,322,000, of which $11,196,261&#13;will expire, if not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December 31, 2017 do not expire&#13;but may only be used against taxable income to 80%. In response to the novel coronavirus COVID-19, the Coronavirus Aid, Relief,&#13;and Economic Security Act temporarily repealed the 80% limitation for NOLs arising in 2018, 2019 and 2020. Pursuant to Section&#13;382 of the Internal Revenue Code of 1986, as amended, use of the Company&amp;#8217;s NOLs carryforwards may be limited in the event&#13;of cumulative changes in ownership of more than 50% within a three-year period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company must assess&#13;the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes&#13;that recovery is not likely, the Company establishes a valuation allowance. Management&amp;#8217;s judgment is required in determining&#13;the Company&amp;#8217;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against&#13;the net deferred tax assets. The Company recorded a full valuation allowance as of December 31, 2020 and 2019. Based on the available&#13;evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the&#13;foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal&#13;of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions&#13;that are consistent with the Company&amp;#8217;s plans. Should the actual amounts differ from the Company&amp;#8217;s estimates, the carrying&#13;value of the Company&amp;#8217;s deferred tax assets could be materially impacted.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company is subject&#13;to examination by the IRS for the calendar year 2016 and thereafter. These examinations may lead to ordinary course adjustments&#13;or proposed adjustments to the Company&amp;#8217;s taxes or the Company&amp;#8217;s net operating losses with respect to years under examination&#13;as well as subsequent periods. The Company has filed Colorado state income tax returns for years 2014 through 2019, Alaska, California&#13;and Connecticut state income tax returns for the years 2017 through 2019, Michigan state income tax returns for the years 2018&#13;and 2019 and Alabama, District of Columbia, Massachusetts, Oklahoma and Texas state income taxes in 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company recognizes&#13;in its consolidated financial statements the impact of a tax position, if that position is more likely than not of being sustained&#13;on audit, based on the technical merits of the position. The Company&amp;#8217;s policy is to recognize interest and penalties accrued&#13;on any unrecognized tax benefits as a component of operating expense. The Company does not believe there are any tax positions&#13;for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease&#13;within twelve months of the reporting date. There were no penalties or interest liabilities accrued as of December 31, 2020 or&#13;2019, nor were any penalties or interest costs included in expense for the years ended December 31, 2020 and 2019.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Principles of Consolidation&#13;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The consolidated financial&#13;statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro Innovations, LLC (&amp;#8220;Hydro&amp;#8221;).&#13;Intercompany transactions, profit, and balances are eliminated in consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Management makes estimates&#13;and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities&#13;at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period.&#13;The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under&#13;the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities&#13;that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation&#13;of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected&#13;revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets as it applies&#13;to impairment analysis, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals,&#13;inventory allowances, and legal contingencies.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Basic and Diluted&#13;Net Loss per Common Share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Basic income (loss) per&#13;common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common&#13;shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share&#13;is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive&#13;common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in&#13;periods when losses are reported where the effect of the common stock equivalents would be antidilutive. Potential common stock&#13;equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units&#13;using the treasury method. As of December 31, 2020, 29,213,500 potential common shares equivalents from warrants and options were&#13;excluded from the diluted EPS calculations as their effect is anti-dilutive.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Goodwill and Intangible&#13;Assets&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company recorded goodwill&#13;in connection with its acquisition of Hydro in July 2014. Goodwill is reviewed for impairment annually on December 31&lt;sup&gt;st&lt;/sup&gt;&#13;or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less&#13;than its carrying value. The Company performs a quantitative impairment test annually during the fourth quarter by comparing the&#13;fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds&#13;its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the&#13;carrying amount exceeds the reporting unit&amp;#8217;s fair value. The Company determined that it has one reporting unit. The Company&#13;completed this assessment as of December 31, 2020 and concluded that no impairment existed.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Separable identifiable&#13;intangibles consist of intellectual property such as patents and trademarks, and capitalized website costs. Except for trademarks,&#13;which are not amortized, the Company&amp;#8217;s separable identifiable intangible assets are subject to amortization on a straight-line&#13;basis over their estimated useful lives. Trademarks are tested annually for impairment. Separable identifiable intangibles are&#13;also subject to evaluation for potential impairment if events or circumstances indicate the carrying value may not be recoverable.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Revenue Recognition&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On January 1, 2018, the&#13;Company adopted Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) 2014-09 (Topic 606), &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;&#13;and all the related amendments (&amp;#8220;ASC 606&amp;#8221; or the &amp;#8220;revenue standard&amp;#8221;) to all contracts and elected the modified&#13;retrospective method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets&#13;forth the Company&amp;#8217;s revenue by source:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;For the Years Ended December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="white-space: nowrap; width: 68%"&gt;&lt;font style="font-size: 10pt"&gt;Equipment and systems sales&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,730,371&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,692,863&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="white-space: nowrap"&gt;&lt;font style="font-size: 10pt"&gt;Engineering and other services&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;568,131&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,239,130&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Shipping and handling&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;215,770&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;292,461&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,514,272&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,224,454&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;u&gt;Revenue Recognition&#13;Accounting Policy Summary&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for&#13;revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer&#13;to transfer a distinct good or service to the customer. Most of the Company&amp;#8217;s contracts contain multiple performance obligations&#13;that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment&#13;and components, which can span multiple phases of a customer&amp;#8217;s project life-cycle from facility design and construction to&#13;equipment delivery and system installation and start-up. The Company does not provide construction services or system installation&#13;services. Some of the Company&amp;#8217;s contracts with customers contain a single performance obligation, typically engineering only&#13;services contracts.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A contract&amp;#8217;s transaction&#13;price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is&#13;satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each&#13;performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable&#13;inputs. The best observable input is the Company&amp;#8217;s actual selling price for the same good or service, however, this input&#13;is generally not available for the Company&amp;#8217;s contracts containing multiple performance obligations. For engineering services,&#13;the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility&#13;size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to&#13;be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment&#13;and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending&#13;on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain&#13;performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the&#13;Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be&#13;recognized as each promise is fulfilled.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Generally, satisfaction&#13;occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for&#13;consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when&#13;control transfers to the customer, which primarily occurs at the time of shipment. The Company&amp;#8217;s historical rates of return&#13;are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the&#13;Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales,&#13;use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing&#13;transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The&#13;revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&amp;#8217;s customers.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company also has performance&#13;obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type&#13;of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company offers assurance-type&#13;warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers&#13;and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve&#13;based on historical warranty costs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;u&gt;Other Judgments and&#13;Assumptions&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company typically receives&#13;customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18,&#13;which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant&#13;financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised&#13;good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining&#13;performance obligations related to customer contracts does not consider the effects of the time value of money.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Applying the practical&#13;expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since&#13;the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include&#13;certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only&#13;when associated revenue has been collected and earned by the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;u&gt;Contract Assets and&#13;Contract Liabilities&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Contract assets reflect&#13;revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments&#13;received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on&#13;the terms established in its contracts.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Contract assets include&#13;unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject&#13;to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets&#13;since revenue is recognized as control of goods are transferred or as services are performed. As of December 31, 2020, and 2019,&#13;the Company had no contract assets.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Contract liabilities&#13;consist of advance payments in excess of revenue recognized. The Company&amp;#8217;s contract liabilities are recorded as a&#13;current liability in deferred revenue in the consolidated balance sheets since the timing of when the Company expects to&#13;recognize revenue is generally less than one year. As of December 31, 2020, and December 31, 2019, deferred revenue, which&#13;was classified as a current liability, was $3,724,189 and $1,444,472, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For the year ended December&#13;31, 2020, the Company recognized revenue of $1,103,447 related to the deferred revenue at January 1, 2020, or 76%. For the year&#13;ended December 31, 2019, the Company recognized revenue of $473,682 related to the deferred revenue at January 1, 2019, or 74%.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;u&gt;Remaining Performance&#13;Obligations&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Remaining performance obligations,&#13;or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has&#13;not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which&#13;exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of&#13;one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts,&#13;including those with an expected duration of one year or less.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Industry uncertainty, project&#13;financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&amp;#8217;s control,&#13;make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are&#13;risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion&#13;of a customer&amp;#8217;s cultivation facility project is dependent upon the customer&amp;#8217;s ability to secure funding and real estate,&#13;obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time&#13;it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by&#13;numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business;&#13;(ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government&#13;delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states&#13;where there is no cap on the number of cultivators; (iv) the customer&amp;#8217;s need to obtain cultivation facility financing; (v)&#13;the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility&#13;(to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate&#13;control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction&#13;project. Further, based on the current economic climate, the uncertainty regarding the COVID-19 virus, and the Company&amp;#8217;s&#13;recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience&#13;contract cancellations, project scope reductions and project delays.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020,&#13;the Company&amp;#8217;s remaining performance obligations, or backlog, was $8,448,000, of which $2,643,000, or 31%, was attributable&#13;to customer contracts for which the Company has only received an initial advance payment to cover the allocated value of the Company&amp;#8217;s&#13;engineering services (&amp;#8220;engineering only paid contracts&amp;#8221;). There is the risk that the equipment portion of these engineering&#13;only paid contracts will not be completed or will be delayed. The reasons include the customer being dissatisfied with the quality&#13;or timeliness of the Company&amp;#8217;s engineering services, delay or abandonment of the project because of the customer&amp;#8217;s&#13;inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall&#13;post-COVID-19 economic downturn, or change in business direction. After the customer has made an advance payment for a portion&#13;of the equipment to be delivered under the contract (&amp;#8220;partial equipment paid contracts&amp;#8221;), the Company is typically&#13;better able to estimate the timing of revenue recognition since the risks and delays associated with licensing, permitting and&#13;project funding are typically mitigated once the initial equipment payment is received. There is significant uncertainty regarding&#13;the timing of the Company&amp;#8217;s recognition of revenue on its remaining performance obligations, and there is no certainty that&#13;these will result in actual revenues. The backlog at December 31, 2020, includes booked sales orders of $390,000 from several customers&#13;that the Company does not expect to be realized until 2022, if at all. Given the present economic uncertainty arising from the&#13;impact of the novel coronavirus COVID-19, the Company believes that several of its current contracts may be delayed or canceled.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The remaining performance&#13;obligations expected to be recognized through 2022 are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 55%"&gt;&lt;font style="font-size: 10pt"&gt;Remaining performance obligations related to engineering only paid contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,355,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;288,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,643,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Remaining performance obligations related to partial equipment paid contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,703,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;102,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,805,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total remaining performance obligations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,058,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;390,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,448,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Concentrations&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Three customers accounted&#13;for 28%, 11% and 10% of the Company&amp;#8217;s revenue for the year ended December 31, 2020. One customer accounted for 44% of the&#13;Company&amp;#8217;s revenue for the year ended December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company&amp;#8217;s accounts&#13;receivable from two customers made up 48% and 38%, respectively, of the total balance as of December 31, 2020. The Company&amp;#8217;s&#13;accounts receivable from three customers made up 59%, 16%, and 10%, respectively, of the total balance as of December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Three suppliers accounted&#13;for 27%, 25% and 12% of the Company&amp;#8217;s purchases of inventory for the year ended December 31, 2020, and three suppliers accounted&#13;for 30%, 17% and 12% of the Company&amp;#8217;s purchases of inventory for the year ended December 31, 2019.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Recently Issued Accounting&#13;Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In August 2020, the FASB&#13;issued ASU 2020-06: &amp;#8220;&lt;i&gt;Accounting for Convertible Instruments and Contracts In An Entity&amp;#8217;s Own Equity&amp;#8221; (&amp;#8220;ASU&#13;2020-06&amp;#8221;)&lt;/i&gt; ASU 2020-04 simplifies the accounting for certain convertible instruments by removing the separation models&#13;for convertible debt with a cash conversion feature and for convertible instruments with a beneficial conversion feature. As a&#13;result, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded&#13;conversion features. Additionally, ASU 2020-04 amends the diluted earnings per share calculation for convertible instruments by&#13;requiring the use of the if-converted method. The treasury stock method is no longer available. Entities may adopt the ASU 2020-04&#13;using either a full or modified retrospective approach, and it is effective for interim and annual reporting periods beginning&#13;after December 15, 2021. Early adoption is permitted for interim and annual reporting periods beginning after December 15, 2020.&#13;The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial&#13;position.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In December 2019, the FASB&#13;issued ASU 2019-12, &lt;i&gt;Income Taxes (Topic 740) &amp;#8211; Simplifying the Accounting for Income Taxes, &lt;/i&gt;which simplifies the accounting&#13;for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent&#13;application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12 is effective&#13;for fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company does not expect this ASU to have a&#13;material impact on its consolidated results of operations, cash flows and financial position.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Other accounting standards&#13;that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material&#13;impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to&#13;have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The remaining performance&#13;obligations expected to be recognized through 2022 are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 55%"&gt;&lt;font style="font-size: 10pt"&gt;Remaining performance obligations related to engineering only paid contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,355,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;288,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,643,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Remaining performance obligations related to partial equipment paid contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,703,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;102,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,805,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total remaining performance obligations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,058,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;390,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,448,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets&#13;forth the Company&amp;#8217;s revenue by source:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;For the Years Ended December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="white-space: nowrap; width: 68%"&gt;&lt;font style="font-size: 10pt"&gt;Equipment and systems sales&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,730,371&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,692,863&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="white-space: nowrap"&gt;&lt;font style="font-size: 10pt"&gt;Engineering and other services&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;568,131&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,239,130&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Shipping and handling&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;215,770&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;292,461&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,514,272&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,224,454&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following is a summary&#13;of such share-based compensation costs included in the Company&amp;#8217;s consolidated statements of operations for the years ended&#13;December 31, 2020 and 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;For the Years Ended December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Share-based compensation expense included in:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Cost of revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;31,006&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;91,081&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Advertising and marketing expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,333&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;33,977&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Product development costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;21,882&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;45,330&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Selling, general and administrative expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;344,396&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,121,677&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total share-based compensation expense included in consolidated statement of operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;405,617&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,292,065&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The lease cost, cash flows&#13;and other information related to the Facility Lease were as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="white-space: nowrap; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;For the Year Ended&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 82%"&gt;&lt;font style="font-size: 10pt"&gt;Operating lease cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;216,889&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Operating cash outflow from operating lease&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;160,934&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 82%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;As of&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;December 31, 2020&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Operating lease right-of-use assset&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;343,950&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Operating lease liability, current&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;266,105&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Operating lease liability, long-term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;169,119&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Remaining lease term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.7 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Discount rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Future annual minimum lease&#13;payments on the Facility Lease as of December 31, 2020 were as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Years ended December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 82%"&gt;&lt;font style="font-size: 10pt"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;281,864&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;170,891&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Total minimum lease payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;452,755&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Less imputed interest&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(17,531&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Present value of minimum lease payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;435,224&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Inventory consisted of&#13;the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;As of December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Finished goods&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;201,778&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,041,369&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Work in progress&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,231&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,851&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Raw materials&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;214,145&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;257,399&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Allowance for excess &amp;#38; obsolete inventory&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(93,045&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(71,376&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Inventory, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;327,109&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,231,243&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Property and equipment&#13;consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;As of December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Furniture and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;398,422&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;389,090&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Vehicles&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Leasehold improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;215,193&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;215,193&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;628,615&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;619,283&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Accumulated depreciation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(480,883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(361,360&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Property and equipment, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;147,732&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;257,923&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Accounts payable and accrued&#13;liabilities consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;As of December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;918,639&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,299,015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Sales commissions payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;48,263&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;69,532&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accrued payroll liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;288,071&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;169,052&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Product warranty accrual&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;173,365&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;185,234&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Other accrued expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;356,623&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;110,127&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,784,961&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,832,959&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2020-01-01to2020-12-31_custom_TwoThousandSeventeenEquityPlanMember_srt_DirectorMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of the non-qualified&#13;stock options granted to directors under the 2017 Equity Plan during the years ended December 31, 2020 and 2019 are presented in&#13;the table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Term&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Value ($000)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 44%"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;900,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.135&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited/Cancelled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;900,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.135&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,500,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.057&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited/Cancelled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.067&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Exerciseable, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.073&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2020-01-01to2020-12-31_custom_TwoThousandSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;A&#13;summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the years ended&#13;December 31, 2020 and 2019 are presented in the table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Remaining Contractual Term&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Aggregate Intrinsic&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 44%"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,560,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.104&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.4&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.080&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,408,333&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.116&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(16,667&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.105&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,135,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.096&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,616,900&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.070&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,500,900&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.101&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;14,251,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.083&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Exercisable, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;14,251,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.083&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="From2020-01-01to2020-12-31_custom_TwoThousandSeventeenEquityPlanMember_srt_DirectorMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of non-vested&#13;non-qualified stock options activity for directors under the 2017 Equity Plan for the years ended December 31, 2020 and 2019 are&#13;presented in the table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font: 10pt Tahoma, Helvetica, Sans-Serif"&gt;&amp;#65279;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Grant-Date Fair Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Aggregate Intrinsic Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Grant-Date Fair Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Tahoma, Helvetica, Sans-Serif"&gt;&amp;#65279;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Nonvested, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Nonvested, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 44%; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,500,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.057&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;373,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(5,500,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.063&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;344,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Nonvested, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.029&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;29,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="From2020-01-01to2020-12-31_custom_TwoThousandSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of non-vested&#13;non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the years ended December 31,&#13;2020 and 2019 are presented in the table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Tahoma, Helvetica, Sans-Serif"&gt;&amp;#65279;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number of&lt;br /&gt;&#13;Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted&lt;br /&gt;&#13;Average&lt;br /&gt;&#13;Grant-Date&lt;br /&gt;&#13;Fair Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Aggregate&lt;br /&gt;&#13;Intrinsic&lt;br /&gt;&#13;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Grant-Date&lt;br /&gt;&#13;Fair Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Tahoma, Helvetica, Sans-Serif"&gt;&amp;#65279;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 46%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Nonvested, December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7,333,329&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.086&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;628,756&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 6.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.065&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;130,120&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 6.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(4,924,996&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.074&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;362,998&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 6.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2,408,333&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.102&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;246,344&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 6.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Nonvested, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.075&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;149,534&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 6.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6,616,900&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.059&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;387,199&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 6.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(8,616,900&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.062&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;536,733&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 6.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 6.75pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Nonvested, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of the RSUs awarded&#13;to employees, directors and consultants under the 2017 Equity Plan during the years ended December 31, 2020 and 2019 are presented&#13;in the table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Units&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Grant-Date&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 55%"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,867,368&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.140&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;730,185&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Vested and settled with share issuance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(1,120,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.181&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited/canceled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(1,197,368&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.179&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,550,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.128&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Vested and settled with share issuance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(6,750,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.121&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited/canceled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(800,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.184&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:OtherLiabilities contextRef="AsOf2019-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:OtherLiabilities contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">74156</us-gaap:OtherLiabilities>
    <SRNA:WarrantsDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 13 &amp;#8211; Outstanding Warrants&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following table summarizes&#13;information with respect to outstanding warrants to purchase common stock during the years ended December 31, 2020 and 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="white-space: nowrap; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Remaining Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Intrincic&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;In Months&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 44%"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;40,010,250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Issued&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(901,250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(0.66&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;39,109,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Issued&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(31,546,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(0.23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,562,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following table summarizes&#13;information about warrants outstanding at December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Weighted Average Life of&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;Exercise price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;In Months&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 32%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 30%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,562,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 30%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Series 2 Warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In October 2014, the Company&#13;offered up to 60 investment units at a price per unit of $50,000. Each unit consisted of (i) 250,000 shares of the Company&amp;#8217;s&#13;common stock, (ii) a $50,000 10% convertible promissory note (&amp;#8220;Series 2 Convertible Note&amp;#8221;), and (iii) warrants for&#13;the purchase of 50,000 shares of the Company&amp;#8217;s common stock (&amp;#8220;Series 2 Warrants&amp;#8221;). As of December 31, 2018, Series&#13;2 Warrants to purchase 901,250 shares of common stock were outstanding, all of which expired unexercised during the year ended&#13;December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Warrants Issued to&#13;Investment Bank&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Pursuant to a certain agreement&#13;for services rendered in connection with the conversion of the Series 2 Convertible Notes, during the year ended December 31, 2017,&#13;the Company issued to an investment bank or its designees a warrant (&amp;#8220;Banker Warrant&amp;#8221;) to purchase, at an exercise&#13;price $0.35 per share, 500,000 shares of the Company&amp;#8217;s common stock. The Banker Warrants were fully vested on the date of&#13;issuance, were exercisable beginning December 20, 2017 and expired unexercised on June 20, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Q1 2017 Warrants&#13;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In March 2017, the Company&#13;issued 16,781,250 investment units, for aggregate gross proceeds of $2,685,000, or $0.16 per unit. Each unit consisted of one share&#13;of the Company&amp;#8217;s common stock and one warrant for the purchase of one share of the Company&amp;#8217;s common stock (&amp;#8220;Q1&#13;2017 Warrants&amp;#8221;); however, one investor declined receipt of the warrant to purchase 468,750 shares of the Company&amp;#8217;s&#13;common stock. Pursuant to the Q1 2017 Warrants, the holder thereof may at any time on or after six months after the issuance date&#13;and on or prior to the close of business on the date that is the third anniversary of the issuance date, purchase up to the number&#13;of shares of the Company&amp;#8217;s common stock as set forth in the respective warrant. The exercise price per share of the common&#13;stock under the Q1 2017 Warrants is $0.26, subject to customary adjustments as provided in the warrant. Each Q1 2017 Warrant was&#13;callable at the Company&amp;#8217;s option commencing six months from the issuance date, provided the closing price of the Company&amp;#8217;s&#13;common stock was $0.42 or greater for five consecutive trading days. Commencing at any time after the date on which such call condition&#13;was satisfied, the Company had the right, upon 30 days&amp;#8217; notice to the holder, to redeem the warrant shares at a price of&#13;$0.01 per warrant share. The holder could have exercised the warrant at any time (in whole or in part) prior to the redemption&#13;date at the exercise price. These warrants expired unexercised in March 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Q4 2017 Warrants&#13;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In December 2017, the Company&#13;issued 14,734,000 investment units for aggregate proceeds of $1,768,080, or $0.12 per unit. Each unit consisted of one share of&#13;the Company&amp;#8217;s common stock and one warrant for the purchase of one share of the Company&amp;#8217;s common stock (&amp;#8220;Q4 2017&#13;Warrants&amp;#8221;). The Q4 2017 Warrants had an exercise price of $0.20 per share, subject to customary adjustments as provided in&#13;the warrant, and had a term of three years. The Q4 2017 Warrants were callable at the Company&amp;#8217;s option, provided the closing&#13;price of the Company&amp;#8217;s common stock was $0.36 or greater for five consecutive trading days. Commencing at any time after&#13;the date on which the call condition is satisfied, the Company had the right, upon notice to the holders, to redeem the shares&#13;of common stock underlying each warrant at a price of $0.01 per share, but such redemption could not occur earlier than sixty-one&#13;(61) days following the date of the receipt of notice by the holder. The holder could exercise the warrant at any time (in whole&#13;or in part) prior to the redemption date at the exercise price. These warrants expired unexercised in December 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Q2 2018 Warrants&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In June 2018, the Company&#13;completed a private placement offering of investment units, with each unit consisting of one share of the Company&amp;#8217;s common&#13;stock and one Q2 2018 Warrant. The Q2 2018 Warrants have an exercise price of $0.25 per share of the common stock underlying each&#13;warrant, subject to customary adjustments as provided in the warrant. The Q2 2018 Warrants are exercisable commencing July 1, 2018&#13;until June 30, 2021. The Q2 2018 Warrants are callable at the Company&amp;#8217;s option, beginning on July 1, 2019 until the expiration&#13;thereof on June 30, 2021, provided the closing price of the Company&amp;#8217;s common stock is $0.40 (subject to adjustment as provided&#13;in the warrant) or greater for five consecutive trading days. Commencing at any time after the date on which the call condition&#13;is satisfied, the Company has the right, upon notice to the holders, to redeem the shares of common stock underlying each warrant&#13;at a price of $0.01 per share, but such redemption may not occur earlier than sixty-one (61) days following the date of the receipt&#13;of notice by the holder. The holder may exercise the warrant (in whole or in part) prior to the redemption date at the exercise&#13;price. As of December 31, 2020, Q2 2018 Warrants to purchase 7,562,500 shares of common stock were outstanding.&lt;/p&gt;</SRNA:WarrantsDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-04-22_us-gaap_SubsequentEventMember" unitRef="usd" decimals="0">554000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2020-12-11" unitRef="usd" decimals="0">554000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2021-02-10_us-gaap_SubsequentEventMember" unitRef="usd" decimals="0">514200</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2020-04-22_us-gaap_SubsequentEventMember" unitRef="Percentage" decimals="INF">0.01</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2021-02-10_us-gaap_SubsequentEventMember" unitRef="Percentage" decimals="INF">0.01</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2014-10-31_custom_SeriesTwoWarrantsMember_custom_SeriesTwoConvertibleNotesMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-04-21to2020-04-22_us-gaap_SubsequentEventMember">2022-04-20</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2021-02-09to2021-02-10_us-gaap_SubsequentEventMember">2026-02-05</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2020-04-21to2020-04-22_us-gaap_ExtendedMaturityMember">2025-04-20</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">3203</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest contextRef="From2020-12-10to2020-12-11" unitRef="usd" decimals="0">3203</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <SRNA:NumberOfUnitsVestedButNotSettled contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF">6750000</SRNA:NumberOfUnitsVestedButNotSettled>
    <SRNA:NumberOfUnitsVestedAndSettled contextRef="From2020-03-08to2020-03-09_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF">6750000</SRNA:NumberOfUnitsVestedAndSettled>
    <SRNA:NumberOfUnitsVestedAndSettled contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF">6750000</SRNA:NumberOfUnitsVestedAndSettled>
    <us-gaap:LossContingencyDamagesAwardedValue contextRef="From2020-03-08to2020-03-09_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="0">10000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue contextRef="From2020-06-07to2020-06-09_us-gaap_SubsequentEventMember_custom_FormerEmployeeMember" unitRef="usd" decimals="0">33985</us-gaap:LossContingencyDamagesAwardedValue>
    <SRNA:RestrictedStockUnitsSharesIssuedInterestPercentage contextRef="From2020-06-07to2020-06-09_us-gaap_SubsequentEventMember_custom_FormerEmployeeMember" unitRef="Percentage" decimals="INF">0.08</SRNA:RestrictedStockUnitsSharesIssuedInterestPercentage>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember" unitRef="shares" decimals="INF">50000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <SRNA:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod contextRef="From2019-01-01to2019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember" unitRef="shares" decimals="INF">2000000</SRNA:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod>
    <SRNA:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod contextRef="From2020-01-01to2020-03-24_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember_us-gaap_SubsequentEventMember" unitRef="shares" decimals="INF">1000000</SRNA:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember" unitRef="usd" decimals="0">6412</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember" unitRef="usd" decimals="0">6412</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2019-01-01to2019-12-31_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanMember" unitRef="shares" decimals="INF">16667</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">2500900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_srt_DirectorMember" unitRef="shares" decimals="INF">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_srt_DirectorMember" unitRef="shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward contextRef="From2020-06-23to2020-06-24_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_TwoNewIndependentDirectorsMember" unitRef="shares" decimals="INF">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember1368509609" unitRef="shares" decimals="INF">10250000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward contextRef="From2019-12-30to2020-01-02_custom_TwoThousandAndNineteenSpecialEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward contextRef="From2019-12-30to2020-01-02_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="shares" decimals="INF">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-01-01to2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-01-01to2019-12-31_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanMember" unitRef="shares" decimals="INF">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-06-23to2020-06-24_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_TwoNewIndependentDirectorsMember" unitRef="shares" decimals="INF">39600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">6616900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">6500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="shares" decimals="INF">6616900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="shares" decimals="INF">6500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2021-01-01to2021-01-02_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember" unitRef="shares" decimals="INF">1035800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-12-30to2020-01-02_custom_TwoThousandAndNineteenSpecialEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">234126</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-12-30to2020-01-02_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">29266</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2020-01-01to2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="From2020-06-23to2020-06-24_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_TwoNewIndependentDirectorsMember" unitRef="Percentage" decimals="INF">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="From2020-06-23to2020-06-24_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_AprilOneTwentyTwentyOneMember_custom_TwoNewIndependentDirectorsMember" unitRef="Percentage" decimals="INF">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-01-01to2019-12-31_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanMember">P8Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-06-23to2020-06-24_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_TwoNewIndependentDirectorsMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">P7Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">P7Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-12-30to2020-01-02_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">P8Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharePrice contextRef="AsOf2020-06-24_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.029</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="AsOf2020-01-02_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.07</us-gaap:SharePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested contextRef="From2018-01-01to2018-12-31_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="0">1035750</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="0">79120</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested contextRef="From2020-01-01to2020-12-31_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="0">199125</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="shares" decimals="INF">4924996</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2019-01-01to2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="shares" decimals="INF">1680000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-04-29to2020-04-30_us-gaap_SubsequentEventMember_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF">800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="shares" decimals="INF">8616900</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="shares" decimals="INF">5500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-01-01to2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">10135000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">14251000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">7400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" unitRef="shares" decimals="INF">10560000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2019-01-01to2019-12-31_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2019-01-01to2019-12-31_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanMember" unitRef="shares" decimals="INF">2408333</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">14251000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">6400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="AsOf2019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember_custom_AprilThirtyTwoThousandAndTwentyMember" unitRef="shares" decimals="INF">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.096</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.083</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.135</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.067</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" decimals="INF">0.104</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.135</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanMember" unitRef="usdPershares" decimals="INF">0.080</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.070</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.057</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2021-01-01to2021-01-02_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember" unitRef="usdPershares" decimals="INF">0.13</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanMember" unitRef="usdPershares" decimals="INF">0.116</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanMember" unitRef="usdPershares" decimals="INF">0.105</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.101</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.083</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.057</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.073</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2019-01-01to2019-12-31_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanMember">P7Y8M12D</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">P8Y3M19D</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">P7Y6M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">P7Y7M6D</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="shares" decimals="INF">1197368</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="From2019-01-01to2019-12-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember" unitRef="shares" decimals="INF">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="shares" decimals="INF">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-12-31" unitRef="usdPershares" decimals="INF">0.24</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2018-12-31" unitRef="usdPershares" decimals="INF">0.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember" unitRef="usdPershares" decimals="INF">0.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember" unitRef="usdPershares" decimals="INF">0.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31" unitRef="usdPershares" decimals="INF">0.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31_custom_WarrantsRangeMember" unitRef="usdPershares" decimals="INF">0.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-12-31_us-gaap_WarrantMember_custom_InvestmentBankMember" unitRef="usdPershares" decimals="INF">0.35</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" unitRef="usdPershares" decimals="INF">0.26</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2019-12-31" unitRef="shares" decimals="INF">39109000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2018-12-31" unitRef="shares" decimals="INF">40010250</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">7562500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31_custom_WarrantsRangeMember" unitRef="shares" decimals="INF">7562500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <SRNA:ClassOfWarrantOrRightIssued contextRef="From2020-01-01to2020-12-31" unitRef="shares" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightIssued contextRef="From2019-01-01to2019-12-31" unitRef="shares" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightExercised contextRef="From2020-01-01to2020-12-31" unitRef="shares" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightExercised contextRef="From2019-01-01to2019-12-31" unitRef="shares" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightExpired contextRef="From2020-01-01to2020-12-31" unitRef="shares" decimals="INF">31546500</SRNA:ClassOfWarrantOrRightExpired>
    <SRNA:ClassOfWarrantOrRightExpired contextRef="From2019-01-01to2019-12-31" unitRef="shares" decimals="INF">901250</SRNA:ClassOfWarrantOrRightExpired>
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceIssued contextRef="From2020-01-01to2020-12-31" unitRef="usdPershares" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceIssued contextRef="From2019-01-01to2019-12-31" unitRef="usdPershares" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExercised contextRef="From2020-01-01to2020-12-31" unitRef="usdPershares" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExercised contextRef="From2019-01-01to2019-12-31" unitRef="usdPershares" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired contextRef="From2020-01-01to2020-12-31" unitRef="usdPershares" decimals="INF">-0.23</SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired>
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired contextRef="From2019-01-01to2019-12-31" unitRef="usdPershares" decimals="INF">-0.66</SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2020-01-01to2020-12-31">P6M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2019-01-01to2019-12-31">P9M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2020-01-01to2020-12-31_custom_WarrantsRangeOneMember">P6M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">0</SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue>
    <SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue contextRef="AsOf2018-12-31" unitRef="usd" decimals="0">0</SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue>
    <SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">0</SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue>
    <SRNA:ClassOfWarrantOrRightIssuedAggregateIntrinsicValue contextRef="From2020-01-01to2020-12-31" unitRef="usd" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightIssuedAggregateIntrinsicValue contextRef="From2019-01-01to2019-12-31" unitRef="usd" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightExercisedAggregateIntrinsicValue contextRef="From2020-01-01to2020-12-31" unitRef="usd" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightExercisedAggregateIntrinsicValue contextRef="From2019-01-01to2019-12-31" unitRef="usd" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">0</SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue>
    <SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">0</SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2020-01-01to2020-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2019-01-01to2019-12-31" unitRef="usd" xsi:nil="true" />
    <SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following table summarizes&#13;information with respect to outstanding warrants to purchase common stock during the years ended December 31, 2020 and 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="white-space: nowrap; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Remaining Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Intrincic&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;In Months&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 44%"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;40,010,250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;21&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Issued&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(901,250&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(0.66&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;39,109,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Issued&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(31,546,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(0.23&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,562,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2020-01-01to2020-12-31">P9M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2019-01-01to2019-12-31">P21M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 9 &amp;#8211; Note Payable and Accrued&#13;Interest&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On April 22, 2020, the&#13;Company entered into a note payable with its current bank in the principal amount of $554,000, for working capital purposes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The loan amount was subject&#13;to interest at 1% and was initially due on April 20, 2022. Subsequently, the term of the loan was potentially to be extended to&#13;April 20, 2025. The loan could be repaid in advance without penalty. The loan was also potentially forgivable in full provided&#13;proceeds were used for payment of payroll expenses, rent, utilities and mortgage interest and certain other terms and conditions&#13;were met. The loan had typical default provisions, including for change of ownership, general lender insecurity as to repayment,&#13;non-payment of amounts due, defaults on other debt instruments, insolvency, dissolution or termination of the business as a going&#13;concern and bankruptcy.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#13;31, 2020, interest of $3,203 was accrued in respect of this note payable.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On December 11, 2020, the&#13;Company received notice from the bank that its loan received on April 22, 2020, in the principal amount of $554,000 and all accrued&#13;interest of $3,203, was fully forgiven. This gain on loan forgiveness&#13;was recorded as Other Income in the Statement of Operations during the year.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As further discussed in&#13;&lt;i&gt;Note 16 Subsequent Events&lt;/i&gt; below, on February 10, 2021, we received funding based on a loan agreement entered into on February&#13;5, 2021 with its current bank in the principal amount of $514,200 for working capital purposes. Consistent with the loan provisions,&#13;the Company will use the proceeds to meet payroll and benefit expenses as well as for rent and utilities. The loan amount bears&#13;interest at 1% and is due on February 5, 2026. The loan may be repaid in advance without penalty. The loan has typical default&#13;provisions, including for change of ownership, general lender insecurity as to repayment, non-payment of amounts due, defaults&#13;on other debt instruments, insolvency, dissolution or termination of the business as a going concern and bankruptcy.&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2020-01-01to2020-12-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2020-01-01to2020-12-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityPublicFloat contextRef="AsOf2020-06-30" unitRef="usd" decimals="0">7090000</dei:EntityPublicFloat>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2020-01-01to2020-12-31" unitRef="shares" decimals="INF">236168059</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2019-01-01to2019-12-31" unitRef="shares" decimals="INF">227662184</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2020-01-01to2020-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:IncomeTaxesPaidNet contextRef="From2019-01-01to2019-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:InterestPaidNet contextRef="From2020-01-01to2020-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:InterestPaidNet contextRef="From2019-01-01to2019-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">922177</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2018-12-31" unitRef="usd" decimals="0">253387</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">2284881</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">1362704</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">668790</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">554000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2019-01-01to2019-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:ProceedsFromNotesPayable contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">554000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2019-01-01to2019-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">-9332</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">-3043</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">9332</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">3043</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">818036</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">671833</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:IncreaseDecreaseInDeferredCompensation contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">128434</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInDeferredCompensation contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">503466</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <SRNA:IncreaseDecreaseOperatingLeaseLiabilityNet contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">-135828</SRNA:IncreaseDecreaseOperatingLeaseLiabilityNet>
    <SRNA:IncreaseDecreaseOperatingLeaseLiabilityNet contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">-20039</SRNA:IncreaseDecreaseOperatingLeaseLiabilityNet>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">2279717</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">802674</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">26157</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">23830</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">768333</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">141143</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">-882466</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">71386</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">-91452</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">-39179</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">-4124</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">-115359</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">13425</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">32651</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">120103</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">161180</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">190183</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="From2019-01-01to2019-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">3203</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="From2019-01-01to2019-12-31" unitRef="usd" xsi:nil="true" />
    <SRNA:GainOnForgivenessOfNotePayable contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">557203</SRNA:GainOnForgivenessOfNotePayable>
    <SRNA:GainOnForgivenessOfNotePayable contextRef="From2019-01-01to2019-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:NatureOfOperations contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 1 &amp;#8211; Description of Business&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Surna Inc. (the &amp;#8220;Company&amp;#8221;)&#13;was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the&#13;Controlled Environment Agriculture (CEA) industry. The CEA industry is one of the fastest-growing sectors of the United States&amp;#8217;&#13;economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage),&#13;ethnic vegetables and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes and&#13;cannabis and hemp, some producers grow crops indoors in response to market dynamics or as part of their preferred farming practice.&#13;In service of the CEA industry, our principal technologies include: (i) liquid-based process cooling systems and other climate&#13;control systems, (ii) air handling equipment and systems, (iii) a full-service engineering package for designing and engineering&#13;commercial scale thermodynamic systems specific to cultivation facilities, and (iv) automation and control devices, systems and&#13;technologies used for environmental, lighting and climate control. Our customers include commercial, state- and provincial-regulated&#13;CEA growers in the U.S. and Canada as well as other international locations. Customers are those growers building new facilities&#13;and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our&#13;products, services and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet.&#13;Headquartered in Boulder, Colorado, we leverage our experience in this space to bring value-added climate control solutions to&#13;our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving&#13;state and local codes, permitting and regulatory requirements. Although our customers do, we neither produce nor sell cannabis&#13;or its related products.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Impact of the COVID-19&#13;Pandemic on Our Business&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The&#13;impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of&#13;our markets and disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project&#13;implementation, operating margins, and working capital. As of the date of this filing, uncertainty continues to exist concerning&#13;the magnitude and duration of the economic impact of the COVID-19 pandemic.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In response to the COVID-19&#13;pandemic and its changing conditions the Company reduced its operational expenses to conserve its cash resources. Many expenses,&#13;including travel, marketing, headcount, work hours, and compensation were reduced, deferred, or eliminated while still allowing&#13;us to meet our customer obligations and develop new business. As the fiscal year progressed and our sales rebounded, and we were&#13;able to obtain additional funds through a forgivable bank loan, we restored our workforce and compensation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;Due&#13;to the speed with which the COVID-19 pandemic developed and the resulting uncertainties, including the depth and duration of the&#13;disruptions to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition,&#13;cannot be predicted. We expect that the economic disruptions will continue to have an effect on our business over the longer term.&#13;Despite this uncertainty, we continue to monitor costs and continue to take actions to reduce costs so as to mitigate the impact&#13;of the COVID-19 pandemic to the best of our ability, although they may not be sufficient in the long-run for us to avoid reduced&#13;sales, increased losses and reduced operating cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;Refer&#13;to &lt;i&gt;Risk Factors&lt;/i&gt;, included in Part I, Item 1A of this Annual Report on Form 10-K above, for further discussion of the possible&#13;impact of the COVID-19 pandemic on our business.&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 3 &amp;#8211; Going Concern &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The&#13;accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which&#13;contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The&#13;Company has experienced recurring losses since its inception. The Company incurred a net loss of approximately $1,759,000 for the&#13;year ended December 31, 2020 and had an accumulated deficit of approximately $27,444,000 and a shareholders&amp;#8217; deficit of approximately&#13;$1,334,000 as of December 31, 2020. Since inception, the Company has financed its activities principally through debt and equity&#13;financing, advance payments from customers and revenues from completed contracts. Management expects to incur additional losses&#13;and cash outflows in the foreseeable future in connection with its operating activities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The&#13;Company is subject to a number of risks similar to those of other similar stage and situated companies, including general economic&#13;conditions, its customers&amp;#8217; operations and prospects for and ability to obtain project financing, and market and business&#13;disruptions, that include the outbreak of COVID-19, dependence on key individuals, successful development, marketing and branding&#13;of products; uncertainty of product development and generation of revenues; dependence on outside sources of financing; risks associated&#13;with research, development; dependence on third-party suppliers and collaborators; protection of intellectual property; and competition&#13;with larger, better-capitalized companies. Ultimately, the attainment of profitable operations is dependent on future events, including&#13;obtaining adequate financing to fulfill its development activities and generating a level of revenues adequate to support the Company&amp;#8217;s&#13;cost structure.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;There&#13;can be no assurance that the Company will be able to raise debt or equity financing in sufficient amounts, when and if needed,&#13;on acceptable terms or at all. The Company&amp;#8217;s ability to raise equity capital is also limited by the Company&amp;#8217;s stock&#13;price, and any such issuance could be highly dilutive to existing shareholders.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The&#13;Company&amp;#8217;s 2020 revenue of approximately $8,514,000 which represents a decrease of 44% over the prior year. The Company&amp;#8217;s&#13;revenue recognition on contracts continues to be unpredictable and inconsistent quarter-over-quarter, and the Company has incurred,&#13;and expects to incur, additional operating expenses to support such growth. The Company generated approximately $818,000 in cash&#13;flow from operating activities in 2020. However, as a result of the Company&amp;#8217;s growth and its efforts to expand and upgrade&#13;its products, the Company&amp;#8217;s working capital deficit as of December 31, 2020 was approximately $2,220,000, compared to approximately&#13;$1,437,000 as of December 31, 2019.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The&#13;Company also will be affected by constraints on the availability of capital to its customers and prospects who have commenced,&#13;or are contemplating, new or expanded cultivation facilities and the overall impact of the COVID-19 pandemic. The extent to which&#13;COVID-19 will impact the Company&amp;#8217;s business and financial results will depend on future developments, which are uncertain&#13;and cannot be predicted. See Note 16. The duration and likelihood of operational success going forward resulting from the fiscal&#13;year 2020 measures of adjusting the workforce reductions and cost-cutting measures are uncertain. If these actions do not meet&#13;management&amp;#8217;s expectations, or additional capital is not available, there is substantial doubt about the Company&amp;#8217;s&#13;ability to continue as a going concern for a period of one year from the issuance of these financial statements. Other factors&#13;that will impact the Company&amp;#8217;s ability to continue operations include the market demand for the Company&amp;#8217;s products&#13;and services, the ability to service its customers and prospects, potential contract cancellations, project scope reductions and&#13;project delays, the Company&amp;#8217;s ability to fulfill its backlog, the management of working capital, and the continuation of&#13;normal payment terms and conditions for purchase of the Company&amp;#8217;s products. The Company believes its cash balances and cash&#13;flow from operations will be insufficient to fund its operations for the next twelve months. If the Company is unable to increase&#13;revenues, or otherwise generate cash flows from operations, there is substantial doubt about the Company&amp;#8217;s ability to continue&#13;as a going concern for a period of one year from the date the financial statements are issued. These consolidated financial statements&#13;do not include any adjustment that might result from the outcome of this uncertainty.&lt;/p&gt;</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 7 &amp;#8211; Intangible Assets&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Intangible assets consisted&#13;of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;As of December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Patents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,110&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,234&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Website development costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;22,713&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;22,713&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Trademarks&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,830&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,830&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;32,653&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;36,777&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Accumulated amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(25,426&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(24,847&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Intangible assets, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,227&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;11,930&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Patents when issued are&#13;amortized over 14 years, and web site development costs are amortized over five years. Trademarks are not amortized since they&#13;have an indefinite life. Amortization expense for intangibles amounted to $579 and $3,320 for the years ended December 31, 2020&#13;and 2019, respectively. During the years ended December 31, 2020 and 2019, the Company wrote-off $4,124 and $7,778, respectively,&#13;related to patents that had been abandoned.&lt;/p&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 10 &amp;#8211; Related Party Agreements&#13;and Transactions&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Agreements and Transaction&#13;with Company&amp;#8217;s Co-Founders&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following describes&#13;certain agreements and transactions between the Company and its co-founders (the &amp;#8220;Co-founders&amp;#8221;). The Co-founders held&#13;various executive officer and director positions with the Company until May 2018. One of the Co-founders also was a consultant&#13;to the Company until May 2018. The Co-founders are also shareholders of the Company. Based on information available to the Company,&#13;the Co-founders did not own more than 10% of the Company&amp;#8217;s outstanding common stock at any time during 2019 or 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;u&gt;Equipment, Demonstration&#13;and Product Testing Agreement&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In May 2017, the Company&#13;entered into a three-year equipment, demonstration and product testing agreement with a licensed cannabis cultivation company affiliated&#13;with one of the Co-founders. Under this agreement, the Company agreed to lease the cultivation company certain cultivation equipment&#13;in exchange for a quarterly fee of $16,500, which was increased to $18,330 to reflect additional leased equipment requested by&#13;the cultivation company (the &amp;#8220;Lease Fee&amp;#8221;). In consideration for access to the cultivation facility to conduct demonstration&#13;tours and for the product testing and data to be provided by the cultivation company, the Company agreed to pay the cultivation&#13;company a quarterly fee of $12,000 (the &amp;#8220;Demo and Testing Fee&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company and the cultivation&#13;company each made their respective payments under this agreement through June 30, 2018. Thereafter, the cultivation company failed&#13;to make any subsequent payments of the Lease Fee and, as a result, the Company did not pay the Demo and Testing Fee. During the&#13;second quarter of 2019, the Company notified the cultivation company of its breach for non-payment of the Lease Fee. In February&#13;2020, the parties mutually agreed to terminate this agreement and release each other from all claims related to this agreement,&#13;including any unpaid Lease Fees or Demo and Testing Fees. The Company also agreed to transfer the equipment to the cultivation&#13;company for no additional consideration.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#13;31, 2018, the Company recorded Demo and Testing Fees of $32,000 as operating expenses in the consolidated statements of operations.&#13;During the year ended December 31, 2018, the Company also recorded Lease Fees of $48,880 as &amp;#8220;Other income, net&amp;#8221; in&#13;the consolidated statements of operations. As of December 31, 2018, unpaid Lease Fees of $36,660 were included in accounts receivable&#13;and unpaid Demo and Testing Fees of $24,000 were included in accounts payable.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the third quarter&#13;of 2019, the Company determined that it was unlikely that any further payment of Lease Fees would be paid by the cultivation company,&#13;and the Company: (i) wrote off the balance of the accounts receivable related to unpaid Lease Fees, with a corresponding charge&#13;to &amp;#8220;Other income, net&amp;#8221; in the consolidated statements of operations, (ii) reversed the accounts payable related to&#13;the unpaid Demo and Testing Fees, with a corresponding credit to operating expenses, and (iii) wrote-off the remaining carrying&#13;value of the leased equipment of $107,581, which was included in property and equipment on the Company&amp;#8217;s consolidated balance&#13;sheet. For the year ended December 31, 2019, the net impact of the foregoing items on the consolidated statements of operations&#13;was a charge of $120,241.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;u&gt;Employment Agreement&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In May 2018, the Company&#13;and one of the Co-founders entered into an employment agreement which provided for an initial base salary of $150,000 per year&#13;and certain sales incentive. Pursuant to the employment agreement, the Company awarded 4,800,000 restricted stock units (&amp;#8220;RSUs&amp;#8221;)&#13;to the Co-founder that vested at certain dates in the future, subject to the co-founder&amp;#8217;s continued employment. As of December&#13;31, 2019: (i) the Company has issued 2,000,000 shares of common stock in settlement of vested RSUs, (ii) 1,000,000 shares of common&#13;stock in settlement of RSUs that vested December 31, 2019 were issued subsequent to December 31, 2019, (iii) the parties mutually&#13;agreed to cancel 1,000,000 RSUs, and (iii) 800,000 RSUs vested on April 30, 2020, however, the holder elected to cancel the RSUs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;u&gt;Consulting Agreement&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As further discussed &lt;i&gt;in&#13;Note 16 Subsequent Events&lt;/i&gt; below, on January 7, 2021, the Company entered into a consulting agreement with RSX Enterprises,&#13;Inc. (RSX), a company controlled by Mr. James R. Shipley, a director of the Company. RSX will provide consulting services to the&#13;Company focused on product offerings, engineering requirements, key customer marketing outreach, and related matters, as mutually&#13;determined by the Company and RSX. The Company will pay a monthly consulting fee of $6,500 for up to 50 hours per month for the&#13;various consulting activities undertaken and provide for reimbursement of expenses. The term of the agreement is set for three&#13;months. Any intellectual property developed by RSX will belong to the Company, and the contract provides for typical indemnification&#13;obligations and confidentiality provisions.&amp;#160;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 12 &amp;#8211; Preferred and Common Stock&#13;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2020,&#13;and 2019, there were 42,030,331 shares of Series A preferred stock, par value $0.00001 per share, issued and outstanding. The holders&#13;of Series A preferred stock have one vote per share of Series A preferred stock equivalent to one vote of the Company&amp;#8217;s common&#13;stock. The Series A preferred stock ranks senior to the Company&amp;#8217;s common stock. The holders of shares of Series A preferred&#13;stock are not entitled to receive dividends and have no conversion or preemptive rights. Upon liquidation, dissolution or winding&#13;up of the Company&amp;#8217;s business, after payment to the holders of any senior securities, the holders of Series A preferred stock&#13;are entitled to receive a preferential cash payment per share of Series A preferred stock equal to the stated value of the preferred&#13;stock, prior to any payment to the holders of common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Common Stock&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#13;31, 2020, the Company did not issue any shares of its common stock in a private, non-registered transaction.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended&#13;December 31, 2019, the Company did not issue any shares of its common stock in a private, non-registered transaction.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#13;31, 2020, the Company issued shares of its common stock under the 2017 Equity Plan as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 72px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;1,000,000 shares to an employee in settlement of certain RSUs that vested December 31, 2019;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;560,000 shares pursuant to a special incentive stock bonus approved by the Board for the period ended December 31, 2019; and&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;6,750,000 shares in settlement of restricted stock units to a former employee after taking measures to mitigate the Company&amp;#8217;s exposure to penalties and liability for the failure to properly withhold income taxes, as further discussed in &lt;i&gt;Note 11 &amp;#8211; Commitments and Contingencies, Litigation&lt;/i&gt; above.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the year ended December&#13;31, 2019, the Company issued shares of its common stock under the Company&amp;#8217;s 2017 Equity Plan as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 72px"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 24px"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;197,370 shares of common stock were issued to independent directors in lieu of cash director fees; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;789,474 shares of common stock were issued to independent directors as the 2019 equity retainer fee; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;1,120,000 shares of common stock were issued to certain employees in settlement of vested restricted stock units; and&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;1,120,000 shares of common stock were issued to certain employees as a stock incentive bonus.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:InventoryAdjustments contextRef="AsOf2019-12-31_us-gaap_InventoryValuationAndObsolescenceMember" unitRef="usd" decimals="0">71376</us-gaap:InventoryAdjustments>
    <us-gaap:InventoryAdjustments contextRef="AsOf2020-12-31_us-gaap_InventoryValuationAndObsolescenceMember" unitRef="usd" decimals="0">93045</us-gaap:InventoryAdjustments>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="From2020-01-01to2020-12-31">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">1103447</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">473682</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <SRNA:ContractWithCustomerLiabilityRevenueRecognizedPercentage contextRef="From2020-01-01to2020-12-31" unitRef="Percentage" decimals="INF">0.76</SRNA:ContractWithCustomerLiabilityRevenueRecognizedPercentage>
    <SRNA:ContractWithCustomerLiabilityRevenueRecognizedPercentage contextRef="From2019-01-01to2019-12-31" unitRef="Percentage" decimals="INF">0.74</SRNA:ContractWithCustomerLiabilityRevenueRecognizedPercentage>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">8448000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyTwoMember" unitRef="usd" decimals="0">390000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyOneMember" unitRef="usd" decimals="0">8058000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="AsOf2020-12-31_us-gaap_CustomerContractsMember" unitRef="usd" decimals="0">2643000</us-gaap:RevenueRemainingPerformanceObligation>
    <SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">2643000</SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyTwoMember" unitRef="usd" decimals="0">288000</SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyOneMember" unitRef="usd" decimals="0">2355000</SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="AsOf2020-12-31" unitRef="Percentage" decimals="INF">0.31</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:ProductWarrantyAccrual contextRef="AsOf2019-12-31_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" unitRef="usd" decimals="0">185234</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual contextRef="AsOf2020-12-31_us-gaap_AccountsPayableAndAccruedLiabilitiesMember" unitRef="usd" decimals="0">173365</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember" unitRef="Percentage" decimals="INF">0.59</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember" unitRef="Percentage" decimals="INF">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierOneMember" unitRef="Percentage" decimals="INF">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierTwoMember" unitRef="Percentage" decimals="INF">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2019-01-01to2019-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierThreeMember" unitRef="Percentage" decimals="INF">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember" unitRef="Percentage" decimals="INF">0.28</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember" unitRef="Percentage" decimals="INF">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember" unitRef="Percentage" decimals="INF">0.48</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember" unitRef="Percentage" decimals="INF">0.38</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_OneCustomerMember" unitRef="Percentage" decimals="INF">0.44</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierOneMember" unitRef="Percentage" decimals="INF">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierTwoMember" unitRef="Percentage" decimals="INF">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-12-31_us-gaap_SupplierConcentrationRiskMember_custom_PurchasesOfInventoryMember_custom_SupplierThreeMember" unitRef="Percentage" decimals="INF">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities contextRef="From2020-01-01to2020-12-31" unitRef="shares" decimals="INF">29213500</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">5805000</SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyTwoMember" unitRef="usd" decimals="0">102000</SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts contextRef="AsOf2020-12-31_custom_TwoThousandAndTwentyOneMember" unitRef="usd" decimals="0">5703000</SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">405617</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31_us-gaap_CostOfSalesMember" unitRef="usd" decimals="0">31006</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31_us-gaap_AdvertisingMember" unitRef="usd" decimals="0">8333</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" unitRef="usd" decimals="0">21882</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember" unitRef="usd" decimals="0">344396</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2019-01-01to2019-12-31_us-gaap_CostOfSalesMember" unitRef="usd" decimals="0">91081</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2019-01-01to2019-12-31_us-gaap_AdvertisingMember" unitRef="usd" decimals="0">33977</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2019-01-01to2019-12-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" unitRef="usd" decimals="0">45330</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2019-01-01to2019-12-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember" unitRef="usd" decimals="0">1121677</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">1292065</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndTwentyIncentiveAwardsMember" unitRef="usd" decimals="0">128434</us-gaap:AllocatedShareBasedCompensationExpense>
    <SRNA:DecreaseInRevenuePercentage contextRef="From2020-01-01to2020-12-31" unitRef="Percentage" decimals="INF">0.44</SRNA:DecreaseInRevenuePercentage>
    <SRNA:WorkingCapitalDeficit contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">1437000</SRNA:WorkingCapitalDeficit>
    <SRNA:WorkingCapitalDeficit contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">2220000</SRNA:WorkingCapitalDeficit>
    <us-gaap:AreaOfLand contextRef="AsOf2017-06-27_custom_FacilityLeaseMember" unitRef="Sqft" decimals="INF">12700</us-gaap:AreaOfLand>
    <us-gaap:AreaOfLand contextRef="AsOf2018-01-02_custom_FacilityLeaseMember" unitRef="Sqft" decimals="INF">18600</us-gaap:AreaOfLand>
    <us-gaap:PaymentsForRent contextRef="From2017-06-26to2017-06-27_custom_FacilityLeaseMember" unitRef="usd" decimals="0">12967</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="From2017-12-30to2018-01-02_custom_FacilityLeaseMember" unitRef="usd" decimals="0">18979</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="From2018-08-30to2018-09-02_custom_FacilityLeaseMember" unitRef="usd" decimals="0">19549</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="From2019-08-30to2019-09-02_custom_FacilityLeaseMember" unitRef="usd" decimals="0">20135</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="From2020-01-01to2020-12-31_custom_AgreementWithLandLordMember" unitRef="usd" decimals="0">52600</us-gaap:PaymentsForRent>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="From2017-06-26to2017-06-27_custom_FacilityLeaseMember">Until January 1, 2018</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="From2017-12-30to2018-01-02_custom_FacilityLeaseMember">Until August 31, 2018</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="From2020-01-01to2020-12-31_custom_FacilityLeaseMember">On each September 1 through the end of the lease, the monthly rent will increase by 3%.</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="From2020-01-01to2020-12-31_custom_AgreementWithLandLordMember">The deposit required on the lease will be reduced to approximately $32,000 and will be payable in 12 monthly installments from January through December of 2021. Further, the landlord also agreed to defer payment of fifty percent of the three months of lease payments (base rent only) for the period July to September 2020. The deferred lease payments amount to approximately $30,000 and will be payable in 12 monthly installments from January to December 2021.</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:SecurityDeposit contextRef="AsOf2017-07-31" unitRef="usd" decimals="0">51000</us-gaap:SecurityDeposit>
    <us-gaap:PaymentsForDeposits contextRef="From2020-01-01to2020-12-31_custom_FacilityLeaseMember" unitRef="usd" decimals="0">1600</us-gaap:PaymentsForDeposits>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="AsOf2020-12-31_custom_FacilityLeaseMember">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member" unitRef="usd" decimals="0">822374</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">435224</us-gaap:OperatingLeaseLiability>
    <us-gaap:TenantImprovements contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member_srt_MinimumMember" unitRef="usd" decimals="0">100000</us-gaap:TenantImprovements>
    <SRNA:UnamortizedAmountOfTenantImprovementAllowance contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member" unitRef="usd" decimals="0">81481</SRNA:UnamortizedAmountOfTenantImprovementAllowance>
    <us-gaap:OperatingLeaseCost contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">216889</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeasePayments contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">160934</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2020-12-31">P1Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2020-12-31" unitRef="Percentage" decimals="INF">0.0500</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">281864</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">170891</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">452755</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:CostOfGoodsAndServicesSoldOverhead contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">17974</us-gaap:CostOfGoodsAndServicesSoldOverhead>
    <us-gaap:CostOfGoodsAndServicesSoldOverhead contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">31831</us-gaap:CostOfGoodsAndServicesSoldOverhead>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">1041369</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">201778</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">3851</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">4231</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">257399</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">214145</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">71376</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">93045</us-gaap:InventoryValuationReserves>
    <us-gaap:Depreciation contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">119524</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2019-01-01to2019-12-31_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember" unitRef="usd" decimals="0">7010</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">157860</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2020-01-01to2020-12-31_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember" unitRef="usd" decimals="0">6394</us-gaap:Depreciation>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">619283</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_us-gaap_FurnitureAndFixturesMember" unitRef="usd" decimals="0">389090</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_us-gaap_VehiclesMember" unitRef="usd" decimals="0">15000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2019-12-31_us-gaap_LeaseholdImprovementsMember" unitRef="usd" decimals="0">215193</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">628615</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember" unitRef="usd" decimals="0">398422</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31_us-gaap_VehiclesMember" unitRef="usd" decimals="0">15000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember" unitRef="usd" decimals="0">215193</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2018-12-31_custom_CoFoundersMember" unitRef="usd" decimals="0">176042</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">361360</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">480883</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2018-12-31_custom_CoFoundersMember" unitRef="usd" decimals="0">39120</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="From2020-01-01to2020-12-31_us-gaap_PatentsMember">P14Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="From2020-01-01to2020-12-31_custom_WebSiteDevelopmentCostsMember">P5Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">579</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">3320</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">36777</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2019-12-31_us-gaap_PatentsMember" unitRef="usd" decimals="0">12234</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2019-12-31_custom_WebSiteDevelopmentCostsMember" unitRef="usd" decimals="0">22713</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2019-12-31_us-gaap_TrademarksMember" unitRef="usd" decimals="0">1830</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">32653</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2020-12-31_us-gaap_PatentsMember" unitRef="usd" decimals="0">8110</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2020-12-31_custom_WebSiteDevelopmentCostsMember" unitRef="usd" decimals="0">22713</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2020-12-31_us-gaap_TrademarksMember" unitRef="usd" decimals="0">1830</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">24847</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">25426</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">11930</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">7227</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">1299015</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">918639</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedSalesCommissionCurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">69532</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">48263</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">169052</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">288071</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">185234</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">173365</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">110127</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">356623</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">17531</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-12-31_custom_CoFoundersMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2020-12-31_custom_CoFoundersMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="From2017-05-01to2017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember" unitRef="usd" decimals="0">16500</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax contextRef="From2017-05-01to2017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember_srt_MaximumMember" unitRef="usd" decimals="0">18330</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2017-05-31_custom_EquipmentDemonstrationAndProductTestingAgreementMember_custom_CoFoundersMember" unitRef="usd" decimals="0">12000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:OperatingLeaseExpense contextRef="From2018-01-01to2018-12-31" unitRef="usd" decimals="0">48880</us-gaap:OperatingLeaseExpense>
    <SRNA:UnpaidLeaseFees contextRef="From2018-01-01to2018-12-31_us-gaap_AccountsReceivableMember" unitRef="usd" decimals="0">36660</SRNA:UnpaidLeaseFees>
    <SRNA:UnpaidDemoAndTestingFees contextRef="From2018-01-01to2018-12-31_us-gaap_AccountsPayableMember1108719890" unitRef="usd" decimals="0">24000</SRNA:UnpaidDemoAndTestingFees>
    <SRNA:NetOfImpactOfForegoingItemCharge contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">120241</SRNA:NetOfImpactOfForegoingItemCharge>
    <us-gaap:SalariesWagesAndOfficersCompensation contextRef="From2018-05-01to2018-05-31_custom_EmploymentAgreementMember_custom_CoFoundersMember" unitRef="usd" decimals="0">150000</us-gaap:SalariesWagesAndOfficersCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod contextRef="From2018-05-01to2018-05-31_custom_EmploymentAgreementMember_us-gaap_RestrictedStockUnitsRSUMember_custom_CoFoundersMember" unitRef="shares" decimals="INF">4800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <SRNA:NumberOfInvestmentUnitOffered contextRef="From2014-10-01to2014-10-31_custom_SeriesTwoWarrantsMember" unitRef="Number" decimals="INF">60</SRNA:NumberOfInvestmentUnitOffered>
    <SRNA:NumberOfInvestmentUnitOffered contextRef="From2017-03-01to2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" unitRef="Number" decimals="INF">16781250</SRNA:NumberOfInvestmentUnitOffered>
    <SRNA:NumberOfInvestmentUnitOffered contextRef="From2017-12-01to2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember" unitRef="Number" decimals="INF">14734000</SRNA:NumberOfInvestmentUnitOffered>
    <SRNA:OfferedInvestmentsPricePerUnit contextRef="AsOf2014-10-31_custom_SeriesTwoWarrantsMember" unitRef="usd" decimals="0">50000</SRNA:OfferedInvestmentsPricePerUnit>
    <us-gaap:ConvertibleDebt contextRef="AsOf2014-10-31_custom_SeriesTwoWarrantsMember_custom_SeriesTwoConvertibleNotesMember" unitRef="usd" decimals="0">50000</us-gaap:ConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="AsOf2019-12-31_custom_QTwoTwoThousandEighteenWarrantsMember" unitRef="shares" decimals="INF">7562500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="AsOf2014-10-31_custom_SeriesTwoWarrantsMember" unitRef="shares" decimals="INF">50000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="AsOf2018-12-31_custom_SeriesTwoWarrantsMember1464400812" unitRef="shares" decimals="INF">901250</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="AsOf2017-12-31_us-gaap_WarrantMember_custom_InvestmentBankMember" unitRef="shares" decimals="INF">500000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="AsOf2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" unitRef="shares" decimals="INF">468750</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <SRNA:WarrantDescription contextRef="From2017-01-01to2017-12-31_custom_InvestmentBankMember">The Banker Warrants were fully vested on the date of issuance, were exercisable beginning December 20, 2017 and expired unexercised on June 20, 2020.</SRNA:WarrantDescription>
    <SRNA:WarrantDescription contextRef="From2017-03-01to2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember">These warrants expired unexercised in March 2020</SRNA:WarrantDescription>
    <SRNA:WarrantDescription contextRef="From2017-12-01to2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember">These warrants expired unexercised in December 2020.</SRNA:WarrantDescription>
    <SRNA:WarrantDescription contextRef="From2018-06-01to2018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember">The Q2 2018 Warrants are exercisable commencing July 1, 2018 until June 30, 2021.</SRNA:WarrantDescription>
    <SRNA:ProceedsFromInvestment contextRef="From2017-03-01to2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" unitRef="usd" decimals="0">2685000</SRNA:ProceedsFromInvestment>
    <SRNA:ProceedsFromInvestment contextRef="From2017-12-01to2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember" unitRef="usd" decimals="0">1768080</SRNA:ProceedsFromInvestment>
    <SRNA:ProceedsFromInvestmentPerUnit contextRef="From2017-03-01to2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" unitRef="usdPershares" decimals="INF">0.16</SRNA:ProceedsFromInvestmentPerUnit>
    <SRNA:ProceedsFromInvestmentPerUnit contextRef="From2017-12-01to2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember" unitRef="usdPershares" decimals="INF">0.12</SRNA:ProceedsFromInvestmentPerUnit>
    <us-gaap:ConversionOfStockDescription contextRef="From2017-03-01to2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember"> Each unit consisted of one share of the Company's common stock and one warrant for the purchase of one share of the Company's common stock ("Q1 2017 Warrants").</us-gaap:ConversionOfStockDescription>
    <us-gaap:ConversionOfStockDescription contextRef="From2017-12-01to2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember">Each unit consisted of one share of the Company's common stock and one warrant for the purchase of one share of the Company's common stock ("Q4 2017 Warrants")</us-gaap:ConversionOfStockDescription>
    <us-gaap:ConversionOfStockDescription contextRef="From2018-06-01to2018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember">Each unit consisting of one share of the Company's common stock and one Q2 2018 Warrant.</us-gaap:ConversionOfStockDescription>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember" unitRef="usdPershares" decimals="INF">0.36</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember" unitRef="usdPershares" decimals="INF">0.40</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" unitRef="usdPershares" decimals="INF">0.42</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="From2017-03-01to2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" unitRef="Number" decimals="INF">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="From2017-12-01to2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember" unitRef="Number" decimals="INF">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="From2018-06-01to2018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember" unitRef="Number" decimals="INF">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <SRNA:RedeemWarrantSharesAtPrice contextRef="AsOf2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember" unitRef="usdPershares" decimals="INF">0.01</SRNA:RedeemWarrantSharesAtPrice>
    <SRNA:RedeemWarrantSharesAtPrice contextRef="AsOf2018-06-30_custom_QTwoTwoThousandEighteenWarrantsMember" unitRef="usdPershares" decimals="INF">0.01</SRNA:RedeemWarrantSharesAtPrice>
    <SRNA:RedeemWarrantSharesAtPrice contextRef="AsOf2017-03-31_custom_QOneTwoThousandSeventeenWarrantsMember" unitRef="usdPershares" decimals="INF">0.01</SRNA:RedeemWarrantSharesAtPrice>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2017-12-31_custom_QFourTwoThousandSeventeenWarrantsMember">P3Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <SRNA:StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember" unitRef="shares" decimals="INF">1000000</SRNA:StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock>
    <SRNA:StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock contextRef="From2019-01-01to2019-12-31_custom_EmployeeMember_custom_TwoThousandAndSeventeenEquityPlanMember" unitRef="shares" decimals="INF">1120000</SRNA:StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock>
    <SRNA:StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeeMember" unitRef="shares" decimals="INF">560000</SRNA:StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus>
    <SRNA:StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus contextRef="From2019-01-01to2019-12-31_custom_EmployeeMember_custom_TwoThousandAndSeventeenEquityPlanMember" unitRef="shares" decimals="INF">1120000</SRNA:StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsOneMember" unitRef="shares" decimals="INF">789474</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2018-01-01to2018-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsMember" unitRef="shares" decimals="INF">197370</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-01-01to2019-12-31_custom_IndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember" unitRef="shares" decimals="INF">197370</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-01-01to2019-12-31_custom_IndependentDirectorsOneMember_custom_TwoThousandAndSeventeenEquityPlanMember" unitRef="shares" decimals="INF">789474</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProfessionalFees contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsOneMember" unitRef="usd" decimals="0">60000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="From2018-01-01to2018-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember_custom_IndependentDirectorsMember" unitRef="usd" decimals="0">15000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="From2021-01-06to2021-01-07_custom_ConsultingAgreementMember_custom_MrJamesRShipleyMember_us-gaap_SubsequentEventMember" unitRef="usd" decimals="0">6500</us-gaap:ProfessionalFees>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" unitRef="Percentage" decimals="INF">1.1497</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" unitRef="Percentage" decimals="INF">1.2248</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" unitRef="Percentage" decimals="INF">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" unitRef="Percentage" decimals="INF">0.0237</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <SRNA:ShareBasedCompensationArrangementStockIssuedAndOutstanding contextRef="AsOf2020-06-24_custom_TwoNewIndependentDirectorsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">21651000</SRNA:ShareBasedCompensationArrangementStockIssuedAndOutstanding>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement contextRef="From2019-01-01to2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember" unitRef="usd" decimals="0">58240</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement contextRef="From2020-01-01to2020-12-31_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="0">1105750</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement contextRef="From2020-01-01to2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember" unitRef="usd" decimals="0">0</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited contextRef="From2019-01-01to2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember" unitRef="usd" decimals="0">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited contextRef="From2020-01-01to2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember" unitRef="usd" decimals="0">0</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationForfeited>
    <SRNA:StockOptionToPurchaseThresholdsPerformanceBased contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember1368509609" unitRef="shares" decimals="INF">6000000</SRNA:StockOptionToPurchaseThresholdsPerformanceBased>
    <SRNA:NumberOfSharesForfeitedForTerminations contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember1368509609" unitRef="shares" decimals="INF">4250000</SRNA:NumberOfSharesForfeitedForTerminations>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted contextRef="From2019-01-01to2019-12-31_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember_custom_TwoThousandAndSeventeenEquityPlanMember">P0Y</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">P10Y</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">P8Y6M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">P4Y3M19D</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">P8Y3M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember">P3M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="shares" decimals="INF">7333329</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="shares" decimals="INF">2000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="shares" decimals="INF">1000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="shares" decimals="INF">2408333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares contextRef="From2019-01-01to2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares contextRef="From2020-01-01to2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="shares" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="shares" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="shares" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="shares" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" decimals="INF">0.086</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" decimals="INF">0.075</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usdPershares" decimals="INF">0.029</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" decimals="INF">0.065</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" decimals="INF">0.059</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usdPershares" decimals="INF">0.057</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2020-01-01to2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" decimals="INF">0.074</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="usdPershares" decimals="INF">0.112</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" decimals="INF">0.062</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usdPershares" decimals="INF">0.063</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="From2020-01-01to2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" decimals="INF">0.102</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue contextRef="From2020-01-01to2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="usdPershares" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usdPershares" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usdPershares" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1 contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1 contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1 contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1 contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1 contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" decimals="0">5800</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1 contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" decimals="0">628756</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" decimals="0">149534</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" decimals="0">29000</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" decimals="0">130120</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" decimals="0">387199</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" decimals="0">373000</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" decimals="0">362998</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" decimals="0">536733</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" decimals="0">344000</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" decimals="0">246344</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="shares" decimals="INF">9867368</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="shares" decimals="INF">7550000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="shares" decimals="INF">1120000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="shares" decimals="INF">6750000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usdPershares" decimals="INF">0.140</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usdPershares" decimals="INF">0.128</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usdPershares" decimals="INF">0.181</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usdPershares" decimals="INF">0.121</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="From2019-01-01to2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usdPershares" decimals="INF">0.179</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="From2020-01-01to2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usdPershares" decimals="INF">0.184</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="AsOf2018-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usd" decimals="0">730185</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="AsOf2019-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1 contextRef="AsOf2018-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="shares" decimals="INF">1680000</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1 contextRef="AsOf2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="shares" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1 contextRef="AsOf2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="shares" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1 contextRef="AsOf2018-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="usdPershares" decimals="INF">0.112</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1 contextRef="AsOf2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="usdPershares" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1 contextRef="AsOf2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue contextRef="AsOf2018-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="usdPershares" decimals="INF">124320</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue contextRef="AsOf2019-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue contextRef="AsOf2020-12-31_custom_IncentiveStockBonusAwardsMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">19322000</us-gaap:OperatingLossCarryforwards>
    <SRNA:NetOperatingLossCarryForwardExpectedToExpireAmount contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">11196261</SRNA:NetOperatingLossCarryForwardExpectedToExpireAmount>
    <SRNA:NetOperatingLossExpirationTerm contextRef="From2020-01-01to2020-12-31">2034 through 2037</SRNA:NetOperatingLossExpirationTerm>
    <SRNA:NolsUsageAgainstTaxableIncomePercentage contextRef="AsOf2020-12-31" unitRef="Percentage" decimals="INF">0.80</SRNA:NolsUsageAgainstTaxableIncomePercentage>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="AsOf2020-12-31" unitRef="Percentage" decimals="INF">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <SRNA:NolsCarryforwardsTerm contextRef="From2020-01-01to2020-12-31">P3Y</SRNA:NolsCarryforwardsTerm>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense contextRef="From2020-01-01to2020-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense contextRef="From2019-01-01to2019-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">-369000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">-281000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">-69000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">-53000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">-136000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">17000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <SRNA:IncomeTaxReconciliationTrueUpAdjustments contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">115000</SRNA:IncomeTaxReconciliationTrueUpAdjustments>
    <SRNA:IncomeTaxReconciliationTrueUpAdjustments contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">199000</SRNA:IncomeTaxReconciliationTrueUpAdjustments>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">-17000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">-86000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">476000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">204000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">4081000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">4821000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">392000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">118000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">149000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">169000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">4622000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">5108000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">58000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">68000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilities contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">58000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">68000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">4564000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">5040000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">4564000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">5040000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2019-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2020-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;All highly liquid investments&#13;with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may,&#13;from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has not experienced&#13;any losses to date on depository accounts.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Accounts Receivable&#13;and Allowance for Doubtful Accounts&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Accounts receivables&#13;are recorded at the invoiced amount or based on revenue earned for items not yet invoiced, and generally do not bear&#13;interest. An allowance for doubtful accounts is established, as necessary, based on past experience and other factors, which,&#13;in management&amp;#8217;s judgment, deserve current recognition in estimating bad debts. Based on the Company&amp;#8217;s review, it&#13;establishes or adjusts the allowance for specific customers and the accounts receivable portfolio as a whole. As of December&#13;31, 2020, and December 31, 2019, the allowance for doubtful accounts was $165,098 and $151,673, respectively. If the&#13;financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments,&#13;additional allowances may be required.&lt;/p&gt;</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Inventory&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Inventory is stated&#13;at the lower of cost or net realizable value. The inventory is valued based on a first-in, first-out (&amp;#8220;FIFO&amp;#8221;)&#13;basis. Lower of cost or net realizable value is evaluated by considering obsolescence, excessive levels of inventory,&#13;deterioration and other factors. Adjustments to reduce the cost of inventory to its net realizable value, if required, are&#13;made for estimated excess, obsolescence or impaired inventory. Excess and obsolete inventory is charged to cost of revenue&#13;and a new lower-cost basis for that inventory is established and subsequent changes in facts and circumstances do not result&#13;in the restoration or increase in that newly established cost basis. As of December 31, 2020, and December 31, 2019, the&#13;allowance for excess and obsolete inventory was $93,045 and $71,376, respectively.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Property and Equipment&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Property and equipment&#13;are stated at cost. For financial statement purposes, property and equipment are recorded at cost and depreciated using the straight-line&#13;method over their estimated useful lives, which is generally five years. Leasehold improvements are amortized on a straight-line&#13;basis over the lesser of their useful lives or the life of the lease. Upon sale or retirement of assets, the cost and related accumulated&#13;depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operations. Maintenance&#13;and repairs are charged to operations as incurred.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Long-lived Assets&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Long-lived tangible assets,&#13;including property and equipment, are reviewed for impairment whenever events or changes in business circumstances indicate the&#13;carrying value of the assets may not be recoverable. When such an event occurs, management determines whether there has been impairment&#13;by comparing the anticipated undiscounted future net cash flows to the related asset&amp;#8217;s carrying value. If an asset is considered&#13;impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value,&#13;depending on the nature of the asset. The Company has not identified any indicators of impairment during the years ended December&#13;31, 2020 and 2019.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Fair Value Measurement&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company records its&#13;financial assets and liabilities at fair value. The accounting standard for fair value provides a framework for measuring fair&#13;value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined&#13;as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction&#13;between market participants at the reporting date. The accounting standard establishes a three-tier hierarchy, which prioritizes&#13;the inputs used in the valuation methodologies in measuring fair value:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Level 1 - inputs are quoted&#13;prices (unadjusted) in active markets for identical assets or liabilities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;Level 2 - inputs are quoted prices&#13;for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly&#13;or indirectly through market corroboration, for substantially the full term of the financial instrument.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"&gt;Level 3 - inputs are unobservable&#13;inputs based on the Company&amp;#8217;s assumptions used to measure assets and liabilities at fair value.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A financial asset or liability&amp;#8217;s&#13;classification within the hierarchy is determined based on the lowest level of input that is significant to the fair value measurement.&#13;The Company&amp;#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires&#13;management to make judgments and consider factors specific to the asset or liability.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Due to their short-term&#13;nature, the carrying values of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses, approximate&#13;fair value.&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Derivative Financial&#13;Instruments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company evaluates&#13;its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded&#13;derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is&#13;initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in&#13;the statements of operations. For stock-based derivative financial instruments, the Company uses the Black-Scholes Option&#13;Pricing Model (the &amp;#8220;Black-Scholes Model&amp;#8221;) to value the derivative instruments. The classification of derivative&#13;instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of&#13;each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based&#13;on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance&#13;sheet date. As of December 31, 2020, and December 31, 2019, there were no derivative financial instruments.&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:StandardProductWarrantyPolicy contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Product Warranty&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company warrants the&#13;products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment.&#13;The Company&amp;#8217;s warranty provides for the repair, rework, or replacement of products (at the Company&amp;#8217;s option) that fail&#13;to perform within stated specification. The Company&amp;#8217;s third-party suppliers also warrant their products under similar terms,&#13;which are passed through to the Company&amp;#8217;s customers.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company assesses the&#13;historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue&#13;generated on these products. Based on the Company&amp;#8217;s warranty policy, an accrual is established at 1% of the trailing 18 months&#13;revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and&#13;other factors. As of December 31, 2020, and December 31, 2019, the Company had an accrued warranty reserve amount of $173,365 and $185,234,&#13;respectively, which are included in accounts payable and accrued liabilities on the Company&amp;#8217;s consolidated balance sheets.&lt;/p&gt;</us-gaap:StandardProductWarrantyPolicy>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Cost of Sales&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Cost of sales includes&#13;product costs (material, direct labor and overhead costs), shipping and handling expense, outside engineering costs, engineering,&#13;project management and service salaries and benefits, client visits and warranty.&lt;/p&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Product Development&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company expenses&#13;product development costs as incurred. Internal product development costs are expensed as incurred, and third-party product&#13;developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. For&#13;the years ended December 31, 2020 and December 31, 2019, the Company incurred $390,229 and $521,044, respectively, on product&#13;development.&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company accounts for&#13;income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the&#13;expected future tax consequences of events that have been included in the financial statements. Under this method, the Company&#13;determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of&#13;assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The&#13;effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the&#13;enactment date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company recognizes&#13;deferred tax assets to the extent that the Company believes that these assets are more likely than not to be realized. In making&#13;such a determination, the Company considers all available positive and negative evidence, including future reversals of existing&#13;taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the&#13;Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount,&#13;the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income&#13;taxes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company records uncertain&#13;tax positions on the basis of a two-step process in which: (i) the Company determines whether it is more likely than not that the&#13;tax positions will be sustained on the basis of the technical merits of the position, and (ii) for those tax positions that meet&#13;the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more likely than&#13;not to be realized upon ultimate settlement with the related tax authority.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Commitments and Contingencies&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In the normal course of&#13;business, the Company is subject to loss contingencies, such as legal proceedings and claims arising out of its business, that&#13;cover a wide range of matters, including, among others, customer disputes, government investigations and tax matters. An accrual&#13;for a loss contingency is recognized when it is probable that an asset had been impaired or a liability had been incurred and the&#13;amount of loss can be reasonably estimated.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <SRNA:OtherRisksAndUncertaintiesPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Other Risks and Uncertainties&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;To achieve profitable operations,&#13;the Company must successfully develop, manufacture and market its products. There can be no assurance that any such products can&#13;be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that such products will&#13;be successfully marketed. These factors could have a material adverse effect upon the Company&amp;#8217;s financial results, financial&#13;position, and future cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company is subject&#13;to risks common to similarly-situated companies including, but not limited to, general economic conditions, its customers&amp;#8217;&#13;operations and access to capital, and market and business disruptions including severe weather conditions, natural disasters, health&#13;hazards, terrorist activities, financial crises, political crises or other major events, or the prospect of these events, new technological&#13;innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, uncertainty&#13;of market acceptance of products, product liability, and the need to obtain additional financing. As a supplier of services and&#13;equipment to cannabis cultivators, the Company is also subject to risks related to the cannabis industry. Although certain states&#13;have legalized medical and/or recreational cannabis, U.S. federal laws continue to prohibit marijuana in all its forms as well&#13;as its derivatives. Any changes in the enforcement of U.S. federal laws may adversely affect the implementation of state and local&#13;cannabis laws and regulations that permit medical or recreational cannabis and, correspondingly, may adversely impact the Company&amp;#8217;s&#13;customers. The Company&amp;#8217;s success is also dependent upon its ability to raise additional capital and to successfully develop&#13;and market its products. See Note 3.&lt;/p&gt;</SRNA:OtherRisksAndUncertaintiesPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Segment Information&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Operating segments are&#13;defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the&#13;Company&amp;#8217;s senior management team in deciding how to allocate resources and in assessing performance. The Company has one&#13;operating segment that is dedicated to the manufacture and sale of its products.&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Intangible assets consisted&#13;of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;As of December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Patents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,110&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,234&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Website development costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;22,713&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;22,713&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Trademarks&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,830&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,830&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;32,653&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;36,777&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Accumulated amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(25,426&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(24,847&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Intangible assets, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,227&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;11,930&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The differences between&#13;income taxes expected at the U.S. federal statutory income tax rate and the reported provision for income taxes are summarized&#13;as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Income taxes computed at the federal statutory rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(369,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(281,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;States taxes, net of federal benefits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(69,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(53,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Permanent differences&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(136,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;17,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;True-up adjustments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;115,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;199,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Adjustment to net operating loss&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(17,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(86,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Change in valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;476,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;204,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Reported income tax (benefit) expense&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The components of the net&#13;deferred tax assets as of December 31, 2020 and 2019 are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Deferred tax assets:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 62%; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Net operating losses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,821,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,081,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Equity compensation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;118,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;392,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Other deferred tax assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;169,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;149,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 20pt"&gt;&lt;font style="font-size: 10pt"&gt;Total deferred tax assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,108,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,622,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Deferred tax liabilities:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Other deferred tax liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(68,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(58,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 20pt"&gt;&lt;font style="font-size: 10pt"&gt;Total deferred tax liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(68,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(58,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Net deferred tax assets before valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,040,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,564,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Less valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(5,040,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(4,564,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Net deferred tax assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:InventoryWriteDown contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">21669</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">-223971</us-gaap:InventoryWriteDown>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Accounting for Share-Based&#13;Compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company recognizes&#13;the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted&#13;stock units that the Company grants under its equity incentive plan in its consolidated financial statements based on their grant&#13;date fair value. For awards subject to service conditions, compensation expense is recognized over the vesting period on a straight-line&#13;basis. Awards subject to performance conditions are attributed separately for each vesting tranche of the award and are recognized&#13;ratably from the service inception date to the vesting date for each tranche, based on the probability of vesting. The probability&#13;of awards with future performance conditions is evaluated each reporting period and compensation expense is adjusted based on the&#13;probability assessment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Awards are considered granted,&#13;and the service inception date begins, when mutual understanding of the key terms and conditions of the award between the Company&#13;and the recipient has been established. For awards that provide discretion to adjust the amount of the award, the service inception&#13;date for such awards could precede the grant date as a mutual understanding of the key terms and conditions of the award between&#13;the Company and the recipient has not yet been established. For awards in which the service inception date precedes the grant date,&#13;compensation cost is accrued beginning on the service inception date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Subsequent to December&#13;31, 2020, the Company&amp;#8217;s Board of Directors (the &amp;#8220;Board&amp;#8221;) approved annual incentive compensation awards to certain&#13;employees payable in non-qualified stock options, based on the Company&amp;#8217;s performance and each employee&amp;#8217;s contributions&#13;to such performance for the 2020 year. See Note 16. The non-qualified stock options were granted subsequent to December 31, 2020,&#13;were not subject to an additional service requirement and were immediately vested at the date of the grant. The final amount of&#13;the annual incentive compensation award, and number of non-qualified stock options granted, were determined, and communicated to&#13;the employee, subsequent to December 31, 2020. The estimated compensation expense of $128,434 related to the 2020 incentive awards&#13;was accrued as of December 31, 2020. Since such incentive awards will be settled in non-qualified stock options, the accrued compensation&#13;expense has been classified as a current liability until the number of non-qualified stock options is fixed pursuant to a grant&#13;by the Board. At that time, the incentive award becomes equity-classified.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The grant date fair value&#13;of stock options is based on the Black-Scholes Model. The Black-Scholes Model requires judgmental assumptions including volatility&#13;and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose&#13;term is consistent with the expected term of the option.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The grant date fair value&#13;of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company has elected&#13;to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical&#13;data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of&#13;employees have significantly different forfeiture expectations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Share-based compensation&#13;costs (including expenses from the accrued compensation liabilities related to the annual incentive awards subsequently settled&#13;in non-qualified stock options totaled $405,617 and $1,292,065 for the years ended December 31, 2020 and 2019, respectively. Such&#13;share-based compensation costs are classified in the Company&amp;#8217;s consolidated financial statements in the same manner as if&#13;such compensation was paid in cash.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following is a summary&#13;of such share-based compensation costs included in the Company&amp;#8217;s consolidated statements of operations for the years ended&#13;December 31, 2020 and 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;For the Years Ended December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Share-based compensation expense included in:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Cost of revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;31,006&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;91,081&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Advertising and marketing expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,333&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;33,977&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Product development costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;21,882&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;45,330&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Selling, general and administrative expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;344,396&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,121,677&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total share-based compensation expense included in consolidated statement of operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;405,617&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,292,065&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Financial Statement&#13;Presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The preparation of the&#13;consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&amp;#8220;GAAP&amp;#8221;)&#13;requires management to make estimates and assumptions that affect reported amounts and related disclosures.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As further discussed in&#13;&lt;i&gt;Note 3 Going Concern&lt;/i&gt; below, the accompanying consolidated financial statements have been prepared on a going-concern basis,&#13;which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company&#13;has not generated sufficient revenue and has historically funded its operations through the sale of common stock, the issuance&#13;of debt and the receipt of advance payments from customers. The Company is subject to risks, expenses and uncertainties similar&#13;to those encountered by similarly situated companies.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following table summarizes&#13;information about warrants outstanding at December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Weighted Average Life of&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;Exercise price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;In Months&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 32%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 30%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,562,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 30%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of the&#13;incentive stock bonus awards granted to employees under the 2017 Equity Plan during the years ended December 31, 2020 and&#13;2019 are presented in the table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Number of&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Average Grant-Date&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap"&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/p&gt;&#13;        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font: 10pt Tahoma, Helvetica, Sans-Serif"&gt;&amp;#65279;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 55%"&gt;&lt;font style="font-size: 10pt"&gt;Unvested, December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,680,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.112&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;124,320&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Awarded&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(1,680,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.112&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Unvested, December 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Awarded&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Vested&lt;sup&gt;1&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Unvested, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock>
    <us-gaap:StandardProductWarrantyDescription contextRef="From2020-01-01to2020-12-31">The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company's warranty policy, an accrual is established at 1% of the trailing 18 months revenue. </us-gaap:StandardProductWarrantyDescription>
    <us-gaap:StandardProductWarrantyDescription contextRef="From2020-01-01to2020-12-31_custom_ThreeCustomersMember">Since the issue is limited to these three projects and is not anticipated to reoccur in the future, we have made no adjustment to the ongoing 1% warranty reserve that we accrue on all sales</us-gaap:StandardProductWarrantyDescription>
    <us-gaap:DeferredRentCreditCurrent contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member" unitRef="usd" decimals="0">26477</us-gaap:DeferredRentCreditCurrent>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="From2019-01-01to2019-12-31_us-gaap_PatentsMember" unitRef="usd" decimals="0">7778</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="From2020-01-01to2020-12-31_us-gaap_PatentsMember" unitRef="usd" decimals="0">4124</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <SRNA:CommonstockSharesToBeIssued contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="usd" decimals="0">1000000</SRNA:CommonstockSharesToBeIssued>
    <SRNA:CommonstockSharesToBeIssued contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" unitRef="usd" decimals="0">1560000</SRNA:CommonstockSharesToBeIssued>
    <SRNA:CommonstockSharesToBeIssued contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2018-12-31_us-gaap_PreferredStockMember" unitRef="shares" decimals="INF">42030331</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember" unitRef="shares" decimals="INF">42030331</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">224989794</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">228216638</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember" unitRef="shares" decimals="INF">42030331</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">236526638</us-gaap:SharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="From2019-01-01to2019-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="From2019-01-01to2019-12-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="usd" decimals="0">23</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">-23</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">560000</SRNA:CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross contextRef="From2019-01-01to2019-12-31_us-gaap_PreferredStockMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">2240000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">75000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2019-01-01to2019-12-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="usd" decimals="0">10</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">74990</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2019-01-01to2019-12-31_us-gaap_PreferredStockMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">986844</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">25163</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">278906</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-12-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">278906</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-12-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">25163</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">252020</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">390484</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-12-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">390484</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-12-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">252020</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees contextRef="From2019-01-01to2019-12-31" unitRef="usd" decimals="0">44209</SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees>
    <SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees contextRef="From2019-01-01to2019-12-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees contextRef="From2019-01-01to2019-12-31_us-gaap_CommonStockMember" unitRef="usd" xsi:nil="true" />
    <SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees contextRef="From2019-01-01to2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">44209</SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees>
    <SRNA:FairValueOfVestedIncentiveStockBonusesAwardedToEmployees contextRef="From2019-01-01to2019-12-31_us-gaap_RetainedEarningsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">503466</SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued contextRef="From2020-01-01to2020-12-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="usd" xsi:nil="true" />
    <SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">503466</SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued>
    <SRNA:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses contextRef="From2020-01-01to2020-12-31" unitRef="usd" xsi:nil="true" />
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses contextRef="From2020-01-01to2020-12-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="usd" decimals="0">83</SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses contextRef="From2020-01-01to2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">-83</SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses contextRef="From2020-01-01to2020-12-31_us-gaap_RetainedEarningsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">-1560000</SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares contextRef="From2020-01-01to2020-12-31_us-gaap_PreferredStockMember" unitRef="shares" xsi:nil="true" />
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares contextRef="From2020-01-01to2020-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">8310000</SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 11 &amp;#8211; Commitments and Contingencies&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Litigation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2019, there&#13;were 6,750,000 restricted stock units that had not been settled due to a dispute with a former employee over the required withholding&#13;taxes to be paid to the Company for remittance to the appropriate tax authorities. The Company commenced an arbitration action against&#13;the former employee regarding the dispute. The former employee also made claims in the arbitration action against the Company for unpaid&#13;wages. As stated in a pleading in the arbitration, on March 9, 2020, the Company issued the former employee 6,750,000 shares of the Company&amp;#8217;s&#13;common stock in settlement of these restricted stock units after taking measures to mitigate the Company&amp;#8217;s exposure to penalties&#13;and liability for the failure to properly withhold income taxes. The Arbitrator issued an interim award of approximately $10,000 in the&#13;Company&amp;#8217;s favor and a finding against the former employee. Effective June 9, 2020, the Arbitrator issued his final award in the&#13;Company&amp;#8217;s favor in the Colorado arbitration. The Arbitrator found against the former employee and awarded the Company costs of $33,985,&#13;with interest at 8% per year. Effective July 22, 2020, the Colorado Court confirmed the Arbitration award and entered a final judgement&#13;in favor of the Company and against the former employee. The Company pursued collection of this debt and has now collected the debt owed.&#13;This former employee is continuing to pursue separate litigation against the Company for recovery of alleged consulting fees owed to him&#13;for the 2015 calendar year prior to his appointment as an executive officer of the Company. The Company strongly disputes the ongoing litigation and in the&#13;remote event of an adverse outcome, the amount of any settlement loss for this case is not reasonably estimable as of the date&#13;of the issuance of these financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;From time to time, in the normal&#13;course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal&#13;business operations. Moreover, the results of complex legal proceedings are difficult to predict and the Company&amp;#8217;s view of these&#13;matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The&#13;Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss&#13;can be reasonably estimated. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company&amp;#8217;s&#13;operations or its financial position, liquidity or results of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Other Commitments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In the ordinary course of business,&#13;the Company may provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties&#13;with respect to certain matters, including, but not limited to, losses arising out of the Company&amp;#8217;s breach of such agreements, services&#13;to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered&#13;into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other&#13;things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees.&#13;The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its&#13;directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2020-01-01to2020-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 16 &amp;#8211; Subsequent Events &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In accordance with ASC 855, &lt;i&gt;Subsequent&#13;Events&lt;/i&gt;, the Company has evaluated all subsequent events through the date the financial statements were available to be issued. The&#13;following events occurred after December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Board approved annual incentive&#13;compensation awards to certain employees payable in non-qualified stock options, based on the Company&amp;#8217;s performance and each employee&amp;#8217;s&#13;contributions to such performance for the 2020 year. A total of 1,035,800 non-qualified stock options were granted under the 2017 Equity&#13;Plan subsequent to December 31, 2020, with an exercise price of $0.13 per share. These non-qualified stock options were immediately vested&#13;at the date of the grant. The estimated compensation expense of $128,434 related to the 2020 incentive awards was accrued as of December&#13;31, 2020. The accrued compensation expense was classified as a current liability as of December 31, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As further discussed &lt;i&gt;in Note&#13;10 Related Party Agreements and Transactions &lt;/i&gt;above, on January 7, 2021, the Company entered into a consulting agreement with RSX Enterprises,&#13;Inc. (RSX), a company controlled by Mr. James R. Shipley, a director of the Company. RSX will provide consulting services to the Company&#13;focused on product offerings, engineering requirements, key customer marketing outreach, and related matters, as mutually determined by&#13;the Company and RSX. The Company will pay a monthly consulting fee of $6,500 for up to 50 hours per month for the various consulting activities&#13;undertaken and provide for reimbursement of expenses. The term of the agreement is set for three months. Any intellectual property developed&#13;by RSX will belong to the Company, and the contract provides for typical indemnification obligations and confidentiality provisions.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As further discussed in &lt;i&gt;Note&#13;9 Note Payable and Accrued Interest&lt;/i&gt; above, on February 10, 2021, we received funding based on a loan agreement entered into on February&#13;9, 2021 with our current bank in the principal amount of $514,200 for working capital purposes. Consistent with the loan provisions, the&#13;Company will use the proceeds to meet payroll and benefit expenses as well as for rent and utilities. The loan amount bears interest at&#13;1% and is due on February 5, 2026. The loan may be repaid in advance without penalty. The loan has typical default provisions, including&#13;for change of ownership, general lender insecurity as to repayment, non-payment of amounts due, defaults on other debt instruments, insolvency,&#13;dissolution or termination of the business as a going concern and bankruptcy.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As further discussed in Note 11&#13;Commitments and Contingencies above, a former employee is pursuing litigation against the Company for recovery of alleged consulting fees&#13;owed to him for the 2015 calendar year prior to his appointment as an executive officer of the Company. The Company strongly disputes the ongoing litigation and in the&#13;remote event of an adverse outcome, the amount of any settlement loss for this case is not reasonably estimable as of the date&#13;of the issuance of these financial statements.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>15
<FILENAME>srna-20201231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SRNA %2D 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D23T20:34:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaGOKbP9z5Z8aekhvWB6bTkqTystq8VInChF9xTW0QQB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:SRNA="http://surna.com/20201231" elementFormDefault="qualified" targetNamespace="http://surna.com/20201231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://surna.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/StatementsOfOperations" id="StatementsOfOperations">
	  <link:definition>00000004 - Statement - Consolidated Statements of Operations</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" id="StatementsOfChangesInShareholdersDeficit">
	  <link:definition>00000005 - Statement - Consolidated Statements of Changes in Shareholders' Deficit</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000006 - Statement - Consolidated Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/DescriptionOfBusiness" id="DescriptionOfBusiness">
	  <link:definition>00000007 - Disclosure - Description of Business</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies" id="BasisOfPresentationSummaryOfSignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/GoingConcern" id="GoingConcern">
	  <link:definition>00000009 - Disclosure - Going Concern</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Leases" id="Leases">
	  <link:definition>00000010 - Disclosure - Leases</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Inventory" id="Inventory">
	  <link:definition>00000011 - Disclosure - Inventory</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
	  <link:definition>00000012 - Disclosure - Property and Equipment</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IntangibleAssets" id="IntangibleAssets">
	  <link:definition>00000013 - Disclosure - Intangible Assets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
	  <link:definition>00000014 - Disclosure - Accounts Payable and Accrued Liabilities</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/NotePayableAndAccruedInterest" id="NotePayableAndAccruedInterest">
	  <link:definition>00000015 - Disclosure - Note Payable and Accrued Interest</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/RelatedPartyAgreementsAndTransactions" id="RelatedPartyAgreementsAndTransactions">
	  <link:definition>00000016 - Disclosure - Related Party Agreements and Transactions</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000017 - Disclosure - Commitments and Contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PreferredAndCommonStock" id="PreferredAndCommonStock">
	  <link:definition>00000018 - Disclosure - Preferred and Common Stock</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/OutstandingWarrants" id="OutstandingWarrants">
	  <link:definition>00000019 - Disclosure - Outstanding Warrants</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlan" id="EquityIncentivePlan">
	  <link:definition>00000020 - Disclosure - Equity Incentive Plan</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000021 - Disclosure - Income Taxes</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000022 - Disclosure - Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" id="BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000023 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" id="BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000024 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/LeasesTables" id="LeasesTables">
	  <link:definition>00000025 - Disclosure - Leases (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/InventoryTables" id="InventoryTables">
	  <link:definition>00000026 - Disclosure - Inventory (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
	  <link:definition>00000027 - Disclosure - Property and Equipment (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
	  <link:definition>00000028 - Disclosure - Intangible Assets (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" id="AccountsPayableAndAccruedLiabilitiesTables">
	  <link:definition>00000029 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/OutstandingWarrantsTables" id="OutstandingWarrantsTables">
	  <link:definition>00000030 - Disclosure - Outstanding Warrants (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlanTables" id="EquityIncentivePlanTables">
	  <link:definition>00000031 - Disclosure - Equity Incentive Plan (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000032 - Disclosure - Income Taxes (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" id="BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000033 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRevenueBySourceDetails" id="BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRevenueBySourceDetails">
	  <link:definition>00000034 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Revenue by Source (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" id="BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails">
	  <link:definition>00000035 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfShare-basedCompensationCostsDetails" id="BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfShare-basedCompensationCostsDetails">
	  <link:definition>00000036 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Share-based Compensation Costs (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/GoingConcernDetailsNarrative" id="GoingConcernDetailsNarrative">
	  <link:definition>00000037 - Disclosure - Going Concern (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/LeasesDetailsNarrative" id="LeasesDetailsNarrative">
	  <link:definition>00000038 - Disclosure - Leases (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Leases-ScheduleOfLeaseCostDetails" id="Leases-ScheduleOfLeaseCostDetails">
	  <link:definition>00000039 - Disclosure - Leases - Schedule of Lease Cost (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" id="Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails">
	  <link:definition>00000040 - Disclosure - Leases - Schedule of Future Annual Minimum Lease Payments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/InventoryDetailsNarrative" id="InventoryDetailsNarrative">
	  <link:definition>00000041 - Disclosure - Inventory (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Inventory-ScheduleOfInventoryDetails" id="Inventory-ScheduleOfInventoryDetails">
	  <link:definition>00000042 - Disclosure - Inventory - Schedule of Inventory (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
	  <link:definition>00000043 - Disclosure - Property and Equipment (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" id="PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails">
	  <link:definition>00000044 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IntangibleAssetsDetailsNarrative" id="IntangibleAssetsDetailsNarrative">
	  <link:definition>00000045 - Disclosure - Intangible Assets (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" id="IntangibleAssets-ScheduleOfIntangibleAssetsDetails">
	  <link:definition>00000046 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" id="AccountsPayableAndAccruedLiabilitiesDetailsNarrative">
	  <link:definition>00000047 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" id="AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails">
	  <link:definition>00000048 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" id="NotePayableAndAccruedInterestDetailsNarrative">
	  <link:definition>00000049 - Disclosure - Note Payable and Accrued Interest (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative" id="RelatedPartyAgreementsAndTransactionsDetailsNarrative">
	  <link:definition>00000050 - Disclosure - Related Party Agreements and Transactions (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000051 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PreferredAndCommonStockDetailsNarrative" id="PreferredAndCommonStockDetailsNarrative">
	  <link:definition>00000052 - Disclosure - Preferred and Common Stock (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/OutstandingWarrantsDetailsNarrative" id="OutstandingWarrantsDetailsNarrative">
	  <link:definition>00000053 - Disclosure - Outstanding Warrants (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/OutstandingWarrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" id="OutstandingWarrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails">
	  <link:definition>00000054 - Disclosure - Outstanding Warrants - Schedule of Outstanding Warrants to Purchase Common Stock (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/OutstandingWarrants-ScheduleOfWarrantsOutstandingDetails" id="OutstandingWarrants-ScheduleOfWarrantsOutstandingDetails">
	  <link:definition>00000055 - Disclosure - Outstanding Warrants - Schedule of Warrants Outstanding (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlanDetailsNarrative" id="EquityIncentivePlanDetailsNarrative">
	  <link:definition>00000056 - Disclosure - Equity Incentive Plan (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" id="EquityIncentivePlan-ScheduleOfStockOptionActivityDetails">
	  <link:definition>00000057 - Disclosure - Equity Incentive Plan - Schedule of Stock Option Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" id="EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails">
	  <link:definition>00000058 - Disclosure - Equity Incentive Plan - Summary of Non-vested Non-qualified Stock Option Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" id="EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails">
	  <link:definition>00000059 - Disclosure - Equity Incentive Plan - Schedule of Restricted Stock Units Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlans-ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" id="EquityIncentivePlans-ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails">
	  <link:definition>00000060 - Disclosure - Equity Incentive Plans - Schedule of Incentive Bonus Awards Granted to Employees (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000061 - Disclosure - Income Taxes (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IncomeTaxes-ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" id="IncomeTaxes-ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails">
	  <link:definition>00000062 - Disclosure - Income Taxes - Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails" id="IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails">
	  <link:definition>00000063 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000064 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://xbrl.sec.gov/currency/2020-01-31" schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
    <element id="SRNA_WarrantsDisclosureTextBlock" name="WarrantsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NumberOfUnitsVestedButNotSettled" name="NumberOfUnitsVestedButNotSettled" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NumberOfUnitsVestedAndSettled" name="NumberOfUnitsVestedAndSettled" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" name="RestrictedStockUnitsSharesIssuedInterestPercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightIssued" name="ClassOfWarrantOrRightIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightExercised" name="ClassOfWarrantOrRightExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightExpired" name="ClassOfWarrantOrRightExpired" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" name="ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" name="ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" name="ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" name="ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" name="ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" name="ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" name="ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" name="ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet" name="IncreaseDecreaseOperatingLeaseLiabilityNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_GainOnForgivenessOfNotePayable" name="GainOnForgivenessOfNotePayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage" name="ContractWithCustomerLiabilityRevenueRecognizedPercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" name="RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" name="RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DecreaseInRevenuePercentage" name="DecreaseInRevenuePercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WorkingCapitalDeficit" name="WorkingCapitalDeficit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_UnamortizedAmountOfTenantImprovementAllowance" name="UnamortizedAmountOfTenantImprovementAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_UnpaidLeaseFees" name="UnpaidLeaseFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_UnpaidDemoAndTestingFees" name="UnpaidDemoAndTestingFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NetOfImpactOfForegoingItemCharge" name="NetOfImpactOfForegoingItemCharge" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NumberOfInvestmentUnitOffered" name="NumberOfInvestmentUnitOffered" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_OfferedInvestmentsPricePerUnit" name="OfferedInvestmentsPricePerUnit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WarrantDescription" name="WarrantDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ProceedsFromInvestment" name="ProceedsFromInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ProceedsFromInvestmentPerUnit" name="ProceedsFromInvestmentPerUnit" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_RedeemWarrantSharesAtPrice" name="RedeemWarrantSharesAtPrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" name="StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" name="StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding" name="ShareBasedCompensationArrangementStockIssuedAndOutstanding" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_StockOptionToPurchaseThresholdsPerformanceBased" name="StockOptionToPurchaseThresholdsPerformanceBased" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NumberOfSharesForfeitedForTerminations" name="NumberOfSharesForfeitedForTerminations" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" name="NetOperatingLossCarryForwardExpectedToExpireAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NetOperatingLossExpirationTerm" name="NetOperatingLossExpirationTerm" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NolsUsageAgainstTaxableIncomePercentage" name="NolsUsageAgainstTaxableIncomePercentage" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NolsCarryforwardsTerm" name="NolsCarryforwardsTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_IncomeTaxReconciliationTrueUpAdjustments" name="IncomeTaxReconciliationTrueUpAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_OtherRisksAndUncertaintiesPolicyTextBlock" name="OtherRisksAndUncertaintiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonstockSharesToBeIssued" name="CommonstockSharesToBeIssued" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" name="CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" name="FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" name="AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" name="CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" name="CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" name="CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EmployeesDirectorsandConsultantsMember" name="EmployeesDirectorsandConsultantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_IncentiveStockBonusAwardsMember" name="IncentiveStockBonusAwardsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EmployeesMember" name="EmployeesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_QFourTwoThousandSeventeenWarrantsMember" name="QFourTwoThousandSeventeenWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EngineeringAndOtherServicesMember" name="EngineeringAndOtherServicesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndSeventeenEquityPlanMember" name="TwoThousandAndSeventeenEquityPlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" name="TwoThousandAndSeventeenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_IndependentDirectorsOneMember" name="IndependentDirectorsOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EmployeesAndConsultantsMember" name="EmployeesAndConsultantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CustomerOneMember" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CustomerTwoMember" name="CustomerTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CustomerThreeMember" name="CustomerThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_PurchasesOfInventoryMember" name="PurchasesOfInventoryMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SupplierOneMember" name="SupplierOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SupplierTwoMember" name="SupplierTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SupplierThreeMember" name="SupplierThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EquipmentAndSystemsSalesMember" name="EquipmentAndSystemsSalesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_FacilityLeaseMember" name="FacilityLeaseMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CoFoundersMember" name="CoFoundersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WebSiteDevelopmentCostsMember" name="WebSiteDevelopmentCostsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EquipmentDemonstrationAndProductTestingAgreementMember" name="EquipmentDemonstrationAndProductTestingAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EmploymentAgreementMember" name="EmploymentAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_QTwoTwoThousandEighteenWarrantsMember" name="QTwoTwoThousandEighteenWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_IndependentDirectorsMember" name="IndependentDirectorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NonQualifiedStockOptionsMember" name="NonQualifiedStockOptionsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndTwentyTwoMember" name="TwoThousandAndTwentyTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndTwentyOneMember" name="TwoThousandAndTwentyOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandSeventeenEquityPlanMember" name="TwoThousandSeventeenEquityPlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoNewIndependentDirectorsMember" name="TwoNewIndependentDirectorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_AprilOneTwentyTwentyOneMember" name="AprilOneTwentyTwentyOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DirectorsMember" name="DirectorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_FormerEmployeeMember" name="FormerEmployeeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_AgreementWithLandLordMember" name="AgreementWithLandLordMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WarrantsRangeOneMember" name="WarrantsRangeOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WarrantsRangeMember" name="WarrantsRangeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_OneCustomerMember" name="OneCustomerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndTwentyIncentiveAwardsMember" name="TwoThousandAndTwentyIncentiveAwardsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ThreeCustomersMember" name="ThreeCustomersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_LeasedEquipmentMember" name="LeasedEquipmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_AprilThirtyTwoThousandAndTwentyMember" name="AprilThirtyTwoThousandAndTwentyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ConsultingAgreementMember" name="ConsultingAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_MrJamesRShipleyMember" name="MrJamesRShipleyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SeriesTwoWarrantsMember" name="SeriesTwoWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SeriesTwoConvertibleNotesMember" name="SeriesTwoConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_InvestmentBankMember" name="InvestmentBankMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_QOneTwoThousandSeventeenWarrantsMember" name="QOneTwoThousandSeventeenWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EmployeeMember" name="EmployeeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_UnvestedOptionsMember" name="UnvestedOptionsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" name="TwoThousandAndNineteenSpecialEquityPlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_UnvestedRestrictedStockUnitsRSUMember" name="UnvestedRestrictedStockUnitsRSUMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_AggregateSharesIssuedUponExecutionOfSettlement" name="AggregateSharesIssuedUponExecutionOfSettlement" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>16
<FILENAME>srna-20201231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SRNA %2D 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D23T20:34:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://surna.com/role/DocumentAndEntityInformation" xlink:href="srna-20201231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheets" xlink:href="srna-20201231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheetsParenthetical" xlink:href="srna-20201231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfOperations" xlink:href="srna-20201231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:href="srna-20201231.xsd#StatementsOfChangesInShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfCashFlows" xlink:href="srna-20201231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/DescriptionOfBusiness" xlink:href="srna-20201231.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GoingConcern" xlink:href="srna-20201231.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases" xlink:href="srna-20201231.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory" xlink:href="srna-20201231.xsd#Inventory" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment" xlink:href="srna-20201231.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssets" xlink:href="srna-20201231.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="srna-20201231.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterest" xlink:href="srna-20201231.xsd#NotePayableAndAccruedInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/RelatedPartyAgreementsAndTransactions" xlink:href="srna-20201231.xsd#RelatedPartyAgreementsAndTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingencies" xlink:href="srna-20201231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PreferredAndCommonStock" xlink:href="srna-20201231.xsd#PreferredAndCommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/OutstandingWarrants" xlink:href="srna-20201231.xsd#OutstandingWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan" xlink:href="srna-20201231.xsd#EquityIncentivePlan" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes" xlink:href="srna-20201231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEvents" xlink:href="srna-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesTables" xlink:href="srna-20201231.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryTables" xlink:href="srna-20201231.xsd#InventoryTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentTables" xlink:href="srna-20201231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssetsTables" xlink:href="srna-20201231.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="srna-20201231.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/OutstandingWarrantsTables" xlink:href="srna-20201231.xsd#OutstandingWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlanTables" xlink:href="srna-20201231.xsd#EquityIncentivePlanTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesTables" xlink:href="srna-20201231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRevenueBySourceDetails" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRevenueBySourceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfShare-basedCompensationCostsDetails" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfShare-basedCompensationCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GoingConcernDetailsNarrative" xlink:href="srna-20201231.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesDetailsNarrative" xlink:href="srna-20201231.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases-ScheduleOfLeaseCostDetails" xlink:href="srna-20201231.xsd#Leases-ScheduleOfLeaseCostDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:href="srna-20201231.xsd#Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryDetailsNarrative" xlink:href="srna-20201231.xsd#InventoryDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory-ScheduleOfInventoryDetails" xlink:href="srna-20201231.xsd#Inventory-ScheduleOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="srna-20201231.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:href="srna-20201231.xsd#PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssetsDetailsNarrative" xlink:href="srna-20201231.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:href="srna-20201231.xsd#IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:href="srna-20201231.xsd#AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="srna-20201231.xsd#AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:href="srna-20201231.xsd#NotePayableAndAccruedInterestDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:href="srna-20201231.xsd#RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="srna-20201231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PreferredAndCommonStockDetailsNarrative" xlink:href="srna-20201231.xsd#PreferredAndCommonStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/OutstandingWarrantsDetailsNarrative" xlink:href="srna-20201231.xsd#OutstandingWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/OutstandingWarrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:href="srna-20201231.xsd#OutstandingWarrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/OutstandingWarrants-ScheduleOfWarrantsOutstandingDetails" xlink:href="srna-20201231.xsd#OutstandingWarrants-ScheduleOfWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlanDetailsNarrative" xlink:href="srna-20201231.xsd#EquityIncentivePlanDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:href="srna-20201231.xsd#EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:href="srna-20201231.xsd#EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="srna-20201231.xsd#EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlans-ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:href="srna-20201231.xsd#EquityIncentivePlans-ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:href="srna-20201231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes-ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:href="srna-20201231.xsd#IncomeTaxes-ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails" xlink:href="srna-20201231.xsd#IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:href="srna-20201231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredCompensationLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Shareholders&apos; Deficit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsAndNotesReceivable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsAndNotesReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredCompensation" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet" xlink:label="loc_SRNAIncreaseDecreaseOperatingLeaseLiabilityNet" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SRNAIncreaseDecreaseOperatingLeaseLiabilityNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_GainOnForgivenessOfNotePayable" xlink:label="loc_SRNAGainOnForgivenessOfNotePayable" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SRNAGainOnForgivenessOfNotePayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/DescriptionOfBusiness" xlink:title="00000007 - Disclosure - Description of Business" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/GoingConcern" xlink:title="00000009 - Disclosure - Going Concern" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Leases" xlink:title="00000010 - Disclosure - Leases" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory" xlink:title="00000011 - Disclosure - Inventory" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment" xlink:title="00000012 - Disclosure - Property and Equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssets" xlink:title="00000013 - Disclosure - Intangible Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000014 - Disclosure - Accounts Payable and Accrued Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterest" xlink:title="00000015 - Disclosure - Note Payable and Accrued Interest" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/RelatedPartyAgreementsAndTransactions" xlink:title="00000016 - Disclosure - Related Party Agreements and Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PreferredAndCommonStock" xlink:title="00000018 - Disclosure - Preferred and Common Stock" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/OutstandingWarrants" xlink:title="00000019 - Disclosure - Outstanding Warrants" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan" xlink:title="00000020 - Disclosure - Equity Incentive Plan" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEvents" xlink:title="00000022 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000023 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:title="00000024 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesTables" xlink:title="00000025 - Disclosure - Leases (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryTables" xlink:title="00000026 - Disclosure - Inventory (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentTables" xlink:title="00000027 - Disclosure - Property and Equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssetsTables" xlink:title="00000028 - Disclosure - Intangible Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000029 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/OutstandingWarrantsTables" xlink:title="00000030 - Disclosure - Outstanding Warrants (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlanTables" xlink:title="00000031 - Disclosure - Equity Incentive Plan (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesTables" xlink:title="00000032 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000033 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRevenueBySourceDetails" xlink:title="00000034 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Revenue by Source (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:title="00000035 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligation" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligation" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfShare-basedCompensationCostsDetails" xlink:title="00000036 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Share-based Compensation Costs (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/GoingConcernDetailsNarrative" xlink:title="00000037 - Disclosure - Going Concern (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesDetailsNarrative" xlink:title="00000038 - Disclosure - Leases (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Leases-ScheduleOfLeaseCostDetails" xlink:title="00000039 - Disclosure - Leases - Schedule of Lease Cost (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:title="00000040 - Disclosure - Leases - Schedule of Future Annual Minimum Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryDetailsNarrative" xlink:title="00000041 - Disclosure - Inventory (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory-ScheduleOfInventoryDetails" xlink:title="00000042 - Disclosure - Inventory - Schedule of Inventory (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000043 - Disclosure - Property and Equipment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000044 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000045 - Disclosure - Intangible Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:title="00000046 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:title="00000047 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000048 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_us-gaapAccruedSalesCommissionCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalesCommissionCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:title="00000049 - Disclosure - Note Payable and Accrued Interest (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:title="00000050 - Disclosure - Related Party Agreements and Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000051 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PreferredAndCommonStockDetailsNarrative" xlink:title="00000052 - Disclosure - Preferred and Common Stock (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/OutstandingWarrantsDetailsNarrative" xlink:title="00000053 - Disclosure - Outstanding Warrants (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/OutstandingWarrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:title="00000054 - Disclosure - Outstanding Warrants - Schedule of Outstanding Warrants to Purchase Common Stock (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/OutstandingWarrants-ScheduleOfWarrantsOutstandingDetails" xlink:title="00000055 - Disclosure - Outstanding Warrants - Schedule of Warrants Outstanding (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlanDetailsNarrative" xlink:title="00000056 - Disclosure - Equity Incentive Plan (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:title="00000057 - Disclosure - Equity Incentive Plan - Schedule of Stock Option Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:title="00000058 - Disclosure - Equity Incentive Plan - Summary of Non-vested Non-qualified Stock Option Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:title="00000059 - Disclosure - Equity Incentive Plan - Schedule of Restricted Stock Units Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlans-ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:title="00000060 - Disclosure - Equity Incentive Plans - Schedule of Incentive Bonus Awards Granted to Employees (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000061 - Disclosure - Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes-ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:title="00000062 - Disclosure - Income Taxes - Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IncomeTaxReconciliationTrueUpAdjustments" xlink:label="loc_SRNAIncomeTaxReconciliationTrueUpAdjustments" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_SRNAIncomeTaxReconciliationTrueUpAdjustments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000063 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaapDeferredTaxLiabilitiesOther" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000064 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>17
<FILENAME>srna-20201231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SRNA %2D 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D23T20:34:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://surna.com/role/DocumentAndEntityInformation" xlink:href="srna-20201231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheets" xlink:href="srna-20201231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheetsParenthetical" xlink:href="srna-20201231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfOperations" xlink:href="srna-20201231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:href="srna-20201231.xsd#StatementsOfChangesInShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfCashFlows" xlink:href="srna-20201231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/DescriptionOfBusiness" xlink:href="srna-20201231.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GoingConcern" xlink:href="srna-20201231.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases" xlink:href="srna-20201231.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory" xlink:href="srna-20201231.xsd#Inventory" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment" xlink:href="srna-20201231.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssets" xlink:href="srna-20201231.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="srna-20201231.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterest" xlink:href="srna-20201231.xsd#NotePayableAndAccruedInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/RelatedPartyAgreementsAndTransactions" xlink:href="srna-20201231.xsd#RelatedPartyAgreementsAndTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingencies" xlink:href="srna-20201231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PreferredAndCommonStock" xlink:href="srna-20201231.xsd#PreferredAndCommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/OutstandingWarrants" xlink:href="srna-20201231.xsd#OutstandingWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan" xlink:href="srna-20201231.xsd#EquityIncentivePlan" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes" xlink:href="srna-20201231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEvents" xlink:href="srna-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesTables" xlink:href="srna-20201231.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryTables" xlink:href="srna-20201231.xsd#InventoryTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentTables" xlink:href="srna-20201231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssetsTables" xlink:href="srna-20201231.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="srna-20201231.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/OutstandingWarrantsTables" xlink:href="srna-20201231.xsd#OutstandingWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlanTables" xlink:href="srna-20201231.xsd#EquityIncentivePlanTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesTables" xlink:href="srna-20201231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRevenueBySourceDetails" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRevenueBySourceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfShare-basedCompensationCostsDetails" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfShare-basedCompensationCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GoingConcernDetailsNarrative" xlink:href="srna-20201231.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesDetailsNarrative" xlink:href="srna-20201231.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases-ScheduleOfLeaseCostDetails" xlink:href="srna-20201231.xsd#Leases-ScheduleOfLeaseCostDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:href="srna-20201231.xsd#Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryDetailsNarrative" xlink:href="srna-20201231.xsd#InventoryDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory-ScheduleOfInventoryDetails" xlink:href="srna-20201231.xsd#Inventory-ScheduleOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="srna-20201231.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:href="srna-20201231.xsd#PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssetsDetailsNarrative" xlink:href="srna-20201231.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:href="srna-20201231.xsd#IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:href="srna-20201231.xsd#AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="srna-20201231.xsd#AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:href="srna-20201231.xsd#NotePayableAndAccruedInterestDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:href="srna-20201231.xsd#RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="srna-20201231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PreferredAndCommonStockDetailsNarrative" xlink:href="srna-20201231.xsd#PreferredAndCommonStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/OutstandingWarrantsDetailsNarrative" xlink:href="srna-20201231.xsd#OutstandingWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/OutstandingWarrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:href="srna-20201231.xsd#OutstandingWarrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/OutstandingWarrants-ScheduleOfWarrantsOutstandingDetails" xlink:href="srna-20201231.xsd#OutstandingWarrants-ScheduleOfWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlanDetailsNarrative" xlink:href="srna-20201231.xsd#EquityIncentivePlanDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:href="srna-20201231.xsd#EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:href="srna-20201231.xsd#EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="srna-20201231.xsd#EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlans-ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:href="srna-20201231.xsd#EquityIncentivePlans-ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:href="srna-20201231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes-ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:href="srna-20201231.xsd#IncomeTaxes-ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails" xlink:href="srna-20201231.xsd#IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:href="srna-20201231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Shareholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CommonstockSharesToBeIssued" xlink:label="loc_SRNACommonstockSharesToBeIssued_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonstockSharesToBeIssued_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" xlink:label="loc_SRNACommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" xlink:label="loc_SRNAFairValueOfVestedIncentiveStockBonusesAwardedToEmployees_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAFairValueOfVestedIncentiveStockBonusesAwardedToEmployees_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" xlink:label="loc_SRNAAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="17" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/DescriptionOfBusiness" xlink:title="00000007 - Disclosure - Description of Business" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/GoingConcern" xlink:title="00000009 - Disclosure - Going Concern" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Leases" xlink:title="00000010 - Disclosure - Leases" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory" xlink:title="00000011 - Disclosure - Inventory" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment" xlink:title="00000012 - Disclosure - Property and Equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssets" xlink:title="00000013 - Disclosure - Intangible Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000014 - Disclosure - Accounts Payable and Accrued Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterest" xlink:title="00000015 - Disclosure - Note Payable and Accrued Interest" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/RelatedPartyAgreementsAndTransactions" xlink:title="00000016 - Disclosure - Related Party Agreements and Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PreferredAndCommonStock" xlink:title="00000018 - Disclosure - Preferred and Common Stock" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/OutstandingWarrants" xlink:title="00000019 - Disclosure - Outstanding Warrants" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan" xlink:title="00000020 - Disclosure - Equity Incentive Plan" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEvents" xlink:title="00000022 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000023 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:title="00000024 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesTables" xlink:title="00000025 - Disclosure - Leases (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryTables" xlink:title="00000026 - Disclosure - Inventory (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentTables" xlink:title="00000027 - Disclosure - Property and Equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssetsTables" xlink:title="00000028 - Disclosure - Intangible Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000029 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/OutstandingWarrantsTables" xlink:title="00000030 - Disclosure - Outstanding Warrants (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlanTables" xlink:title="00000031 - Disclosure - Equity Incentive Plan (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandSeventeenEquityPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:label="loc_us-gaapShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesTables" xlink:title="00000032 - Disclosure - Income Taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000033 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:label="loc_us-gaapChangeInAccountingEstimateByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapChangeInAccountingEstimateByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:label="loc_us-gaapChangeInAccountingEstimateTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapChangeInAccountingEstimateByTypeAxis" xlink:to="loc_us-gaapChangeInAccountingEstimateTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:label="loc_us-gaapChangeInAccountingEstimateTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapChangeInAccountingEstimateByTypeAxis" xlink:to="loc_us-gaapChangeInAccountingEstimateTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationAndObsolescenceMember" xlink:label="loc_us-gaapInventoryValuationAndObsolescenceMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapChangeInAccountingEstimateTypeDomain" xlink:to="loc_us-gaapInventoryValuationAndObsolescenceMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerContractsMember" xlink:label="loc_us-gaapCustomerContractsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerContractsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="loc_SRNATwoThousandAndTwentyTwoMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyTwoMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="loc_us-gaapSupplierConcentrationRiskMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapSupplierConcentrationRiskMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_PurchasesOfInventoryMember" xlink:label="loc_SRNAPurchasesOfInventoryMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_SRNAPurchasesOfInventoryMember_190" xlink:type="arc" order="192" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CustomerOneMember" xlink:label="loc_SRNACustomerOneMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerOneMember_100" xlink:type="arc" order="103" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CustomerTwoMember" xlink:label="loc_SRNACustomerTwoMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerTwoMember_110" xlink:type="arc" order="113" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CustomerThreeMember" xlink:label="loc_SRNACustomerThreeMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerThreeMember_120" xlink:type="arc" order="123" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_OneCustomerMember" xlink:label="loc_SRNAOneCustomerMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNAOneCustomerMember_130" xlink:type="arc" order="133" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SupplierOneMember" xlink:label="loc_SRNASupplierOneMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNASupplierOneMember_190" xlink:type="arc" order="193" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SupplierTwoMember" xlink:label="loc_SRNASupplierTwoMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNASupplierTwoMember_200" xlink:type="arc" order="203" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SupplierThreeMember" xlink:label="loc_SRNASupplierThreeMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNASupplierThreeMember_210" xlink:type="arc" order="213" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndTwentyIncentiveAwardsMember" xlink:label="loc_SRNATwoThousandAndTwentyIncentiveAwardsMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndTwentyIncentiveAwardsMember_250" xlink:type="arc" order="251" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_270" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryAdjustments" xlink:label="loc_us-gaapInventoryAdjustments_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryAdjustments_270" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_270" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent_270" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized_270" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:label="loc_SRNAContractWithCustomerLiabilityRevenueRecognizedPercentage_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAContractWithCustomerLiabilityRevenueRecognizedPercentage_270" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligation_270" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationPercentage_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationPercentage_270" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyDescription" xlink:label="loc_us-gaapStandardProductWarrantyDescription_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStandardProductWarrantyDescription_270" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual" xlink:label="loc_us-gaapProductWarrantyAccrual_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProductWarrantyAccrual_270" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_270" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_270" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_270" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities_270" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRevenueBySourceDetails" xlink:title="00000034 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Revenue by Source (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EngineeringAndOtherServicesMember" xlink:label="loc_SRNAEngineeringAndOtherServicesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SRNAEngineeringAndOtherServicesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapShippingAndHandlingMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:title="00000035 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndTwentyOneMember" xlink:label="loc_SRNATwoThousandAndTwentyOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyOneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="loc_SRNATwoThousandAndTwentyTwoMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyTwoMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligation_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfShare-basedCompensationCostsDetails" xlink:title="00000036 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Share-based Compensation Costs (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingMember" xlink:label="loc_us-gaapAdvertisingMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapAdvertisingMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/GoingConcernDetailsNarrative" xlink:title="00000037 - Disclosure - Going Concern (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesDetailsNarrative" xlink:title="00000038 - Disclosure - Leases (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaapLesseeLeaseDescriptionLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaapLesseeLeaseDescriptionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapLesseeLeaseDescriptionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLesseeLeaseDescriptionTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_FacilityLeaseMember" xlink:label="loc_SRNAFacilityLeaseMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAFacilityLeaseMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_AgreementWithLandLordMember" xlink:label="loc_SRNAAgreementWithLandLordMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAAgreementWithLandLordMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLesseeLeaseDescriptionTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaapAccountingStandardsUpdate201602Member_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_us-gaapAccountingStandardsUpdate201602Member_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLesseeLeaseDescriptionTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapAreaOfLand_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapPaymentsForRent_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="loc_us-gaapLesseeOperatingLeaseDescription_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseDescription_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapSecurityDeposit_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForDeposits" xlink:label="loc_us-gaapPaymentsForDeposits_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapPaymentsForDeposits_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaapLesseeOperatingLeaseRenewalTerm_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseRenewalTerm_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="loc_us-gaapDeferredRentCreditCurrent_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapDeferredRentCreditCurrent_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TenantImprovements" xlink:label="loc_us-gaapTenantImprovements_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapTenantImprovements_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:label="loc_SRNAUnamortizedAmountOfTenantImprovementAllowance_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_SRNAUnamortizedAmountOfTenantImprovementAllowance_130" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Leases-ScheduleOfLeaseCostDetails" xlink:title="00000039 - Disclosure - Leases - Schedule of Lease Cost (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:title="00000040 - Disclosure - Leases - Schedule of Future Annual Minimum Lease Payments (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryDetailsNarrative" xlink:title="00000041 - Disclosure - Inventory (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory-ScheduleOfInventoryDetails" xlink:title="00000042 - Disclosure - Inventory - Schedule of Inventory (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000043 - Disclosure - Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CoFoundersMember" xlink:label="loc_SRNACoFoundersMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNACoFoundersMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciation_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_60" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000044 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_90" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000045 - Disclosure - Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WebSiteDevelopmentCostsMember" xlink:label="loc_SRNAWebSiteDevelopmentCostsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_SRNAWebSiteDevelopmentCostsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived_60" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:title="00000046 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WebSiteDevelopmentCostsMember" xlink:label="loc_SRNAWebSiteDevelopmentCostsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_SRNAWebSiteDevelopmentCostsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet_90" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:title="00000047 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ThreeCustomersMember" xlink:label="loc_SRNAThreeCustomersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_SRNAThreeCustomersMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyDescription" xlink:label="loc_us-gaapStandardProductWarrantyDescription_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStandardProductWarrantyDescription_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000048 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:title="00000049 - Disclosure - Note Payable and Accrued Interest (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoanRestructuringModificationAxis" xlink:label="loc_us-gaapLoanRestructuringModificationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLoanRestructuringModificationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoanRestructuringModificationDomain" xlink:label="loc_us-gaapLoanRestructuringModificationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLoanRestructuringModificationAxis" xlink:to="loc_us-gaapLoanRestructuringModificationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoanRestructuringModificationDomain" xlink:label="loc_us-gaapLoanRestructuringModificationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLoanRestructuringModificationAxis" xlink:to="loc_us-gaapLoanRestructuringModificationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtendedMaturityMember" xlink:label="loc_us-gaapExtendedMaturityMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLoanRestructuringModificationDomain" xlink:to="loc_us-gaapExtendedMaturityMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest_90" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:title="00000050 - Disclosure - Related Party Agreements and Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CoFoundersMember" xlink:label="loc_SRNACoFoundersMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNACoFoundersMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_MrJamesRShipleyMember" xlink:label="loc_SRNAMrJamesRShipleyMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAMrJamesRShipleyMember_150" xlink:type="arc" order="153" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EquipmentDemonstrationAndProductTestingAgreementMember" xlink:label="loc_SRNAEquipmentDemonstrationAndProductTestingAgreementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAEquipmentDemonstrationAndProductTestingAgreementMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmploymentAgreementMember" xlink:label="loc_SRNAEmploymentAgreementMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAEmploymentAgreementMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ConsultingAgreementMember" xlink:label="loc_SRNAConsultingAgreementMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAConsultingAgreementMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapAccountsReceivableMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="loc_us-gaapAccountsPayableMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapAccountsPayableMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_LeasedEquipmentMember" xlink:label="loc_SRNALeasedEquipmentMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_SRNALeasedEquipmentMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_AprilThirtyTwoThousandAndTwentyMember" xlink:label="loc_SRNAAprilThirtyTwoThousandAndTwentyMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNAAprilThirtyTwoThousandAndTwentyMember_140" xlink:type="arc" order="144" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_UnpaidLeaseFees" xlink:label="loc_SRNAUnpaidLeaseFees_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAUnpaidLeaseFees_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_UnpaidDemoAndTestingFees" xlink:label="loc_SRNAUnpaidDemoAndTestingFees_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAUnpaidDemoAndTestingFees_170" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_170" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NetOfImpactOfForegoingItemCharge" xlink:label="loc_SRNANetOfImpactOfForegoingItemCharge_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNANetOfImpactOfForegoingItemCharge_170" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalariesWagesAndOfficersCompensation" xlink:label="loc_us-gaapSalariesWagesAndOfficersCompensation_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSalariesWagesAndOfficersCompensation_170" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_170" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" xlink:label="loc_SRNAShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_170" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_170" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_170" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfessionalFees_170" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000051 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_FormerEmployeeMember" xlink:label="loc_SRNAFormerEmployeeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAFormerEmployeeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NumberOfUnitsVestedButNotSettled" xlink:label="loc_SRNANumberOfUnitsVestedButNotSettled_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNANumberOfUnitsVestedButNotSettled_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NumberOfUnitsVestedAndSettled" xlink:label="loc_SRNANumberOfUnitsVestedAndSettled_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNANumberOfUnitsVestedAndSettled_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue" xlink:label="loc_us-gaapLossContingencyDamagesAwardedValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLossContingencyDamagesAwardedValue_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:label="loc_SRNARestrictedStockUnitsSharesIssuedInterestPercentage_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNARestrictedStockUnitsSharesIssuedInterestPercentage_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="loc_us-gaapLossContingencyDamagesPaidValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLossContingencyDamagesPaidValue_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement_40" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PreferredAndCommonStockDetailsNarrative" xlink:title="00000052 - Disclosure - Preferred and Common Stock (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeeMember" xlink:label="loc_SRNAEmployeeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeeMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IndependentDirectorsMember" xlink:label="loc_SRNAIndependentDirectorsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAIndependentDirectorsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IndependentDirectorsOneMember" xlink:label="loc_SRNAIndependentDirectorsOneMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAIndependentDirectorsOneMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" xlink:label="loc_SRNAStockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAStockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" xlink:label="loc_SRNAStockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAStockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NumberOfUnitsVestedAndSettled" xlink:label="loc_SRNANumberOfUnitsVestedAndSettled_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNANumberOfUnitsVestedAndSettled_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_80" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/OutstandingWarrantsDetailsNarrative" xlink:title="00000053 - Disclosure - Outstanding Warrants (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SeriesTwoWarrantsMember" xlink:label="loc_SRNASeriesTwoWarrantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNASeriesTwoWarrantsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_QOneTwoThousandSeventeenWarrantsMember" xlink:label="loc_SRNAQOneTwoThousandSeventeenWarrantsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNAQOneTwoThousandSeventeenWarrantsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_QFourTwoThousandSeventeenWarrantsMember" xlink:label="loc_SRNAQFourTwoThousandSeventeenWarrantsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNAQFourTwoThousandSeventeenWarrantsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_QTwoTwoThousandEighteenWarrantsMember" xlink:label="loc_SRNAQTwoTwoThousandEighteenWarrantsMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNAQTwoTwoThousandEighteenWarrantsMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SeriesTwoConvertibleNotesMember" xlink:label="loc_SRNASeriesTwoConvertibleNotesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_SRNASeriesTwoConvertibleNotesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_InvestmentBankMember" xlink:label="loc_SRNAInvestmentBankMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SRNAInvestmentBankMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NumberOfInvestmentUnitOffered" xlink:label="loc_SRNANumberOfInvestmentUnitOffered_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNANumberOfInvestmentUnitOffered_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_OfferedInvestmentsPricePerUnit" xlink:label="loc_SRNAOfferedInvestmentsPricePerUnit_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAOfferedInvestmentsPricePerUnit_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleDebt_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_140" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_140" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WarrantDescription" xlink:label="loc_SRNAWarrantDescription_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAWarrantDescription_140" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ProceedsFromInvestment" xlink:label="loc_SRNAProceedsFromInvestment_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAProceedsFromInvestment_140" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ProceedsFromInvestmentPerUnit" xlink:label="loc_SRNAProceedsFromInvestmentPerUnit_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAProceedsFromInvestmentPerUnit_140" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockDescription" xlink:label="loc_us-gaapConversionOfStockDescription_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockDescription_140" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_140" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="loc_us-gaapDebtInstrumentConvertibleThresholdConsecutiveTradingDays1_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleThresholdConsecutiveTradingDays1_140" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_RedeemWarrantSharesAtPrice" xlink:label="loc_SRNARedeemWarrantSharesAtPrice_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNARedeemWarrantSharesAtPrice_140" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_140" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/OutstandingWarrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:title="00000054 - Disclosure - Outstanding Warrants - Schedule of Outstanding Warrants to Purchase Common Stock (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/OutstandingWarrants-ScheduleOfWarrantsOutstandingDetails" xlink:title="00000055 - Disclosure - Outstanding Warrants - Schedule of Warrants Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WarrantsRangeMember" xlink:label="loc_SRNAWarrantsRangeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_SRNAWarrantsRangeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WarrantsRangeOneMember" xlink:label="loc_SRNAWarrantsRangeOneMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_SRNAWarrantsRangeOneMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlanDetailsNarrative" xlink:title="00000056 - Disclosure - Equity Incentive Plan (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityIncentivePlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityIncentivePlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" xlink:label="loc_SRNATwoThousandAndNineteenSpecialEquityPlanMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndNineteenSpecialEquityPlanMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IndependentDirectorsMember" xlink:label="loc_SRNAIndependentDirectorsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAIndependentDirectorsMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IndependentDirectorsOneMember" xlink:label="loc_SRNAIndependentDirectorsOneMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAIndependentDirectorsOneMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoNewIndependentDirectorsMember" xlink:label="loc_SRNATwoNewIndependentDirectorsMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNATwoNewIndependentDirectorsMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="loc_SRNAEmployeesDirectorsandConsultantsMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesDirectorsandConsultantsMember_200" xlink:type="arc" order="202" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesMember" xlink:label="loc_SRNAEmployeesMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesMember_260" xlink:type="arc" order="262" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_UnvestedOptionsMember" xlink:label="loc_SRNAUnvestedOptionsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNAUnvestedOptionsMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IncentiveStockBonusAwardsMember" xlink:label="loc_SRNAIncentiveStockBonusAwardsMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNAIncentiveStockBonusAwardsMember_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_AprilOneTwentyTwentyOneMember" xlink:label="loc_SRNAAprilOneTwentyTwentyOneMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNAAprilOneTwentyTwentyOneMember_180" xlink:type="arc" order="184" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_290" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_290" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_290" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapProfessionalFees_290" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_290" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_290" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_290" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_290" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_290" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_290" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensation_290" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_290" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_StockOptionToPurchaseThresholdsPerformanceBased" xlink:label="loc_SRNAStockOptionToPurchaseThresholdsPerformanceBased_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAStockOptionToPurchaseThresholdsPerformanceBased_290" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NumberOfSharesForfeitedForTerminations" xlink:label="loc_SRNANumberOfSharesForfeitedForTerminations_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNANumberOfSharesForfeitedForTerminations_290" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_290" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_290" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharePrice_290" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_290" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding" xlink:label="loc_SRNAShareBasedCompensationArrangementStockIssuedAndOutstanding_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAShareBasedCompensationArrangementStockIssuedAndOutstanding_290" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_290" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_290" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_290" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationForfeited_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationForfeited_290" xlink:type="arc" order="22" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:title="00000057 - Disclosure - Equity Incentive Plan - Schedule of Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_50" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_50" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_50" xlink:type="arc" order="28" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:title="00000058 - Disclosure - Equity Incentive Plan - Summary of Non-vested Non-qualified Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_50" xlink:type="arc" order="21" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:title="00000059 - Disclosure - Equity Incentive Plan - Schedule of Restricted Stock Units Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="loc_SRNAEmployeesDirectorsandConsultantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesDirectorsandConsultantsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_30" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlans-ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:title="00000060 - Disclosure - Equity Incentive Plans - Schedule of Incentive Bonus Awards Granted to Employees (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IncentiveStockBonusAwardsMember" xlink:label="loc_SRNAIncentiveStockBonusAwardsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNAIncentiveStockBonusAwardsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesMember" xlink:label="loc_SRNAEmployeesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_30" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000061 - Disclosure - Income Taxes (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes-ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:title="00000062 - Disclosure - Income Taxes - Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000063 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000064 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ConsultingAgreementMember" xlink:label="loc_SRNAConsultingAgreementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAConsultingAgreementMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_MrJamesRShipleyMember" xlink:label="loc_SRNAMrJamesRShipleyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAMrJamesRShipleyMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredCompensationLiabilityCurrent_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfessionalFees_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="loc_us-gaapLossContingencyDamagesPaidValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLossContingencyDamagesPaidValue_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement_60" xlink:type="arc" order="8" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>18
<FILENAME>srna-20201231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SRNA %2D 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D23T20:34:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesMember_lbl" xml:lang="en-US">Cost of Revenue [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingMember" xlink:label="us-gaap_AdvertisingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingMember" xlink:to="us-gaap_AdvertisingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingMember_lbl" xml:lang="en-US">Advertising and Marketing Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xml:lang="en-US">Product Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="SRNA_EmployeesDirectorsandConsultantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesDirectorsandConsultantsMember" xlink:to="SRNA_EmployeesDirectorsandConsultantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EmployeesDirectorsandConsultantsMember_lbl" xml:lang="en-US">Employees, Directors and Consultants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IncentiveStockBonusAwardsMember" xlink:label="SRNA_IncentiveStockBonusAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncentiveStockBonusAwardsMember" xlink:to="SRNA_IncentiveStockBonusAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_IncentiveStockBonusAwardsMember_lbl" xml:lang="en-US">Incentive Stock Bonus Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesMember" xlink:label="SRNA_EmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesMember" xlink:to="SRNA_EmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EmployeesMember_lbl" xml:lang="en-US">Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_QFourTwoThousandSeventeenWarrantsMember" xlink:label="SRNA_QFourTwoThousandSeventeenWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_QFourTwoThousandSeventeenWarrantsMember" xlink:to="SRNA_QFourTwoThousandSeventeenWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_QFourTwoThousandSeventeenWarrantsMember_lbl" xml:lang="en-US">Q4 2017 Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EngineeringAndOtherServicesMember" xlink:label="SRNA_EngineeringAndOtherServicesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EngineeringAndOtherServicesMember" xlink:to="SRNA_EngineeringAndOtherServicesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EngineeringAndOtherServicesMember_lbl" xml:lang="en-US">Engineering and Other Services [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="us-gaap_ShippingAndHandlingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShippingAndHandlingMember" xlink:to="us-gaap_ShippingAndHandlingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShippingAndHandlingMember_lbl" xml:lang="en-US">Shipping and Handling [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xml:lang="en-US">Asset Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="SRNA_TwoThousandAndSeventeenEquityPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndSeventeenEquityPlanMember_lbl" xml:lang="en-US">2017 Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201602Member" xlink:to="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xml:lang="en-US">ASU 2016-02 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:label="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_lbl" xml:lang="en-US">2017 Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IndependentDirectorsOneMember" xlink:label="SRNA_IndependentDirectorsOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IndependentDirectorsOneMember" xlink:to="SRNA_IndependentDirectorsOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_IndependentDirectorsOneMember_lbl" xml:lang="en-US">Independent Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="SRNA_EmployeesAndConsultantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesAndConsultantsMember" xlink:to="SRNA_EmployeesAndConsultantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EmployeesAndConsultantsMember_lbl" xml:lang="en-US">Employees and Consultants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:label="us-gaap_ChangeInAccountingEstimateByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:to="us-gaap_ChangeInAccountingEstimateByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ChangeInAccountingEstimateByTypeAxis_lbl" xml:lang="en-US">Change in Accounting Estimate by Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationAndObsolescenceMember" xlink:label="us-gaap_InventoryValuationAndObsolescenceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationAndObsolescenceMember" xlink:to="us-gaap_InventoryValuationAndObsolescenceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationAndObsolescenceMember_lbl" xml:lang="en-US">Inventory Valuation and Obsolescence [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesMember_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CustomerOneMember" xlink:label="SRNA_CustomerOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerOneMember" xlink:to="SRNA_CustomerOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CustomerOneMember_lbl" xml:lang="en-US">Customer One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CustomerTwoMember" xlink:label="SRNA_CustomerTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerTwoMember" xlink:to="SRNA_CustomerTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CustomerTwoMember_lbl" xml:lang="en-US">Customer Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CustomerThreeMember" xlink:label="SRNA_CustomerThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerThreeMember" xlink:to="SRNA_CustomerThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CustomerThreeMember_lbl" xml:lang="en-US">Customer Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="us-gaap_SupplierConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplierConcentrationRiskMember" xlink:to="us-gaap_SupplierConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplierConcentrationRiskMember_lbl" xml:lang="en-US">Supplier Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_PurchasesOfInventoryMember" xlink:label="SRNA_PurchasesOfInventoryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PurchasesOfInventoryMember" xlink:to="SRNA_PurchasesOfInventoryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_PurchasesOfInventoryMember_lbl" xml:lang="en-US">Purchases of Inventory [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SupplierOneMember" xlink:label="SRNA_SupplierOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SupplierOneMember" xlink:to="SRNA_SupplierOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SupplierOneMember_lbl" xml:lang="en-US">Supplier One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SupplierTwoMember" xlink:label="SRNA_SupplierTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SupplierTwoMember" xlink:to="SRNA_SupplierTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SupplierTwoMember_lbl" xml:lang="en-US">Supplier Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SupplierThreeMember" xlink:label="SRNA_SupplierThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SupplierThreeMember" xlink:to="SRNA_SupplierThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SupplierThreeMember_lbl" xml:lang="en-US">Supplier Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_FacilityLeaseMember" xlink:label="SRNA_FacilityLeaseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FacilityLeaseMember" xlink:to="SRNA_FacilityLeaseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_FacilityLeaseMember_lbl" xml:lang="en-US">Facility Lease [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="us-gaap_PropertyPlantAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentMember" xlink:to="us-gaap_PropertyPlantAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentMember_lbl" xml:lang="en-US">Property and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CoFoundersMember" xlink:label="SRNA_CoFoundersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CoFoundersMember" xlink:to="SRNA_CoFoundersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CoFoundersMember_lbl" xml:lang="en-US">Co-Founders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember" xlink:label="us-gaap_PatentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PatentsMember" xlink:to="us-gaap_PatentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PatentsMember_lbl" xml:lang="en-US">Patents [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WebSiteDevelopmentCostsMember" xlink:label="SRNA_WebSiteDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WebSiteDevelopmentCostsMember" xlink:to="SRNA_WebSiteDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WebSiteDevelopmentCostsMember_lbl" xml:lang="en-US">Website Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TrademarksMember_lbl" xml:lang="en-US">Trademarks [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EquipmentDemonstrationAndProductTestingAgreementMember" xlink:label="SRNA_EquipmentDemonstrationAndProductTestingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EquipmentDemonstrationAndProductTestingAgreementMember" xlink:to="SRNA_EquipmentDemonstrationAndProductTestingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EquipmentDemonstrationAndProductTestingAgreementMember_lbl" xml:lang="en-US">Equipment, Demonstration and Product Testing Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="us-gaap_AccountsPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableMember" xlink:to="us-gaap_AccountsPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableMember_lbl" xml:lang="en-US">Accounts Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmploymentAgreementMember" xlink:label="SRNA_EmploymentAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmploymentAgreementMember" xlink:to="SRNA_EmploymentAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EmploymentAgreementMember_lbl" xml:lang="en-US">Employment Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_QTwoTwoThousandEighteenWarrantsMember" xlink:label="SRNA_QTwoTwoThousandEighteenWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_QTwoTwoThousandEighteenWarrantsMember" xlink:to="SRNA_QTwoTwoThousandEighteenWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_QTwoTwoThousandEighteenWarrantsMember_lbl" xml:lang="en-US">Q2 2018 Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IndependentDirectorsMember" xlink:label="SRNA_IndependentDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IndependentDirectorsMember" xlink:to="SRNA_IndependentDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_IndependentDirectorsMember_lbl" xml:lang="en-US">Independent Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="SRNA_NonQualifiedStockOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NonQualifiedStockOptionsMember" xlink:to="SRNA_NonQualifiedStockOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NonQualifiedStockOptionsMember_lbl" xml:lang="en-US">Non-Qualified Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="us-gaap_AwardDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateAxis_lbl" xml:lang="en-US">Award Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="SRNA_TwoThousandAndTwentyTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyTwoMember" xlink:to="SRNA_TwoThousandAndTwentyTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndTwentyTwoMember_lbl" xml:lang="en-US">2022 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Sales Revenue, Net [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndTwentyOneMember" xlink:label="SRNA_TwoThousandAndTwentyOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyOneMember" xlink:to="SRNA_TwoThousandAndTwentyOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndTwentyOneMember_lbl" xml:lang="en-US">2021 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US">Equipment and Systems Sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandSeventeenEquityPlanMember" xlink:label="SRNA_TwoThousandSeventeenEquityPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandSeventeenEquityPlanMember" xlink:to="SRNA_TwoThousandSeventeenEquityPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandSeventeenEquityPlanMember_lbl" xml:lang="en-US">2017 Equity Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoNewIndependentDirectorsMember" xlink:label="SRNA_TwoNewIndependentDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoNewIndependentDirectorsMember" xlink:to="SRNA_TwoNewIndependentDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoNewIndependentDirectorsMember_lbl" xml:lang="en-US">Two New Independent Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_AprilOneTwentyTwentyOneMember" xlink:label="SRNA_AprilOneTwentyTwentyOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AprilOneTwentyTwentyOneMember" xlink:to="SRNA_AprilOneTwentyTwentyOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_AprilOneTwentyTwentyOneMember_lbl" xml:lang="en-US">April 1, 2021 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_DirectorsMember" xlink:label="SRNA_DirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DirectorsMember" xlink:to="SRNA_DirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_DirectorsMember_lbl" xml:lang="en-US">Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_FormerEmployeeMember" xlink:label="SRNA_FormerEmployeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FormerEmployeeMember" xlink:to="SRNA_FormerEmployeeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_FormerEmployeeMember_lbl" xml:lang="en-US">Former Employee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_AgreementWithLandLordMember" xlink:label="SRNA_AgreementWithLandLordMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AgreementWithLandLordMember" xlink:to="SRNA_AgreementWithLandLordMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_AgreementWithLandLordMember_lbl" xml:lang="en-US">Agreement with Landlord [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WarrantsRangeOneMember" xlink:label="SRNA_WarrantsRangeOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsRangeOneMember" xlink:to="SRNA_WarrantsRangeOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WarrantsRangeOneMember_lbl" xml:lang="en-US">Warrants Range One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WarrantsRangeMember" xlink:label="SRNA_WarrantsRangeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsRangeMember" xlink:to="SRNA_WarrantsRangeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WarrantsRangeMember_lbl" xml:lang="en-US">Warrants Range [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_OneCustomerMember" xlink:label="SRNA_OneCustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OneCustomerMember" xlink:to="SRNA_OneCustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_OneCustomerMember_lbl" xml:lang="en-US">One Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndTwentyIncentiveAwardsMember" xlink:label="SRNA_TwoThousandAndTwentyIncentiveAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyIncentiveAwardsMember" xlink:to="SRNA_TwoThousandAndTwentyIncentiveAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndTwentyIncentiveAwardsMember_lbl" xml:lang="en-US">2020 Incentive Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ThreeCustomersMember" xlink:label="SRNA_ThreeCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ThreeCustomersMember" xlink:to="SRNA_ThreeCustomersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ThreeCustomersMember_lbl" xml:lang="en-US">Three Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_LeasedEquipmentMember" xlink:label="SRNA_LeasedEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_LeasedEquipmentMember" xlink:to="SRNA_LeasedEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_LeasedEquipmentMember_lbl" xml:lang="en-US">Leased Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_AprilThirtyTwoThousandAndTwentyMember" xlink:label="SRNA_AprilThirtyTwoThousandAndTwentyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AprilThirtyTwoThousandAndTwentyMember" xlink:to="SRNA_AprilThirtyTwoThousandAndTwentyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_AprilThirtyTwoThousandAndTwentyMember_lbl" xml:lang="en-US">April 30, 2020 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ConsultingAgreementMember" xlink:label="SRNA_ConsultingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ConsultingAgreementMember" xlink:to="SRNA_ConsultingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ConsultingAgreementMember_lbl" xml:lang="en-US">Consulting Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_MrJamesRShipleyMember" xlink:label="SRNA_MrJamesRShipleyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_MrJamesRShipleyMember" xlink:to="SRNA_MrJamesRShipleyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_MrJamesRShipleyMember_lbl" xml:lang="en-US">Mr. James R. Shipley [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SeriesTwoWarrantsMember" xlink:label="SRNA_SeriesTwoWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SeriesTwoWarrantsMember" xlink:to="SRNA_SeriesTwoWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SeriesTwoWarrantsMember_lbl" xml:lang="en-US">Series 2 Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SeriesTwoConvertibleNotesMember" xlink:label="SRNA_SeriesTwoConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SeriesTwoConvertibleNotesMember" xlink:to="SRNA_SeriesTwoConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SeriesTwoConvertibleNotesMember_lbl" xml:lang="en-US">Series 2 Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_InvestmentBankMember" xlink:label="SRNA_InvestmentBankMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_InvestmentBankMember" xlink:to="SRNA_InvestmentBankMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_InvestmentBankMember_lbl" xml:lang="en-US">Investment Bank [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_QOneTwoThousandSeventeenWarrantsMember" xlink:label="SRNA_QOneTwoThousandSeventeenWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_QOneTwoThousandSeventeenWarrantsMember" xlink:to="SRNA_QOneTwoThousandSeventeenWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_QOneTwoThousandSeventeenWarrantsMember_lbl" xml:lang="en-US">Q1 2017 Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeeMember" xlink:label="SRNA_EmployeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeeMember" xlink:to="SRNA_EmployeeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EmployeeMember_lbl" xml:lang="en-US">Employee [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IndependentDirectorsOneMember" xlink:to="SRNA_IndependentDirectorsOneMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_IndependentDirectorsOneMember_2_lbl" xml:lang="en-US">Independent Directors One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_UnvestedOptionsMember" xlink:label="SRNA_UnvestedOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnvestedOptionsMember" xlink:to="SRNA_UnvestedOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_UnvestedOptionsMember_lbl" xml:lang="en-US">Unvested Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" xlink:label="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" xlink:to="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember_lbl" xml:lang="en-US">2019 Special Equity Award [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerContractsMember" xlink:label="us-gaap_CustomerContractsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerContractsMember" xlink:to="us-gaap_CustomerContractsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerContractsMember_lbl" xml:lang="en-US">Customer Contracts [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoanRestructuringModificationAxis" xlink:label="us-gaap_LoanRestructuringModificationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoanRestructuringModificationAxis" xlink:to="us-gaap_LoanRestructuringModificationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoanRestructuringModificationAxis_lbl" xml:lang="en-US">Loan Restructuring Modification [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtendedMaturityMember" xlink:label="us-gaap_ExtendedMaturityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtendedMaturityMember" xlink:to="us-gaap_ExtendedMaturityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtendedMaturityMember_lbl" xml:lang="en-US">Extended Maturity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable (net of allowance for doubtful accounts of $165,098 and $151,673, respectively)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">Noncurrent Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right-of-use asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total Noncurrent Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="us-gaap_DeferredCompensationLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationLiabilityCurrent" xlink:to="us-gaap_DeferredCompensationLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationLiabilityCurrent_lbl" xml:lang="en-US">Accrued equity compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Current portion of operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">NONCURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liability, net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Noncurrent Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies (Note 11)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">SHAREHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.00001 par value; 150,000,000 shares authorized; 42,030,331 shares issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.00001 par value; 350,000,000 shares authorized; 236,526,638 and 228,216,638 shares issued and outstanding, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Shareholders' Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowance for doubtful accounts, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenue, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="us-gaap_MarketingAndAdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingAndAdvertisingExpense" xlink:to="us-gaap_MarketingAndAdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketingAndAdvertisingExpense_lbl" xml:lang="en-US">Advertising and marketing expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Product development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expense):</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income (expense), net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Loss per common share - basic and dilutive</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average number of common shares outstanding, basic and dilutive</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CommonstockSharesToBeIssued" xlink:label="SRNA_CommonstockSharesToBeIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonstockSharesToBeIssued" xlink:to="SRNA_CommonstockSharesToBeIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_CommonstockSharesToBeIssued_lbl" xml:lang="en-US">Balance, shares to be issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xml:lang="en-US">Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" xlink:label="SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" xlink:to="SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued_lbl" xml:lang="en-US">Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares to be issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US">Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Common shares issued as compensation for services</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Common shares issued as compensation for services, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Fair value of vested restricted stock units awarded to employees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Fair value of vested stock options granted to employees, directors and consultants</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" xlink:label="SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" xlink:to="SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees_lbl" xml:lang="en-US">Fair value of vested incentive stock bonuses awarded to employees</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" xlink:label="SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" xlink:to="SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued_lbl" xml:lang="en-US">Fair value of vested stock options accrued in 2019 and issued to employees and directors in 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_lbl" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_lbl" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_lbl" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonstockSharesToBeIssued" xlink:to="SRNA_CommonstockSharesToBeIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_CommonstockSharesToBeIssued_2_lbl" xml:lang="en-US">Balance, shares to be issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows From Operating Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and intangible asset amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_GainOnForgivenessOfNotePayable" xlink:label="SRNA_GainOnForgivenessOfNotePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_GainOnForgivenessOfNotePayable" xlink:to="SRNA_GainOnForgivenessOfNotePayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="SRNA_GainOnForgivenessOfNotePayable_lbl" xml:lang="en-US">Gain on forgiveness of note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Provision for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWriteDown_lbl" xml:lang="en-US">Provision for excess and obsolete inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="us-gaap_GainLossOnDispositionOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-gaap_GainLossOnDispositionOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnDispositionOfAssets_lbl" xml:lang="en-US">Loss on disposal of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization of ROU Asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xml:lang="en-US">Prepaid expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet" xlink:label="SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet" xlink:to="SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet_lbl" xml:lang="en-US">Operating lease liability, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="us-gaap_IncreaseDecreaseInDeferredCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation_lbl" xml:lang="en-US">Accrued equity compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows From Investing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows From Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Proceeds from issuance of note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase in cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash, beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Non-cash investing and financing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">Description of Business</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Basis of Presentation; Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">Going Concern</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAbstract_lbl" xml:lang="en-US">Leases [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Note Payable and Accrued Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Agreements and Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Preferred and Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WarrantsDisclosureTextBlock" xlink:label="SRNA_WarrantsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsDisclosureTextBlock" xlink:to="SRNA_WarrantsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WarrantsDisclosureTextBlock_lbl" xml:lang="en-US">Outstanding Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Equity Incentive Plan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Financial Statement Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_lbl" xml:lang="en-US">Accounts Receivable and Allowance for Doubtful Accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Long-lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Derivative Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="us-gaap_StandardProductWarrantyPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyPolicy" xlink:to="us-gaap_StandardProductWarrantyPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StandardProductWarrantyPolicy_lbl" xml:lang="en-US">Product Warranty</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xml:lang="en-US">Cost of Sales</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentrations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Product Development</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Accounting for Share-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Basic and Diluted Net Loss Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_OtherRisksAndUncertaintiesPolicyTextBlock" xlink:label="SRNA_OtherRisksAndUncertaintiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OtherRisksAndUncertaintiesPolicyTextBlock" xlink:to="SRNA_OtherRisksAndUncertaintiesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_OtherRisksAndUncertaintiesPolicyTextBlock_lbl" xml:lang="en-US">Other Risks and Uncertainties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Segment Information</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of Revenue by Source</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_lbl" xml:lang="en-US">Schedule of Remaining Performance Obligations Expected to be Recognized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Compensation Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Schedule of Lease Cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of Future Annual Minimum Lease Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Schedule of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:label="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:to="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_lbl" xml:lang="en-US">Schedule of Outstanding Warrants to Purchase Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Warrants Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_lbl" xml:lang="en-US">Summary of Non-vested Non-qualified Stock Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Restricted Stock Units Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:label="us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Incentive Bonus Awards Granted to Employees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryAdjustments" xlink:label="us-gaap_InventoryAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryAdjustments" xlink:to="us-gaap_InventoryAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryAdjustments_lbl" xml:lang="en-US">Inventory adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Property and equipment useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xml:lang="en-US">Revenue recognized</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:label="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:to="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage_lbl" xml:lang="en-US">Revenue recognized, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xml:lang="en-US">Remaining performance obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" xml:lang="en-US">Remaining performance obligations, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyDescription" xlink:label="us-gaap_StandardProductWarrantyDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyDescription" xlink:to="us-gaap_StandardProductWarrantyDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StandardProductWarrantyDescription_lbl" xml:lang="en-US">Product warranty description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual" xlink:label="us-gaap_ProductWarrantyAccrual" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductWarrantyAccrual" xlink:to="us-gaap_ProductWarrantyAccrual_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductWarrantyAccrual_lbl" xml:lang="en-US">Accrued warranty reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Share based compensation cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xml:lang="en-US">Potentially dilutive equity instruments that are convertible into common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xml:lang="en-US">Total revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_lbl" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_lbl" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:to="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_lbl" xml:lang="en-US">Remaining performance obligations related to engineering only paid contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:to="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_lbl" xml:lang="en-US">Remaining performance obligations related to partial equipment paid contracts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_2_lbl" xml:lang="en-US">Total remaining performance obligations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xml:lang="en-US">Total share-based compensation expense included in consolidated statement of operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholder's deficit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_DecreaseInRevenuePercentage" xlink:label="SRNA_DecreaseInRevenuePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DecreaseInRevenuePercentage" xlink:to="SRNA_DecreaseInRevenuePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DecreaseInRevenuePercentage_lbl" xml:lang="en-US">Decrease in revenue percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Cash flow from operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WorkingCapitalDeficit" xlink:label="SRNA_WorkingCapitalDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WorkingCapitalDeficit" xlink:to="SRNA_WorkingCapitalDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WorkingCapitalDeficit_lbl" xml:lang="en-US">Working capital deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TypeOfArrangementAxis_2_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_2_lbl" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="srt_RangeAxis_2_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfLand" xlink:to="us-gaap_AreaOfLand_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AreaOfLand_lbl" xml:lang="en-US">Area of land</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Lease rental expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="us-gaap_LesseeOperatingLeaseDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDescription" xlink:to="us-gaap_LesseeOperatingLeaseDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseDescription_lbl" xml:lang="en-US">Operating lease term description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityDeposit_lbl" xml:lang="en-US">Security deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForDeposits" xlink:label="us-gaap_PaymentsForDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForDeposits" xlink:to="us-gaap_PaymentsForDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForDeposits_lbl" xml:lang="en-US">Payment to deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xml:lang="en-US">Operating lease renewal term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="us-gaap_DeferredRentCreditCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRentCreditCurrent" xlink:to="us-gaap_DeferredRentCreditCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRentCreditCurrent_lbl" xml:lang="en-US">Deferred rent reclassified to operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TenantImprovements" xlink:label="us-gaap_TenantImprovements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TenantImprovements" xlink:to="us-gaap_TenantImprovements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TenantImprovements_lbl" xml:lang="en-US">Tenant improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:label="SRNA_UnamortizedAmountOfTenantImprovementAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:to="SRNA_UnamortizedAmountOfTenantImprovementAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_UnamortizedAmountOfTenantImprovementAllowance_lbl" xml:lang="en-US">Unamortized amount of tenant improvement allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Operating cash outflow from operating lease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">Operating lease liability, current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Operating lease liability, long-term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Remaining lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total minimum lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less imputed interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiability_2_lbl" xml:lang="en-US">Present value of minimum lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:label="us-gaap_CostOfGoodsAndServicesSoldOverhead" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:to="us-gaap_CostOfGoodsAndServicesSoldOverhead_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSoldOverhead_lbl" xml:lang="en-US">Overhead expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work in progress</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InventoryValuationReserves_lbl" xml:lang="en-US">Allowance for excess &amp; obsolete inventory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Inventory, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_2_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Cost of equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_2_lbl" xml:lang="en-US">Property and equipment, gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_lbl" xml:lang="en-US">Intangible assets amortization period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xml:lang="en-US">Written-off finite lived intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Intangible assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Accounts payable and other accrued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandardProductWarrantyDescription" xlink:to="us-gaap_StandardProductWarrantyDescription_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StandardProductWarrantyDescription_2_lbl" xml:lang="en-US">Warranty reserve description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="us-gaap_AccruedSalesCommissionCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalesCommissionCurrent" xlink:to="us-gaap_AccruedSalesCommissionCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalesCommissionCurrent_lbl" xml:lang="en-US">Sales commissions payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued payroll liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="us-gaap_ProductWarrantyAccrualClassifiedCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:to="us-gaap_ProductWarrantyAccrualClassifiedCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductWarrantyAccrualClassifiedCurrent_lbl" xml:lang="en-US">Product warranty accrual</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other accrued expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Loan principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Loan interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Loan due date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Ownership percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_lbl" xml:lang="en-US">Quarterly fee, receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Quarterly fee, payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_2_lbl" xml:lang="en-US">Demo and testing fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xml:lang="en-US">Lease fees</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_UnpaidLeaseFees" xlink:label="SRNA_UnpaidLeaseFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnpaidLeaseFees" xlink:to="SRNA_UnpaidLeaseFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_UnpaidLeaseFees_lbl" xml:lang="en-US">Unpaid lease fees</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_UnpaidDemoAndTestingFees" xlink:label="SRNA_UnpaidDemoAndTestingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnpaidDemoAndTestingFees" xlink:to="SRNA_UnpaidDemoAndTestingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_UnpaidDemoAndTestingFees_lbl" xml:lang="en-US">Unpaid demo and testing Fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_3_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NetOfImpactOfForegoingItemCharge" xlink:label="SRNA_NetOfImpactOfForegoingItemCharge" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOfImpactOfForegoingItemCharge" xlink:to="SRNA_NetOfImpactOfForegoingItemCharge_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NetOfImpactOfForegoingItemCharge_lbl" xml:lang="en-US">Net of impact of foregoing item charge</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalariesWagesAndOfficersCompensation" xlink:label="us-gaap_SalariesWagesAndOfficersCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalariesWagesAndOfficersCompensation" xlink:to="us-gaap_SalariesWagesAndOfficersCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalariesWagesAndOfficersCompensation_lbl" xml:lang="en-US">Base salary</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xml:lang="en-US">Share based payment award, shares issued in period</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" xlink:label="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" xlink:to="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_lbl" xml:lang="en-US">Number of shares vested and to be settled with issued shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Stock cancelled during period, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Number of stock expected to vest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Monthly consulting fee</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NumberOfUnitsVestedButNotSettled" xlink:label="SRNA_NumberOfUnitsVestedButNotSettled" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfUnitsVestedButNotSettled" xlink:to="SRNA_NumberOfUnitsVestedButNotSettled_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NumberOfUnitsVestedButNotSettled_lbl" xml:lang="en-US">Number of units, vested but not settled</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NumberOfUnitsVestedAndSettled" xlink:label="SRNA_NumberOfUnitsVestedAndSettled" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfUnitsVestedAndSettled" xlink:to="SRNA_NumberOfUnitsVestedAndSettled_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NumberOfUnitsVestedAndSettled_lbl" xml:lang="en-US">Number of units, vested and settled</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue" xlink:label="us-gaap_LossContingencyDamagesAwardedValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesAwardedValue" xlink:to="us-gaap_LossContingencyDamagesAwardedValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDamagesAwardedValue_lbl" xml:lang="en-US">Interim awarded value</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:label="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:to="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage_lbl" xml:lang="en-US">Restricted stock units shares issued interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="us-gaap_LossContingencyDamagesPaidValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesPaidValue" xlink:to="us-gaap_LossContingencyDamagesPaidValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDamagesPaidValue_lbl" xml:lang="en-US">Obligate to pay for dispute</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="SRNA_AggregateSharesIssuedUponExecutionOfSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:to="SRNA_AggregateSharesIssuedUponExecutionOfSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_AggregateSharesIssuedUponExecutionOfSettlement_lbl" xml:lang="en-US">Aggregate common shares issued upon execution of settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" xlink:label="SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" xlink:to="SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_lbl" xml:lang="en-US">Number of common stock shares issued in settlement of vested restricted stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" xlink:label="SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" xlink:to="SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_lbl" xml:lang="en-US">Number of shares issued for stock incentive bonus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Number of shares of common stock issued, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NumberOfInvestmentUnitOffered" xlink:label="SRNA_NumberOfInvestmentUnitOffered" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfInvestmentUnitOffered" xlink:to="SRNA_NumberOfInvestmentUnitOffered_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NumberOfInvestmentUnitOffered_lbl" xml:lang="en-US">Number of investment unit offered</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_OfferedInvestmentsPricePerUnit" xlink:label="SRNA_OfferedInvestmentsPricePerUnit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OfferedInvestmentsPricePerUnit" xlink:to="SRNA_OfferedInvestmentsPricePerUnit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_OfferedInvestmentsPricePerUnit_lbl" xml:lang="en-US">Offered investments, price per unit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_2_lbl" xml:lang="en-US">Common stock shares, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebt" xlink:label="us-gaap_ConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebt_lbl" xml:lang="en-US">Convertible promissory note</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xml:lang="en-US">Debt instrument, interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Warrants for the purchase of shares of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Exercise price of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WarrantDescription" xlink:label="SRNA_WarrantDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantDescription" xlink:to="SRNA_WarrantDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WarrantDescription_lbl" xml:lang="en-US">Warrant description</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ProceedsFromInvestment" xlink:label="SRNA_ProceedsFromInvestment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ProceedsFromInvestment" xlink:to="SRNA_ProceedsFromInvestment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ProceedsFromInvestment_lbl" xml:lang="en-US">Proceeds from investment</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ProceedsFromInvestmentPerUnit" xlink:label="SRNA_ProceedsFromInvestmentPerUnit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ProceedsFromInvestmentPerUnit" xlink:to="SRNA_ProceedsFromInvestmentPerUnit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ProceedsFromInvestmentPerUnit_lbl" xml:lang="en-US">Proceeds from investment per unit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockDescription" xlink:label="us-gaap_ConversionOfStockDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockDescription" xlink:to="us-gaap_ConversionOfStockDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockDescription_lbl" xml:lang="en-US">Conversion stock, description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_lbl" xml:lang="en-US">Consecutive trading days</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_RedeemWarrantSharesAtPrice" xlink:label="SRNA_RedeemWarrantSharesAtPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RedeemWarrantSharesAtPrice" xlink:to="SRNA_RedeemWarrantSharesAtPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_RedeemWarrantSharesAtPrice_lbl" xml:lang="en-US">Redeem warrant shares at a price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Warrant term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants Outstanding, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightIssued" xlink:label="SRNA_ClassOfWarrantOrRightIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightIssued" xlink:to="SRNA_ClassOfWarrantOrRightIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightIssued_lbl" xml:lang="en-US">Warrants, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightExercised" xlink:label="SRNA_ClassOfWarrantOrRightExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExercised" xlink:to="SRNA_ClassOfWarrantOrRightExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightExercised_lbl" xml:lang="en-US">Warrants, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightExpired" xlink:label="SRNA_ClassOfWarrantOrRightExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpired" xlink:to="SRNA_ClassOfWarrantOrRightExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="SRNA_ClassOfWarrantOrRightExpired_lbl" xml:lang="en-US">Warrants, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Warrants Outstanding, Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_lbl" xml:lang="en-US">Weighted Average Exercise Price, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_lbl" xml:lang="en-US">Weighted Average Exercise Price, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xml:lang="en-US">Weighted Average Exercise Price, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xml:lang="en-US">Weighted Average Life of Outstanding Warrants in Months, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Life of Outstanding Warrants in Months, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:label="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:label="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:label="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xml:lang="en-US">Warrants Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_2_lbl" xml:lang="en-US">Weighted Average Life of Outstanding Warrants in Months</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Number of common stock shares issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Unrecognized compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Unrecognized compensation expense term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProfessionalFees_2_lbl" xml:lang="en-US">Director fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Number of shares of common stock issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US">Expected stock price volatility, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Expected stock price volatility, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US">Risk-free interest rate, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Risk-free interest rate, maximum</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_lbl" xml:lang="en-US">Number of options to purchase shares</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_StockOptionToPurchaseThresholdsPerformanceBased" xlink:label="SRNA_StockOptionToPurchaseThresholdsPerformanceBased" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_StockOptionToPurchaseThresholdsPerformanceBased" xlink:to="SRNA_StockOptionToPurchaseThresholdsPerformanceBased_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_StockOptionToPurchaseThresholdsPerformanceBased_lbl" xml:lang="en-US">Stock option to purchase - thresholds - performance based</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NumberOfSharesForfeitedForTerminations" xlink:label="SRNA_NumberOfSharesForfeitedForTerminations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfSharesForfeitedForTerminations" xlink:to="SRNA_NumberOfSharesForfeitedForTerminations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NumberOfSharesForfeitedForTerminations_lbl" xml:lang="en-US">Number of shares forfeited for terminations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Number of options, granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Non-qualified stock options term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Closing price of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US">Non-qualified stock options vested percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding" xlink:label="SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding" xlink:to="SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding_lbl" xml:lang="en-US">Share based compensation arrangement stock issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_lbl" xml:lang="en-US">Total intrinsic value of restricted stock unit</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_lbl" xml:lang="en-US">Intrinsic value of vested and settled with issuance of share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xml:lang="en-US">Number of fully vested shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited_lbl" xml:lang="en-US">Share based compensation award forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number of options, outstanding beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Number of options, exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Number of options, forfeited/cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Number of options, expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Number of options, outstanding ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Number of options, exercisable ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_2_lbl" xml:lang="en-US">Number of options, outstanding vested and expected to vest ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercisable Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding vested and Expected to vest Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Outstanding Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Outstanding Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Exercisable Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Outstanding vested and expected to vest, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xml:lang="en-US">Number of Options Nonvested, Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Number of Options Nonvested, Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xml:lang="en-US">Number of Options Nonvested, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xml:lang="en-US">Number of Options Nonvested, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_lbl" xml:lang="en-US">Number of Options Nonvested, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xml:lang="en-US">Number of Options Nonvested, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Nonvested Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_2_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Nonvested Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_2_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Number of Units, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Number of Units, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Number of Units, Vested and settled with share issuance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_lbl" xml:lang="en-US">Number of Units, Forfeited/canceled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xml:lang="en-US">Number of Units, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Vested and settled with share issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Forfeited/canceled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Outstanding beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Outstanding ending</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_lbl" xml:lang="en-US">Number of Shares, Nonvested, Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xml:lang="en-US">Number of Shares, Awarded</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_3_lbl" xml:lang="en-US">Number of Shares, Vested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xml:lang="en-US">Number of Shares, Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_2_lbl" xml:lang="en-US">Number of Shares, Nonvested, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_lbl" xml:lang="en-US">Weighted Average Grant-date Fair Value, Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Grant-date Fair Value, Awarded</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Grant-date Fair Value, Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_2_lbl" xml:lang="en-US">Weighted Average Grant-date Fair Value, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Nonvested Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_2_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Nonvested Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carry forward amount</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" xlink:label="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" xlink:to="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount_lbl" xml:lang="en-US">Net operating loss carry forward expected to expire amount</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NetOperatingLossExpirationTerm" xlink:label="SRNA_NetOperatingLossExpirationTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOperatingLossExpirationTerm" xlink:to="SRNA_NetOperatingLossExpirationTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NetOperatingLossExpirationTerm_lbl" xml:lang="en-US">Net operating loss expiration term</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NolsUsageAgainstTaxableIncomePercentage" xlink:label="SRNA_NolsUsageAgainstTaxableIncomePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NolsUsageAgainstTaxableIncomePercentage" xlink:to="SRNA_NolsUsageAgainstTaxableIncomePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NolsUsageAgainstTaxableIncomePercentage_lbl" xml:lang="en-US">NOLs usage against taxable income, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Percentage of ownership change</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NolsCarryforwardsTerm" xlink:label="SRNA_NolsCarryforwardsTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NolsCarryforwardsTerm" xlink:to="SRNA_NolsCarryforwardsTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NolsCarryforwardsTerm_lbl" xml:lang="en-US">NOLs carryforwards term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense_lbl" xml:lang="en-US">Penalties and interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Income taxes computed at the federal statutory rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">States taxes, net of federal benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">Permanent differences</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IncomeTaxReconciliationTrueUpAdjustments" xlink:label="SRNA_IncomeTaxReconciliationTrueUpAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncomeTaxReconciliationTrueUpAdjustments" xlink:to="SRNA_IncomeTaxReconciliationTrueUpAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_IncomeTaxReconciliationTrueUpAdjustments_lbl" xml:lang="en-US">True-up adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US">Adjustment to net operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Reported income tax (benefit) expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating losses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Equity compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Other deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Total deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="us-gaap_DeferredTaxLiabilitiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_lbl" xml:lang="en-US">Other deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US">Total deferred tax liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Net deferred tax assets before valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Less valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Stock option exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationLiabilityCurrent" xlink:to="us-gaap_DeferredCompensationLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredCompensationLiabilityCurrent_2_lbl" xml:lang="en-US">Estimated compensation expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AprilThirtyTwoThousandAndTwentyMember" xlink:to="SRNA_AprilThirtyTwoThousandAndTwentyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_AprilThirtyTwoThousandAndTwentyMember_doc" xml:lang="en-US">Cash disbursed for equipment held for lease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CoFoundersMember" xlink:to="SRNA_CoFoundersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CoFoundersMember_doc" xml:lang="en-US">Co-Founders [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ConsultingAgreementMember" xlink:to="SRNA_ConsultingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ConsultingAgreementMember_doc" xml:lang="en-US">Consulting Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerOneMember" xlink:to="SRNA_CustomerOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CustomerOneMember_doc" xml:lang="en-US">Customer One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerThreeMember" xlink:to="SRNA_CustomerThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CustomerThreeMember_doc" xml:lang="en-US">Customer Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerTwoMember" xlink:to="SRNA_CustomerTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CustomerTwoMember_doc" xml:lang="en-US">Customer Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DirectorsMember" xlink:to="SRNA_DirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_DirectorsMember_doc" xml:lang="en-US">Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeeMember" xlink:to="SRNA_EmployeeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EmployeeMember_doc" xml:lang="en-US">Employee [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesAndConsultantsMember" xlink:to="SRNA_EmployeesAndConsultantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EmployeesAndConsultantsMember_doc" xml:lang="en-US">Employees and Consultants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesDirectorsandConsultantsMember" xlink:to="SRNA_EmployeesDirectorsandConsultantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EmployeesDirectorsandConsultantsMember_doc" xml:lang="en-US">Employees, Directors and Consultants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesMember" xlink:to="SRNA_EmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EmployeesMember_doc" xml:lang="en-US">Employees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmploymentAgreementMember" xlink:to="SRNA_EmploymentAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EmploymentAgreementMember_doc" xml:lang="en-US">Employment Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EngineeringAndOtherServicesMember" xlink:to="SRNA_EngineeringAndOtherServicesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EngineeringAndOtherServicesMember_doc" xml:lang="en-US">Engineering and Other Services [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EquipmentAndSystemsSalesMember" xlink:label="SRNA_EquipmentAndSystemsSalesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EquipmentAndSystemsSalesMember" xlink:to="SRNA_EquipmentAndSystemsSalesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EquipmentAndSystemsSalesMember_doc" xml:lang="en-US">Equipment and Systems Sales [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EquipmentDemonstrationAndProductTestingAgreementMember" xlink:to="SRNA_EquipmentDemonstrationAndProductTestingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EquipmentDemonstrationAndProductTestingAgreementMember_doc" xml:lang="en-US">Cash disbursed for equipment held for lease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FacilityLeaseMember" xlink:to="SRNA_FacilityLeaseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_FacilityLeaseMember_doc" xml:lang="en-US">Facility Lease [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FormerEmployeeMember" xlink:to="SRNA_FormerEmployeeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_FormerEmployeeMember_doc" xml:lang="en-US">Former Employee [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncentiveStockBonusAwardsMember" xlink:to="SRNA_IncentiveStockBonusAwardsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_IncentiveStockBonusAwardsMember_doc" xml:lang="en-US">Incentive Stock Bonus Awards [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IndependentDirectorsMember" xlink:to="SRNA_IndependentDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_IndependentDirectorsMember_doc" xml:lang="en-US">IndependentDirectors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IndependentDirectorsOneMember" xlink:to="SRNA_IndependentDirectorsOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_IndependentDirectorsOneMember_doc" xml:lang="en-US">Independent Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_LeasedEquipmentMember" xlink:to="SRNA_LeasedEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_LeasedEquipmentMember_doc" xml:lang="en-US">Cash disbursed for equipment held for lease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NonQualifiedStockOptionsMember" xlink:to="SRNA_NonQualifiedStockOptionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NonQualifiedStockOptionsMember_doc" xml:lang="en-US">Non-qualified Stock Options [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OneCustomerMember" xlink:to="SRNA_OneCustomerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_OneCustomerMember_doc" xml:lang="en-US">One Customer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PurchasesOfInventoryMember" xlink:to="SRNA_PurchasesOfInventoryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_PurchasesOfInventoryMember_doc" xml:lang="en-US">Purchases of Inventory [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_QFourTwoThousandSeventeenWarrantsMember" xlink:to="SRNA_QFourTwoThousandSeventeenWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_QFourTwoThousandSeventeenWarrantsMember_doc" xml:lang="en-US">Q4 2017 Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_QOneTwoThousandSeventeenWarrantsMember" xlink:to="SRNA_QOneTwoThousandSeventeenWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_QOneTwoThousandSeventeenWarrantsMember_doc" xml:lang="en-US">Q1 2017 Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_QTwoTwoThousandEighteenWarrantsMember" xlink:to="SRNA_QTwoTwoThousandEighteenWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_QTwoTwoThousandEighteenWarrantsMember_doc" xml:lang="en-US">Q2 2018 Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SeriesTwoConvertibleNotesMember" xlink:to="SRNA_SeriesTwoConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SeriesTwoConvertibleNotesMember_doc" xml:lang="en-US">Series 2 Convertible Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SeriesTwoWarrantsMember" xlink:to="SRNA_SeriesTwoWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SeriesTwoWarrantsMember_doc" xml:lang="en-US">Series 2 Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SupplierOneMember" xlink:to="SRNA_SupplierOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SupplierOneMember_doc" xml:lang="en-US">Supplier One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SupplierThreeMember" xlink:to="SRNA_SupplierThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SupplierThreeMember_doc" xml:lang="en-US">Supplier Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SupplierTwoMember" xlink:to="SRNA_SupplierTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SupplierTwoMember_doc" xml:lang="en-US">Supplier Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_doc" xml:lang="en-US">2017 Equity Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndSeventeenEquityPlanMember_doc" xml:lang="en-US">2017 Equity Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyOneMember" xlink:to="SRNA_TwoThousandAndTwentyOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndTwentyOneMember_doc" xml:lang="en-US">2021 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyTwoMember" xlink:to="SRNA_TwoThousandAndTwentyTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndTwentyTwoMember_doc" xml:lang="en-US">2022 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandSeventeenEquityPlanMember" xlink:to="SRNA_TwoThousandSeventeenEquityPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandSeventeenEquityPlanMember_doc" xml:lang="en-US">2017 Equity Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnvestedOptionsMember" xlink:to="SRNA_UnvestedOptionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_UnvestedOptionsMember_doc" xml:lang="en-US">Unvested Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_UnvestedRestrictedStockUnitsRSUMember" xlink:label="SRNA_UnvestedRestrictedStockUnitsRSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnvestedRestrictedStockUnitsRSUMember" xlink:to="SRNA_UnvestedRestrictedStockUnitsRSUMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_UnvestedRestrictedStockUnitsRSUMember_doc" xml:lang="en-US">Unvested Restricted Stock Units (RSUs) [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WebSiteDevelopmentCostsMember" xlink:to="SRNA_WebSiteDevelopmentCostsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WebSiteDevelopmentCostsMember_doc" xml:lang="en-US">Web Site Development Costs [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfUnitsVestedButNotSettled" xlink:to="SRNA_NumberOfUnitsVestedButNotSettled_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NumberOfUnitsVestedButNotSettled_doc" xml:lang="en-US">Number of Units, Vested but not settled .</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfUnitsVestedAndSettled" xlink:to="SRNA_NumberOfUnitsVestedAndSettled_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NumberOfUnitsVestedAndSettled_doc" xml:lang="en-US">Number of units, vested and settled.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:to="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage_doc" xml:lang="en-US">Restricted stock units shares issued interest percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoNewIndependentDirectorsMember" xlink:to="SRNA_TwoNewIndependentDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoNewIndependentDirectorsMember_doc" xml:lang="en-US">Two New Independent Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AprilOneTwentyTwentyOneMember" xlink:to="SRNA_AprilOneTwentyTwentyOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_AprilOneTwentyTwentyOneMember_doc" xml:lang="en-US">April 1, 2021 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" xlink:to="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod_doc" xml:lang="en-US">Number of shares vested and to be settled with issued shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_doc" xml:lang="en-US">Weighted average remaining contractual term, granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Weighted Average Remaining Contractual Term, Ending.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_doc" xml:lang="en-US">Number of Options, Expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_doc" xml:lang="en-US">Weighted Average Grant Date Fair Value, Expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_doc" xml:lang="en-US">Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Grant Date Fair Value, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOperatingLossExpirationTerm" xlink:to="SRNA_NetOperatingLossExpirationTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NetOperatingLossExpirationTerm_doc" xml:lang="en-US">Net operating loss expiration term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NolsUsageAgainstTaxableIncomePercentage" xlink:to="SRNA_NolsUsageAgainstTaxableIncomePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NolsUsageAgainstTaxableIncomePercentage_doc" xml:lang="en-US">NOLs usage against taxable income percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NolsCarryforwardsTerm" xlink:to="SRNA_NolsCarryforwardsTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NolsCarryforwardsTerm_doc" xml:lang="en-US">NOLs carryforwards term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsDisclosureTextBlock" xlink:to="SRNA_WarrantsDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WarrantsDisclosureTextBlock_doc" xml:lang="en-US">Warrants [Text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AgreementWithLandLordMember" xlink:to="SRNA_AgreementWithLandLordMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_AgreementWithLandLordMember_doc" xml:lang="en-US">Agreement with Landlord [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired_doc" xml:lang="en-US">Weighted average remaining contractual term, expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Weighted average life of outstanding warrants in months, ending balance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsRangeOneMember" xlink:to="SRNA_WarrantsRangeOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WarrantsRangeOneMember_doc" xml:lang="en-US">Warrants Range One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet" xlink:to="SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet_doc" xml:lang="en-US">Increase Decrease in Operating Lease Liability Net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:to="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_doc" xml:lang="en-US">Schedule of Outstanding Warrants to Purchase Common Stock Table TextBlock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" xlink:to="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember_doc" xml:lang="en-US">2019 special equity plan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightIssued" xlink:to="SRNA_ClassOfWarrantOrRightIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightIssued_doc" xml:lang="en-US">Warrants issued during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExercised" xlink:to="SRNA_ClassOfWarrantOrRightExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightExercised_doc" xml:lang="en-US">Warrants exercised during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpired" xlink:to="SRNA_ClassOfWarrantOrRightExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightExpired_doc" xml:lang="en-US">Warrants expired during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_doc" xml:lang="en-US">Weighted average exercise price of warrants issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_doc" xml:lang="en-US">Weighted average exercise price of warrants exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_doc" xml:lang="en-US">Weighted average exercise price of warrants expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_doc" xml:lang="en-US">Aggregate intrinsic value of outstanding warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_doc" xml:lang="en-US">Aggregate intrinsic value of warrants issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_doc" xml:lang="en-US">Aggregate intrinsic value of warrants exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_doc" xml:lang="en-US">Aggregate intrinsic value of warrants expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_doc" xml:lang="en-US">Weighted average life of outstanding warrants in months, beginning balance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_GainOnForgivenessOfNotePayable" xlink:to="SRNA_GainOnForgivenessOfNotePayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_GainOnForgivenessOfNotePayable_doc" xml:lang="en-US">Gain on forgiveness of note payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyIncentiveAwardsMember" xlink:to="SRNA_TwoThousandAndTwentyIncentiveAwardsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndTwentyIncentiveAwardsMember_doc" xml:lang="en-US">2020 Incentive Awards [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:to="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage_doc" xml:lang="en-US">Contract with customer liability revenue recognized percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:to="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_doc" xml:lang="en-US">Remaining performance obligations related to engineering only paid contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:to="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_doc" xml:lang="en-US">Remaining performance obligations related to partial equipment paid contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DecreaseInRevenuePercentage" xlink:to="SRNA_DecreaseInRevenuePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_DecreaseInRevenuePercentage_doc" xml:lang="en-US">Decrease in revenue percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WorkingCapitalDeficit" xlink:to="SRNA_WorkingCapitalDeficit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WorkingCapitalDeficit_doc" xml:lang="en-US">Working capital deficit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:to="SRNA_UnamortizedAmountOfTenantImprovementAllowance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_UnamortizedAmountOfTenantImprovementAllowance_doc" xml:lang="en-US">Unamortized amount of tenant improvement allowance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ThreeCustomersMember" xlink:to="SRNA_ThreeCustomersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ThreeCustomersMember_doc" xml:lang="en-US">Three Customers [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OtherRisksAndUncertaintiesPolicyTextBlock" xlink:to="SRNA_OtherRisksAndUncertaintiesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_OtherRisksAndUncertaintiesPolicyTextBlock_doc" xml:lang="en-US">Other Risks and Uncertainties [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnpaidLeaseFees" xlink:to="SRNA_UnpaidLeaseFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_UnpaidLeaseFees_doc" xml:lang="en-US">Unpaid lease fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnpaidDemoAndTestingFees" xlink:to="SRNA_UnpaidDemoAndTestingFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_UnpaidDemoAndTestingFees_doc" xml:lang="en-US">Unpaid demo and Testing Fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOfImpactOfForegoingItemCharge" xlink:to="SRNA_NetOfImpactOfForegoingItemCharge_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NetOfImpactOfForegoingItemCharge_doc" xml:lang="en-US">Net of impact of foregoing item charge.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_MrJamesRShipleyMember" xlink:to="SRNA_MrJamesRShipleyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_MrJamesRShipleyMember_doc" xml:lang="en-US">Mr. James R. Shipley [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_InvestmentBankMember" xlink:to="SRNA_InvestmentBankMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_InvestmentBankMember_doc" xml:lang="en-US">Investment Bank [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfInvestmentUnitOffered" xlink:to="SRNA_NumberOfInvestmentUnitOffered_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NumberOfInvestmentUnitOffered_doc" xml:lang="en-US">Number of investment unit offered.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OfferedInvestmentsPricePerUnit" xlink:to="SRNA_OfferedInvestmentsPricePerUnit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_OfferedInvestmentsPricePerUnit_doc" xml:lang="en-US">Offered investments, price per unit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantDescription" xlink:to="SRNA_WarrantDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WarrantDescription_doc" xml:lang="en-US">Warrant description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ProceedsFromInvestment" xlink:to="SRNA_ProceedsFromInvestment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ProceedsFromInvestment_doc" xml:lang="en-US">Proceeds from investment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ProceedsFromInvestmentPerUnit" xlink:to="SRNA_ProceedsFromInvestmentPerUnit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ProceedsFromInvestmentPerUnit_doc" xml:lang="en-US">Proceeds from investment per unit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RedeemWarrantSharesAtPrice" xlink:to="SRNA_RedeemWarrantSharesAtPrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_RedeemWarrantSharesAtPrice_doc" xml:lang="en-US">Redeem warrant shares at a price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:to="SRNA_AggregateSharesIssuedUponExecutionOfSettlement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_AggregateSharesIssuedUponExecutionOfSettlement_doc" xml:lang="en-US">Aggregate common shares issued upon execution of settlement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" xlink:to="SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock_doc" xml:lang="en-US">Number of common stock shares issued in settlement of vested restricted stock, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" xlink:to="SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus_doc" xml:lang="en-US">Number of shares issued for stock incentive bonus.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding" xlink:to="SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding_doc" xml:lang="en-US">Share based compensation arrangement stock issued and outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement_doc" xml:lang="en-US">Intrinsic value of vested and settled with issuance of share.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_StockOptionToPurchaseThresholdsPerformanceBased" xlink:to="SRNA_StockOptionToPurchaseThresholdsPerformanceBased_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_StockOptionToPurchaseThresholdsPerformanceBased_doc" xml:lang="en-US">Stock option to purchase - thresholds - performance based.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfSharesForfeitedForTerminations" xlink:to="SRNA_NumberOfSharesForfeitedForTerminations_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NumberOfSharesForfeitedForTerminations_doc" xml:lang="en-US">Number of shares forfeited for terminations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_doc" xml:lang="en-US">Number of non-vested options outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_doc" xml:lang="en-US">Weighted average grant-date fair value of non-vested options outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" xlink:to="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount_doc" xml:lang="en-US">Net operating loss carry forward expected to expire amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncomeTaxReconciliationTrueUpAdjustments" xlink:to="SRNA_IncomeTaxReconciliationTrueUpAdjustments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_IncomeTaxReconciliationTrueUpAdjustments_doc" xml:lang="en-US">Income tax reconciliation True-up adjustments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonstockSharesToBeIssued" xlink:to="SRNA_CommonstockSharesToBeIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonstockSharesToBeIssued_doc" xml:lang="en-US">Common stock shares to be issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" xlink:to="SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued_doc" xml:lang="en-US">Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares to be issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" xlink:to="SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees_doc" xml:lang="en-US">Fair value of vested incentive stock bonuses awarded to employees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" xlink:to="SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued_doc" xml:lang="en-US">Adjustments to additional paid in capital share based compensation stock options accrued and issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_doc" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_doc" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_doc" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsRangeMember" xlink:to="SRNA_WarrantsRangeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WarrantsRangeMember_doc" xml:lang="en-US">Warrants Range [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_3_lbl" xml:lang="en-US">TwoThousandAndSeventeenEquityIncentivePlanMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IndependentDirectorsMember" xlink:to="SRNA_IndependentDirectorsMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_IndependentDirectorsMember_3_lbl" xml:lang="en-US">IndependentDirectorsMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DirectorsMember" xlink:to="SRNA_DirectorsMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DirectorsMember_3_lbl" xml:lang="en-US">DirectorsMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonstockSharesToBeIssued" xlink:to="SRNA_CommonstockSharesToBeIssued_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonstockSharesToBeIssued_4_lbl" xml:lang="en-US">CommonstockSharesToBeIssued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_GainOnForgivenessOfNotePayable" xlink:to="SRNA_GainOnForgivenessOfNotePayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_GainOnForgivenessOfNotePayable_3_lbl" xml:lang="en-US">GainOnForgivenessOfNotePayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-gaap_GainLossOnDispositionOfAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets_2_lbl" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts and Notes Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expenses, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="us-gaap_IncreaseDecreaseInDeferredCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation_2_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_2_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_2_lbl" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationReserves_2_lbl" xml:lang="en-US">Inventory Valuation Reserves</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_2_lbl" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpired" xlink:to="SRNA_ClassOfWarrantOrRightExpired_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightExpired_3_lbl" xml:lang="en-US">ClassOfWarrantOrRightExpired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_4_lbl" xml:lang="en-US">ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_4_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_4_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_4_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_4_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instrument Other than Option, Nonvested, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesOther" xlink:to="us-gaap_DeferredTaxLiabilitiesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesOther_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_2_lbl" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>19
<FILENAME>srna-20201231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.6c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SRNA %2D 20201231 10K FY DFN.xfr; Date: 2021%2D03%2D23T20:34:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://surna.com/role/DocumentAndEntityInformation" xlink:href="srna-20201231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheets" xlink:href="srna-20201231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheetsParenthetical" xlink:href="srna-20201231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfOperations" xlink:href="srna-20201231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:href="srna-20201231.xsd#StatementsOfChangesInShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfCashFlows" xlink:href="srna-20201231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/DescriptionOfBusiness" xlink:href="srna-20201231.xsd#DescriptionOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GoingConcern" xlink:href="srna-20201231.xsd#GoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases" xlink:href="srna-20201231.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory" xlink:href="srna-20201231.xsd#Inventory" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment" xlink:href="srna-20201231.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssets" xlink:href="srna-20201231.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="srna-20201231.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterest" xlink:href="srna-20201231.xsd#NotePayableAndAccruedInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/RelatedPartyAgreementsAndTransactions" xlink:href="srna-20201231.xsd#RelatedPartyAgreementsAndTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingencies" xlink:href="srna-20201231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PreferredAndCommonStock" xlink:href="srna-20201231.xsd#PreferredAndCommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/OutstandingWarrants" xlink:href="srna-20201231.xsd#OutstandingWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan" xlink:href="srna-20201231.xsd#EquityIncentivePlan" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes" xlink:href="srna-20201231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEvents" xlink:href="srna-20201231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesTables" xlink:href="srna-20201231.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryTables" xlink:href="srna-20201231.xsd#InventoryTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentTables" xlink:href="srna-20201231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssetsTables" xlink:href="srna-20201231.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="srna-20201231.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/OutstandingWarrantsTables" xlink:href="srna-20201231.xsd#OutstandingWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlanTables" xlink:href="srna-20201231.xsd#EquityIncentivePlanTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesTables" xlink:href="srna-20201231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRevenueBySourceDetails" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRevenueBySourceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfShare-basedCompensationCostsDetails" xlink:href="srna-20201231.xsd#BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfShare-basedCompensationCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GoingConcernDetailsNarrative" xlink:href="srna-20201231.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesDetailsNarrative" xlink:href="srna-20201231.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases-ScheduleOfLeaseCostDetails" xlink:href="srna-20201231.xsd#Leases-ScheduleOfLeaseCostDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:href="srna-20201231.xsd#Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryDetailsNarrative" xlink:href="srna-20201231.xsd#InventoryDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory-ScheduleOfInventoryDetails" xlink:href="srna-20201231.xsd#Inventory-ScheduleOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="srna-20201231.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:href="srna-20201231.xsd#PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssetsDetailsNarrative" xlink:href="srna-20201231.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:href="srna-20201231.xsd#IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:href="srna-20201231.xsd#AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="srna-20201231.xsd#AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:href="srna-20201231.xsd#NotePayableAndAccruedInterestDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:href="srna-20201231.xsd#RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="srna-20201231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PreferredAndCommonStockDetailsNarrative" xlink:href="srna-20201231.xsd#PreferredAndCommonStockDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/OutstandingWarrantsDetailsNarrative" xlink:href="srna-20201231.xsd#OutstandingWarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/OutstandingWarrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:href="srna-20201231.xsd#OutstandingWarrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/OutstandingWarrants-ScheduleOfWarrantsOutstandingDetails" xlink:href="srna-20201231.xsd#OutstandingWarrants-ScheduleOfWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlanDetailsNarrative" xlink:href="srna-20201231.xsd#EquityIncentivePlanDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:href="srna-20201231.xsd#EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:href="srna-20201231.xsd#EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="srna-20201231.xsd#EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlans-ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:href="srna-20201231.xsd#EquityIncentivePlans-ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:href="srna-20201231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes-ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:href="srna-20201231.xsd#IncomeTaxes-ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails" xlink:href="srna-20201231.xsd#IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:href="srna-20201231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredCompensationLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Shareholders&apos; Deficit">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CommonstockSharesToBeIssued" xlink:label="loc_SRNACommonstockSharesToBeIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonstockSharesToBeIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" xlink:label="loc_SRNACommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees" xlink:label="loc_SRNAFairValueOfVestedIncentiveStockBonusesAwardedToEmployees" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAFairValueOfVestedIncentiveStockBonusesAwardedToEmployees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" xlink:label="loc_SRNAAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CommonstockSharesToBeIssued" xlink:label="loc_SRNACommonstockSharesToBeIssued_2" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonstockSharesToBeIssued_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_GainOnForgivenessOfNotePayable" xlink:label="loc_SRNAGainOnForgivenessOfNotePayable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_SRNAGainOnForgivenessOfNotePayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsAndNotesReceivable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsAndNotesReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet" xlink:label="loc_SRNAIncreaseDecreaseOperatingLeaseLiabilityNet" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_SRNAIncreaseDecreaseOperatingLeaseLiabilityNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredCompensation" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/DescriptionOfBusiness" xlink:title="00000007 - Disclosure - Description of Business">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/GoingConcern" xlink:title="00000009 - Disclosure - Going Concern">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Leases" xlink:title="00000010 - Disclosure - Leases">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory" xlink:title="00000011 - Disclosure - Inventory">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment" xlink:title="00000012 - Disclosure - Property and Equipment">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssets" xlink:title="00000013 - Disclosure - Intangible Assets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000014 - Disclosure - Accounts Payable and Accrued Liabilities">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterest" xlink:title="00000015 - Disclosure - Note Payable and Accrued Interest">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/RelatedPartyAgreementsAndTransactions" xlink:title="00000016 - Disclosure - Related Party Agreements and Transactions">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PreferredAndCommonStock" xlink:title="00000018 - Disclosure - Preferred and Common Stock">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/OutstandingWarrants" xlink:title="00000019 - Disclosure - Outstanding Warrants">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WarrantsDisclosureTextBlock" xlink:label="loc_SRNAWarrantsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAWarrantsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan" xlink:title="00000020 - Disclosure - Equity Incentive Plan">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes" xlink:title="00000021 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEvents" xlink:title="00000022 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000023 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:label="loc_us-gaapReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaapDerivativesPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyPolicy" xlink:label="loc_us-gaapStandardProductWarrantyPolicy" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStandardProductWarrantyPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="loc_us-gaapCostOfSalesPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCostOfSalesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_OtherRisksAndUncertaintiesPolicyTextBlock" xlink:label="loc_SRNAOtherRisksAndUncertaintiesPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SRNAOtherRisksAndUncertaintiesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables" xlink:title="00000024 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesTables" xlink:title="00000025 - Disclosure - Leases (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryTables" xlink:title="00000026 - Disclosure - Inventory (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentTables" xlink:title="00000027 - Disclosure - Property and Equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssetsTables" xlink:title="00000028 - Disclosure - Intangible Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000029 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/OutstandingWarrantsTables" xlink:title="00000030 - Disclosure - Outstanding Warrants (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:label="loc_SRNAScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlanTables" xlink:title="00000031 - Disclosure - Equity Incentive Plan (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:label="loc_us-gaapShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesTables" xlink:title="00000032 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000033 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:label="loc_us-gaapChangeInAccountingEstimateByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapChangeInAccountingEstimateByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:label="loc_us-gaapChangeInAccountingEstimateTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapChangeInAccountingEstimateByTypeAxis" xlink:to="loc_us-gaapChangeInAccountingEstimateTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationAndObsolescenceMember" xlink:label="loc_us-gaapInventoryValuationAndObsolescenceMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapChangeInAccountingEstimateTypeDomain" xlink:to="loc_us-gaapInventoryValuationAndObsolescenceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerContractsMember" xlink:label="loc_us-gaapCustomerContractsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerContractsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardDateAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="loc_SRNATwoThousandAndTwentyTwoMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaapBalanceSheetLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBalanceSheetLocationAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaapBalanceSheetLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationAxis" xlink:to="loc_us-gaapBalanceSheetLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBalanceSheetLocationDomain" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplierConcentrationRiskMember" xlink:label="loc_us-gaapSupplierConcentrationRiskMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapSupplierConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_PurchasesOfInventoryMember" xlink:label="loc_SRNAPurchasesOfInventoryMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_SRNAPurchasesOfInventoryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CustomerOneMember" xlink:label="loc_SRNACustomerOneMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CustomerTwoMember" xlink:label="loc_SRNACustomerTwoMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CustomerThreeMember" xlink:label="loc_SRNACustomerThreeMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_OneCustomerMember" xlink:label="loc_SRNAOneCustomerMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNAOneCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SupplierOneMember" xlink:label="loc_SRNASupplierOneMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNASupplierOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SupplierTwoMember" xlink:label="loc_SRNASupplierTwoMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNASupplierTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SupplierThreeMember" xlink:label="loc_SRNASupplierThreeMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNASupplierThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="90" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndTwentyIncentiveAwardsMember" xlink:label="loc_SRNATwoThousandAndTwentyIncentiveAwardsMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndTwentyIncentiveAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryAdjustments" xlink:label="loc_us-gaapInventoryAdjustments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInventoryAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:label="loc_SRNAContractWithCustomerLiabilityRevenueRecognizedPercentage" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAContractWithCustomerLiabilityRevenueRecognizedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationPercentage" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyDescription" xlink:label="loc_us-gaapStandardProductWarrantyDescription" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStandardProductWarrantyDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual" xlink:label="loc_us-gaapProductWarrantyAccrual" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProductWarrantyAccrual" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRevenueBySourceDetails" xlink:title="00000034 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Revenue by Source (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapDisaggregationOfRevenueLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EngineeringAndOtherServicesMember" xlink:label="loc_SRNAEngineeringAndOtherServicesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SRNAEngineeringAndOtherServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapShippingAndHandlingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:title="00000035 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="loc_us-gaapAwardDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndTwentyOneMember" xlink:label="loc_SRNATwoThousandAndTwentyOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="loc_SRNATwoThousandAndTwentyTwoMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfShare-basedCompensationCostsDetails" xlink:title="00000036 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Share-based Compensation Costs (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingMember" xlink:label="loc_us-gaapAdvertisingMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapAdvertisingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/GoingConcernDetailsNarrative" xlink:title="00000037 - Disclosure - Going Concern (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_DecreaseInRevenuePercentage" xlink:label="loc_SRNADecreaseInRevenuePercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_SRNADecreaseInRevenuePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WorkingCapitalDeficit" xlink:label="loc_SRNAWorkingCapitalDeficit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_SRNAWorkingCapitalDeficit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesDetailsNarrative" xlink:title="00000038 - Disclosure - Leases (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaapLesseeLeaseDescriptionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeLeaseDescriptionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaapLesseeLeaseDescriptionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionTable" xlink:to="loc_us-gaapLesseeLeaseDescriptionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_FacilityLeaseMember" xlink:label="loc_SRNAFacilityLeaseMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAFacilityLeaseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_AgreementWithLandLordMember" xlink:label="loc_SRNAAgreementWithLandLordMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAAgreementWithLandLordMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaapAccountingStandardsUpdate201602Member" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_us-gaapAccountingStandardsUpdate201602Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapAreaOfLand" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapPaymentsForRent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="loc_us-gaapLesseeOperatingLeaseDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForDeposits" xlink:label="loc_us-gaapPaymentsForDeposits" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapPaymentsForDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaapLesseeOperatingLeaseRenewalTerm" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseRenewalTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="loc_us-gaapDeferredRentCreditCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapDeferredRentCreditCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TenantImprovements" xlink:label="loc_us-gaapTenantImprovements" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapTenantImprovements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:label="loc_SRNAUnamortizedAmountOfTenantImprovementAllowance" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_SRNAUnamortizedAmountOfTenantImprovementAllowance" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Leases-ScheduleOfLeaseCostDetails" xlink:title="00000039 - Disclosure - Leases - Schedule of Lease Cost (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:title="00000040 - Disclosure - Leases - Schedule of Future Annual Minimum Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryDetailsNarrative" xlink:title="00000041 - Disclosure - Inventory (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:label="loc_us-gaapCostOfGoodsAndServicesSoldOverhead" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSoldOverhead" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory-ScheduleOfInventoryDetails" xlink:title="00000042 - Disclosure - Inventory - Schedule of Inventory (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000043 - Disclosure - Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CoFoundersMember" xlink:label="loc_SRNACoFoundersMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNACoFoundersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000044 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000045 - Disclosure - Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WebSiteDevelopmentCostsMember" xlink:label="loc_SRNAWebSiteDevelopmentCostsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_SRNAWebSiteDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:title="00000046 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PatentsMember" xlink:label="loc_us-gaapPatentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapPatentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WebSiteDevelopmentCostsMember" xlink:label="loc_SRNAWebSiteDevelopmentCostsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_SRNAWebSiteDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:title="00000047 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ThreeCustomersMember" xlink:label="loc_SRNAThreeCustomersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_SRNAThreeCustomersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyDescription" xlink:label="loc_us-gaapStandardProductWarrantyDescription" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStandardProductWarrantyDescription" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000048 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_us-gaapAccruedSalesCommissionCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalesCommissionCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:title="00000049 - Disclosure - Note Payable and Accrued Interest (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoanRestructuringModificationAxis" xlink:label="loc_us-gaapLoanRestructuringModificationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLoanRestructuringModificationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoanRestructuringModificationDomain" xlink:label="loc_us-gaapLoanRestructuringModificationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLoanRestructuringModificationAxis" xlink:to="loc_us-gaapLoanRestructuringModificationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtendedMaturityMember" xlink:label="loc_us-gaapExtendedMaturityMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLoanRestructuringModificationDomain" xlink:to="loc_us-gaapExtendedMaturityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative" xlink:title="00000050 - Disclosure - Related Party Agreements and Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_CoFoundersMember" xlink:label="loc_SRNACoFoundersMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNACoFoundersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_MrJamesRShipleyMember" xlink:label="loc_SRNAMrJamesRShipleyMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAMrJamesRShipleyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EquipmentDemonstrationAndProductTestingAgreementMember" xlink:label="loc_SRNAEquipmentDemonstrationAndProductTestingAgreementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAEquipmentDemonstrationAndProductTestingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmploymentAgreementMember" xlink:label="loc_SRNAEmploymentAgreementMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAEmploymentAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ConsultingAgreementMember" xlink:label="loc_SRNAConsultingAgreementMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAConsultingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="loc_us-gaapFairValueByAssetClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFairValueByAssetClassAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueByAssetClassAxis" xlink:to="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="loc_us-gaapAccountsPayableMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="loc_us-gaapAccountsPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_LeasedEquipmentMember" xlink:label="loc_SRNALeasedEquipmentMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_SRNALeasedEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardDateAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_AprilThirtyTwoThousandAndTwentyMember" xlink:label="loc_SRNAAprilThirtyTwoThousandAndTwentyMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNAAprilThirtyTwoThousandAndTwentyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="loc_us-gaapOperatingLeaseExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_UnpaidLeaseFees" xlink:label="loc_SRNAUnpaidLeaseFees" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAUnpaidLeaseFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_UnpaidDemoAndTestingFees" xlink:label="loc_SRNAUnpaidDemoAndTestingFees" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAUnpaidDemoAndTestingFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NetOfImpactOfForegoingItemCharge" xlink:label="loc_SRNANetOfImpactOfForegoingItemCharge" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNANetOfImpactOfForegoingItemCharge" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalariesWagesAndOfficersCompensation" xlink:label="loc_us-gaapSalariesWagesAndOfficersCompensation" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSalariesWagesAndOfficersCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" xlink:label="loc_SRNAShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000051 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_FormerEmployeeMember" xlink:label="loc_SRNAFormerEmployeeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAFormerEmployeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NumberOfUnitsVestedButNotSettled" xlink:label="loc_SRNANumberOfUnitsVestedButNotSettled" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNANumberOfUnitsVestedButNotSettled" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NumberOfUnitsVestedAndSettled" xlink:label="loc_SRNANumberOfUnitsVestedAndSettled" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNANumberOfUnitsVestedAndSettled" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue" xlink:label="loc_us-gaapLossContingencyDamagesAwardedValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLossContingencyDamagesAwardedValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:label="loc_SRNARestrictedStockUnitsSharesIssuedInterestPercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNARestrictedStockUnitsSharesIssuedInterestPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="loc_us-gaapLossContingencyDamagesPaidValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLossContingencyDamagesPaidValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PreferredAndCommonStockDetailsNarrative" xlink:title="00000052 - Disclosure - Preferred and Common Stock (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeeMember" xlink:label="loc_SRNAEmployeeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IndependentDirectorsMember" xlink:label="loc_SRNAIndependentDirectorsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAIndependentDirectorsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IndependentDirectorsOneMember" xlink:label="loc_SRNAIndependentDirectorsOneMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAIndependentDirectorsOneMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="loc_us-gaapSeriesAPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesAPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" xlink:label="loc_SRNAStockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAStockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" xlink:label="loc_SRNAStockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAStockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NumberOfUnitsVestedAndSettled" xlink:label="loc_SRNANumberOfUnitsVestedAndSettled" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNANumberOfUnitsVestedAndSettled" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/OutstandingWarrantsDetailsNarrative" xlink:title="00000053 - Disclosure - Outstanding Warrants (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SeriesTwoWarrantsMember" xlink:label="loc_SRNASeriesTwoWarrantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNASeriesTwoWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_QOneTwoThousandSeventeenWarrantsMember" xlink:label="loc_SRNAQOneTwoThousandSeventeenWarrantsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNAQOneTwoThousandSeventeenWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_QFourTwoThousandSeventeenWarrantsMember" xlink:label="loc_SRNAQFourTwoThousandSeventeenWarrantsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNAQFourTwoThousandSeventeenWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_QTwoTwoThousandEighteenWarrantsMember" xlink:label="loc_SRNAQTwoTwoThousandEighteenWarrantsMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNAQTwoTwoThousandEighteenWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SeriesTwoConvertibleNotesMember" xlink:label="loc_SRNASeriesTwoConvertibleNotesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_SRNASeriesTwoConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_InvestmentBankMember" xlink:label="loc_SRNAInvestmentBankMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SRNAInvestmentBankMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NumberOfInvestmentUnitOffered" xlink:label="loc_SRNANumberOfInvestmentUnitOffered" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNANumberOfInvestmentUnitOffered" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_OfferedInvestmentsPricePerUnit" xlink:label="loc_SRNAOfferedInvestmentsPricePerUnit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAOfferedInvestmentsPricePerUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WarrantDescription" xlink:label="loc_SRNAWarrantDescription" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAWarrantDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ProceedsFromInvestment" xlink:label="loc_SRNAProceedsFromInvestment" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAProceedsFromInvestment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ProceedsFromInvestmentPerUnit" xlink:label="loc_SRNAProceedsFromInvestmentPerUnit" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAProceedsFromInvestmentPerUnit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockDescription" xlink:label="loc_us-gaapConversionOfStockDescription" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:label="loc_us-gaapDebtInstrumentConvertibleThresholdConsecutiveTradingDays1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_RedeemWarrantSharesAtPrice" xlink:label="loc_SRNARedeemWarrantSharesAtPrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNARedeemWarrantSharesAtPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/OutstandingWarrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:title="00000054 - Disclosure - Outstanding Warrants - Schedule of Outstanding Warrants to Purchase Common Stock (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightIssued" xlink:label="loc_SRNAClassOfWarrantOrRightIssued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightExercised" xlink:label="loc_SRNAClassOfWarrantOrRightExercised" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightExpired" xlink:label="loc_SRNAClassOfWarrantOrRightExpired" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightExpired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:label="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:label="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceExercised" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:label="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceExpired" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightIssuedAggregateIntrinsicValue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightExercisedAggregateIntrinsicValue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightExpiredAggregateIntrinsicValue" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_2" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/OutstandingWarrants-ScheduleOfWarrantsOutstandingDetails" xlink:title="00000055 - Disclosure - Outstanding Warrants - Schedule of Warrants Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WarrantsRangeMember" xlink:label="loc_SRNAWarrantsRangeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_SRNAWarrantsRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_WarrantsRangeOneMember" xlink:label="loc_SRNAWarrantsRangeOneMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_SRNAWarrantsRangeOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlanDetailsNarrative" xlink:title="00000056 - Disclosure - Equity Incentive Plan (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityIncentivePlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityIncentivePlanMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" xlink:label="loc_SRNATwoThousandAndNineteenSpecialEquityPlanMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndNineteenSpecialEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IndependentDirectorsMember" xlink:label="loc_SRNAIndependentDirectorsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAIndependentDirectorsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IndependentDirectorsOneMember" xlink:label="loc_SRNAIndependentDirectorsOneMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAIndependentDirectorsOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoNewIndependentDirectorsMember" xlink:label="loc_SRNATwoNewIndependentDirectorsMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNATwoNewIndependentDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="loc_SRNAEmployeesDirectorsandConsultantsMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesDirectorsandConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesMember" xlink:label="loc_SRNAEmployeesMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_UnvestedOptionsMember" xlink:label="loc_SRNAUnvestedOptionsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNAUnvestedOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IncentiveStockBonusAwardsMember" xlink:label="loc_SRNAIncentiveStockBonusAwardsMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNAIncentiveStockBonusAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardDateAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_AprilOneTwentyTwentyOneMember" xlink:label="loc_SRNAAprilOneTwentyTwentyOneMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNAAprilOneTwentyTwentyOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_StockOptionToPurchaseThresholdsPerformanceBased" xlink:label="loc_SRNAStockOptionToPurchaseThresholdsPerformanceBased" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAStockOptionToPurchaseThresholdsPerformanceBased" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NumberOfSharesForfeitedForTerminations" xlink:label="loc_SRNANumberOfSharesForfeitedForTerminations" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNANumberOfSharesForfeitedForTerminations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding" xlink:label="loc_SRNAShareBasedCompensationArrangementStockIssuedAndOutstanding" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNAShareBasedCompensationArrangementStockIssuedAndOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationForfeited" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensationForfeited" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:title="00000057 - Disclosure - Equity Incentive Plan - Schedule of Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:title="00000058 - Disclosure - Equity Incentive Plan - Summary of Non-vested Non-qualified Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_2" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:title="00000059 - Disclosure - Equity Incentive Plan - Schedule of Restricted Stock Units Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="loc_SRNAEmployeesDirectorsandConsultantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesDirectorsandConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlans-ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails" xlink:title="00000060 - Disclosure - Equity Incentive Plans - Schedule of Incentive Bonus Awards Granted to Employees (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IncentiveStockBonusAwardsMember" xlink:label="loc_SRNAIncentiveStockBonusAwardsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNAIncentiveStockBonusAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_EmployeesMember" xlink:label="loc_SRNAEmployeesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000061 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" xlink:label="loc_SRNANetOperatingLossCarryForwardExpectedToExpireAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNANetOperatingLossCarryForwardExpectedToExpireAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NetOperatingLossExpirationTerm" xlink:label="loc_SRNANetOperatingLossExpirationTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNANetOperatingLossExpirationTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NolsUsageAgainstTaxableIncomePercentage" xlink:label="loc_SRNANolsUsageAgainstTaxableIncomePercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNANolsUsageAgainstTaxableIncomePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_NolsCarryforwardsTerm" xlink:label="loc_SRNANolsCarryforwardsTerm" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNANolsCarryforwardsTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes-ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails" xlink:title="00000062 - Disclosure - Income Taxes - Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_IncomeTaxReconciliationTrueUpAdjustments" xlink:label="loc_SRNAIncomeTaxReconciliationTrueUpAdjustments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNAIncomeTaxReconciliationTrueUpAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000063 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaapDeferredTaxLiabilitiesOther" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilitiesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000064 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_ConsultingAgreementMember" xlink:label="loc_SRNAConsultingAgreementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAConsultingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_MrJamesRShipleyMember" xlink:label="loc_SRNAMrJamesRShipleyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAMrJamesRShipleyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredCompensationLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="loc_us-gaapLossContingencyDamagesPaidValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLossContingencyDamagesPaidValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20201231.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224162097304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 23, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Surna Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001482541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,090,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236,526,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224161839944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,284,881<span></span>
</td>
<td class="nump">$ 922,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable (net of allowance for doubtful accounts of $165,098 and $151,673, respectively)</a></td>
<td class="nump">33,480<span></span>
</td>
<td class="nump">138,357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">327,109<span></span>
</td>
<td class="nump">1,231,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">1,037,823<span></span>
</td>
<td class="nump">269,491<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">3,683,293<span></span>
</td>
<td class="nump">2,561,268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Noncurrent Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">147,732<span></span>
</td>
<td class="nump">257,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">631,064<span></span>
</td>
<td class="nump">631,064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">7,227<span></span>
</td>
<td class="nump">11,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">51,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">343,950<span></span>
</td>
<td class="nump">534,133<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total Noncurrent Assets</a></td>
<td class="nump">1,129,973<span></span>
</td>
<td class="nump">1,486,050<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">4,813,266<span></span>
</td>
<td class="nump">4,047,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,784,961<span></span>
</td>
<td class="nump">1,832,959<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">3,724,189<span></span>
</td>
<td class="nump">1,444,472<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrent', window );">Accrued equity compensation</a></td>
<td class="nump">128,434<span></span>
</td>
<td class="nump">503,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">266,105<span></span>
</td>
<td class="nump">217,843<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">5,903,689<span></span>
</td>
<td class="nump">3,998,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>NONCURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">74,156<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, net of current portion</a></td>
<td class="nump">169,119<span></span>
</td>
<td class="nump">404,209<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Noncurrent Liabilities</a></td>
<td class="nump">243,275<span></span>
</td>
<td class="nump">404,209<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">6,146,964<span></span>
</td>
<td class="nump">4,402,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 11)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS' DEFICIT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.00001 par value; 150,000,000 shares authorized; 42,030,331 shares issued and outstanding</a></td>
<td class="nump">420<span></span>
</td>
<td class="nump">420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.00001 par value; 350,000,000 shares authorized; 236,526,638 and 228,216,638 shares issued and outstanding, respectively</a></td>
<td class="nump">2,366<span></span>
</td>
<td class="nump">2,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="nump">26,107,159<span></span>
</td>
<td class="nump">25,326,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(27,443,643)<span></span>
</td>
<td class="num">(25,684,927)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders' Deficit</a></td>
<td class="num">(1,333,698)<span></span>
</td>
<td class="num">(355,631)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT</a></td>
<td class="nump">$ 4,813,266<span></span>
</td>
<td class="nump">$ 4,047,318<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19512-108361<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6409875&amp;loc=d3e20028-108363<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224162984280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts, net</a></td>
<td class="nump">$ 165,098<span></span>
</td>
<td class="nump">$ 151,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">350,000,000<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">236,526,638<span></span>
</td>
<td class="nump">228,216,638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">236,526,638<span></span>
</td>
<td class="nump">228,216,638<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224163161352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 8,514,272<span></span>
</td>
<td class="nump">$ 15,224,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">6,961,305<span></span>
</td>
<td class="nump">10,675,601<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,552,967<span></span>
</td>
<td class="nump">4,548,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Advertising and marketing expenses</a></td>
<td class="nump">430,012<span></span>
</td>
<td class="nump">675,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Product development costs</a></td>
<td class="nump">390,229<span></span>
</td>
<td class="nump">521,044<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">3,095,350<span></span>
</td>
<td class="nump">4,662,695<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">3,915,591<span></span>
</td>
<td class="nump">5,859,442<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(2,362,624)<span></span>
</td>
<td class="num">(1,310,589)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">621,340<span></span>
</td>
<td class="num">(27,977)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(17,432)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="nump">603,908<span></span>
</td>
<td class="num">(27,977)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before provision for income taxes</a></td>
<td class="num">(1,758,716)<span></span>
</td>
<td class="num">(1,338,566)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,758,716)<span></span>
</td>
<td class="num">$ (1,338,566)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Loss per common share - basic and dilutive</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of common shares outstanding, basic and dilutive</a></td>
<td class="nump">236,168,059<span></span>
</td>
<td class="nump">227,662,184<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224162776504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Shareholders' Deficit - USD ($)<br></strong></div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid in Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="nump">$ 24,538,027<span></span>
</td>
<td class="num">$ (24,346,361)<span></span>
</td>
<td class="nump">$ 194,336<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonstockSharesToBeIssued', window );">Balance, shares to be issued at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2018</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">224,989,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued', window );">Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares to be issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">560,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,240,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Common shares issued as compensation for services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">74,990<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common shares issued as compensation for services, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">986,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Fair value of vested restricted stock units awarded to employees</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">278,906<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">278,906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Fair value of vested stock options granted to employees, directors and consultants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">390,484<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">390,484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees', window );">Fair value of vested incentive stock bonuses awarded to employees</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">44,209<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">44,209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,338,566)<span></span>
</td>
<td class="num">(1,338,566)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">2,283<span></span>
</td>
<td class="nump">25,326,593<span></span>
</td>
<td class="num">(25,684,927)<span></span>
</td>
<td class="num">(355,631)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonstockSharesToBeIssued', window );">Balance, shares to be issued at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,560,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2019</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">228,216,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Fair value of vested restricted stock units awarded to employees</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,163<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Fair value of vested stock options granted to employees, directors and consultants</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">252,020<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">252,020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued', window );">Fair value of vested stock options accrued in 2019 and issued to employees and directors in 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">503,466<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">503,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses', window );">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="num">(83)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued', window );">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,560,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares', window );">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,310,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,758,716)<span></span>
</td>
<td class="num">(1,758,716)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">2,366<span></span>
</td>
<td class="nump">$ 26,107,159<span></span>
</td>
<td class="num">$ (27,443,643)<span></span>
</td>
<td class="num">$ (1,333,698)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonstockSharesToBeIssued', window );">Balance, shares to be issued at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">236,526,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital share based compensation stock options accrued and issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsAccruedAndIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued on settlement of restricted stock units and award of stock bonuses, vested restricted stock units canceled, shares to be issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesVestedRestrictedStockUnitsCanceledSharesToBeIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonstockSharesToBeIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock shares to be issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonstockSharesToBeIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of vested incentive stock bonuses awarded to employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_FairValueOfVestedIncentiveStockBonusesAwardedToEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224163216680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows From Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,758,716)<span></span>
</td>
<td class="num">$ (1,338,566)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and intangible asset amortization expense</a></td>
<td class="nump">120,103<span></span>
</td>
<td class="nump">161,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_GainOnForgivenessOfNotePayable', window );">Gain on forgiveness of note payable</a></td>
<td class="num">(557,203)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">277,183<span></span>
</td>
<td class="nump">788,599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">13,425<span></span>
</td>
<td class="nump">32,651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Provision for excess and obsolete inventory</a></td>
<td class="nump">21,669<span></span>
</td>
<td class="num">(223,971)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on disposal of assets</a></td>
<td class="nump">4,124<span></span>
</td>
<td class="nump">115,359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of ROU Asset</a></td>
<td class="nump">190,183<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable', window );">Accounts receivable</a></td>
<td class="nump">91,452<span></span>
</td>
<td class="nump">39,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">882,466<span></span>
</td>
<td class="num">(71,386)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses and other</a></td>
<td class="num">(768,333)<span></span>
</td>
<td class="num">(141,143)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">26,157<span></span>
</td>
<td class="nump">23,830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">2,279,717<span></span>
</td>
<td class="nump">802,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Accrued interest</a></td>
<td class="nump">3,203<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet', window );">Operating lease liability, net</a></td>
<td class="num">(135,828)<span></span>
</td>
<td class="num">(20,039)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCompensation', window );">Accrued equity compensation</a></td>
<td class="nump">128,434<span></span>
</td>
<td class="nump">503,466<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">818,036<span></span>
</td>
<td class="nump">671,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(9,332)<span></span>
</td>
<td class="num">(3,043)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(9,332)<span></span>
</td>
<td class="num">(3,043)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance of note payable</a></td>
<td class="nump">554,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">554,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash</a></td>
<td class="nump">1,362,704<span></span>
</td>
<td class="nump">668,790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, beginning of period</a></td>
<td class="nump">922,177<span></span>
</td>
<td class="nump">253,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, end of period</a></td>
<td class="nump">2,284,881<span></span>
</td>
<td class="nump">922,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_GainOnForgivenessOfNotePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain on forgiveness of note payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_GainOnForgivenessOfNotePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease in Operating Lease Liability Net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_IncreaseDecreaseOperatingLeaseLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of the sum of amounts due within one year (or one business cycle) from customers for the credit sale of goods and services; and from note holders for outstanding loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInterestPayableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInterestPayableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224269967096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of Business</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 1 &#8211; Description of Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Surna Inc. (the &#8220;Company&#8221;)
was incorporated in Nevada on October 15, 2009. We design, engineer and sell environmental control and other technologies for the
Controlled Environment Agriculture (CEA) industry. The CEA industry is one of the fastest-growing sectors of the United States&#8217;
economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage),
ethnic vegetables and small fruits (such as strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes and
cannabis and hemp, some producers grow crops indoors in response to market dynamics or as part of their preferred farming practice.
In service of the CEA industry, our principal technologies include: (i) liquid-based process cooling systems and other climate
control systems, (ii) air handling equipment and systems, (iii) a full-service engineering package for designing and engineering
commercial scale thermodynamic systems specific to cultivation facilities, and (iv) automation and control devices, systems and
technologies used for environmental, lighting and climate control. Our customers include commercial, state- and provincial-regulated
CEA growers in the U.S. and Canada as well as other international locations. Customers are those growers building new facilities
and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our
products, services and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet.
Headquartered in Boulder, Colorado, we leverage our experience in this space to bring value-added climate control solutions to
our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving
state and local codes, permitting and regulatory requirements. Although our customers do, we neither produce nor sell cannabis
or its related products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Impact of the COVID-19
Pandemic on Our Business</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The
impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of
our markets and disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project
implementation, operating margins, and working capital. As of the date of this filing, uncertainty continues to exist concerning
the magnitude and duration of the economic impact of the COVID-19 pandemic.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In response to the COVID-19
pandemic and its changing conditions the Company reduced its operational expenses to conserve its cash resources. Many expenses,
including travel, marketing, headcount, work hours, and compensation were reduced, deferred, or eliminated while still allowing
us to meet our customer obligations and develop new business. As the fiscal year progressed and our sales rebounded, and we were
able to obtain additional funds through a forgivable bank loan, we restored our workforce and compensation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Due
to the speed with which the COVID-19 pandemic developed and the resulting uncertainties, including the depth and duration of the
disruptions to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition,
cannot be predicted. We expect that the economic disruptions will continue to have an effect on our business over the longer term.
Despite this uncertainty, we continue to monitor costs and continue to take actions to reduce costs so as to mitigate the impact
of the COVID-19 pandemic to the best of our ability, although they may not be sufficient in the long-run for us to avoid reduced
sales, increased losses and reduced operating cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Refer
to <i>Risk Factors</i>, included in Part I, Item 1A of this Annual Report on Form 10-K above, for further discussion of the possible
impact of the COVID-19 pandemic on our business.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224251683144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation; Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Basis of Presentation; Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 2 &#8211; Basis of Presentation; Summary
of Significant Accounting Policies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Financial Statement
Presentation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The preparation of the
consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;)
requires management to make estimates and assumptions that affect reported amounts and related disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As further discussed in
<i>Note 3 Going Concern</i> below, the accompanying consolidated financial statements have been prepared on a going-concern basis,
which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company
has not generated sufficient revenue and has historically funded its operations through the sale of common stock, the issuance
of debt and the receipt of advance payments from customers. The Company is subject to risks, expenses and uncertainties similar
to those encountered by similarly situated companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Principles of Consolidation
</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro Innovations, LLC (&#8220;Hydro&#8221;).
Intercompany transactions, profit, and balances are eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Use of Estimates</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Management makes estimates
and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities
at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period.
The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities
that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation
of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected
revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets as it applies
to impairment analysis, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals,
inventory allowances, and legal contingencies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Cash and Cash Equivalents</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">All highly liquid investments
with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may,
from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has not experienced
any losses to date on depository accounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Accounts Receivable
and Allowance for Doubtful Accounts</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Accounts receivables
are recorded at the invoiced amount or based on revenue earned for items not yet invoiced, and generally do not bear
interest. An allowance for doubtful accounts is established, as necessary, based on past experience and other factors, which,
in management&#8217;s judgment, deserve current recognition in estimating bad debts. Based on the Company&#8217;s review, it
establishes or adjusts the allowance for specific customers and the accounts receivable portfolio as a whole. As of December
31, 2020, and December 31, 2019, the allowance for doubtful accounts was $165,098 and $151,673, respectively. If the
financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments,
additional allowances may be required.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Inventory</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Inventory is stated
at the lower of cost or net realizable value. The inventory is valued based on a first-in, first-out (&#8220;FIFO&#8221;)
basis. Lower of cost or net realizable value is evaluated by considering obsolescence, excessive levels of inventory,
deterioration and other factors. Adjustments to reduce the cost of inventory to its net realizable value, if required, are
made for estimated excess, obsolescence or impaired inventory. Excess and obsolete inventory is charged to cost of revenue
and a new lower-cost basis for that inventory is established and subsequent changes in facts and circumstances do not result
in the restoration or increase in that newly established cost basis. As of December 31, 2020, and December 31, 2019, the
allowance for excess and obsolete inventory was $93,045 and $71,376, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Property and Equipment</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Property and equipment
are stated at cost. For financial statement purposes, property and equipment are recorded at cost and depreciated using the straight-line
method over their estimated useful lives, which is generally five years. Leasehold improvements are amortized on a straight-line
basis over the lesser of their useful lives or the life of the lease. Upon sale or retirement of assets, the cost and related accumulated
depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operations. Maintenance
and repairs are charged to operations as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Long-lived Assets</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Long-lived tangible assets,
including property and equipment, are reviewed for impairment whenever events or changes in business circumstances indicate the
carrying value of the assets may not be recoverable. When such an event occurs, management determines whether there has been impairment
by comparing the anticipated undiscounted future net cash flows to the related asset&#8217;s carrying value. If an asset is considered
impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value,
depending on the nature of the asset. The Company has not identified any indicators of impairment during the years ended December
31, 2020 and 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;<b>&#160;</b></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Goodwill and Intangible
Assets</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company recorded goodwill
in connection with its acquisition of Hydro in July 2014. Goodwill is reviewed for impairment annually on December 31<sup>st</sup>
or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less
than its carrying value. The Company performs a quantitative impairment test annually during the fourth quarter by comparing the
fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds
its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the
carrying amount exceeds the reporting unit&#8217;s fair value. The Company determined that it has one reporting unit. The Company
completed this assessment as of December 31, 2020 and concluded that no impairment existed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Separable identifiable
intangibles consist of intellectual property such as patents and trademarks, and capitalized website costs. Except for trademarks,
which are not amortized, the Company&#8217;s separable identifiable intangible assets are subject to amortization on a straight-line
basis over their estimated useful lives. Trademarks are tested annually for impairment. Separable identifiable intangibles are
also subject to evaluation for potential impairment if events or circumstances indicate the carrying value may not be recoverable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Fair Value Measurement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company records its
financial assets and liabilities at fair value. The accounting standard for fair value provides a framework for measuring fair
value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined
as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction
between market participants at the reporting date. The accounting standard establishes a three-tier hierarchy, which prioritizes
the inputs used in the valuation methodologies in measuring fair value:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Level 1 - inputs are quoted
prices (unadjusted) in active markets for identical assets or liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 2 - inputs are quoted prices
for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly
or indirectly through market corroboration, for substantially the full term of the financial instrument.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 3 - inputs are unobservable
inputs based on the Company&#8217;s assumptions used to measure assets and liabilities at fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A financial asset or liability&#8217;s
classification within the hierarchy is determined based on the lowest level of input that is significant to the fair value measurement.
The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires
management to make judgments and consider factors specific to the asset or liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Due to their short-term
nature, the carrying values of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses, approximate
fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Derivative Financial
Instruments</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company evaluates
its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is
initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in
the statements of operations. For stock-based derivative financial instruments, the Company uses the Black-Scholes Option
Pricing Model (the &#8220;Black-Scholes Model&#8221;) to value the derivative instruments. The classification of derivative
instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of
each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based
on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance
sheet date. As of December 31, 2020, and December 31, 2019, there were no derivative financial instruments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Revenue Recognition</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On January 1, 2018, the
Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 (Topic 606), <i>Revenue from Contracts with Customers</i>
and all the related amendments (&#8220;ASC 606&#8221; or the &#8220;revenue standard&#8221;) to all contracts and elected the modified
retrospective method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets
forth the Company&#8217;s revenue by source:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Years Ended December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="white-space: nowrap; width: 68%"><font style="font-size: 10pt">Equipment and systems sales</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">7,730,371</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">13,692,863</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap"><font style="font-size: 10pt">Engineering and other services</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">568,131</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,239,130</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Shipping and handling</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,770</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">292,461</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total revenue</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,514,272</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">15,224,454</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><u>Revenue Recognition
Accounting Policy Summary</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company accounts for
revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer
to transfer a distinct good or service to the customer. Most of the Company&#8217;s contracts contain multiple performance obligations
that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment
and components, which can span multiple phases of a customer&#8217;s project life-cycle from facility design and construction to
equipment delivery and system installation and start-up. The Company does not provide construction services or system installation
services. Some of the Company&#8217;s contracts with customers contain a single performance obligation, typically engineering only
services contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A contract&#8217;s transaction
price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is
satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each
performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&#8217;s actual selling price for the same good or service, however, this input
is generally not available for the Company&#8217;s contracts containing multiple performance obligations. For engineering services,
the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility
size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to
be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment
and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending
on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain
performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the
Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be
recognized as each promise is fulfilled.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Generally, satisfaction
occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for
consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when
control transfers to the customer, which primarily occurs at the time of shipment. The Company&#8217;s historical rates of return
are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the
Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales,
use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing
transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The
revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&#8217;s customers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company also has performance
obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type
of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company offers assurance-type
warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers
and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve
based on historical warranty costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><u>Other Judgments and
Assumptions</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company typically receives
customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18,
which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant
financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised
good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining
performance obligations related to customer contracts does not consider the effects of the time value of money.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Applying the practical
expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since
the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only
when associated revenue has been collected and earned by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><u>Contract Assets and
Contract Liabilities</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Contract assets reflect
revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments
received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on
the terms established in its contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Contract assets include
unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject
to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets
since revenue is recognized as control of goods are transferred or as services are performed. As of December 31, 2020, and 2019,
the Company had no contract assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Contract liabilities
consist of advance payments in excess of revenue recognized. The Company&#8217;s contract liabilities are recorded as a
current liability in deferred revenue in the consolidated balance sheets since the timing of when the Company expects to
recognize revenue is generally less than one year. As of December 31, 2020, and December 31, 2019, deferred revenue, which
was classified as a current liability, was $3,724,189 and $1,444,472, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the year ended December
31, 2020, the Company recognized revenue of $1,103,447 related to the deferred revenue at January 1, 2020, or 76%. For the year
ended December 31, 2019, the Company recognized revenue of $473,682 related to the deferred revenue at January 1, 2019, or 74%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><u>Remaining Performance
Obligations</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Remaining performance obligations,
or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has
not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which
exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts,
including those with an expected duration of one year or less.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Industry uncertainty, project
financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#8217;s control,
make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are
risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&#8217;s cultivation facility project is dependent upon the customer&#8217;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time
it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by
numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business;
(ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government
delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states
where there is no cap on the number of cultivators; (iv) the customer&#8217;s need to obtain cultivation facility financing; (v)
the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility
(to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate
control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction
project. Further, based on the current economic climate, the uncertainty regarding the COVID-19 virus, and the Company&#8217;s
recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience
contract cancellations, project scope reductions and project delays.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020,
the Company&#8217;s remaining performance obligations, or backlog, was $8,448,000, of which $2,643,000, or 31%, was attributable
to customer contracts for which the Company has only received an initial advance payment to cover the allocated value of the Company&#8217;s
engineering services (&#8220;engineering only paid contracts&#8221;). There is the risk that the equipment portion of these engineering
only paid contracts will not be completed or will be delayed. The reasons include the customer being dissatisfied with the quality
or timeliness of the Company&#8217;s engineering services, delay or abandonment of the project because of the customer&#8217;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall
post-COVID-19 economic downturn, or change in business direction. After the customer has made an advance payment for a portion
of the equipment to be delivered under the contract (&#8220;partial equipment paid contracts&#8221;), the Company is typically
better able to estimate the timing of revenue recognition since the risks and delays associated with licensing, permitting and
project funding are typically mitigated once the initial equipment payment is received. There is significant uncertainty regarding
the timing of the Company&#8217;s recognition of revenue on its remaining performance obligations, and there is no certainty that
these will result in actual revenues. The backlog at December 31, 2020, includes booked sales orders of $390,000 from several customers
that the Company does not expect to be realized until 2022, if at all. Given the present economic uncertainty arising from the
impact of the novel coronavirus COVID-19, the Company believes that several of its current contracts may be delayed or canceled.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The remaining performance
obligations expected to be recognized through 2022 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2022</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Total</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 55%"><font style="font-size: 10pt">Remaining performance obligations related to engineering only paid contracts</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">2,355,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">288,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">2,643,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Remaining performance obligations related to partial equipment paid contracts</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,703,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">102,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,805,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total remaining performance obligations</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,058,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">390,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,448,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Product Warranty</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company warrants the
products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment.
The Company&#8217;s warranty provides for the repair, rework, or replacement of products (at the Company&#8217;s option) that fail
to perform within stated specification. The Company&#8217;s third-party suppliers also warrant their products under similar terms,
which are passed through to the Company&#8217;s customers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company assesses the
historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue
generated on these products. Based on the Company&#8217;s warranty policy, an accrual is established at 1% of the trailing 18 months
revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and
other factors. As of December 31, 2020, and December 31, 2019, the Company had an accrued warranty reserve amount of $173,365 and $185,234,
respectively, which are included in accounts payable and accrued liabilities on the Company&#8217;s consolidated balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Cost of Sales</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Cost of sales includes
product costs (material, direct labor and overhead costs), shipping and handling expense, outside engineering costs, engineering,
project management and service salaries and benefits, client visits and warranty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Concentrations</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Three customers accounted
for 28%, 11% and 10% of the Company&#8217;s revenue for the year ended December 31, 2020. One customer accounted for 44% of the
Company&#8217;s revenue for the year ended December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s accounts
receivable from two customers made up 48% and 38%, respectively, of the total balance as of December 31, 2020. The Company&#8217;s
accounts receivable from three customers made up 59%, 16%, and 10%, respectively, of the total balance as of December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Three suppliers accounted
for 27%, 25% and 12% of the Company&#8217;s purchases of inventory for the year ended December 31, 2020, and three suppliers accounted
for 30%, 17% and 12% of the Company&#8217;s purchases of inventory for the year ended December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Product Development</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company expenses
product development costs as incurred. Internal product development costs are expensed as incurred, and third-party product
developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. For
the years ended December 31, 2020 and December 31, 2019, the Company incurred $390,229 and $521,044, respectively, on product
development.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Accounting for Share-Based
Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company recognizes
the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted
stock units that the Company grants under its equity incentive plan in its consolidated financial statements based on their grant
date fair value. For awards subject to service conditions, compensation expense is recognized over the vesting period on a straight-line
basis. Awards subject to performance conditions are attributed separately for each vesting tranche of the award and are recognized
ratably from the service inception date to the vesting date for each tranche, based on the probability of vesting. The probability
of awards with future performance conditions is evaluated each reporting period and compensation expense is adjusted based on the
probability assessment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Awards are considered granted,
and the service inception date begins, when mutual understanding of the key terms and conditions of the award between the Company
and the recipient has been established. For awards that provide discretion to adjust the amount of the award, the service inception
date for such awards could precede the grant date as a mutual understanding of the key terms and conditions of the award between
the Company and the recipient has not yet been established. For awards in which the service inception date precedes the grant date,
compensation cost is accrued beginning on the service inception date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Subsequent to December
31, 2020, the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) approved annual incentive compensation awards to certain
employees payable in non-qualified stock options, based on the Company&#8217;s performance and each employee&#8217;s contributions
to such performance for the 2020 year. See Note 16. The non-qualified stock options were granted subsequent to December 31, 2020,
were not subject to an additional service requirement and were immediately vested at the date of the grant. The final amount of
the annual incentive compensation award, and number of non-qualified stock options granted, were determined, and communicated to
the employee, subsequent to December 31, 2020. The estimated compensation expense of $128,434 related to the 2020 incentive awards
was accrued as of December 31, 2020. Since such incentive awards will be settled in non-qualified stock options, the accrued compensation
expense has been classified as a current liability until the number of non-qualified stock options is fixed pursuant to a grant
by the Board. At that time, the incentive award becomes equity-classified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The grant date fair value
of stock options is based on the Black-Scholes Model. The Black-Scholes Model requires judgmental assumptions including volatility
and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose
term is consistent with the expected term of the option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The grant date fair value
of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has elected
to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical
data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of
employees have significantly different forfeiture expectations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Share-based compensation
costs (including expenses from the accrued compensation liabilities related to the annual incentive awards subsequently settled
in non-qualified stock options totaled $405,617 and $1,292,065 for the years ended December 31, 2020 and 2019, respectively. Such
share-based compensation costs are classified in the Company&#8217;s consolidated financial statements in the same manner as if
such compensation was paid in cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 1pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following is a summary
of such share-based compensation costs included in the Company&#8217;s consolidated statements of operations for the years ended
December 31, 2020 and 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Years Ended December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Share-based compensation expense included in:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 62%"><font style="font-size: 10pt">Cost of revenue</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">31,006</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">91,081</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Advertising and marketing expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">8,333</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">33,977</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Product development costs</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">21,882</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">45,330</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Selling, general and administrative expenses</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">344,396</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,121,677</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total share-based compensation expense included in consolidated statement of operations</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">405,617</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,292,065</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Income Taxes</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company accounts for
income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the
expected future tax consequences of events that have been included in the financial statements. Under this method, the Company
determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of
assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The
effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the
enactment date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company recognizes
deferred tax assets to the extent that the Company believes that these assets are more likely than not to be realized. In making
such a determination, the Company considers all available positive and negative evidence, including future reversals of existing
taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the
Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount,
the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income
taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company records uncertain
tax positions on the basis of a two-step process in which: (i) the Company determines whether it is more likely than not that the
tax positions will be sustained on the basis of the technical merits of the position, and (ii) for those tax positions that meet
the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more likely than
not to be realized upon ultimate settlement with the related tax authority.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Basic and Diluted
Net Loss per Common Share</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Basic income (loss) per
common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common
shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share
is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in
periods when losses are reported where the effect of the common stock equivalents would be antidilutive. Potential common stock
equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units
using the treasury method. As of December 31, 2020, 29,213,500 potential common shares equivalents from warrants and options were
excluded from the diluted EPS calculations as their effect is anti-dilutive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Commitments and Contingencies</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In the normal course of
business, the Company is subject to loss contingencies, such as legal proceedings and claims arising out of its business, that
cover a wide range of matters, including, among others, customer disputes, government investigations and tax matters. An accrual
for a loss contingency is recognized when it is probable that an asset had been impaired or a liability had been incurred and the
amount of loss can be reasonably estimated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Other Risks and Uncertainties</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">To achieve profitable operations,
the Company must successfully develop, manufacture and market its products. There can be no assurance that any such products can
be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that such products will
be successfully marketed. These factors could have a material adverse effect upon the Company&#8217;s financial results, financial
position, and future cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"></p>

<p style="font: 1pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company is subject
to risks common to similarly-situated companies including, but not limited to, general economic conditions, its customers&#8217;
operations and access to capital, and market and business disruptions including severe weather conditions, natural disasters, health
hazards, terrorist activities, financial crises, political crises or other major events, or the prospect of these events, new technological
innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, uncertainty
of market acceptance of products, product liability, and the need to obtain additional financing. As a supplier of services and
equipment to cannabis cultivators, the Company is also subject to risks related to the cannabis industry. Although certain states
have legalized medical and/or recreational cannabis, U.S. federal laws continue to prohibit marijuana in all its forms as well
as its derivatives. Any changes in the enforcement of U.S. federal laws may adversely affect the implementation of state and local
cannabis laws and regulations that permit medical or recreational cannabis and, correspondingly, may adversely impact the Company&#8217;s
customers. The Company&#8217;s success is also dependent upon its ability to raise additional capital and to successfully develop
and market its products. See Note 3.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Segment Information</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Operating segments are
defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the
Company&#8217;s senior management team in deciding how to allocate resources and in assessing performance. The Company has one
operating segment that is dedicated to the manufacture and sale of its products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Recently Issued Accounting
Pronouncements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In August 2020, the FASB
issued ASU 2020-06: &#8220;<i>Accounting for Convertible Instruments and Contracts In An Entity&#8217;s Own Equity&#8221; (&#8220;ASU
2020-06&#8221;)</i> ASU 2020-04 simplifies the accounting for certain convertible instruments by removing the separation models
for convertible debt with a cash conversion feature and for convertible instruments with a beneficial conversion feature. As a
result, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded
conversion features. Additionally, ASU 2020-04 amends the diluted earnings per share calculation for convertible instruments by
requiring the use of the if-converted method. The treasury stock method is no longer available. Entities may adopt the ASU 2020-04
using either a full or modified retrospective approach, and it is effective for interim and annual reporting periods beginning
after December 15, 2021. Early adoption is permitted for interim and annual reporting periods beginning after December 15, 2020.
The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial
position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In December 2019, the FASB
issued ASU 2019-12, <i>Income Taxes (Topic 740) &#8211; Simplifying the Accounting for Income Taxes, </i>which simplifies the accounting
for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent
application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12 is effective
for fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company does not expect this ASU to have a
material impact on its consolidated results of operations, cash flows and financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Other accounting standards
that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material
impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to
have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224164590072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Going Concern<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">Going Concern</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 3 &#8211; Going Concern </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which
contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Company has experienced recurring losses since its inception. The Company incurred a net loss of approximately $1,759,000 for the
year ended December 31, 2020 and had an accumulated deficit of approximately $27,444,000 and a shareholders&#8217; deficit of approximately
$1,334,000 as of December 31, 2020. Since inception, the Company has financed its activities principally through debt and equity
financing, advance payments from customers and revenues from completed contracts. Management expects to incur additional losses
and cash outflows in the foreseeable future in connection with its operating activities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Company is subject to a number of risks similar to those of other similar stage and situated companies, including general economic
conditions, its customers&#8217; operations and prospects for and ability to obtain project financing, and market and business
disruptions, that include the outbreak of COVID-19, dependence on key individuals, successful development, marketing and branding
of products; uncertainty of product development and generation of revenues; dependence on outside sources of financing; risks associated
with research, development; dependence on third-party suppliers and collaborators; protection of intellectual property; and competition
with larger, better-capitalized companies. Ultimately, the attainment of profitable operations is dependent on future events, including
obtaining adequate financing to fulfill its development activities and generating a level of revenues adequate to support the Company&#8217;s
cost structure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">There
can be no assurance that the Company will be able to raise debt or equity financing in sufficient amounts, when and if needed,
on acceptable terms or at all. The Company&#8217;s ability to raise equity capital is also limited by the Company&#8217;s stock
price, and any such issuance could be highly dilutive to existing shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Company&#8217;s 2020 revenue of approximately $8,514,000 which represents a decrease of 44% over the prior year. The Company&#8217;s
revenue recognition on contracts continues to be unpredictable and inconsistent quarter-over-quarter, and the Company has incurred,
and expects to incur, additional operating expenses to support such growth. The Company generated approximately $818,000 in cash
flow from operating activities in 2020. However, as a result of the Company&#8217;s growth and its efforts to expand and upgrade
its products, the Company&#8217;s working capital deficit as of December 31, 2020 was approximately $2,220,000, compared to approximately
$1,437,000 as of December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Company also will be affected by constraints on the availability of capital to its customers and prospects who have commenced,
or are contemplating, new or expanded cultivation facilities and the overall impact of the COVID-19 pandemic. The extent to which
COVID-19 will impact the Company&#8217;s business and financial results will depend on future developments, which are uncertain
and cannot be predicted. See Note 16. The duration and likelihood of operational success going forward resulting from the fiscal
year 2020 measures of adjusting the workforce reductions and cost-cutting measures are uncertain. If these actions do not meet
management&#8217;s expectations, or additional capital is not available, there is substantial doubt about the Company&#8217;s
ability to continue as a going concern for a period of one year from the issuance of these financial statements. Other factors
that will impact the Company&#8217;s ability to continue operations include the market demand for the Company&#8217;s products
and services, the ability to service its customers and prospects, potential contract cancellations, project scope reductions and
project delays, the Company&#8217;s ability to fulfill its backlog, the management of working capital, and the continuation of
normal payment terms and conditions for purchase of the Company&#8217;s products. The Company believes its cash balances and cash
flow from operations will be insufficient to fund its operations for the next twelve months. If the Company is unable to increase
revenues, or otherwise generate cash flows from operations, there is substantial doubt about the Company&#8217;s ability to continue
as a going concern for a period of one year from the date the financial statements are issued. These consolidated financial statements
do not include any adjustment that might result from the outcome of this uncertainty.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 40<br> -URI http://asc.fasb.org/subtopic&amp;trid=51888271<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224164381864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 4 &#8211; Leases</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In February 2016, the FASB
issued ASU 2016-02, <i>Leases (Topic 842)</i>(&#8220;ASC 842&#8221; or the &#8220;new lease standard&#8221;). The Company adopted
ASC 842 as of January 1, 2019, using the effective date method. Consequently, financial information will not be updated, and the
disclosures required under the new lease standard will not be provided, for dates and periods prior to January 1, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The new lease standard
provides a number of optional practical expedients in transition. The Company has elected to apply the &#8220;package of practical
expedients&#8221; which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii) the
lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization
under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original
term of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On June 27, 2017, the Company
entered into a lease for its manufacturing and office space (the &#8220;Facility Lease&#8221;), which commenced September 29, 2017
and continues through August 31, 2022. The Company occupied its 12,700 square foot space for $12,967 per month until January 1,
2018. On January 2, 2018, the leased space was expanded to 18,600 square feet, and the monthly rental rate increased to $18,979
until August 31, 2018. Beginning September 1, 2018 and 2019, the monthly rent increased to $19,549 and $20,135, respectively. On
each September 1 through the end of the lease, the monthly rent will increase by 3%. Pursuant to the current lease, the Company
made a security deposit of $51,000 on July 31, 2017. The deposit of $1,600 paid to the previous owner of the property was forwarded
to the current landlord. The Company has the option to renew the Facility Lease for an additional five years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During 2020, the Company
entered into an agreement with its landlord to apply its rent deposit of $52,600 to rent payments due during the period. The deposit
required on the lease will be reduced to approximately $32,000 and will be payable in 12 monthly installments from January through
December of 2021. Further, the landlord also agreed to defer payment of fifty percent of the three months of lease payments (base
rent only) for the period July to September 2020. The deferred lease payments amount to approximately $30,000 and will be payable
in 12 monthly installments from January to December 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Total rent under the Facility
Lease is charged to expense over the term of the lease on a straight-line basis, resulting in the same monthly rent expense throughout
the lease. The difference between the rent expense amount and the actual rent paid is recorded to operating lease liability on
the Company&#8217;s condensed consolidated balance sheets. As of January 1, 2019, the remaining deferred rent of $26,477 was reclassified
to the operating lease liability under the new lease standard.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Upon adoption of the new
lease standard, the Company recognized its lease for manufacturing and office space (the &#8220;Facility Lease&#8221;) on the balance
sheet as an operating lease right-of-use asset in the amount of $714,416 and as a lease liability of $822,374. The renewal option
to extend the Facility Lease is not included in the right-of-use asset or lease liability as the option is not reasonably certain
of exercise. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will
include the renewal period in its lease term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Under the Facility Lease,
the landlord agreed to pay the Company or the Company&#8217;s contractors for tenant improvements made by the Company not to exceed
$100,000, which were used for normal tenant improvements. The Company determined that these improvements were not specialized and
could be utilized by a subsequent tenant and, as such, the improvements were considered assets of the lessor. As of January 1,
2019, the unamortized amount of tenant improvement allowance of $81,481 was treated as a reduction in measuring the right-of-use
asset.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Under the Facility Lease,
the Company pays the actual amounts for property taxes and insurance, excludes such payments from lease contract consideration,
and records such payments as incurred. The Company also pays the landlord for common area maintenance, which is considered a non-lease
component. For the Facility Lease, the Company has elected to exclude non-lease components from lease contract consideration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In determining the right-of-use
asset and lease liability, the Company applied a discount rate to the minimum lease payments under the Facility Lease. ASC 842
requires the Company to use the rate of interest that the Company would have to pay to borrow on a collateralized basis over a
similar term an amount equal to the lease payments in a similar economic environment. Since the discount rate is not implicit in
the lease agreement, we utilized an estimated incremental borrowing rate provided by the Company&#8217;s depository bank.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The lease cost, cash flows
and other information related to the Facility Lease were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center"><font style="font-size: 10pt"><b>For the Year Ended</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap; text-align: center"><font style="font-size: 10pt"><b>December 31, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%"><font style="font-size: 10pt">Operating lease cost</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 10pt">216,889</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Operating cash outflow from operating lease</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">160,934</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 82%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 31, 2020</b></p></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Operating lease right-of-use assset</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">343,950</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Operating lease liability, current</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">266,105</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Operating lease liability, long-term</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">169,119</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Remaining lease term</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.7 years</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Discount rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.00</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Future annual minimum lease
payments on the Facility Lease as of December 31, 2020 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt"><b>Years ended December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%"><font style="font-size: 10pt">2021</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 10pt">281,864</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">2022</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">170,891</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Total minimum lease payments</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">452,755</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Less imputed interest</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(17,531</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Present value of minimum lease payments</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">435,224</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224164619176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 5 &#8211; Inventory</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Inventory consisted of
the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>As of December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Finished goods</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">201,778</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,041,369</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Work in progress</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,231</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3,851</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Raw materials</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">214,145</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">257,399</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Allowance for excess &#38; obsolete inventory</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(93,045</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(71,376</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Inventory, net</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">327,109</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,231,243</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Overhead expenses of $17,974
and $31,831 were included in the inventory balance as of December 31, 2020 and 2019, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224164399576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 6 &#8211; Property and Equipment</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Property and equipment
consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>As of December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Furniture and equipment</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">398,422</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">389,090</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Vehicles</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Leasehold improvements</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,193</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,193</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">628,615</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">619,283</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Accumulated depreciation</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(480,883</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(361,360</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Property and equipment, net</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">147,732</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">257,923</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Depreciation expense amounted
to $119,524 for the year ended December 31, 2020, of which $6,394 was allocated to cost of revenue. Depreciation expense amounted
to $157,860 for the year ended December 31, 2019, of which $7,010 was allocated to cost of revenue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2018,
the Company&#8217;s property and equipment, net included the gross cost of the equipment leased to a cultivation company affiliated
with one of the Co-founders of $176,042, and accumulated depreciation of $39,120. During the year ended December 31, 2019, the
Company wrote-off the carrying value of the leased equipment. See Note 10.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224164651352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 7 &#8211; Intangible Assets</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Intangible assets consisted
of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>As of December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Patents</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">8,110</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">12,234</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Website development costs</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">22,713</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">22,713</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Trademarks</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,830</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,830</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">32,653</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">36,777</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Accumulated amortization</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(25,426</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(24,847</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Intangible assets, net</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">7,227</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">11,930</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Patents when issued are
amortized over 14 years, and web site development costs are amortized over five years. Trademarks are not amortized since they
have an indefinite life. Amortization expense for intangibles amounted to $579 and $3,320 for the years ended December 31, 2020
and 2019, respectively. During the years ended December 31, 2020 and 2019, the Company wrote-off $4,124 and $7,778, respectively,
related to patents that had been abandoned.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224164583800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 8 &#8211; Accounts Payable and Accrued
Liabilities </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Accounts payable and accrued
liabilities consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>As of December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Accounts payable</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">918,639</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,299,015</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Sales commissions payable</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">48,263</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">69,532</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Accrued payroll liabilities</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">288,071</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">169,052</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Product warranty accrual</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">173,365</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">185,234</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Other accrued expenses</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">356,623</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">110,127</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt">Total</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,784,961</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,832,959</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Accounts payable and other
accrued expenses includes $402,651 relating to a one-time warranty issue experienced on three customers&#8217; projects. The expenses
related to parts and labor to repair units that had been delivered to these customers prior to year-end. Since the issue is limited
to these three projects and is not anticipated to reoccur in the future, we have made no adjustment to the ongoing 1% warranty
reserve that we accrue on all sales.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224168630056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note Payable and Accrued Interest<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Note Payable and Accrued Interest</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 9 &#8211; Note Payable and Accrued
Interest</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On April 22, 2020, the
Company entered into a note payable with its current bank in the principal amount of $554,000, for working capital purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The loan amount was subject
to interest at 1% and was initially due on April 20, 2022. Subsequently, the term of the loan was potentially to be extended to
April 20, 2025. The loan could be repaid in advance without penalty. The loan was also potentially forgivable in full provided
proceeds were used for payment of payroll expenses, rent, utilities and mortgage interest and certain other terms and conditions
were met. The loan had typical default provisions, including for change of ownership, general lender insecurity as to repayment,
non-payment of amounts due, defaults on other debt instruments, insolvency, dissolution or termination of the business as a going
concern and bankruptcy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2020, interest of $3,203 was accrued in respect of this note payable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On December 11, 2020, the
Company received notice from the bank that its loan received on April 22, 2020, in the principal amount of $554,000 and all accrued
interest of $3,203, was fully forgiven. This gain on loan forgiveness
was recorded as Other Income in the Statement of Operations during the year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As further discussed in
<i>Note 16 Subsequent Events</i> below, on February 10, 2021, we received funding based on a loan agreement entered into on February
5, 2021 with its current bank in the principal amount of $514,200 for working capital purposes. Consistent with the loan provisions,
the Company will use the proceeds to meet payroll and benefit expenses as well as for rent and utilities. The loan amount bears
interest at 1% and is due on February 5, 2026. The loan may be repaid in advance without penalty. The loan has typical default
provisions, including for change of ownership, general lender insecurity as to repayment, non-payment of amounts due, defaults
on other debt instruments, insolvency, dissolution or termination of the business as a going concern and bankruptcy.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224164659544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Agreements and Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Agreements and Transactions</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 10 &#8211; Related Party Agreements
and Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Agreements and Transaction
with Company&#8217;s Co-Founders</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following describes
certain agreements and transactions between the Company and its co-founders (the &#8220;Co-founders&#8221;). The Co-founders held
various executive officer and director positions with the Company until May 2018. One of the Co-founders also was a consultant
to the Company until May 2018. The Co-founders are also shareholders of the Company. Based on information available to the Company,
the Co-founders did not own more than 10% of the Company&#8217;s outstanding common stock at any time during 2019 or 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><u>Equipment, Demonstration
and Product Testing Agreement</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In May 2017, the Company
entered into a three-year equipment, demonstration and product testing agreement with a licensed cannabis cultivation company affiliated
with one of the Co-founders. Under this agreement, the Company agreed to lease the cultivation company certain cultivation equipment
in exchange for a quarterly fee of $16,500, which was increased to $18,330 to reflect additional leased equipment requested by
the cultivation company (the &#8220;Lease Fee&#8221;). In consideration for access to the cultivation facility to conduct demonstration
tours and for the product testing and data to be provided by the cultivation company, the Company agreed to pay the cultivation
company a quarterly fee of $12,000 (the &#8220;Demo and Testing Fee&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company and the cultivation
company each made their respective payments under this agreement through June 30, 2018. Thereafter, the cultivation company failed
to make any subsequent payments of the Lease Fee and, as a result, the Company did not pay the Demo and Testing Fee. During the
second quarter of 2019, the Company notified the cultivation company of its breach for non-payment of the Lease Fee. In February
2020, the parties mutually agreed to terminate this agreement and release each other from all claims related to this agreement,
including any unpaid Lease Fees or Demo and Testing Fees. The Company also agreed to transfer the equipment to the cultivation
company for no additional consideration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2018, the Company recorded Demo and Testing Fees of $32,000 as operating expenses in the consolidated statements of operations.
During the year ended December 31, 2018, the Company also recorded Lease Fees of $48,880 as &#8220;Other income, net&#8221; in
the consolidated statements of operations. As of December 31, 2018, unpaid Lease Fees of $36,660 were included in accounts receivable
and unpaid Demo and Testing Fees of $24,000 were included in accounts payable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the third quarter
of 2019, the Company determined that it was unlikely that any further payment of Lease Fees would be paid by the cultivation company,
and the Company: (i) wrote off the balance of the accounts receivable related to unpaid Lease Fees, with a corresponding charge
to &#8220;Other income, net&#8221; in the consolidated statements of operations, (ii) reversed the accounts payable related to
the unpaid Demo and Testing Fees, with a corresponding credit to operating expenses, and (iii) wrote-off the remaining carrying
value of the leased equipment of $107,581, which was included in property and equipment on the Company&#8217;s consolidated balance
sheet. For the year ended December 31, 2019, the net impact of the foregoing items on the consolidated statements of operations
was a charge of $120,241.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><u>Employment Agreement</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In May 2018, the Company
and one of the Co-founders entered into an employment agreement which provided for an initial base salary of $150,000 per year
and certain sales incentive. Pursuant to the employment agreement, the Company awarded 4,800,000 restricted stock units (&#8220;RSUs&#8221;)
to the Co-founder that vested at certain dates in the future, subject to the co-founder&#8217;s continued employment. As of December
31, 2019: (i) the Company has issued 2,000,000 shares of common stock in settlement of vested RSUs, (ii) 1,000,000 shares of common
stock in settlement of RSUs that vested December 31, 2019 were issued subsequent to December 31, 2019, (iii) the parties mutually
agreed to cancel 1,000,000 RSUs, and (iii) 800,000 RSUs vested on April 30, 2020, however, the holder elected to cancel the RSUs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><u>Consulting Agreement</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As further discussed <i>in
Note 16 Subsequent Events</i> below, on January 7, 2021, the Company entered into a consulting agreement with RSX Enterprises,
Inc. (RSX), a company controlled by Mr. James R. Shipley, a director of the Company. RSX will provide consulting services to the
Company focused on product offerings, engineering requirements, key customer marketing outreach, and related matters, as mutually
determined by the Company and RSX. The Company will pay a monthly consulting fee of $6,500 for up to 50 hours per month for the
various consulting activities undertaken and provide for reimbursement of expenses. The term of the agreement is set for three
months. Any intellectual property developed by RSX will belong to the Company, and the contract provides for typical indemnification
obligations and confidentiality provisions.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224269970632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 11 &#8211; Commitments and Contingencies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Litigation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2019, there
were 6,750,000 restricted stock units that had not been settled due to a dispute with a former employee over the required withholding
taxes to be paid to the Company for remittance to the appropriate tax authorities. The Company commenced an arbitration action against
the former employee regarding the dispute. The former employee also made claims in the arbitration action against the Company for unpaid
wages. As stated in a pleading in the arbitration, on March 9, 2020, the Company issued the former employee 6,750,000 shares of the Company&#8217;s
common stock in settlement of these restricted stock units after taking measures to mitigate the Company&#8217;s exposure to penalties
and liability for the failure to properly withhold income taxes. The Arbitrator issued an interim award of approximately $10,000 in the
Company&#8217;s favor and a finding against the former employee. Effective June 9, 2020, the Arbitrator issued his final award in the
Company&#8217;s favor in the Colorado arbitration. The Arbitrator found against the former employee and awarded the Company costs of $33,985,
with interest at 8% per year. Effective July 22, 2020, the Colorado Court confirmed the Arbitration award and entered a final judgement
in favor of the Company and against the former employee. The Company pursued collection of this debt and has now collected the debt owed.
This former employee is continuing to pursue separate litigation against the Company for recovery of alleged consulting fees owed to him
for the 2015 calendar year prior to his appointment as an executive officer of the Company. The Company strongly disputes the ongoing litigation and in the
remote event of an adverse outcome, the amount of any settlement loss for this case is not reasonably estimable as of the date
of the issuance of these financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">From time to time, in the normal
course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal
business operations. Moreover, the results of complex legal proceedings are difficult to predict and the Company&#8217;s view of these
matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The
Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss
can be reasonably estimated. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company&#8217;s
operations or its financial position, liquidity or results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Other Commitments</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In the ordinary course of business,
the Company may provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties
with respect to certain matters, including, but not limited to, losses arising out of the Company&#8217;s breach of such agreements, services
to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered
into indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other
things, indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers, or employees.
The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its
directors and certain of its officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224164620584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred and Common Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Preferred and Common Stock</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 12 &#8211; Preferred and Common Stock
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Preferred Stock</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020,
and 2019, there were 42,030,331 shares of Series A preferred stock, par value $0.00001 per share, issued and outstanding. The holders
of Series A preferred stock have one vote per share of Series A preferred stock equivalent to one vote of the Company&#8217;s common
stock. The Series A preferred stock ranks senior to the Company&#8217;s common stock. The holders of shares of Series A preferred
stock are not entitled to receive dividends and have no conversion or preemptive rights. Upon liquidation, dissolution or winding
up of the Company&#8217;s business, after payment to the holders of any senior securities, the holders of Series A preferred stock
are entitled to receive a preferential cash payment per share of Series A preferred stock equal to the stated value of the preferred
stock, prior to any payment to the holders of common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Common Stock</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2020, the Company did not issue any shares of its common stock in a private, non-registered transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the year ended
December 31, 2019, the Company did not issue any shares of its common stock in a private, non-registered transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2020, the Company issued shares of its common stock under the 2017 Equity Plan as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 72px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#9679;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">1,000,000 shares to an employee in settlement of certain RSUs that vested December 31, 2019;</font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><font style="font-size: 10pt">&#9679;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">560,000 shares pursuant to a special incentive stock bonus approved by the Board for the period ended December 31, 2019; and</font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><font style="font-size: 10pt">&#9679;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">6,750,000 shares in settlement of restricted stock units to a former employee after taking measures to mitigate the Company&#8217;s exposure to penalties and liability for the failure to properly withhold income taxes, as further discussed in <i>Note 11 &#8211; Commitments and Contingencies, Litigation</i> above.</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2019, the Company issued shares of its common stock under the Company&#8217;s 2017 Equity Plan as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 72px">&#160;</td>
    <td style="width: 24px"><font style="font-size: 10pt">&#9679;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">197,370 shares of common stock were issued to independent directors in lieu of cash director fees; </font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><font style="font-size: 10pt">&#9679;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">789,474 shares of common stock were issued to independent directors as the 2019 equity retainer fee; </font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><font style="font-size: 10pt">&#9679;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">1,120,000 shares of common stock were issued to certain employees in settlement of vested restricted stock units; and</font></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td><font style="font-size: 10pt">&#9679;</font></td>
    <td style="text-align: justify"><font style="font-size: 10pt">1,120,000 shares of common stock were issued to certain employees as a stock incentive bonus.</font></td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224164352712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Outstanding Warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_WarrantsDisclosureTextBlock', window );">Outstanding Warrants</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 13 &#8211; Outstanding Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table summarizes
information with respect to outstanding warrants to purchase common stock during the years ended December 31, 2020 and 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Aggregate</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Number</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center"><font style="font-size: 10pt"><b>Remaining Life</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Intrincic</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Outstanding</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>In Months</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 44%"><font style="font-size: 10pt">Outstanding at December 31, 2018</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">40,010,250</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.25</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">21</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Issued</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(901,250</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(0.66</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Outstanding at December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">39,109,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.24</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Issued</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(31,546,500</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(0.23</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding at December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">7,562,500</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.25</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table summarizes
information about warrants outstanding at December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Weighted Average Life of</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Warrants</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Outstanding Warrants</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">Exercise price</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Outstanding</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">In Months</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 1%">&#160;</td>
    <td style="width: 32%; text-align: right"><font style="font-size: 10pt">0.25</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 30%; text-align: right"><font style="font-size: 10pt">7,562,500</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 30%; text-align: right"><font style="font-size: 10pt">6</font></td>
    <td style="width: 1%">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Series 2 Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In October 2014, the Company
offered up to 60 investment units at a price per unit of $50,000. Each unit consisted of (i) 250,000 shares of the Company&#8217;s
common stock, (ii) a $50,000 10% convertible promissory note (&#8220;Series 2 Convertible Note&#8221;), and (iii) warrants for
the purchase of 50,000 shares of the Company&#8217;s common stock (&#8220;Series 2 Warrants&#8221;). As of December 31, 2018, Series
2 Warrants to purchase 901,250 shares of common stock were outstanding, all of which expired unexercised during the year ended
December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Warrants Issued to
Investment Bank</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to a certain agreement
for services rendered in connection with the conversion of the Series 2 Convertible Notes, during the year ended December 31, 2017,
the Company issued to an investment bank or its designees a warrant (&#8220;Banker Warrant&#8221;) to purchase, at an exercise
price $0.35 per share, 500,000 shares of the Company&#8217;s common stock. The Banker Warrants were fully vested on the date of
issuance, were exercisable beginning December 20, 2017 and expired unexercised on June 20, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Q1 2017 Warrants
</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In March 2017, the Company
issued 16,781,250 investment units, for aggregate gross proceeds of $2,685,000, or $0.16 per unit. Each unit consisted of one share
of the Company&#8217;s common stock and one warrant for the purchase of one share of the Company&#8217;s common stock (&#8220;Q1
2017 Warrants&#8221;); however, one investor declined receipt of the warrant to purchase 468,750 shares of the Company&#8217;s
common stock. Pursuant to the Q1 2017 Warrants, the holder thereof may at any time on or after six months after the issuance date
and on or prior to the close of business on the date that is the third anniversary of the issuance date, purchase up to the number
of shares of the Company&#8217;s common stock as set forth in the respective warrant. The exercise price per share of the common
stock under the Q1 2017 Warrants is $0.26, subject to customary adjustments as provided in the warrant. Each Q1 2017 Warrant was
callable at the Company&#8217;s option commencing six months from the issuance date, provided the closing price of the Company&#8217;s
common stock was $0.42 or greater for five consecutive trading days. Commencing at any time after the date on which such call condition
was satisfied, the Company had the right, upon 30 days&#8217; notice to the holder, to redeem the warrant shares at a price of
$0.01 per warrant share. The holder could have exercised the warrant at any time (in whole or in part) prior to the redemption
date at the exercise price. These warrants expired unexercised in March 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Q4 2017 Warrants
</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In December 2017, the Company
issued 14,734,000 investment units for aggregate proceeds of $1,768,080, or $0.12 per unit. Each unit consisted of one share of
the Company&#8217;s common stock and one warrant for the purchase of one share of the Company&#8217;s common stock (&#8220;Q4 2017
Warrants&#8221;). The Q4 2017 Warrants had an exercise price of $0.20 per share, subject to customary adjustments as provided in
the warrant, and had a term of three years. The Q4 2017 Warrants were callable at the Company&#8217;s option, provided the closing
price of the Company&#8217;s common stock was $0.36 or greater for five consecutive trading days. Commencing at any time after
the date on which the call condition is satisfied, the Company had the right, upon notice to the holders, to redeem the shares
of common stock underlying each warrant at a price of $0.01 per share, but such redemption could not occur earlier than sixty-one
(61) days following the date of the receipt of notice by the holder. The holder could exercise the warrant at any time (in whole
or in part) prior to the redemption date at the exercise price. These warrants expired unexercised in December 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Q2 2018 Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In June 2018, the Company
completed a private placement offering of investment units, with each unit consisting of one share of the Company&#8217;s common
stock and one Q2 2018 Warrant. The Q2 2018 Warrants have an exercise price of $0.25 per share of the common stock underlying each
warrant, subject to customary adjustments as provided in the warrant. The Q2 2018 Warrants are exercisable commencing July 1, 2018
until June 30, 2021. The Q2 2018 Warrants are callable at the Company&#8217;s option, beginning on July 1, 2019 until the expiration
thereof on June 30, 2021, provided the closing price of the Company&#8217;s common stock is $0.40 (subject to adjustment as provided
in the warrant) or greater for five consecutive trading days. Commencing at any time after the date on which the call condition
is satisfied, the Company has the right, upon notice to the holders, to redeem the shares of common stock underlying each warrant
at a price of $0.01 per share, but such redemption may not occur earlier than sixty-one (61) days following the date of the receipt
of notice by the holder. The holder may exercise the warrant (in whole or in part) prior to the redemption date at the exercise
price. As of December 31, 2020, Q2 2018 Warrants to purchase 7,562,500 shares of common stock were outstanding.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_WarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants [Text block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_WarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224168880936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity Incentive Plan</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 14 &#8211; Equity Incentive Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">On
August 1, 2017, the Board adopted and approved the Company&#8217;s 2017 Equity Incentive Plan (the &#8220;2017 Equity Plan&#8221;)
in order to attract, motivate, retain, and reward high-quality executives and other employees, officers, directors, consultants,
and other persons who provide services to the Company by enabling such persons to acquire an equity interest in the Company. Under
the 2017 Equity Plan, the Board (or the compensation committee of the Board, if one is established) may award stock options, stock
appreciation rights (&#8220;SARs&#8221;), restricted stock awards (&#8220;RSAs&#8221;), restricted stock unit awards (&#8220;RSUs&#8221;),
shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017 Equity Plan allocates
50,000,000 shares of the Company&#8217;s common stock (&#8220;Plan Shares&#8221;) for issuance of equity awards under the 2017
Equity Plan. As of December 31, 2020, the Company has granted, under the 2017 Equity Plan, awards in the form of RSAs for services
rendered by independent directors and consultants, non-qualified stock options, RSUs and stock bonus awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The
total unrecognized compensation expense for unvested non-qualified stock options at December 31, 2020 was $6,412, which will be
recognized over approximately 3 months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><u>Restricted Stock Awards</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2018,
the Company had accrued fees owed to the Company&#8217;s independent directors totaling $15,000, which were payable in equity.
During the year ended December 31, 2019, the Company issued 197,370 shares of restricted stock, which were fully vested at the
time of the award, in settlement of these accrued fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the year ended December
31, 2019, the Company also awarded 789,474 shares of restricted stock under the 2017 Equity Plan to the Company&#8217;s independent
directors and consultants as an equity retainer fee for 2019. These restricted shares were fully vested at the time of the award
and the aggregate value attributable to these shares was $60,000, as calculated using the fair value of the Company&#8217;s common
stock on date the Board approved these awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><u>Non-Qualified
Stock Options</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Company uses the Black-Scholes Model to determine the fair value of options granted. Option-pricing models require the input of
highly subjective assumptions, particularly for the expected stock price volatility and the expected term of options. Changes in
the subjective input assumptions can materially affect the fair value estimate. The expected stock price volatility assumptions
are based on the historical volatility of the Company&#8217;s common stock over periods that are similar to the expected terms
of grants and other relevant factors. The Company derives the expected term based on an average of the contract term and the vesting
period taking into consideration the vesting schedules and future employee behavior with regard to option exercise. The risk-free
interest rate is based on U.S. Treasury yields for a maturity approximating the expected term calculated at the date of grant.
The Company has never paid any cash dividends on its common stock and the Company has no intention to pay a dividend at this time;
therefore, the Company assumes that no dividends will be paid over the expected terms of option awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><font style="font-size: 10pt">The
Company determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected
stock price volatility, expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant
dates. As such, the Company may use different assumptions for options granted throughout the year. The valuation assumptions used
to determine the fair value of each option award on the date of grant were: expected stock price volatility 114.97% - 122.48%;
expected term in 5 years and risk-free interest rate 0.2% - 2.37%.</font><font style="font-size: 1pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><i><u>Employee
and Consultant Options</u></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the years ended
December 31, 2020 and 2019 are presented in the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number of Options</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted Average Exercise Price</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted Average Remaining Contractual Term</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Aggregate Intrinsic</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Value</b></p></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 46%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, December 31, 2018</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10,560,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.104</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8.4</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.080</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2,408,333</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.116</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(16,667</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.105</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10,135,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.096</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7.7</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,616,900</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.070</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">10.0</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2,500,900</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.101</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">4.3</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, December 31, 2020</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14,251,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.083</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8.3</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Exercisable, December 31, 2020</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">14,251,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.083</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8.3</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of non-vested
non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the years ended December 31,
2020 and 2019 are presented in the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Tahoma, Helvetica, Sans-Serif">&#65279;</font></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number of<br />
Options</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted<br />
Average<br />
Grant-Date<br />
Fair Value</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Aggregate<br />
Intrinsic<br />
Value</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Grant-Date<br />
Fair Value</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Tahoma, Helvetica, Sans-Serif">&#65279;</font></td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 46%"><font style="font: 10pt Times New Roman, Times, Serif">Nonvested, December 31, 2018</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,333,329</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.086</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">628,756</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 6.75pt"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.065</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">130,120</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 6.75pt"><font style="font: 10pt Times New Roman, Times, Serif">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4,924,996</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.074</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">362,998</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 6.75pt"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2,408,333</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.102</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">246,344</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 6.75pt"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Nonvested, December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.075</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">149,534</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 6.75pt"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,616,900</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.059</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">387,199</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 6.75pt"><font style="font: 10pt Times New Roman, Times, Serif">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(8,616,900</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.062</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">536,733</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 6.75pt"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 6.75pt"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Nonvested, December 31, 2020</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the years ended December
31, 2020 and 2019, the Company recorded $189,568 and $390,485 as compensation expense related to vested options issued to employees
and consultants, net of forfeitures, respectively. As of December 31, 2020, there was no unrecognized share-based compensation
related to unvested options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="font-size: 10pt">As
of December 31, 2020, the Company had granted non-qualified options to purchase 10,250,000 shares which were performance-based.
At December 31, 2020, non-qualified options to purchase 6,000,000 shares were forfeited due to the failure to satisfy the 2017,
2018 and 2019 revenue-based performance thresholds and 4,250,000 shares were forfeited due to employee terminations. No compensation
expense had been recognized with respect to these performance-based awards since the likelihood of performance levels being obtained
was determined to be remote.</font><font style="font-size: 1pt">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><i>Director Options</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of the non-qualified
stock options granted to directors under the 2017 Equity Plan during the years ended December 31, 2020 and 2019 are presented in
the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Number of</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Options</b></p></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Weighted</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Average</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Exercise</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Price</b></p></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Weighted</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Average</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Remaining</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Contractual</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Term</b></p></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Aggregate</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Intrinsic</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Value ($000)</b></p></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 46%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, December 31, 2018</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">900,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.135</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8.6</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited/Cancelled</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">900,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.135</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7.6</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,500,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.057</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8.5</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited/Cancelled</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, December 31, 2020</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,400,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.067</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7.5</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Exerciseable, December 31, 2020</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,400,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.073</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">8.0</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of non-vested
non-qualified stock options activity for directors under the 2017 Equity Plan for the years ended December 31, 2020 and 2019 are
presented in the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Tahoma, Helvetica, Sans-Serif">&#65279;</font></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number of Options</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted Average Grant-Date Fair Value</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Aggregate Intrinsic Value</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Grant-Date Fair Value</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Tahoma, Helvetica, Sans-Serif">&#65279;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Nonvested, December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Nonvested, December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 40%; padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,500,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.057</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">373,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(5,500,000</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.063</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">344,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Nonvested, December 31, 2020</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.029</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">5,800</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">29,000</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the years ended
December 31, 2020 and 2019, the Company incurred $62,452 and $0, respectively, as compensation expense related to 1,500,000 and
0 vested options, respectively, issued to directors. As of December 31, 2020, total unrecognized share-based compensation related
to unvested options was $6,412.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Effective January 2, 2020,
the Company issued 4,000,000 fully vested stock options to directors valued at $234,126 in respect of a 2019 special equity award
that had been accrued for in full in the Company&#8217;s financial statements at December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Further on January 2, 2020,
the Company issued an additional 500,000 fully vested, non-qualified stock options under the 2017 Equity Plan valued at $29,266
to directors. The options have a term of 5 years and have an exercise price equal to the closing price of the Company&#8217;s common
stock on The OTC Markets on the day immediately preceding the grant date of $0.07.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Effective June 24, 2020<i>,&#160;</i>the
Company issued 2,000,000 non-qualified stock options under the 2017 Equity Plan, valued at $39,600, to newly appointed directors.
The options vested 50% upon grant and 50% on April 1, 2021, if the Director remains on the Board up to that time. The options have
a term of 5 years and have an exercise price equal to the closing price of the Company&#8217;s common stock on The OTC Markets
on the day immediately preceding the grant date of $0.029.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">As
of December 31, 2020, awards related to 21,651,000 shares remain issued and outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Restricted Stock Units</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of the RSUs awarded
to employees, directors and consultants under the 2017 Equity Plan during the years ended December 31, 2020 and 2019 are presented
in the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Number of</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Units</b></p></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Weighted</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Average</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Grant-Date</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Fair Value</b></p></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Aggregate</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Intrinsic</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Value</b></p></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 53%"><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, December 31, 2018</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">9,867,368</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.140</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">730,185</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Vested and settled with share issuance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,120,000</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.181</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited/canceled</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,197,368</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.179</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,550,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.128</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Vested and settled with share issuance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(6,750,000</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.121</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited/canceled</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(800,000</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.184</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Outstanding, December 31, 2020</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the years ended December
31, 2020 and 2019, the Company recorded $25,163 and $278,906 as compensation expense related to vested RSUs issued to employees,
directors and consultants. As of December 31, 2020, there was no unrecognized share-based compensation related to unvested RSUs.
The total intrinsic value of RSUs vested and settled with share issuance was $199,125 and $79,120 for the years ended December
31, 2020 and 2019. During the year ended December 31, 2020, the total intrinsic value of RSUs vested and settled with share issuance
was $1,105,750, including the intrinsic value of $1,035,750 related to RSUs that had vested in 2018 but had not been settled until
2020 due to a dispute with a former employee over the required withholding taxes to be paid to the Company for remittance to the
appropriate tax authorities as further discussed in Note 11 Commitments and Contingencies above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Effective April 30, 2020,
800,000 RSUs vested. However, the holder elected to cancel the RSUs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><u>Incentive Stock Bonuses</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has entered
into certain &#8220;at-will&#8221; employment agreements with certain employees. Under these agreements, the employees are eligible
to receive special incentive stock bonuses, provided the Board has determined, in its sole discretion, that the employee&#8217;s
performance has been average or better for the applicable special bonus period. This special stock incentive bonus is payable only
if the employee continues in the employment of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For accounting purposes,
the Company treats these special incentive stock bonuses as vesting over each bonus&#8217;s service period based on the fair value
of the award at the time of grant. Even though these bonuses are subject to Board approval, the awards are vested over each service
period because it is more likely than not that the Board will approve the award based on the &#8220;average or better&#8221; employee
performance standard. Since the awards are denominated in shares of common stock, the fair value of the vested bonus is charged
to additional paid-in capital.</p>

<p style="font: 1pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of the incentive
stock bonus awards granted to employees under the 2017 Equity Plan during the years ended December 31, 2020 and 2019 are presented
in the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Number of</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Shares</b></p></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Weighted</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Average Grant-Date</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Fair Value</b></p></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Aggregate</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Intrinsic</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Value</b></p></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Tahoma, Helvetica, Sans-Serif">&#65279;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font: 10pt Times New Roman, Times, Serif">Unvested, December 31, 2018</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">1,680,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.112</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">124,320</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Awarded</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(1,680,000</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.112</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Unvested, December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Awarded</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Unvested, December 31, 2020</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the years ended December
31, 2020 and 2019, the Company recorded $0 and $44,209 as compensation expense related to vested stock bonus awards issued to employees,
net of forfeitures of $0 and $0, respectively. As of December 31, 2020, there was no unrecognized share-based compensation related
to unvested stock bonus awards. The total intrinsic value of stock bonus awards vested and settled with share issuance was $0 and
$58,240 for the years ended December 31, 2020 and 2019, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224168830392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 15 &#8211; Income Taxes </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For financial reporting
purposes, there were no provisions for U.S. federal, state or international income taxes for the years ended December 31, 2020
or 2019 due to the Company&#8217;s net operating losses (&#8220;NOLs&#8221;) in such periods and full valuation allowance recorded
against the net deferred tax assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The differences between
income taxes expected at the U.S. federal statutory income tax rate and the reported provision for income taxes are summarized
as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Income taxes computed at the federal statutory rate</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">(369,000</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">(281,000</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">States taxes, net of federal benefits</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(69,000</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(53,000</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Permanent differences</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(136,000</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">17,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">True-up adjustments</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">115,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">199,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Adjustment to net operating loss</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(17,000</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(86,000</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Change in valuation allowance</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">476,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">204,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Reported income tax (benefit) expense</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The components of the net
deferred tax assets as of December 31, 2020 and 2019 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Deferred tax assets:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 62%; padding-left: 10pt"><font style="font-size: 10pt">Net operating losses</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4,821,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4,081,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Equity compensation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">118,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">392,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Other deferred tax assets</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">169,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">149,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 20pt"><font style="font-size: 10pt">Total deferred tax assets</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,108,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">4,622,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Deferred tax liabilities:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Other deferred tax liabilities</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(68,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(58,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 20pt"><font style="font-size: 10pt">Total deferred tax liabilities</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(68,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(58,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Net deferred tax assets before valuation allowance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,040,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,564,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less valuation allowance</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(5,040,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(4,564,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Net deferred tax assets</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020,
the Company has U.S. federal and state net operating losses (&#8220;NOLs&#8221;) of approximately $19,322,000, of which $11,196,261
will expire, if not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December 31, 2017 do not expire
but may only be used against taxable income to 80%. In response to the novel coronavirus COVID-19, the Coronavirus Aid, Relief,
and Economic Security Act temporarily repealed the 80% limitation for NOLs arising in 2018, 2019 and 2020. Pursuant to Section
382 of the Internal Revenue Code of 1986, as amended, use of the Company&#8217;s NOLs carryforwards may be limited in the event
of cumulative changes in ownership of more than 50% within a three-year period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company must assess
the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes
that recovery is not likely, the Company establishes a valuation allowance. Management&#8217;s judgment is required in determining
the Company&#8217;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against
the net deferred tax assets. The Company recorded a full valuation allowance as of December 31, 2020 and 2019. Based on the available
evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the
foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal
of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions
that are consistent with the Company&#8217;s plans. Should the actual amounts differ from the Company&#8217;s estimates, the carrying
value of the Company&#8217;s deferred tax assets could be materially impacted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company is subject
to examination by the IRS for the calendar year 2016 and thereafter. These examinations may lead to ordinary course adjustments
or proposed adjustments to the Company&#8217;s taxes or the Company&#8217;s net operating losses with respect to years under examination
as well as subsequent periods. The Company has filed Colorado state income tax returns for years 2014 through 2019, Alaska, California
and Connecticut state income tax returns for the years 2017 through 2019, Michigan state income tax returns for the years 2018
and 2019 and Alabama, District of Columbia, Massachusetts, Oklahoma and Texas state income taxes in 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company recognizes
in its consolidated financial statements the impact of a tax position, if that position is more likely than not of being sustained
on audit, based on the technical merits of the position. The Company&#8217;s policy is to recognize interest and penalties accrued
on any unrecognized tax benefits as a component of operating expense. The Company does not believe there are any tax positions
for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease
within twelve months of the reporting date. There were no penalties or interest liabilities accrued as of December 31, 2020 or
2019, nor were any penalties or interest costs included in expense for the years ended December 31, 2020 and 2019.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224164667128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 16 &#8211; Subsequent Events </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In accordance with ASC 855, <i>Subsequent
Events</i>, the Company has evaluated all subsequent events through the date the financial statements were available to be issued. The
following events occurred after December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Board approved annual incentive
compensation awards to certain employees payable in non-qualified stock options, based on the Company&#8217;s performance and each employee&#8217;s
contributions to such performance for the 2020 year. A total of 1,035,800 non-qualified stock options were granted under the 2017 Equity
Plan subsequent to December 31, 2020, with an exercise price of $0.13 per share. These non-qualified stock options were immediately vested
at the date of the grant. The estimated compensation expense of $128,434 related to the 2020 incentive awards was accrued as of December
31, 2020. The accrued compensation expense was classified as a current liability as of December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As further discussed <i>in Note
10 Related Party Agreements and Transactions </i>above, on January 7, 2021, the Company entered into a consulting agreement with RSX Enterprises,
Inc. (RSX), a company controlled by Mr. James R. Shipley, a director of the Company. RSX will provide consulting services to the Company
focused on product offerings, engineering requirements, key customer marketing outreach, and related matters, as mutually determined by
the Company and RSX. The Company will pay a monthly consulting fee of $6,500 for up to 50 hours per month for the various consulting activities
undertaken and provide for reimbursement of expenses. The term of the agreement is set for three months. Any intellectual property developed
by RSX will belong to the Company, and the contract provides for typical indemnification obligations and confidentiality provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As further discussed in <i>Note
9 Note Payable and Accrued Interest</i> above, on February 10, 2021, we received funding based on a loan agreement entered into on February
9, 2021 with our current bank in the principal amount of $514,200 for working capital purposes. Consistent with the loan provisions, the
Company will use the proceeds to meet payroll and benefit expenses as well as for rent and utilities. The loan amount bears interest at
1% and is due on February 5, 2026. The loan may be repaid in advance without penalty. The loan has typical default provisions, including
for change of ownership, general lender insecurity as to repayment, non-payment of amounts due, defaults on other debt instruments, insolvency,
dissolution or termination of the business as a going concern and bankruptcy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As further discussed in Note 11
Commitments and Contingencies above, a former employee is pursuing litigation against the Company for recovery of alleged consulting fees
owed to him for the 2015 calendar year prior to his appointment as an executive officer of the Company. The Company strongly disputes the ongoing litigation and in the
remote event of an adverse outcome, the amount of any settlement loss for this case is not reasonably estimable as of the date
of the issuance of these financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224158977864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation; Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Financial Statement Presentation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Financial Statement
Presentation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The preparation of the
consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;)
requires management to make estimates and assumptions that affect reported amounts and related disclosures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As further discussed in
<i>Note 3 Going Concern</i> below, the accompanying consolidated financial statements have been prepared on a going-concern basis,
which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company
has not generated sufficient revenue and has historically funded its operations through the sale of common stock, the issuance
of debt and the receipt of advance payments from customers. The Company is subject to risks, expenses and uncertainties similar
to those encountered by similarly situated companies.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Principles of Consolidation
</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The consolidated financial
statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro Innovations, LLC (&#8220;Hydro&#8221;).
Intercompany transactions, profit, and balances are eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Use of Estimates</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Management makes estimates
and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities
at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period.
The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities
that are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation
of transaction prices to performance obligations under contracts with customers, standalone selling prices, timing of expected
revenue recognition on remaining performance obligations under contracts with customers, valuation of intangible assets as it applies
to impairment analysis, valuation of equity-based compensation, valuation of deferred tax assets and liabilities, warranty accruals,
inventory allowances, and legal contingencies.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Cash and Cash Equivalents</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">All highly liquid investments
with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may,
from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has not experienced
any losses to date on depository accounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable and Allowance for Doubtful Accounts</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Accounts Receivable
and Allowance for Doubtful Accounts</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Accounts receivables
are recorded at the invoiced amount or based on revenue earned for items not yet invoiced, and generally do not bear
interest. An allowance for doubtful accounts is established, as necessary, based on past experience and other factors, which,
in management&#8217;s judgment, deserve current recognition in estimating bad debts. Based on the Company&#8217;s review, it
establishes or adjusts the allowance for specific customers and the accounts receivable portfolio as a whole. As of December
31, 2020, and December 31, 2019, the allowance for doubtful accounts was $165,098 and $151,673, respectively. If the
financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments,
additional allowances may be required.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Inventory</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Inventory is stated
at the lower of cost or net realizable value. The inventory is valued based on a first-in, first-out (&#8220;FIFO&#8221;)
basis. Lower of cost or net realizable value is evaluated by considering obsolescence, excessive levels of inventory,
deterioration and other factors. Adjustments to reduce the cost of inventory to its net realizable value, if required, are
made for estimated excess, obsolescence or impaired inventory. Excess and obsolete inventory is charged to cost of revenue
and a new lower-cost basis for that inventory is established and subsequent changes in facts and circumstances do not result
in the restoration or increase in that newly established cost basis. As of December 31, 2020, and December 31, 2019, the
allowance for excess and obsolete inventory was $93,045 and $71,376, respectively.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Property and Equipment</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Property and equipment
are stated at cost. For financial statement purposes, property and equipment are recorded at cost and depreciated using the straight-line
method over their estimated useful lives, which is generally five years. Leasehold improvements are amortized on a straight-line
basis over the lesser of their useful lives or the life of the lease. Upon sale or retirement of assets, the cost and related accumulated
depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operations. Maintenance
and repairs are charged to operations as incurred.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-lived Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Long-lived Assets</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Long-lived tangible assets,
including property and equipment, are reviewed for impairment whenever events or changes in business circumstances indicate the
carrying value of the assets may not be recoverable. When such an event occurs, management determines whether there has been impairment
by comparing the anticipated undiscounted future net cash flows to the related asset&#8217;s carrying value. If an asset is considered
impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value,
depending on the nature of the asset. The Company has not identified any indicators of impairment during the years ended December
31, 2020 and 2019.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Goodwill and Intangible
Assets</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company recorded goodwill
in connection with its acquisition of Hydro in July 2014. Goodwill is reviewed for impairment annually on December 31<sup>st</sup>
or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less
than its carrying value. The Company performs a quantitative impairment test annually during the fourth quarter by comparing the
fair value of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds
its carrying amount, goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the
carrying amount exceeds the reporting unit&#8217;s fair value. The Company determined that it has one reporting unit. The Company
completed this assessment as of December 31, 2020 and concluded that no impairment existed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Separable identifiable
intangibles consist of intellectual property such as patents and trademarks, and capitalized website costs. Except for trademarks,
which are not amortized, the Company&#8217;s separable identifiable intangible assets are subject to amortization on a straight-line
basis over their estimated useful lives. Trademarks are tested annually for impairment. Separable identifiable intangibles are
also subject to evaluation for potential impairment if events or circumstances indicate the carrying value may not be recoverable.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurement</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Fair Value Measurement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company records its
financial assets and liabilities at fair value. The accounting standard for fair value provides a framework for measuring fair
value, clarifies the definition of fair value, and expands disclosures regarding fair value measurements. Fair value is defined
as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction
between market participants at the reporting date. The accounting standard establishes a three-tier hierarchy, which prioritizes
the inputs used in the valuation methodologies in measuring fair value:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Level 1 - inputs are quoted
prices (unadjusted) in active markets for identical assets or liabilities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 2 - inputs are quoted prices
for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly
or indirectly through market corroboration, for substantially the full term of the financial instrument.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">Level 3 - inputs are unobservable
inputs based on the Company&#8217;s assumptions used to measure assets and liabilities at fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A financial asset or liability&#8217;s
classification within the hierarchy is determined based on the lowest level of input that is significant to the fair value measurement.
The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety requires
management to make judgments and consider factors specific to the asset or liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Due to their short-term
nature, the carrying values of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses, approximate
fair value.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Derivative Financial
Instruments</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company evaluates
its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded
derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is
initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in
the statements of operations. For stock-based derivative financial instruments, the Company uses the Black-Scholes Option
Pricing Model (the &#8220;Black-Scholes Model&#8221;) to value the derivative instruments. The classification of derivative
instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of
each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based
on whether or not net-cash settlement of the derivative instrument could be required within twelve months of the balance
sheet date. As of December 31, 2020, and December 31, 2019, there were no derivative financial instruments.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Revenue Recognition</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On January 1, 2018, the
Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 (Topic 606), <i>Revenue from Contracts with Customers</i>
and all the related amendments (&#8220;ASC 606&#8221; or the &#8220;revenue standard&#8221;) to all contracts and elected the modified
retrospective method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets
forth the Company&#8217;s revenue by source:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Years Ended December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="white-space: nowrap; width: 68%"><font style="font-size: 10pt">Equipment and systems sales</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">7,730,371</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">13,692,863</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap"><font style="font-size: 10pt">Engineering and other services</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">568,131</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,239,130</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Shipping and handling</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,770</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">292,461</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total revenue</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,514,272</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">15,224,454</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><u>Revenue Recognition
Accounting Policy Summary</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company accounts for
revenue in accordance with ASC 606. Under the revenue standard, a performance obligation is a promise in a contract with a customer
to transfer a distinct good or service to the customer. Most of the Company&#8217;s contracts contain multiple performance obligations
that include engineering and technical services as well as the delivery of a diverse range of climate control system equipment
and components, which can span multiple phases of a customer&#8217;s project life-cycle from facility design and construction to
equipment delivery and system installation and start-up. The Company does not provide construction services or system installation
services. Some of the Company&#8217;s contracts with customers contain a single performance obligation, typically engineering only
services contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A contract&#8217;s transaction
price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is
satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price to each
performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&#8217;s actual selling price for the same good or service, however, this input
is generally not available for the Company&#8217;s contracts containing multiple performance obligations. For engineering services,
the Company estimates the standalone selling price by reference to certain physical characteristics of the project, such as facility
size and mechanical systems involved, which are indicative of the scope and complexity of the mechanical engineering services to
be provided. For equipment sales, the standalone selling price is determined by forecasting the expected costs of the equipment
and components and then adding an appropriate margin, based on a range of acceptable margins established by management. Depending
on the nature of the performance obligations, the Company may use a combination of different methods and observable inputs if certain
performance obligations have highly variable or uncertain standalone selling prices. Once the selling prices are determined, the
Company applies the relative values to the total contract consideration and estimates the amount of the transaction price to be
recognized as each promise is fulfilled.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Generally, satisfaction
occurs when control of the promised goods is transferred to the customer or as services are rendered or completed in exchange for
consideration in an amount for which the Company expects to be entitled. The Company recognizes revenue for the sale of goods when
control transfers to the customer, which primarily occurs at the time of shipment. The Company&#8217;s historical rates of return
are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the time the
Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g., sales,
use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing
transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The
revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&#8217;s customers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company also has performance
obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type
of performance obligation as services are rendered based on the percentage completion towards certain specified milestones.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company offers assurance-type
warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers
and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve
based on historical warranty costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><u>Other Judgments and
Assumptions</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company typically receives
customer payments in advance of its performance of services or transfers of goods. Applying the practical expedient in ASC 606-10-32-18,
which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of a significant
financing component since the Company expects, at contract inception, that the period between when the Company transfers a promised
good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the remaining
performance obligations related to customer contracts does not consider the effects of the time value of money.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Applying the practical
expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since
the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only
when associated revenue has been collected and earned by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><u>Contract Assets and
Contract Liabilities</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Contract assets reflect
revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments
received in advance of the satisfaction of performance under the contract. The Company receives payments from customers based on
the terms established in its contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Contract assets include
unbilled amounts where revenue recognized exceeds the amount billed to the customer and the right of payment is conditional, subject
to completing a milestone, such as a phase of a project. The Company typically does not have material amounts of contract assets
since revenue is recognized as control of goods are transferred or as services are performed. As of December 31, 2020, and 2019,
the Company had no contract assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Contract liabilities
consist of advance payments in excess of revenue recognized. The Company&#8217;s contract liabilities are recorded as a
current liability in deferred revenue in the consolidated balance sheets since the timing of when the Company expects to
recognize revenue is generally less than one year. As of December 31, 2020, and December 31, 2019, deferred revenue, which
was classified as a current liability, was $3,724,189 and $1,444,472, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the year ended December
31, 2020, the Company recognized revenue of $1,103,447 related to the deferred revenue at January 1, 2020, or 76%. For the year
ended December 31, 2019, the Company recognized revenue of $473,682 related to the deferred revenue at January 1, 2019, or 74%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><u>Remaining Performance
Obligations</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Remaining performance obligations,
or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has
not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which
exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts,
including those with an expected duration of one year or less.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Industry uncertainty, project
financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#8217;s control,
make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are
risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&#8217;s cultivation facility project is dependent upon the customer&#8217;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time
it takes for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by
numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business;
(ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government
delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states
where there is no cap on the number of cultivators; (iv) the customer&#8217;s need to obtain cultivation facility financing; (v)
the time needed, and coordination required, for our customers to acquire real estate and properly design and build the facility
(to the stage when climate control systems can be installed); (vi) the large price tag and technical complexities of the climate
control and air sanitation system; (vii) the availability of power; and (viii) delays that are typical in completing any construction
project. Further, based on the current economic climate, the uncertainty regarding the COVID-19 virus, and the Company&#8217;s
recent cost cutting measures, there is no assurance that the Company will be able to fulfill its backlog, and the Company may experience
contract cancellations, project scope reductions and project delays.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2020,
the Company&#8217;s remaining performance obligations, or backlog, was $8,448,000, of which $2,643,000, or 31%, was attributable
to customer contracts for which the Company has only received an initial advance payment to cover the allocated value of the Company&#8217;s
engineering services (&#8220;engineering only paid contracts&#8221;). There is the risk that the equipment portion of these engineering
only paid contracts will not be completed or will be delayed. The reasons include the customer being dissatisfied with the quality
or timeliness of the Company&#8217;s engineering services, delay or abandonment of the project because of the customer&#8217;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall
post-COVID-19 economic downturn, or change in business direction. After the customer has made an advance payment for a portion
of the equipment to be delivered under the contract (&#8220;partial equipment paid contracts&#8221;), the Company is typically
better able to estimate the timing of revenue recognition since the risks and delays associated with licensing, permitting and
project funding are typically mitigated once the initial equipment payment is received. There is significant uncertainty regarding
the timing of the Company&#8217;s recognition of revenue on its remaining performance obligations, and there is no certainty that
these will result in actual revenues. The backlog at December 31, 2020, includes booked sales orders of $390,000 from several customers
that the Company does not expect to be realized until 2022, if at all. Given the present economic uncertainty arising from the
impact of the novel coronavirus COVID-19, the Company believes that several of its current contracts may be delayed or canceled.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The remaining performance
obligations expected to be recognized through 2022 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2022</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Total</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 55%"><font style="font-size: 10pt">Remaining performance obligations related to engineering only paid contracts</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">2,355,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">288,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">2,643,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Remaining performance obligations related to partial equipment paid contracts</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,703,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">102,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,805,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total remaining performance obligations</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,058,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">390,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,448,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Product Warranty</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Product Warranty</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company warrants the
products that it manufactures for a warranty period equal to the lesser of 12 months from start-up or 18 months from shipment.
The Company&#8217;s warranty provides for the repair, rework, or replacement of products (at the Company&#8217;s option) that fail
to perform within stated specification. The Company&#8217;s third-party suppliers also warrant their products under similar terms,
which are passed through to the Company&#8217;s customers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company assesses the
historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue
generated on these products. Based on the Company&#8217;s warranty policy, an accrual is established at 1% of the trailing 18 months
revenue. The Company continues to assess the need to record a warranty reserve at the time of sale based on historical claims and
other factors. As of December 31, 2020, and December 31, 2019, the Company had an accrued warranty reserve amount of $173,365 and $185,234,
respectively, which are included in accounts payable and accrued liabilities on the Company&#8217;s consolidated balance sheets.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Sales</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Cost of Sales</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Cost of sales includes
product costs (material, direct labor and overhead costs), shipping and handling expense, outside engineering costs, engineering,
project management and service salaries and benefits, client visits and warranty.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Concentrations</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Three customers accounted
for 28%, 11% and 10% of the Company&#8217;s revenue for the year ended December 31, 2020. One customer accounted for 44% of the
Company&#8217;s revenue for the year ended December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s accounts
receivable from two customers made up 48% and 38%, respectively, of the total balance as of December 31, 2020. The Company&#8217;s
accounts receivable from three customers made up 59%, 16%, and 10%, respectively, of the total balance as of December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Three suppliers accounted
for 27%, 25% and 12% of the Company&#8217;s purchases of inventory for the year ended December 31, 2020, and three suppliers accounted
for 30%, 17% and 12% of the Company&#8217;s purchases of inventory for the year ended December 31, 2019.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Product Development</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Product Development</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company expenses
product development costs as incurred. Internal product development costs are expensed as incurred, and third-party product
developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. For
the years ended December 31, 2020 and December 31, 2019, the Company incurred $390,229 and $521,044, respectively, on product
development.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Accounting for Share-Based Compensation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Accounting for Share-Based
Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company recognizes
the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted
stock units that the Company grants under its equity incentive plan in its consolidated financial statements based on their grant
date fair value. For awards subject to service conditions, compensation expense is recognized over the vesting period on a straight-line
basis. Awards subject to performance conditions are attributed separately for each vesting tranche of the award and are recognized
ratably from the service inception date to the vesting date for each tranche, based on the probability of vesting. The probability
of awards with future performance conditions is evaluated each reporting period and compensation expense is adjusted based on the
probability assessment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Awards are considered granted,
and the service inception date begins, when mutual understanding of the key terms and conditions of the award between the Company
and the recipient has been established. For awards that provide discretion to adjust the amount of the award, the service inception
date for such awards could precede the grant date as a mutual understanding of the key terms and conditions of the award between
the Company and the recipient has not yet been established. For awards in which the service inception date precedes the grant date,
compensation cost is accrued beginning on the service inception date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Subsequent to December
31, 2020, the Company&#8217;s Board of Directors (the &#8220;Board&#8221;) approved annual incentive compensation awards to certain
employees payable in non-qualified stock options, based on the Company&#8217;s performance and each employee&#8217;s contributions
to such performance for the 2020 year. See Note 16. The non-qualified stock options were granted subsequent to December 31, 2020,
were not subject to an additional service requirement and were immediately vested at the date of the grant. The final amount of
the annual incentive compensation award, and number of non-qualified stock options granted, were determined, and communicated to
the employee, subsequent to December 31, 2020. The estimated compensation expense of $128,434 related to the 2020 incentive awards
was accrued as of December 31, 2020. Since such incentive awards will be settled in non-qualified stock options, the accrued compensation
expense has been classified as a current liability until the number of non-qualified stock options is fixed pursuant to a grant
by the Board. At that time, the incentive award becomes equity-classified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The grant date fair value
of stock options is based on the Black-Scholes Model. The Black-Scholes Model requires judgmental assumptions including volatility
and expected term, both based on historical experience. The risk-free interest rate is based on U.S. Treasury interest rates whose
term is consistent with the expected term of the option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The grant date fair value
of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has elected
to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical
data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups of
employees have significantly different forfeiture expectations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Share-based compensation
costs (including expenses from the accrued compensation liabilities related to the annual incentive awards subsequently settled
in non-qualified stock options totaled $405,617 and $1,292,065 for the years ended December 31, 2020 and 2019, respectively. Such
share-based compensation costs are classified in the Company&#8217;s consolidated financial statements in the same manner as if
such compensation was paid in cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following is a summary
of such share-based compensation costs included in the Company&#8217;s consolidated statements of operations for the years ended
December 31, 2020 and 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Years Ended December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Share-based compensation expense included in:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 62%"><font style="font-size: 10pt">Cost of revenue</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">31,006</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">91,081</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Advertising and marketing expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">8,333</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">33,977</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Product development costs</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">21,882</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">45,330</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Selling, general and administrative expenses</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">344,396</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,121,677</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total share-based compensation expense included in consolidated statement of operations</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">405,617</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,292,065</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Income Taxes</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company accounts for
income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the
expected future tax consequences of events that have been included in the financial statements. Under this method, the Company
determines deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of
assets and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The
effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the
enactment date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company recognizes
deferred tax assets to the extent that the Company believes that these assets are more likely than not to be realized. In making
such a determination, the Company considers all available positive and negative evidence, including future reversals of existing
taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the
Company determines that it would be able to realize its deferred tax assets in the future in excess of their net recorded amount,
the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income
taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company records uncertain
tax positions on the basis of a two-step process in which: (i) the Company determines whether it is more likely than not that the
tax positions will be sustained on the basis of the technical merits of the position, and (ii) for those tax positions that meet
the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more likely than
not to be realized upon ultimate settlement with the related tax authority.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Net Loss Per Common Share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Basic and Diluted
Net Loss per Common Share</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Basic income (loss) per
common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common
shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per common share
is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in
periods when losses are reported where the effect of the common stock equivalents would be antidilutive. Potential common stock
equivalents consist of common stock issuable upon exercise of stock options and warrants and the vesting of restricted stock units
using the treasury method. As of December 31, 2020, 29,213,500 potential common shares equivalents from warrants and options were
excluded from the diluted EPS calculations as their effect is anti-dilutive.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Commitments and Contingencies</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In the normal course of
business, the Company is subject to loss contingencies, such as legal proceedings and claims arising out of its business, that
cover a wide range of matters, including, among others, customer disputes, government investigations and tax matters. An accrual
for a loss contingency is recognized when it is probable that an asset had been impaired or a liability had been incurred and the
amount of loss can be reasonably estimated.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_OtherRisksAndUncertaintiesPolicyTextBlock', window );">Other Risks and Uncertainties</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Other Risks and Uncertainties</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">To achieve profitable operations,
the Company must successfully develop, manufacture and market its products. There can be no assurance that any such products can
be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that such products will
be successfully marketed. These factors could have a material adverse effect upon the Company&#8217;s financial results, financial
position, and future cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company is subject
to risks common to similarly-situated companies including, but not limited to, general economic conditions, its customers&#8217;
operations and access to capital, and market and business disruptions including severe weather conditions, natural disasters, health
hazards, terrorist activities, financial crises, political crises or other major events, or the prospect of these events, new technological
innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, uncertainty
of market acceptance of products, product liability, and the need to obtain additional financing. As a supplier of services and
equipment to cannabis cultivators, the Company is also subject to risks related to the cannabis industry. Although certain states
have legalized medical and/or recreational cannabis, U.S. federal laws continue to prohibit marijuana in all its forms as well
as its derivatives. Any changes in the enforcement of U.S. federal laws may adversely affect the implementation of state and local
cannabis laws and regulations that permit medical or recreational cannabis and, correspondingly, may adversely impact the Company&#8217;s
customers. The Company&#8217;s success is also dependent upon its ability to raise additional capital and to successfully develop
and market its products. See Note 3.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Segment Information</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Operating segments are
defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the
Company&#8217;s senior management team in deciding how to allocate resources and in assessing performance. The Company has one
operating segment that is dedicated to the manufacture and sale of its products.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Recently Issued Accounting
Pronouncements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In August 2020, the FASB
issued ASU 2020-06: &#8220;<i>Accounting for Convertible Instruments and Contracts In An Entity&#8217;s Own Equity&#8221; (&#8220;ASU
2020-06&#8221;)</i> ASU 2020-04 simplifies the accounting for certain convertible instruments by removing the separation models
for convertible debt with a cash conversion feature and for convertible instruments with a beneficial conversion feature. As a
result, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded
conversion features. Additionally, ASU 2020-04 amends the diluted earnings per share calculation for convertible instruments by
requiring the use of the if-converted method. The treasury stock method is no longer available. Entities may adopt the ASU 2020-04
using either a full or modified retrospective approach, and it is effective for interim and annual reporting periods beginning
after December 15, 2021. Early adoption is permitted for interim and annual reporting periods beginning after December 15, 2020.
The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash flows and financial
position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In December 2019, the FASB
issued ASU 2019-12, <i>Income Taxes (Topic 740) &#8211; Simplifying the Accounting for Income Taxes, </i>which simplifies the accounting
for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent
application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12 is effective
for fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company does not expect this ASU to have a
material impact on its consolidated results of operations, cash flows and financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Other accounting standards
that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material
impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to
have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_OtherRisksAndUncertaintiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Risks and Uncertainties [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_OtherRisksAndUncertaintiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6052-115624<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224161709384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation; Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue by Source</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets
forth the Company&#8217;s revenue by source:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Years Ended December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="white-space: nowrap; width: 68%"><font style="font-size: 10pt">Equipment and systems sales</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">7,730,371</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">13,692,863</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap"><font style="font-size: 10pt">Engineering and other services</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">568,131</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,239,130</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Shipping and handling</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,770</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">292,461</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total revenue</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,514,272</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">15,224,454</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock', window );">Schedule of Remaining Performance Obligations Expected to be Recognized</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The remaining performance
obligations expected to be recognized through 2022 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2022</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Total</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 55%"><font style="font-size: 10pt">Remaining performance obligations related to engineering only paid contracts</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">2,355,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">288,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">2,643,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Remaining performance obligations related to partial equipment paid contracts</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,703,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">102,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,805,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total remaining performance obligations</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,058,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">390,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">8,448,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of Share-based Compensation Costs</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following is a summary
of such share-based compensation costs included in the Company&#8217;s consolidated statements of operations for the years ended
December 31, 2020 and 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Years Ended December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Share-based compensation expense included in:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 62%"><font style="font-size: 10pt">Cost of revenue</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">31,006</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">91,081</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Advertising and marketing expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">8,333</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">33,977</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Product development costs</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">21,882</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">45,330</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Selling, general and administrative expenses</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">344,396</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,121,677</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total share-based compensation expense included in consolidated statement of operations</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">405,617</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,292,065</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of expected timing for satisfying remaining performance obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224161616104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Cost</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The lease cost, cash flows
and other information related to the Facility Lease were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center"><font style="font-size: 10pt"><b>For the Year Ended</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap; text-align: center"><font style="font-size: 10pt"><b>December 31, 2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%"><font style="font-size: 10pt">Operating lease cost</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 10pt">216,889</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Operating cash outflow from operating lease</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">160,934</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 82%; padding-bottom: 1.5pt">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>December 31, 2020</b></p></td>
    <td style="width: 1%; padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Operating lease right-of-use assset</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">343,950</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Operating lease liability, current</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">266,105</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Operating lease liability, long-term</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">169,119</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Remaining lease term</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.7 years</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Discount rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.00</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Annual Minimum Lease Payments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Future annual minimum lease
payments on the Facility Lease as of December 31, 2020 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt"><b>Years ended December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 82%"><font style="font-size: 10pt">2021</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 15%; text-align: right"><font style="font-size: 10pt">281,864</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">2022</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">170,891</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Total minimum lease payments</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">452,755</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Less imputed interest</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(17,531</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Present value of minimum lease payments</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">435,224</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224164579976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Inventory consisted of
the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>As of December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Finished goods</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">201,778</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,041,369</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Work in progress</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,231</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3,851</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Raw materials</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">214,145</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">257,399</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Allowance for excess &#38; obsolete inventory</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(93,045</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(71,376</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Inventory, net</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">327,109</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,231,243</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224168784616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Property and equipment
consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>As of December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%; text-align: justify"><font style="font-size: 10pt">Furniture and equipment</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">398,422</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">389,090</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Vehicles</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Leasehold improvements</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,193</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,193</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">628,615</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">619,283</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Accumulated depreciation</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(480,883</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(361,360</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Property and equipment, net</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">147,732</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">257,923</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224164597368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Intangible assets consisted
of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>As of December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Patents</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">8,110</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">12,234</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Website development costs</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">22,713</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">22,713</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Trademarks</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,830</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,830</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">32,653</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">36,777</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Accumulated amortization</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(25,426</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(24,847</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Intangible assets, net</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">7,227</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">11,930</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224168856296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Accounts payable and accrued
liabilities consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>As of December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Accounts payable</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">918,639</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,299,015</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Sales commissions payable</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">48,263</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">69,532</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Accrued payroll liabilities</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">288,071</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">169,052</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Product warranty accrual</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">173,365</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">185,234</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Other accrued expenses</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">356,623</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">110,127</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt">Total</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,784,961</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,832,959</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224162083944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Outstanding Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock', window );">Schedule of Outstanding Warrants to Purchase Common Stock</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table summarizes
information with respect to outstanding warrants to purchase common stock during the years ended December 31, 2020 and 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Aggregate</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Number</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="white-space: nowrap; text-align: center"><font style="font-size: 10pt"><b>Remaining Life</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Intrincic</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Outstanding</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>In Months</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 44%"><font style="font-size: 10pt">Outstanding at December 31, 2018</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">40,010,250</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.25</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">21</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Issued</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(901,250</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(0.66</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Outstanding at December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">39,109,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.24</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Issued</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(31,546,500</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(0.23</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding at December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">7,562,500</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.25</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Warrants Outstanding</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table summarizes
information about warrants outstanding at December 31, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Weighted Average Life of</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Warrants</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Outstanding Warrants</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">Exercise price</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Outstanding</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">In Months</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 1%">&#160;</td>
    <td style="width: 32%; text-align: right"><font style="font-size: 10pt">0.25</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 30%; text-align: right"><font style="font-size: 10pt">7,562,500</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 30%; text-align: right"><font style="font-size: 10pt">6</font></td>
    <td style="width: 1%">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Outstanding Warrants to Purchase Common Stock Table TextBlock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224270008664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plan (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Restricted Stock Units Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of the RSUs awarded
to employees, directors and consultants under the 2017 Equity Plan during the years ended December 31, 2020 and 2019 are presented
in the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Number of</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Units</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Weighted</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Average</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Grant-Date</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Fair Value</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Aggregate</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Intrinsic</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Value</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 55%"><font style="font-size: 10pt">Outstanding, December 31, 2018</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">9,867,368</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">0.140</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">730,185</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Vested and settled with share issuance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(1,120,000</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.181</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Forfeited/canceled</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,197,368</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">0.179</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Outstanding, December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7,550,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.128</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Vested and settled with share issuance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(6,750,000</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.121</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Forfeited/canceled</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(800,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">0.184</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding, December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock', window );">Schedule of Incentive Bonus Awards Granted to Employees</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of the
incentive stock bonus awards granted to employees under the 2017 Equity Plan during the years ended December 31, 2020 and
2019 are presented in the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Number of</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Shares</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Weighted</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Average Grant-Date</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Fair Value</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Aggregate</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Intrinsic</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Value</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Tahoma, Helvetica, Sans-Serif">&#65279;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 55%"><font style="font-size: 10pt">Unvested, December 31, 2018</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">1,680,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">0.112</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">124,320</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Awarded</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(1,680,000</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.112</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Forfeited</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Unvested, December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Awarded</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Vested<sup>1</sup></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Forfeited</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Unvested, December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandSeventeenEquityPlanMember', window );">2017 Equity Plan [Member] | Employees and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the years ended
December 31, 2020 and 2019 are presented in the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Options</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Term</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Aggregate Intrinsic</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Value</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 44%"><font style="font-size: 10pt">Outstanding, December 31, 2018</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">10,560,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.104</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">8.4</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.080</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(2,408,333</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.116</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(16,667</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">0.105</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Outstanding, December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10,135,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.096</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7.7</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6,616,900</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.070</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10.0</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(2,500,900</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">0.101</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">4.3</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding, December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">14,251,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">0.083</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">8.3</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Exercisable, December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">14,251,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">0.083</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">8.3</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Summary of Non-vested Non-qualified Stock Option Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of non-vested
non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the years ended December 31,
2020 and 2019 are presented in the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Tahoma, Helvetica, Sans-Serif">&#65279;</font></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number of<br />
Options</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted<br />
Average<br />
Grant-Date<br />
Fair Value</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Aggregate<br />
Intrinsic<br />
Value</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Grant-Date<br />
Fair Value</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font: 10pt Tahoma, Helvetica, Sans-Serif">&#65279;</font></td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 46%"><font style="font: 10pt Times New Roman, Times, Serif">Nonvested, December 31, 2018</font></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">7,333,329</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.086</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">628,756</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 6.75pt"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.065</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">130,120</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 6.75pt"><font style="font: 10pt Times New Roman, Times, Serif">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(4,924,996</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.074</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">362,998</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 6.75pt"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(2,408,333</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.102</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">246,344</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 6.75pt"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Nonvested, December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">2,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.075</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">149,534</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 6.75pt"><font style="font: 10pt Times New Roman, Times, Serif">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">6,616,900</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.059</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">387,199</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 6.75pt"><font style="font: 10pt Times New Roman, Times, Serif">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">(8,616,900</font></td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">0.062</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">536,733</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 6.75pt"><font style="font: 10pt Times New Roman, Times, Serif">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 6.75pt"><font style="font: 10pt Times New Roman, Times, Serif">Expired</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font: 10pt Times New Roman, Times, Serif">Nonvested, December 31, 2020</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td>&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandSeventeenEquityPlanMember', window );">2017 Equity Plan [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of the non-qualified
stock options granted to directors under the 2017 Equity Plan during the years ended December 31, 2020 and 2019 are presented in
the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Number of</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Options</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Weighted</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Average</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Exercise</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Price</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Weighted</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Average</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Remaining</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Contractual</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Term</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Aggregate</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Intrinsic</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Value ($000)</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 44%"><font style="font-size: 10pt">Outstanding, December 31, 2018</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">900,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.135</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">8.6</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Forfeited/Cancelled</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Outstanding, December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">900,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.135</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7.6</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6,500,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.057</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">8.5</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Forfeited/Cancelled</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding, December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">7,400,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">0.067</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">7.5</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Exerciseable, December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,400,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">0.073</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">8.0</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Summary of Non-vested Non-qualified Stock Option Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of non-vested
non-qualified stock options activity for directors under the 2017 Equity Plan for the years ended December 31, 2020 and 2019 are
presented in the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><font style="font: 10pt Tahoma, Helvetica, Sans-Serif">&#65279;</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Options</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Grant-Date Fair Value</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Aggregate Intrinsic Value</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Grant-Date Fair Value</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font: 10pt Tahoma, Helvetica, Sans-Serif">&#65279;</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Nonvested, December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Nonvested, December 31, 2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 44%; padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">6,500,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.057</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">373,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(5,500,000</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.063</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">344,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Nonvested, December 31, 2020</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,000,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">0.029</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">5,800</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">29,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for outstanding performance shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224162955208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The differences between
income taxes expected at the U.S. federal statutory income tax rate and the reported provision for income taxes are summarized
as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Income taxes computed at the federal statutory rate</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">(369,000</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">(281,000</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">States taxes, net of federal benefits</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(69,000</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(53,000</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Permanent differences</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(136,000</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">17,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">True-up adjustments</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">115,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">199,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Adjustment to net operating loss</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(17,000</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(86,000</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Change in valuation allowance</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">476,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">204,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Reported income tax (benefit) expense</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The components of the net
deferred tax assets as of December 31, 2020 and 2019 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2019</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Deferred tax assets:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 62%; padding-left: 10pt"><font style="font-size: 10pt">Net operating losses</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4,821,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4,081,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Equity compensation</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">118,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">392,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Other deferred tax assets</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">169,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">149,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 20pt"><font style="font-size: 10pt">Total deferred tax assets</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5,108,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">4,622,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Deferred tax liabilities:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Other deferred tax liabilities</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(68,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(58,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 20pt"><font style="font-size: 10pt">Total deferred tax liabilities</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(68,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(58,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Net deferred tax assets before valuation allowance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,040,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,564,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less valuation allowance</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(5,040,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(4,564,000</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Net deferred tax assets</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224159699432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 165,098<span></span>
</td>
<td class="nump">$ 151,673<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment useful lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">$ 3,724,189<span></span>
</td>
<td class="nump">1,444,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">$ 1,103,447<span></span>
</td>
<td class="nump">$ 473,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage', window );">Revenue recognized, percentage</a></td>
<td class="nump">76.00%<span></span>
</td>
<td class="nump">74.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 8,448,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining performance obligations, percentage</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyDescription', window );">Product warranty description</a></td>
<td class="text">The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company's warranty policy, an accrual is established at 1% of the trailing 18 months revenue. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Product development costs</a></td>
<td class="nump">$ 390,229<span></span>
</td>
<td class="nump">$ 521,044<span></span>
</td>
<td class="nump">$ 32,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation cost</a></td>
<td class="nump">$ 405,617<span></span>
</td>
<td class="nump">$ 1,292,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Potentially dilutive equity instruments that are convertible into common stock</a></td>
<td class="nump">29,213,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndTwentyIncentiveAwardsMember', window );">2020 Incentive Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation cost</a></td>
<td class="nump">$ 128,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Customer One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">28.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Customer Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Customer Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | One Customer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">59.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk [Member] | Purchases of Inventory [Member] | Supplier One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk [Member] | Purchases of Inventory [Member] | Supplier Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk [Member] | Purchases of Inventory [Member] | Supplier Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts Payable and Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Accrued warranty reserve</a></td>
<td class="nump">$ 173,365<span></span>
</td>
<td class="nump">$ 185,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember', window );">2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">390,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Customer Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">2,643,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=us-gaap_InventoryValuationAndObsolescenceMember', window );">Inventory Valuation and Obsolescence [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryAdjustments', window );">Inventory adjustments</a></td>
<td class="nump">$ 93,045<span></span>
</td>
<td class="nump">$ 71,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with customer liability revenue recognized percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ContractWithCustomerLiabilityRevenueRecognizedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of inventory reserves for last-in first-out (LIFO) and other inventory valuation methods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the nature of the product warranty, including the approximate term of the product warranty, how the product warranty arose, and the events or circumstances that would require the warrantor to perform under the product warranty.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12069-110248<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndTwentyIncentiveAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndTwentyIncentiveAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=SRNA_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=SRNA_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=SRNA_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=SRNA_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=SRNA_CustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=SRNA_CustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=SRNA_OneCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=SRNA_OneCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=SRNA_PurchasesOfInventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=SRNA_PurchasesOfInventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_SupplierOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_SupplierOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_SupplierTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_SupplierTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_SupplierThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_SupplierThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=us-gaap_InventoryValuationAndObsolescenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=us-gaap_InventoryValuationAndObsolescenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224163243960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Revenue by Source (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 8,514,272<span></span>
</td>
<td class="nump">$ 15,224,454<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_EquipmentMember', window );">Equipment and Systems Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">7,730,371<span></span>
</td>
<td class="nump">13,692,863<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SRNA_EngineeringAndOtherServicesMember', window );">Engineering and Other Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">568,131<span></span>
</td>
<td class="nump">1,239,130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 215,770<span></span>
</td>
<td class="nump">$ 292,461<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SRNA_EngineeringAndOtherServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SRNA_EngineeringAndOtherServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224161820136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts', window );">Remaining performance obligations related to engineering only paid contracts</a></td>
<td class="nump">$ 2,643,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts', window );">Remaining performance obligations related to partial equipment paid contracts</a></td>
<td class="nump">5,805,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total remaining performance obligations</a></td>
<td class="nump">8,448,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyOneMember', window );">2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts', window );">Remaining performance obligations related to engineering only paid contracts</a></td>
<td class="nump">2,355,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts', window );">Remaining performance obligations related to partial equipment paid contracts</a></td>
<td class="nump">5,703,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total remaining performance obligations</a></td>
<td class="nump">8,058,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember', window );">2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts', window );">Remaining performance obligations related to engineering only paid contracts</a></td>
<td class="nump">288,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts', window );">Remaining performance obligations related to partial equipment paid contracts</a></td>
<td class="nump">102,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total remaining performance obligations</a></td>
<td class="nump">$ 390,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining performance obligations related to engineering only paid contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining performance obligations related to partial equipment paid contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224159689352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Share-based Compensation Costs (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="nump">$ 405,617<span></span>
</td>
<td class="nump">$ 1,292,065<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="nump">31,006<span></span>
</td>
<td class="nump">91,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_AdvertisingMember', window );">Advertising and Marketing Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="nump">8,333<span></span>
</td>
<td class="nump">33,977<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Product Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="nump">21,882<span></span>
</td>
<td class="nump">45,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="nump">$ 344,396<span></span>
</td>
<td class="nump">$ 1,121,677<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_AdvertisingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_AdvertisingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224167877240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Going Concern (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (1,758,716)<span></span>
</td>
<td class="num">$ (1,338,566)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(27,443,643)<span></span>
</td>
<td class="num">(25,684,927)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholder's deficit</a></td>
<td class="num">(1,333,698)<span></span>
</td>
<td class="num">(355,631)<span></span>
</td>
<td class="nump">$ 194,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 8,514,272<span></span>
</td>
<td class="nump">15,224,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DecreaseInRevenuePercentage', window );">Decrease in revenue percentage</a></td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flow from operating activities</a></td>
<td class="nump">$ 818,036<span></span>
</td>
<td class="nump">671,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_WorkingCapitalDeficit', window );">Working capital deficit</a></td>
<td class="nump">$ 2,220,000<span></span>
</td>
<td class="nump">$ 1,437,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DecreaseInRevenuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in revenue percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DecreaseInRevenuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Working capital deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224159428408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 02, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 02, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 02, 2018 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 27, 2017 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 02, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 343,950<span></span>
</td>
<td class="nump">$ 534,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 435,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">ASU 2016-02 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditCurrent', window );">Deferred rent reclassified to operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">714,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">822,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_UnamortizedAmountOfTenantImprovementAllowance', window );">Unamortized amount of tenant improvement allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">ASU 2016-02 [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TenantImprovements', window );">Tenant improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SRNA_FacilityLeaseMember', window );">Facility Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of land | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,600<span></span>
</td>
<td class="nump">12,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Lease rental expense</a></td>
<td class="nump">$ 20,135<span></span>
</td>
<td class="nump">$ 19,549<span></span>
</td>
<td class="nump">$ 18,979<span></span>
</td>
<td class="nump">$ 12,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Operating lease term description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Until August 31, 2018<span></span>
</td>
<td class="text">Until January 1, 2018<span></span>
</td>
<td class="text">On each September 1 through the end of the lease, the monthly rent will increase by 3%.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForDeposits', window );">Payment to deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SRNA_AgreementWithLandLordMember', window );">Agreement with Landlord [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Lease rental expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Operating lease term description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The deposit required on the lease will be reduced to approximately $32,000 and will be payable in 12 monthly installments from January through December of 2021. Further, the landlord also agreed to defer payment of fifty percent of the three months of lease payments (base rent only) for the period July to September 2020. The deferred lease payments amount to approximately $30,000 and will be payable in 12 monthly installments from January to December 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_UnamortizedAmountOfTenantImprovementAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unamortized amount of tenant improvement allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_UnamortizedAmountOfTenantImprovementAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the cumulative difference as of the balance sheet date between the payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, within one year of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549951&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of lessee's operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for deposits on goods and services during the period; excludes time deposits and deposits with other institutions, which pertain to financial service entities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8,17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of improvements having a life longer than one year that were made for the benefit of one or more tenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SRNA_FacilityLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SRNA_FacilityLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SRNA_AgreementWithLandLordMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SRNA_AgreementWithLandLordMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224169202600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Lease Cost (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 216,889<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflow from operating lease</a></td>
<td class="nump">160,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">343,950<span></span>
</td>
<td class="nump">$ 534,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">266,105<span></span>
</td>
<td class="nump">217,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, long-term</a></td>
<td class="nump">$ 169,119<span></span>
</td>
<td class="nump">$ 404,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Remaining lease term</a></td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Discount rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224161734376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Future Annual Minimum Lease Payments (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 281,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">170,891<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">452,755<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(17,531)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of minimum lease payments</a></td>
<td class="nump">$ 435,224<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224167939800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldOverhead', window );">Overhead expenses</a></td>
<td class="nump">$ 17,974<span></span>
</td>
<td class="nump">$ 31,831<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldOverhead">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indirect cost incurred related to good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldOverhead</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224162713944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory - Schedule of Inventory (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 201,778<span></span>
</td>
<td class="nump">$ 1,041,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in progress</a></td>
<td class="nump">4,231<span></span>
</td>
<td class="nump">3,851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">214,145<span></span>
</td>
<td class="nump">257,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Allowance for excess &amp; obsolete inventory</a></td>
<td class="num">(93,045)<span></span>
</td>
<td class="num">(71,376)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">$ 327,109<span></span>
</td>
<td class="nump">$ 1,231,243<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224161831032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 119,524<span></span>
</td>
<td class="nump">$ 157,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost of equipment</a></td>
<td class="nump">628,615<span></span>
</td>
<td class="nump">619,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="nump">480,883<span></span>
</td>
<td class="nump">361,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember', window );">Co-Founders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Cost of equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 176,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property and Equipment [Member] | Cost of Revenue [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 6,394<span></span>
</td>
<td class="nump">$ 7,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_CoFoundersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224159610744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 628,615<span></span>
</td>
<td class="nump">$ 619,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(480,883)<span></span>
</td>
<td class="num">(361,360)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">147,732<span></span>
</td>
<td class="nump">257,923<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">398,422<span></span>
</td>
<td class="nump">389,090<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 215,193<span></span>
</td>
<td class="nump">$ 215,193<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224162928584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 579<span></span>
</td>
<td class="nump">$ 3,320<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Intangible assets amortization period</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Written-off finite lived intangible assets</a></td>
<td class="nump">$ 4,124<span></span>
</td>
<td class="nump">$ 7,778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=SRNA_WebSiteDevelopmentCostsMember', window );">Website Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Intangible assets amortization period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=SRNA_WebSiteDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=SRNA_WebSiteDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224242751912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets</a></td>
<td class="nump">$ 32,653<span></span>
</td>
<td class="nump">$ 36,777<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(25,426)<span></span>
</td>
<td class="num">(24,847)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, Net</a></td>
<td class="nump">7,227<span></span>
</td>
<td class="nump">11,930<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets</a></td>
<td class="nump">8,110<span></span>
</td>
<td class="nump">12,234<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=SRNA_WebSiteDevelopmentCostsMember', window );">Website Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets</a></td>
<td class="nump">22,713<span></span>
</td>
<td class="nump">22,713<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets</a></td>
<td class="nump">$ 1,830<span></span>
</td>
<td class="nump">$ 1,830<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=SRNA_WebSiteDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=SRNA_WebSiteDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224161696920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and other accrued</a></td>
<td class="nump">$ 1,784,961<span></span>
</td>
<td class="nump">$ 1,832,959<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyDescription', window );">Warranty reserve description</a></td>
<td class="text">The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company's warranty policy, an accrual is established at 1% of the trailing 18 months revenue. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=SRNA_ThreeCustomersMember', window );">Three Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and other accrued</a></td>
<td class="nump">$ 402,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyDescription', window );">Warranty reserve description</a></td>
<td class="text">Since the issue is limited to these three projects and is not anticipated to reoccur in the future, we have made no adjustment to the ongoing 1% warranty reserve that we accrue on all sales<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the nature of the product warranty, including the approximate term of the product warranty, how the product warranty arose, and the events or circumstances that would require the warrantor to perform under the product warranty.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121555522&amp;loc=d3e12069-110248<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=SRNA_ThreeCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=SRNA_ThreeCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224164307624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 918,639<span></span>
</td>
<td class="nump">$ 1,299,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Sales commissions payable</a></td>
<td class="nump">48,263<span></span>
</td>
<td class="nump">69,532<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll liabilities</a></td>
<td class="nump">288,071<span></span>
</td>
<td class="nump">169,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent', window );">Product warranty accrual</a></td>
<td class="nump">173,365<span></span>
</td>
<td class="nump">185,234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">356,623<span></span>
</td>
<td class="nump">110,127<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 1,784,961<span></span>
</td>
<td class="nump">$ 1,832,959<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12524-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68070138&amp;loc=d3e11281-110244<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224159677688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note Payable and Accrued Interest (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 10, 2021</div></th>
<th class="th"><div>Dec. 11, 2020</div></th>
<th class="th"><div>Apr. 22, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 554,000<span></span>
</td>
<td class="nump">$ 554,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Loan interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Loan due date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 20,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,203<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan principal amount</a></td>
<td class="nump">$ 514,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Loan interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Loan due date</a></td>
<td class="text">Feb.  05,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoanRestructuringModificationAxis=us-gaap_ExtendedMaturityMember', window );">Extended Maturity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Loan due date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 20,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoanRestructuringModificationAxis=us-gaap_ExtendedMaturityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoanRestructuringModificationAxis=us-gaap_ExtendedMaturityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224159118232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Agreements and Transactions (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 07, 2021</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>Mar. 24, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Demo and testing fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 390,229<span></span>
</td>
<td class="nump">$ 521,044<span></span>
</td>
<td class="nump">$ 32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Lease fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 147,732<span></span>
</td>
<td class="nump">257,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NetOfImpactOfForegoingItemCharge', window );">Net of impact of foregoing item charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=SRNA_LeasedEquipmentMember', window );">Leased Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107,581<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_UnpaidLeaseFees', window );">Unpaid lease fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AccountsPayableMember', window );">Accounts Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_UnpaidDemoAndTestingFees', window );">Unpaid demo and testing Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember', window );">Co-Founders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember', window );">Co-Founders [Member] | Equipment, Demonstration and Product Testing Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Quarterly fee, receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Quarterly fee, payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember', window );">Co-Founders [Member] | Equipment, Demonstration and Product Testing Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Quarterly fee, receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember', window );">Co-Founders [Member] | Employment Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalariesWagesAndOfficersCompensation', window );">Base salary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember', window );">Co-Founders [Member] | Employment Agreement [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share based payment award, shares issued in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod', window );">Number of shares vested and to be settled with issued shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Stock cancelled during period, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember', window );">Co-Founders [Member] | Employment Agreement [Member] | Restricted Stock Units (RSUs) [Member] | April 30, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of stock expected to vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_MrJamesRShipleyMember', window );">Mr. James R. Shipley [Member] | Consulting Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Monthly consulting fee</a></td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NetOfImpactOfForegoingItemCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net of impact of foregoing item charge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NetOfImpactOfForegoingItemCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares vested and to be settled with issued shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndSettledWithIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_UnpaidDemoAndTestingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unpaid demo and Testing Fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_UnpaidDemoAndTestingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_UnpaidLeaseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unpaid lease fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_UnpaidLeaseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118262090&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalariesWagesAndOfficersCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by nonofficer and officer employees. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalariesWagesAndOfficersCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=SRNA_LeasedEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=SRNA_LeasedEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_AccountsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_AccountsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_CoFoundersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_CoFoundersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SRNA_EquipmentDemonstrationAndProductTestingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SRNA_EquipmentDemonstrationAndProductTestingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SRNA_EmploymentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SRNA_EmploymentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=SRNA_AprilThirtyTwoThousandAndTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=SRNA_AprilThirtyTwoThousandAndTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_MrJamesRShipleyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_MrJamesRShipleyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SRNA_ConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SRNA_ConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224167885592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 09, 2020</div></th>
<th class="th"><div>Mar. 09, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_FormerEmployeeMember', window );">Former Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Interim awarded value</a></td>
<td class="nump">$ 33,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage', window );">Restricted stock units shares issued interest percentage</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfUnitsVestedButNotSettled', window );">Number of units, vested but not settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfUnitsVestedAndSettled', window );">Number of units, vested and settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Interim awarded value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NumberOfUnitsVestedAndSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of units, vested and settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NumberOfUnitsVestedAndSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NumberOfUnitsVestedButNotSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Units, Vested but not settled .</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NumberOfUnitsVestedButNotSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restricted stock units shares issued interest percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_FormerEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_FormerEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224159084520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Preferred and Common Stock (Details Narrative) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 09, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfUnitsVestedAndSettled', window );">Number of units, vested and settled</a></td>
<td class="nump">6,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_EmployeeMember', window );">Employee [Member] | 2017 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock', window );">Number of common stock shares issued in settlement of vested restricted stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,120,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus', window );">Number of shares issued for stock incentive bonus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">560,000<span></span>
</td>
<td class="nump">1,120,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_EmployeeMember', window );">Employee [Member] | 2017 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfUnitsVestedAndSettled', window );">Number of units, vested and settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsMember', window );">Independent Directors [Member] | 2017 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares of common stock issued, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,370<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsOneMember', window );">Independent Directors One [Member] | 2017 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares of common stock issued, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">789,474<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NumberOfUnitsVestedAndSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of units, vested and settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NumberOfUnitsVestedAndSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for stock incentive bonus.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_StockIssuedDuringPeriodSharesIssuedForStockIncentiveBonus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common stock shares issued in settlement of vested restricted stock, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_StockIssuedDuringPeriodSharesIssuedInSettlementOfVestedRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224155802120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Outstanding Warrants (Details Narrative)<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2018 </div>
<div>Number </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($) </div>
<div>Number </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($) </div>
<div>Number </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Oct. 31, 2014 </div>
<div>USD ($) </div>
<div>Number </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Apr. 22, 2020</div></th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares, issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236,526,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,216,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SRNA_InvestmentBankMember', window );">Investment Bank [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_WarrantDescription', window );">Warrant description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Banker Warrants were fully vested on the date of issuance, were exercisable beginning December 20, 2017 and expired unexercised on June 20, 2020.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=SRNA_SeriesTwoWarrantsMember', window );">Series 2 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfInvestmentUnitOffered', window );">Number of investment unit offered | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_OfferedInvestmentsPricePerUnit', window );">Offered investments, price per unit | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock shares, issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrants for the purchase of shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">901,250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=SRNA_SeriesTwoWarrantsMember', window );">Series 2 Warrants [Member] | Series 2 Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible promissory note | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Investment Bank [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrants for the purchase of shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=SRNA_QOneTwoThousandSeventeenWarrantsMember', window );">Q1 2017 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfInvestmentUnitOffered', window );">Number of investment unit offered | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,781,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrants for the purchase of shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">468,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_WarrantDescription', window );">Warrant description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">These warrants expired unexercised in March 2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ProceedsFromInvestment', window );">Proceeds from investment | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,685,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ProceedsFromInvestmentPerUnit', window );">Proceeds from investment per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockDescription', window );">Conversion stock, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> Each unit consisted of one share of the Company's common stock and one warrant for the purchase of one share of the Company's common stock ("Q1 2017 Warrants").<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RedeemWarrantSharesAtPrice', window );">Redeem warrant shares at a price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=SRNA_QFourTwoThousandSeventeenWarrantsMember', window );">Q4 2017 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfInvestmentUnitOffered', window );">Number of investment unit offered | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,734,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_WarrantDescription', window );">Warrant description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">These warrants expired unexercised in December 2020.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ProceedsFromInvestment', window );">Proceeds from investment | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,768,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ProceedsFromInvestmentPerUnit', window );">Proceeds from investment per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockDescription', window );">Conversion stock, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Each unit consisted of one share of the Company's common stock and one warrant for the purchase of one share of the Company's common stock ("Q4 2017 Warrants")<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RedeemWarrantSharesAtPrice', window );">Redeem warrant shares at a price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrant term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=SRNA_QTwoTwoThousandEighteenWarrantsMember', window );">Q2 2018 Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrants for the purchase of shares of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,562,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_WarrantDescription', window );">Warrant description</a></td>
<td class="text">The Q2 2018 Warrants are exercisable commencing July 1, 2018 until June 30, 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockDescription', window );">Conversion stock, description</a></td>
<td class="text">Each unit consisting of one share of the Company's common stock and one Q2 2018 Warrant.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | Number</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RedeemWarrantSharesAtPrice', window );">Redeem warrant shares at a price</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NumberOfInvestmentUnitOffered">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investment unit offered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NumberOfInvestmentUnitOffered</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_OfferedInvestmentsPricePerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Offered investments, price per unit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_OfferedInvestmentsPricePerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ProceedsFromInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ProceedsFromInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ProceedsFromInvestmentPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from investment per unit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ProceedsFromInvestmentPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_RedeemWarrantSharesAtPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeem warrant shares at a price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_RedeemWarrantSharesAtPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_WarrantDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_WarrantDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique description of a noncash or part noncash stock conversion. The description would be expected to include sufficient information to provide an understanding of the nature and purpose of the conversion. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SRNA_InvestmentBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SRNA_InvestmentBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=SRNA_SeriesTwoWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=SRNA_SeriesTwoWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=SRNA_SeriesTwoConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=SRNA_SeriesTwoConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=SRNA_QOneTwoThousandSeventeenWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=SRNA_QOneTwoThousandSeventeenWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=SRNA_QFourTwoThousandSeventeenWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=SRNA_QFourTwoThousandSeventeenWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=SRNA_QTwoTwoThousandEighteenWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=SRNA_QTwoTwoThousandEighteenWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224159624040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Outstanding Warrants - Schedule of Outstanding Warrants to Purchase Common Stock (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants Outstanding, Beginning Balance</a></td>
<td class="nump">39,109,000<span></span>
</td>
<td class="nump">40,010,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightIssued', window );">Warrants, Issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightExercised', window );">Warrants, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightExpired', window );">Warrants, Expired</a></td>
<td class="num">(31,546,500)<span></span>
</td>
<td class="num">(901,250)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants Outstanding, Ending Balance</a></td>
<td class="nump">7,562,500<span></span>
</td>
<td class="nump">39,109,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted Average Exercise Price, Beginning Balance</a></td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued', window );">Weighted Average Exercise Price, Issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired', window );">Weighted Average Exercise Price, Expired</a></td>
<td class="num">(0.23)<span></span>
</td>
<td class="num">(0.66)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted Average Exercise Price, Ending Balance</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted Average Life of Outstanding Warrants in Months, Beginning Balance</a></td>
<td class="text">9 months<span></span>
</td>
<td class="text">21 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Life of Outstanding Warrants in Months, Ending Balance</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">9 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Beginning Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Expired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Ending Balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants exercised during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants expired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of outstanding warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average life of outstanding warrants in months, ending balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average life of outstanding warrants in months, beginning balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224168270696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Outstanding Warrants - Schedule of Warrants Outstanding (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants Outstanding</a></td>
<td class="nump">7,562,500<span></span>
</td>
<td class="nump">39,109,000<span></span>
</td>
<td class="nump">40,010,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Life of Outstanding Warrants in Months</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">9 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeMember', window );">Warrants Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants Outstanding</a></td>
<td class="nump">7,562,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeOneMember', window );">Warrants Range One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Life of Outstanding Warrants in Months</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average life of outstanding warrants in months, ending balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224154744088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plan (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 24, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Jan. 02, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 277,183<span></span>
</td>
<td class="nump">$ 788,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested', window );">Total intrinsic value of restricted stock unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,125<span></span>
</td>
<td class="nump">79,120<span></span>
</td>
<td class="nump">$ 1,035,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement', window );">Intrinsic value of vested and settled with issuance of share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,105,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of fully vested shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesMember', window );">Employees [Member] | Incentive Stock Bonus Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">44,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement', window );">Intrinsic value of vested and settled with issuance of share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">58,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited', window );">Share based compensation award forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember', window );">Employees, Directors and Consultants [Member] | Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,163<span></span>
</td>
<td class="nump">278,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember', window );">2017 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of common stock shares issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember', window );">2017 Equity Incentive Plan [Member] | Independent Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Director fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,370<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember', window );">2017 Equity Incentive Plan [Member] | Independent Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Director fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">789,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Non-Qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Number of options to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_StockOptionToPurchaseThresholdsPerformanceBased', window );">Stock option to purchase - thresholds - performance based</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfSharesForfeitedForTerminations', window );">Number of shares forfeited for terminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Unvested Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Employees and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,616,900<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of fully vested shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,616,900<span></span>
</td>
<td class="nump">4,924,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Employees and Consultants [Member] | Non-Qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 189,568<span></span>
</td>
<td class="nump">$ 390,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,616,900<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Non-qualified stock options term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
<td class="text">8 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Non-Qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected stock price volatility, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114.97%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected stock price volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122.48%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.37%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Independent Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">197,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Independent Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">789,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,452<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Directors [Member] | Non-Qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Number of options to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Non-qualified stock options term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing price of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Two New Independent Directors [Member] | Non-Qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Number of options to purchase shares</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, granted</a></td>
<td class="nump">39,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Non-qualified stock options term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing price of common stock</a></td>
<td class="nump">$ 0.029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Non-qualified stock options vested percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding', window );">Share based compensation arrangement stock issued and outstanding</a></td>
<td class="nump">21,651,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Two New Independent Directors [Member] | Non-Qualified Stock Options [Member] | April 1, 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Non-qualified stock options vested percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndNineteenSpecialEquityPlanMember', window );">2019 Special Equity Award [Member] | Directors [Member] | Non-Qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward', window );">Number of options to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">234,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NumberOfSharesForfeitedForTerminations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares forfeited for terminations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NumberOfSharesForfeitedForTerminations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement stock issued and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ShareBasedCompensationArrangementStockIssuedAndOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of vested and settled with issuance of share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVestedForSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_StockOptionToPurchaseThresholdsPerformanceBased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock option to purchase - thresholds - performance based.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_StockOptionToPurchaseThresholdsPerformanceBased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118262090&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares purchased for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph c(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_IncentiveStockBonusAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_IncentiveStockBonusAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_IndependentDirectorsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_UnvestedOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_UnvestedOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=SRNA_NonQualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=SRNA_NonQualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_TwoNewIndependentDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_TwoNewIndependentDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=SRNA_AprilOneTwentyTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=SRNA_AprilOneTwentyTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndNineteenSpecialEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndNineteenSpecialEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224159305544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plan - Schedule of Stock Option Activity (Details) - 2017 Equity Incentive Plan [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, granted</a></td>
<td class="nump">6,500,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">Non-Qualified Stock Options [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options, outstanding beginning</a></td>
<td class="nump">900,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, granted</a></td>
<td class="nump">6,500,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of options, exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of options, forfeited/cancelled</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of options, expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options, outstanding ending</a></td>
<td class="nump">7,400,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of options, exercisable ending</a></td>
<td class="nump">6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Beginning</a></td>
<td class="nump">$ 0.135<span></span>
</td>
<td class="nump">$ 0.135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="nump">0.057<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Ending</a></td>
<td class="nump">0.067<span></span>
</td>
<td class="nump">0.135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable Ending</a></td>
<td class="nump">$ 0.073<span></span>
</td>
<td class="nump">$ 0.057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term, Outstanding Beginning</a></td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
<td class="text">8 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted', window );">Weighted Average Remaining Contractual Term, Granted</a></td>
<td class="text">8 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Term, Outstanding Ending</a></td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Term, Exercisable Ending</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">Employees and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, granted</a></td>
<td class="nump">6,616,900<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">Employees and Consultants [Member] | Non-Qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options, outstanding beginning</a></td>
<td class="nump">10,135,000<span></span>
</td>
<td class="nump">10,560,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, granted</a></td>
<td class="nump">6,616,900<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of options, exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of options, forfeited/cancelled</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,408,333)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of options, expired</a></td>
<td class="num">(2,500,900)<span></span>
</td>
<td class="num">(16,667)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options, outstanding ending</a></td>
<td class="nump">14,251,000<span></span>
</td>
<td class="nump">10,135,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of options, exercisable ending</a></td>
<td class="nump">14,251,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Beginning</a></td>
<td class="nump">$ 0.096<span></span>
</td>
<td class="nump">$ 0.104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="nump">0.070<span></span>
</td>
<td class="nump">0.080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">0.116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expired</a></td>
<td class="nump">0.101<span></span>
</td>
<td class="nump">0.105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Ending</a></td>
<td class="nump">0.083<span></span>
</td>
<td class="nump">$ 0.096<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable Ending</a></td>
<td class="nump">$ 0.083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term, Outstanding Beginning</a></td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
<td class="text">8 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted', window );">Weighted Average Remaining Contractual Term, Granted</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">0 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired', window );">Weighted Average Remaining Contractual Term, Expired</a></td>
<td class="text">4 years 3 months 19 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Term, Outstanding Ending</a></td>
<td class="text">8 years 3 months 19 days<span></span>
</td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Term, Exercisable Ending</a></td>
<td class="text">8 years 3 months 19 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding vested and Expected to vest Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Term, Ending.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term, expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term, granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224158339720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plan - Summary of Non-vested Non-qualified Stock Option Activity (Details) - 2017 Equity Incentive Plan [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options Nonvested, Granted</a></td>
<td class="nump">6,500,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of Options Nonvested, Vested</a></td>
<td class="num">(5,500,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of Options Nonvested, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired', window );">Number of Options Nonvested, Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Ending</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Granted</a></td>
<td class="nump">0.057<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Vested</a></td>
<td class="nump">0.063<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired', window );">Weighted Average Grant-Date Fair Value, Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Ending</a></td>
<td class="nump">$ 0.029<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Ending</a></td>
<td class="nump">5,800<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted', window );">Grant Date Fair Value Nonvested, Granted</a></td>
<td class="nump">373,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested', window );">Grant Date Fair Value Nonvested, Vested</a></td>
<td class="nump">344,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited', window );">Grant Date Fair Value Nonvested, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired', window );">Grant Date Fair Value Nonvested, Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Ending</a></td>
<td class="nump">$ 29,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">Employees and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Beginning</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">7,333,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options Nonvested, Granted</a></td>
<td class="nump">6,616,900<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of Options Nonvested, Vested</a></td>
<td class="num">(8,616,900)<span></span>
</td>
<td class="num">(4,924,996)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of Options Nonvested, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,408,333)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired', window );">Number of Options Nonvested, Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Beginning</a></td>
<td class="nump">$ 0.075<span></span>
</td>
<td class="nump">$ 0.086<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Granted</a></td>
<td class="nump">0.059<span></span>
</td>
<td class="nump">0.065<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Vested</a></td>
<td class="nump">0.062<span></span>
</td>
<td class="nump">0.074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">0.102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired', window );">Weighted Average Grant-Date Fair Value, Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Beginning</a></td>
<td class="nump">149,534<span></span>
</td>
<td class="nump">628,756<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted', window );">Grant Date Fair Value Nonvested, Granted</a></td>
<td class="nump">387,199<span></span>
</td>
<td class="nump">130,120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested', window );">Grant Date Fair Value Nonvested, Vested</a></td>
<td class="nump">536,733<span></span>
</td>
<td class="nump">362,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited', window );">Grant Date Fair Value Nonvested, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">246,344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired', window );">Grant Date Fair Value Nonvested, Expired</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 149,534<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Grant Date Fair Value, Expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Grant Date Fair Value, Expired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Options, Expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224158338456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plan - Schedule of Restricted Stock Units Activity (Details) - 2017 Equity Incentive Plan [Member] - Employees, Directors and Consultants [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Units, beginning</a></td>
<td class="nump">7,550,000<span></span>
</td>
<td class="nump">9,867,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of Units, Granted</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of Units, Vested and settled with share issuance</a></td>
<td class="num">(6,750,000)<span></span>
</td>
<td class="num">(1,120,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of Units, Forfeited/canceled</a></td>
<td class="num">(800,000)<span></span>
</td>
<td class="num">(1,197,368)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Units, ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">7,550,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, beginning</a></td>
<td class="nump">$ 0.128<span></span>
</td>
<td class="nump">$ 0.140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Granted</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Vested and settled with share issuance</a></td>
<td class="nump">0.121<span></span>
</td>
<td class="nump">0.181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Forfeited/canceled</a></td>
<td class="nump">0.184<span></span>
</td>
<td class="nump">0.179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Aggregated Intrinsic Value, Outstanding beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 730,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Aggregated Intrinsic Value, Outstanding ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224159092072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plans - Schedule of Incentive Bonus Awards Granted to Employees (Details) - Incentive Stock Bonus Awards [Member] - 2017 Equity Incentive Plan [Member] - Employees [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1', window );">Number of Shares, Nonvested, Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,680,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Shares, Awarded</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of Shares, Vested</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,680,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of Shares, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1', window );">Number of Shares, Nonvested, Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1', window );">Weighted Average Grant-date Fair Value, Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 0.112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-date Fair Value, Awarded</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Vested</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">0.112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-date Fair Value, Forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1', window );">Weighted Average Grant-date Fair Value, Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue', window );">Aggregated Intrinsic Value, Nonvested Beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">124,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue', window );">Aggregated Intrinsic Value, Nonvested Ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_IncentiveStockBonusAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_IncentiveStockBonusAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224242908712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carry forward amount</a></td>
<td class="nump">$ 19,322,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount', window );">Net operating loss carry forward expected to expire amount</a></td>
<td class="nump">$ 11,196,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NetOperatingLossExpirationTerm', window );">Net operating loss expiration term</a></td>
<td class="text">2034 through 2037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NolsUsageAgainstTaxableIncomePercentage', window );">NOLs usage against taxable income, percentage</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of ownership change</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NolsCarryforwardsTerm', window );">NOLs carryforwards term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense', window );">Penalties and interest</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carry forward expected to expire amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NetOperatingLossExpirationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating loss expiration term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NetOperatingLossExpirationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NolsCarryforwardsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>NOLs carryforwards term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NolsCarryforwardsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NolsUsageAgainstTaxableIncomePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>NOLs usage against taxable income percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NolsUsageAgainstTaxableIncomePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224242890936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income taxes computed at the federal statutory rate</a></td>
<td class="num">$ (369,000)<span></span>
</td>
<td class="num">$ (281,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">States taxes, net of federal benefits</a></td>
<td class="num">(69,000)<span></span>
</td>
<td class="num">(53,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Permanent differences</a></td>
<td class="num">(136,000)<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_IncomeTaxReconciliationTrueUpAdjustments', window );">True-up adjustments</a></td>
<td class="nump">115,000<span></span>
</td>
<td class="nump">199,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Adjustment to net operating loss</a></td>
<td class="num">(17,000)<span></span>
</td>
<td class="num">(86,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">476,000<span></span>
</td>
<td class="nump">204,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Reported income tax (benefit) expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_IncomeTaxReconciliationTrueUpAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation True-up adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_IncomeTaxReconciliationTrueUpAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224161907176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">$ 4,821,000<span></span>
</td>
<td class="nump">$ 4,081,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Equity compensation</a></td>
<td class="nump">118,000<span></span>
</td>
<td class="nump">392,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other deferred tax assets</a></td>
<td class="nump">169,000<span></span>
</td>
<td class="nump">149,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">5,108,000<span></span>
</td>
<td class="nump">4,622,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other deferred tax liabilities</a></td>
<td class="num">(68,000)<span></span>
</td>
<td class="num">(58,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(68,000)<span></span>
</td>
<td class="num">(58,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Net deferred tax assets before valuation allowance</a></td>
<td class="nump">5,040,000<span></span>
</td>
<td class="nump">4,564,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowance</a></td>
<td class="num">(5,040,000)<span></span>
</td>
<td class="num">(4,564,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140224159387880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 10, 2021</div></th>
<th class="th"><div>Jan. 07, 2021</div></th>
<th class="th"><div>Jan. 02, 2021</div></th>
<th class="th"><div>Apr. 22, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 11, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrent', window );">Estimated compensation expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 503,466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 554,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 554,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Loan interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Loan due date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 20,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan principal amount</a></td>
<td class="nump">$ 514,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Loan interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Loan due date</a></td>
<td class="text">Feb.  05,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Consulting Agreement [Member] | Mr. James R. Shipley [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Monthly consulting fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | 2017 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,035,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Stock option exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrent', window );">Estimated compensation expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19512-108361<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6409875&amp;loc=d3e20028-108363<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118262090&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SRNA_ConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SRNA_ConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_MrJamesRShipleyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_MrJamesRShipleyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>84
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MOA* YRL!'-+<J$/Z]DN9Z7]02P,$%     @ &I!W4MW*W[[[ @  'PH  !@
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MTL<#>YGI$QP($Z"?KSE7KP-S1JC/A+-_4$L#!!0    ( !J0=U(DT6U*HP0
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MR'S&V1YP92W1U$E%5^4M"YP6JF<]""Z?IM)/S!>L*%F6)D30!#P(>9#=1I2
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M1(.F73]L1 \TJYXS8EQ/9%^"#*AQC:5D$T'?Q\% YHU@@6;%\J_LBVQI#5M
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M<;>0#;?:L3B!5 <F-?[G#!J7"(K'40([ZTNYC MU.[FB \/I0=31^+8WMN)
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M 1BZ0R"<!@D9KJ;G\<.F<Q%WF&7_P^XCF K=O<Z /74E4RS>?L!_9&0E@PP
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MX4O*; 6[]%PN_ 4H1SI'I7H)/ YP(DW&$3VTED1D4_]%T"?9RD1>Q[/0]U5
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M, YHT",_)[5Z#?R#I !?M^ 2'L!K/NDA22> C=,8XLE>73?*T_, !ASQ ,8
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M"+"0\W.%&0"9#8D^X@:QS4TP"+A&(5.27>@W/A-G&'K,"X! *C-R"9@$&^H
M<7V4KVX-&_ ^*(C>Q,B*1""XH2L_26CD*8 DRA\R&!:WWS4%3'%;HB?59;\2
M_S$?@7_CEG_I*J#Q%SA.G'?I</I=?7F( 7R(DS"5N,0! Z+@C8XVR9:#]:H6
MWA%: 8D%+4'N*+GCC&^=XTAYZD04P6[1';0V!Q<F,=.85"+T2/AP'PX5)/>!
MP\!Y5SOZ-[OV3#_2_1GDQ')&^AU]8<,9<0-@,D-C8Z8XC;%E@ 2['#UO?[#-
M?8@PK>/M&=X>:S3_AH,-CDYN[;9[$@5GV6\25_DM"C;\"C99 ;I^O\]XWAMV
MW/F4A*JC=(XH\>16-"V7_;&C()+ZEM_=_N'1$6V\L_-7V8O?NQVP[*OSJZ]S
MOP'RZKQ/PYCOO9\>D73=H>.0+%G2/%  HT8# T\$/VCBU5X"QZ_-CZ*K_$^R
M@G](K&"$H2$K& %I@A.1_*Q[1\$F]'&Y['EVG5\OS_/E]1S^GB_SJU>+_.9J
M:7X <Z>U[/X./FS4.4C)N[RZR>=@J<[SQ?(5_'5N;C?U;J>C@055%"9>S"_S
MZVO8"$Q[<34WOW<#1;OY/,^SF_QR?I$OKA>X^F6^6%SD%Y<74U=I#G.#]CZW
M*98F7G0!-'TDFA1!I%\B&;J/=[?O\=9FV1\4=&8-G$>KJIVC.C 9JD8Z+]#V
MV=;L7BY\U%K2B'Q<QJ3& Q@S< (8AAX&I$6!J I]?6P&[,]YBCS$AQ B5R&W
M13_A#H-8T[%U(PYX3M*Q!Y<[V'+3DC[N+[C @!(:0VJJH3W->61X"O@;3MZC
MI"$%HR$E0#-[!,EB/W7+\?6N9=[+%@KH7:#V%/'V-Y0W0JLH+/RQ >!D<*/;
M]JS<EXV0&FA0;)"!(0H*G5>O@#6PWV;H3/!R^Z,$:B ^ J(X>&SA(^A6XR[U
M5E6=97>5F+WI*AYV>*W'\QK]?9;=PK&>OMLT_<%?=9&A!_[D50-_V^_P+C'4
M$=USUX+5XK?H5T'%7C_X/<2F*YO,B/"<8,*V TDSC\PGJ(3]ST3!?['D5!)#
MUV_.LI-5AY-T9C ?PZ'D$\\M2P44BD_AO JH0)RIFJ('8@P_RIC18YH3>_-V
MRZGL&-EP%.PFI2L>,J$W^22H0P./47&%YE%DL[*1PBKBL<'##L%D26_EN@*0
M\( -Y=D&##"@#MQ8[7AVDX1JR.EW7X#='9O,3W(H7/^I"V.],T9:Q=?<Q' *
MV4^BQ4Z"'Z5ECWD[%/+$D*7MB8!VF[TC9H?Q$-@C+ 43EEYW$3:3>_^I\A?C
M (\)J[<6M6SFF")/,6D#]*!*>1MBJ/CU4&=1@[,$-3M3;MB@]VBOOT633L$
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M%_W?=0@,U'%()<>P<-(7 W_VK0<X5&JUB5G$5U..+[CB?7W&;G=-M[<VV"(
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M-A*]\U>@E-T]T=:'-?%,[''5?&R2.4QF*I-D#UM[ $E(1 P2# !:UO[Z?=T
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MM #/-Q8]G+[0 >-+\;O_ 5!+ P04    "  :D'=2\E_=A5 *  #\&0  &0
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M?H9K5/59FL"(JQ"F^"YGPZY"H#@B992XI4*\APEEP <678Y4HR^D'";:R-J
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MG2 46%J'P.CWB&]1" =$,KX,F).1TCE>C\_H/_G8*98],_A6B;]X9>OUI)A
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M!LBZ,]#&NT<-!@,L2N8JT!824!= 2K3$D32<1<;2.[CP$\)!SA')V8RHB]I
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M'<5>#/!^[<!\OY$ AR^SQ7]02P,$%     @ &I!W4NPUOJWZ!P  Q14  !D
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MR/,"/*\<AHU\PP>,7\-N_P=02P,$%     @ &I!W4DR/@Y(3!0  ^0T  !D
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MA]W8B^\T8%[RN&H\ 2CX.)^A,V KHCV51BT*"7I% Y,VO^@T"*\CTR373UA
MU5+P)M[,U<VKL#\<4_50(@/ V+D@ZQ-#=2TP#@#S*LLV'+W!RBM(5 I-!1D&
M719% BII:6T7L=M,+E1!+:8-6QRZL%&I'$(/2/\![NN%P&W\Y\CM:%D+J4E
M-%S\.UQ3QS^:!-,KA^M=L@FP(@%!=5ODBU(;@S6?2)E2G%[%P>1JC,$+,&40
MV6C2\M)1,M)@,\6:G5+/Z#WN:/*/-NVR1"OQ+(;X.6*=:#48NN%+O98 \H $
MN[" UE0F.!:E4#V)5"O;*&LL\[EB-+D*IN-SR+;?J6!<O9M-E[^ESJ!T\;*4
M(#87&P?S#;=P2$%08-+F%O&MOO+<32/N >YO0$BH9"ZZN 6* R/K5.,D2L&<
M509<AK3[4+9+T*@,/;!+5::@OE!(&'"<:GSMZ FVD7&]#5<4-&8A",Z@=V&
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M>9E5A5692]'0G4&B%R2>RDC;HQ =<%I]U]SI<W@#0-$/0*P9A)O34&/)[YB
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M.P5O@J/PIBN@/!K.#,2!H^$^N!_.!/? F</W?P3.L(MSL)(G]Z&:A1=S 4-
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MW)U?7+@Z&FWYSE.HRU+Y_14;M[OL9_UNXEYOME$F1HN+2FWX@>-OU9W'U^B
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M)E#!Q&GFO:32:+72!DG^"I]>\9>!UK4'24^%#C@&15B0G[1)+QO3?1O)G?*
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M7,13( VW>'NQ%P.LKQURV7[(!H?7W.)O4$L#!!0    ( !J0=U*[,#C2IBX
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MELY,.-&_0#<JUWM4'5$E+0HR^-V+['[Q7QQ;CS(U.4!1?V'0*%3)LM>-Y4<
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M&70Q&'KVR[IN'K0^2GL<Y%14A>%^ %>'O3LK,FY[ZSM4$1K;'FU@-^*>,W&
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MOU=4$/9#UF???0-RY-Z^!1E+ZG@-)()Q1_<M-B?%"H@WMXMGK^!-__AWW^R
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MB14T7<#SM5)VMR$#XPR\^ ]02P,$%     @ &I!W4KV1E-I5 P  KP<  !D
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M4VIT.1SXH#M;=PNKFM9**V7)F.VTHI<0M0N@\[52]K!P!/W;.O\#4$L#!!0
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M.TM1.0=[OY;2[ V7H)_.\[]02P,$%     @ &I!W4G#U:1.M @  B 4  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL?51-;]LP#+W[5PA&#RU@Q+;L
MQ&F0!$C:??10(&B[]3#LH-A,+%26/$ENNOWZ47;B96B3BR5*Y'LDY<?I3ND7
M4P)8\E8):69^:6T]"4.3EU Q,U U2+S9*%TQBZ;>AJ;6P(HVJ!(AC:)16#$N
M_?FT/5OI^50U5G )*TU,4U5,_UZ"4+N9'_N'@P>^+:T[".?3FFWA$>RW>J71
M"GN4@E<@#5>2:-C,_$4\6:;.OW7XSF%GCO;$5;)6ZL49=\7,CUQ"(""W#H'A
M\@HW((0#PC1^[3']GM(%'N\/Z)_;VK&6-3-PH\0S+VPY\\<^*6##&F$?U.XK
M[.L9.KQ<"=-^R:[S'28^R1MC5;4/Q@PJ+KN5O>W[<!0PCDX$T'T ;?/NB-HL
M;YEE\ZE6.Z*=-Z*Y35MJ&XW)<>D>Y=%JO.489^=WTC*YY6L!9&$,6$,NGQA:
MYFH:6L1W7F&^QUIV6/0$5DS)O9*V-.23+*#X'R#$Q/KLZ"&[)3V+> OY@"1Q
M0&A$HS-X25]MTN(E)_"^*%7LN!"$R8*\+_V6FUPHTV@@/Q9K8S7^,S_/T*8]
M;=K2IB=H'U%*18,\:O.>]:,^GX5S.IV8FN4P\U&(!O0K^,</R;IJ<H72,18*
M#VEM"62C!&J0R^W$6QB7"[87JC5HUV+/M1C['%][*V9!(L %&0=Q'.$:TX F
MJ?<,:\,MX%__BFJN49L660RZ4AID<;)?O"?-"IP=.%=('(R3J/MZ"0U&PX0D
MHR#+,F^1YTW5".0J"*N4MOP/:X5Z28=!2D?D"G=I,$XS<N6]JRX@$B?6!<D"
M2C.781Q<(]%'CQ4>J:,"O6UG@&M/(VTGE/ZT'S.+3EW_W+L9=<_TEDM#!&PP
M-!ID0Y_H3O>=857=:FVM+"JWW98X*D$[![S?*&4/AB/HA^_\+U!+ P04
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M3 6IAVBH?84I@T?1$T8X3^!Y'?,E8DO1IYBQ(H1:1J>&;IA8QQBCLS*B;VC
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M"XLI<'3_XLAZR38<S3B'5<H:K+X*6&[PY GA5U8?69IFT&7)'VC!4PXR"!U
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ME^;I#=(N,/-S(?2F8U^#Y6-^\!=02P,$%     @ &I!W4IP FG-% P  A H
M !D   !X;"]W;W)K<VAE971S+W-H965T,S8N>&ULS5;);MLP$/T50N@A =)(
ME+RFM@$OZ7((8,1->RAZ8*2Q380B79*RT[_OD%(4Q7:,]):+Q&5F^-[CD)S!
M3ND'LP:PY#$7T@R#M;6;JS TZ1IR9B[5!B3.+)7.F<6N7H5FHX%EWBD781Q%
MG3!G7 :C@1^;Z]% %59P"7--3)'G3/^=@%"[84"#IX%;OEI;-Q".!ANV@@78
MN\U<8R^LHV0\!VFXDD3#<AB,Z=64>@=O\8/#SC3:Q%&Y5^K!=;YEPR!RB$!
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MMKN'MD&,MH?%'AAI;!&12"])Q]G]]24I17%L6<A%(JEYCV^&&LY,]U+=ZPK
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M ?R?2*GW#^9[4?T5=?HO4$L#!!0    ( !J0=U)LZ[MG] (  )H(   9
M>&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;)V6;6_:,!#'OXH5;5(K%1+GB5 !
M4@N;-FG5JJ)N+Z:],,F%6'5B9IM2OOUL!U):0M;N#=C.W?]^=XY]&6VX>) %
M@$)/):ODV"F46EVZKDP+*(GL\Q54^DG.14F4GHJE*U<"2&:=2N;ZGA>[):&5
M,QG9M5LQ&?&U8K2"6X'DNBR)V%X#XYNQ@YW]PAU=%LHLN)/1BBQA#NI^=2OT
MS&U4,EI")2FOD(!\[%SARRGVC(.U^$%A(P_&R*2RX/S!3+YF8\<S1, @54:"
MZ+]'F )C1DES_-F).DU,XW@XWJM_MLGK9!9$PI2SGS13Q=A)')1!3M9,W?'-
M%]@E%!F]E#-I?]&FMHU\!Z5KJ7BY<]8$):WJ?_*T*\2!@Q^></!W#OXK!WS*
M(=@Y!#;1FLRF-2.*3$:";Y PUEK-#&QMK+?.AE9F&^=*Z*=4^ZG)-] UD*B'
MYOH%R=8,$,^17413+A4ZFX$BE,ES;7(_GZ&S#^<C5^G QMU-=T&NZR#^B2#8
M1S>\4H5$GZH,LI<"KB9NL/T]]K7?J3B#M(\"?(%\S_=:@*9O=L?##IR@J6)@
M]8+N*OZZ6D@E])OYNT,S;#1#JQF>T/R^ D$4K9:(V>U(]7:TE;Y6B:R*.;2/
M$Q_'2:+3>FR)'C71HS=&3XDLD+X <GWB42YXB?A+LC:H6CP^@,*Q-PS"=JBX
M@8K?51)ASFB/Y[VUGA IH;5 \1%+$ ;#R&M8ZC<F/JIC%(0X"-J1!PWRX%W(
MC)(%951M+_3I%@*J5N3!$;(?Q]B+7B&WF.%!$IY 3AKDY'^1&:^6/06B;(-.
MC@J(XR'&PU?0QV:A%_K>B?=UV$ /.Z'OP/2L9^A3D-TJ&&V!")2@LKZN],65
MD:WL.,W8>[YHO4[M&94I7U<*Z>*VGIE_^$=]S_O81N(>W/XEB*5MBA+98'4C
M:%:;QGMEVXW[;%YW[1LBEK22NH:Y=O7Z [U-HFZ$]43QE>TE"ZYT9[+#0G\\
M@# &^GG.N=I/3(#F<V3R%U!+ P04    "  :D'=2]QAX;U<"  #-!0  &0
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MZTIH<_?=TO8 I TP^VLA]-ZP"8;W+G\!4$L#!!0    ( !J0=U+/I-QIH (
M /T&   9    >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;(V5;4_;,!#'OXH5
M31-(0)X;RM)(T J-%Y,0%>/%M!=N<FTM'#NSW0>^_<Y)R$J;=KQ);.?^=[^[
M7"[I1JI7O00P9%MRH4?.TICJQG5UOH22ZBM9@< G<ZE*:G"K%JZN%-"B%I7<
M#3QOX):4"2=+Z[-'E:5R93@3\*B(7I4E56]WP.5FY/C.^\$36RR-/7"SM*(+
MF()YKAX5[MS.2\%*$)I)013,1\ZM?S-.K'UM\)/!1N^LB<UD)N6KW3P4(\>S
M0, A-]8#Q=L:QL"Y=808?UJ?3A?2"G?7[][OZ]PQEQG5,);\A15F.7*N'5+
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M_0"F#.3W!:6BF2@'[0_-^"]02P,$%     @ &I!W4LF%?P/T @  90H  !D
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M6J#NJ7:8ZU</I#'0^YD0>)@8!^T[&O\!4$L#!!0    ( !J0=U)]Z08-K@(
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M,EB2#5/W?/<%&D-#PY=R)JM?M*MC0\="Z48JGC=@K2"G1?TESTTB.@#7?P.
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M;BI?QV&4/HDW(_V.V8W0E!!<DVJ_-Z%2VF9,-AMOJCAI5L83Y^*RI"\+M$&
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MS!@%?YH-IQXAX,/38>Z:PT8$>[[_>MB-Q1J4!Z\:]2J6817+T!G+9P:JVQ;
MS1X[/IC2#X*@94J_FM)W3GDOH>R9G6M2R+[E/#.[UY8_OQ$Q]B>3(7F3/[_A
M)1E-IF1H=W-4N3ERNOD%JK98(9YDH";F"JHT6PNSWERS!(4;*M?,MA=&3;=A
MV_C8[L^X\F?\_96*T-5+PM!?=RQ9,OFW@]&3RO;D_UF2VTDS-F\R"EIB"ZKY
M ^?\9V$H<J/@<Q8R_D27,>L2WK0R/W6:?T@SRB,4.[D^;;!H.!Z/6[B.O;I6
M>=U"NZ>[KG'A@TJ(NT06O56DZY8@2W.'ZT?\5A'!M2)BMR1>B/?7$&;$I.H4
M8"U/V*U/OVU3L+GA&0*"AD!*:MUSU]\Q@[V^Y_UJ+5P_#GP=2BU[V*U[MARA
M?^H-?8Q,84F5-IV*Z:EA/6%C1CG(S]=R7:MFIU.6:ZG#;JW[/8=6BLEX9W;'
M,1P(7G:AM4VQZ-MXU,JA6M^P6^#>.)'M]XO5@W%CK^+V4HAK%<1N&?PY*P06
M[N@S3_*DTZ+5FHG=HOECBQ8T%RT8#MM25BLK=DMK6\J2+!:[(@T_1%E2ZRIQ
MZ^JYT7)%8SCMVCKQ$OTJ7N!H&T=(K;C$K;C_)6!X/P=Z2!Z:8\M"B_ 1/:0<
MBL*[^>)!'77*S$%WZM;B!30FK#A-1V83%9[0+971,5+FE4)<J1Q>\M2(*A>1
M-8'$TOMYC@S6DD[<DOHE-[&:CJITYPER ^X4]4N@)2PKTSJ&)UNN-R_.[L?:
M#CZDV:5B[[6G99_='$@\5TBUM!.WM.^7-*1IR&+C>)1+HP7[[!ZW^_Z1-'O7
MM[Z_=JF6=.*6])_*4QAXEDD>EZ<JXG5B<%T)B+L2'#"D\($]9ZQP">AAR&+-
M9+,F..E:%P7B+@IW<'#^1!/@Z;R/%M")Q&QWF(@+* AYW*[]BWRIH*4V3Z^>
MNLI@702(NPC<B51OH 2$M1=0#6R?-DBS EBJ]N#@LXSY<G@'AQR>*NB=5P#S
M^A/ R_W'N/V-%EGQI68IM!9)<;EA%&AG!L#[E1#ZY<9\_*D^B<[^!5!+ P04
M    "  :D'=2T+2K2ZD"  !J!P  &0   'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6RM55MKVS 4_BO";-!"%SO.M<4)K,G&6F@I"=D>QAX4^R01U<63Y+C]
M]SN279.QQ&1C>8@EZWP7'1T?):72SV8'8,F+X-),@IVU^4T8FG0'@IJ.RD'B
MRD9I02U.]38TN0::>9#@81Q%PU!0)H-IXM\]Z6FB"LN9A"=-3"$$U:^WP%4Y
M";K!VXL%V^ZL>Q%.DYQN80EVE3]IG(4-2\8$2,.4)!HVD^!C]V8^=O$^X"N#
MTAR,B=O)6JEG-[G+)D'D# &'U#H&BH\]S(!S1X0V?M:<02/I@(?C-_;/?N^X
MES4U,%/\&\OL;A*, Y+!AA;<+E3Y!>K]#!Q?JKCQ_Z2L8H=10-+"6"5J,#H0
M3%9/^E+GX0#0[9\ Q#4@/A?0JP&]<P']&M#WF:FVXO,PIY9.$ZU*HETTLKF!
M3Z9'X_:9=,>^M!I7&>+L=*:$8!;/T1I"949F2EHFMR!3!H9<S,%2Q@UYI%I3
M=T*7Y -9+>?DXMUE$EHTX&C"M!:[K<3B$V+WA>R0Z/J*Q%$<'8'/VN$/5+?"
MY^WP.:0=TNLZ>/?Z=WB(66M2%S>IBSU?_P2?JSO0Y)/(N7H%(-\?0*Q!_VBA
M[C74O5;J.VE!,T%H274&&=E37L"Q?%<T T_COO#]M->['@^2<']$O=^H]UO5
M%V"L9JE%8:R_])D4DF%YF!W56!/,F )7F+.(@20'G6+Y8(\X9K!=:=R)HO<M
M^1HTC@?G.EYZQROO^&*Q7)G+<PYFV @-6X4>"\=$U*;*R179HS*JK@M+I++$
M@+4<LF/%61$/#XYJ.!I$^#M^6*/&T>B?'+F/^;2;V>COW(P;-^/_4KBS\1^%
MVSVB'AXT-G<+80?8,FD(APWBHLX("735V:N)5;GO=6MEL7/ZX0XO0] N -<W
M2MFWB6N?S?4Z_0502P,$%     @ &I!W4BVE0;>P P  $P\  !D   !X;"]W
M;W)K<VAE971S+W-H965T-3(N>&ULM5==;YLP%/TK%MK#)G4% PG)E$1:DTWK
MP[:H4;>':0\.W"16P<YLD[32?OQLH! :0EF7]:'AXWZ<>WRO#Q[MN;B3&P"%
M[I.8R;&U46K[SK9EN(&$R$N^!:;?K+A(B-*W8FW+K0 294Y);+N.T[<30IDU
M&67/YF(RXJF**8.Y0#)-$B(>KB#F^[&%K<<'-W2]4>:!/1EMR1H6H&ZW<Z'O
M[#)*1!-@DG*&!*S&UGO\;H:'QB&S^$9A+P^ND2EER?F=N;F.QI9C$$$,H3(A
MB/[9P13BV$32.'X50:TRIW$\O'Z,_C$K7A>S)!*F//Y.([496P,+1; B::QN
M^/X3% 7U3+R0QS+[C_:%K6.A,)6*)X6S1I!0EO^2^X*( P?LGW!P"P>WJX-7
M.'A='?S"P<^8R4O)>)@1128CP?=(&&L=S5QD9&;>NGS*S+HOE-!OJ?93D[FF
M&82 "!$6H2E/$KT8"\7#._1Z!HK06*(O1 ABEN<->HM>(1O)#1$@1[;2 $P8
M.RR27>7)W!/)/A-QB9SA!7(=UVEPG[:[SR"\1!X^Z3[K[(Z'=7=;LU92YY;4
MN5D\_UGJI.'K FV)0#L2I]!46AXKR&*98=Q-,+QU>B-[=UC!<U8UH%X)U/L[
MH/GZ(2IE"E$3V#Q>_P"&[SJ>XWGX"=X.AC7(?@G9?Q%DO7-)I3N5LG43;K\K
M[@Z&-=R]$G>O%?<-2"5HJ#3P?(AN&542O;Y9W,HWZ,=G2)8@?K8T7[],U&]-
M]"4UD1!?H=1DN$ [G;F88@E*Q8T+>]4_JKL?]!S]UUQV4*()6M$L0%"].N]1
MM6YY^1TJ'I0Y!F<<MT&G<7O.J@9T6 (=GGG<AEW;MH-A#3)V*AEP_L? %5$[
M0.]B6<=^(&&X%?N'9!OS!X"RV]!OL\<'Z,.OE*H'=,U"8$:_T#PFK$M/XDH#
M<+L(5',8YMJ9T5=?<D19,9/Z@TD9VV)81;5;U%AO9-H]X@\[3FUT"Z(;#+%[
M>L9Q)2.X74>J6NOEZ:_/HFQ:,KWD+&VNXU@R>OVF,H[MVLNHI 6W:\L+VT5;
M_?/NCBL=P>U"\K+]?5I$[;S!XTIO<+O@7+,(]&$C,AT\HT)_MG,ASSAQE=3@
M=JTYZL*GLY=W9<LLS8H,M=X:!EYPBJ1*HG"[1C63])6=<VNJ9 BWZ] YB#H6
MG& P] /_"5'VP0'$'!?UA_Z:,HEB6&E'YS+0;2GR$UA^H_@V.Y,LN=(GG.QR
MHT^M((R!?K_B7#W>F&-.>0Z>_ %02P,$%     @ &I!W4CSRW?Y!!P  ]"0
M !D   !X;"]W;W)K<VAE971S+W-H965T-3,N>&ULS9I=;]LV%(;_"F%T6 L$
ML43*LAPD!FHY61,@;=JLZ\6P"T:F8R'Z&D7'#= ?/U*B14FF:#GUAO6BD62>
M5X<\A^>A*)UO4OJ4KPAAX'L<)?G%8,58=C8<YL&*Q#@_33.2\%^6*8TQXZ?T
M<9AGE.!%811'0VA9[C#&83*8GA?7[NCT/%VS*$S('07Y.HXQ?9F1*-U<#.S!
M]L*7\''%Q(7A]#S#C^2>L*_9'>5GPTIE$<8DR<,T 90L+P;O[;,;QQ,&18L_
M0K+):\= =.4A39_$R?7B8F )CTA$ B8D,/_S3'P214*)^_&W%!U4]Q2&]>.M
M^E71>=Z9!YP3/XV^A0NVNAAX [ @2[R.V)=T\X'(#HV$7I!&>?$_V)1MW=$
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M3EY^S9OS3:S 15N9,=JIVE?K[:!=Z ;O3"MWJ. %S?"ZJ]:MA1_:P1MK@NC
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M##\L7"=UR"R^4SC(VC5*I;QP_IK>/(<3RTD9002!2B&(_MO# J(H1=(\_BE
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MC[/++9 01&J@WZ^Y_@(N;M(!RK.LZ7]02P,$%     @ &I!W4CE-R,O0 @
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MI9"15:%N^>8S-((&AB_AA;1?M*EM1Z&#DI54O&S .H*2LOI/'IM$[ "\X1&
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MWJ["F<N:;#+PC.SP_-&!8C 7L9X$BH%G9"_7VP+E-I??@A@+WAD01EU!>-]
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M[V"/-/C>L CN6O=W2K!JJ=^08-6!]@0SE(/MFP(=83^+"$M+143:N+MM4<G
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M$,Q$X=.!R@KK/(GA1-D2:%CVIU9W^^CLCIRZLULS$ HT6&=C[+SP;-(GR;,
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M!#"!^#OVCY,;\NFOSWW?H&1+W(_6\JYR>6&%/!J2>RG,0I-;$4.\#^!CK(J
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M^FKQJDFI)I)MS#T_9U)U#6:X5HT=<&V@UI>,R9>);AV:5C'] U!+ P04
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ME5=P"0?EA:R*F17A9_W11IJ%?=1%6U5G4';=7!I9;CZ7W'SJ>?PO4$L#!!0
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M&?7.WZEW'3\/I5Y[OM;X_.^D>CS?6ZZ/ORR_3D[>W@O.Z;:B/O\%4$L#!!0
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M460M4&0M4&0M4&0M4&0M_E/69VN7?QP_///6U-TAGPU_NYJ] 5!+ 0(4 Q0
M   ( !J0=U('04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ &I!W4L&O)T+N    *P(  !$
M     ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ &I!W4IE<
MG",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX
M;6Q02P$"% ,4    "  :D'=2\/U]XA,$   =#P  &               @($-
M"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ &I!W4D5[
M3"6N!@  H!D  !@              ("!5@P  'AL+W=O<FMS:&5E=',O<VAE
M970R+GAM;%!+ 0(4 Q0    ( !J0=U+=RM^^^P(  !\*   8
M  " @3H3  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    "  :
MD'=2)-%M2J,$  !T$   &               @(%K%@  >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ &I!W4L:.GPL8!@  )R0  !@
M         ("!1!L  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( !J0=U)WA*<]5P8  +D9   8              " @9(A  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    "  :D'=2>@&'V-H(  !U$P
M&               @($?*   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ &I!W4I5V4^PP*P  ,(8  !@              ("!+S$  'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( !J0=U)D$EBK.0D
M " 7   8              " @95<  !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    "  :D'=2\E_=A5 *  #\&0  &0              @($$
M9@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( !J0=U+^
M9 \LUP(  -4%   9              " @8MP  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ &I!W4B3(2L&( P  #P@  !D
M     ("!F7,  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !J0=U*+!*,@Q <  !D3   9              "
M@9&+  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ &I!W
M4DR/@Y(3!0  ^0T  !D              ("!C),  'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    "  :D'=2R[H/'9L(  #L&P  &0
M        @('6F   >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( !J0=U+K=5($)A   %@T   9              " @:BA  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ &I!W4EQ3@D0M"0  _!8
M !D              ("!!;(  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    "  :D'=2'%2QUVP$  #9"0  &0              @(%INP
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( !J0=U*[,#C2
MIBX  (68   9              " @0S   !X;"]W;W)K<VAE971S+W-H965T
M,C,N>&UL4$L! A0#%     @ &I!W4HYAYQ&3!   #PL  !D
M ("!Z>X  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    "  :
MD'=2O9&4VE4#  "O!P  &0              @(&S\P  >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( !J0=U*+1M1OIP(  &<%   9
M          " @3_W  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#
M%     @ &I!W4E8!S>>P @  J04  !D              ("!'?H  'AL+W=O
M<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    "  :D'=2</5I$ZT"  "(
M!0  &0              @($$_0  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM
M;%!+ 0(4 Q0    ( !J0=U+,SK;=R@(  .<%   9              " @>C_
M  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ &I!W4INV
MZ.18 P  5P@  !D              ("!Z0(! 'AL+W=O<FMS:&5E=',O<VAE
M970S,"YX;6Q02P$"% ,4    "  :D'=2,F/?5SX&  !D%P  &0
M    @(%X!@$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (
M !J0=U*>^G][X@,  *()   9              " @>T, 0!X;"]W;W)K<VAE
M971S+W-H965T,S(N>&UL4$L! A0#%     @ &I!W4B4@.F;C!@  P1\  !D
M             ("!!A$! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"
M% ,4    "  :D'=2/%6122,#  "I"0  &0              @($@& $ >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( !J0=U(#L ,=%@,
M -@+   9              " @7H; 0!X;"]W;W)K<VAE971S+W-H965T,S4N
M>&UL4$L! A0#%     @ &I!W4IP FG-% P  A H  !D              ("!
MQQX! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    "  :D'=2
M7%^@?V(#  "N"0  &0              @(%#(@$ >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;%!+ 0(4 Q0    ( !J0=U([[<"LA 4  %$5   9
M      " @=PE 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%
M  @ &I!W4FSKNV?T @  F@@  !D              ("!ERL! 'AL+W=O<FMS
M:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    "  :D'=2]QAX;U<"  #-!0
M&0              @('"+@$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+
M 0(4 Q0    ( !J0=U)=2 &)+P(  /L$   9              " @5 Q 0!X
M;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ &I!W4L^DW&F@
M @  _08  !D              ("!MC,! 'AL+W=O<FMS:&5E=',O<VAE970T
M,BYX;6Q02P$"% ,4    "  :D'=2LGL<=>4"  #<"   &0
M@(&--@$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( !J0
M=U+)A7\#] (  &4*   9              " @:DY 0!X;"]W;W)K<VAE971S
M+W-H965T-#0N>&UL4$L! A0#%     @ &I!W4ANX6@6? @  4P<  !D
M         ("!U#P! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
M    "  :D'=2?>D&#:X"  !/"   &0              @(&J/P$ >&PO=V]R
M:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( !J0=U)2;$* AP,  +<(
M   9              " @8]" 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL
M4$L! A0#%     @ &I!W4L-9%L+' @  X0<  !D              ("!348!
M 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    "  :D'=2%3:!
M[MD"  "7"0  &0              @(%+20$ >&PO=V]R:W-H965T<R]S:&5E
M=#0Y+GAM;%!+ 0(4 Q0    ( !J0=U*7: Z:0P4  !X5   9
M  " @5M, 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @
M&I!W4M"TJTNI @  :@<  !D              ("!U5$! 'AL+W=O<FMS:&5E
M=',O<VAE970U,2YX;6Q02P$"% ,4    "  :D'=2+:5!M[ #   3#P  &0
M            @(&U5 $ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4
M Q0    ( !J0=U(\\MW^00<  /0D   9              " @9Q8 0!X;"]W
M;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ &I!W4EM4+^L;!
MUQ(  !D              ("!%& ! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX
M;6Q02P$"% ,4    "  :D'=2.4W(R] "  !T"0  &0              @(%F
M9 $ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( !J0=U(E
MD'RHP @  ($W   9              " @6UG 0!X;"]W;W)K<VAE971S+W-H
M965T-38N>&UL4$L! A0#%     @ &I!W4@.@\NUA!P  7C$  !D
M     ("!9' ! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !J0=U+>\L]V7 ,  -0)   9              "
M@1F* 0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ &I!W
M4C4!0/8* P  -@H  !D              ("!K(T! 'AL+W=O<FMS:&5E=',O
M<VAE970V,RYX;6Q02P$"% ,4    "  :D'=2QK2<7*0#   T#0  &0
M        @('MD $ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0
M   ( !J0=U(B<Z)S*P,  !@3   -              "  <B4 0!X;"]S='EL
M97,N>&UL4$L! A0#%     @ &I!W4I>*NQS     $P(   L
M ( !'I@! %]R96QS+RYR96QS4$L! A0#%     @ &I!W4C89!!3J!   ;BH
M  \              ( !!YD! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M !J0=U+22;QM$0(  !<F   :              "  1Z> 0!X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( !J0=U+ B&UTZ0$  'XE   3
M              "  6>@ 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !(
- $@ KQ,  (&B 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>202</ContextCount>
  <ElementCount>433</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>85</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/StatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Changes in Shareholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/StatementsOfChangesInShareholdersDeficit</Role>
      <ShortName>Consolidated Statements of Changes in Shareholders' Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/DescriptionOfBusiness</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation; Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Going Concern</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/GoingConcern</Role>
      <ShortName>Going Concern</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Accounts Payable and Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>Accounts Payable and Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Note Payable and Accrued Interest</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/NotePayableAndAccruedInterest</Role>
      <ShortName>Note Payable and Accrued Interest</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Related Party Agreements and Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/RelatedPartyAgreementsAndTransactions</Role>
      <ShortName>Related Party Agreements and Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Preferred and Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PreferredAndCommonStock</Role>
      <ShortName>Preferred and Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Outstanding Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/OutstandingWarrants</Role>
      <ShortName>Outstanding Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Equity Incentive Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlan</Role>
      <ShortName>Equity Incentive Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation; Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation; Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/Leases</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/Inventory</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/PropertyAndEquipment</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/IntangibleAssets</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables</Role>
      <ShortName>Accounts Payable and Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/AccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Outstanding Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/OutstandingWarrantsTables</Role>
      <ShortName>Outstanding Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/OutstandingWarrants</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Equity Incentive Plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlanTables</Role>
      <ShortName>Equity Incentive Plan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/EquityIncentivePlan</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/IncomeTaxes</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Basis of Presentation; Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Revenue by Source (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRevenueBySourceDetails</Role>
      <ShortName>Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Revenue by Source (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails</Role>
      <ShortName>Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Share-based Compensation Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BasisOfPresentationSummaryOfSignificantAccountingPolicies-ScheduleOfShare-basedCompensationCostsDetails</Role>
      <ShortName>Basis of Presentation; Summary of Significant Accounting Policies - Schedule of Share-based Compensation Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Going Concern (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/GoingConcernDetailsNarrative</Role>
      <ShortName>Going Concern (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/GoingConcern</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Leases (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/LeasesDetailsNarrative</Role>
      <ShortName>Leases (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/LeasesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Leases - Schedule of Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Leases-ScheduleOfLeaseCostDetails</Role>
      <ShortName>Leases - Schedule of Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Leases - Schedule of Future Annual Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails</Role>
      <ShortName>Leases - Schedule of Future Annual Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Inventory (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/InventoryDetailsNarrative</Role>
      <ShortName>Inventory (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/InventoryTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Inventory - Schedule of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Inventory-ScheduleOfInventoryDetails</Role>
      <ShortName>Inventory - Schedule of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Property and Equipment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>Property and Equipment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>Property and Equipment - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Intangible Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IntangibleAssetsDetailsNarrative</Role>
      <ShortName>Intangible Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/IntangibleAssetsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets - Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative</Role>
      <ShortName>Accounts Payable and Accrued Liabilities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Note Payable and Accrued Interest (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative</Role>
      <ShortName>Note Payable and Accrued Interest (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/NotePayableAndAccruedInterest</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Related Party Agreements and Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/RelatedPartyAgreementsAndTransactionsDetailsNarrative</Role>
      <ShortName>Related Party Agreements and Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/RelatedPartyAgreementsAndTransactions</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - Preferred and Common Stock (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PreferredAndCommonStockDetailsNarrative</Role>
      <ShortName>Preferred and Common Stock (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/PreferredAndCommonStock</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Outstanding Warrants (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/OutstandingWarrantsDetailsNarrative</Role>
      <ShortName>Outstanding Warrants (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/OutstandingWarrantsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - Outstanding Warrants - Schedule of Outstanding Warrants to Purchase Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/OutstandingWarrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails</Role>
      <ShortName>Outstanding Warrants - Schedule of Outstanding Warrants to Purchase Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - Outstanding Warrants - Schedule of Warrants Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/OutstandingWarrants-ScheduleOfWarrantsOutstandingDetails</Role>
      <ShortName>Outstanding Warrants - Schedule of Warrants Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - Equity Incentive Plan (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlanDetailsNarrative</Role>
      <ShortName>Equity Incentive Plan (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/EquityIncentivePlanTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - Equity Incentive Plan - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlan-ScheduleOfStockOptionActivityDetails</Role>
      <ShortName>Equity Incentive Plan - Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - Equity Incentive Plan - Summary of Non-vested Non-qualified Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails</Role>
      <ShortName>Equity Incentive Plan - Summary of Non-vested Non-qualified Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - Equity Incentive Plan - Schedule of Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Equity Incentive Plan - Schedule of Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - Equity Incentive Plans - Schedule of Incentive Bonus Awards Granted to Employees (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlans-ScheduleOfIncentiveBonusAwardsGrantedToEmployeesDetails</Role>
      <ShortName>Equity Incentive Plans - Schedule of Incentive Bonus Awards Granted to Employees (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/IncomeTaxesTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - Income Taxes - Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IncomeTaxes-ScheduleOfU.s.FederalStatutoryIncomeTaxRateAndReportedProvisionForIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of U.S. Federal Statutory Income Tax Rate and Reported Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="srna-20201231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/SubsequentEvents</ParentRole>
      <Position>64</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>srna-20201231.xml</File>
    <File>srna-20201231.xsd</File>
    <File>srna-20201231_cal.xml</File>
    <File>srna-20201231_def.xml</File>
    <File>srna-20201231_lab.xml</File>
    <File>srna-20201231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>89
<FILENAME>0001493152-21-006659-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-21-006659-xbrl.zip
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MIM%8Z)?=?/[]VOJI]<9J-5M-I]5V+*?YW]:[OUMOWOU^]7T*FWGC)O <?.W
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M?QELU5;>&;SE5LCIPYL%E\"=$_'U9C8_W3TM2=13W1,]$K^/XU1,JM'^"NA
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M"6+81]L=CBGBYZ6]H9!Y96'_X@RW4HJ_M,#8"L>95D1JR*0H^C)C1A\@'S%
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M,9S*U)N-@34OH(7I5Q(L5%LCG)L9;3IS95+'W+QD";W%84S)+(R%AK\,[.4
MR_%)_Y38\'TP@2= YNO<)+0FI%.P%"[&9P(9'<+#]H&[@E@E9W/C-Z/]%XX4
M7AB-9;0S:L:HD# V912'/I\\M<OT$LK7PH:<23$KD;QMT&K>.)'!O(2CPLM6
M7,C.[D::));FO%2V![WX6XFL4*, >% J,SEU_M5L)H/ @1'-9C3SE01%BGU*
M? MDWDZ";& ;>8-9>M#*E'/$"G7G"H,LS5SEH5,6(.;2H?68+L)\=#V?5)K-
M<8[%&#/MIFDP44>-NZ3002*'7W%LE;JKCRF4JI,#1ZGG3V0WSE+@8I+)#Y1?
MG]#(Z)"21"01Y=(02P0.HHW%0D(_Y_N!+.Z1.<0B<W=U3G\8H6D<8J]Z>'#)
M%\ $:0Q_TJ3< @51O[E)!(0-F^3@:)#"DIC>JWJW:E'UTOK9^X5YAN;/P),C
M'O;(8X7IFB#74E[-:L\:S@'WAK@U(! XG?Q1JR%R+$-^]N1B.MW4XXPD@\VY
M>39GK](\1AT=IV/ESL@A7FSQD5+39(Z6S;T$HPN_PIYP(7Y*%B DPLCJ(6 F
M8'@^,(TO*(45EI!4$AMO!%QRXU:J(L-KN,2=3O7@RP+6U*@URGH<JV1/\G*X
MTR,G6:J^EQR-X01S+Z90@+O0<]KT6Q5&X>AP<W>_K.:/0,AYE$SXI92M12>\
M[.Z7+/"&9XV_USE3(9$T_SH;JHQTG)_*CE=D8_K:Y$"5;+"@L05&28EFO7P^
M\\_2"HHI4X33CTK+8F+BR9%0%2%B\@ON)$?(,A74+=;GY"A/LK%<)9?31Q<-
MV*C7#6AJ%6;<T^*TDEQ*9J$S5O'T<;KSK_1;? B>DD2FDW)D!(M3R;)P6/"0
MJWZ1I1 R O8.!V%A,F$NJ48YV\#^03CWQFH7+'T,M6D,N" 1\O&O[]\TG*%U
MYT6IH3-+E)R."P=RE.TX)093.7JQG2-=G8JRK(74#:@26C+UEC2=MJ,+D)#J
M0MLI\H1R8+(<85Q'U@+%VC"0">TTKRS1=U#J2SZ+4S"T#@5!H9'C2?:97!64
M*L9*"ZWK-GEIENFA411J8'<Z [O9Q(#&5.K9'UMVK].6'^+B/_'#;I)$WBA-
M="%,^4U[>;(Q3TO+$C[P-L>2O7Z+@4HV U1R9>80YL;/K6+-TOP_LU]CL52-
MQ\YH^,W.C,J<E/4\:$UF;)S5=%"36FT Q;E*2.F*+2W#W"_G466)W8@[*1:(
M,U50%D?2&SY7_NYA)*C7L1=GEV#D9N%#9.<G>CP&V:T\P7:-'5]:Y\, D:T[
M @D2!F8VLA(G(S%VTU@?4IDVEFZA8;-*M:S>D3DQU#=?>BU$B]RQ1R$CNR,9
MSU#C(=2WQHA>J2<S%Q3]YCN*!;,R ?'=T*)?ZPR<0(LIW78V-S(W^I<'C,"!
M@X$[3=1%GSH,)/2Y.Q&4?E^@:VJ(K<A%^09Y6N)D?%E!J@,8YE5BCIC)"D7C
M(B/&E=2<CT!R+BO?''%2H$AP,TH;J?*20@2^<&O -H".U+._Q</=2<<;R0=$
MDL9Q9K:IOCO7%*"\E\PX0&<+5KNE5X5J/25 S.WK:S<E:0PN-HL!2JT!T^Z3
M.UXM;C,,&(BIZJIJU9Y9N1H<E#$*DE@HIQ@+$^0(G31K,J(*$5FLHQ]:<I>A
M0S6C,/R&V3*4ET(=(4@0_-@>-E'@RS"5("8II*\NV2_ZNI%C.9)TI4^-E)MX
M/J[?LBG.10[RE?5G\L%89E" ,&,\\T1<("6:@R4K %AJP,)C+7."$&>-@%<8
M!B[9;=J,RU/Z")A)W*DL<+4YF4ZH+,9,,*.%E8E?BYTXL*OJDJB2A,Y2,E]*
MT]?!/D4B^O)#S6A",I$U)[)S;WR QKMFH\NZ[^[3^C,5WG+,_JU.P90_LQY@
MQT1=JT;=HU!'?;\.AKN2)DC[ZGW+TJG;K=[<=.-EH7F[O<D9VPZ/Y]##M?6D
M'JXMN]WMHJ5V+,Q<(DX'@QJC.Z92&4#: TYW)/NV[@.Y7>?6K83@1B?^&)KX
MK%J0=NU^\S$$=Q)&RSDBW&FVG@6Z]R!B]\L'@^9CS(/3-4!WTXYW@S!^(K;J
M7K"%1KW-[F,LJKI1[P$.1P9ZZZ,YO:/1=[%[/IP2X;W7%LI;15F/.<OQ$_<
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MBM1 #[,I?+[Y%?W4+M^O(7:P:3I5NLK1(-2>>H%^M2P$)@PR@J@:=F>(T8I
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M=K\. TJR1L'P/@#+*LT'=FGJ/6:Q7 ?66_A9DA<('^_A8[H;,7I+6C\;"P-
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M! 4IZ)8%>E7LV*Y K"'=6V.'4S)U,L+XPXLT;MRZ[N+EQ^C6#;Q_TX]?:U:
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MCAZHAYV12OIZR#F)X52.MOBQ9[>''9J@@J-5QJJ?.W8VQJ<B<2>"5%Q9%:$
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M_H=D\@[!L35]1]<\%N%<GQ7/-<0!X@+^LV$XO8>YS[?:78@/[)@\VD# M"<
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M\$EKLPG\/YPU+. ^:]\:<WW(D_,Z_A6<//L!?FOHQGRBFQ.#X'ER7!<K^YV
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M""R#2"7YY#3C8HHT%"S%.0=_ =Q#3(+#.KGF/\AQ7%<0$)B#"AFCMSG'Y;&
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M8[E7.=1Y6&L \52?#@?Z<&I<"C-7B%-CJ$_FICZ;#%M :D/B>'RR^JXPEA=
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M!0E>6SO Q!$X(8II]C.-OR*+ P(8!TB6FX1<H@41G2XJRH\HX0,Z2?C&R3\
ML!B->QQP=41% GQX)0-U(C6;8, E6TDGG;>(%J=4$H\\,27D=G(_ET]7%/T,
MT?XX6M8A<\4"^CK=T_: 2SYE$^U9TILO3)9L;^",F+&@R8.\5>/R=.T2CR79
M=GXOWW^GLS,\7I1]EYD!JO+K1^4T31R"DF6.G#:<.,(;ZUF.A@)_Y9&+PHI+
M;58Z5KF4:.IR2EL,[@)$6L])JSW*9C*794DS9N$+(H-_8PQNAN:-,<LV)$7%
M7MH>!Y%/U\Q[_FEDEO?0I1_-6YE%9CKCK?)B=3[@!N!/Y^J%CHPZMSQY'7W0
M)&+$IS8B3RM'X@EKMV#1$W9J/HE,7DJ7!(/)H03G[X(#AC2-+B9QB;6R1)3S
M+JW=(PHYLAK#:II\"G_#=M$"#R\9HG(PD,^HQP2$5!\G)))$V,9]XKLGK9QK
M .U9*<)\QKI0G/CYQ[9(#4>#&_A_YOAFM-=3QU_3I$415R0)+7\A4Y.9MAC4
MM\D$0V(X>#>F4)J$(DE%YGK\,B[>0](4F(A$XCJ@9G_",(@WU9*!SKB 3EC
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M(N.>$4<5&7>6--TL,FXJB;V=(W_KA'+P+SS[<24^UYO,-\]2TQ$I)8:3.Q,
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MH=3EW'/3-*;3E"_/"7/7\#4K@2]S/!S.%+Z$_2F!+W,VFLV,*T#8)X@._"5
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M-$RX:\J)Q@!R?PW?0.;77&:MGC6L0P31>/6[Y3(@TY,3AEC+%BQU;0W?IQ]
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M7.=?L;.\X76F5)2)A/1]EYCD&6@CNB XQ]HNJ/6(R>I_XF?QE [KP8(6 /\
M+] "+#F3(%)E'L0GJ<;Y1FY#B@_M%>B%_1DH$UR\J(L?UL@\)8!8KW$N)&PR
MM($7$17!VA>X37: 1?/."GX!Z$<)@@B*%.;*LD6&1:?E7SF/ %A,9,>_B_X/
MVN>2(9SP8 8MO,@UB]VD*R4G_#H@&CP@N0N!1KGTK?81R&6+E%Q"(2W=G(Z2
M$+$;>INJ23W\]4W [F,7]117&\ "R'Y\#2[8MU]NZ:4WEH=*+%-)RRE*U;&\
MPA,K3GV;&[U;[4T"CA4@6GU@7KGX(G9<*F'U0&.G."0@\&/\:?;'1LQ?H)I=
MV.G*B0@'[ ^'#NDR[^('J4;9%=P;,##ZH > GYFUII)=(/LCL2E@+W"P/!X5
M4AAO-NXS?28.9+DM"".6M@KFXBR<HQ,R0LH[7%(SX&C8ETD0TB?8(Q7D8MUO
M2$OYV$2$:+$\L& #*N\/_Q4CJE:,15Q(_XM92_R=K-36?L)6*1;HVAL<@F$M
M?:KZ=AFO%*1M8\TSZ"6L,R82.LB\EDV*8T'"\6BY,;NQEECFO\5(FJS=#677
MEI]C+&IG>&#N1G/6R$5,:!N?MN>2VM( 8LI)XSZ?'>:")O?!O5@[_T8A9<']
ML^@^@VUI; 52Y?#:89)Q8)\0%#SR'GOTW4<IJ,2_] CR&%K#)<K2!@N,HT0P
M!#_[ 39FT%$C'3S>:G<NXO[^0<MO2&#08PXQL]#"F@>T) LLU37'14"U\ $C
MB=$DEZAFASPL23^5[&SX *Z2;#D"._/QKQ_>WAAS NT3$(VAHD7G""B3\SZ=
MQ/L\=R_6P8%.W<#U82"_"D?0R:'^'N742^QIKAJ?.VE B:RGD:67MI&TPBX%
MBXJ80 K@5]26!*(?AO3"VOJG3\T&_BI1(=QEX6ITZ818WP_O8H,(4AXD"5M5
M11?&[@=!AZ%:H^\!5 _6(]=85-.';14@R@Q5"2Y";8OPR1"L.2H(OK;$ADL*
M@6P4JB618Q#X%T9\JV\%E$?BYRY1"<G>N96#3HH. :)H_10'<0@6&0@R4[*Y
M02HRCB+P2"(TT820.,AU2"2D< H%)\&+4CPY6#YX>WF76W7)3M3!$X6\=T:T
MGX@.72W;< 1&%XP!?]:7X;R5-@=S'\!#'X'Q!:WP 6$ ]K/1(_F%NN-E*[%H
M)I+=.Q!A/#)PS+AH$",]@+VG3*G.10,L5B!XTLZ6,U +L8".VG3(T]?136)@
MT+'A!J7KP7'1_<&V*3#.%+<1#'':-96UAIJ_ $2+G 7Q)?@5+AAT=-*DGB!A
MX)$6^LN\)W5#X1EUM9&K+Z4/8%R@?D+82+ 8@<[=/$S!8.O9@IJF<:B*0"_V
MKN$W K+75K:KF]K/L%-*=+L!X.@9X0<18?"DS7;0I<2DG,UX&S,Y+  )#"$/
M,A&VY\$S]L,>8R"81) >GP&R8(0$+)XJ1@J0,KR/JI1M8.D"_4= "",A7-&,
MQT9.(GKL#@78*':KF#(:7/]+]2\95I>_X&"1)D^$60B7>&+%:U9YJH6SHYX$
M[3ZV!&)8O:3R7\K<<*/$O>*<XLY"3VV+TBPDY@O<_F)XR9<6#9'>O1@DP,.!
MMZ#=@%C<^&2,#@E#]@MK'ZP+-@?Z893,($C^&EF_P_?M!+=<D8B'0U_T"()7
MC<J =UMR0\2M^1YC)%7N0O0BXYY$:0@@67K?\,0S-48*?(:Q\/\C&7#BKF^"
MF-J3-:ZIK$??64I]QX,!;ML=D?+&F" ,96Y&:.W4N)-:7H$"O+"K?@5^Y6>T
M-5)+) [^9R?\77MO448P]=REP//0]1.FIS[HVH>(K37C+G&B[CP/XD7M,]OX
M 0G#>S^ !P8W_P/L [+ Y\!LM4]GG*4-4-[!:5J[[NXNCV[)6F&#Z6X"?SO%
MCQW:D45#1^B$\PZ,7/07GX]/0E>ONW.1AKG4/\&L":"U=B,M_G^W)K%8_V9Q
ME NW+-OFOJ/P*FG<,3ECJ6T)Y0B%D%N"!6,8 ;&-%=#<A3#^_^U]:9/CQK'@
M]XW8_X#0DW9'$>@V =[2/D6TYM".0Z,93[>L]2<'2!:;L$" QM$]]*_?/*H*
M!1 DP9OLX=M8N8<$45E9>5<>4U:14JD4RM^U'%\LGK993>O0J@!G!Z/Q4B?#
M%O^CM:S':1-*8W/0A54"?AT8&6Q2+(? E:08,W2UX)D*'CJ[8[D(D?I0:BB"
MWG4>Q$-]ALT7\*"ED@.\#]G?P#_(RI".LWP#?)Q1Z-\#TSVEG]&AS\!._T+Q
MOF!N?>O8W39-]"W<'%7TF-$=;_G.PD-+#UN09%,.':,# CH\K5C#[=JMEM&[
MQ*(JZ$F$04SSFFCI*P@F +79E&^AG2Q =FO=,U(40NP"ZR!*F0&E-^?EZ??Z
MD@,;5TF?@UH<T&W!OS.P7PB(L2IHLG4?!]DW(>$8;]%$E=%G]5V$D0=5-XX7
M,>P=>H^R&0<9DF3LT.&9[A"?N@Z-DS$#^H;L&<6=<((B$8)\)&D-^Y2-$@IF
M:MW(([>*<AQ<67C/+.SK[FL6=\2CZT"DW!@L)>3@J1\ GY')'+$\Y=L4]0W=
M6[*OXZ>9QY2#+R\Y4JK3A_(\E/27X0Q;-F^1E&ER7.X#J3NAA&D0I0$QJTPM
MSWUT&4JS3%; ;FA\'4F].U3XMN3"V;(1DKR70I(%$AZ 5OH3]ZX,-8QES%#X
M('<!U?XI4)B-@$Q'8"/B=4PVQ O&<18HOY.[F.@8"D,1\[61\E=4H/['0J0N
M_\)\%[V L:JTH6+E'TO0P0X2'W8CPSWXJ,;,C_*D0=%&F+PE_19B0V15+QY.
M;'/=\LO!-HY'-WBG.\_=7>G*!0%8QC'><@!,L(=4:,V-MW%!(*B!)WY%558_
MYB&1E.@BAP5H[1'ODP8B!3_S1D8\_?^8]'9K_0[N/,MCEJM>BCC4/?/H7HYD
MCT%4=-_&.R*S7CGI3ZIGC"1A/B0B,#J_$<A<=#LU*I$ X<#':/X@-1<.*Y?C
MYKGA>^A6+##/+W\WO!%QB@Z'H28,[D@D'R78.3@&$@'0KU)R=RDI8W]#," &
M:%.2N1N3,JVV=^$I%2B,/3\1K)HQSDF:V: 2D$]&,$'V,4*;6/ MO#\&8TA@
M*%*U,P(3!HP%?CTU:T3!EV*HM&!.F61A"D6&1\*A6ESYLBLE1F%1: _FRR@,
MS@,<1'G=[ \%RU+<..6@^( 8PHONCCGQ'R?8IA/;O?A/0M\O4**%859=Z72_
MVKQP:&0&J\R"17NW9V/_,S14.60:8_)N0C:BASF-%*W"W[5:W^6!/CA_(#WJ
MF[>,\ @@M2XVZ</[(Y+Y86Y2%B^?@&2R4,8K=>-C3$W3K==D:L$- G(C_V%K
MI] TGI5'86LSM&RQVJ;)FAN9YE6)$KE$WY@)DDZ*?HL4W^BXE-#J] BI:-."
M^<OV.-B_;%Q7F;3X*#L&_S=ZQO0(FSUF#@+K %'%"3-@^HY(C,$>2N5MWHQ9
M=&1EL\<8M G'G-+$RA-&EKVVW M/.3Q+'!INVUERIFS7;7!K9-+-,=^&5OI+
MK69WN;_D]*\R8L\6/PE]K;'4W?B [H,QE] /^6*:K*<G#VQ\J4C@=!1)("N9
MUGK)+G^>Z)OOZ91" [;*2L&LH3SD0X8YWME%L:19M.8JD]8TLZL$GG4WSL2O
MU-F97)L\XJ0?)23(URQCAKP%8&A&QM0-#;V"C4?#<C3LOD3&NFCCVJ8W7.2*
MZYI[(2S98I-WH6^=**?(_U,$_B2*1H7[(0S7L<LA8VT@#+"GOG''I?N]\H5H
M'D0A-IZ"P ?@.?XR(G*3UU_Y?25=6.2>&%J=-\.,<YKT[PL[O;7>TP$E^3W.
M**(K%;S4)1"F.KA0P#R+;77W%14"#88-@Z^29(KIN>B:"NG5JL@W3=Y(,4:?
MK;:B#9-I1?22W4Y,Y_+E&82RX;%&L#:)(K7YJJ#JK>Q;.Y;7$9QRX:6U"+,*
M5M.G,?Q7E83+Z2\RA%;Y4J4<-'VJI$+I3.5KJE36%6+ SAN>:\6/!#\$MT\=
MJ_+3DR' 7B(OE=](#XQ$X,U7*"T#--,#0\$81(^VQ(..8L&YE-1<;DU(="JG
MFL"0,675?K2J8SKW9Y?C3U:I;9V,5[ H!L#4(#:2/#MCX 6(++G.4F-"7]P.
M,))F.!:$BK"4$Z*3[T'L?H%GGD4 <GH*6YXDBE<M(SB4A<JI43>8IGW'C$GQ
MH&=T,9199-QCEF'=GD6K2)X)=1L6':D+X\KK#B]F)D9Q_$ ,O/:*A -)+-L4
M]Y&^)5G*9(/,/<7L:&7=:7!@W]2\6MTU&N&?RJN_^A=[%5TC,9<(R^_I:N42
M9J1T"W>!^0XLWL)U'LJ2+#.-)T\7'Y-'-3+S(\:1S+CZX? @#ZF7=TWCF7U!
M5!>8%@X 8HD=_5L.MJ)_%T%SUX/V[(_2">ZB\1U8SCRPBR*5LT3\8*F_\FF-
M!,J:L8];SA4_WJ!=V!8@,?SO;SH:8YO-OC5/KL:H,LT:=PMN78E%SFI [BYS
M</=]4NZ13TI/"CW&V;PTU#G]<R;K+:?22DG9<;^KC9)/7JH'0=1'@1+)WVU,
M,:5?UH!PTY&.:H7.=[N,;NS9CK/I^,:]8>4%XM-Q;;?9.@!"]\1=JZ>JU]C@
M'V*08 :M>8=(>:\U]USWX#<ED.V/S'7MKM,\$?@7M\WC2?D5^J?&=A_P=@$C
M3)O*_/U8#.OT^]Y?N)/0LGO-76?XGL2PNB+[A,KB(J5@T[4[[9<O[)L=N]OM
M?C7"_LY(I?6,QE97T;\.<Z_<MMUR._M#5(TUO[\>R_IC:=F]5ET&/O2Q'%J=
M+(/?W0C^A; R7N&G.Z+0W1^MN;<NT@;>* 7B8&[L^J5WH<NN[;J[4N5V*+T>
MS&JKTK'[.YN5ZW!:(0?^0I<AA8].="MSF&4/OMBZRS(9N.0L7+[ZQ5M@OF!F
M4P<K=3$1TFG17;)JP2$&5G6DAFZ12[\=8SXL_?K6REUG>I(R6?337#J%1<@$
M@JK$1L#'/K:PLP)_+&ZM0E-7F<-(U]^^%M.)S#'F)+QOV]T^ ?YMTVZZNJ2*
M@5I63Z430C#2;:O1W+"78'YKE>9^+WV)E;^@D#V-90$WT7AL?=NR';?%P'7!
ML.X55[)EZ@';G["5F3PS[O7DC;A T1O "W#N:>7%>8WK[_*-^6=>$<N"YW!F
M82(SF2[AYMQI%*[.Y5:HQ'F.31:%D;R >#?W1^B[7JNO[QJ5X]$JX9# H_*5
MJH26U]'-.VHZ$I^ZBU3MK9:.Y.P@?C 3&K"AXC#V![(F46;4Y)/%95*I0?)8
M7?2,0L044+H)3W0SEL=5T615?V<V6E4Y7OD/)R+@[(LG+_:C#/,<Q9#+)"),
MW9)-54=^3&U++=7./<G'CRNX0*3[@?7!FZ-0[=U:'T,C[RQ?D1-^*4D*\S^R
M /.&.-DP6OF^,NBDSO!E9@U'*=/MUOI9S7'WPS%FS7'BJLK0M(IKFJ/3\X5&
M_HBT8?0<%GH/?K<JK2[*YPU3WC&L2G4K5"@#NTN!O#"3%K]')829:Y1W?WJB
M/9,\<LWR&?ZA!YW9H,FGG!NN11J2Z"=9DOC 4^AR;4*;R,Y#'IP3:M^'BKFZ
MQ416!(5L8>H_0G6XZ020><,E[OE!C,R#4-FV= BI/ 0MVUA<>& E#M$D'.G^
MD(7\^J$2<6/L$%<L_HPJQ<FM]3O^+V<IZM6*%AU]3!9:0%5$E%5;L:H2R.9W
M>K<$B(\V+<\CE3F=LO@'.Z(*@N];IV.WL=*$\^QE5VO9; ?M7:=G-YL-;A\T
MQH+30LDZ/Y=W[\5>G-RG>3#7PJD*^+(&H.;_UCLABO+_?<A9=R-5IDO;X$1]
M*0LK"AY4DJNL^2VS7XJ]+2PSFWN!#E"'>*DGRZMF<KZ>JO*KV-"R(YQY"S]A
M;:J>K#H2ETIZRBA".<(6DH2RC*W3\^@YR8N'D@VRZA2$![0_]4:JS6WN-^6]
M'[(*QM6-)/Z: ;LW&W:N^X&%QE1FMXP#QJ#3I<"@5M]_"ED4.DB0B>#E>FDI
M1S2/X'X*=6Y%ZE,&@**]*L(Q_4Z"(<'. B-%C;CDHJ\)+_7'OEC I=X3%J9C
MW4!,"$7N"J/P1N7]E[=![/U.#&)8DZ4%6A2\)!;$8]W2-,,*]\!D*2P?H,Z'
MY</@=APL- D ;K5 6>+4M#CP_&G>UI?D1T$,2Z&I>BZP58<CP'*8J7BX"J&E
M@@2R] R8T4H>RS+07%PNBK "63(""Z4[IC"\,GP!EE(@I11'(8!D662O2-98
M9AOSLQ7G2B*YZ>HJR\625]F;I5#C8%1#%/H0R@9_*T&UJL$DDM*PFA2)L9^>
MW>L1@(;&X (I+ 6>"KYFR-6%)>OHZD-N+28C2R@KF 1QUK$[G0;W,#4;Q'EJ
M)E6L)Y1IJUB^:?E!N++J>NE+9SSTY<H;RWB#&HXH.4^@5,KZD6 Y2](>6[JD
M9!QF(550SOE#$E*R8Y\AY0U">%9=#>A<5]A/F@0,('CR!$4XT;WGMI-<UZ64
M204QF0)^@3)M9=D#&W$3879Y)]@?12GC^BQ4G_'EU LL_8H3J4++1&M KGES
M%4<LVPP6PY)R6116:GJ%KQ![HQ ;BZELS3+TXGBN.K;0$ &%[05[G\S51M=N
M]YR2"Z$Y4S6GT7VVY"\+4:)"+** 3WG>;*-,<&("-HY<)SHE,6-7M&*E,S;0
MXF(WGT9S1!L<(3MW' HB>I'6>L-V6\Y5X"P)A$QG03174XG.,,2Q-C9[)E&/
MWF+4@UL:5X8MBP&1T!+Y,1A!#F)8[=UR0S +[\>P.!-'_6![;S#.F=#;/+T$
M^(%83X.@ A'<"AQOWD)TG6ZM3^!G9UYNYU8!4;)QL.@>0&G9/3DK!7M_QU3:
M+P.2.*4ML5X9,OKS_>^%L'$Q.JMPPAHKGR*EH!Y1[TS57X]:$-AF5S<6#^HM
M94$E1Q/D.RN;2:;=V6>%MM!TA>]+R<3D^3 8(::W%$*QB&*1IH$NPI:;P?U+
M]>(L?0<+T.KWX L*Z%D0I]+@8D -%Q7P4R%Z6;U4N7%,,]HMXGIV VK>2JZB
M>L;G"CC Q]TL]@/I;Z/'.%&]7W!-#JU;(M!S).0R^"6^Z"JJJT7U:[[?N$:C
M:\!REY1;50.I:5TB?2O9AL2ZSQGF[9,N\*(GL7-!]$R]Z__JA1@(L;I$U4Y1
M,)8"W,/\J$HQZ\_W_\]ZBP\#B^AA%#S9$+[ZWJ8?RP!RI(<'@F'^(;X%$!!7
MGV^M^XD_"P0V=,_OTLI75;@2M4Z0"L0$2H_38@%*0+S648UA)B^Y5-P5;%":
MU);8A>ENYF0GFYI$ZA$6>2/(*$LIW&2K^ _9<%,/^QPF%"4K"!_#KRGV;*.?
MPYZ*<1S>H(>!6FKS$,S-;:J(+<70N9']#+?<;O!(#]*5]+M"[UUU>6F>8M[1
MBO0,]N[7=Q2$W3'-1O.G VS,K"2W,NL9:-R9=HPT66"O"+"#&0#XD$!0/2ON
MJ(UP12])8]X#X$F?-9(KMVHT[R$+W3^H4XF$6C;,F,\P]Y+2;Z8ACM?+8UWE
M623PAK$_XL8G&,F?J3'3(+8K^#]/3=D@SV2ASSNJ17DC^Y;Z_"'G7D2"BEM(
M4/FDAT'2)#\V'NYU_\%K2DK-/(T<CXR\LTS6.#-U6-7=+H_J:)\\YM% 5@O,
M73#@FDW',%41"/CKSIAJ2B:KC88DSS.TOFW<@D78<$BVTD]MG7%(,XET(@,+
M1=6$7$:ZEBW!+=?0FWI"QM(O7P46A3, *FD)ZQ^OR+,H&^,,X](%0(YA&VD1
M8N/(HM"M>*UEO-)(,%F%7\,M4%F4*'O3@"UGCJH)BUHS"QS7Q*WAGZBI*TA#
MC&91IR>:1 MN$%V:458P7G;/X"N>'.MQMW8PEM3H2?S-LY\W< ;5N0)Q^9@?
MNE?+FTE%AM'/[=?P%HTQEF!+?3FUM?34,I0SQ6(#XPHT>/)IU9<+^S0I0&I3
M#'< 1' HT#2R"B&VBI.Q9>-0\N3G*W9>H()3"85F@[+%STY$+4KY@GX\I8@_
M.US5ODI3U[7EJV<2R,R)6OAP$F QGH$,A3<!&%N/0IQ2C V6J.%I;L)=_?7U
MA\/7BM51\.OA7 #GJ-C:\A-144Q!.7 6.RK6IP"'M"0R;3<Y2!<R.=)I]42G
ME]&0+(UF-7KZ=-W9EVV;P[@M]=L:!5/\_GZGV_]QPZJI5;[8^N+_4A39O$,0
M8C& K&+IZP/)R[=14;:U\3'5/9)-CZXFT9]J)V=+2.U.@8QFQGV0AW-'J0FH
MOC"2<FX0A9GLB?Z41^E^CK =LT[8Y-ZD2RY_:0[*E="^(D+KV-UV@=061-22
M>T2B1*RTP!LC)=_8PTR]/PN=N<NS4JN\5/%E1A%#2OT5H1?HYNMJU-Y<TS F
M@*I'*>@:S"F$CPZ=S#@!&+X(#F(OWC;X87[AP,% IQ ,1/?&3_-*G==T6_DH
MPB'YP[_R7E3_";Z-H$F<MYNPSIY+:_=C:IRAO5<VQC>Q]ZH'E!S7!MRW27ZU
M!B_&&NQW[69W:5:"F1E C<[S:6#JZI#$<>"+C*=@))/\4G$L<-[:55=_1;JZ
MV^O;K6YK)WKR$N4(]]5DKEB@"R*(I*X4]551E&,[[LK,J1)-*7=5&7P5YJ+T
M7ZNMQJM_<:6P32F,TH95:%4YO.3J;FEN&],LZJ8O+ ZSP&RD*)[?Z2D;22'%
MX2[Y.$89RVD-_Y2_^Z?^W=^]@">]W(6CCX,D"D0RQ(E5'\CZ_8:XA5Z4):-O
M<"Z>/_6"!"V[G[I.L]LQ&XLL@K(EN"H+8Z_@]IN-5GLS<#_)3!JTSE-849>$
M_YZ(<1;\ZH]%[7R23^U_Y(O7>'$9EM<R+^</\"]?RQRJ7Y5'^IG'T7SF:8/_
MD<.K:X"U"F&.TVBV6MT<ZLU V/L&@(CU!A1!K]Q J]OL]-Q=X;___-O=AC_]
M)&*4#S@7>N-SR']K[N;];^^^^:EQB_RV$SR'VM2:LUF]J=:>-I7GD<E'93D,
M/$F=.$!.?-2Y:BO$SDJBZK5:/= B9M9:C=7V#>(_.8WRGP_/T<,DRA*P9D",
M/#P#0N;P60UQV.PWSGL;'\,Z4KW7:)_#<2A%I<A6D7)28PMNI]7<?@O$.:L?
M361BY4/T-D_-_1@&\T^>/]*0;LL0&OR]07+,K>W.2&ZO]S*W7X\!W6:[?9C]
M;\0.2[334CI>J9&:SH;,N%P7R29!?WAQ#*;>_&XXC#,Y#W*-B7XG2TL_<64I
M' O]6(R42O1%'>GB]-INLU4P/2L VAKL!0FX+["[S6:GO2G8-/LOE)UB/OO)
MG_G!.#6MEBI17GPG0[^PX<^Z?%D^(%E+O:>*G5928;M?,%V7;NR2D% E4E<B
MP>F\0"1@#<>&:&B<'@WWV6P6^,O1('?Y28Z !?&@?>SB$^I%&W-$\R5B87.6
MZ+Y$+&S!$^Y1\%#EKV\L&NZQL%J:$K^)=$\:PNV], QLS@O.2\/ V>J&O>#@
M8,92ZX)8X6#&4O."D+"2&^#XU7LV)(/6Z3%P>CO)/8Z%<%PL;,P-;OLE8N%X
M=M)[["*+EU)>P'56]W1Q>I>FL3_(Z!;S(7JM"P@_CM^(07JOZ_4VO_K@B]F%
M';A]UVFVS0#ICI!M%6##JG3?"_1-W5YBI^U>8XO@V4I0CKJYW:.G#KSKA2*@
M7ORTW6UL$3ZOA0'%+G=!$ WQ=\0FU)\>\U%%F-!;W\JA*7NX,FXUVAW3/:VW
M\D'AS0V3*$D_CLGLJ',]YC0:G?/<R-V($G<2H)(Z%V3-9O,\]W$?C=-G>!\P
MC/KS33Y""(^KUNV9TS/O^,]J@R((X)!^$:&(O0 CX:,I,#=W,G\2\JVUJ+'5
M:O9/1XZKHZ,;\57?:?2<\]S(9GS5;/:[IY-TJX-S>V&L5KMIQEO/:H-[8RS'
M<9W.F9WC:H#!&FZ8%V/G(/!6&$'O5:;D'?:%K'4D;J]E7EANMD&RHMX(GG_Q
M/I0!AH,E9+54[M**)0N@_1'%6)/VVIOYX+V\$6-_Z*<KKH-7HZK5[.:V8^6K
MMUJ\7MZ'ZS9J+JZ/$E#T<?RK;!)6WG'WIM&Y<;N*FM[)22#4^7F!;N[_/4X7
MSL-QNZ:;F"^W&2 ]H@=W%T!ZG7J ?)(#(MY%\6<1IE42@M'2(0FQ$8HJA4?'
MD'6EQ;>"#>FD0;!MA+6J/(5^M[]/V ">G@%;?Q?8^NW67F'K&[#U=X,-WM!L
M[Q&V50)>]Q3%#$TDYU^C>%3'QW4+[+ &QE]%D@CQ434^)T2\H4%VLX4TO.UX
MY*??:=*;:M<IIR#D *Z!8"\ ;\0X$N"[[!&>T6,;C@CP*JJH!/ACR -<[L4L
MY=)^1X_:H4;2V.C-:$G/I;6J02>VY^)NE6J4%381:'YW>R9;7L4(/V'OMI&@
MN86J_^E(=:GGT3:R#R=\.\J&7&Y"S1*^ ,ND.)I!3RO!^;KR835AP ^Q9Z3"
ME!\FH&\#KJ2@.3F*JA6V=6\%&A+A.K?6.RY$9Y0'L$8 T)?GW8RPB9DY$F+L
MC[&9)YLUZNRH'2D#0Q4UO#\]]N@5=2"GTXS"8/Y]N?O#7[. )GWE5$(3"2U&
MH6R[5GHGS_*MPEEC=YP9S; )5UO3FXPVS]](0JBV=[IK \1.(3.X]-85TET^
M43<*O[5F7";8U?IU^!"4@'CV@@?L?;L^U%HI;@K5-6O6*(-4?% 7'%0;Y2RJ
M2S>Y\-M[[%B)'L[O,VQ'#\]V&FZ=\)SK-KN&M[,$F.UAKA>W;;9==W,H'D3H
MA>G[*?5Y65%[M@72_IG$Z3\_@%,_S::UKA&*U0R+D!4<H=]#/6C\CL3)Q_'"
M+]#O?*9!-<<A!*>%@;'-P5M-&ACMV4=DWW4ZO5Y_&87@*JOA4*)A+X5IG4:_
MN91:U4JKX?E#8(-3P.\3?/J8IW?3ER@EG%6\]-,GYQ^]#X[[9AD0ZU^_$7A8
M"8IT\!DH2@86]I#FWBA<JFX*0!W)KB6'.I0WF.SQ)7UX%L&3^,!FP[;QAQYX
MV:W54K_.^MONXQ_"PYR$;<%WNHU>W]D<?+GLME!OK2':;K?=WAS<Q>0*O"WX
M)8I&"8:GY9"!^R@8?01*FPAO/Z6KW7ZWD FT;M&]@+EQ,+?I])K.+F#J9)%W
M&/Z>B!']>.MP8J/E-#N&D*]^_=9 U&-K,(R[O:UAP#CD^_!3'-& X2T1T>RU
MG0H("N_>&H)Z[.8VMX?@L_?\ >1T[,/;MD6!V^XV^U6D8+Y\6PAJ6APMI[)@
MOQ8$NE' 9X&33,36B%C6Y6!A@9U J86191T,UH("SEB,G1HWB'2LN37KMTUW
MP7S_AFNOO.=;VB:AE$NZV15TMV%F3.\9]M5X:W=[G?VLO3+QX#!XZS3[-<]\
MZ?J_Q-'V4KGC]-V>D<NR>I6]P:2Q]2Z+ ;B,[M7?^5_PKUJY&[U^H]\X'=A_
M%Q-_6.^$G7;!B3XVI&1$8A<<TV^OE0+4=OK'(XQ:(K+C]CI.^^@P[4RL_5[+
M=4\']MD2ZP*D%T*L3J\8/7T=O9,#1FL587<:K:VIX6XXS*89):R:R@+^#H1L
MX73'82ZNH5_V\JVM^ YX,^8M_)[@.>(^Z_D*O4;/U(L7N,^=J+39=]PC'#/Z
MGZGXU7\2H_=AZH6//K8W2!*!A5PRO%=X,5UQ;5PQ\@D SR7)3Y^<EG&SL24,
M1]Z*/,0_Q. >EEF2>EB\LMG3QLQ'L)2F^*9]N#YM,TEE]7([ [=Y/*E98(2-
MH%MQ CM9[<U.U\RO7+?,'L%:PE*K$Z0*O5*."6PMIEF=C]=UFJ=%]$/LC03.
M=:W7F,9,+SX"N+7XN^EVVL?%XAH-L/K.T#D-"B^16A?P?![4:I@KIL#>.F[;
MZK7JB=LE"Q\$]'H!WW;+[1P)]-_$]DG7X+[5(P589&>0:F&NZ[KUSKP"HE*_
MKM=9'._@<SENO]\PXQ[5K]\:B'IQ<J?7:?:W@ ';E%$TE :O)%@[O",^.OUV
MTRU LGR-70&JZ2RZG>:6 +V5K;!E%:K1T&U7JNGT&VT#36L7V@=D-9,,>HVN
MLP-DU7WK7@<>('KLB]&NF*O5W6]AN?U!6?,ZODXSO[50?L2LU<5N@KNBT&DX
MIOA<O<K.,-6S0MN=CMO<%J:5N1F_AR.9RR-&;[_@/3*GF&U_MNUFW32696LO
ML#.UP/\@TDDTPEM.;L_^\3D4<3+Q9RM[?98=JA6AI-I=E6K#L\^-E&WMDVY$
M%K5A7$*U&3"[=+\/AT&&(Y_0S,#19@_>ER5U&FT5T*"_\^WIN-L;,8W"1+8H
MN0M'4E@\ +"X@,J\+[5,VBBLW6E7M%O>9&^7CA[.KO6^U,VN[15*@?> L#>9
M>(BD$J5>%EJ8P99^B\+A<IE^0KIQ"S=.-?>P.M%S16EPSXC^]6J9=F"L+,OG
MK"J3_3V<>?Z(OGXG*AOV5,&PMHW9FG!@I]/0:<Z%]2M@PS/%4F(^PUV E+8_
M0P@JO]=U^KU^8XTOG=>W+H.G #2X5Q_'[Z<S8(B/XW=1+!XC>.Q]*J:O)UZ\
M4EVM(SRWI9+#URVR4(GB!5X,M/D'B'7,*_PX'OM#('BSB'H)5MLY5HL\1U8P
M9:'O@ZW:Q=S].@ O;+*R-OP.[<M'@N_G>?Z(3$^EBG3N'/6>QOZ\E]<*>\.&
M(L+/>@85#?KY'7"1?+[_O3;.EC3&HD$4!<SM$PM%RLX0).Y.QD8#;@).AH;)
M5^"K=>,T%+[H[QQ?..=1) _/D;3_%_?+JRWL5PN.E=#L!C=HEZ:A@IL&W'_[
M& JCQ<$]:L%4B'#3;3B=;L]QVT?9#,@6O9F"-?DW(+9X+[MI=9N&G*R_&_E9
M_F#R"7@$JPOP%U6B<F,ZJKB^,UH6K :@HBL@M8<!)8+=Y+:';^%KX\TX]6N#
M;2R!;0%T=*P_CB48'^//6-JA#BIOB_?:"P(Q^GG^UAM.BL_6<+/^AK24D]-;
MJAY904U+1%JWW7$+QOG.L!\%&1M3YI+ME\_U(C9?RMU8LGFGU6F!G #)MQX-
M_0;+Q\O"0[=D>LI?%+D^ES8_>^&?&]'%!2)D-_VYS.SI]+H'H0YN9,-?K6\X
MX2S1K)4G3$T!\-\BMM1^>>+D. N"N1I6*KL$8.$H#10'@PQ+/&U^5'P1\=!/
MJ*)](![]$+-BS()UFV>*8P6\^#*CO@-9*'_%;_\K_%L^Z#9N5>^>A2UOAY$=
M#2?$$39'4.BIVH(?6A^\>#@A^/<+_LZF4DWXS08#^SV"'G8^R7V4SDVSL9EZ
M)BK]FTO-17(R]4JDAU-318@#W[E_@^Q&8F7<5 4IK,D4YM3<'A4TB5&"^\C9
MY]#F>=4HLY[1CK<:JJT!WZ,I7IFIVVOT=H:\RO@^#.8_8<2Y4KSSS)_U0.ZZ
MG?V>Q\K]N)OLIVC4<_]J"AL<7@!;J!MI6[A XK-.&H/B$#PU6;5]P?""%\[_
M=V(51BBCXL%GI0C,N[W(]N:;O.O5-W]S6)TI*+_Y_K;L\E1C9W=,[JX+S@N3
MK3(FCX/(W172 AI1ZVR!QY)2VY*0S#"9BA709ZO<@4-)E6:G%/BK FRG'6QU
M9+7A;Y4#EWN'_\!JRJR,J;T!C,^\QVNJC+,E=> &!SLD6$\$GR7@M&#/5,Q0
M!()_X\V3R@E=1PA6&ED;6X-^8!P</L9Y]DC86= >%05RTL%(B*D$0\WO(-8Y
MA3!M.'H PS*P=H#^L(+TL+ ?6(AN +RB/[7473BB\$WR,4L3[+H%=+:DA]S6
M9MRGIE&DM&[A I;)EF"%\":+>:*''Y5NVNY%F@9T,_=Q_'<* 96N"C<LN2IV
MX-:[XK0?K' K!B-5-F/=R!MW65->YGYV>!RD5;:9J,3"AJBL@33'/3G2WD4Q
M/Z6ZL?\<A=FFO2$/3%SMSF9HJM[3P3!S212T&C7:9EWUHM_$,WVU*2I6;EK#
MLT@M[\.1F GX3YB^\6,Q3*,XJ1J@M.S>L-=OF1V_ZNUM?QBI2D$Z $9J4TR_
MV^PV3H>.%02R?%O[YYO+PH(F][TC8C_<\2F.QH+J0[Q@62K>"25#1?%-H]PA
MI #_-OL[%9_7:7^RZ^9<AS9'7?3EW[J+/GIT6; BD?9#_%=O*I+/]Q-_%@@U
MO%)=A=]G@T3\.X-?O7W2/UU]=NU-=K=UXML[SX^Q?1K6QV53"OHEF"J+EM;?
MHP!>@W4+V/54]B(^K,WT6Q3^+?,"*H(A)OW((&V2\>_<.JU^=P])@1OCYA2G
MPCGLEW JKFO.J#X>;BI/9;!^Y<$F*R]V3#[V*13[B1QNDP<E<IS(^P[DZWO
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M !)?A@+7A'>/.?X*&X;',H3$HZNNXLH L15&^$/P0GP!(F!$@.!W 8A3V#]
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MRS<,^=6M=;VV/=BUK='6;5D@ZZ?_^3_^SU^^#.+ _P'_"__\_U!+ P04
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MTGY&$9 )R&AV6^\7,P]/(;O&HQGWQAD) Q[K\K$(^2@R+>&$=MOF57W;)+4
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M)28C(T@?D6]8I09@X]+D=#[(J5UMAA)WK!=EJ@_>;LD*E]BO(:(=KW%9KW$
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M(IQ\W3G8W=\!, EQA)*GKSL/=Y/CN].+BQV09D$2!3%.X->=!._\[3__]5\
M_>^W?YM,P#F"<?0%3'$XN4AF^%=P%<SA%_ -)I $&2:_@K\'<<Z^P><HA@2<
MXODBAAFD/Q05?P$?=S^%8#(Q8/MWF$28/-Q>U&R?LVSQ96_O]?5U-\$OP2LF
M/]+=$,_-^-WAG(2P9G9W>W4,_OUP"@[W#_</#H\.P,'^?X'S?X#I^=7NVXP*
M,PTR6H[^?$"+[1_1/PZ/[@_WOQQ]^'+TR_\85IH%69[6E>Z_[9?_%>2_Q2CY
M\87]\1BD$% 3)>F7MQ1]W6G(^GJTB\G3WN'^_L'>?W^_O N?X3R8H(29*H0[
M%17C(J,[^/SY\Q[_M2HJE'Q[)'%5Q]%>!:?F3']%BO(-)"GZDG)XES@,,NYI
MVFI ;PGVKTE5;,*^FAP<3HX.=M_2:*=2/M<@P3&\A3/ _J8>4]>:YB0)F(OL
ML5_VJ'7R.4RRXR0Z2S*4+9FIR)PCI>@YJV<"9U]W4DHWJ3R#U?<G$]ILN:#-
M)D7,ZW? WCH03X*8Z?+N&<(LU6&2%AX:Q$U J-C/,$-A$%LADE(. (\U*LAL
MD5[/KA>L[Z$VT"I+334PK-/G('F"Z45R]TR5\(SCB': 4SA#(<IL@)KP&1IZ
MD#Z?Q_C52J$"T0"@IC -"5HP,UW/3O(4)3#5@E(2#=(T4D3EO2$PI9)S'[K+
MY_. +*]G=^@I0=0T >TEPA#GM)M(GFYP3(T%#=KRAHP'$.X;IGQ/,6W 1-L?
MRLH. .$2TKY>JZQVJ0&JO4A>J-8Q6>IJ%@H.4/D-P;0_RI8LM/S,T8*U*1T.
M%<T@^J A_0D]QO X30TB45_Y :"4'D^CR3)@_).(?D-R&%VBX!'%*#-H7#8\
M!H!\A3,H5$55!&GCUEK6B'@ D+<PIOUW1(,T]:(G HNNG%9Y3X(D#4*CH&K%
M9 #0=$0Q1UE5">U^6$](QS$&/F! .DA;AC-("(QX'?,Y[<4S'/[0-V<EV0#
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MXVT]1$LX)+B&BKKU&N,TX#'2:,16M38\1H+<4)8"S3J"V'$>80!F[^AF]"-
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M%L3L:?:<;4.K2[);2_GEIPM,6&[>>/%5U(-<?/7=$&U#/^S>[8(2#*C1-"@
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MGT?5G]&P"7,'+(U^WQBI3G(SB_W>\<+:9S4#,1M=Y5)UO@A4-YP7T+8-+@,
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M<T+&P'9"X#=DM'%P9":-#BYC-FZNW27O[?=$@H1<D%BJ$MN&XS%DH.U%59&
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MNE*G#*<IP\FZ(M++QT&53_9:,END-X?L<>4HB2]HG#]"0S%@DFFWEK)M%4/
M5*"'.&"> 9L0 '7J;^:,CO0UT''Z5K_2*-J\ZKR<N*LT_(S?UXF7UM:$#S/Y
M7+P\ZX:"[@LOL&?:O![5.*ZLE[0PH8^OU'TAO)S: A^<IEV[S%VZ?K_]MIZ(
MEX4=X(=8ICD3Y?#^/B3W#.ZR%'U_I,'I,YDGG%RS179XERVC>H&.3HO@94]/
M7"!6E9)<!@M]N&3,)F&8*ET>M$"#]*!0"WLXJ(<]K%?+@Q[X>DZZX!3S,,4\
M_$PQ#VO8L]!)_NY#@S3 2.PC$D]#[BE2P1F;'5^#5>:' (9;\A,I$;RMR .
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MF]'-EC.:A/WYHC;;UC53G3$=\( X\UDW9S@\&Y!._?L'=;ZHS&5J#CM;U-&
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M):K5D/I8]REF*SGKI1R^%K8B4K)*PU"A815?HX:U;5X.U][E_N6896Y-?9_
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M*IE6PFQ-:>!MH-YA MEX4>+E?9DM?ON2QF5Q=_]%Z]4,/#X!8Z5^%T!:!C"
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MH,*Y"0P1 K0L/6;+M<[>+!D>L@4;F"M<33I:O-1E#PZH_&;+2%7LI\7T2,#
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M]%=S>$ZI,*D^R*A0D0-"E$E'$5(=#B"8NL,%)@U(SU[/R"R=9&QO\_R-7D[
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M3.VB=X08,#@>K_L0T7^NHISXV>0=K3 ^HD]>XO@%S@'$684?LGI?^Y9HNMT
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M>^R-U2][S'(@;:].8(>ZQEI+CA@]B,/X78%LD +AZ'XG^&I%P/#JH_5V0&K
MA(!=$6H6%/I4V,Y0RZR"_8.JI>H.: V9E+ [7/5B0H/5QDBKS(9]!*J%XDXP
M#;'Q"2+D Y0Y,8D=+KW^7RD5O_X!6N69W<S0UQF U,6[9CSY/:[0Y>);JVJ3
MZ!3"!7_-NV%@*D\!:(.)-L9@7"RY7SSC9940;VE\M*]0O=KW$#TFRHO%T\GW
M>A%YZF;I75R>2C@8WSZU1<+KK;5\.JH8]S%__;W[#=3]"'I\[Q'6'T+L2^@O
M[%O_"60$CGTL\RI.\66)A5/K*07OQ1.M0D-,\OAJ*Q7.*)O*%&%X60PIPXBB
MGT#L&T"&5:?V[&FTB<LHX1>/[W"!\Q=68_^B*JN<I:?2A9TJ;'67X[<FRT@S
M%06%[82 &1)C-7=_.F2*TYYID'V^WB39.\;WQ$*R6I5[A>LLY0^;L/%9/&2D
M:;I_/\T*^K[I?^#R#B^RIS3^NY %ZN%[/D?*[,W6'5&S?0S,R)O;PN$(_9+F
M+0D=I-M)BC[OG1:'/CCY(QO$G]6_HG2J$CN^E3B(8:QM8"]C6ZK!X0]XG=G.
M7L!8LV-&: [?FY>!1WB3'LS.FE%#H7)[3/J"N%&TPOJ'>N9<,\[]Z!*X[G'4
M>^3[2S FT]$+WHLHSMGIW0FQ9LUW?,^)@Z#/^_V<)41,$I?O])V"G^(T7E>J
M4DT^%=B+K9;1#3O)EHSSU\%,GMY-%D\X.4\]RGD]]9=6P!%:<_:O9^!';X$'
M?J/ H0W\?L/Z'OC\ZU_5P.^9[#[P.3N@@3_F9%?77/3T5K54GO.#W@?VK TG
M#.19O@9KX,YIHG*@PJDZ.:GSNHN+WRYRC+NOA'F,OK6?W]LIV*)19YN -=^&
M-8K]&2S4,28<QRO"TG_5[I"C;6DC^8NUM9\_K&'N*<[6?/LK&N;:&%L]S,VQ
MM7<(V@,&X.:G7D]I7@OB^2IPCPQ'@Y?O^=[6KT'2$Q3VZZG'B/(S>^%.#8TT
MB=M4?&/_W:/>,/790L8]*2JS[6.E_+QAKI(@='.#IW8_9(V^[=,DQ2W.5UF^
MICD\S$9I4KFK"']E.,89M[TRX,8?'+8[*"W, &S3B\.QA\9C5+:RR#\V6W%\
MOI@)I^USP&PPD/&TPG')!A;=&HA3-C"E9:AL.;VATLV4%HQV;# PZ*2K\:1U
MU?#SAYP[$O8\#JFOU/S(+KA<IOQ ^L<\*R;/3-=]:2^B$7-331*0J#\3?&#-
M;YLQ+#E"3Y095);#F)WFT5?9/DV]Y[V+)GMQ2K)[4T]R?#)>#5CC/HCM@E_(
MTN._$9IX%;?'H^W"!=89C.RE0AF!][$DO$<H_A46\G2O#IXF64'OZO(S\D%B
M'" TC!D][']^QD5)#.35$,C$N2!_)0-GZI&J_]9>^'N;YIK$H^L^!&ODS&2=
MBU?FJ>5TL5[+F+/ K"XV[23AGJ1+]3N,.TOS6^IU)Y/[%2I&B0H.^&GTMSZ&
MB#K7:[O9UXB(0YE=M9,]F'O._U;%Y?OV]>CBIGS&^<-SU!3C4!1K^ID-]ZE]
MTJ[:[,7\-4V33S+#[:9*<)< P_ZA2V$7J^AI<UVJ[(5RT)"5'CZ3\'6;\%FE
M<0FM#OMN37*1Y?>X+!/V":4##ZX7_"KM,W3#[F6J)E0JN.^ UA)#+W(I^H\Z
MQ*8!2,'8E^@U+I_;$@CM><:>QR1U$_*VZI_SS+1Q)?_47D03%HTUY?:F[#O!
MQ[('X]0'%ZLJ2=Z;L3E-(L5$XX_&&#_RTY3N=53FB.1-U1ZCJAIX)Y%>Q],$
MQ@M7DD?*@S,^=C?"?OW,:D^UY^I AL2.!YN=_03N &8Z0)5\9Y^.T)7--.4!
MNO 12$^?S&VDQ3EZ9X\*/39OHP 9AKHZ"9WDLD+UI.\N@KS/0J,,M2Z'(97B
M9RC\P(="RM8YVE<P1UM@@7,\U?L4,*:8>L*M2,,T"30S^1;IE_9IFM$TU903
MC>0SX,;7;"9:#, VQOMN07<ADN10AB)[4H1G@<X\%*5?VJ>AJ&FJ*8>BY#.'
M-A35)EK-A2%?_][390.@YW/F-])QX8"AG7'O-+)8H$C+R\^Z>)=\9[]<N:*9
MIG7D@X\<WAA4F6B_I*&L%B,0,);XAOI)NFR+K&3T5UX<O>VW#]'_.]ON."UT
M3B)Q6QHG8[\^J"E#G=#>>\YL_EE<__5]FEX<FW2FT$_WZ0/?1[8PW?B*5OLF
M'^,ZZKVF]1G87K.IY92/'DDOL\WA!J;4 )0KF+YIG=S!=)^'<X+KW69G7_ C
MN/N;N[178UU0!^"HQ%[Y@%$-/*D;<-)@/ZHNS6R]LT^8[ UY(%Y!<EX2PB\X
MJ[%7GF%D(T_J&QQU.)PX89SASH[A8L_RP\S>5#B]"1,P.*JQ5XYA9"-/'#0X
MZ7" 8<,8^T<$#@=RH EUK^L -[]=3=]IM^O\@':[.R=6 7:[K;\.:JZ:MDEG
M.F(%,S/Y/GB=<2W+#F</:?2;SPP#.(5=E=HG7S%-!_@]0O^Z/,LD[;%3N-$Y
M>#\?'KR;G1'@^ZM[7+T/9B7^0(U@1'<K G5D("IDIF/DJ0MDC&ZD^F!LT&FA
ME8%?"F.J!M^]_L6NF@3?'@9A_DXN8J+393!.H=[@@M%/K3('[!0&#1[0*=2:
M?*U.H6_^3D[!8I=XKYP"C XZ:#< 8/Q_K0-_ZI4"N$VX'5I3O7>I:LW)'T_>
M19-]JIBU0U-/N>,P0HW@CB.\[3N&"X!W\'=H3N?M2=\^94H%]\G53-\QTY?T
MFT*[@W%,DS?)9,&.YN;=$3QG-DT61[^$ZOQ9(\/O[=,AHK'99DHRZG_LP*_0
M28T=#O&V C#:EO)E]"/..?X+<*8^..P\-H6Q(R$';IJ89@G1;R0/ZV+A@_L4
MDYH;;J95[N!K0,?MG+8Z#%O02]7I,VDZYBH*Z/O-[+'19Y^BPYV;W4-VF5D9
MH"XC8%.,# 1VRR;;GR#A.DM?_#TFH?S:/H4'AB:;,C90? KL&G(V4]5%F&IV
MU/(?[?VZ,> SZS 3-F<RT@E4%ME5@'U6T#=P/('*L1#M7%8ZH8I+.K!0HG]/
MWG=H8?KZ7H8:=DTZ2^BA__2A#6TWLYW&^F0%'69*QAN:WEC<O=8^3SJN[9?W
M)NG.K2DG2[2S^VSPHVC_MCJ-4P"%%?9[=0KUP&E&4]T =HC[1X.L#[9<.B.S
M]444Y\;M:4\*[&7H9]VPLPQMX]</>B_*UGIC#A/C/*:LB/(V.\[[5A!XEPJJ
M;A[!IQ;[=$PULHGGVS>$Y2",F8_>[1[K&N#5"MYYPRQ4B&#]]7V*#QR;=/I-
MWCT;^-[L'3O@OXJMX."KA!$*[9-7V+WAO>PA?SV^8^<F&.M.]FVWV>/V\O[O
M)_O:0#[H'6/'*@N*<78@N\70=YD.>4_9WOK1()UDQWF^F8#'OLW2NK5[>%%A
M_L_MTXQ@:K0I9P75MR#M_GJR59E0O!0SBMLA'BPG\:# !F@2\&;K.+A!=_A<
MS5FCO/URYOT&F3Z@/T1'W;-L.$Y8)(0&D9!SECB$42+&@\6,]5*M/KM_(\O<
MB-./.?4W#VQ!;334>7#"KF6J,?SG^2<V]4</85C^//-$J/KBP0_)GW>:+:<Y
MG9II/(K&MKO?<S2R]G-[,P8M&FVRT:?YUF&,.[.!SB-NWPYP%#<EQ);Q>-+C
MKM/>#-^IFG^VLR-7A0[#$4S4"L[>(LPQU-[L?AS@SN' ,G?$0+N%,"8U\_QO
M55R^7Z9%F5?TE\5-^8SSA^<HE5_<F#HUU/W[>Y%L/+99)TDS=OTXI*W-4,:K
M[Q]]2>.R.$*/!W+3P-@^_2QM[]TS_/QA#'=YH_H9[?UO!X\2 QEL'.#P[@O,
MTCC]\U+O?3/\_&$,;WFC^AG>_6^#+"?ASV[C*.=<K"Q=@<LR(3^_QN4S*J@2
M*"Z**B(XVK>Z5\;&:E?183 J?!YH22//QAO1VK)^MZ"P3,*FR1[^0@C0+D<X
MXXVHQ%_7QH?W:]B3JG88 =8$:?:!]?I*-UFFO:4UW([]:K=EX/FDPRP:,5>W
MA-CY@>6B(&P-S>V<OLHM)7BNR5F_PW!-([LEQ*[5?[FFL2TRUC7MO@]V")ZK
MWE^I"$K@N2TWY0[#9XWI$*];F%::?07>:D1SC'557],F*##0'T!] 2CM,A;]
MX#9;QR3=&1M4\015YT$I71\'4VDO*EM-V/B3U"Z90!^PFZEAV\/EJGOWK3:K
M3=3_@K:?KH0ZD89NC['@GF8"G?L.4/]VPUQU>Q3?VK\[.XKFFO[BP^!#D"8>
M'X:J<P$XW=%_/1LXQ6=^_=XKL$J<^W\T\'MK2#%)>UL1,.A+@9YPU$^K>[""
MTURFFO%DOGH/&$Y[\()=D%S.V4'G:KT9AU87TO\K]%)%)( 61GX,=0J^]J-@
MG7&_=-Z5C\WG]V\Q9-^HTP]2\[</=\ED;;MEU>'EJ->M]F9!M1=O+1WX^^V3
M5\H6,+O?B[>#>?X#)H[#ML582!]&W X\2CC8Z-[!]K$ _<HJT?3/BL(E?PSU
M.(P4/$,S>TX\ZBL!:2T1NA'VZQF%KQRW@&:W\(T0\D6&:2:Y&]+"I+G2IZNL
M*$ZC/']?93EMFT+1V#H&G].&6?'N.%%3@\EP-JHH;*+B$F4-$TH(%UI0-E3S
MH6B=56DYTT8J^;JH\07_\OG;!B_HR4;&:U&>,$5DL>D8*=ZV-<>;V*X[W$4$
MQ^-N>CN#%-?24)G1GXD\O[AE-K )XP'G:YNV&'($PZ-<=27V^N0P<2;5T0)3
MN.5#)6&<"SM94GPIR/+UY"DB<WOY$+U%CPF^3!?9&M]BTBAI2?XJ-=26U1^:
MW(S9PLJ.#PB^G)05@'9S5:"*LJ.(\Z.2"T QDW"$-JT,&/'<YZJ(4UP4)PL2
MVQ8Q'1%;,V]6/V=TS)#8%)-F+CF56(!]5V$^X\#=#.[&B.,D!<?Y).H/D;_E
MI(?TV6N*\^(YWJ#%,UU3S>A>>X&O<D:6$WIUG4I%>XY2H H.%Z-J4B>XZ!)/
M,L5.X^ZX(R=>_?PM6L=IQ%&?1DD9X^(D739XIS%K6JAV6)VE^'1P(TWL>C9'
M$<$QNIO>HB^K.5B-@+CF 8;?.TRA$"<Q,[)C.+/L,T[Q*BY/R@N\)'%O<E]&
M9454>M_R1Z41W=-\(PCVIVP>Z<B8X@/PQLV$5@U'%:>A\3 96.3'3<6J<) (
M^1FC%1>(BD8B(HLS(!&RHG&H\9CXE"ORY:2EP:IM4&<I (:-R42+@:$2 1WZ
M!KV'X&;D!0?W$4KI?L.J!?4C'S8%:#A?9#F.G]+>2#Z+5RLR]Z5E'#DVGUD:
M 'C;FFP!<Y,HZ'"WU%^RZEM'*2%!RYIX@7>&N6*QI]#\(:_PE\W)\J]54;(C
M.=GRQ9[7VY+0U9QVE6C+&!QR8[0= HS2'5<;%&TI07O1ZRQ=XF6U*./'!%NN
M(6TD /"6.M,L/*2,/3A$Q^LL'.2W *7G4JEPX  :M:=LD^XR/</$A^=X20A.
MB@*7!<U$X+D129*]TA)4;@WH)!@ QD<TA 7T':1"'Q'NI@P'"I> XA2]-"PH
M:G@"968IUKF&G;$NJ><LIS(KHT27X612<]@K=WB3Y70]'K>K=/2[>MWR>W;D
M3H3 \&$"])PSDIPD^/1*(TSK8M.!'8R?<=?9?+B_^Q)D)J22'YK?U>.REW^8
M+NMA6L@3%$^S8I@3->^G@F)_PL;2#I()O@-W-$UGW'#8\518MI';4 ,==2Q'
MU]K]<.*P7K^KL-[!4TJXZ.NJ-\0/^QM:UBPLX(@8$U 4D6G&UFQ&&A1!'66U
M^"%TL.)6C8;"UA"5M1< NHJC1[* HB?*EKY(Y @$)Y7J"E0-R:&]=&A6U<)-
M)5M.R%!S:@(( +/'5I"B2PZN2U35PGE!AA7WQ;VR@";'71,'G0:5=0SEE' #
MJ:YZLO6O9!9$CY@LG+'K+EM >%EO-H/;31ZY70QF/WC4!.JX[WN%BV*/P-AQ
MX0Z1_Y K* CE)F@!V&<!OC20*FOI':%> 2]V*6ET_H;S15S@VSR6.QR/GP=:
MA<>S\6*:6+;X#65,'L(U"]I0GD"(;$95MTV:@?5^6N4T_T?G.G1\\##@I+6P
MXUF4\9I=U>]N>C:'8[Y="LNN.2'021Z>X[Q\?WC-'IZSJHC2Y4FZ?'@EEKS_
MA(?ORMMS_;K,%MZZCGR+U5-@+2I+(W)163AQCHIGM(R+QRHG YO>(T;X;U6\
M8<D:SSCAOTIPI#_AG*L/3[.+K$J7."\4W34D@-4S"NV$3LB.&SKT%T[YGV%:
M.RVJA!X5GCSEF/E]9;,K**&UOUY-L2,:>M0RA.V1JBBS-<YO4JSJB2$%L!Y0
MJ">T?$V'""&(%G\@*RA3FW=H8+:ZJ*"RW1DIC)9_S4SMWE  ;?6!>NHV?\V"
MMOA9G.-%F2DGU\'?8;6V7+EA6[=401OZ?+U)LG>E/^G_&58S2W43HO^:"$0C
MT[NL]41.UZ2&-I=2P^P"G:JJ'N'7=#M<,+JH'9:14U]IV8!VFHW.RMX[0EL'
M!K(C33T&NFLL1U#XAF:[;88EF9(28N.KU91W UN(P5B2G:=/<8IQ3A>5Z9*E
M0-SC_"5>J >#B0-8#UFJ*_34EH_Y*IX=TK!:]=D.-R#/FUTKHO/]>U'B=7$?
M)<,^Z=EIX/!VV]%.]2V<M.3 L&2CJRQ[EF] 4AC5;(CQA1WYC5YG>)W1,K=-
MGO!MGM&+< ^XL-D[&R<&:+^.L6'/]J OH@4[ KFB"BCZ5$(#J\/4"@Y[HZ%$
MC#3H@+O(\C7.#8MG&1&PME=K*#0^(T4@UM.7*2U:%[]@=C#[.4NK@IWXJN8E
M SVL/K%35E*FAW,A?EC-^/C31F&GILMTB3>8_ _QR(9-/34IM!XRZ"EVCL@
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M_/6 & 9TP[\$9?,,%,0K1VH%#0] A;QPU"_O=4^+;=!73YHDAGJ)8_W@BUG
MK]__FCPFWGJM9W>WMT;K+5SA=Q049O=ZB<GJ8$ET.8MSO"@S97D%-2F4GK/0
M4-R/5K$$J?)CZ *@[6[;V&%;N"J.GZ)H\^M)02;$XK3*\T&^FY3@UT_!VUBO
ME[!)P*B.4$T7M)&O":&IG;<TX)I:HIJJM;>D01M<W<S@&M?0I(&:L:EO&6.=
MAQ"I #6O1KEA4W=(0SN,CBIZKR$EA-G\%OZCUP/!G4A'&T/3PVQPFV8.W[1T
M,4 7V#0S%^<%7P\8VEO* [,3]*IJ>H;M07#R0)WT8YX5Q6V>K6*IZ^G\&5#3
MR[02BJ93&L2) K5MFQQ&D\'20NYA!") [:S632A\T6:O-:2AVYRG7=&T/&VK
M;\D@MKM$.W7+UXEFOZ/DOP_4_)=IB>EV:XT"6=,/2  UNTHSR9TC1M=@/5!;
MD]@IZP-%T^I*8D#M;]912)SM<+3XKYG"#8%FS-+:'+1.=YQ6M/X[5S1+B\^8
M5IIKTTIQ<?Y6YE&6+^,TRM]IW3H61]/JVUF2L,;@@),/I]D^!P@:/JQ4).YR
M?\IKIFP_C+9?1H_LTPW^V,?YRF;[,=1\;9_S>_\0' [6*LH/#J4\@=P$5T-Q
MUUU)!&#_VZR;]&XZ&1(=VOU_5BI\1[AH*7M22LT6:BU*E*+.]B8]BXM-5L2\
MT(YZGU?+ &CVLM-3^NQ7/?MD*>JPTH0%LK(E,U#YCNAI:HG:QT&.2%2Z2"KV
MQ-M-G+ =AA^C8DO/*A+'[#9D\[MPD1)[VF+[*,;)8D%O-=$-%0K'X@XO</PR
M')YC^ &A893:DN"$/PORNT;,[VDV;".)]3*3A;;"P'0S+5B7EEFNV'35,H#N
M2)F>ECW780733[<YIFG6S98.*]YAUV$R3M ]IU78L@MK&>T6&(EXJ!@PW=DX
MAWJ6I_EW/!O>< @R3A+H[G8RP-7WUD*9#Z[%HO#',6(C:%\[M ."5@1H!-AI
M;MGU_8<>&W%';:_#B;#.\ KG>?]>CEU7RSA!][!68<N.;62@KI! G5G7H*"W
MKA8DVL]Q$[ZS%0!Q8>T:0-:A]MR .G6$TD+1XUH$S1&OA;3KGB.^>#IJCV&9
MJ%#;^;@\C8IGHMM+O,3+S^]?"GI7DQ=W)JNYDT49ORCG:'MN0-T[0FE9Z0PJ
M S5"T.,[^AV50X;O[U$K"FUEP>K?BSB-TL78_I5PP^]?G=*._=N*"M^_5$OZ
M_ZD?>8D2ZG.VMU[H'XB[ZO^B0TFF'[YGPW=YHN3'/*LVA(/\>\$/'?!R>^0@
M0XC/[P/8_0QJMG"\0,0><9QVI!^A[8?Y'^D\,_Q=CZ%5"#4:(:82X^PJU3E_
M"A9;\@V+=\V+B"9:0+[*J*+LJ23&0*((_KIA^%<.V[A)%299])4M+Z"^<U99
M\C)&-R#LQX, ^[<]YK8:>W):0/UG5%%Q-$\X '8./6N.><T*@D6>,O"$292B
M?3S6G1M0!XY06G9"7XM@PZ\G!& O7^&BP'A;_X]N&;3;/<VB\ZR2'ES9\@+J
M86>5A:QG)N (;?,5F8S.'ME1?8V;5I*!V*E?TB4-P*J4A&[G;PM"*M:UW$G0
MOG2W4?\Q?=\5BKA4Q,6&CF]I\2P6:9/('><OJC,2%36@7K504AGEHI8'-4R!
M.H:L^>.2H/&%[B641-F8GN"P7(J3Q:):5TE$J_&NL[R,_Z[<X':7 J@C=U!>
MJ.?&1!TS66@K##77/#OR4%<@O,Z_QE)7K.?8CT[M*NK:@80W4%^=X<=R^_9'
M<\)2GXCJ<IJM& 'UG)N^0HT PHVV[&P3*.?S8W-Z'#1[.(EH>F!=I^4FOZ-%
MRWE1:TGZL(88P*:AO8["\D3#!*97.@FVBH=U[#K,+ =,+OB.ZEMULUE>R!QR
MW2MB]1,&GQ5/&'0,X^]CR)SQY!\!X ?FMTV: W_,RY-VOX4Z'Z-'6UVZ^H.(
M?9&NGM@W>WGT9'JO A:6T;YGV"WW>OZ&\T4\>,]JO!1 <_\.RL^)D>9K!4M,
M9"KMJ9.JGY&J:)7!E%LRAYN2? 82RF:T;DX8=KZ[]T!DT1X_<IT3B)+/'! 0
M==;-ZP_;[QX $)EOISG&\X5MPD<."H0JVSQ,R?2KH<.VZ<+>P>-G3=AQF\<+
MZ=&7IT\?YAK#RF)O*X_V^;I:G3;F1$PAJ-@N[)S#-E":'.*3:K!/;GD>P\<
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MZ4!HPC$<@,GE6$ $E ^4W=LUG: @'\+ZT@5D<$%%['6UBX&[!Y/VAT/86;H
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MFZGGARD(93& 17_TNL1PA"TYHS1O[]E2J.0=6T=Q!P<R8'?T^L/V)R4;N="
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M:EBM^4_7@=ZYP2![$T,.)PDHWJ]X,"D/I:I'7-Y0UH[&SF*,79:17GNB.K#
MQ;O4=+%#DRY$6=,</QA9K3PU\6LX<//D4'UE&JH7>=%0T@YO!]8+JKVF*)ET
MM(I7WS.]W4C:087J)#ZXDU![?ZHQ"96W@NGJ3DNH8/MWA>HLV#:CCD3+YT7U
M4:U@)>V@8NV_XKRM6)5,TCATEZF];KTX?7V(O3 IZDDEIZ_UO^C-$39C#.$\
MTH&MVGLV$3!-1@E96QK@V*ND!CBWQYC*WF@ZQDC:H=^2U,JRDY=5Q:&C/:'Z
MGND,(VD'E:@STXR=1 ]U@-E\SWB D;:$2M59P@!+J?9_>ADS'7;-=/CSF.GP
MN#(=;ASE-LF(<T<[?:XPB_[0Q>9'$DD/8=*@L?R<!$'T(OR"+B-^6<D>TT46
MM(W-93DPC<7=;IBAY)[J))T:L)RO(F+]NI"8DOR<]F<6/T8)R]O2" @[F?^#
MWU'S;,YJ[.6ML?,,@#'6,4MCCBJ+A'U*&%?(:W^AB24'=1Y,\B<+4=# KHI0
M$:D-*WO/IH:I<5F%]<:.J@2C9R., <"WJ<X^BY:A_\]M.A!+("7C "'MWXS9
M*Z1* ;FRR5L1<\MB<3SSEK+5,[=\=QX.")\S+P,S?/OQ1VF*;@@5)W.1G&2;
MS6WZ&/C+7.@Z>R>H.Q!19Q<0\(2T$L> $-3.5AO>.\Q39]&P_:)*=8;>BS2*
M_ +,#V_SC"\W16&FUW.6S&)_K9^>D+[8087P])-@0=  KD%G65=1>]>0ML<.
M?;*Y7F@8I@%*RXMM.^W?:P^@FE[@RSHZ0A#N:>!TQT7(:7CBM]1SOGH'47Y/
MO?@BTLYJ]S!M-W0_8XLM"\ _#:B$F6_F57G&6_F!C9A!^^-Y4W4Q?,(E0@/%
MJW 6Y\QY05D.M$CFG*:Q_YBE>7+0Z$RDE(\3SH-()_J8WK-9%N>AK#H#YYX#
MXSE[V1M#>Y'A8'.NOMLFFRV/W*>O]U'&MY@R)^J&PYTDK-_WGX3UW:0B1;0N
MB9D\ODX*<C9)6L?4K'W5+/66RY@5-ZD-^H9$K?I>--Z+K=.VZIDBDL15061K
M?0-C=DTMP2M$(V'(7;M._@H*GBCO5M/XGL7/_DSE\,*;REL.#Q4E*T[2N-J
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M 4;*+49LV>((%YBK,$F:8E]C0/K6"FU1<$SCHG$R?V;\5I0 '#,D3;$O$%T
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M8!0L;9Y^FKR9;)2:CMB.$MW  LJ#!GAE2O;7<[:.$IV34JLAMA]#-W 4_-(
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MB6C/E%WS5:FE8*>O'[U_1/%9X"6&ZJ96@PP(-RN^:%CX-"1O";[Q5D9KG_5
M-'#MH,]PT.6,D[ &WG)U!M@O&LVPKRH=M;55]4C"NZ.J!+^QQWM.\CE[9D&4
MGWZ%<Z7>1\O0!_M"L"<(  XI69 TW&Y2I>[<<EGL1W--4MG. P[%+VQ/B=&
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M7AG+TT_:G;H 7;$MH/;0@>5! [[&\:!D,G]K\Q<^FQM!! ^ _;YH#Z6E;&@
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MF@[GAB1D528EMW' Q1=-1=A5C;&=-C'0T95G?^,/QNBN\0>/S#^F[!Z'C8[
MCPCM$ DQ/IAB/)@B1I=2>AKM8ZTYJ.&NR J]J6PFMEU8#:0?FS:Z8J3)9JB)
M&(M8$:0MP=-%75'N6"#B!LZB)$U:>I*8373[CHMYL=Q8:;N7"389_?K[!(U+
M9#]JU+PO]B<E*A9($Q\J-B 6RQ[&IJ%,O4] VW+M $D1,:96)<CU5M#=5F\#
MY%V>:9@LY07CU7C1,A3*=$TA=+?&N5HICI-:?13)P4UK'K(?!ON2*->?^JF_
MJV@PC0-=4-X/W Z8.G-SW!-3+93NX+CA.Z$@XG[-9KX7= +%. :Z"ZHM-D"I
M.#&])G%:VXCX?S4W(?ZKOS^("ZM(43_WG_TYO[0KS@V\K:(IC:W(V>%!S;B3
MBD+=0/O-3Y_RBY4PTCSYZX?H0E_[0\:5:1!DH-5 F $SL>:JCLB<K865*4S/
M_9C->#]]\2%=![1T%EWDV5X6S;(@>."0$6UZ8C3T04M+X0[&PSPD@A;&BB8E
M0KQ1LPU>9.C^D$C8<7WDNV$OUNN:N1N>MWH_\P(J&$>X7*S60?3*6++Y+#]^
MBD2A69 :BW-".T-?N?J_[/:#D9V0:'A#''5->M=&75 Y^[U*\HWE["T$+@7I
MH.7L;Z+PO_C2X2]\-J_Y4>F71U,G;',1N&8QC'L:ZU[Y2GCKQ>GK U\&$F^6
MTWKZ6O^+?A&T&8/(!'*\(MI(I'81(:('IK51UI8&KO;:K '.[1*Y.22==#A
MROM@Y]53ZY#T=*ACW/7Q'29FVP.YLXAM2\E2W&B*-9-_1;^7-)K16%9<;Q<-
MIFL'&<H.,TI6M^R$<^B[NYNOT5 ?J>K;.L9TXG\PIWN+B'MW5?H<*CS\>B -
MPN\3O4]Y63 VAX"F:(N=R?-02&E%16-;O>,$QOXL+55)E'E+[NX_*5'='"BT
MW? LD =$&"8*IW-QXQ:4?_HT"K,DI]_T>FGHA7Y>/=0$!<J/QE3-*3OGYWC
M"7C;C,81YB GX"W3M:V> F"FPVNK(0W0I JG$KS;(^/).O:#:<@>7CC9K\4_
M30_\AC[H"9H4ZE%?GT!LTUB=:B7/SKRUGWI!$17-MT<6/[/Y911?9FD6YXGK
MO5!:CK"*D[0?"CL,N+?@D%:9UXY2I:$4E47IGA/KSYA<3#=1>4PNMMZ'B'-9
M_[N(0+J)TK^Q]([-HF4H(NPU#V_N/HGM0^Y,RYS#=.3:>)MGK>-SL?R5:*=)
M=7!H.M"CG@>GMUI :2CS;1PM6"(*@'O!)6.Z$+)62^R*:\X40B64X2?0R(\
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M_C]02P$"% ,4    "  :D'=2MQ=VPQI$ 0#XB X $0              @ $
M    <W)N82TR,#(P,3(S,2YX;6Q02P$"% ,4    "  :D'=2;%MQ91,4  "
MYP  $0              @ %)1 $ <W)N82TR,#(P,3(S,2YX<V102P$"% ,4
M    "  :D'=2-G]E#?05  !6$P$ %0              @ &+6 $ <W)N82TR
M,#(P,3(S,5]C86PN>&UL4$L! A0#%     @ &I!W4F:1"/7O.@  E($$ !4
M             ( !LFX! '-R;F$M,C R,#$R,S%?9&5F+GAM;%!+ 0(4 Q0
M   ( !J0=U)#!AGS<W<  ,I9!P 5              "  =2I 0!S<FYA+3(P
M,C Q,C,Q7VQA8BYX;6Q02P$"% ,4    "  :D'=266RPK!I3  "0*@8 %0
M            @ %Z(0( <W)N82TR,#(P,3(S,5]P<F4N>&UL4$L%!@     &
-  8 B@$  ,=T @    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
